|
4572 genotypes with 9980 annotations displayed
of selected term and subterms
|
|
Searched Term: muscle phenotype
|
2310039L15RikTg(Prnp-SNCA*A53T)23Mkle/0
(involves: C3H/HeJ * C57BL/6J)
|
dystonia
|
J:77344
|
2610005L07RikGt(ROSA)73Sor/2610005L07RikGt(ROSA)73Sor
Pdgfratm1Sor/Pdgfra+
(either: (involves: 129S4/SvJaeSor) or (involves: 129S4/SvJaeSor * C57BL/6))
|
abnormal vascular smooth muscle morphology
|
J:142042
|
4933430I17Riktm1b(EUCOMM)Wtsi/4933430I17Riktm1b(EUCOMM)Wtsi
(C57BL/6N-4933430I17Riktm1b(EUCOMM)Wtsi/Ics)
|
increased cardiac muscle contractility
|
J:211773
|
4933434E20Riktm1a(EUCOMM)Wtsi/4933434E20Riktm1a(EUCOMM)Wtsi
(C57BL/6N-4933434E20Riktm1a(EUCOMM)Wtsi/Wtsi)
|
abnormal eye muscle morphology
|
J:239583
|
| abnormal infrahyoid muscle connection
|
J:239583
|
| abnormal pectinate muscle morphology
|
J:239583
|
5430431A17Rikem1Doca/5430431A17Rikem1Doca
(C57BL/6-5430431A17Rikem1Doca)
|
abnormal skeletal muscle fiber morphology
|
J:266332
|
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: 129S/Sv * C57BL/6 * FVB/N)
|
abnormal myocardium layer morphology
|
J:164749
|
| decreased cardiac muscle contractility
|
J:164749
|
| dilated cardiomyopathy
|
J:164749
|
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
Ak2em1.1Dze/Ak2em1.1Dze
(involves: 129 * C57BL/6 * FVB/N)
|
decreased ventricle muscle contractility
|
J:305579
|
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
Clk4em1Yihc/Clk4em1Yihc
(B6(FVB)-Clk4em1Yihc A1cfTg(Myh6-cre/Esr1*)1Jmk)
|
abnormal sarcomere morphology
|
J:327369
|
| decreased ventricle muscle contractility
|
J:327369
|
| diffuse Z line
|
J:327369
|
| increased myocardial fiber size
|
J:327369
|
| myocardium hypertrophy
|
J:327369
|
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
Dusp12em1Zhzy/Dusp12em1Zhzy
(involves: FVB/N)
|
cardiomyopathy
|
J:345360
|
| decreased cardiac muscle contractility
|
J:345360
|
| myocardium hypertrophy
|
J:345360
|
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
Ppiftm1Jmol/Ppiftm1Jmol
Slc8b1tm1c(EUCOMM)Wtsi/Slc8b1tm1c(EUCOMM)Wtsi
(involves: 129S4/SvJaeSor * C57BL/6N * FVB/N)
|
abnormal sarcomere morphology
|
J:325413
|
| decreased ventricle muscle contractility
|
J:325413
|
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
Tg(CAG-cat,-Dusp14)4Lyg/0
(involves: C57BL/6J * FVB/N)
|
decreased cardiac muscle contractility
|
J:263251
|
| increased myocardial fiber size
|
J:263251
|
| myocardium hypertrophy
|
J:263251
|
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
Tg(CAG-DMPK*)1323Coop/0
(involves: FVB)
|
abnormal cardiac muscle relaxation
|
J:127391
|
| abnormal myocardial fiber morphology
|
J:127391
|
| decreased cardiac muscle contractility
|
J:127391
|
| dilated cardiomyopathy
|
J:127391
|
| increased myocardial fiber size
|
J:127391
|
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
Tg(Myh6-2A)#Know/0
(involves: BALB/c * C57BL/6 * FVB/N)
|
abnormal intercalated disk morphology
|
J:128060
|
| abnormal myocardial fiber morphology
|
J:128060
|
| abnormal sarcolemma morphology
|
J:128060
|
| abnormal sarcomere morphology
|
J:128060
|
| abnormal Z line morphology
|
J:128060
|
| decreased cardiac muscle contractility
|
J:128060
|
| dilated cardiomyopathy
|
J:128060
|
Aars1sti/Aars1tm1.1Slac
(involves: C57BL/6J * FVB/N)
|
abnormal myocardial fiber morphology
|
J:216802
|
Aars1sti/Aars1tm1Slac
(involves: C57BL/6J)
|
abnormal myocardial fiber mitochondrial morphology
|
J:216802
|
| abnormal myocardial fiber morphology
|
J:216802
|
| abnormal sarcoplasmic reticulum morphology
|
J:216802
|
| decreased ventricle muscle contractility
|
J:216802
|
| myocardial fiber disarray
|
J:216802
|
Abca1tm1Wpfl/Abca1+
(involves: 129P2/OlaHsd * C57BL/6J)
|
cardiomyopathy
|
J:64390
|
| heart left ventricle hypertrophy
|
J:64390
|
| heart right ventricle hypertrophy
|
J:64390
|
Abca1tm1Wpfl/Abca1tm1Wpfl
(involves: 129P2/OlaHsd * C57BL/6J)
|
cardiomyopathy
|
J:64390
|
| heart left ventricle hypertrophy
|
J:64390
|
| heart right ventricle hypertrophy
|
J:64390
|
Abca5tm1Akya/Abca5tm1Akya
(involves: C57BL/6NCrj * CBA/JNCrj)
|
dilated cardiomyopathy
|
J:99152
|
| myocardial fiber degeneration
|
J:99152
|
Abca5tm1Akya/Abca5tm1Akya
(involves: C57BL/6NCrlj * CBA/JNCrlj * ICR)
|
dilated cardiomyopathy
|
J:99152
|
| myocardial fiber degeneration
|
J:99152
|
Abcb8tm1Hard/Abcb8tm1Hard
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: FVB)
|
abnormal cardiac muscle relaxation
|
J:182234
|
| abnormal myocardial fiber morphology
|
J:182234
|
| cardiomyopathy
|
J:182234
|
| decreased cardiac muscle contractility
|
J:182234
|
Abcc9em1Nich/Abcc9+
(involves: C57BL/6J * CBA/J)
|
abnormal vascular smooth muscle physiology
|
J:281903
|
| increased vasodilation
|
J:281903
|
Abcc9em1Nich/Abcc9em1Nich
(involves: C57BL/6J * CBA/J)
|
abnormal vascular smooth muscle physiology
|
J:281903
|
Abcc9em2Nich/Abcc9em2Nich
(involves: C57BL/6J * CBA/J)
|
decreased cardiac muscle contractility
|
J:281630
|
| increased muscle fatigability
|
J:281630
|
Abcc9em3Nich/Abcc9+
(B6.Cg-Abcc9em3Nich)
|
abnormal myocardial fiber morphology
|
J:308986
|
Abcc9em3Nich/Abcc9em3Nich
(B6.Cg-Abcc9em3Nich)
|
abnormal aorta smooth muscle morphology
|
J:308986
|
| abnormal myocardial fiber morphology
|
J:308986
|
Abcc9tm1.1Mcn/Abcc9tm1.1Mcn
Tg(Tagln-cre)1Her/0
(involves: 129 * 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal myocardial fiber mitochondrial morphology
|
J:216539
|
| cardiomyopathy
|
J:216539
|
| decreased cardiac muscle contractility
|
J:216539
|
Abcc9tm1Cfb/Abcc9tm1Cfb
(involves: CD-1)
|
increased muscle cell glucose uptake
|
J:71840
|
Abcc9tm1Cfb/Abcc9tm1Cfb
(Not Specified)
|
abnormal vascular smooth muscle physiology
|
J:78066
|
Abcg5trac/Abcg5trac
(A/J-Abcg5trac)
|
cardiomyopathy
|
J:157223
|
Abcg8tm1b(KOMP)Wtsi/Abcg8tm1b(KOMP)Wtsi
(C57BL/6N-Abcg8tm1b(KOMP)Wtsi/Ccpcz)
|
increased cardiac muscle contractility
|
J:211773
|
Abhd5tm1Rze/Abhd5tm1Rze
Tg(Ckmm-cre)5Khn/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB)
|
decreased ventricle muscle contractility
|
J:197835
|
| increased cardiac muscle cell glucose uptake
|
J:197835
|
| increased cardiac muscle triglyceride level
|
J:197835
|
| increased skeletal muscle triglyceride level
|
J:197835
|
| myocardium steatosis
|
J:197835
|
Abhd6tm1a(EUCOMM)Hmgu/Abhd6tm1a(EUCOMM)Hmgu
(C57BL/6N-Abhd6tm1a(EUCOMM)Hmgu)
|
increased muscle cell glucose uptake
|
J:234876
|
Abhd12tm1Crv/Abhd12tm1Crv
(involves: C57BL/6)
|
muscle weakness
|
J:193716
|
Abi1tm1Pen/Abi1tm1Pen
(involves: CD-1)
|
disorganized myocardium
|
J:169009
|
Abi3bptm1Tac/Abi3bptm1Tac
(involves: 129S5/SvEvBrd)
|
decreased cardiac muscle contractility
|
J:251000
|
Abitramtm1b(EUCOMM)Wtsi/Abitramtm1b(EUCOMM)Wtsi
(C57BL/6N-Abitramtm1b(EUCOMM)Wtsi/Bay)
|
increased cardiac muscle contractility
|
J:211773
|
Abl1tm1.1Gcos/Abl1+
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal myogenesis
|
J:168843
|
Abl1tm1.1Gcos/Abl1tm1.1Gcos
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal myogenesis
|
J:168843
|
Abl1tm1Gcos/Abl1+
Myf5tm2Tajb/Myf5tm2Tajb
Myf6tm1Tajb/Myf6tm1Tajb
Myod1tm2.1(icre)Glh/Myod1+
(involves: 129S * 129X1/SvJ * C57BL/6J)
|
abnormal myogenesis
|
J:168843
|
Abl1tm1Mlg/Abl1tm1Mlg
(B6.129-Abl1tm1Mlg)
|
abnormal myocardial fiber morphology
|
J:156743
|
| abnormal myocardium compact layer morphology
|
J:156743
|
| abnormal trabecula carnea morphology
|
J:156743
|
| increased fetal cardiomyocyte proliferation
|
J:156743
|
| increased myocardial fiber number
|
J:156743
|
| myocardial fiber disarray
|
J:156743
|
Acacbtm1.1Dejs/Acacbtm1.1Dejs
(B6.Cg-Acacbtm1.1Dejs)
|
increased skeletal muscle glycogen level
|
J:157000
|
Acad9tm1c(KOMP)Wtsi/Acad9tm1c(KOMP)Wtsi
Tg(ACTA1-cre)79Jme/0
(involves: C57BL/6J * C57BL/6N * FVB/N * SJL)
|
abnormal muscle morphology
|
J:326969
|
| centrally nucleated skeletal muscle fibers
|
J:326969
|
| muscle weakness
|
J:326969
|
Acad9tm1c(KOMP)Wtsi/Acad9tm1c(KOMP)Wtsi
Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6N * FVB/N)
|
cardiomyopathy
|
J:326969
|
| decreased cardiac muscle contractility
|
J:326969
|
| myocardial fiber disarray
|
J:326969
|
Acadmtm1Uab/Acadmtm1Uab
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal myocardial fiber morphology
|
J:115759
|
| cardiomyopathy
|
J:115759
|
| myocardial fiber degeneration
|
J:115759
|
Acadsdel-J/Acadsdel-J
(involves: BALB/cByJ)
|
abnormal skeletal muscle morphology
|
J:14707
|
Acadvltm1Vje/Acadvltm1Vje
(involves: 129/Sv * C57BL/6)
|
abnormal myocardial fiber morphology
|
J:98627
|
| abnormal skeletal muscle fiber morphology
|
J:98627
|
| cardiomyopathy
|
J:98627
|
| myocardial fiber degeneration
|
J:98627
|
Acadvltm1Vje/Acadvltm1Vje
(involves: 129/Sv * Black Swiss * C57BL/6)
|
abnormal myocardial fiber morphology
|
J:106714
|
Acadvltm1Zkhu/Acadvltm1Zkhu
Tg(Myh6-cre)1Jmk/0
(involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NCr)
|
abnormal myocardial fiber morphology
|
J:208711
|
| decreased ventricle muscle contractility
|
J:208711
|
| dilated cardiomyopathy
|
J:208711
|
Acanb2b183Clo/Acanb2b183Clo
(C57BL/6J-Acanb2b183Clo)
|
cardiomyopathy
|
J:175213
|
Ace2tm1Hira/Y
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased ventricle muscle contractility
|
J:135766
|
Ace2tm1Pngr/Y
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased cardiac muscle contractility
|
J:124548,
J:77232
|
| dilated cardiomyopathy
|
J:124548
|
Ace2tm1Pngr/Y
Pik3cgtm1Pngr/Pik3cgtm1Pngr
(involves: 129P2/OlaHsd * C57BL/6)
|
increased cardiac muscle contractility
|
J:124548
|
Ace2tm1Pngr/Ace2tm1Pngr
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased cardiac muscle contractility
|
J:77232
|
Achetm1.1Pata/Achetm1.1Pata
(involves: 129X1/SvJ * C57BL/6)
|
muscle weakness
|
J:132775
|
Achetm2Pata/Achetm2Pata
(involves: 129X1/SvJ * C57BL/6 * FVB/N)
|
muscle weakness
|
J:132775
|
Achetm4.1Pata/Achetm4.1Pata
(involves: 129X1/SvJ * Black Swiss * C57BL/6 * FVB * FVB/N)
|
muscle weakness
|
J:147855
|
Achetm4Pata/Achetm4Pata
(involves: 129X1/SvJ * Black Swiss * C57BL/6 * FVB)
|
muscle weakness
|
J:147855
|
Ackr3tm1Jgo/Ackr3+
(involves: 129S/SvEvBrd * C57BL/6)
|
myocardial fiber degeneration
|
J:136246
|
Ackr3tm1Jgo/Ackr3tm1Jgo
(involves: 129S/SvEvBrd * C57BL/6)
|
myocardial fiber degeneration
|
J:136246
|
Ackr3tm1Twb/Ackr3tm1.1Twb
Tg(Tek-cre)12Flv/0
(involves: 129S/SvEv * BALB/cJ * C3H * C57BL/6)
|
abnormal myocardial fiber morphology
|
J:167833
|
| heart left ventricle hypertrophy
|
J:167833
|
| increased myocardial fiber size
|
J:167833
|
| myocardial fiber disarray
|
J:167833
|
Acp1Gt(RRK222)Byg/Acp1Gt(RRK222)Byg
(C.129P2(B6)-Acp1Gt(RRK222)Byg)
|
decreased cardiomyocyte apoptosis
|
J:227733
|
Acta1tm1Hrd/Acta1+
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6JArc))
|
abnormal muscle fiber morphology
|
J:184588
|
| abnormal sarcomere morphology
|
J:184588
|
| decreased muscle weight
|
J:184588
|
| facial muscle atrophy
|
J:184588
|
Acta1tm1Hrd/Acta1+
Tg(ACTA1-FHL1)#Cmit/?
(either: (involves: 129S1/Sv * 129X1/SvJ * FVB/N) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6JArc * FVB/N))
|
abnormal muscle fiber morphology
|
J:184588
|
| abnormal muscle weight
|
J:184588
|
Acta1tm1Hrd/Acta1+
Tg(MSV-SKI)33Hugh/?
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6JArc))
|
abnormal muscle fiber morphology
|
J:184588
|
| abnormal muscle weight
|
J:184588
|
Acta1tm1Hrd/Acta1+
Tg(Myl1-Igf1)1Nros/?
(either: (involves: 129S1/Sv * 129X1/SvJ * FVB/N) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6JArc * FVB/N))
|
abnormal muscle fiber morphology
|
J:184588
|
| abnormal muscle weight
|
J:184588
|
Acta1tm1Jll/Acta1+
Tg(ACTA1*D286G)#Kjno/Tg(ACTA1*D286G)#Kjno
(involves: C57BL/6 * CBA)
|
abnormal muscle fiber morphology
|
J:209273
|
| abnormal skeletal muscle morphology
|
J:209273
|
| abnormal Z line morphology
|
J:209273
|
| increased variability of skeletal muscle fiber size
|
J:209273
|
Acta1tm1Jll/Acta1tm1Jll
(involves: 129P2/OlaHsd * Black Swiss)
|
abnormal muscle development
|
J:78070
|
| abnormal muscle physiology
|
J:78070
|
| abnormal skeletal muscle fiber morphology
|
J:78070
|
| decreased skeletal muscle fiber diameter
|
J:78070
|
| decreased skeletal muscle glycogen level
|
J:78070
|
| muscle weakness
|
J:78070
|
Acta2tm1Rjs/Acta2tm1Rjs
(involves: 129S7/SvEvBrd * C57)
|
decreased vasoconstriction
|
J:113261
|
Actbem1Erv/Actbem1Erv
(involves: C57BL/6)
|
muscle phenotype
|
J:265862
|
Actbtm1(PyVT)Arge/Actb+
Waptm1(cre)Arge/Wap+
(involves: 129S1/Sv)
|
decreased cardiac muscle contractility
|
J:87544
|
Actbtm2(Tag)Arge/Actb+
Tg(Hsp70-1-cre)1Arge/0
(involves: 129S1/Sv * C57BL/6J * CBA)
|
abnormal smooth muscle morphology
|
J:87544
|
| increased leiomyosarcoma incidence
|
J:87544
|
Actc1tm1Jll/Actc1tm1Jll
(involves: 129P2/OlaHsd * Black Swiss)
|
abnormal myocardial fiber morphology
|
J:102007
|
| abnormal sarcomere morphology
|
J:40165
|
| disorganized myocardium
|
J:102007
|
| increased cardiomyocyte apoptosis
|
J:102007
|
| muscle degeneration
|
J:102007
|
| myocardial fiber degeneration
|
J:102007
|
| myocardial fiber disarray
|
J:40165
|
Actc1tm1Jll/Actc1tm1Jll
Tg(Myh6-Actg2)1Jll/0
(involves: 129P2/OlaHsd * Black Swiss * FVB/N)
|
abnormal cardiac muscle relaxation
|
J:40165
|
| decreased cardiac muscle contractility
|
J:107848,
J:40165
|
| decreased ventricle muscle contractility
|
J:40165
|
| heart left ventricle hypertrophy
|
J:40165
|
Actg1tm1.2Erv/Actg1tm1.2Erv
Tg(ACTA1-cre)79Jme/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
abnormal skeletal muscle fiber morphology
|
J:112808
|
| abnormal Z line morphology
|
J:112808
|
| centrally nucleated skeletal muscle fibers
|
J:112808
|
| impaired skeletal muscle contractility
|
J:112808
|
| increased variability of skeletal muscle fiber size
|
J:112808
|
Actg1tm1Erv/Actg1tm1Erv
Tg(ACTA1-cre)79Jme/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
abnormal skeletal muscle fiber morphology
|
J:112808
|
| abnormal Z line morphology
|
J:112808
|
| centrally nucleated skeletal muscle fibers
|
J:112808
|
| impaired skeletal muscle contractility
|
J:112808
|
| increased variability of skeletal muscle fiber size
|
J:112808
|
Actmapem1Nki/Actmapem1Nki
(FVB/N-Actmapem1Nki)
|
abnormal skeletal muscle fiber morphology
|
J:331923
|
| centrally nucleated skeletal muscle fibers
|
J:331923
|
| impaired skeletal muscle contractility
|
J:331923
|
| muscle weakness
|
J:331923
|
Actn2em1Kage/Actn2+
(C57BL/6-Actn2em1Kage)
|
muscle phenotype
|
J:334092
|
Actn2em1Kage/Actn2em1Kage
(C57BL/6-Actn2em1Kage)
|
abnormal sarcomere morphology
|
J:334092
|
| abnormal Z line morphology
|
J:334092
|
| decreased fetal cardiomyocyte proliferation
|
J:334092
|
Actn3tm1Knno/Actn3tm1Knno
(involves: 129 * 129S1/Sv * 129X1/SvJ)
|
abnormal muscle physiology
|
J:125639
|
| abnormal skeletal muscle morphology
|
J:125639
|
Actn4tm1a(EUCOMM)Wtsi/Actn4tm1a(EUCOMM)Wtsi
(C57BL/6N-Actn4tm1a(EUCOMM)Wtsi/Wtsi)
|
abnormal eye muscle morphology
|
J:239583
|
| abnormal infrahyoid muscle connection
|
J:239583
|
Acvr1tm1Emsh/Acvr1+
(chimera involves: BALB/c * C57BL/6 * CD-1)
|
skeletal muscle degeneration
|
J:194134
|
Acvr1tm1Mak/Acvr1+
Olig2tm1.1(cre)Wdr/Olig2+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
muscle spasm
|
J:285841
|
Acvr2btm1.1Zuk/Acvr2btm1.1Zuk
Tg(Myl1-cre)1Sjl/0
(involves: 129P2/OlaHsd * C57BL/6 * SJL/J)
|
increased skeletal muscle weight
|
J:188599
|
Acvrl1tm1Dgen/Acvrl1tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal trabecula carnea morphology
|
J:186473
|
Acvrl1tm1Dyl/Acvrl1tm1Dyl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal vascular smooth muscle morphology
|
J:65521
|
| increased vasodilation
|
J:85366
|
Acvrl1tm1Enl/Acvrl1+
(involves: C57BL/6)
|
telangiectasia
|
J:82115
|
Acvrl1tm1Enl/Acvrl1tm1Enl
(involves: C57BL/6)
|
abnormal myocardium layer morphology
|
J:61177
|
| abnormal vascular smooth muscle morphology
|
J:61177
|
Acvrl1tm2Spo/Acvrl1tm2Spo
Tg(Acvrl1-cre)L1Spo/0
(involves: 129 * 129S4/SvJae * C57BL/6 * FVB/N)
|
vascular smooth muscle hypotrophy
|
J:130020
|
Adatm1Mw/Adatm1Mw
(involves: 129S7/SvEvBrd)
|
heart right ventricle hypertrophy
|
J:231559
|
| increased vascular smooth muscle cell proliferation
|
J:231559
|
| vascular smooth muscle hypertrophy
|
J:231559
|
Adam12tm1Asf/Adam12tm1Asf
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal skeletal muscle morphology
|
J:81009
|
| decreased skeletal muscle fiber density
|
J:81009
|
Adam17tm1.1Rain/Adam17tm1.2Rain
Tg(Tek-cre)12Flv/0
(B6.Cg-Adam17tm1.1Rain Adam17tm1.2Rain Tg(Tek-cre)12Flv)
|
decreased cardiac muscle contractility
|
J:195050
|
Adam17tm1.1Wesh/Adam17tm1.1Wesh
Nkx2-5tm1(cre)Rjs/Nkx2-5+
(involves: 129S7/SvEvBrd * C57BL/6 * FVB/N)
|
abnormal myocardial trabeculae morphology
|
J:210193
|
| abnormal myocardium layer morphology
|
J:210193
|
| thin myocardium
|
J:210193
|
Adam17tm1Imx/Adam17tm1Imx
(involves: 129 * C57BL/6)
|
abnormal fetal cardiomyocyte proliferation
|
J:85547
|
| abnormal trabecula carnea morphology
|
J:85547
|
| increased myocardial fiber size
|
J:85547
|
Adam17tm1Imx/Adam17tm1Imx
Adam19Gt(Betageo)1Bbl/Adam19Gt(Betageo)1Bbl
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
abnormal myocardium layer morphology
|
J:99649
|
| absent myocardial trabeculae
|
J:99649
|
Adam19Gt(Betageo)1Bbl/Adam19Gt(Betageo)1Bbl
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
abnormal vascular smooth muscle morphology
|
J:87592
|
Adam19tm1Asf/Adam19tm1Asf
(either: B6.129P2-Adam19tm1Asf or (involves: 129P2/OlaHsd * C57BL/6J))
|
abnormal skeletal muscle morphology
|
J:106261
|
| heart right ventricle hypertrophy
|
J:106261
|
| thin diaphragm muscle
|
J:106261
|
Adamts2tm1Prc/Adamts2tm1Prc
(involves: 129 * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal tendon collagen fibril morphology
|
J:271185
|
Adamts6b2b1879.1Clo/Adamts6b2b1879.1Clo
(C57BL/6J-Adamts6b2b1879.1Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
Adamts6b2b2029Clo/Adamts6b2b2029Clo
(C57BL/6J-Adamts6b2b2029Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
Adamts6b2b2182Clo/Adamts6b2b2182Clo
(C57BL/6J-Adamts6b2b2182Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
Adamts6b2b2187.1Clo/Adamts6b2b2187.1Clo
(C57BL/6J-Adamts6b2b2187.1Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
Adamts6b2b2228Clo/Adamts6b2b2228Clo
(C57BL/6J-Adamts6b2b2228Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
Adamts6b2b2405Clo/Adamts6b2b2405Clo
(C57BL/6J-Adamts6b2b2405Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
Adamts6b2b2407Clo/Adamts6b2b2407Clo
(C57BL/6J-Adamts6b2b2407Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
Adamts6b2b2744Clo/Adamts6b2b2744Clo
(C57BL/6J-Adamts6b2b2744Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
Adamts10em1Cbal/Adamts10em1Cbal
(involves: C57BL/6 * C57BL/6J * DBA/2)
|
abnormal skeletal muscle morphology
|
J:266801
|
| decreased skeletal muscle fiber size
|
J:266801
|
| increased skeletal muscle fiber number
|
J:266801
|
| increased skeletal muscle mass
|
J:266801
|
Adamts14Gt(511E11)Cmhd/Adamts14Gt(511E11)Cmhd
(involves: 129 * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
muscle phenotype
|
J:271185
|
Adamts14Gt(511E11)Cmhd/Adamts14Gt(511E11)Cmhd
Adamts2tm1Prc/Adamts2tm1Prc
(involves: 129 * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal tendon collagen fibril morphology
|
J:271185
|
Adamtsl2tm1b(KOMP)Wtsi/Adamtsl2tm1b(KOMP)Wtsi
(C57BL/6-Adamtsl2tm1b(KOMP)Wtsi)
|
muscle phenotype
|
J:221347
|
Adamtsl2tm1c(KOMP)Wtsi/Adamtsl2tm1c(KOMP)Wtsi
Tg(Prrx1-cre)1Cjt/0
(B6.Cg-Adamtsl2tm1c(KOMP)Wtsi Tg(Prrx1-cre)1Cjt)
|
abnormal calcaneal tendon morphology
|
J:280264
|
| abnormal tendon cell morphology
|
J:280264
|
| abnormal tendon collagen fibril morphology
|
J:280264
|
Adamtsl2tm1c(KOMP)Wtsi/Adamtsl2tm1c(KOMP)Wtsi
Tg(Scx-GFP/cre)1Stzr/0
(involves: C57BL/6 * C57BL/6N)
|
abnormal calcaneal tendon morphology
|
J:280264
|
Adarb1tm1.1Skwa/Adarb1tm1.1Skwa
Tg(SLC18A3-cre)KMisa/0
(involves: C57BL/6)
|
abnormal skeletal muscle fiber morphology
|
J:164294
|
| centrally nucleated skeletal muscle fibers
|
J:164294
|
| skeletal muscle fiber atrophy
|
J:164294
|
Adck2tm1(KOMP)Vlcg/Adck2+
(C57BL/6-Adck2tm1(KOMP)Vlcg)
|
abnormal muscle physiology
|
J:280282
|
| increased variability of skeletal muscle fiber size
|
J:280282
|
Adcy6tm1Hkh/Adcy6tm1Hkh
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased ventricle muscle contractility
|
J:143138
|
Adcyap1tm1Nms/Adcyap1tm1Nms
(either: (involves: 129S1/Sv * 129X1/SvJ * C57BL/6) or (involves: C57BL/6))
|
abnormal skeletal muscle morphology
|
J:71968
|
Adgbem1(IMPC)Mbp/Adgbem1(IMPC)Mbp
(C57BL/6NCrl-Adgbem1(IMPC)Mbp/Mmucd)
|
increased skeletal muscle mass
|
J:211773
|
Adgrg6em2Jlp/Adgrg6em2Jlp
(C57BL/6-Adgrg6em2Jlp)
|
abnormal myocardial trabeculae morphology
|
J:315981
|
| thin myocardium compact layer
|
J:315981
|
Adgrg6tm1Apr/Adgrg6tm1Apr
(either: 129S/SvEv-Gpr126tm1Apr or B6.129S-Gpr126tm1Apr or (involves: 129S/SvEv * MF1))
|
thin myocardium
|
J:167309
|
Adgrg6tm1Arte/Adgrg6tm1Arte
Tg(Scx-GFP/cre)1Stzr/0
(involves: 129S5/SvEvBrd)
|
abnormal tendon physiology
|
J:313834
|
Adgrg6tm1Lex/Adgrg6tm1Lex
(involves: 129S/SvEvBrd)
|
myocardial trabeculae hypoplasia
|
J:202002
|
Adgrg6tm1Taki/Adgrg6tm1Taki
(involves: C57BL/6)
|
abnormal myocardial trabeculae morphology
|
J:202002
|
| increased cardiac muscle triglyceride level
|
J:202002
|
Adgrg7tm1Wfro/Adgrg7tm1Wfro
(129/Sv-Adgrg7tm1Wfro)
|
interstinal hyperperistalsis
|
J:243849
|
Adipoqtm1Chan/Adipoqtm1Chan
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal skeletal muscle fiber morphology
|
J:138678
|
Adipoqtm1Ish/Adipoqtm1Ish
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal vasodilation
|
J:103106
|
| decreased ventricle muscle contractility
|
J:106599
|
| muscle phenotype
|
J:199264
|
Adipor1tm2Tka/Adipor1tm2Tka
Tg(Ckmm-cre)5Khn/0
(B6.Cg-Adipor1tm2Tka Tg(Ckmm-cre)5Khn)
|
abnormal skeletal muscle fiber mitochondrial morphology
|
J:159462
|
| abnormal skeletal muscle fiber type ratio
|
J:159462
|
| increased skeletal muscle triglyceride level
|
J:159462
|
Admtm1Hku/Adm+
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased ventricle muscle contractility
|
J:106173
|
Admtm1Unc/Adm+
Tg(Alb1-Ren)2Unc/?
(129S6/SvEvTac-Admtm1Unc Tg(Alb1-Ren)2Unc)
|
increased myocardial fiber size
|
J:125933
|
Admtm1Unc/Admtm1Unc
(involves: 129S6/SvEvTac)
|
abnormal myocardial trabeculae morphology
|
J:67044
|
| disorganized myocardium
|
J:67044
|
| increased cardiomyocyte apoptosis
|
J:106927
|
Adora2atm1Jfc/Adora2atm1Jfc
(B6.129S4-Adora2atm1Jfc)
|
heart right ventricle hypertrophy
|
J:194389
|
| vascular smooth muscle hypertrophy
|
J:194389
|
Adra1atm1Pcs/Adra1atm1Pcs
(involves: 129X1/SvJ * FVB/N)
|
decreased vasoconstriction
|
J:77732
|
Adra1atm1Pcs/Adra1atm1Pcs
Adra1btm1Cta/Adra1btm1Cta
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * FVB/N)
|
abnormal cardiac muscle contractility
|
J:102648
|
| decreased myocardial fiber size
|
J:83876
|
| increased cardiac muscle contractility
|
J:83876
|
Adra1atm1Pcs/Adra1atm1Pcs
Adra1btm1Cta/Adra1btm1Cta
(B6.129-Adra1btm1Cta Adra1atm1Pcs)
|
decreased myocardial fiber size
|
J:83876
|
Adra1btm1Cta/Adra1btm1Cta
(involves: 129P2/OlaHsd)
|
decreased cardiac muscle contractility
|
J:103581,
J:43591
|
| decreased vasoconstriction
|
J:103581
|
Adra1btm1Cta/Adra1btm1Cta
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased skeletal muscle glycogen level
|
J:87718
|
Adra1dtm1Gzt/Adra1dtm1Gzt
(involves: 129X1/SvJ * C57BL/6)
|
abnormal muscle tone
|
J:91151
|
Adra2btm1Gsb/Adra2btm1Gsb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal vasoconstriction
|
J:34819
|
Adrb1tm1Bkk/Adrb1tm1Bkk
Adrb2tm1Bkk/Adrb2tm1Bkk
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * DBA/2 * FVB/N)
|
decreased cardiac muscle contractility
|
J:55553
|
Aebp2Gt(BC0681)Wtsi/Aebp2+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal intestinal peristalsis
|
J:177673
|
Afg3l2Emv66/Afg3l2Emv66
(FVB.MEV2-Afg3l2Emv66/TyJ)
|
abnormal skeletal muscle fiber morphology
|
J:132285
|
| centrally nucleated skeletal muscle fibers
|
J:132285
|
| decreased skeletal muscle fiber size
|
J:132285
|
| progressive muscle weakness
|
J:132285
|
Afg3l2par/Afg3l2par
(Not Specified)
|
abnormal skeletal muscle fiber morphology
|
J:132285
|
| centrally nucleated skeletal muscle fibers
|
J:132285
|
| decreased skeletal muscle fiber size
|
J:106411,
J:132285
|
| muscle weakness
|
J:34237
|
| muscular atrophy
|
J:106411,
J:34237
|
| progressive muscle weakness
|
J:13950,
J:132285
|
Agertm1.1Arnd/Agertm1.1Arnd
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal vascular smooth muscle physiology
|
J:82620
|
| decreased vascular smooth muscle cell proliferation
|
J:82620
|
Agltm1a(EUCOMM)Wtsi/Agltm1a(EUCOMM)Wtsi
(involves: C57BL/6N)
|
increased cardiac muscle glycogen level
|
J:212003
|
| increased skeletal muscle glycogen level
|
J:212003
|
| muscle weakness
|
J:212003
|
Agltm1Geno/Agltm1Geno
(C57BL/6J-Agltm1Geno)
|
increased cardiac muscle glycogen level
|
J:218471
|
| increased skeletal muscle glycogen level
|
J:218471
|
Agrnnmf380/Agrnnmf380
(C57BL/6J-Agrnnmf380/J)
|
abnormal skeletal muscle fiber type ratio
|
J:176117
|
| muscle spasm
|
J:87349
|
| myopathy
|
J:87349
|
| skeletal muscle atrophy
|
J:176117
|
Agrnnmf380/Agrnnmf380
(involves: C57BL/6J * DBA)
|
skeletal muscle atrophy
|
J:176117
|
Agrnnmf380/Agrnnmf380
(involves: C57BL/6J * CAST)
|
muscle phenotype
|
J:176117
|
Agrntm1Rwb/Agrntm1Rwb
Tg(Pax3-cre)1Joe/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
abnormal diaphragm morphology
|
J:122821
|
Agttm1Afu/Agttm1Afu
(involves: C57BL/6 * CBA * ICR)
|
vascular smooth muscle hyperplasia
|
J:36820
|
Agtpbp1pcd-6J/Agtpbp1pcd-6J
(C57BL/6J-Agtpbp1pcd-6J/J)
|
decreased skeletal muscle fiber size
|
J:87349
|
Agtr2tm1Gsb/Y
(FVB.129-Agtr2tm1Gsb)
|
abnormal vascular smooth muscle morphology
|
J:103237
|
| abnormal vasoconstriction
|
J:103237
|
| increased vasoconstriction
|
J:103376
|
| vascular smooth muscle hypertrophy
|
J:103376
|
Agtr2tm1Tin/Y
(involves: 129P2/OlaHsd)
|
abnormal skeletal muscle triglyceride level
|
J:105210
|
Agtr2tm1Tin/Y
(B6.129P2-Agtr2tm1Tin)
|
abnormal myocardial fiber morphology
|
J:63751
|
Agtr2tm1Tin/Y
Efemp2tm1.1Hiya/Efemp2tm1.2Hiya
Tg(Tagln-cre)1Her/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * SJL)
|
abnormal aorta smooth muscle morphology
|
J:213282
|
Agxt2tm1Lex/Agxt2tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
increased vasodilation
|
J:207876
|
Ahcyem1Cya/Ahcy+
(C57BL/6N-Ahcyem1Cya/Cya)
|
abnormal vasodilation
|
J:298071
|
Ahrtm1Gonz/Ahrtm1Gonz
(involves: 129S4/SvJae * C57BL/6N)
|
vascular smooth muscle hypertrophy
|
J:44690
|
Ahsgtm1Mbl/Ahsgtm1Mbl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
calcified muscle
|
J:44632
|
Aifm1Hq/Y
(B6CBACa Aw-J/A-Aifm1Hq/J)
|
decreased cardiac muscle contractility
|
J:110278
|
| increased cardiomyocyte apoptosis
|
J:110278
|
Aifm1Hq/Aifm1Hq
(B6CBACa Aw-J/A-Aifm1Hq/J)
|
decreased cardiac muscle contractility
|
J:110278
|
| increased cardiomyocyte apoptosis
|
J:110278
|
Aifm1tm2Pngr/Y
Tg(Ckmm-cre)5Khn/0
(involves: 129P2/OlaHsd * FVB)
|
abnormal myocardial fiber morphology
|
J:113016
|
| abnormal skeletal muscle fiber morphology
|
J:113016
|
| decreased cardiac muscle contractility
|
J:113016
|
| decreased skeletal muscle mass
|
J:113016
|
| dilated cardiomyopathy
|
J:113016
|
| increased myocardial fiber size
|
J:113016
|
| increased skeletal muscle fiber diameter
|
J:113016
|
| muscle degeneration
|
J:113016
|
| muscular atrophy
|
J:113016
|
Ak1tm1Bew/Ak1tm1Bew
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal muscle physiology
|
J:66101
|
Ak1tm1Bew/Ak1tm1Bew
Ckmtm1Bew/Ckmtm1Bew
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)
|
abnormal muscle contractility
|
J:109659
|
Akap6tm1.1Mskf/Akap6tm1.1Mskf
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: C57BL/6 * FVB/N * SJL)
|
heart left ventricle hypertrophy
|
J:214288
|
| increased cardiomyocyte apoptosis
|
J:214288
|
| increased myocardial fiber size
|
J:214288
|
Akap12Gt(XE450)Byg/Akap12Gt(XE450)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal myocardial fiber morphology
|
J:207542
|
| increased cardiac muscle contractility
|
J:207542
|
Akap13Gt(CSJ306)Byg/Akap13Gt(CSJ306)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased ventricle muscle contractility
|
J:231257
|
Akap13tm1Segj/Akap13tm1Segj
(involves: 129 * C57BL/6)
|
abnormal sarcomere morphology
|
J:181087
|
| myocardial trabeculae hypoplasia
|
J:181087
|
| thin myocardium
|
J:181087
|
Akt1tm1Mbb/Akt1tm1Mbb
(involves: 129P2/OlaHsd)
|
decreased myocardial fiber size
|
J:96823
|
Akt1tm1Nhy/Akt1tm1Nhy
Akt2tm1Rsg/Akt2tm1Rsg
(involves: 129/Sv * C57BL/6 * DBA/1LacJ)
|
muscle hypoplasia
|
J:83741
|
Akt2tm1.1Mbb/Akt2tm1.1Mbb
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased muscle cell glucose uptake
|
J:71491
|
Albtm1(cre/ERT2)Mtz/Albtm1(cre/ERT2)Mtz
Slc2a2tm2Thor/Slc2a2tm2Thor
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
increased muscle cell glucose uptake
|
J:197607
|
Aldh1a2tm1Dll/Aldh1a2tm1Ipc
Tg(Rarb-cre)1Mrc/0
(Not Specified)
|
muscle phenotype
|
J:97213
|
Aldh1a2tm1Ipc/Aldh1a2tm1Ipc
(Not Specified)
|
abnormal myocardium layer morphology
|
J:67816
|
| absent myocardial trabeculae
|
J:54067
|
| thick myocardium
|
J:67816
|
Aldh2tm1Dmro/Aldh2+
(B6.129-Aldh2tm1Dmro)
|
decreased cardiac muscle contractility
|
J:261952
|
Aldh5a1tm1Kmg/Aldh5a1tm1Kmg
(involves: 129/Sv * C57BL/6)
|
myoclonus
|
J:71949
|
Alpk3Gt(OST149512)Lex/Alpk3Gt(OST149512)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
abnormal intercalated disk morphology
|
J:222361
|
| abnormal myocardial fiber morphology
|
J:222361
|
| abnormal myocardium layer morphology
|
J:222361
|
| cardiomyopathy
|
J:222361
|
| decreased cardiac muscle contractility
|
J:222361
|
| decreased ventricle muscle contractility
|
J:222361
|
| myocardium hypertrophy
|
J:222361
|
Alpk3tm1b(EUCOMM)Hmgu/Alpk3tm1b(EUCOMM)Hmgu
(C57BL/6N-Alpk3tm1b(EUCOMM)Hmgu/H)
|
decreased cardiac muscle contractility
|
J:211773
|
Alpltm1Jlm/Alpltm1Jlm
(either: (involves: 129S2/SvPas) or (involves: 129S2/SvPas * C57BL/6J))
|
abnormal muscle morphology
|
J:39015
|
Als2tm1Jei/Als2tm1Jei
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal skeletal muscle fiber morphology
|
J:104446
|
| abnormal skeletal muscle fiber type ratio
|
J:104446
|
| centrally nucleated skeletal muscle fibers
|
J:104446
|
| skeletal muscle fiber atrophy
|
J:104446
|
Alx4M1Yzcm/Alx4M1Yzcm
(C57BL/6-Alx4M1Yzcm)
|
abnormal muscle morphology
|
J:199512
|
Ampd1tm1Tm/Ampd1tm1Tm
(B6.129S2-Ampd1tm1Tm)
|
muscle phenotype
|
J:260685
|
Angpt1tm1Sato/Angpt1tm1Sato
(involves: 129P2/OlaHsd * C57BL/6)
|
absent myocardial trabeculae
|
J:37459
|
Angpt1tm2Sato/Angpt1tm2Sato
(involves: 129P2/OlaHsd * C57BL/6)
|
absent myocardial trabeculae
|
J:37459
|
Ank1tm1Vso/Ank1tm1Vso
(B6J.129S4-Ank1tm1Vso)
|
abnormal diaphragm morphology
|
J:223673
|
| abnormal extensor digitorum longus morphology
|
J:223673
|
| abnormal muscle electrophysiology
|
J:223673
|
| abnormal sarcolemma morphology
|
J:223673
|
| abnormal sarcoplasmic reticulum morphology
|
J:223673
|
| abnormal skeletal muscle fiber triad morphology
|
J:223673
|
| impaired skeletal muscle contractility
|
J:223673
|
| myopathy
|
J:223673
|
| skeletal muscle fiber degeneration
|
J:223673
|
Ank2em1Melr/Ank2em1Melr
(B6.Cg-Ank2em1Melr)
|
decreased cardiac muscle contractility
|
J:338515
|
Ank2tm2.1Bnt/Ank2tm2.1Bnt
(STOCK Ank2tm2Bnt/J)
|
muscle phenotype
|
J:222913
|
Ank2tm3.1Bnt/Ank2tm3.1Bnt
(B6.129(C)-Ank2tm3.1Bnt/J)
|
decreased muscle cell glucose uptake
|
J:222913
|
| increased muscle cell glucose uptake
|
J:222913
|
Ankank/Ankank
(involves: C3HeB/FeJ * C57BL/6J * JGBF/LeJ)
|
abnormal tendon morphology
|
J:6580
|
| calcified tendon
|
J:6580
|
Ankrd1tm1Krc/Ankrd1tm1Krc
Ankrd2tm1Krc/Ankrd2tm1Krc
Ankrd23tm1Krc/Ankrd23tm1Krc
(involves: 129 * Black Swiss)
|
abnormal muscle physiology
|
J:125819
|
| abnormal sarcomere morphology
|
J:125819
|
Ankrd2tm1Krc/Ankrd2tm1Krc
(involves: 129 * Black Swiss)
|
abnormal skeletal muscle morphology
|
J:214867
|
Ankrd17tm1.1Yty/Ankrd17tm1.1Yty
(B6.129P2-Ankrd17tm1.1Yty)
|
abnormal vascular smooth muscle morphology
|
J:152840
|
| thin myocardium
|
J:152840
|
| trabecula carnea hypoplasia
|
J:152840
|
Ano1tm1.1Cahb/Ano1tm1.1Cahb
Tg(Myh11-icre/ERT2)1Soff/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
abnormal vascular smooth muscle morphology
|
J:207993
|
| decreased vasoconstriction
|
J:207993
|
Ano1tm1Bdh/Ano1tm1Bdh
(involves: 129S1/Sv)
|
abnormal tracheal smooth muscle morphology
|
J:138613
|
Ano5em1Huyi/Ano5em1Huyi
(C57BL/6N-Ano5em1Huyi)
|
abnormal skeletal muscle morphology
|
J:294237
|
Ano5tm1.2Naga/Ano5tm1.2Naga
(involves: C57BL/6)
|
muscle phenotype
|
J:236134
|
Ano5tm1Lrk/Ano5tm1Lrk
(involves: C57BL/6)
|
abnormal diaphragm morphology
|
J:235810
|
| abnormal gastrocnemius morphology
|
J:235810
|
| abnormal skeletal muscle fiber mitochondrial morphology
|
J:235810
|
| abnormal skeletal muscle morphology
|
J:235810
|
| abnormal tibialis anterior morphology
|
J:235810
|
| centrally nucleated skeletal muscle fibers
|
J:235810
|
| delayed skeletal muscle regeneration
|
J:235810
|
| impaired skeletal muscle regeneration
|
J:235810
|
| increased muscle fatigability
|
J:235810
|
| muscle phenotype
|
J:235810
|
| skeletal muscle fiber necrosis
|
J:235810
|
Anpepem1(IMPC)Hmgu/Anpepem1(IMPC)Hmgu
(C57BL/6N-Anpepem1(IMPC)Hmgu/Ieg)
|
increased cardiac muscle contractility
|
J:211773
|
Anxa6tm1Moss/Anxa6tm1Moss
(involves: 129P2/OlaHsd * C57BL/6)
|
increased ventricle muscle contractility
|
J:75832
|
Ap2b1b2b2321Clo/Ap2b1b2b2321Clo
(C57BL/6J-Ap2b1b2b2321Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
Ap4e1tm1b(KOMP)Wtsi/Ap4e1tm1b(KOMP)Wtsi
(C57BL/6N-Ap4e1tm1b(KOMP)Wtsi/Ieg)
|
increased cardiac muscle contractility
|
J:211773
|
ApcMin/Apc+
Il6tm1Kopf/Il6tm1Kopf
(involves: 129S2/SvPas * C57BL/6)
|
muscle phenotype
|
J:130429
|
Apcdd1em1Jlp/Apcdd1+
Asxl3em1Jlp/Asxl3+
Mib1em1Jlp/Mib1+
(C57BL/6-Apcdd1em1Jlp Asxl3em1Jlp Mib1em1Jlp)
|
thin ventricle myocardium compact layer
|
J:338889
|
Apex1tm1Cur/Apex1+
(involves: 129S1/Sv)
|
abnormal vascular smooth muscle physiology
|
J:119957
|
| decreased vasoconstriction
|
J:102294
|
| decreased vasodilation
|
J:102294
|
| increased vasoconstriction
|
J:102294
|
Aph1atm1.1Bdes/Aph1atm1.1Bdes
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal dermomyotome development
|
J:96106
|
Aplntm1Pngr/Y
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased ventricle muscle contractility
|
J:140286
|
Aplntm1Pngr/Aplntm1Pngr
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased ventricle muscle contractility
|
J:140286
|
Aplntm1Tq/Y
(B6.129S6-Aplntm1Tq)
|
decreased cardiac muscle contractility
|
J:154303
|
Aplntm1Tq/Aplntm1Tq
(B6.129S6-Aplntm1Tq)
|
decreased cardiac muscle contractility
|
J:154303
|
Aplnrtm1.1Path/Aplnrtm1.1Path
(Not Specified)
|
heart right ventricle hypertrophy
|
J:227456
|
Aplnrtm1.1Tq/Aplnrtm1.1Tq
(C57BL/6-Aplnrtm1.1Tq)
|
decreased cardiac muscle contractility
|
J:154303
|
Aplnrtm1Path/Aplnrtm1Path
Tg(Kdr-cre)#Brei/0
(involves: C57BL/6)
|
heart right ventricle hypertrophy
|
J:227456
|
Apobtm2Sgy/Apobtm2Sgy
Ldlrtm1Her/Ldlrtm1Her
(involves: 129S7/SvEvBrd * C57BL/6J)
|
decreased cardiac muscle contractility
|
J:227165
|
Apobtm2Sgy/Apobtm2Sgy
Ldlrtm1Her/Ldlrtm1Her
Tg(Ins-Igf2)1Fbos/?
(involves: 129S7/SvEvBrd * C57BL/6 * C57BL/6J * SJL)
|
decreased cardiac muscle contractility
|
J:227165
|
| heart left ventricle hypertrophy
|
J:227165
|
Apobec2tm1Msn/Apobec2tm1Msn
(B6.129P2-Apobec2tm1Msn)
|
abnormal skeletal muscle fiber type ratio
|
J:221028
|
| abnormal soleus morphology
|
J:221028
|
| centrally nucleated skeletal muscle fibers
|
J:221028
|
| decreased soleus weight
|
J:221028
|
| decreased tibialis anterior weight
|
J:221028
|
| increased variability of skeletal muscle fiber size
|
J:221028
|
| myopathy
|
J:221028
|
Apoetm1.1Mae/Apoetm1.1Mae
Tg(Fabp4-cre)1Rev/0
(B6.Cg-Apoetm1.1Mae Tg(Fabp4-cre)1Rev)
|
decreased cardiac muscle triglyceride level
|
J:219838
|
| decreased skeletal muscle triglyceride level
|
J:219838
|
Apoetm1Bres/Apoetm1Bres
Cd59atm1Bpm/Cd59atm1Bpm
(involves: 129 * 129P2/OlaHsd)
|
vascular smooth muscle hyperplasia
|
J:158457
|
| vascular smooth muscle hypoplasia
|
J:158457
|
Apoetm1Unc/Apoetm1Unc
(B6.129P2-Apoetm1Unc/J)
|
abnormal vascular smooth muscle physiology
|
J:338121
|
| abnormal vasodilation
|
J:298071
|
| decreased vasodilation
|
J:101576
|
| impaired muscle relaxation
|
J:60364
|
Apoetm1Unc/Apoetm1Unc
(involves: 129P2/OlaHsd)
|
decreased vasodilation
|
J:154332
|
Apoetm1Unc/Apoetm1Unc
Ccr5tm1Kuz/Ccr5tm1Kuz
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal vascular smooth muscle morphology
|
J:128063
|
Apoetm1Unc/Apoetm1Unc
Cdkn1atm1Tyj/Cdkn1atm1Tyj
(B6.129-Apoetm1Unc Cdkn1atm1Tyj)
|
abnormal vascular smooth muscle physiology
|
J:125247
|
| increased vascular smooth muscle cell proliferation
|
J:125247
|
Apoetm1Unc/Apoetm1Unc
Cst3tm1Karl/Cst3tm1Karl
(involves: 129S/SvEv * C57BL/6)
|
vascular smooth muscle hyperplasia
|
J:106879
|
Apoetm1Unc/Apoetm1Unc
Il1r1tm1Imx/Il1r1tm1Imx
(B6.129-Il1r1tm1Imx Apoetm1Unc)
|
increased vasoconstriction
|
J:148173
|
| increased vasodilation
|
J:148173
|
Apoetm1Unc/Apoetm1Unc
Klf15tm2Jain/Klf15tm2Jain
Tg(Tagln-cre)1Jjl/0
(involves: 129P2/OlaHsd * FVB/N)
|
vascular smooth muscle hypoplasia
|
J:203920
|
Apoetm1Unc/Apoetm1Unc
Mmp9tm1Tvu/Mmp9tm1Tvu
(involves: 129P2/OlaHsd * 129S6/SvEvTac)
|
vascular smooth muscle hypoplasia
|
J:110044
|
Apoetm1Unc/Apoetm1Unc
Nos3tm1Plh/Nos3tm1Plh
(B6.129-Nos3tm1Plh Apoetm1Unc)
|
decreased cardiac muscle contractility
|
J:103306
|
Apoetm1Unc/Apoetm1Unc
Sprr3tm1.1Ppy/Sprr3tm1.1Ppy
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6J * SJL)
|
abnormal vascular smooth muscle physiology
|
J:230470
|
| vascular smooth muscle hypoplasia
|
J:230470
|
Apptm2.1Ldad/Apptm2.1Ldad
(involves: 129 * C57BL/6J)
|
centrally nucleated skeletal muscle fibers
|
J:166989
|
| increased variability of skeletal muscle fiber size
|
J:166989
|
| muscle degeneration
|
J:166989
|
| myositis
|
J:166989
|
Appl1tm1Ymli/Appl1tm1Ymli
(involves: 129S1/Sv * C57BL/6J)
|
decreased vasodilation
|
J:189487
|
| increased vasoconstriction
|
J:189487
|
Appl2tm1Smoc/Appl2tm1Smoc
Tg(Ckmm-cre)5Khn/0
(involves: FVB)
|
increased muscle cell glucose uptake
|
J:230004
|
Aqp5tm1Amn/Aqp5tm1Amn
(involves: 129X1/SvJ * Black Swiss)
|
muscle phenotype
|
J:72954
|
Artm1Chc/Y
Tmem163Tg(ACTB-cre)2Mrt/0
(involves: 129S/SvEv * C57BL/6J * FVB/N)
|
increased skeletal muscle triglyceride level
|
J:98775
|
Artm1Ska/Y
Tg(CMV-cre)1Ipc/?
(involves: C57BL/6 * CBA)
|
abnormal myocardial fiber morphology
|
J:101049
|
| decreased myocardial fiber size
|
J:101049
|
| decreased ventricle muscle contractility
|
J:101049
|
Artm3(AR)Dmr/Y
(involves: 129S1/Sv * C57BL/6J)
|
muscle phenotype
|
J:114552
|
Artm4(AR)Dmr/Y
(involves: 129S1/Sv * C57BL/6J)
|
abnormal muscle electrophysiology
|
J:114552
|
| abnormal skeletal muscle fiber morphology
|
J:114552
|
| centrally nucleated skeletal muscle fibers
|
J:114552
|
| impaired muscle relaxation
|
J:114552
|
| increased variability of skeletal muscle fiber size
|
J:114552
|
| muscle weakness
|
J:114552
|
| myopathy
|
J:114552
|
| progressive muscle weakness
|
J:114552
|
| skeletal muscle fiber atrophy
|
J:114552
|
Artm4(AR)Dmr/Ar+
(involves: 129S1/Sv * C57BL/6J)
|
muscle weakness
|
J:114552
|
Araftm1Mmc/Y
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal muscle morphology
|
J:33951
|
Araftm1Mmc/Araftm1Mmc
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal muscle morphology
|
J:33951
|
Arb2aTg(Tyr)TpNpin/Arb2aTg(Tyr)TpNpin
(involves: FVB/N)
|
heart left ventricle hypertrophy
|
J:260599
|
Arfgef3tm1Hong/Arfgef3tm1Hong
(129.129P2(B6)-Arfgef3tm1Hong)
|
decreased muscle cell glucose uptake
|
J:216529
|
Arhgap1tm1Yizh/Arhgap1tm1Yizh
(involves: 129S6/SvEvTac * C57BL/6)
|
muscular atrophy
|
J:119516
|
Arhgap26Gt(OST135790)Lex/Arhgap26Gt(OST135790)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
abnormal myoblast fusion
|
J:215392
|
| decreased skeletal muscle fiber size
|
J:215392
|
| impaired skeletal muscle regeneration
|
J:215392
|
Arhgap42Gt(CE0477)Wtsi/Arhgap42Gt(CE0477)Wtsi
(involves: 129P2/OlaHsd * C57BL/6)
|
increased vasoconstriction
|
J:221301
|
Arhgef1tm1Rmt/Arhgef1tm1Rmt
X/Tg(Myh11-icre/ERT2)1Soff
(involves: C57BL/6 * FVB/N)
|
decreased vasoconstriction
|
J:157074
|
Arhgef3em1Chej/Arhgef3em1Chej
(involves: C57BL/6N)
|
abnormal muscle contractility
|
J:304135
|
| enhanced muscle regeneration
|
J:304135
|
| muscle phenotype
|
J:304135
|
Arhgef12tm1Soff/Arhgef12tm1Soff
(Not Specified)
|
decreased vasoconstriction
|
J:141641
|
Arid1am1Mag/Arid1am1Mag
(involves: 129 * CD-1)
|
absent myocardial trabeculae
|
J:192829
|
Arid1bem1Hzhu/Arid1b+
(C57BL/6J-Arid1bem1Hzhu)
|
muscle weakness
|
J:256668
|
Arid2tm1a(EUCOMM)Wtsi/Arid2tm1a(EUCOMM)Wtsi
(involves: C57BL/6J * C57BL/6N)
|
decreased fetal cardiomyocyte proliferation
|
J:223458
|
| thin myocardium compact layer
|
J:223458
|
Arid3atm1Pwt/Arid3atm1Pwt
(involves: 129S6/SvEvTac * C57BL/6)
|
thin myocardium compact layer
|
J:169178
|
Arid5bGt(ROSA)75Sor/Arid5bGt(ROSA)75Sor
(involves: 129S4/SvJaeSor)
|
abnormal smooth muscle morphology
|
J:117491
|
Ark2cGt(P9-3F)Sor/Ark2c+
Smad9tm1Rob/Smad9tm1Rob
Tg(Hlxb9-GFP)1Tmj/0
(involves: 129S/SvEv * C57BL/6 * CBA)
|
skeletal muscle atrophy
|
J:198828
|
Ark2cGt(P9-3F)Sor/Ark2cGt(P9-3F)Sor
Tg(Hlxb9-GFP)1Tmj/0
(involves: 129S4/SvJaeSor * C57BL/6 * CBA)
|
skeletal muscle atrophy
|
J:198828
|
Ark2nem1Wehi/Ark2nem1Wehi
(C57BL/6J-8030462N17Rikem1Wehi)
|
abnormal muscle physiology
|
J:330717
|
| decreased skeletal muscle fiber size
|
J:330717
|
| impaired skeletal muscle contractility
|
J:330717
|
Arl16em1(IMPC)Ccpcz/Arl16em1(IMPC)Ccpcz
(C57BL/6NCrl-Arl16em1(IMPC)Ccpcz/Ccpcz)
|
abnormal skeletal muscle morphology
|
J:211773
|
Arrb1tm1Jse/Arrb1tm1Jse
(involves: 129X1/SvJ * Black Swiss)
|
increased ventricle muscle contractility
|
J:44953
|
Arsbm1J/Arsbm1J
(C57BL/6J-Arsbm1J/GrsrJ)
|
skeletal muscle degeneration
|
J:149960
|
Arsbtm1Cptr/Arsbtm1Cptr
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
decreased cardiac muscle contractility
|
J:102290
|
Arxtm1.1Ics/Y
(involves: 129S2/SvPas * C57BL/6J * C57BL/6N)
|
muscle spasm
|
J:262482
|
Arxtm1.1Jno/Y
(involves: 129S7/SvEvBrd * C57BL/6J)
|
myoclonus
|
J:151082
|
Arxtm1.1Jno/Arxtm1.1Jno
(involves: 129S7/SvEvBrd * C57BL/6J)
|
myoclonus
|
J:151082
|
Arxtm4Kki/Y
(involves: 129S/SvEv * C57BL/6NHsd)
|
myoclonus
|
J:260340
|
Arxtm5Kki/Y
(involves: 129S/SvEv * C57BL/6NHsd)
|
myoclonus
|
J:260340
|
Asah1tm1.2Geno/Asah1tm1.2Geno
(involves: C57BL/6)
|
centrally nucleated skeletal muscle fibers
|
J:285931
|
| dystrophic muscle
|
J:285931
|
| skeletal muscle fiber atrophy
|
J:285931
|
Asb7em1(IMPC)Ccpcz/Asb7em1(IMPC)Ccpcz
(C57BL/6N-Asb7em1(IMPC)Ccpcz/Ccpcz)
|
increased cardiac muscle contractility
|
J:211773
|
Asic2tm1Wsh/Asic2+
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased vasoconstriction
|
J:135644
|
Asic2tm1Wsh/Asic2tm1Wsh
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased vasoconstriction
|
J:135644
|
Asltm1Brle/Asltm1Brle
(involves: 129S7/SvEvBrd)
|
abnormal myocardial fiber morphology
|
J:180208
|
| decreased vasodilation
|
J:180208
|
Asnsd1Gt(OST460318)Lex/Asnsd1Gt(OST460318)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
abnormal limb muscle morphology
|
J:320329
|
| abnormal skeletal muscle fiber morphology
|
J:320329
|
| centrally nucleated skeletal muscle fibers
|
J:320329
|
| decreased skeletal muscle mass
|
J:320329
|
| enhanced skeletal muscle regeneration
|
J:320329
|
| muscle weakness
|
J:320329
|
| myopathy
|
J:320329
|
| skeletal muscle fiber degeneration
|
J:320329
|
| skeletal muscle fiber necrosis
|
J:320329
|
Aspatm1a(EUCOMM)Wtsi/Aspatm1a(EUCOMM)Wtsi
(involves: C57BL/6J * C57BL/6N)
|
abnormal muscle tone
|
J:172582
|
| muscle hypertonia
|
J:172582
|
| muscle weakness
|
J:172582
|
Asphtm1Egk/Asphtm1Egk
(Not Specified)
|
increased cardiac muscle contractility
|
J:130155
|
Asxl3tm1.1(ASXL3*P723R)Clia/Asxl3tm2.1(ASXL3*P1817A)Clia
(Not Specified)
|
abnormal cardiac muscle tissue morphology
|
J:322485
|
| abnormal myocardial fiber morphology
|
J:322485
|
| abnormal myocardium layer morphology
|
J:322485
|
| decreased cardiac muscle contractility
|
J:322485
|
| myocardium hypertrophy
|
J:322485
|
Atad3atm1c(KOMP)Wtsi/Atad3atm1c(KOMP)Wtsi
Myl1tm1(cre)Sjb/Myl1+
(B6J.Cg-Myl1tm1(cre)Sjb Atad3atm1c(KOMP)Wtsi)
|
abnormal muscle fiber mitochondrial morphology
|
J:263681
|
| abnormal muscle fiber morphology
|
J:263681
|
| decreased skeletal muscle fiber mitochondrial DNA content
|
J:263681
|
| decreased skeletal muscle weight
|
J:263681
|
| skeletal muscle fiber atrophy
|
J:263681
|
| skeletal muscle fiber degeneration
|
J:263681
|
Atcayji-hes/Atcayji-hes
(C3H/HeJ-Atcayji-hes)
|
dystonia
|
J:85793
|
Atcayji/Atcayji
(Not Specified)
|
dystonia
|
J:14903
|
| muscle spasm
|
J:14903
|
Ate1tm1Akas/Ate1tm1Akas
(Not Specified)
|
abnormal intercalated disk morphology
|
J:144625
|
| abnormal myocardial fiber morphology
|
J:144625
|
| decreased cardiac muscle contractility
|
J:144625
|
| thin myocardium
|
J:144625
|
Ate1tm1Avar/Ate1tm1Avar
(either: (involves: 129S1/Sv) or (involves: 129S1/Sv * C57BL/6J))
|
ventricle myocardium hypoplasia
|
J:77750
|
Atf4tm1.1Cmad/Atf4tm1.1Cmad
Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6 * FVB)
|
decreased susceptibility to induced muscular atrophy
|
J:206503
|
| muscle phenotype
|
J:206503
|
Atg5tm1Myok/Atg5tm1Myok
A1cfTg(Myh6-cre/Esr1*)1Jmk/?
(involves: 129S/SvEv * FVB/N)
|
abnormal cardiac muscle contractility
|
J:121778
|
| increased myocardial fiber size
|
J:121778
|
Atg5tm1Myok/Atg5tm1Myok
Cnot3tm1.1Kjkb/Cnot3tm1.1Kjkb
Tg(Ckmm-cre)5Khn/0
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6 * FVB)
|
decreased cardiac muscle contractility
|
J:260012
|
Atg7tm1Tchi/Atg7tm1Tchi
Cnot1tm1Tya/Cnot1tm1Tya
Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6NCrlj * CBA/JNCrlj * FVB)
|
cardiac muscle necrosis
|
J:260012
|
| decreased cardiac muscle contractility
|
J:260012
|
Atg7tm1Tchi/Atg7tm1Tchi
Cnot3tm1.1Kjkb/Cnot3tm1.1Kjkb
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: 129P2/OlaHsd * C57BL/6NCrlj * CBA/JNCrlj * FVB/N)
|
decreased cardiac muscle contractility
|
J:260012
|
Atg7tm1Tchi/Atg7tm1Tchi
Cnot3tm1.1Kjkb/Cnot3tm1.1Kjkb
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cfTg(Myh6-cre/Esr1*)1Jmk
(involves: 129P2/OlaHsd * C57BL/6NCrlj * CBA/JNCrlj * FVB/N)
|
decreased cardiac muscle contractility
|
J:260012
|
Atg16l1tm1a(EUCOMM)Wtsi/Atg16l1tm1a(EUCOMM)Wtsi
(C57BL/6N-Atg16l1tm1a(EUCOMM)Wtsi/Wtsi)
|
abnormal eye muscle morphology
|
J:239583
|
Atictm1c(EUCOMM)Hmgu/Atictm1c(EUCOMM)Hmgu
Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6J * C57BL/6N)
|
decreased vascular smooth muscle cell proliferation
|
J:338121
|
Atictm1c(EUCOMM)Hmgu/Atictm1c(EUCOMM)Hmgu
X/Tg(Myh11-icre/ERT2)1Soff
(involves: 129S4/SvJaeSor * C57BL/6J * C57BL/6N * FVB/N)
|
decreased vascular smooth muscle cell proliferation
|
J:338121
|
Atl1tm1.1Cbla/Atl1tm1.1Cbla
Reep1Gt(OST398247)Tigm/Reep1Gt(OST398247)Tigm
(B6.Cg-Reep1Gt(OST398247)Tigm Atl1tm1.1Cbla)
|
abnormal muscle morphology
|
J:334532
|
| skeletal muscle atrophy
|
J:334532
|
Atp1a1em1(IMPC)Ccpcz/Atp1a1+
(C57BL/6NCrl-Atp1a1em1(IMPC)Ccpcz/Ccpcz)
|
abnormal skeletal muscle morphology
|
J:211773
|
Atp1a1tm1Ling/Atp1a1+
(involves: 129P2/OlaHsd * C57BL/6 * Black Swiss)
|
decreased cardiac muscle contractility
|
J:55191
|
Atp1a1tm1Ling/Atp1a1+
(involves: 129P2/OlaHsd)
|
impaired muscle contractility
|
J:114415
|
Atp1a1tm2Ling/Atp1a1tm2Ling
Atp1a2tm3Ling/Atp1a2tm3Ling
(involves: 129S6/SvEvTac * Black Swiss)
|
increased cardiac muscle contractility
|
J:95157
|
Atp1a2tm2Ling/Atp1a2+
(involves: 129P2/OlaHsd * C57BL/6 * Black Swiss)
|
decreased cardiac muscle contractility
|
J:55191
|
Atp1a2tm2Ling/Atp1a2+
(involves: 129P2/OlaHsd)
|
abnormal muscle contractility
|
J:114415
|
Atp1a2tm3Ling/Atp1a2tm3Ling
(involves: 129S6/SvEvTac * Black Swiss)
|
abnormal cardiac muscle contractility
|
J:87082
|
Atp1a3tm1.1Kwk/Atp1a3+
(B6JJcl.Cg-Atp1a3tm1.1Kwk/Kwk)
|
dystonia
|
J:210870
|
Atp1a3tm1Mika/Atp1a3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
dystonia
|
J:264408
|
Atp1a3tm1Ute/Atp1a3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
dystonia
|
J:262419
|
Atp1b1tm1.1Akra/Atp1b1tm1.1Akra
Myl2tm1(cre)Krc/Myl2+
(involves: 129S/SvEv * 129S4/SvJae)
|
abnormal cardiac muscle contractility
|
J:152596
|
| decreased ventricle muscle contractility
|
J:152596
|
Atp2a1tm1Dhm/Atp2a1tm1Dhm
(involves: CD-1)
|
abnormal diaphragm morphology
|
J:82947
|
| abnormal muscle physiology
|
J:82947
|
| impaired muscle relaxation
|
J:82947
|
| impaired skeletal muscle contractility
|
J:82947
|
| increased muscle fatigability
|
J:82947
|
Atp2a2tm1.1Iemr/Atp2a2tm1.1Iemr
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: 129P2/OlaHsd * C57BL/6J * FVB/N)
|
decreased cardiac muscle contractility
|
J:157143
|
Atp2a2tm1Fwuy/Atp2a2tm1Fwuy
(involves: 129S1/Sv * 129X1/SvJ * Swiss)
|
abnormal cardiac muscle relaxation
|
J:111247
|
| decreased cardiac muscle contractility
|
J:111247
|
| heart left ventricle hypertrophy
|
J:111247
|
| thin ventricle myocardium compact layer
|
J:111247
|
Atp2a2tm1Fwuy/Atp2a2tm1Fwuy
Plntm1Egk/Plntm1Egk
(involves: 129 * FVB/N * Swiss)
|
abnormal cardiac muscle relaxation
|
J:110974
|
| increased myocardial fiber size
|
J:110974
|
Atp2a2tm1Ges/Atp2a2+
(involves: 129X1/SvJ * Black Swiss)
|
abnormal cardiac muscle relaxation
|
J:95608,
J:52186
|
| decreased ventricle muscle contractility
|
J:95608,
J:52186,
J:66006
|
| heart left ventricle hypertrophy
|
J:95608
|
Atp2a3tm1Ges/Atp2a3tm1Ges
(involves: Black Swiss)
|
abnormal muscle relaxation
|
J:44333
|
Atp2b1Tg(Thy1-CHMP2B*)1Rene/Atp2b1+
(involves: C57BL/6 * DBA/2 * FVB/N)
|
abnormal muscle electrophysiology
|
J:237873
|
| muscle fasciculation
|
J:237873
|
Atp2b1Tg(Thy1-CHMP2B*)1Rene/Atp2b1Tg(Thy1-CHMP2B*)1Rene
(involves: C57BL/6 * DBA/2 * FVB/N)
|
abnormal muscle electrophysiology
|
J:237873
|
| muscle fasciculation
|
J:237873
|
Atp2b1tm1.1Hiraw/Atp2b1tm1.1Hiraw
Tg(Tagln-cre)1Her/0
(B6J.Cg-Atp2b1tm1.1Hiraw Tg(Tagln-cre)1Her)
|
increased vasoconstriction
|
J:225010
|
Atp2b1tm1Ges/Atp2b1+
Atp2b4tm1Ges/Atp2b4tm1Ges
(Black Swiss)
|
decreased vasoconstriction
|
J:91844
|
Atp2b4tm1Ges/Atp2b4tm1Ges
(involves: 129X1/SvJ * Black Swiss)
|
decreased vasoconstriction
|
J:91844
|
Atp5if1tm1Ksuj/Atp5if1tm1Ksuj
(involves: C57BL/6J)
|
abnormal cardiac muscle contractility
|
J:256558
|
Atp6ap2tm1.1Aich/Y
Tg(Myh6-cre)2182Mds/?
(involves: C57BL/6 * FVB/N)
|
decreased cardiac muscle contractility
|
J:165020
|
Atp6v0d1em1Nju/Atp6v0d1em1Nju
Tg(Adipoq-cre)1Evdr/0
(involves: FVB/NJ)
|
decreased cardiac muscle contractility
|
J:346448
|
| increased myocardial fiber size
|
J:346448
|
Atp7aMo-dp2/Atp7a+
(Not Specified)
|
calcified tendon
|
J:13104
|
Atp7atm1.1Mjp/Y
Mnx1tm4(cre)Tmj/Mnx1+
(involves: 129S1/Sv * C57BL/6)
|
decreased skeletal muscle mass
|
J:221066
|
| muscular atrophy
|
J:221066
|
Atp7atm1.2Mlke/Y
(involves: C57BL/6J)
|
abnormal skeletal muscle fiber morphology
|
J:266704
|
| increased skeletal muscle fiber diameter
|
J:266704
|
Atp7btx/Atp7btx
(DL-Atp7btx)
|
abnormal muscle physiology
|
J:7102
|
Atp7btx/Atp7btx
(involves: C57BL/6 * DL)
|
abnormal muscle physiology
|
J:7102
|
Atp11atm1a(KOMP)Wtsi/Atp11atm1a(KOMP)Wtsi
(C57BL/6N-Atp11atm1a(KOMP)Wtsi/Wtsi)
|
abnormal eye muscle morphology
|
J:239583
|
| absent pectinate muscle
|
J:239583
|
| thin myocardium compact layer
|
J:239583
|
Atp11atm1c(KOMP)Wtsi/Atp11atm1c(KOMP)Wtsi
Myf5tm3(cre)Sor/Myf5+
(involves: 129S4/SvJaeSor * C57BL/6JJcl * C57BL/6N)
|
abnormal myoblast differentiation
|
J:262981
|
| abnormal skeletal muscle regeneration
|
J:262981
|
| muscle phenotype
|
J:262981
|
Atrnmg-3J/Atrnmg-3J
(C3HeB/FeJ-Atrnmg-3J/J)
|
abnormal muscle physiology
|
J:80364
|
Atrnmg-3J/Atrnmg-3J
Atrnl1tm1Gsb/Atrnl1tm1Gsb
(involves: 129S1/Sv * 129X1/SvJ * C3H * C3HeB/FeJ)
|
cardiomyopathy
|
J:130463
|
Atxn1tm1Hzo/Atxn1+
(involves: 129S7/SvEvBrd * C57BL/6)
|
muscle degeneration
|
J:77225
|
Atxn7tm1Hzo/Atxn7+
(involves: 129S7/SvEvBrd * C57BL/6)
|
myoclonus
|
J:82072
|
avc3/avc3
(involves: C57BL/6J * FVB/N)
|
abnormal myocardium compact layer morphology
|
J:163196
|
Avpi1tm1b(EUCOMM)Hmgu/Avpi1tm1b(EUCOMM)Hmgu
(C57BL/6N-Avpi1tm1b(EUCOMM)Hmgu/Cnrm)
|
increased cardiac muscle contractility
|
J:211773
|
Avpr1atm1Gzt/Avpr1atm1Gzt
(involves: 129 * C57BL/6J)
|
abnormal vasoconstriction
|
J:110099
|
Awat2tm1.2Golc/Y
(involves: 129 * C57BL/6 * C57BL/6J)
|
conjunctival telangiectasia
|
J:308387
|
Awat2tm1.2Golc/Awat2tm1.2Golc
(involves: 129 * C57BL/6 * C57BL/6J)
|
conjunctival telangiectasia
|
J:308387
|
b2b227.2Clo/b2b227.2Clo
(C57BL/6J-b2b227.2Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
b2b227Clo/b2b227Clo
(C57BL/6J-b2b227Clo)
|
cardiomyopathy
|
J:175213
|
| heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
b2b246Clo/b2b246Clo
(C57BL/6J-b2b246Clo)
|
abnormal myocardium compact layer morphology
|
J:175213
|
b2b370Clo/b2b370Clo
(C57BL/6J-b2b370Clo)
|
diaphragmatic hernia
|
J:175213
|
| heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
b2b383Clo/b2b383Clo
(C57BL/6J-b2b383Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
b2b386.1Clo/b2b386.1Clo
(C57BL/6J-b2b386.1Clo)
|
abnormal myocardial trabeculae morphology
|
J:175213
|
b2b386Clo/b2b386Clo
(C57BL/6J-b2b386Clo)
|
abnormal myocardial trabeculae morphology
|
J:175213
|
b2b827Clo/b2b827Clo
(C57BL/6J-b2b827Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
b2b842Clo/b2b842Clo
(C57BL/6J-b2b842Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
b2b904.1Clo/b2b904.1Clo
(C57BL/6J-b2b904.1Clo)
|
abnormal myocardial trabeculae morphology
|
J:175213
|
| abnormal myocardium layer morphology
|
J:175213
|
b2b904.2Clo/b2b904.2Clo
(C57BL/6J-b2b904.2Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
b2b904Clo/b2b904Clo
(C57BL/6J-b2b904Clo)
|
abnormal myocardial trabeculae morphology
|
J:175213
|
| abnormal myocardium layer morphology
|
J:175213
|
| heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
b2b913Clo/b2b913Clo
(C57BL/6J-b2b913Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
b2b918Clo/b2b918Clo
(C57BL/6J-b2b918Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
b2b972Clo/b2b972Clo
(C57BL/6J-b2b972Clo)
|
abnormal myocardial trabeculae morphology
|
J:175213
|
b2b977Clo/b2b977Clo
(C57BL/6J-b2b977Clo)
|
abnormal myocardial trabeculae morphology
|
J:175213
|
b2b999Clo/b2b999Clo
(C57BL/6J-b2b999Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
b2b1117.2Clo/b2b1117.2Clo
(C57BL/6J-b2b1117.2Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
b2b1117Clo/b2b1117Clo
(C57BL/6J-b2b1117Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
b2b1163.2Clo/b2b1163.2Clo
(C57BL/6J-b2b1163.2Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
b2b1163Clo/b2b1163Clo
(C57BL/6J-b2b1163Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
b2b1200.2Clo/b2b1200.2Clo
(C57BL/6J-b2b1200.2Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
b2b1200Clo/b2b1200Clo
(C57BL/6J-b2b1200Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
b2b1247Clo/b2b1247Clo
(C57BL/6J-b2b1247Clo)
|
abnormal myocardial trabeculae morphology
|
J:175213
|
| abnormal myocardium layer morphology
|
J:175213
|
| abnormal ventricle myocardium morphology
|
J:175213
|
| ventricular cardiomyopathy
|
J:175213
|
b2b1511.2Clo/b2b1511.2Clo
(C57BL/6J-b2b1511.2Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
b2b1511Clo/b2b1511Clo
(C57BL/6J-b2b1511Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
b2b1528Clo/b2b1528Clo
(C57BL/6J-b2b1528Clo)
|
diaphragmatic hernia
|
J:175213
|
b2b1594Clo/b2b1594Clo
(C57BL/6J-b2b1594Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
b2b1639Clo/b2b1639Clo
(C57BL/6J-b2b1639Clo)
|
heart right ventricle hypertrophy
|
J:175213
|
b2b1714Clo/b2b1714Clo
(C57BL/6J-b2b1714Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
b2b1723Clo/b2b1723Clo
(C57BL/6J-b2b1723Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
b2b1835Clo/b2b1835Clo
(C57BL/6J-b2b1835Clo)
|
ventricular cardiomyopathy
|
J:175213
|
b2b1876Clo/b2b1876Clo
(C57BL/6J-b2b1876Clo)
|
abnormal myocardium compact layer morphology
|
J:175213
|
b2b1879Clo/b2b1879Clo
(C57BL/6J-b2b1879Clo)
|
abnormal myocardium compact layer morphology
|
J:175213
|
| heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
b2b2025.2Clo/b2b2025.2Clo
(C57BL/6J-b2b2025.2Clo)
|
abnormal myocardium compact layer morphology
|
J:175213
|
b2b2025Clo/b2b2025Clo
(C57BL/6J-b2b2025Clo)
|
abnormal myocardium compact layer morphology
|
J:175213
|
b2b2059Clo/b2b2059Clo
(C57BL/6J-b2b2059Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
b2b2110.2Clo/b2b2110.2Clo
(C57BL/6J-b2b2110.2Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
b2b2110Clo/b2b2110Clo
(C57BL/6J-b2b2110Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
b2b2140Clo/b2b2140Clo
(C57BL/6J-b2b2140Clo)
|
diaphragmatic hernia
|
J:175213
|
| heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
b2b2153.1Clo/b2b2153.1Clo
(C57BL/6J-b2b2153.1Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
b2b2153.2Clo/b2b2153.2Clo
(C57BL/6J-b2b2153.2Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
b2b2153Clo/b2b2153Clo
(C57BL/6J-b2b2153Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
b2b2187.2Clo/b2b2187.2Clo
(C57BL/6J-b2b2187.2Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
b2b2187Clo/b2b2187Clo
(C57BL/6J-b2b2187Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
b2b2362.2Clo/b2b2362.2Clo
(C57BL/6J-b2b2362.2Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
b2b2362Clo/b2b2362Clo
(C57BL/6J-b2b2362Clo)
|
abnormal myocardial trabeculae morphology
|
J:175213
|
| heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
b2b2459Clo/b2b2459Clo
(C57BL/6J-b2b2459Clo)
|
abnormal myocardium compact layer morphology
|
J:175213
|
b2b2696.2Clo/b2b2696.2Clo
(C57BL/6J-b2b2696.2Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
b2b2738Clo/b2b2738Clo
(C57BL/6J-b2b2738Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
b2b2739Clo/b2b2739Clo
(C57BL/6J-b2b2739Clo)
|
abnormal myocardium compact layer morphology
|
J:175213
|
b2b3260.2Clo/b2b3260.2Clo
(C57BL/6J-b2b3260.2Clo)
|
abnormal myocardium compact layer morphology
|
J:175213
|
b2b3260Clo/b2b3260Clo
(C57BL/6J-b2b3260Clo)
|
abnormal myocardium compact layer morphology
|
J:175213
|
B4gat1m1Ddg/B4gat1m1Ddg
(involves: C3H/He * C57BL/6)
|
dystrophic muscle
|
J:194150
|
B4gat1m1Ddg/B4gat1tm1(KOMP)Vlcg
(involves: C3H/He * C57BL/6 * C57BL/6NTac)
|
dystrophic muscle
|
J:194150
|
| skeletal muscle atrophy
|
J:194150
|
B9d1tm1a(EUCOMM)Wtsi/B9d1tm1a(EUCOMM)Wtsi
(involves: C57BL/6N)
|
thin myocardium
|
J:178421
|
B9d2tm1a(EUCOMM)Wtsi/B9d2tm1a(EUCOMM)Wtsi
(C57BL/6N-B9d2tm1a(EUCOMM)Wtsi/Wtsi)
|
abnormal diaphragm morphology
|
J:239583
|
| abnormal eye muscle morphology
|
J:239583
|
| abnormal infrahyoid muscle connection
|
J:239583
|
| abnormal pectinate muscle morphology
|
J:239583
|
Bace1tm1Cdi/Bace1tm1Cdi
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal muscle physiology
|
J:86936
|
Bace1tm1Psa/Bace1+
(involves: 129S2/SvPas * C57BL/6)
|
decreased muscle spindle number
|
J:199150
|
Bace1tm1Psa/Bace1tm1Psa
(involves: 129S2/SvPas * C57BL/6)
|
abnormal muscle spindle morphology
|
J:199150
|
| decreased muscle spindle number
|
J:199150
|
Bace1tm1Psa/Bace1tm1Psa
Nrg1tm4.1Cbm/Nrg1+
(involves: 129P2/OlaHsd * 129S2/SvPas * BALB/cJ * C57BL/6)
|
abnormal muscle spindle morphology
|
J:199150
|
| decreased muscle spindle number
|
J:199150
|
Bace1tm1Psa/Bace1tm1Psa
Tg(Thy1-Nrg1*I)1Kan/0
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
decreased muscle spindle number
|
J:199150
|
Bach1tm1Igar/Bach1tm1Igar
(B6.129P2-Bach1tm1Igar)
|
abnormal vascular smooth muscle morphology
|
J:123370
|
| decreased cardiomyocyte apoptosis
|
J:123370
|
Bag3Gt(OST16086)Lex/Bag3Gt(OST16086)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal skeletal muscle morphology
|
J:112361
|
| abnormal Z line morphology
|
J:112361
|
| increased cardiomyocyte apoptosis
|
J:112361
|
| myocardial fiber degeneration
|
J:112361
|
| skeletal muscle fiber degeneration
|
J:112361
|
Bag3tm1c(EUCOMM)Hmgu/Bag3tm1.1Chen
Tg(Myhca-cre)1Abel/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * C57BL/6N * FVB/N)
|
decreased cardiac muscle contractility
|
J:246352
|
| dilated cardiomyopathy
|
J:246352
|
Bag3tm1c(EUCOMM)Hmgu/Bag3tm1c(EUCOMM)Hmgu
Tg(Myhca-cre)1Abel/0
(involves: C57BL/6N * FVB/N)
|
decreased cardiac muscle contractility
|
J:246352
|
| dilated cardiomyopathy
|
J:246352
|
Bag5em1Asay/Bag5em1Asay
(C57BL/6JJcl-Bag5em1Asay)
|
abnormal myocardial fiber morphology
|
J:327046
|
| decreased cardiac muscle contractility
|
J:327046
|
Baiap2l2tm1a(EUCOMM)Hmgu/Baiap2l2tm1a(EUCOMM)Hmgu
(C57BL/6N-Baiap2l2tm1a(EUCOMM)Hmgu/Ics)
|
increased cardiac muscle contractility
|
J:211773
|
Bap1tm1.1Geno/Bap1tm1.1Geno
Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+
(involves: C57BL/6 * C57BL/6NTac)
|
cardiac muscle necrosis
|
J:187380
|
Barx2tm1Rsd/Barx2tm1Rsd
(involves: 129/Sv * C57BL/6)
|
abnormal muscle fiber morphology
|
J:187799
|
| abnormal skeletal muscle fiber morphology
|
J:187799
|
| abnormal skeletal muscle morphology
|
J:187799
|
| decreased skeletal muscle fiber diameter
|
J:187799
|
| decreased skeletal muscle mass
|
J:187799
|
| decreased skeletal muscle weight
|
J:187799
|
| impaired skeletal muscle regeneration
|
J:187799
|
| increased variability of skeletal muscle fiber size
|
J:187799
|
| skeletal muscle fiber atrophy
|
J:187799
|
| skeletal muscle fibrosis
|
J:187799
|
| thin diaphragm muscle
|
J:187799
|
Barx2tm1Rsd/Barx2tm1Rsd
Dmdmdx/Y
(involves: 129 * C57BL/6 * C57BL/10ScSn)
|
abnormal diaphragm morphology
|
J:187799
|
| decreased muscle weight
|
J:187799
|
| impaired skeletal muscle regeneration
|
J:187799
|
| increased variability of skeletal muscle fiber size
|
J:187799
|
| progressive muscle weakness
|
J:187799
|
| skeletal muscle endomysial fibrosis
|
J:187799
|
| skeletal muscle fiber necrosis
|
J:187799
|
| skeletal muscle fibrosis
|
J:187799
|
| thin diaphragm muscle
|
J:187799
|
Barx2tm1Rsd/Barx2tm1Rsd
Dmdmdx/Dmdmdx
(involves: 129 * C57BL/6 * C57BL/10ScSn)
|
abnormal diaphragm morphology
|
J:187799
|
| decreased muscle weight
|
J:187799
|
| impaired skeletal muscle regeneration
|
J:187799
|
| increased variability of skeletal muscle fiber size
|
J:187799
|
| progressive muscle weakness
|
J:187799
|
| skeletal muscle endomysial fibrosis
|
J:187799
|
| skeletal muscle fiber necrosis
|
J:187799
|
| skeletal muscle fibrosis
|
J:187799
|
| thin diaphragm muscle
|
J:187799
|
Baxtm1Sjk/Baxtm1Sjk
Lama2tm1Eeng/Lama2tm1Eeng
(B6.129-Baxtm1Sjk Lama2tm1Eeng)
|
abnormal skeletal muscle fiber morphology
|
J:94431
|
| impaired skeletal muscle regeneration
|
J:94431
|
| increased skeletal muscle mass
|
J:94431
|
Baxtm1Sjk/Baxtm1Sjk
Ntf3tm1Jae/Ntf3tm1Jae
(involves: 129S4/SvJae * 129X1/SvJ * C57BL/6)
|
absent muscle spindles
|
J:83461
|
Baxtm1Sjk/Baxtm1Sjk
Ntrk1tm2(Ntrk3)Apat/Ntrk1tm2(Ntrk3)Apat
(involves: 129S1/Sv * 129X1/SvJ)
|
increased muscle spindle number
|
J:92099
|
Baz1btm1Ska/Baz1b+
(involves: C57BL/6 * CBA)
|
abnormal myocardial trabeculae morphology
|
J:149990
|
Baz1btm1Ska/Baz1btm1Ska
(involves: C57BL/6 * CBA)
|
abnormal myocardial trabeculae morphology
|
J:149990
|
| abnormal myocardium layer morphology
|
J:149990
|
Bcar1tm1Hhi/Bcar1tm1Hhi
(involves: 129S/SvEv * C57BL/6)
|
abnormal myocardial fiber morphology
|
J:48967
|
| abnormal Z line morphology
|
J:48967
|
| decreased cardiac muscle contractility
|
J:48967
|
| increased vasodilation
|
J:48967
|
| thin myocardium
|
J:48967
|
Bcar1tm2.1Homy/Bcar1tm2.1Homy
Tg(Ckmm-cre)5Khn/0
(involves: 129P2/OlaHsd * C57BL/6)
|
muscle phenotype
|
J:195063
|
BckdkGt(VICT48)710Lex/BckdkGt(VICT48)710Lex
(B6.129S5/SvEvBrd-BckdkGt(VICT48)710Lex)
|
decreased muscle weight
|
J:117564
|
Bcl2tm1.1Sjk/Bcl2tm1.1Sjk
Tg(CAG-EGFP/Map1lc3b)53Nmz/0
(involves: 129X1/SvJ * C57BL/6 * C57BL/6NCrj * SJL)
|
decreased muscle cell glucose uptake
|
J:181308
|
| muscle phenotype
|
J:181308
|
Bcl2tm1Sjk/Bcl2tm1Sjk
(B6;129S2-Bcl2tm1Sjk/J)
|
abnormal skeletal muscle fiber type ratio
|
J:66494
|
Bcl6tm1Gdba/Bcl6tm1Gdba
Tg(Adipoq-cre)1Evdr/0
(involves: C57BL/6 * FVB/NJ)
|
increased muscle cell glucose uptake
|
J:271078
|
Bcl6tm1Htno/Bcl6tm1Htno
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
myocardial fiber degeneration
|
J:55952
|
Bcl9tm1.1Agt/Bcl9tm1.1Agt
Bcl9ltm1.1Agt/Bcl9ltm1.1Agt
Myf5tm1(cre)Mrc/Myf5+
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ)
|
abnormal muscle development
|
J:154476
|
| decreased skeletal muscle fiber size
|
J:154476
|
| impaired skeletal muscle regeneration
|
J:154476
|
Bdh1tm1c(EUCOMM)Wtsi/Bdh1tm1c(EUCOMM)Wtsi
Tg(Myh6-cre)2182Mds/0
(involves: 129S4/SvJaeSor * C57BL/6 * FVB/N)
|
decreased ventricle muscle contractility
|
J:274475
|
bella/bella
(involves: BALB/c * C3H/HeH)
|
centrally nucleated skeletal muscle fibers
|
J:177995
|
Best3tm1.1Zhoj/Best3tm1.1Zhoj
Tg(Tagln-cre)1Her/0
(involves: C57BL/6 * SJL)
|
abnormal vascular smooth muscle physiology
|
J:338981
|
Bex1Gt(OST125186)Lex/Bex1Gt(OST125186)Lex
(involves: 129S5/SvEvBrd)
|
abnormal skeletal muscle regeneration
|
J:127357
|
Bgntm1Mfy/Y
(involves: 129S4/SvJae * C57BL/6)
|
abnormal tendon collagen fibril morphology
|
J:76203
|
Bgntm1Mfy/Y
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)
|
abnormal tendon collagen fibril morphology
|
J:91512
|
Bgntm1Mfy/Y
Fmodtm1Aol/Fmodtm1Aol
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6)
|
abnormal tendon collagen fibril morphology
|
J:76203
|
| abnormal tendon morphology
|
J:76203
|
| decreased tendon stiffness
|
J:76203
|
Bicraem3Hzhg/Bicraem3Hzhg
H2az2Tg(Wnt1-cre)11Rth/H2az2+
(involves: C57BL/6J * CBA/J)
|
decreased ventricle muscle contractility
|
J:335098
|
Bidtm1Sjk/Bidtm1Sjk
Cstbtm1Rm/Cstbtm1Rm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
myoclonus
|
J:115694
|
Bin1tm1Gcp/Bin1tm1Gcp
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal A band morphology
|
J:83753
|
| abnormal myocardial fiber morphology
|
J:83753
|
| abnormal sarcomere morphology
|
J:83753
|
| diffuse Z line
|
J:83753
|
| disorganized myocardium
|
J:83753
|
| ventricular cardiomyopathy
|
J:83753
|
Birc2tm1.1Rbr/Birc2tm1.1Rbr
Birc3tm1.1Rbr/Birc3tm1.1Rbr
(involves: BALB/cJ * C57BL/6 * SJL)
|
decreased cardiac muscle contractility
|
J:182515
|
Birc2tm1.1Rbr/Birc2tm1.1Rbr
Xiaptm1Vdr/Xiaptm1Vdr
(involves: 129S1/Sv * BALB/cJ * C57BL/6)
|
decreased cardiac muscle contractility
|
J:182515
|
Bmal1tm1.1Shbi/Bmal1tm1.1Shbi
Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6J * FVB)
|
muscle phenotype
|
J:177865
|
Bmal1tm1.2Shbi/Bmal1tm1.2Shbi
(involves: C57BL/6J)
|
increased skeletal muscle triglyceride level
|
J:177865
|
Bmal1tm1Bra/Bmal1tm1Bra
(B6.129-Bmal1tm1Bra)
|
abnormal vascular smooth muscle physiology
|
J:191844
|
| calcified calcaneal tendon
|
J:116189,
J:97108
|
| calcified tendon
|
J:97108
|
| decreased muscle weight
|
J:110697
|
| decreased vasodilation
|
J:191844
|
| increased vasoconstriction
|
J:191844
|
| vascular smooth muscle hyperplasia
|
J:191844
|
Bmal1tm1Bra/Bmal1tm1Bra
Tg(ACTA1-Arntl)1Jt/0
(involves: 129/Sv * C57BL/6J * CD-1)
|
calcified calcaneal tendon
|
J:116189
|
Bmp1tm1.1Dgr/Bmp1tm1.1Dgr
Tll1tm2.1Dgr/Tll1tm2.1Dgr
Ndor1Tg(UBC-cre/ERT2)1Ejb/0
(involves: 129S/SvEv * 129S6/SvEvTac * C57BL/6 * SJL)
|
abnormal tendon collagen fibril morphology
|
J:210366
|
Bmp2tm1Jfm/Bmp2tm1Jfm
Nkx2-5tm1(cre)Rjs/Nkx2-5+
(involves: 129S4/SvJaeSor)
|
abnormal myocardium layer morphology
|
J:104417
|
Bmp4tm2(tetO-Bmp4,lacZ)Jfm/?
Gt(ROSA)26Sortm1(rtTA,EGFP)Nagy/?
Tg(Mef2c-cre)2Blk/?
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ)
|
thick myocardium
|
J:169047
|
Bmp4tm2Blh/Bmp4+
(involves: 129S6/SvEvTac * ICR)
|
abnormal vascular smooth muscle morphology
|
J:112335
|
| heart right ventricle hypertrophy
|
J:112335
|
Bmp10tm1.1(Gdf2)Minh/Bmp10tm1.1(Gdf2)Minh
(C57BL/6N-Bmp10tm1.1(Gdf2)Minh)
|
decreased fetal cardiomyocyte proliferation
|
J:222016
|
Bmp10tm1Shou/Bmp10tm1Shou
(either: 129S/SvEv or (involves: 129S/SvEv * C57BL/6J))
|
trabecula carnea hypoplasia
|
J:89476
|
Bmpr1atm1Bhr/Bmpr1atm2.1Bhr
Tg(GATA6-cre)#Jbeb/0
(involves: 129S7/SvEvBrd * C57BL/6 * FVB)
|
decreased cardiac muscle contractility
|
J:111392
|
Bmpr1atm2.1Bhr/Bmpr1atm2.1Bhr
Kdrtm1(cre)Sato/Kdr+
(involves: 129S1/Sv * 129S7/SvEvBrd)
|
vascular smooth muscle hypoplasia
|
J:112269
|
Bmpr1atm2.1Bhr/Bmpr1atm2.2Bhr
Isl1tm1(cre)Sev/Isl1+
(involves: 129S4/SvJae * 129S7/SvEvBrd)
|
abnormal cardiomyocyte apoptosis
|
J:107396
|
| abnormal fetal cardiomyocyte proliferation
|
J:107396
|
Bmpr2b2b2556Clo/Bmpr2b2b2556Clo
(C57BL/6J-Bmpr2b2b2556Clo)
|
abnormal myocardium compact layer morphology
|
J:175213
|
Bmpr2tm1.1Enl/Bmpr2tm1.1Enl
Tg(Acvrl1-cre)L1Spo/0
(involves: 129S4/SvJae * FVB)
|
heart right ventricle hypertrophy
|
J:158116
|
| increased vascular smooth muscle cell proliferation
|
J:158116
|
Bmpr2tm1Kmi/Bmpr2+
(involves: 129S4/SvJae * C57BL/6J)
|
increased vasoconstriction
|
J:117167
|
Bmpr2tm1Mmue/Bmpr2+
Smad1tm1Rjle/Smad1+
(involves: 129S1/SvImJ * 129S6/SvEvTac * C57BL/6)
|
heart right ventricle hypertrophy
|
J:224752
|
Bms1tm1b(EUCOMM)Hmgu/Bms1+
(C57BL/6N-Bms1tm1b(EUCOMM)Hmgu/Ieg)
|
increased cardiac muscle contractility
|
J:211773
|
Bnip3tm1Gwd/Bnip3tm1Gwd
(Not Specified)
|
decreased cardiomyocyte apoptosis
|
J:127533
|
Bnip3ltm1.1Gwd/Bnip3ltm1.1Gwd
Tg(Myh6-Gnaq)#Gwd/0
(involves: 129 * FVB/N)
|
decreased cardiac muscle contractility
|
J:145086
|
| increased cardiomyocyte apoptosis
|
J:145086
|
Bnip3ltm1Gwd/Bnip3ltm1Gwd
Nkx2-5tm1(cre)Rjs/Nkx2-5+
(involves: 129 * 129S7/SvEvBrd)
|
decreased cardiomyocyte apoptosis
|
J:145086
|
| increased cardiac muscle contractility
|
J:145086
|
Braftm1Bbd/Braf+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CD-1)
|
increased cardiac muscle contractility
|
J:170095
|
Braftm1Tumg/Braf+
Tg(CAG-cre)2Osb/0
(involves: C57BL * C57BL/6J * DBA)
|
abnormal myocardial trabeculae morphology
|
J:216228
|
| thin myocardium compact layer
|
J:216228
|
Braftm1Tumg/Braf+
Tg(CAG-cre)2Osb/0
(involves: C57BL * C57BL/6J * DBA * ICR)
|
abnormal myocardial fiber morphology
|
J:226977
|
| abnormal myocardial trabeculae morphology
|
J:226977
|
Braftm2Cpri/Braf+
Tg(CMV-cre)1Cgn/0
(B6.Cg-Braftm2Cpri Tg(CMV-cre)1Cgn)
|
increased myocardial fiber size
|
J:187371
|
Brca1tm2.1Cxd/Brca1tm2.1Cxd
Trp53tm1Brd/Trp53+
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * Black Swiss * FVB)
|
muscular atrophy
|
J:81559
|
Brd2em1(IMPC)Wtsi/Brd2em1(IMPC)Wtsi
(C57BL/6N-Brd2em1(IMPC)Wtsi/WtsiIeg)
|
abnormal pectinate muscle morphology
|
J:239583
|
| absent eye muscles
|
J:239583
|
| absent pectinate muscle
|
J:239583
|
| thin myocardium compact layer
|
J:239583
|
Bsgtm1Itl/Bsgtm1Itl
Tg(ACTA1-cre/Esr1*)2Kesr/0
(involves: 129S/SvEv * C3H * C57BL/6)
|
muscle phenotype
|
J:288233
|
Bsntm1Gund/Bsntm1Gund
(Not Specified)
|
myoclonus
|
J:82241
|
Btaf1m1Fme/Btaf1m1Fme
(involves: C57BL/6J * FVB/NJ)
|
myocardial trabeculae hypoplasia
|
J:173663
|
Btctm1Dcl/Btctm1Dcl
Hbegftm1Dcl/Hbegftm1Dcl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased ventricle muscle contractility
|
J:83820
|
Btdtm1Bwol/Btdtm1Bwol
(B6.Cg-Btdtm1Bwol)
|
hypotonia
|
J:168391
|
Bub1btm1Jvd/Bub1btm1Jvd
(involves: 129S6/SvEvTac)
|
muscular atrophy
|
J:91128
|
Bub1btm1Jvd/Bub1btm1Jvd
(involves: 129S6/SvEvTac * C57BL/6)
|
skeletal muscle fiber atrophy
|
J:293084
|
Bub1btm1Jvd/Bub1btm3.1Jvd
(involves: 129S6/SvEvTac * C57BL/6)
|
skeletal muscle fiber atrophy
|
J:293084
|
Bub1btm2.1Jvd/Bub1b+
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6)
|
decreased skeletal muscle fiber diameter
|
J:194926
|
| muscular atrophy
|
J:194926
|
Bub3tm1Jvd/Bub3+
Rae1tm1Jvd/Rae1+
(Not Specified)
|
muscle degeneration
|
J:105717
|
| muscular atrophy
|
J:105717
|
Bud23em2Asil/Bud23em2Asil
Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6 * C57BL/6J * DBA/2)
|
decreased cardiac muscle contractility
|
J:290738
|
| decreased myocardial fiber mitochondrial DNA content
|
J:290738
|
| dilated cardiomyopathy
|
J:290738
|
Bvestm1Tbd/Bvestm1Tbd
(involves: 129S4/SvJae)
|
abnormal sinoatrial node morphology
|
J:184566
|
| delayed skeletal muscle regeneration
|
J:74656
|
C1qtnf9tm1(KOMP)Vlcg/C1qtnf9tm1(KOMP)Vlcg
(C57BL/6-C1qtnf9tm1(KOMP)Vlcg)
|
abnormal muscle physiology
|
J:212299
|
| abnormal skeletal muscle morphology
|
J:212299
|
C2cd5Gt(IST12020E4)Tigm/C2cd5Gt(IST12020E4)Tigm
(C57BL/6N-C2cd5Gt(IST12020E4)Tigm)
|
decreased cardiac muscle cell glucose uptake
|
J:284780
|
| decreased muscle cell glucose uptake
|
J:284780
|
C3tm1Crr/C3tm1Crr
Dysftm1Kcam/Dysftm1Kcam
(B6.129-Dysftm1Kcam C3tm1Crr)
|
muscle weakness
|
J:171870
|
C3tm1Hrc/C3tm1Hrc
Lama2dy/Lama2dy
(either: (involves: 129S2/SvPas * 129P1/ReJ) or (involves: 129X1/SvJ * 129P1/ReJ))
|
abnormal skeletal muscle morphology
|
J:102959
|
| dystrophic muscle
|
J:102959
|
| skeletal muscle interstitial fibrosis
|
J:102959
|
cab/cab
(STOCK Cacna1smdg)
|
abnormal myocardium layer morphology
|
J:6195
|
Cacna1atg-la/Cacna1aWb
(involves: AKR/J * C3H/HeJ * C57BL/6J)
|
dystonia
|
J:119639
|
Cacna1atg-rol/Cacna1atg-rol
(involves: C57BL/6 * SIII)
|
abnormal muscle electrophysiology
|
J:164115
|
| muscle weakness
|
J:164115
|
Cacna1atg/Cacna1atg
(B6.D2-Cacna1atg/J)
|
abnormal muscle electrophysiology
|
J:233263
|
| dystonia
|
J:233263
|
Cacna1atg/Cacna1atm2.1Maag
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J * FVB/N)
|
abnormal muscle electrophysiology
|
J:233263
|
| dystonia
|
J:233263
|
Cacna1atg/Cacna1atm2.1Maag
Tg(Pcp2-cre)2Mpin/0
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6J * DBA/2J * FVB/N)
|
dystonia
|
J:233263
|
Cacna1atm1(CACNA1A)Ttan/Cacna1atm1(CACNA1A)Ttan
(involves: 129S4/SvJae)
|
dystonia
|
J:123243
|
Cacna1atm1.1(CACNA1A)Ttan/Cacna1atm1.1(CACNA1A)Ttan
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J * SJL)
|
dystonia
|
J:123243
|
Cacna1atm1Hssh/Cacna1atm1Hssh
(involves: 129 * C57BL/6J)
|
muscle spasm
|
J:59076
|
Cacna1atm2.1(CACNA1A)Ttan/Cacna1atm2.1(CACNA1A)Ttan
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J * SJL)
|
dystonia
|
J:123243
|
Cacna1atm2.1Maag/Cacna1atm2.2Maag
Tg(EIIa-cre)C5379Lmgd/0
(involves: 129P2/OlaHsd * FVB/N)
|
dystonia
|
J:117062
|
Cacna1aWb/Cacna1aWb
(either: C3.B6-Cacna1aWb or (involves: C3H/HeJ * C57BL/6J))
|
dystonia
|
J:119639
|
Cacna1ctm1.1Wac/Cacna1ctm1.1Wac
(involves: C57BL/6)
|
abnormal cardiac muscle contractility
|
J:203057
|
| abnormal muscle electrophysiology
|
J:203057
|
| decreased cardiac muscle contractility
|
J:203057
|
| increased myocardial fiber size
|
J:203057
|
Cacna1ctm1Ggm/Cacna1ctm1Ggm
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
decreased cardiac muscle contractility
|
J:189406
|
Cacna1ctm1Itl/Cacna1ctm1Itl
(B6.129S6-Cacna1ctm1Itl)
|
heart right ventricle hypertrophy
|
J:171162
|
| increased myocardial fiber size
|
J:171162
|
Cacna1ctm2.1Wac/Cacna1ctm2.1Wac
(involves: C57BL/6)
|
decreased cardiac muscle contractility
|
J:216746
|
Cacna1ctm3Hfm/Cacna1ctm4Hfm
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
abnormal muscle electrophysiology
|
J:175463
|
Cacna1htm1Kcam/Cacna1htm1Kcam
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal myocardial fiber morphology
|
J:86616
|
| increased vasoconstriction
|
J:86616
|
Cacna1smdg/Cacna1smdg
(involves: STOCK T/t4)
|
abnormal diaphragm morphology
|
J:7295,
J:7296
|
| abnormal muscle development
|
J:14970,
J:5576
|
| abnormal muscle fiber morphology
|
J:7295,
J:7296
|
| abnormal muscle physiology
|
J:641
|
| abnormal sarcomere morphology
|
J:18533
|
| abnormal skeletal muscle fiber morphology
|
J:4724,
J:5283,
J:18533
|
| abnormal tongue muscle morphology
|
J:14970
|
| abnormal Z line morphology
|
J:5283,
J:18533
|
| absent skeletal muscle
|
J:4466
|
| decreased skeletal muscle mass
|
J:14970
|
| dilated sarcoplasmic reticulum
|
J:5283
|
| impaired skeletal muscle contractility
|
J:4724,
J:18533
|
| muscle degeneration
|
J:14970
|
| thin diaphragm muscle
|
J:4466
|
Cacna1smdg/Cacna1smdg
(involves: 129P1/ReJ * STOCK T/t4)
|
abnormal diaphragm morphology
|
J:6592
|
| abnormal muscle morphology
|
J:6592
|
| impaired skeletal muscle contractility
|
J:5371
|
Cacna1smdg/Cacna1smdg
(involves: 129 * STOCK T/t4)
|
abnormal muscle development
|
J:15029
|
| impaired muscle contractility
|
J:7390,
J:15029
|
Cacna1stm1.1Arte/Cacna1stm1.1Arte
(involves: C57BL/6N)
|
abnormal muscle electrophysiology
|
J:235534
|
| abnormal muscle physiology
|
J:235534
|
| abnormal skeletal muscle fiber mitochondrial morphology
|
J:235534
|
| abnormal skeletal muscle fiber type ratio
|
J:235534
|
| impaired skeletal muscle contractility
|
J:235534
|
| muscle phenotype
|
J:235534
|
Cacna1stm1.1Cann/Cacna1s+
(involves: 129)
|
abnormal muscle contractility
|
J:193967
|
| abnormal muscle physiology
|
J:193967
|
| dilated sarcoplasmic reticulum
|
J:193967
|
Cacna1stm1.1Cann/Cacna1stm1.1Cann
(involves: 129)
|
abnormal muscle contractility
|
J:193967
|
| abnormal muscle physiology
|
J:193967
|
| centrally nucleated skeletal muscle fibers
|
J:193967
|
| dilated sarcoplasmic reticulum
|
J:193967
|
| myopathy
|
J:193967
|
Cacna2d1tm1Aschw/Cacna2d1tm1Aschw
(involves: Black Swiss)
|
abnormal muscle electrophysiology
|
J:151101
|
| decreased cardiac muscle contractility
|
J:151101
|
Cacna2d2du-3J/Cacna2d2du-3J
(involves: BALB/cByJ * C57BL/6J)
|
myoclonus
|
J:82238
|
Cacna2d2du/Cacna2d2du
(TKDU)
|
skeletal muscle hypoplasia
|
J:152373
|
Cacna2d2tm1Svi/Cacna2d2tm1Svi
(involves: 129S1/Sv * C57BL/6J)
|
myoclonus
|
J:92396
|
Cacnb1tm1Rgg/Cacnb1tm1Rgg
(involves: 129S7/SvEvBrd)
|
abnormal muscle physiology
|
J:37052
|
| abnormal skeletal muscle fiber morphology
|
J:37052
|
| decreased skeletal muscle mass
|
J:37052
|
| impaired skeletal muscle contractility
|
J:37052
|
Cacnb2tm1.1Mfre/Cacnb2tm1.1Mfre
Tg(CAG-Bgeo/GFP)21Lbe/?
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6N * FVB/N)
|
thin myocardium
|
J:126506
|
Cacnb3tm1Acv/Cacnb3tm1Acv
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal vascular smooth muscle morphology
|
J:86381
|
| abnormal vascular smooth muscle physiology
|
J:86381
|
| vascular smooth muscle hypertrophy
|
J:86381
|
Cacnb4lh/Cacnb4lh
(involves: BALB/cGn * C3H/HeSnJ * C57BL/6JEi)
|
facial muscle spasm
|
J:79139
|
Cacng1tm1Rgg/Cacng1+
(involves: 129S7/SvEvBrd)
|
abnormal muscle electrophysiology
|
J:146419
|
Cacng1tm1Rgg/Cacng1tm1Rgg
(involves: 129S7/SvEvBrd)
|
abnormal muscle electrophysiology
|
J:146419
|
Cacng1tm1Vfz/Cacng1tm1Vfz
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal muscle electrophysiology
|
J:62133
|
Calb1em1(IMPC)Ccpcz/Calb1em1(IMPC)Ccpcz
(C57BL/6NCrl-Calb1em1(IMPC)Ccpcz/Ccpcz)
|
increased cardiac muscle contractility
|
J:211773
|
Calcrltm1Kmca/Calcrltm1Kmca
(129S6/SvEvTac-Calcrltm1Kmca)
|
abnormal fetal cardiomyocyte proliferation
|
J:106927
|
| abnormal myocardium compact layer morphology
|
J:106927
|
| abnormal myocardium layer morphology
|
J:106927
|
| abnormal vascular smooth muscle morphology
|
J:106927
|
| disorganized myocardium
|
J:106927
|
| increased cardiomyocyte apoptosis
|
J:106927
|
| thin myocardium compact layer
|
J:106927
|
| vascular smooth muscle hypoplasia
|
J:106927
|
Cald1tm1Chac/Cald1+
(involves: C57BL/6 * C57BL/6J)
|
abnormal urinary bladder detrusor smooth muscle morphology
|
J:202998
|
Calrtm1Mlk/Calrtm1Mlk
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal intercalated disk morphology
|
J:119647
|
| abnormal myocardial fiber morphology
|
J:119647
|
| abnormal sarcomere morphology
|
J:119647
|
| abnormal Z line morphology
|
J:119647
|
| decreased myocardial fiber number
|
J:119647
|
| increased cardiac muscle glycogen level
|
J:119647
|
| thin myocardium compact layer
|
J:53466
|
| trabecula carnea hypoplasia
|
J:119647,
J:53466
|
Calrtm1Star/Calrtm1Star
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL))
|
increased cardiomyocyte apoptosis
|
J:61550
|
| trabecula carnea hypoplasia
|
J:61550
|
| ventricular cardiomyopathy
|
J:61550
|
Camk2dtm1.1Jhb/Camk2dtm1.1Jhb
(Not Specified)
|
abnormal sarcoplasmic reticulum morphology
|
J:210426
|
Camkmttm1Rpav/Camkmttm1Rpav
(involves: 129S7/SvEvBrd * C57BL/6J)
|
increased variability of skeletal muscle fiber size
|
J:228818
|
| myopathy
|
J:228818
|
Camkmttm1Rpav/Camkmttm1Rpav
(B6.129S7-Camkmttm1Rpav)
|
muscle phenotype
|
J:228818
|
can/can
(STOCK Tmc1dn)
|
abnormal neck muscle morphology
|
J:5194
|
| calcified muscle
|
J:5194
|
Canxem1(IMPC)Ccpcz/Canxem1(IMPC)Ccpcz
(C57BL/6NCrl-Canxem1(IMPC)Ccpcz/Ccpcz)
|
abnormal skeletal muscle morphology
|
J:211773
|
Cap2tm1a(EUCOMM)Wtsi/Cap2tm1a(EUCOMM)Wtsi
(involves: C57BL/6J * C57BL/6N)
|
decreased ventricle muscle contractility
|
J:234044
|
| dilated cardiomyopathy
|
J:234044
|
Cap2tm1e(EUCOMM)Wtsi/Cap2tm1e(EUCOMM)Wtsi
(C57BL/6N-Cap2tm1e(EUCOMM)Wtsi)
|
abnormal I band morphology
|
J:226742
|
| abnormal M line morphology
|
J:226742
|
| abnormal myocardial fiber morphology
|
J:226742
|
| abnormal myocardium layer morphology
|
J:226742
|
| abnormal sarcomere morphology
|
J:226742
|
| abnormal ventricle myocardium morphology
|
J:226742
|
| decreased myocardial fiber number
|
J:226742
|
| dilated cardiomyopathy
|
J:226742
|
Capn3Gt(OST141731)Lex/Capn3Gt(OST141731)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal A band morphology
|
J:91206
|
| abnormal diaphragm morphology
|
J:91206
|
| abnormal gastrocnemius morphology
|
J:91206
|
| abnormal muscle morphology
|
J:91206
|
| abnormal skeletal muscle fiber morphology
|
J:91206
|
| abnormal soleus morphology
|
J:91206
|
| abnormal tibialis anterior morphology
|
J:91206
|
| decreased skeletal muscle mass
|
J:91206
|
Capn3tm1.1Hiso/Capn3tm1.1Hiso
(B6.129P2-Capn3tm1.1Hiso)
|
abnormal skeletal muscle fiber morphology
|
J:163711
|
| centrally nucleated skeletal muscle fibers
|
J:163711
|
| decreased skeletal muscle fiber diameter
|
J:163711
|
| dystrophic muscle
|
J:163711
|
| skeletal muscle degeneration
|
J:163711
|
Capn3tm1Jsb/Capn3+
Ttntm1.1Isrd/Ttntm1.1Isrd
(involves: 129/Sv * 129S2/SvPas * C57BL/6)
|
centrally nucleated skeletal muscle fibers
|
J:165576
|
| dilated cardiomyopathy
|
J:165576
|
| dystrophic muscle
|
J:165576
|
Capn3tm1Jsb/Capn3tm1Jsb
(either: 129/Sv-Capn3tm1Jsb or (involves: 129/Sv * C57BL/6))
|
abnormal sarcolemma morphology
|
J:66862
|
| dystrophic muscle
|
J:66862
|
Capn6tm1Hiso/Y
(B6.Cg-Capn6tm1Hiso)
|
abnormal myogenesis
|
J:200747
|
Capn6tm1Hiso/Capn6tm1Hiso
(B6.Cg-Capn6tm1Hiso)
|
abnormal tongue muscle morphology
|
J:200747
|
| enhanced skeletal muscle regeneration
|
J:200747
|
Capns1tm1.1Otsu/Capns1tm1.1Otsu
Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6J * FVB/N)
|
decreased cardiac muscle contractility
|
J:176736
|
Car3tm1Gkim/Car3tm1Gkim
(involves: 129S/SvEv * 129S6/SvEvTac)
|
abnormal muscle contractility
|
J:94222
|
Carns1tm1.2Meck/Carns1tm1.2Meck
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * SJL)
|
muscle phenotype
|
J:298850
|
Casp3tm1Flv/Casp3tm1Flv
(B6N.129S1-Casp3tm1Flv/J)
|
increased cardiomyocyte apoptosis
|
J:189241
|
Casp8tm1.1Yuan/Casp8tm1.1Yuan
(involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6 * MF1)
|
abnormal myocardium layer morphology
|
J:49459
|
Casp8tm1Syon/Casp8tm1Syon
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased cardiomyocyte apoptosis
|
J:103506
|
Casp8tm1Syon/Casp8tm1Syon
Tg(Myh7-BVp35-EGFP)#Ksa/?
(involves: 129S1/Sv * 129X1/SvJ * C3H * C57BL/6)
|
increased cardiomyocyte apoptosis
|
J:102279
|
Casp8tm1Wll/Casp8tm1.1Yuan
Tg(Tie1-cre)9Ref/0
(involves: 129S1/Sv * 129X1/SvJ * MF1)
|
myocardium necrosis
|
J:92722
|
Casp8tm1Yuan/Casp8tm1Yuan
(involves: 129S1/Sv * 129X1/SvJ * MF1)
|
abnormal myocardial trabeculae morphology
|
J:49459
|
| abnormal myocardium layer morphology
|
J:49459
|
| thin myocardium
|
J:49459
|
Casq1Gt(OST82566)Lex/Casq1Gt(OST82566)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal muscle electrophysiology
|
J:140828
|
| abnormal muscle physiology
|
J:140828
|
| abnormal sarcomere morphology
|
J:140828
|
| abnormal sarcoplasmic reticulum morphology
|
J:140828
|
| abnormal skeletal muscle fiber morphology
|
J:140828
|
| impaired muscle relaxation
|
J:140828
|
| impaired skeletal muscle contractility
|
J:140828
|
| muscular atrophy
|
J:140828
|
Casq2tm1.1Sgp/Casq2tm1.1Sgp
(involves: 129X1/SvJ * C57BL/6NCrL)
|
abnormal myocardial fiber morphology
|
J:151367
|
Casq2tm1Jse/Casq2tm1Jse
(involves: FVB/N)
|
decreased ventricle muscle contractility
|
J:124211
|
| heart left ventricle hypertrophy
|
J:124211
|
Casq2tm2.1Sgp/Casq2tm2.1Sgp
(involves: 129)
|
abnormal myocardial fiber morphology
|
J:212671
|
| abnormal sarcoplasmic reticulum morphology
|
J:212671
|
Casq2tm2Jse/Casq2tm2Jse
(Not Specified)
|
decreased ventricle muscle contractility
|
J:124211
|
| heart left ventricle hypertrophy
|
J:124211
|
CasrNuf/CasrNuf
(involves: 102/El * C3H/He)
|
calcified muscle
|
J:92612
|
Casz1Gt(CJ0565)Wtsi/Casz1Gt(CJ0565)Wtsi
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal myocardium compact layer morphology
|
J:242127
|
| abnormal sarcomere morphology
|
J:242127
|
| abnormal Z line morphology
|
J:242127
|
| decreased fetal cardiomyocyte proliferation
|
J:242127
|
| myocardium hypoplasia
|
J:242127
|
| thin myocardium
|
J:242127
|
| ventricular myocardium compact layer hypoplasia
|
J:242127
|
Casz1tm1.1Flc/Casz1tm1.1Flc
Nkx2-5tm1(cre)Rjs/Nkx2-5+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * C57BL/6J * SJL)
|
decreased fetal cardiomyocyte proliferation
|
J:221324
|
| thin myocardium
|
J:221324
|
| trabecula carnea hypoplasia
|
J:221324
|
Cav1em2(IMPC)Ics/Cav1em2(IMPC)Ics
(C57BL/6N-Cav1em2(IMPC)Ics/Ics)
|
decreased cardiac muscle contractility
|
J:211773
|
Cav1tm1Krc/Cav1tm1Krc
(involves: 129S4/SvJae * Black Swiss)
|
decreased ventricle muscle contractility
|
J:78603
|
| dilated cardiomyopathy
|
J:78603
|
| heart right ventricle hypertrophy
|
J:78603
|
Cav1tm1Kur/Cav1tm1Kur
(involves: 129X1/SvJ * C57BL/6)
|
abnormal vasoconstriction
|
J:71760
|
| increased vasodilation
|
J:71760
|
Cav1tm1Mls/Cav1tm1Mls
(involves: 129/Sv * C57BL/6 * SJL)
|
abnormal myocardium layer morphology
|
J:87282
|
| abnormal skeletal muscle fiber morphology
|
J:117199
|
| abnormal vasoconstriction
|
J:75193
|
| abnormal vasodilation
|
J:75193
|
| decreased cardiac muscle contractility
|
J:87282
|
| heart left ventricle hypertrophy
|
J:87282
|
| myocardial fiber disarray
|
J:87282
|
Cav1tm1Mls/Cav1tm1Mls
(involves: 129/Sv * C57BL/6J * SJL)
|
decreased vasoconstriction
|
J:120603
|
Cav1tm1Mls/Cav1tm1Mls
(STOCK Cav1tm1Mls/J)
|
decreased vasoconstriction
|
J:132392
|
| increased vasodilation
|
J:132392
|
Cav1tm1Mls/Cav1tm1Mls
(FVB.Cg-Cav1tm1Mls)
|
abnormal skeletal muscle morphology
|
J:182288
|
Cav1tm1Mls/Cav1tm1Mls
Cav3tm1Mls/Cav3tm1Mls
(involves: 129/Sv * C57BL/6J * SJL)
|
abnormal myocardial fiber morphology
|
J:77372
|
| cardiomyopathy
|
J:77372
|
| decreased ventricle muscle contractility
|
J:77372
|
| heart left ventricle hypertrophy
|
J:77372
|
| myocardial fiber disarray
|
J:77372
|
Cav2tm1Mls/Cav2tm1Mls
(involves: 129/Sv * C57BL/6J * SJL)
|
abnormal muscle regeneration
|
J:117199
|
| abnormal skeletal muscle fiber morphology
|
J:117199
|
| increased satellite cell number
|
J:117199
|
| increased skeletal muscle fiber size
|
J:117199
|
Cav3tm1Mls/Cav3tm1Mls
(involves: 129/Sv * C57BL/6J * SJL)
|
abnormal myocardial fiber morphology
|
J:79453
|
| abnormal sarcolemma morphology
|
J:69965
|
| abnormal skeletal muscle fiber morphology
|
J:69965
|
| cardiomyopathy
|
J:79453
|
| decreased ventricle muscle contractility
|
J:79453
|
| dystrophic muscle
|
J:69965
|
| heart left ventricle hypertrophy
|
J:79453
|
| increased variability of skeletal muscle fiber size
|
J:69965
|
| muscle phenotype
|
J:117199
|
| myopathy
|
J:69965
|
| skeletal muscle fiber necrosis
|
J:69965
|
Cav3tm1Ncnp/Cav3+
Dmdmdx/Dmdmdx
(involves: 129S4/SvJae * C57BL/10 * C57BL/10ScSn)
|
abnormal intercostal muscle morphology
|
J:150127
|
| abnormal muscle development
|
J:150127
|
| abnormal muscle fiber morphology
|
J:150127
|
| centrally nucleated skeletal muscle fibers
|
J:150127
|
Cav3tm1Ncnp/Cav3tm1Ncnp
(involves: 129S4/SvJae * C57BL/6J)
|
muscle degeneration
|
J:66558
|
Cav3tm1Ncnp/Cav3tm1Ncnp
(involves: 129S4/SvJae * C57BL/10)
|
abnormal atrium myocardial trabeculae morphology
|
J:150127
|
| abnormal muscle development
|
J:150127
|
| abnormal muscle fiber morphology
|
J:150127
|
| centrally nucleated skeletal muscle fibers
|
J:150127
|
| myocardial fiber disarray
|
J:150127
|
Cavin1tm1Pfp/Cavin1tm1Pfp
(B6.129S6-Cavin1tm1Pfp/J)
|
abnormal urinary bladder detrusor smooth muscle morphology
|
J:217273
|
| impaired contractility of urinary bladder detrusor smooth muscle
|
J:217273
|
Cbltm1Ddlb/Cbltm1Ddlb
(involves: 129S1/Sv * C57BL/6)
|
abnormal muscle physiology
|
J:94416
|
| increased muscle cell glucose uptake
|
J:94416
|
Cbstm1Unc/Cbs+
(B6.129P2-Cbstm1Unc/J)
|
abnormal vasodilation
|
J:64885
|
Cbx6tm1a(EUCOMM)Wtsi/Cbx6tm1a(EUCOMM)Wtsi
(C57BL/6N-Cbx6tm1a(EUCOMM)Wtsi/Wtsi)
|
abnormal infrahyoid muscle connection
|
J:239583
|
Ccl2tm1Rol/Ccl2tm1Rol
(involves: 129S4/SvJae)
|
increased vasodilation
|
J:155025
|
Ccl2tm1Rol/Ccl2tm1Rol
(B6.129S4-Ccl2tm1Rol)
|
abnormal skeletal muscle morphology
|
J:118606
|
| impaired skeletal muscle regeneration
|
J:118606
|
| increased muscle weight
|
J:118606
|
| skeletal muscle necrosis
|
J:118606
|
Ccm2tm1Mlkn/Ccm2tm1Mlkn
Nfatc1tm1.1(cre)Bz/Nfatc1+
(involves: 129 * 129S1/Sv * 129X1/SvJ)
|
thin myocardium
|
J:238897
|
Ccm2tm1Sbn/Ccm2tm1Sbn
(involves: C57BL/6)
|
abnormal vascular smooth muscle morphology
|
J:174085
|
Ccm2tm2.1Sbn/Ccm2tm2.1Sbn
Tg(Tek-cre)1Ywa/0
(involves: C57BL/6 * SJL)
|
abnormal vascular smooth muscle morphology
|
J:174085
|
Ccm2ltm1Mlkn/Ccm2ltm1Mlkn
Heg1tm1Mlkn/Heg1tm1Mlkn
(involves: 129 * C57BL/6)
|
decreased fetal cardiomyocyte proliferation
|
J:187714
|
| decreased ventricle muscle contractility
|
J:187714
|
| thin myocardium
|
J:187714
|
| trabecula carnea hypoplasia
|
J:187714
|
Ccm2ltm1Mlkn/Ccm2ltm1Mlkn
Heg1tm1Mlkn/Heg1tm2.1Mlkn
Tg(Tek-cre)1Ywa/0
(involves: 129 * C57BL/6 * SJL)
|
thin myocardium
|
J:187714
|
Ccn3tm1Cabo/Ccn3+
(involves: 129S/SvEv)
|
ventricular cardiomyopathy
|
J:135676
|
Ccn3tm1Cabo/Ccn3tm1Cabo
(involves: 129S/SvEv)
|
muscular atrophy
|
J:135676
|
| ventricular cardiomyopathy
|
J:135676
|
Ccn3tm1Hko/Ccn3tm1Hko
(B6.129-Ccn3tm1Hko)
|
increased vascular smooth muscle cell proliferation
|
J:172144
|
Ccr2em1(IMPC)H/Ccr2em1(IMPC)H
(C57BL/6N-Ccr2em1(IMPC)H/H)
|
increased cardiac muscle contractility
|
J:211773
|
Ccr5tm1Kuz/Ccr5tm1Kuz
(B6.129P2-Ccr5tm1Kuz/J)
|
decreased skeletal muscle glycogen level
|
J:264446
|
Ccr10/Cntnap1tm1Bhat/Ccr10/Cntnap1tm1Bhat
(involves: 129S7/SvEvBrd)
|
muscle spasm
|
J:69621
|
Ccr10/Cntnap1tm1Bhat/Ccr10/Cntnap1tm1Bhat
(involves: 129S7/SvEvBrd)
|
muscle spasm
|
J:69621
|
Cd36tm1Mfe/Cd36tm1Mfe
(involves: 129S1/Sv * C57BL/6)
|
decreased cardiac muscle glycogen level
|
J:83611
|
| decreased cardiac muscle triglyceride level
|
J:83611
|
| increased cardiac muscle cell glucose uptake
|
J:83611
|
Cd36tm1Mfe/Cd36tm1Mfe
(involves: 129S1/Sv)
|
abnormal muscle physiology
|
J:220343
|
| decreased muscle cell glucose uptake
|
J:220343
|
| decreased skeletal muscle glycogen level
|
J:220343
|
Cd36tm2.1Mfe/Cd36tm2.1Mfe
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(B6.Cg-Cd36tm2.1Mfe A1cfTg(Myh6-cre/Esr1*)1Jmk)
|
decreased cardiac muscle triglyceride level
|
J:225392
|
Cd44tm1Mak/Cd44tm1Mak
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal vascular smooth muscle physiology
|
J:101783
|
Cd47tm1Fpl/Cd47tm1Fpl
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal muscle fiber morphology
|
J:139652
|
| muscle phenotype
|
J:139652
|
Cd55tm1Song/Cd55tm1Song
Cd59atm1Bpm/Cd59atm1Bpm
(B6.129-Cd55tm1Song Cd59atm1Bpm)
|
abnormal muscle morphology
|
J:113567
|
| myositis
|
J:113567
|
Cd59atm1Bpm/Cd59atm1Bpm
(B6.129-Cd59atm1Bpm)
|
myositis
|
J:113567
|
Cd86tm1Shr/Cd86tm1Shr
(NOD.129S4-Cd86tm1Shr)
|
muscular atrophy
|
J:71352
|
Cd163tm1(KOMP)Vlcg/Cd163tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
abnormal gastrocnemius morphology
|
J:224919
|
| abnormal skeletal muscle satellite cell proliferation
|
J:224919
|
| enhanced skeletal muscle regeneration
|
J:224919
|
Cdc26tm1b(EUCOMM)Hmgu/Cdc26+
(C57BL/6N-Cdc26tm1b(EUCOMM)Hmgu/Ics)
|
increased cardiac muscle contractility
|
J:211773
|
Cdc42tm1.1Yizh/Cdc42+
(Not Specified)
|
decreased ventricle muscle contractility
|
J:174208
|
Cdc42tm1.1Yizh/Cdc42+
Nkx2-5tm1Siz/Nkx2-5+
(involves: 129S4/SvJaeSor)
|
decreased ventricle muscle contractility
|
J:174208
|
Cdc73tm1Btt/Cdc73tm1Btt
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
decreased skeletal muscle mass
|
J:135255
|
Cdh2tm1Glr/Cdh2Gt(OST49160)Lex
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: 129S5/SvEvBrd * 129S6/SvEvTac * C57BL/6J * FVB/N)
|
abnormal intercalated disk morphology
|
J:98828
|
| abnormal myocardial fiber morphology
|
J:98828
|
| decreased ventricle muscle contractility
|
J:98828
|
Cdh2tm1Glr/Cdh2tm1Hyn
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: 129S6/SvEvTac * C57BL/6J * FVB/N)
|
abnormal intercalated disk morphology
|
J:98828
|
| abnormal myocardial fiber morphology
|
J:98828
|
| decreased ventricle muscle contractility
|
J:98828
|
Cdh2tm1Hyn/Cdh2tm1Hyn
(involves: 129S2/SvPas)
|
abnormal myocardial fiber morphology
|
J:37888
|
| abnormal myocardium layer morphology
|
J:37888
|
Cdk2tm1Kald/Cdk2tm1Kald
Cdk4tm1Kiyo/Cdk4tm1Kiyo
(involves: 129S1/Sv * C57BL/6)
|
abnormal fetal cardiomyocyte proliferation
|
J:108720
|
| myocardial fiber disarray
|
J:108720
|
Cdk2tm1Sgo/Cdk2tm1Sgo
Cdk4tm1Bbd/Cdk4tm1Bbd
Cdk6tm1Bbd/Cdk6tm1Bbd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased myocardial fiber number
|
J:124678
|
Cdk2tm1Sgo/Cdk2tm1Sgo
Cdk4tm2.1Bbd/Cdk4tm2.1Bbd
(involves: 129S1/Sv * 129X1/SvJ * BALB/cJ * C57BL/6 * SJL)
|
abnormal fetal cardiomyocyte proliferation
|
J:125217
|
| increased myocardial fiber size
|
J:125217
|
Cdk5rap1tm1.2Tomik/Cdk5rap1tm1.2Tomik
(B6J.Cg-Cdk5rap1tm1.2Tomik)
|
decreased cardiac muscle contractility
|
J:220703
|
| increased skeletal muscle fiber mitochondrial DNA content
|
J:220703
|
Cdk10tm1.2Kald/Cdk10tm1.2Kald
(involves: 129 * C57BL/6 * FVB/N)
|
abnormal muscle morphology
|
J:262333
|
Cdk13tm1a(EUCOMM)Hmgu/Cdk13tm1a(EUCOMM)Hmgu
(involves: C57BL/6N)
|
abnormal myocardium layer morphology
|
J:291583
|
| thin myocardium
|
J:291583
|
Cdkal1Gt(6062)Tgen/Cdkal1Gt(6062)Tgen
(involves: C57BL/6 * C57BL/6J * CBA/JNCrj)
|
decreased skeletal muscle triglyceride level
|
J:195460
|
| increased skeletal muscle triglyceride level
|
J:195460
|
Cdkn1atm1Led/Cdkn1atm1Led
Cdkn1ctm1Sje/Cdkn1c+
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6)
|
decreased skeletal muscle mass
|
J:52552
|
| increased skeletal muscle fiber size
|
J:52552
|
| thin diaphragm muscle
|
J:52552
|
Cdkn1atm1Tyj/Cdkn1atm1Tyj
Foxk1tm1Djg/Foxk1tm1Djg
(involves: 129S2/SvPas * 129S4/SvJae)
|
muscle phenotype
|
J:81688
|
Cdkn1atm1Tyj/Cdkn1atm1Tyj
Rb1tm1Tyj/Rb1tm1Tyj
Tg(Rb1)1Blg/0
(involves: 129S2/SvPas)
|
abnormal muscle physiology
|
J:65679
|
| abnormal myogenesis
|
J:65679
|
| abnormal skeletal muscle fiber morphology
|
J:65679
|
Cdkn1atm1Tyj/Cdkn1atm1Tyj
Zfpm2tm1.1Esv/Zfpm2tm1.1Esv
(involves: 129S1/SvImJ * 129S2/SvPas * 129S4/SvJae * 129S6/SvEvTac * C57BL/6)
|
abnormal myocardium compact layer morphology
|
J:216295
|
Cdkn1btm1Ako/Cdkn1btm1Ako
(involves: 129S1/Sv * C57BL)
|
abnormal fetal cardiomyocyte proliferation
|
J:57380
|
| decreased myocardial fiber size
|
J:57380
|
| increased myocardial fiber number
|
J:57380
|
Cdkn1btm1Mlf/Cdkn1b+
Ptch1tm1Mps/Ptch1+
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6)
|
increased rhabdomyosarcoma incidence
|
J:205254
|
Cdkn1btm1Mlf/Cdkn1btm1Mlf
Cdkn2dtm1Maro/Cdkn2dtm1Maro
(involves: 129X1/SvJ * C57BL/6)
|
muscle hypertonia
|
J:58522
|
Cdkn1btm1Mlf/Cdkn1btm1Mlf
Ptch1tm1Mps/Ptch1+
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6)
|
increased rhabdomyosarcoma incidence
|
J:205254
|
Cdkn1ctm1Sje/Cdkn1ctm1Sje
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal skeletal muscle morphology
|
J:40203
|
Cdkn2atm1.1Brn/Cdkn2a+
Nf2tm2Gth/Nf2tm2Gth
Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * 129S7/SvEvBrd)
|
increased rhabdomyosarcoma incidence
|
J:132943
|
Cdkn2atm1.1Brn/Cdkn2atm1.1Brn
Nf2tm2Gth/Nf2tm2Gth
Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * 129S7/SvEvBrd)
|
increased rhabdomyosarcoma incidence
|
J:132943
|
Cdkn2atm1Cjs/Cdkn2a+
Tg(CKMM-tTA)A3Rhvh/0
Tg(tetO-Hgf,-EGFP)24Tcre/0
(involves: 129X1/SvJ * FVB)
|
increased rhabdomyosarcoma incidence
|
J:237183
|
Cdkn2atm1Cjs/Cdkn2atm1Cjs
Pax7tm1Pgr/Pax7+
Tg(CKMM-tTA)A3Rhvh/0
Tg(tetO-Hgf,-EGFP)24Tcre/0
(involves: 129S2/SvPas * 129X1/SvJ * FVB)
|
increased rhabdomyosarcoma incidence
|
J:237183
|
Cdkn2atm1Cjs/Cdkn2atm1Cjs
Pax7tm1Pgr/Pax7tm1Pgr
Tg(CKMM-tTA)A3Rhvh/0
Tg(tetO-Hgf,-EGFP)24Tcre/0
(involves: 129S2/SvPas * 129X1/SvJ * FVB)
|
increased rhabdomyosarcoma incidence
|
J:237183
|
Cdkn2atm1Cjs/Cdkn2atm1Cjs
Tg(CKMM-tTA)A3Rhvh/0
Tg(tetO-Hgf,-EGFP)24Tcre/0
(involves: 129X1/SvJ * FVB)
|
increased rhabdomyosarcoma incidence
|
J:237183
|
| skeletal muscle hyperplasia
|
J:237183
|
Cdkn2atm1Rdp/Cdkn2atm1Rdp
Gt(ROSA)26Sortm1(cre/ERT)Nat/Gt(ROSA)26Sor+
Pdgfratm12Sor/Pdgfra+
(involves: 129 * C57BL/6J * SJL)
|
skeletal muscle interstitial fibrosis
|
J:146617
|
Cdkn2atm1Rdp/Cdkn2atm1Rdp
Tg(Mt1-Hgf)19Lmb/0
(involves: 129/Sv * C57BL/6J * FVB/N * SJL)
|
abnormal myogenesis
|
J:79704
|
| increased rhabdomyosarcoma incidence
|
J:79704
|
| increased satellite cell number
|
J:79704
|
Cdkn2atm2Brn/Cdkn2a+
Nf2tm2Gth/Nf2tm2Gth
(involves: 129P2/OlaHsd)
|
increased uterus leiomyoma incidence
|
J:132943
|
Cdkn2atm2Brn/Cdkn2atm2Brn
Nf2tm2Gth/Nf2+
(involves: 129P2/OlaHsd)
|
increased uterus leiomyoma incidence
|
J:132943
|
Cdkn2atm2Brn/Cdkn2atm2Brn
Nf2tm2Gth/Nf2tm2Gth
(involves: 129P2/OlaHsd)
|
increased rhabdomyosarcoma incidence
|
J:132943
|
| increased uterus leiomyoma incidence
|
J:132943
|
Cdkn2atm4Rdp/Cdkn2atm4Rdp
Myf6tm1(cre)Mrc/Myf6+
Pax3tm1Mrc/Pax3tm1Mrc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
increased rhabdomyosarcoma incidence
|
J:93444
|
Cdkn2atm4Rdp/Cdkn2atm4Rdp
Nf1tm1Par/Nf1tm1Par
(involves: 129S1/Sv * 129X1/SvJ)
|
increased rhabdomyosarcoma incidence
|
J:234760
|
Ceacam2tm1Snaj/Ceacam2tm1Snaj
(involves: 129S4/SvJae * C57BL/6)
|
decreased muscle cell glucose uptake
|
J:181979
|
| increased skeletal muscle triglyceride level
|
J:181979
|
Cebpatm6Nerl/Cebpatm6Nerl
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased muscle cell glucose uptake
|
J:120098
|
Cebpbtm1Kish/Cebpb+
(involves: 129P2/OlaHsd)
|
abnormal skeletal muscle mass
|
J:237461
|
Cebpbtm1Nerl/Cebpbtm1Nerl
Tg(Ckmm-cre)5Khn/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB)
|
muscle phenotype
|
J:153686
|
Cebpbtm1Vpo/Cebpbtm1Vpo
(involves: 129S/SvEv * MF1)
|
increased muscle cell glucose uptake
|
J:62132
|
Cebpbtm3Nerl/Cebpbtm3Nerl
(either: B6.129P2-Cebpbtm3Nerl or (involves: 129P2/OlaHsd * C57BL/6))
|
calcified muscle
|
J:153686
|
| decreased skeletal muscle fiber size
|
J:153686
|
| impaired skeletal muscle regeneration
|
J:153686
|
| myositis
|
J:153686
|
| skeletal muscle fibrosis
|
J:153686
|
Celf4tm1a(EUCOMM)Wtsi/Celf4tm1a(EUCOMM)Wtsi
(C57BL/6N-Celf4tm1a(EUCOMM)Wtsi/Wtsi)
|
abnormal eye muscle morphology
|
J:239583
|
Cenpftm1Dbdr/Cenpftm1Dbdr
Tg(Tnnt2-cre)5Blh/0
(involves: C57BL/6 * DBA/2 * ICR)
|
abnormal intercalated disk morphology
|
J:185133
|
| abnormal myocardial fiber morphology
|
J:185133
|
| decreased fetal cardiomyocyte proliferation
|
J:185133
|
| dilated cardiomyopathy
|
J:185133
|
| myocardial trabeculae hypoplasia
|
J:185133
|
Cenpjtm1a(EUCOMM)Wtsi/Cenpjtm1a(EUCOMM)Wtsi
(B6Brd;B6N-Tyrc-Brd Cenpjtm1a(EUCOMM)Wtsi/Wtsi)
|
abnormal myocardial fiber morphology
|
J:194085
|
Cept1tm1.1Sem/Cept1tm1.1Sem
Tg(ACTA1-cre)79Jme/0
(involves: C57BL/6J * SJL)
|
muscle weakness
|
J:249456
|
Cert1Gt(RRF047)Byg/Cert1Gt(RRF047)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal myocardial fiber mitochondrial morphology
|
J:146172
|
| decreased ventricle muscle contractility
|
J:146172
|
Cert1tm1.1Jsau/Cert1tm1.1Jsau
(involves: 129S/SvEv * BALB/cJ * C57BL/6)
|
abnormal muscle development
|
J:177789
|
Cert1tm1a(KOMP)Wtsi/Cert1tm1a(KOMP)Wtsi
(C57BL/6N-Cert1tm1a(KOMP)Wtsi/Wtsi)
|
abnormal pectinate muscle morphology
|
J:239583
|
Cfap57em1(IMPC)Mbp/Cfap57em1(IMPC)Mbp
(C57BL/6NCrl-Cfap57em1(IMPC)Mbp/Mmucd)
|
abnormal skeletal muscle morphology
|
J:211773
|
Cfap276em1Fuxi/Cfap276+
(C57BL/6J-Cfap276em1Fuxi)
|
skeletal muscle atrophy
|
J:283448
|
Cfap276em1Fuxi/Cfap276em1Fuxi
(C57BL/6J-Cfap276em1Fuxi)
|
skeletal muscle atrophy
|
J:283448
|
Cfap276em2.1Fuxi/Cfap276+
(involves: C57BL/6J)
|
skeletal muscle fiber atrophy
|
J:295996
|
Cfap276em2.1Fuxi/Cfap276em2.1Fuxi
(involves: C57BL/6J)
|
muscular atrophy
|
J:295996
|
| skeletal muscle fiber atrophy
|
J:295996
|
Cfhtm1.1Song/Cfhtm1.1Song
(involves: C57BL/6)
|
impaired muscle relaxation
|
J:240426
|
Cfl2tm1.1Itl/Cfl2tm1.1Itl
(involves: C57BL/6J * C57BL/6NTac)
|
abnormal sarcomere morphology
|
J:182571
|
| abnormal skeletal muscle fiber morphology
|
J:182571
|
| abnormal skeletal muscle fiber type ratio
|
J:182571
|
| abnormal skeletal muscle morphology
|
J:182571
|
| muscle weakness
|
J:182571
|
| skeletal muscle fiber degeneration
|
J:182571
|
Cfl2tm1Itl/Cfl2tm1Itl
Tg(ACTA1-cre)79Jme/0
(involves: C57BL/6J * C57BL/6NTac * SJL)
|
abnormal sarcomere morphology
|
J:182571
|
| abnormal skeletal muscle fiber morphology
|
J:182571
|
| abnormal skeletal muscle morphology
|
J:182571
|
Cfl2tm1Itl/Cfl2tm1Itl
Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6 * C57BL/6NTac * FVB/N)
|
abnormal skeletal muscle morphology
|
J:182571
|
| abnormal Z line morphology
|
J:182571
|
| skeletal muscle fiber degeneration
|
J:182571
|
Cfl2tm1Itl/Cfl2tm1Itl
Tg(Mef2c-cre)1Blk/0
(involves: C57BL/6NTac)
|
abnormal skeletal muscle morphology
|
J:182571
|
| abnormal Z line morphology
|
J:182571
|
Cflartm1Mak/Cflartm1Mak
(either: (involves: 129P2/OlaHsd * C57BL/6J) or (involves: 129P2/OlaHsd * CD-1))
|
abnormal myocardial trabeculae morphology
|
J:63049
|
| thin myocardium
|
J:63049
|
Chat/Slc18a3tm1.1Vpra/Chat/Slc18a3tm1.1Vpra
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal skeletal muscle morphology
|
J:153908
|
| hypotonia
|
J:153908
|
| skeletal muscle atrophy
|
J:153908
|
| skeletal muscle fiber atrophy
|
J:153908
|
Chat/Slc18a3tm1.1Vpra/Chat/Slc18a3tm1.1Vpra
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal skeletal muscle morphology
|
J:153908
|
| hypotonia
|
J:153908
|
| skeletal muscle atrophy
|
J:153908
|
| skeletal muscle fiber atrophy
|
J:153908
|
Chattm1.1Jrs/Chattm1.1Jrs
(Not Specified)
|
abnormal muscle morphology
|
J:91066
|
| diaphragmatic hernia
|
J:91066
|
| thin diaphragm muscle
|
J:91066
|
Chattm1Mlt/Chattm1Mlt
Tg(SLC18A3-cre)KMisa/0
(involves: 129 * C57BL/6)
|
abnormal gastrocnemius morphology
|
J:212048
|
| abnormal muscle morphology
|
J:212048
|
| abnormal soleus morphology
|
J:212048
|
| muscle weakness
|
J:212048
|
| muscular atrophy
|
J:212048
|
| skeletal muscle endomysial fibrosis
|
J:212048
|
| skeletal muscle fibrosis
|
J:212048
|
Chchd10em3Dpn/Chchd10em3Dpn
(C57BL/6J-Chchd10em3Dpn)
|
abnormal tibialis anterior morphology
|
J:344465
|
| decreased myocardial fiber mitochondrial DNA content
|
J:344465
|
| decreased skeletal muscle fiber size
|
J:344465
|
| myopathy
|
J:344465
|
Chchd10em3Dpn/Chchd10em3Dpn
Oma1tm1Otin/Oma1+
(involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NCrl)
|
abnormal muscle fiber mitochondrial morphology
|
J:344465
|
Chchd10em8Lutzy/Chchd10+
(C57BL/6NJ-Chchd10em8Lutzy/J)
|
abnormal sarcomere morphology
|
J:272524
|
| abnormal skeletal muscle fiber morphology
|
J:272524
|
| centrally nucleated skeletal muscle fibers
|
J:272524
|
| decreased skeletal muscle mass
|
J:272524
|
Chd2Gt(RRBO46)Byg/Chd2+
(involves: 129P2/OlaHsd * C57BL/6)
|
cardiomyopathy
|
J:146743
|
| myocardial fiber degeneration
|
J:146743
|
Chd4em1Flc/Chd4em1Flc
(C57BL/6J-Chd4em1Flc)
|
abnormal myocardial fiber morphology
|
J:338019
|
| abnormal myocardial trabeculae morphology
|
J:338019
|
| abnormal skeletal muscle fiber morphology
|
J:338019
|
| abnormal Z line morphology
|
J:338019
|
| decreased skeletal muscle fiber number
|
J:338019
|
| decreased ventricle muscle contractility
|
J:338019
|
| increased fetal cardiomyocyte proliferation
|
J:338019
|
| increased skeletal muscle fiber size
|
J:338019
|
| thin myocardium compact layer
|
J:338019
|
Chd7tm2a(EUCOMM)Wtsi/Chd7tm2a(EUCOMM)Wtsi
(involves: 129S6/SvEvTac * C57BL/6N)
|
decreased fetal cardiomyocyte proliferation
|
J:207089
|
| increased cardiomyocyte apoptosis
|
J:207089
|
| thin myocardium
|
J:207089
|
Chd7tm2a(EUCOMM)Wtsi/Chd7tm2a(EUCOMM)Wtsi
Mesp1tm2(cre)Ysa/Mesp1+
(involves: C57BL/6J * C57BL/6N * C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal myocardial trabeculae morphology
|
J:225736
|
| abnormal myocardium compact layer morphology
|
J:225736
|
| thin ventricle myocardium compact layer
|
J:225736
|
Chd7tm2a(EUCOMM)Wtsi/Chd7tm2a(EUCOMM)Wtsi
Tg(Tek-cre)1Ywa/0
(involves: C57BL/6 * C57BL/6J * C57BL/6N * SJL)
|
abnormal myocardium compact layer morphology
|
J:225736
|
Chgatm1Skmt/Chgatm1Skmt
(involves: 129S1/Sv * C57BL/6J)
|
heart left ventricle hypertrophy
|
J:99805
|
Chkbrmd/Chkbrmd
(involves: BALB/cByJ * C57BL/6J)
|
abnormal muscle fiber morphology
|
J:108320
|
| abnormal muscle physiology
|
J:108320
|
| abnormal sarcolemma morphology
|
J:108320
|
| abnormal skeletal muscle fiber morphology
|
J:108320
|
| centrally nucleated skeletal muscle fibers
|
J:108320
|
| dystrophic muscle
|
J:108320
|
| muscle degeneration
|
J:108320
|
Chn1Gt714Lex/Chn1Gt714Lex
(involves: 129S5/SvEvBrd)
|
abnormal muscle electrophysiology
|
J:128698
|
Chrdtm1Emdr/Chrdtm1Emdr
(either: B6SJL.129-Chrdtm1Emdr or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * SJL/J))
|
heart right ventricle hypertrophy
|
J:83662
|
| increased vasodilation
|
J:83662
|
Chrm2tm1Jwe/Chrm2tm1Jwe
(involves: 129S4/SvJae * CF-1)
|
impaired smooth muscle contractility
|
J:60451,
J:125455
|
Chrm2tm1Minm/Chrm2tm1Minm
(involves: 129X1/SvJ * C57BL/6)
|
muscle phenotype
|
J:99247
|
Chrm2tm1Minm/Chrm2tm1Minm
Chrm3tm1Mmt/Chrm3tm1Mmt
(involves: 129X1/SvJ * C57BL/6)
|
impaired contractility of ileal smooth muscle
|
J:99247
|
| impaired smooth muscle contractility
|
J:99247
|
Chrm3tm1Jwe/Chrm3tm1Jwe
(involves: 129S6/SvEvTac * CF-1)
|
decreased vasodilation
|
J:102321
|
| impaired smooth muscle contractility
|
J:125455
|
Chrm3tm1Jwe/Chrm3tm1Jwe
(involves: 129S6/SvEvTac)
|
impaired smooth muscle contractility
|
J:113518
|
Chrm3tm1Mmt/Chrm3tm1Mmt
(involves: 129X1/SvJ)
|
impaired contractility of ileal smooth muscle
|
J:99247
|
| impaired smooth muscle contractility
|
J:99247
|
Chrm3tm1Mmt/Chrm3tm1Mmt
(involves: 129X1/SvJ * C57BL/6)
|
impaired contractility of ileal smooth muscle
|
J:64069
|
| impaired contractility of urinary bladder detrusor smooth muscle
|
J:64069
|
Chrm4tm1Jwe/Chrm4tm1Jwe
(involves: 129S6/SvEvTac * CF-1)
|
impaired smooth muscle contractility
|
J:125455
|
| muscle phenotype
|
J:60451
|
Chrm5tm1Jwe/Chrm5tm1Jwe
(involves: 129S6/SvEvTac * CF-1)
|
abnormal vasodilation
|
J:72953
|
Chrna3tm1Bay/Chrna3tm1Bay
(involves: 129S7/SvEvBrd * C57BL/6)
|
muscle phenotype
|
J:54994
|
Chrnb2tm1Mdb/Chrnb2tm1Mdb
Chrnb4tm1Mdb/Chrnb4tm1Mdb
(involves: 129S7/SvEvBrd * C57BL/6J)
|
intestinal hypoperistalsis
|
J:73590
|
| muscle phenotype
|
J:73590
|
Chrnetm1Jrs/Chrnetm1Jrs
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
skeletal muscle atrophy
|
J:74958
|
Chrnetm1Vwi/Chrnetm1Vwi
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal skeletal muscle morphology
|
J:36557
|
| decreased muscle weight
|
J:36557
|
| impaired skeletal muscle contractility
|
J:36557
|
| skeletal muscle atrophy
|
J:36557
|
Chrnetm2Vwi/Chrnetm2Vwi
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal skeletal muscle fiber morphology
|
J:182046
|
| impaired skeletal muscle contractility
|
J:182046
|
Chrngtm1(Chrne)Mknn/Chrngtm1(Chrne)Mknn
(involves: 129/Sv * C57BL/6)
|
muscle phenotype
|
J:105142
|
Chrngtm1Mtak/Chrngtm1Mtak
(involves: 129X1/SvJ * C57BL/6)
|
abnormal diaphragm morphology
|
J:99894
|
| abnormal muscle physiology
|
J:99894
|
| abnormal skeletal muscle fiber morphology
|
J:99894
|
| increased variability of skeletal muscle fiber size
|
J:99894
|
Chrngtm2(Chrne)Vwi/Chrngtm2(Chrne)Vwi
(involves: C57BL/6)
|
thin diaphragm muscle
|
J:169541
|
Chst11tm1a(KOMP)Wtsi/Chst11tm1a(KOMP)Wtsi
(C57BL/6N-Chst11tm1a(KOMP)Wtsi/Wtsi)
|
abnormal eye muscle topology
|
J:239583
|
Chtoptm1a(EUCOMM)Wtsi/Chtoptm1a(EUCOMM)Wtsi
(C57BL/6N-Chtoptm1a(EUCOMM)Wtsi/Wtsi)
|
abnormal abdominal muscle morphology
|
J:239583
|
| abnormal eye muscle morphology
|
J:239583
|
| diaphragmatic hernia
|
J:239583
|
Cibar1tm1b(KOMP)Wtsi/Cibar1tm1b(KOMP)Wtsi
(C57BL/6N-Cibar1tm1b(KOMP)Wtsi/Wtsi)
|
calcified tendon
|
J:274784
|
Cir1tm3a(KOMP)Wtsi/Cir1tm3a(KOMP)Wtsi
(C57BL/6N-Cir1tm3a(KOMP)Wtsi/Wtsi)
|
abnormal eye muscle morphology
|
J:239583
|
Cirbilem1Cya/Cirbilem1Cya
(Not Specified)
|
decreased cardiac muscle contractility
|
J:301260
|
| increased cardiomyocyte apoptosis
|
J:301260
|
Cisd2Gt(XS0445)Wtsi/Cisd2Gt(XS0445)Wtsi
(B6.129P2-Cisd2Gt(XS0445)Wtsi)
|
abnormal sarcomere morphology
|
J:183788
|
| abnormal skeletal muscle fiber morphology
|
J:183788
|
| abnormal skeletal muscle fiber type ratio
|
J:183788
|
| abnormal skeletal muscle morphology
|
J:183788
|
| dilated sarcoplasmic reticulum
|
J:183788
|
| impaired skeletal muscle contractility
|
J:183788
|
| muscle phenotype
|
J:183788
|
Cisd2tm1Tfts/Cisd2tm1Tfts
(B6.129S7-Cisd2tm1Tfts)
|
abnormal muscle fiber morphology
|
J:148467
|
| abnormal myocardium layer morphology
|
J:148467
|
| muscle degeneration
|
J:148467
|
Cittm1Fdc/Cittm1Fdc
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
myoclonus
|
J:77297
|
Ckmtm1Bew/Ckmtm1Bew
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal muscle physiology
|
J:76699
|
| decreased cardiac muscle contractility
|
J:76204
|
| impaired skeletal muscle contractility
|
J:76699,
J:20440
|
| increased skeletal muscle glycogen level
|
J:76699
|
Ckmtm1Bew/Ckmtm1Bew
Ckmt2tm1Bew/Ckmt2tm1Bew
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)
|
abnormal muscle physiology
|
J:106327
|
| decreased skeletal muscle mass
|
J:106327
|
| heart left ventricle hypertrophy
|
J:101961
|
| impaired skeletal muscle contractility
|
J:106327
|
Ckmtm1Bew/Ckmtm2Bew
(involves: 129S7/SvEvBrd * C57BL/6)
|
impaired skeletal muscle contractility
|
J:20440
|
Ckmtm2Bew/Ckmtm2Bew
(involves: 129S7/SvEvBrd * C57BL/6)
|
impaired skeletal muscle contractility
|
J:20440
|
Ckmt2tm1Bew/Ckmt2tm1Bew
(involves: 129P2/OlaHsd * C57BL/6)
|
heart left ventricle hypertrophy
|
J:101961
|
| muscle phenotype
|
J:76886
|
cl/cl
(Not Specified)
|
decreased skeletal muscle mass
|
J:294
|
Clcc1m1J/Clcc1m1J
(B6.C3Sn(Cg)-Clcc1m1J/SlacJ)
|
decreased skeletal muscle fiber diameter
|
J:218443
|
| muscular atrophy
|
J:218443
|
| skeletal muscle atrophy
|
J:218443
|
| skeletal muscle fiber atrophy
|
J:218443
|
Clcn1adr-mto2J/Clcn1adr-mto2J
(BALB/cByJ-Clcn1adr-mto2J)
|
impaired muscle relaxation
|
J:112061
|
Clcn1adr-mto7J/Clcn1adr-mto7J
(C57BL/6J-Clcn1adr-mto7J/J)
|
muscle spasm
|
J:82238
|
Clcn1adr-mto8J/Clcn1adr-mto8J
(B6;C3Fe-Clcn1adr-mto8J/CxJ)
|
muscle spasm
|
J:120858
|
Clcn1adr-mto9J/Clcn1adr-mto9J
(C57BL/6J-Clcn1adr-mto9J/J)
|
impaired muscle relaxation
|
J:134519
|
Clcn1adr-mto/Clcn1adr-mto
(SWR/J-Clcn1adr-mto/J)
|
abnormal muscle electrophysiology
|
J:6814,
J:14251
|
| abnormal muscle physiology
|
J:6814
|
| impaired muscle relaxation
|
J:14251
|
| increased skeletal muscle mass
|
J:6814
|
| muscle phenotype
|
J:6814
|
Clcn1adr/Clcn1adr
(A2G-Clcn1adr)
|
abnormal muscle electrophysiology
|
J:25830
|
| abnormal muscle physiology
|
J:4480,
J:25830
|
| abnormal skeletal muscle morphology
|
J:25829
|
| impaired muscle relaxation
|
J:25830
|
| impaired skeletal muscle contractility
|
J:25830
|
| muscle twitch
|
J:7524
|
Clcn1m1Anu/Clcn1m1Anu
(involves: C57BL/6 * CBA/H)
|
muscle hypertonia
|
J:104190
|
Clcn3tm1.1Jrhm/Clcn3tm1.1Jrhm
Tg(Myh6-tTA)6Smbf/0
Tg(tetO-cre)3Jig/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)
|
decreased ventricle muscle contractility
|
J:222375
|
| dilated cardiomyopathy
|
J:222375
|
| myocardium hypertrophy
|
J:222375
|
Cldn12tm1.1(KOMP)Vlcg/Cldn12tm1.1(KOMP)Vlcg
(B6J.B6N-Cldn12tm1.1(KOMP)Vlcg)
|
increased cardiac muscle contractility
|
J:279934
|
Clec9atm1b(KOMP)Wtsi/Clec9atm1b(KOMP)Wtsi
(C57BL/6N-Clec9atm1b(KOMP)Wtsi/Orl)
|
decreased cardiac muscle contractility
|
J:211773
|
Clip3tm1.1Ics/Clip3tm1.1Ics
(involves: C57BL/6)
|
abnormal diaphragm morphology
|
J:194894
|
| impaired muscle contractility
|
J:194894
|
Clmptm1.1Fgr/Clmptm1.1Fgr
(involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6)
|
abnormal intestinal peristalsis
|
J:258315
|
| abnormal intestinal smooth muscle morphology
|
J:258315
|
| abnormal muscle tone
|
J:258315
|
| impaired ureteric peristalsis
|
J:258315
|
Clmptm1Fgr/Clmptm1Fgr
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal intestinal peristalsis
|
J:258315
|
| impaired ureteric peristalsis
|
J:258315
|
Clnkem1(IMPC)Ccpcz/Clnkem1(IMPC)Ccpcz
(C57BL/6NCrl-Clnkem1(IMPC)Ccpcz/Ccpcz)
|
decreased skeletal muscle mass
|
J:211773
|
Clp1tm1.1Pngr/Clp1tm1.1Pngr
(CBA.Cg-Clp1tm1.1Pngr)
|
progressive muscle weakness
|
J:196364
|
| skeletal muscle atrophy
|
J:196364
|
Clp1tm1.1Pngr/Clp1tm1.1Pngr
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * C57BL/6J)
|
muscle phenotype
|
J:196364
|
Cltrntm1Thu/Y
(involves: 129S/SvEv * C57BL/6)
|
abnormal muscle physiology
|
J:148522
|
Clutm1Jakh/Clutm1Jakh
(involves: Black Swiss * FVB/N)
|
abnormal myocardial fiber morphology
|
J:65660
|
| abnormal myocardium layer morphology
|
J:65660
|
| decreased cardiac muscle contractility
|
J:65660
|
| decreased myocardial fiber number
|
J:65660
|
Cmahtm1Avrk/Cmahtm1Avrk
Dmdmdx/Dmdmdx
(involves: 129X1/SvJ * C57BL/10ScSn)
|
cardiac muscle necrosis
|
J:164594
|
| dystrophic muscle
|
J:164594
|
| muscle weakness
|
J:164594
|
| skeletal muscle fibrosis
|
J:164594
|
Cmn1CAST/Ei/?
Ighmbp2nmd-2J/Ighmbp2nmd-2J
MnmC/MnmC
(involves: C57BL/6J * C57BLKS/J * CAST/Ei * DBA/J)
|
dilated cardiomyopathy
|
J:102748
|
Cmn2CAST/Ei/?
Ighmbp2nmd-2J/Ighmbp2nmd-2J
MnmC/MnmC
(involves: C57BL/6J * C57BLKS/J * CAST/Ei * DBA/J)
|
dilated cardiomyopathy
|
J:102748
|
Cmn3C57BL/6J/?
Ighmbp2nmd-2J/Ighmbp2nmd-2J
MnmC/MnmC
(involves: C57BL/6J * C57BLKS/J * CAST/Ei * DBA/J)
|
dilated cardiomyopathy
|
J:102748
|
Cmn3CAST/Ei/?
Ighmbp2nmd-2J/Ighmbp2nmd-2J
MnmC/MnmC
(involves: C57BL/6J * C57BLKS/J * CAST/Ei * DBA/J)
|
dilated cardiomyopathy
|
J:102748
|
Cmtm3em1Wlh/Cmtm3em1Wlh
(involves: C57BL/6)
|
abnormal myocardial fiber morphology
|
J:338327
|
| decreased cardiac muscle contractility
|
J:338327
|
| increased cardiac muscle contractility
|
J:338327
|
| increased myocardial fiber size
|
J:338327
|
| myocardial fiber disarray
|
J:338327
|
| myocardium hypertrophy
|
J:338327
|
cmy1/cmy1
(involves: C57BL/6J * DBA/2J)
|
decreased cardiac muscle contractility
|
J:149470
|
| dilated cardiomyopathy
|
J:149470
|
cmy2/cmy2
(involves: C57BL/6J * DBA/2J)
|
decreased cardiac muscle contractility
|
J:149470
|
| dilated cardiomyopathy
|
J:149470
|
Cmya5tm1Cap/Cmya5tm1Cap
(129-Cmya5tm1Cap)
|
abnormal cardiac muscle tissue morphology
|
J:322761
|
| abnormal gastrocnemius morphology
|
J:322761
|
| abnormal intercalated disk morphology
|
J:322761
|
| abnormal sarcoplasmic reticulum morphology
|
J:322761
|
| abnormal soleus morphology
|
J:322761
|
| decreased ventricle muscle contractility
|
J:322761
|
Cnot1tm1Tya/Cnot1tm1Tya
Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6 * FVB)
|
cardiac muscle necrosis
|
J:260012
|
| decreased cardiac muscle contractility
|
J:260012
|
Cnot3tm1.1Kjkb/Cnot3tm1.1Kjkb
Tg(Ckmm-cre)5Khn/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB)
|
cardiac muscle necrosis
|
J:260012
|
| cardiomyopathy
|
J:260012
|
| decreased cardiac muscle contractility
|
J:260012
|
| decreased myocardial fiber number
|
J:260012
|
| muscle phenotype
|
J:260012
|
Cnot3tm1Pngr/Cnot3+
(B6.Cg-Cnot3tm1Pngr)
|
decreased cardiac muscle contractility
|
J:167954
|
| decreased ventricle muscle contractility
|
J:167954
|
Cnptm1(cre)Kan/Cnptm1(cre)Kan
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
muscle weakness
|
J:91814
|
Cntftm1Mpin/Cntftm1Mpin
(involves: 129S2/SvPas)
|
muscle weakness
|
J:15313
|
Cntn1m1J/Cntn1m1J
(B6;C-Cntn1m1J/GrsrJ)
|
muscle phenotype
|
J:178817
|
Cntnap1em1Bhat/Ccr10/Cntnap1tm1Bhat
(involves: 129S7/SvEvBrd)
|
muscle weakness
|
J:342323
|
Cntnap1em2Bhat/Ccr10/Cntnap1tm1Bhat
(involves: 129S7/SvEvBrd)
|
muscle weakness
|
J:342323
|
Cntnap1tm1Bhat/Cntnap1tm1Bhat
(involves: 129S7/SvEvBrd)
|
muscle spasm
|
J:107653
|
Coa8em1Zev/Coa8em1Zev
(FVB/NJ-Coa8em1Zev)
|
muscle phenotype
|
J:277865
|
Coasytm1.1Vtr/Coasytm1.1Vtr
Tg(Syn1-cre)671Jxm/0
(involves: 129 * C57BL/6N * CBA)
|
dystonia
|
J:299154
|
cod/cod
(Not Specified)
|
decreased skeletal muscle fiber diameter
|
J:13460
|
Col1a1Aga2/Col1a1+
(C3HeB/FeJ-Col1a1Aga2)
|
abnormal myocardium layer morphology
|
J:185988
|
| decreased ventricle muscle contractility
|
J:185988
|
| heart right ventricle hypertrophy
|
J:185988
|
Col1a1M1Jrt/Col1a1+
(involves: C3H/HeJ * C57BL/6J * FVB/NJ)
|
abnormal tendon collagen fibril morphology
|
J:216423
|
| decreased tendon stiffness
|
J:216423
|
| myocardium hypertrophy
|
J:216423
|
Col1a1tm2(CAG-IDH2*R172K)Kkw/Col1a1+
Ndor1Tg(UBC-cre/ERT2)1Ejb/0
(involves: 129S/SvEv * 129S4/SvJae * BALB/c * C57BL/6)
|
abnormal myocardial fiber mitochondrial morphology
|
J:209629
|
| abnormal myocardial fiber morphology
|
J:209629
|
| abnormal sarcomere morphology
|
J:209629
|
| abnormal skeletal muscle fiber mitochondrial morphology
|
J:209629
|
| abnormal skeletal muscle morphology
|
J:209629
|
| abnormal Z line morphology
|
J:209629
|
| decreased cardiac muscle contractility
|
J:209629
|
| dilated cardiomyopathy
|
J:209629
|
| increased cardiac muscle glycogen level
|
J:209629
|
| increased cardiomyocyte apoptosis
|
J:209629
|
| increased skeletal muscle glycogen level
|
J:209629
|
| skeletal muscle endomysial fibrosis
|
J:209629
|
| skeletal muscle fiber degeneration
|
J:209629
|
| skeletal muscle fiber necrosis
|
J:209629
|
Col1a1tm3(CAG-IDH2*R140Q)Kkw/Col1a1+
Ndor1Tg(UBC-cre/ERT2)1Ejb/0
(involves: 129S/SvEv * 129S4/SvJae * BALB/c * C57BL/6)
|
abnormal myocardial fiber mitochondrial morphology
|
J:209629
|
| abnormal myocardial fiber morphology
|
J:209629
|
| abnormal sarcomere morphology
|
J:209629
|
| abnormal skeletal muscle fiber mitochondrial morphology
|
J:209629
|
| abnormal skeletal muscle morphology
|
J:209629
|
| abnormal Z line morphology
|
J:209629
|
| decreased cardiac muscle contractility
|
J:209629
|
| dilated cardiomyopathy
|
J:209629
|
| increased cardiomyocyte apoptosis
|
J:209629
|
| increased skeletal muscle glycogen level
|
J:209629
|
Col1a2oim/Col1a2oim
(involves: C3H/HeJ * C57BL/6JLe)
|
decreased tendon stiffness
|
J:41509
|
Col1a2oim/Col1a2oim
(B6C3Fe a/a-Col1a2oim/J)
|
abnormal tendon morphology
|
J:124000
|
Col3a1m1Lsmi/Col3a1+
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal aorta smooth muscle morphology
|
J:180733
|
| increased vasoconstriction
|
J:180733
|
Col3a1tm1Jae/Col3a1tm1Jae
(involves: 129S4/SvJae)
|
muscle phenotype
|
J:39273
|
Col4a1deltaex40/Col4a1+
(involves: 129S/SvEv * C57BL/6J)
|
myopathy
|
J:172720
|
Col4a1deltaex40/Col4a1+
(involves: 129S/SvEv * C57BL/6J * CAST/EiJ)
|
myopathy
|
J:172720
|
Col4a1tm1.1Ics/Col4a1+
(involves: 129S2/SvPas * C57BL/6)
|
dystrophic muscle
|
J:240798
|
Col4a1tm1.1Ics/Col4a1tm1.1Ics
(involves: 129S2/SvPas * C57BL/6)
|
dystrophic muscle
|
J:240798
|
Col4a2em1(IMPC)Wtsi/Col4a2em1(IMPC)Wtsi
(C57BL/6N-Col4a2em1(IMPC)Wtsi/WtsiOulu)
|
abnormal eye muscle morphology
|
J:239583
|
Col5a3tm1Dgr/Col5a3tm1Dgr
(involves: 129S1/Sv * 129X1/SvJ * ICR)
|
decreased muscle cell glucose uptake
|
J:171817
|
Col6a1tm1Gmb/Col6a1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal diaphragm morphology
|
J:51410
|
| abnormal intercostal muscle morphology
|
J:51410
|
| centrally nucleated skeletal muscle fibers
|
J:51410
|
| myopathy
|
J:51410
|
| skeletal muscle necrosis
|
J:51410
|
Col6a1tm1Gmb/Col6a1tm1Gmb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal diaphragm morphology
|
J:51410
|
| abnormal intercostal muscle morphology
|
J:51410
|
| abnormal muscle morphology
|
J:51410
|
| abnormal skeletal muscle morphology
|
J:86734
|
| impaired skeletal muscle contractility
|
J:86734
|
| muscle phenotype
|
J:51410
|
| myopathy
|
J:51410
|
| skeletal muscle necrosis
|
J:51410
|
Col6a1tm1Sngi/Col6a1tm1Sngi
(B6.Cg-Col6a1tm1Sngi)
|
abnormal muscle development
|
J:278926
|
| abnormal skeletal muscle fiber morphology
|
J:278926
|
| abnormal skeletal muscle morphology
|
J:278926
|
| decreased skeletal muscle fiber number
|
J:278926
|
| decreased skeletal muscle mass
|
J:278926
|
| decreased skeletal muscle size
|
J:278926
|
| impaired skeletal muscle contractility
|
J:278926
|
| increased variability of skeletal muscle fiber size
|
J:278926
|
| muscle weakness
|
J:278926
|
| skeletal muscle endomysial fibrosis
|
J:278926
|
Col6a3tm1Chu/Col6a3tm1Chu
(B6.129-Col6a3tm1Chu)
|
abnormal muscle physiology
|
J:198581
|
| abnormal skeletal muscle regeneration
|
J:198581
|
| abnormal tendon collagen fibril morphology
|
J:198581
|
| centrally nucleated skeletal muscle fibers
|
J:198581
|
| decreased skeletal muscle weight
|
J:198581
|
| increased collagen deposition in the muscles
|
J:198581
|
| increased variability of skeletal muscle fiber size
|
J:198581
|
| myopathy
|
J:198581
|
| skeletal muscle interstitial fibrosis
|
J:198581
|
Col6a3tm2.1Chu/Col6a3+
(B6.129(Cg)-Col6a3tm2.1Chu)
|
abnormal muscle fiber morphology
|
J:208903
|
| abnormal tendon cell morphology
|
J:208903
|
| abnormal tendon collagen fibril morphology
|
J:208903
|
| abnormal tendon morphology
|
J:208903
|
| centrally nucleated skeletal muscle fibers
|
J:208903
|
| dilated sarcoplasmic reticulum
|
J:208903
|
| impaired skeletal muscle contractility
|
J:208903
|
| increased variability of skeletal muscle fiber size
|
J:208903
|
| myopathy
|
J:208903
|
Col6a3tm2.1Chu/Col6a3tm2.1Chu
(B6.129(Cg)-Col6a3tm2.1Chu)
|
abnormal muscle fiber morphology
|
J:208903
|
| abnormal tendon cell morphology
|
J:208903
|
| abnormal tendon collagen fibril morphology
|
J:208903
|
| abnormal tendon morphology
|
J:208903
|
| centrally nucleated skeletal muscle fibers
|
J:208903
|
| dilated sarcoplasmic reticulum
|
J:208903
|
| increased variability of skeletal muscle fiber size
|
J:208903
|
| myopathy
|
J:208903
|
Col12a1tm1Debi/Col12a1tm1Debi
(Not Specified)
|
abnormal muscle physiology
|
J:209074
|
| abnormal quadriceps morphology
|
J:209074
|
| abnormal sarcolemma morphology
|
J:209074
|
| abnormal skeletal muscle morphology
|
J:209074
|
| decreased skeletal muscle weight
|
J:209074
|
Col13a1tm1Pih/Col13a1tm1Pih
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J))
|
abnormal sarcolemma morphology
|
J:71939
|
| abnormal skeletal muscle fiber morphology
|
J:71939
|
| abnormal skeletal muscle morphology
|
J:71939
|
| abnormal Z line morphology
|
J:71939
|
| decreased skeletal muscle fiber diameter
|
J:71939
|
| muscle degeneration
|
J:71939
|
| myopathy
|
J:71939
|
| myositis
|
J:71939
|
Col13a1tm3.1Pih/Col13a1tm3.1Pih
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal diaphragm morphology
|
J:242846
|
| abnormal skeletal muscle fiber morphology
|
J:242846
|
| abnormal skeletal muscle fiber type ratio
|
J:242846
|
| abnormal soleus morphology
|
J:242846
|
| centrally nucleated skeletal muscle fibers
|
J:242846
|
| decreased soleus weight
|
J:242846
|
| muscle weakness
|
J:242846
|
| skeletal muscle fiber atrophy
|
J:242846
|
Col13a1tm4.1Pih/Col13a1tm4.1Pih
(involves: C57BL/6)
|
abnormal diaphragm morphology
|
J:242846
|
| abnormal skeletal muscle fiber morphology
|
J:242846
|
| centrally nucleated skeletal muscle fibers
|
J:242846
|
Col14a1tm1Debi/Col14a1+
(involves: 129S4/SvJae * C57BL/6)
|
decreased tendon stiffness
|
J:148619
|
Col14a1tm1Debi/Col14a1tm1Debi
(involves: 129S4/SvJae * C57BL/6)
|
abnormal muscle physiology
|
J:148619
|
| abnormal tendon morphology
|
J:148619
|
| decreased tendon stiffness
|
J:148619
|
Col15a1tm1Pih/Col15a1tm1Pih
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal muscle fiber morphology
|
J:67212
|
| abnormal muscle morphology
|
J:67212
|
| enhanced skeletal muscle regeneration
|
J:67212
|
| myopathy
|
J:67212
|
Col19a1tm1Rmz/Col19a1tm1Rmz
(involves: 129S1/Sv * 129T2/SvEmsJ * 129X1/SvJ)
|
abnormal esophageal smooth muscle morphology
|
J:92510
|
Col19a1tm2Rmz/Col19a1tm2Rmz
(involves: 129T2/SvEmsJ)
|
impaired muscle relaxation
|
J:92510
|
Col25a1tm1.1Tiwa/Col25a1tm1.1Tiwa
(B6.Cg-Col25a1tm1.1Tiwa)
|
abnormal skeletal muscle morphology
|
J:206855
|
| centrally nucleated skeletal muscle fibers
|
J:206855
|
| decreased skeletal muscle fiber diameter
|
J:206855
|
Commd9Gt(AQ0362)Wtsi/Commd9Gt(AQ0362)Wtsi
(involves: 129P2/OlaHsd)
|
myocardium necrosis
|
J:230747
|
Comptm1Mbri/Comptm1Mbri
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal tendon morphology
|
J:154984
|
| centrally nucleated skeletal muscle fibers
|
J:154984
|
| decreased tendon stiffness
|
J:154984
|
| increased muscle fatigability
|
J:154984
|
| myopathy
|
J:154984
|
Coq8atm1.1Ics/Coq8atm1.1Ics
(involves: 129S2/SvPas * C57BL/6J * C57BL/6N)
|
abnormal skeletal muscle morphology
|
J:249129
|
| skeletal muscle fiber degeneration
|
J:249129
|
Coq9tm1.1Lcl/Coq9tm1.1Lcl
(involves: C57BL/6 * C57BL/6NTac * SJL)
|
myopathy
|
J:193288
|
Corintm1Qwu/Corintm1Qwu
(involves: 129X1/SvJ * C57BL/6)
|
decreased cardiac muscle contractility
|
J:96458
|
Coro1ctm1a(KOMP)Wtsi/Coro1ctm1a(KOMP)Wtsi
(C57BL/6N-Coro1ctm1a(KOMP)Wtsi/Wtsi)
|
abnormal eye muscle morphology
|
J:239583
|
Cox6a1tm1(KOMP)Wtsi/Cox6a1tm1(KOMP)Wtsi
(involves: C57BL/6JJcl * C57BL/6N)
|
abnormal muscle morphology
|
J:230212
|
| muscular atrophy
|
J:230212
|
Cox7a1tm1Hutt/Cox7a1+
(B6.129-Cox7a1tm1Hutt)
|
decreased ventricle muscle contractility
|
J:192141
|
Cox7a1tm1Hutt/Cox7a1tm1Hutt
(B6.129-Cox7a1tm1Hutt)
|
decreased ventricle muscle contractility
|
J:192141
|
| dilated cardiomyopathy
|
J:192141
|
Cox7a2lGt(OST241316)Lex/Cox7a2lGt(OST241316)Lex
(B6.129S5-Cox7a2lGt(OST241316)Lex)
|
decreased quadriceps weight
|
J:215964
|
Cox10tm1Ctm/Cox10tm1Ctm
Myl1tm1(cre)Sjb/Myl1+
(involves: 129X1/SvJ * C57BL/6)
|
abnormal skeletal muscle morphology
|
J:101747
|
| decreased skeletal muscle mass
|
J:101747
|
| increased muscle fatigability
|
J:101747
|
| increased variability of skeletal muscle fiber size
|
J:101747
|
| myopathy
|
J:101747
|
Cox15tm1.1Zev/Cox15tm1.1Zev
Tg(ACTA1-cre)79Jme/0
(involves: 129 * C57BL/6 * C57BL/6J * SJL)
|
abnormal muscle fiber mitochondrial morphology
|
J:176080
|
| centrally nucleated skeletal muscle fibers
|
J:176080
|
| increased variability of skeletal muscle fiber size
|
J:176080
|
| myopathy
|
J:176080
|
Cpetm1Yplo/Cpetm1Yplo
(involves: 129S1/Sv * C57BL/6)
|
abnormal muscle physiology
|
J:95741
|
Cpeb4tm1a(EUCOMM)Wtsi/Cpeb4tm1a(EUCOMM)Wtsi
(involves: C57BL/6 * C57BL/6NTac)
|
muscle phenotype
|
J:236098
|
Cpt1ctm1Dhwu/Cpt1ctm1Dhwu
(involves: 129 * C57BL/6J)
|
decreased muscle cell glucose uptake
|
J:148205
|
Crattm1.1Pbrc/Crattm1.1Pbrc
Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6J * FVB)
|
abnormal muscle physiology
|
J:184778
|
Creb1tm1.1Berd/Creb1tm1.1Berd
(B6NHsd.129S4-Creb1tm1.1Berd)
|
abnormal myotube morphology
|
J:177923
|
| enhanced skeletal muscle regeneration
|
J:177923
|
| increased myoblast proliferation
|
J:177923
|
| muscle phenotype
|
J:177923
|
Creb1tm1.1Berd/Creb1tm1.1Berd
Dmdmdx/Y
(B.Cg-Creb1tm1.1Berd Dmdmdx)
|
enhanced skeletal muscle regeneration
|
J:177923
|
| skeletal muscle degeneration
|
J:177923
|
Creb3Gt1Mbac/Creb3+
(B6NTac.Cg-Creb3Gt1Mbac)
|
decreased skeletal muscle triglyceride level
|
J:345514
|
Crebbptm1Reck/Crebbp+
(involves: 129P2/OlaHsd)
|
muscle phenotype
|
J:85950
|
| thin ventricle myocardium compact layer
|
J:85949
|
Creg1tm1Yal/Creg1+
(involves: 129 * C57BL/6)
|
decreased ventricle muscle contractility
|
J:253911
|
| increased cardiomyocyte apoptosis
|
J:253911
|
Creld1tm1c(EUCOMM)Wtsi/Creld1tm1c(EUCOMM)Wtsi
Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6 * C57BL/6N * FVB/N * SJL)
|
abnormal trabecula carnea morphology
|
J:304446
|
| ventricle myocardium hypoplasia
|
J:304446
|
Cremtm1Gsc/Cremtm1Gsc
(involves: 129 * C57BL/6)
|
decreased ventricle muscle contractility
|
J:81241
|
Crim1em1(IMPC)Wtsi/Crim1em1(IMPC)Wtsi
(C57BL/6N-Crim1em1(IMPC)Wtsi/WtsiOrl)
|
telangiectasia
|
J:239583
|
Crim1Gt(KST264)Byg/Crim1Gt(KST264)Byg
(involves: 129P2/OlaHsd * C57BL/6 * CD-1)
|
impaired ureteric peristalsis
|
J:187026
|
Crktm1.1Cur/Crktm1.1Cur
(involves: 129S/SvEv * C57BL/6)
|
abnormal vascular smooth muscle morphology
|
J:111399
|
| increased vasodilation
|
J:111399
|
cro/?
(involves: C57BL/6J * CBA/J)
|
muscle phenotype
|
J:104881
|
Crppaem2Mbp/Crppaem2Mbp
Myf5tm3(cre)Sor/Myf5+
(B6.Cg-Myf5tm3(cre)Sor Crppaem2Mbp)
|
abnormal skeletal muscle morphology
|
J:324289
|
| centrally nucleated skeletal muscle fibers
|
J:324289
|
| decreased skeletal muscle weight
|
J:324289
|
| dystrophic muscle
|
J:324289
|
| increased variability of skeletal muscle fiber size
|
J:324289
|
| skeletal muscle fiber necrosis
|
J:324289
|
| skeletal muscle fibrosis
|
J:324289
|
Crtc3tm1Mmy/Crtc3tm1Mmy
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased muscle cell glucose uptake
|
J:167211
|
Cry1tm1Asn/Cry1tm1Asn
Cry2tm1Hnos/Cry2tm1Hnos
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal vasoconstriction
|
J:134129
|
Cryabem1Mtc/Cryabem1Mtc
(involves: C57BL/6)
|
decreased ventricle muscle contractility
|
J:342762
|
| myocardium hypertrophy
|
J:342762
|
Cryabtm1.1Ady/Cryab+
(involves: 129X1/SvJ * C57BL/6 * C57BL/6J)
|
centrally nucleated skeletal muscle fibers
|
J:171679
|
| myopathy
|
J:171679
|
| skeletal muscle fiber necrosis
|
J:171679
|
| skeletal muscle fibrosis
|
J:171679
|
Cryabtm1.1Ady/Cryabtm1.1Ady
(involves: 129X1/SvJ * C57BL/6 * C57BL/6J)
|
centrally nucleated skeletal muscle fibers
|
J:171679
|
| myopathy
|
J:171679
|
| skeletal muscle fiber necrosis
|
J:171679
|
| skeletal muscle fibrosis
|
J:171679
|
Csde1tm1Fda/Csde1tm1Fda
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal trabecula carnea morphology
|
J:252972
|
Csf1op/Csf1op
(B6C3Fe a/a-Csf1op/J)
|
abnormal masseter muscle morphology
|
J:20589
|
Csnk1a1tm1c(KOMP)Wtsi/Csnk1a1tm1c(KOMP)Wtsi
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * C57BL/6N * CBA)
|
abnormal myocardium layer morphology
|
J:216977
|
Csnk1g2tm1b(EUCOMM)Wtsi/Csnk1g2tm1b(EUCOMM)Wtsi
(C57BL/6N-Csnk1g2tm1b(EUCOMM)Wtsi/Ieg)
|
increased cardiac muscle contractility
|
J:211773
|
Csnk2a1tm1Dcs/Csnk2a1tm1Dcs
(involves: 129S6/SvEvTac * C57BL/6)
|
trabecula carnea hypoplasia
|
J:129208
|
Csrp1tm1Mbk/Csrp1tm1Mbk
(B6.129-Csrp1tm1Mbk)
|
muscle phenotype
|
J:172149
|
Csrp2tm1Rawe/Csrp2tm1Rawe
(B6.129X1-Csrp2tm1Rawe)
|
abnormal intercalated disk morphology
|
J:138969
|
| increased myocardial fiber size
|
J:138969
|
Csrp2tm1Sfy/Csrp2tm1Sfy
(B6.129S2-Csrp2tm1Sfy)
|
abnormal vascular smooth muscle physiology
|
J:117557
|
Csrp3tm1.1Kage/Csrp3tm1.1Kage
(involves: C57BL/6 * C57BL/6J * C57BL/6N * SJL)
|
abnormal cardiac muscle relaxation
|
J:307893
|
| decreased ventricle muscle contractility
|
J:307893
|
Csrp3tm1.1Rkn/Csrp3+
(either: (involves: Black Swiss) or (involves: C57BL/6N))
|
cardiomyopathy
|
J:170878
|
| increased cardiac muscle contractility
|
J:170878
|
Csrp3tm1.1Rkn/Csrp3tm1.1Rkn
(either: (involves: Black Swiss) or (involves: C57BL/6N))
|
abnormal skeletal muscle fiber morphology
|
J:170878
|
| cardiomyopathy
|
J:170878
|
| increased cardiac muscle contractility
|
J:170878
|
| increased variability of skeletal muscle fiber size
|
J:170878
|
| myocardial fiber disarray
|
J:170878
|
| myopathy
|
J:170878
|
Csrp3tm1Crni/Csrp3tm1Crni
(Not Specified)
|
abnormal intercalated disk morphology
|
J:138969
|
| decreased cardiac muscle contractility
|
J:88510,
J:66250
|
| decreased ventricle muscle contractility
|
J:38213
|
| dilated cardiomyopathy
|
J:38213,
J:88510,
J:66250
|
| increased myocardial fiber size
|
J:138969
|
Csrp3tm1Crni/Csrp3tm1Crni
Plntm1Egk/Plntm1Egk
(involves: 129S2/SvPas * CF-1)
|
increased cardiac muscle contractility
|
J:58299
|
Csrp3tm1Crni/Csrp3tm1Crni
Tg(Myh6-ADRBK1)27Wjk/0
(involves: C57BL/6 * SJL)
|
decreased ventricle muscle contractility
|
J:48062
|
Csrp3tm1Crni/Csrp3tm1Crni
Tg(WTbeta2)4Wjk/0
(Not Specified)
|
decreased ventricle muscle contractility
|
J:48062
|
| dilated cardiomyopathy
|
J:48062
|
Cstbtm1Rm/Cstbtm1Rm
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
facial muscle spasm
|
J:50587
|
| myoclonus
|
J:50587
|
Cstbtm1Rm/Cstbtm1Rm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
myoclonus
|
J:115694
|
Ctbp1tm1Sor/Ctbp1tm1Sor
Ctbp2Gt(ROSA61)Sor/Ctbp2+
(involves: 129S4/SvJaeSor)
|
abnormal diaphragm morphology
|
J:77905
|
| abnormal muscle development
|
J:77905
|
Cthtm1Iish/Cthtm1Iish
(B6.129-Cthtm1Iish/Iish)
|
decreased skeletal muscle fiber diameter
|
J:166184
|
| increased susceptibility to induced muscular atrophy
|
J:166184
|
Cthtm1Liwu/Cthtm1Liwu
(involves: 129S/SvEvBrd * C57BL/6J)
|
decreased vasodilation
|
J:140705
|
Cthrc1tm1Vli/Cthrc1tm1Vli
(129S6.Cg-Cthrc1tm1Vli)
|
increased skeletal muscle glycogen level
|
J:192096
|
Ctnna1tm1Efu/Ctnna1tm1Efu
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: 129X1/SvJ * FVB/N)
|
dilated cardiomyopathy
|
J:197814
|
Ctnna3tm1.1Fvr/Ctnna3tm1.1Fvr
(involves: 129S6/SvEvTac * BALB/cJ)
|
abnormal myocardial fiber morphology
|
J:197814
|
| decreased cardiac muscle contractility
|
J:197814
|
| dilated cardiomyopathy
|
J:197814
|
Ctnnb1tm1Mmt/Ctnnb1tm1Mmt
H2az2Tg(Wnt1-cre)11Rth/H2az2+
(involves: 129X1/SvJ * C57BL/6 * CBA)
|
abnormal muscle development
|
J:124278
|
Ctnnb1tm1Yy/Ctnnb1tm1Yy
Tg(Prrx1-cre)1Cjt/0
(involves: 129S6/SvEvTac * C57BL/6J * SJL/J)
|
abnormal tendon morphology
|
J:184918
|
Ctnstm1Antc/Ctnstm1Antc
(involves: 129/Sv * C57BL/6)
|
muscle degeneration
|
J:79610
|
Ctsltm1Cptr/Ctsltm1Cptr
(involves: 129P2/OlaHsd)
|
abnormal myocardial fiber morphology
|
J:76333
|
| abnormal myocardium layer morphology
|
J:76333
|
| decreased cardiac muscle contractility
|
J:76333
|
| decreased ventricle muscle contractility
|
J:76333
|
| dilated cardiomyopathy
|
J:76333
|
| heart left ventricle hypertrophy
|
J:76333
|
Ctsstm1Hap/Ctsstm1Hap
Dmdmdx/Dmdmdx
(involves: 129S2/SvPas * C57BL/10ScSn)
|
abnormal skeletal muscle fiber morphology
|
J:230788
|
| centrally nucleated skeletal muscle fibers
|
J:230788
|
| dystrophic muscle
|
J:230788
|
| skeletal muscle fiber necrosis
|
J:230788
|
| skeletal muscle fibrosis
|
J:230788
|
Ctsstm1Hap/Ctsstm1Hap
Ldlrtm1Her/Ldlrtm1Her
(B6.129S-Ctsstm1Hap Ldlrtm1Her)
|
vascular smooth muscle hypoplasia
|
J:82520
|
Cul3tm1.1Arte/Cul3+
(involves: C57BL/6J * C57BL/6N)
|
increased vasoconstriction
|
J:229424
|
Cx3cr1tm1Litt/Cx3cr1tm1Litt
(B6.129P2-Cx3cr1tm1Litt)
|
decreased vascular smooth muscle cell proliferation
|
J:124722
|
Cxadrtm1.1Ics/Cxadrtm1.1Ics
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S2/SvPas * C57BL/6 * C57BL/6J * CBA)
|
abnormal intercalated disk morphology
|
J:174138
|
Cxadrtm1.1Mds/Cxadrtm1.1Mds
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6J)
|
abnormal fetal cardiomyocyte proliferation
|
J:121400
|
| abnormal myocardial fiber morphology
|
J:121400
|
| abnormal myocardium layer morphology
|
J:121400
|
Cxadrtm1Dvst/Cxadrtm1Dvst
(involves: 129X1/SvJ * C57BL/6)
|
abnormal myocardial fiber morphology
|
J:100174
|
| abnormal sarcomere morphology
|
J:100174
|
| decreased myocardial fiber size
|
J:100174
|
| increased cardiac muscle glycogen level
|
J:100174
|
Cxadrtm1Know/Cxadrtm1Know
Tg(Myh6-cre)2182Mds/0
(involves: 129 * Black Swiss * FVB/N)
|
abnormal intercalated disk morphology
|
J:140870
|
| decreased cardiac muscle contractility
|
J:140870
|
Cxadrtm1Mgot/Cxadrtm1Mgot
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: FVB)
|
abnormal atrioventricular node morphology
|
J:140109
|
Cxadrtm1Rwf/Cxadrtm1Rwf
(involves: 129S6/SvEvTac * C57BL/6)
|
increased cardiomyocyte apoptosis
|
J:99585
|
| thin myocardium
|
J:99585
|
Cxcl12tm1Tng/Cxcl12tm1Tng
(involves: 129P2/OlaHsd)
|
abnormal vascular smooth muscle morphology
|
J:195048
|
Cxcr4tm1Qma/Cxcr4tm1Qma
(B6.129X-Cxcr4tm1Qma/J)
|
abnormal muscle precursor cell migration
|
J:100909
|
| abnormal myogenesis
|
J:100909
|
Cxcr4tm1Qma/Cxcr4tm1Qma
Gab1tm1Wbm/Gab1tm1Wbm
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6)
|
abnormal intrinsic tongue muscle morphology
|
J:100909
|
| abnormal muscle precursor cell migration
|
J:100909
|
| abnormal myogenesis
|
J:100909
|
| hypaxial muscle hypoplasia
|
J:100909
|
Cxcr4tm1Tng/Cxcr4tm1Tng
(involves: 129P2/OlaHsd)
|
abnormal vascular smooth muscle morphology
|
J:195048
|
Cxcr4tm1Tng/Cxcr4tm2Tng
Tg(Tek-cre)12Flv/0
(involves: 129P2/OlaHsd * C3H * C57BL/6)
|
abnormal vascular smooth muscle morphology
|
J:195048
|
Cxcr4tm2Yzo/Cxcr4tm2Yzo
Tg(Myh6-cre)2182Mds/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
abnormal myocardial fiber morphology
|
J:289614
|
| cardiomyopathy
|
J:289614
|
| decreased ventricle muscle contractility
|
J:289614
|
Cyb5r3tm1c(KOMP)Wtsi/Cyb5r3tm1c(KOMP)Wtsi
Tg(Myh11-icre/ERT2)1Soff/0
(B6.Cg-Cyb5r3tm1c(KOMP)Wtsi Tg(Myh11-icre/ERT2)1Soff)
|
decreased vasodilation
|
J:280543
|
| increased vasoconstriction
|
J:280543
|
| increased vasodilation
|
J:280543
|
Cybbtm1Din/Y
(B6.129S-Cybbtm1Din)
|
abnormal myocardial fiber morphology
|
J:135786
|
Cybbtm1Din/Y
Tg(SOD1*G93A)dl1Gur/0
(B6.Cg-Cybbtm1Din Tg(SOD1*G93A)dl1Gur)
|
increased skeletal muscle fiber size
|
J:111782
|
Cygbtm1Ppam/Cygbtm1Ppam
Tg(Myog-cre)1Eno/0
(involves: 129 * C57BL/6)
|
abnormal muscle precursor cell physiology
|
J:206378
|
| abnormal myoblast differentiation
|
J:206378
|
| impaired muscle regeneration
|
J:206378
|
| skeletal muscle degeneration
|
J:206378
|
Cyp2j5tm1Dcz/Cyp2j5tm1Dcz
(129S/SvEv-Cyp2j5tm1Dcz)
|
increased vasoconstriction
|
J:146047
|
Cyp11a1tm1Bcc/Cyp11a1tm1Bcc
(involves: 129 * C57BL/6)
|
muscular atrophy
|
J:78062
|
Cyp11b2tm2Hsk/Cyp11b2tm2Hsk
(involves: 129S6/SvEvTac)
|
increased myocardial fiber size
|
J:147672
|
Cyp19a1tm1Esi/Cyp19a1tm1Esi
(involves: 129S6/SvEvTac * C57BL/6)
|
increased cardiac muscle contractility
|
J:105620
|
Cyp51tm1.1Bfro/Cyp51tm1.1Bfro
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal lymphatic vessel smooth muscle morphology
|
J:173366
|
D930028M14Riktm1a(EUCOMM)Wtsi/D930028M14Riktm1a(EUCOMM)Wtsi
(C57BL/6N-D930028M14Riktm1a(EUCOMM)Wtsi/Wtsi)
|
abnormal eye muscle morphology
|
J:239583
|
d-58H/d-58H
(involves: 101/H * C3H/HeH)
|
opisthotonus
|
J:178968
|
Daam1Gt(RRT390)Byg/Daam1Gt(RRT390)Byg
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal muscle physiology
|
J:167714
|
| abnormal sarcomere morphology
|
J:167714
|
Daam1tm1.1Tpy/Daam1tm1.1Tpy
Daam2tm1Tpy/Daam2tm1Tpy
Nkx2-5tm1(cre)Rjs/Nkx2-5+
(involves: 129S1/Sv * 129S7/SvEvBrd)
|
abnormal A band morphology
|
J:228507
|
| abnormal H zone morphology
|
J:228507
|
| abnormal I band morphology
|
J:228507
|
| abnormal intercalated disk morphology
|
J:228507
|
| abnormal myocardial fiber morphology
|
J:228507
|
| abnormal myocardial trabeculae morphology
|
J:228507
|
| absent M line
|
J:228507
|
| absent Z line
|
J:228507
|
| diffuse Z line
|
J:228507
|
Daam1tm1.1Tpy/Daam1tm1.1Tpy
Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sor+
Nkx2-5tm1(cre)Rjs/Nkx2-5+
(involves: 129S1/Sv * 129S4/SvJaeSor * 129S7/SvEvBrd)
|
abnormal cardiac muscle tissue morphology
|
J:228507
|
Daam1tm1.1Tpy/Daam1tm1.1Tpy
Nkx2-5tm1(cre)Rjs/Nkx2-5+
(involves: 129S1/Sv * 129S7/SvEvBrd)
|
abnormal myocardial trabeculae morphology
|
J:228507
|
| thin ventricle myocardium compact layer
|
J:228507
|
Daam1tm1.1Tpy/Daam1tm1.1Tpy
Nkx2-5tm1(cre)Rjs/Nkx2-5+
Wnt5atm1Amc/Wnt5a+
(involves: 129S1/Sv * 129S7/SvEvBrd)
|
abnormal myocardial trabeculae morphology
|
J:228507
|
| thick myocardium compact layer
|
J:228507
|
Daam1tm1.1Tpy/Daam1tm1.1Tpy
Nkx2-5tm1(cre)Rjs/Nkx2-5+
Wnt5atm1Amc/Wnt5atm1Amc
(involves: 129S1/Sv * 129S7/SvEvBrd)
|
abnormal myocardial trabeculae morphology
|
J:228507
|
| abnormal myocardium compact layer morphology
|
J:228507
|
Dag1tm1.1Swin/Dag1tm1.1Swin
Dmdmdx/Y
(involves: 129S4/SvJae * C57BL/6 * C57BL/10ScSn)
|
centrally nucleated skeletal muscle fibers
|
J:187750
|
Dag1tm1.1Swin/Dag1tm1.1Swin
Dmdmdx/Dmdmdx
(involves: 129S4/SvJae * C57BL/6 * C57BL/10ScSn)
|
centrally nucleated skeletal muscle fibers
|
J:187750
|
Dag1tm2Kcam/Dag1tm2Kcam
Myl2tm1(cre)Krc/Myl2+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)
|
abnormal cardiac muscle contractility
|
J:169951
|
| dilated cardiomyopathy
|
J:169951
|
| myocardial fiber degeneration
|
J:169951
|
Dag1tm2Kcam/Dag1tm2Kcam
Tg(Ckmm-cre)5Khn/0
(involves: 129S1/Sv * 129X1/SvJ * FVB)
|
abnormal skeletal muscle morphology
|
J:78838
|
| centrally nucleated skeletal muscle fibers
|
J:78838
|
| dystrophic muscle
|
J:78838
|
| increased skeletal muscle fiber diameter
|
J:78838
|
| increased skeletal muscle fiber size
|
J:78838
|
| increased skeletal muscle weight
|
J:78838
|
| increased variability of skeletal muscle fiber size
|
J:78838
|
| skeletal muscle necrosis
|
J:78838
|
Dag1tm4.1Kcam/Dag1tm4.1Kcam
(involves: 129S1/Sv * 129X1/SvJ)
|
centrally nucleated skeletal muscle fibers
|
J:169291
|
| dystrophic muscle
|
J:169291
|
Dcaf6tm1.1Ntuy/Dcaf6tm1.1Ntuy
(B6JNarl.Cg-Dcaf6tm1.1Ntuy)
|
abnormal muscle physiology
|
J:233771
|
| delayed skeletal muscle regeneration
|
J:233771
|
| impaired skeletal muscle regeneration
|
J:233771
|
Dcntm1Ioz/Dcntm1Ioz
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss)
|
abnormal tendon morphology
|
J:39212
|
Dcntm1Ioz/Dcntm1Ioz
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)
|
abnormal tendon morphology
|
J:91512
|
Dctn1tm2.1Cai/Dctn1tm2.1Cai
Tg(Thy1-cre)1Vln/?
(involves: 129S4/SvJaeSor * 129X1/SvJ * C57BL/6 * FVB/N)
|
decreased gastrocnemius weight
|
J:264431
|
| skeletal muscle atrophy
|
J:264431
|
Ddah1tm1Pval/Ddah1+
(involves: 129X1/SvJ * C57BL/6)
|
abnormal vasodilation
|
J:121719
|
| increased vasoconstriction
|
J:121719
|
Ddah1tm1Yjch/Ddah1tm1Yjch
Tg(Tek-cre)12Flv/0
(involves: 129S1/Sv * C57BL/6J)
|
abnormal vascular smooth muscle physiology
|
J:168130
|
Ddr2tm1.1(cre/Esr1*)Rcow/Ddr2tm1.1(cre/Esr1*)Rcow
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal cardiac muscle relaxation
|
J:214642
|
| decreased cardiac muscle contractility
|
J:214642
|
| decreased myocardial fiber size
|
J:214642
|
Ddttm1Lhy/Ddttm1Lhy
Tg(Myh6-cre)2182Mds/0
(involves: 129S4/SvJae * C57BL/6 * FVB/N)
|
cardiac muscle necrosis
|
J:213776
|
| decreased cardiac muscle contractility
|
J:213776
|
Ddx3xtm1.1Lyou/Y
Edil3Tg(Sox2-cre)1Amc/Edil3+
(involves: 129 * C57BL/6 * CBA)
|
abnormal myocardial trabeculae morphology
|
J:231798
|
Degs1Gt(OST368559)Lex/Degs1+
(involves: 129S5/SvEvBrd)
|
increased muscle cell glucose uptake
|
J:203554
|
Del(1Aim2-Ifi205)1Stsn/+
Trex1tm1Tld/Trex1tm1Tld
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6N)
|
myositis
|
J:234263
|
Del(1Aim2-Ifi205)1Stsn/Del(1Aim2-Ifi205)1Stsn
Trex1tm1Tld/Trex1tm1Tld
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6N)
|
myositis
|
J:234263
|
Del(2Hoxd4-Hoxd13)30Ddu/Del(2Hoxd4-Hoxd13)30Ddu
(involves: 129S2/SvPas)
|
abnormal smooth muscle morphology
|
J:92363
|
Del(2Hoxd8,Hoxd9-Hoxd13)1Cx/Del(2Hoxd8,Hoxd9-Hoxd13)1Cx
(involves: NZW/LacJ)
|
muscular atrophy
|
J:103924
|
Del(2Hoxd8-Hoxd13)9Ddu/Del(2Hoxd8-Hoxd13)9Ddu
(involves: 129S2/SvPas)
|
muscular atrophy
|
J:103924
|
Del(2Hoxd9-Hoxd13)8Ddu/Del(2Hoxd9-Hoxd13)8Ddu
(involves: 129S2/SvPas)
|
muscular atrophy
|
J:103924
|
Del(2Hoxd10-Hoxd13)7Ddu/Del(2Hoxd10-Hoxd13)7Ddu
(involves: 129S2/SvPas)
|
muscular atrophy
|
J:103924
|
Del(4C4-C5)1Lap/Del(4C4-C5)1Lap
(involves: 129S6/SvEvTac)
|
abnormal vascular smooth muscle physiology
|
J:158126
|
| increased vascular smooth muscle cell proliferation
|
J:158126
|
Del(4Cyp2j13-Cyp2j5)1Brs/Del(4Cyp2j13-Cyp2j5)1Brs
(involves: C57BL/6)
|
abnormal vasoconstriction
|
J:223128
|
Del(7Ube3a-Snrpn)1Alb/+
(involves: 129S7/SvEvBrd * C57BL/6J)
|
hypotonia
|
J:56617
|
Del(9Hspb2-Cryab)1Wawr/Del(9Hspb2-Cryab)1Wawr
(involves: 129S4/SvJae)
|
abnormal skeletal muscle fiber morphology
|
J:72926
|
| abnormal tongue muscle morphology
|
J:72926
|
| dystrophic muscle
|
J:72926
|
| muscle degeneration
|
J:72926
|
| progressive muscle weakness
|
J:72926
|
Del(11Irf1-D11Mit23)1Rub/Del(11Irf1-D11Mit23)1Rub
(129/Sv-Del(11Irf1-D11Mit23)1Rub)
|
increased cardiac muscle triglyceride level
|
J:60187
|
Del(16Hspa13-App)3Yah/+
(B6J.129P2-Del(16Hspa13-App)3Yah)
|
abnormal muscle physiology
|
J:223518
|
| abnormal skeletal muscle fiber type ratio
|
J:223518
|
| abnormal skeletal muscle morphology
|
J:223518
|
| decreased skeletal muscle mass
|
J:223518
|
Del(18Pcdhg)1Xzw/Del(18Pcdhg)1Xzw
(Not Specified)
|
muscle hypertonia
|
J:188341
|
Del(MTmt-Tk-mt-Nd5)1Jiha
(involves: C57BL/6J * CBA)
|
myopathy
|
J:115155
|
Destm1.1Ccrs/Des+
(involves: 129 * C57BL/6J)
|
abnormal skeletal muscle fiber morphology
|
J:219616
|
| cardiomyopathy
|
J:219616
|
| decreased cardiac muscle contractility
|
J:219616
|
| dilated cardiomyopathy
|
J:219616
|
| muscle phenotype
|
J:219616
|
Destm1.1Ccrs/Destm1.1Ccrs
(involves: 129 * C57BL/6J)
|
abnormal skeletal muscle fiber mitochondrial morphology
|
J:219616
|
| abnormal skeletal muscle fiber morphology
|
J:219616
|
| abnormal soleus morphology
|
J:219616
|
| abnormal Z line morphology
|
J:219616
|
| cardiomyopathy
|
J:219616
|
| centrally nucleated skeletal muscle fibers
|
J:219616
|
| decreased cardiac muscle contractility
|
J:219616
|
| dilated cardiomyopathy
|
J:219616
|
| dystrophic muscle
|
J:219616
|
| impaired skeletal muscle contractility
|
J:219616
|
| increased variability of skeletal muscle fiber size
|
J:219616
|
| myopathy
|
J:219616
|
| progressive muscle weakness
|
J:219616
|
| skeletal muscle degeneration
|
J:219616
|
| skeletal muscle endomysial fibrosis
|
J:219616
|
| skeletal muscle fiber degeneration
|
J:219616
|
Destm1Cap/Destm1Cap
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal cardiac muscle relaxation
|
J:59831
|
| abnormal myocardial fiber morphology
|
J:59831,
J:35123
|
| abnormal myocardium layer morphology
|
J:35123
|
| abnormal skeletal muscle morphology
|
J:35123
|
| abnormal smooth muscle morphology
|
J:35123
|
| cardiomyopathy
|
J:35123
|
| decreased ventricle muscle contractility
|
J:59831
|
| disorganized myocardium
|
J:59831,
J:35123
|
| muscle degeneration
|
J:35123
|
| thin myocardium
|
J:59831
|
Destm1Cap/Destm1Cap
(involves: 129S7/SvEvBrd)
|
abnormal myocardial fiber morphology
|
J:88267
|
| decreased ventricle muscle contractility
|
J:88267
|
| dilated cardiomyopathy
|
J:88267
|
Destm1Cap/Destm1Cap
Tg(Bcl2)BCap/Tg(Bcl2)BCap
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal myocardial fiber morphology
|
J:88267
|
Destm1Cba/Destm1Cba
(involves: 129S2/SvPas)
|
abnormal diaphragm morphology
|
J:32928
|
| abnormal myocardial fiber morphology
|
J:32928
|
| abnormal myocardium layer morphology
|
J:32928
|
| abnormal skeletal muscle fiber morphology
|
J:137067
|
| abnormal vascular smooth muscle morphology
|
J:32928
|
| centrally nucleated skeletal muscle fibers
|
J:137067
|
| decreased skeletal muscle fiber number
|
J:137067
|
| increased skeletal muscle fiber size
|
J:137067
|
| myocardium necrosis
|
J:32928
|
| skeletal muscle fiber atrophy
|
J:137067
|
| skeletal muscle fiber necrosis
|
J:137067
|
| thin diaphragm muscle
|
J:32928
|
Destm1Cba/Destm1Cba
(involves: 129S2/SvPas * C57BL/6J)
|
cardiomyopathy
|
J:130557
|
| decreased cardiac muscle contractility
|
J:130557
|
Destm1Cba/Destm1Cba
Synmtm1.1Ics/Synmtm1.1Ics
(involves: 129S2/SvPas)
|
abnormal myoblast differentiation
|
J:268425
|
| muscle phenotype
|
J:268425
|
Destm1Ltho/Destm1Ltho
(involves: 129S2/SvPas * C57BL/6J * CBA)
|
abnormal intercalated disk morphology
|
J:127515
|
| abnormal myocardial fiber morphology
|
J:127515
|
| abnormal ventricle papillary muscle morphology
|
J:127515
|
| decreased myocardial fiber number
|
J:127515
|
| myocardial fiber degeneration
|
J:127515
|
Dgcr8tm1.1Blel/Dgcr8tm1.1Blel
Tg(Ckmm-cre)5Khn/0
(involves: 129S4/SvJae * C57BL/6 * FVB)
|
decreased ventricle muscle contractility
|
J:161342
|
Dguoktm1.1Anka/Dguoktm1.1Anka
(involves: 129 * C57BL/6N)
|
decreased myocardial fiber mitochondrial DNA content
|
J:294620
|
| decreased skeletal muscle fiber mitochondrial DNA content
|
J:294620
|
Dhcr7tm1Gst/Dhcr7tm1Gst
Tg(APOE-DHCR7)2Hoyu/0
(involves: 129P2/OlaHsd * C57BL * C57BL/6J * FVB/N)
|
hypotonia
|
J:141730
|
Dhfrorana/Dhfr+
(involves: C57BL/6JAnu)
|
decreased vasodilation
|
J:236197
|
Dhrs7bGt(OST255410)Lex/Dhrs7bGt(OST255410)Lex
(B6;129S5-Dhrs7bGt(OST255410)Lex/Mmucd)
|
muscle degeneration
|
J:171883
|
Dhtkd1tm1Mmgu/Dhtkd1tm1Mmgu
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal gastrocnemius morphology
|
J:288186
|
Dhtkd1tm1Zgwg/Dhtkd1tm1Zgwg
(involves: C57BL/6)
|
abnormal sarcomere morphology
|
J:267178
|
| muscular atrophy
|
J:267178
|
| progressive muscle weakness
|
J:267178
|
Dicer1tm1Bdh/Dicer1tm1Bdh
Nkx2-5tm1(cre)Rjs/Nkx2-5+
(involves: 129 * 129S7/SvEvBrd * C57BL/6)
|
abnormal myocardium layer morphology
|
J:211548
|
Dicer1tm1Bdh/Dicer1tm1Bdh
Nkx2-5tm2(cre)Rph/Nkx2-5+
(involves: 129 * 129S1/Sv)
|
thin ventricle myocardium compact layer
|
J:156467
|
Dicer1tm1Bdh/Dicer1tm1Bdh
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129 * C57BL/6 * CBA)
|
impaired skeletal muscle regeneration
|
J:292144
|
Dicer1tm1Smr/Dicer1tm1Smr
Tg(Myh6-cre)2182Mds/0
(involves: 129S7/SvEvBrd * FVB/N)
|
abnormal myocardial fiber morphology
|
J:131962
|
| abnormal sarcomere morphology
|
J:131962
|
| decreased cardiac muscle contractility
|
J:131962
|
| dilated cardiomyopathy
|
J:131962
|
| disorganized myocardium
|
J:131962
|
| increased cardiomyocyte apoptosis
|
J:131962
|
Disp1tm1Ptch/Disp1tm1Ptch
(involves: 129P2/OlaHsd)
|
abnormal dermomyotome development
|
J:79831
|
Dlg1tm1Jhm/Dlg1tm1Jhm
(involves: 129 * C57BL/6J)
|
impaired smooth muscle contractility
|
J:118250
|
| impaired ureteric peristalsis
|
J:118250
|
Dlk1tm1.1Jvs/Dlk1+
Myf5tm3(cre)Sor/Myf5+
(involves: 129P2/SvPas * 129S4/SvJaeSor * C57BL/6 * FVB/N)
|
decreased skeletal muscle fiber number
|
J:167124
|
| impaired skeletal muscle regeneration
|
J:167124
|
| increased skeletal muscle fiber diameter
|
J:167124
|
| increased skeletal muscle fiber size
|
J:167124
|
| skeletal muscle fibrosis
|
J:167124
|
Dll1tm1Gos/Dll1tm2Gos
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal myoblast differentiation
|
J:119082
|
| abnormal myotube differentiation
|
J:119082
|
| decreased skeletal muscle mass
|
J:119082
|
Dll1tm1Gos/Dll1tm2Gos
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal muscle morphology
|
J:148902
|
| abnormal myogenesis
|
J:148902
|
| decreased skeletal muscle mass
|
J:148902
|
Dll1tm3.1Gos/Dll1tm3.1Gos
(Not Specified)
|
muscle phenotype
|
J:213529
|
Dll3pu/Dll3pu
(involves: 101/Rl * C3H/Rl)
|
abnormal dermomyotome development
|
J:14975
|
| abnormal multifidus muscle morphology
|
J:324821
|
Dll3tm1Rbe/Dll3tm1Rbe
(B6.129P2-Dll3tm1Rbe)
|
abnormal multifidus muscle morphology
|
J:324821
|
Dll4tm1Jrt/Dll4tm1Jrt
(involves: 129S1/Sv * 129X1/SvJ * ICR)
|
trabecula carnea hypoplasia
|
J:93157
|
Dll4tm1Nwg/Dll4+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac)
|
abnormal vascular smooth muscle morphology
|
J:94740
|
Dlx2tm1Jlr/Dlx2tm1Jlr
(either: (involves: 129X1/SvJ) or (involves: 129X1/SvJ * CD-1))
|
intestinal hypoperistalsis
|
J:29443
|
Dlx2tm1Jlr/Dlx2tm1Jlr
(involves: 129X1/SvJ)
|
abnormal skeletal muscle morphology
|
J:40427
|
Dlx5tm1Jlr/Dlx5tm1Jlr
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal intrinsic tongue muscle morphology
|
J:56559
|
| abnormal mylohyoid muscle morphology
|
J:56559
|
| abnormal pterygoid muscle morphology
|
J:56559
|
| abnormal tongue muscle morphology
|
J:56559
|
Dmdem1Eno/Y
(involves: C57BL/6J)
|
centrally nucleated skeletal muscle fibers
|
J:253191
|
| dystrophic muscle
|
J:253191
|
| increased variability of skeletal muscle fiber size
|
J:253191
|
| myositis
|
J:253191
|
| skeletal muscle necrosis
|
J:253191
|
Dmdem4Eno/Y
(C57BL/6-Dmdem4Eno)
|
centrally nucleated skeletal muscle fibers
|
J:285447
|
| dystrophic muscle
|
J:285447
|
| muscle weakness
|
J:285447
|
| myositis
|
J:285447
|
| skeletal muscle fiber degeneration
|
J:285447
|
| skeletal muscle fibrosis
|
J:285447
|
Dmdem4Eno/Dmdem4Eno
(C57BL/6-Dmdem4Eno)
|
centrally nucleated skeletal muscle fibers
|
J:285447
|
| dystrophic muscle
|
J:285447
|
| muscle weakness
|
J:285447
|
| myositis
|
J:285447
|
| skeletal muscle fiber degeneration
|
J:285447
|
| skeletal muscle fibrosis
|
J:285447
|
Dmdem#Tve/Y
(involves: C57BL/6 * CBA)
|
abnormal sarcolemma morphology
|
J:275476
|
| centrally nucleated skeletal muscle fibers
|
J:275476
|
| decreased skeletal muscle fiber diameter
|
J:275476
|
| dystrophic muscle
|
J:275476
|
| muscle weakness
|
J:275476
|
| skeletal muscle fiber degeneration
|
J:275476
|
| skeletal muscle fiber necrosis
|
J:275476
|
| skeletal muscle fibrosis
|
J:275476
|
DmdGt(ROSABetageo)1Mpd/Y
(involves: 129S1/Sv)
|
abnormal muscle morphology
|
J:47968
|
| abnormal muscle physiology
|
J:47968
|
DmdGt(ROSABetageo)1Mpd/DmdGt(ROSABetageo)1Mpd
(involves: 129S1/Sv)
|
abnormal muscle morphology
|
J:47968
|
| abnormal muscle physiology
|
J:47968
|
Dmdmdx-2Cv/Y
(involves: C3H/HeHa * C57BL/6Ros * C57BL/10Sn * M. m. castaneus * M. m. musculus)
|
abnormal skeletal muscle fiber morphology
|
J:9638
|
| impaired muscle relaxation
|
J:9638
|
| skeletal muscle fiber degeneration
|
J:9638
|
Dmdmdx-2Cv/Y
(B6Ros.Cg-Dmdmdx-2Cv)
|
abnormal diaphragm morphology
|
J:23502
|
| skeletal muscle fibrosis
|
J:23502
|
Dmdmdx-2Cv/Dmdmdx-2Cv
(B6Ros.Cg-Dmdmdx-2Cv)
|
abnormal diaphragm morphology
|
J:23502
|
| skeletal muscle fibrosis
|
J:23502
|
Dmdmdx-3Cv/Y
(involves: C3H/HeHa * C57BL/6Ros * C57BL/10Sn * M. m. castaneus * M. m. musculus)
|
impaired muscle relaxation
|
J:9638
|
| skeletal muscle fiber degeneration
|
J:9638
|
Dmdmdx-3Cv/Y
(B6Ros.Cg-Dmdmdx-3Cv)
|
abnormal diaphragm morphology
|
J:23502
|
| centrally nucleated skeletal muscle fibers
|
J:23502
|
| increased variability of skeletal muscle fiber size
|
J:12150
|
| skeletal muscle fibrosis
|
J:23502
|
Dmdmdx-3Cv/Y
(B6.Cg-Dmdmdx-3Cv/J)
|
abnormal muscle contractility
|
J:134272
|
| abnormal skeletal muscle morphology
|
J:134272
|
| centrally nucleated skeletal muscle fibers
|
J:134272
|
| increased variability of skeletal muscle fiber size
|
J:134272
|
Dmdmdx-3Cv/Y
Utrntm1Ked/Utrntm1Ked
(involves: 129 * C3H/HeHa * C57BL * M. m. castaneus * M. m. musculus)
|
abnormal skeletal muscle morphology
|
J:116348
|
Dmdmdx-3Cv/Dmdmdx-3Cv
(B6Ros.Cg-Dmdmdx-3Cv)
|
abnormal diaphragm morphology
|
J:23502
|
| centrally nucleated skeletal muscle fibers
|
J:23502
|
| increased variability of skeletal muscle fiber size
|
J:12150
|
| skeletal muscle fibrosis
|
J:23502
|
Dmdmdx-3Cv/Dmdmdx-3Cv
Utrntm1Ked/Utrntm1Ked
(involves: 129 * C3H/HeHa * C57BL * M. m. castaneus * M. m. musculus)
|
abnormal skeletal muscle morphology
|
J:116348
|
Dmdmdx-4Cv/Y
(B6Ros.Cg-Dmdmdx-4Cv)
|
abnormal diaphragm morphology
|
J:23502
|
| skeletal muscle fibrosis
|
J:23502
|
Dmdmdx-4Cv/Y
(B6Ros.Cg-Dmdmdx-4Cv/J)
|
abnormal muscle contractility
|
J:134272
|
| abnormal skeletal muscle morphology
|
J:134272
|
| centrally nucleated skeletal muscle fibers
|
J:134272
|
| increased variability of skeletal muscle fiber size
|
J:134272
|
Dmdmdx-4Cv/Dmdmdx-4Cv
(B6Ros.Cg-Dmdmdx-4Cv)
|
abnormal diaphragm morphology
|
J:23502
|
| skeletal muscle fibrosis
|
J:23502
|
Dmdmdx-4Cv/Dmdmdx-4Cv
(involves: C3H/HeHa * C57BL/6Ros * C57BL/10Sn * M. m. castaneus * M. m. musculus)
|
abnormal skeletal muscle fiber morphology
|
J:128921
|
| centrally nucleated skeletal muscle fibers
|
J:128921
|
| increased satellite cell number
|
J:128921
|
| skeletal muscle fiber necrosis
|
J:128921
|
Dmdmdx-4Cv/Dmdmdx-4Cv
Myf5tm2Tajb/Myf5tm2Tajb
(involves: 129S2/SvPas * C3H/HeHa * C57BL * M. m. castaneus * M. m. musculus)
|
increased skeletal muscle fiber diameter
|
J:128921
|
| skeletal muscle fiber necrosis
|
J:128921
|
Dmdmdx-4Cv/Dmdmdx-4Cv
Terctm1Rdp/Terctm1Rdp
(B6.Cg-Terctm1Rdp Dmdmdx-4Cv)
|
abnormal myocardial fiber morphology
|
J:200365
|
| decreased ventricle muscle contractility
|
J:200365
|
| dilated cardiomyopathy
|
J:200365
|
| ventricular cardiomyopathy
|
J:200365
|
Dmdmdx-5Cv/Y
(B6Ros.Cg-Dmdmdx-5Cv)
|
abnormal diaphragm morphology
|
J:23502
|
| impaired skeletal muscle contractility
|
J:177391
|
| increased muscle fatigability
|
J:177391
|
| muscle phenotype
|
J:177391
|
| skeletal muscle fibrosis
|
J:177391,
J:23502
|
Dmdmdx-5Cv/Dmdmdx-5Cv
(B6Ros.Cg-Dmdmdx-5Cv)
|
abnormal diaphragm morphology
|
J:23502
|
| skeletal muscle fibrosis
|
J:23502
|
Dmdmdx-5Cv/Dmdmdx-5Cv
(B6Ros.Cg-Dmdmdx-5Cv/J)
|
abnormal muscle contractility
|
J:164891
|
| centrally nucleated skeletal muscle fibers
|
J:164891
|
| increased satellite cell number
|
J:164891
|
| increased variability of skeletal muscle fiber size
|
J:164891
|
Dmdmdx-5Cv/Dmdmdx-5Cv
Flt1tm1Jrt/Flt1+
(involves: C3HA * C57BL/6Ros)
|
abnormal muscle contractility
|
J:164891
|
| abnormal muscle development
|
J:164891
|
| abnormal skeletal muscle fiber morphology
|
J:164891
|
| abnormal skeletal muscle fiber size
|
J:164891
|
| increased satellite cell number
|
J:164891
|
| muscle phenotype
|
J:164891
|
Dmdmdx-5Cv/Dmdmdx-5Cv
Flt1tm1Jrt/Flt1+
Utrntm1Jrs/Utrntm1Jrs
(involves: 129S1/Sv * 129X1/SvJ * C3HA * C57BL/6Ros)
|
centrally nucleated skeletal muscle fibers
|
J:164891
|
Dmdmdx/?
(B6.B10ScSn-Dmdmdx)
|
abnormal skeletal muscle fiber morphology
|
J:85088
|
| abnormal skeletal muscle morphology
|
J:85088
|
| dystrophic muscle
|
J:85088
|
Dmdmdx/Y
(C57BL/10ScSn-Dmdmdx/J)
|
abnormal muscle morphology
|
J:7361
|
| abnormal muscle physiology
|
J:3666
|
| abnormal skeletal muscle fiber morphology
|
J:7361
|
| dilated sarcoplasmic reticulum
|
J:7361
|
| dystrophic muscle
|
J:7361
|
| increased variability of skeletal muscle fiber size
|
J:7361
|
| muscle degeneration
|
J:7361
|
| muscular atrophy
|
J:7361
|
| myopathy
|
J:7361
|
| skeletal muscle fibrosis
|
J:7361
|
| skeletal muscle necrosis
|
J:7361
|
Dmdmdx/Y
(C57BL/10ScSn-Dmdmdx)
|
abnormal atrium myocardial trabeculae morphology
|
J:150127
|
| abnormal intercostal muscle morphology
|
J:150127
|
| abnormal muscle contractility
|
J:152525
|
| abnormal muscle development
|
J:150127
|
| abnormal myocardial fiber morphology
|
J:150127
|
| abnormal myotube morphology
|
J:150127
|
| abnormal skeletal muscle fiber morphology
|
J:152525
|
| centrally nucleated skeletal muscle fibers
|
J:150127,
J:152525
|
| impaired muscle relaxation
|
J:9638
|
| impaired skeletal muscle contractility
|
J:177391
|
| muscle phenotype
|
J:177391
|
| myocardial fiber degeneration
|
J:9638
|
| skeletal muscle fiber degeneration
|
J:9638
|
| skeletal muscle fiber necrosis
|
J:152525
|
| skeletal muscle fibrosis
|
J:177391
|
Dmdmdx/Y
(involves: C57BL/10ScSn)
|
abnormal diaphragm morphology
|
J:152891,
J:95776
|
| abnormal intercostal muscle morphology
|
J:152891
|
| abnormal muscle electrophysiology
|
J:142492
|
| abnormal muscle tone
|
J:152749
|
| abnormal skeletal muscle fiber morphology
|
J:152749
|
| centrally nucleated skeletal muscle fibers
|
J:19034
|
| diaphragmitis
|
J:140282
|
| increased skeletal muscle fiber diameter
|
J:19034,
J:152749
|
| increased skeletal muscle mass
|
J:19034
|
| myositis
|
J:140282
|
| skeletal muscle endomysial fibrosis
|
J:19034,
J:140282
|
| skeletal muscle fiber necrosis
|
J:19034
|
| skeletal muscle hypertrophy
|
J:19034
|
| skeletal muscle necrosis
|
J:95776
|
Dmdmdx/Y
(involves: 129S4/SvJae * C57BL/10ScSn)
|
dystrophic muscle
|
J:48851
|
Dmdmdx/Y
Dtnatm1Jrs/Dtnatm1Jrs
(involves: 129X1/SvJ * C57BL/10ScSn)
|
cardiomyopathy
|
J:59675
|
| dystrophic muscle
|
J:59675
|
Dmdmdx/Y
Dtnatm1Jrs/Dtnatm1Jrs
Utrntm1Jrs/Utrntm1Jrs
(involves: 129S1/Sv * 129X1/SvJ * C57BL/10ScSn)
|
cardiomyopathy
|
J:59675
|
| dystrophic muscle
|
J:59675
|
| skeletal muscle necrosis
|
J:59675
|
Dmdmdx/?
Fgf2tm1Zllr/Fgf2tm1Zllr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/10ScSn)
|
dystrophic muscle
|
J:85088
|
Dmdmdx/?
Fgf2tm1Zllr/Fgf2tm1Zllr
Fgf6tm1Thbr/Fgf6tm1Thbr
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6 * C57BL/10ScSn)
|
abnormal muscle physiology
|
J:85088
|
| abnormal skeletal muscle fiber morphology
|
J:85088
|
| abnormal skeletal muscle morphology
|
J:85088
|
| decreased satellite cell number
|
J:85088
|
| dystrophic muscle
|
J:85088
|
| increased variability of skeletal muscle fiber size
|
J:85088
|
| muscle phenotype
|
J:85088
|
| skeletal muscle fiber necrosis
|
J:85088
|
Dmdmdx/?
Fgf6tm1Thbr/Fgf6tm1Thbr
(involves: 129S4/SvJae * C57BL/6 * C57BL/10ScSn)
|
abnormal diaphragm morphology
|
J:42574
|
| abnormal epaxial muscle morphology
|
J:42574
|
| abnormal hypaxial muscle morphology
|
J:42574
|
| dystrophic muscle
|
J:85088
|
| muscle phenotype
|
J:42574
|
| myopathy
|
J:42574
|
Dmdmdx/Y
Foxk1tm1Djg/Foxk1tm1Djg
(involves: 129S4/SvJae * C57BL/10ScSn)
|
skeletal muscle fibrosis
|
J:62225
|
| skeletal muscle necrosis
|
J:62225
|
Dmdmdx/Y
Foxn1nu/Foxn1nu
(involves: C57BL/10ScSn)
|
abnormal muscle morphology
|
J:95776
|
| decreased skeletal muscle fiber size
|
J:95776
|
| increased skeletal muscle fiber size
|
J:95776
|
Dmdmdx/Y
Mirc37tm1Boet/Mirc37tm1Boet
(involves: C57BL/10ScSn)
|
dystrophic muscle
|
J:241493
|
Dmdmdx/?
Myod1tm1Jae/Myod1tm1Jae
(involves: 129S4/SvJae * C57BL/10ScSn)
|
dilated cardiomyopathy
|
J:52248
|
| increased myocardial fiber size
|
J:52248
|
| myocardium necrosis
|
J:52248
|
Dmdmdx/Y
Nos1tm1Plh/Nos1tm1Plh
(involves: 129S4/SvJae * C57BL/10ScSn)
|
dystrophic muscle
|
J:48851
|
Dmdmdx/Y
Spp1tm1Blh/Spp1tm1Blh
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/10 * C57BL/10ScSn)
|
abnormal muscle physiology
|
J:150572
|
Dmdmdx/Y
Terctm1Rdp/Terc+
(involves: 129/Sv * C57BL/6J * C57BL/10ScSn * SJL)
|
abnormal diaphragm morphology
|
J:167294
|
| abnormal muscle physiology
|
J:167294
|
| centrally nucleated skeletal muscle fibers
|
J:167294
|
Dmdmdx/Y
Terctm1Rdp/Terctm1Rdp
(involves: 129/Sv * C57BL/6J * C57BL/10ScSn * SJL)
|
abnormal diaphragm morphology
|
J:167294
|
| abnormal muscle electrophysiology
|
J:167294
|
| abnormal muscle physiology
|
J:167294
|
| abnormal skeletal muscle morphology
|
J:167294
|
| calcified muscle
|
J:167294
|
| centrally nucleated skeletal muscle fibers
|
J:167294
|
| decreased satellite cell number
|
J:167294
|
| dystrophic muscle
|
J:167294
|
| increased variability of skeletal muscle fiber size
|
J:167294
|
| muscle weakness
|
J:167294
|
| muscular atrophy
|
J:167294
|
| myositis
|
J:167294
|
| skeletal muscle degeneration
|
J:167294
|
| skeletal muscle fibrosis
|
J:167294
|
| skeletal muscle necrosis
|
J:167294
|
Dmdmdx/Y
Tg(DMD*)#Spc/0
(involves: 129P2/OlaHsd * C57BL/10ScSn * DBA/2)
|
dystrophic muscle
|
J:280218
|
| myositis
|
J:280218
|
| skeletal muscle fibrosis
|
J:280218
|
Dmdmdx/Y
Utrntm1Jrs/Utrn+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/10ScSn)
|
diaphragmitis
|
J:140282
|
| myositis
|
J:140282
|
| skeletal muscle endomysial fibrosis
|
J:140282
|
Dmdmdx/Dmd+
(involves: C57BL/10ScSn)
|
abnormal skeletal muscle fiber morphology
|
J:121251
|
Dmdmdx/Dmd+
(involves: 129S4/SvJae * C57BL/10ScSn)
|
dystrophic muscle
|
J:48851
|
Dmdmdx/Dmd+
Foxk1tm1Djg/Foxk1+
(involves: 129S4/SvJae * C57BL/10ScSn)
|
skeletal muscle necrosis
|
J:62225
|
Dmdmdx/Dmd+
Nos1tm1Plh/Nos1tm1Plh
(involves: 129S4/SvJae * C57BL/10ScSn)
|
dystrophic muscle
|
J:48851
|
Dmdmdx/Dmdmdx
(involves: C57BL/10ScSn)
|
abnormal diaphragm morphology
|
J:152891
|
| abnormal intercostal muscle morphology
|
J:152891
|
| abnormal muscle contractility
|
J:152525
|
| abnormal muscle electrophysiology
|
J:142492
|
| abnormal muscle physiology
|
J:152750
|
| abnormal muscle tone
|
J:152749
|
| abnormal scalene muscle morphology
|
J:152891
|
| abnormal skeletal muscle fiber morphology
|
J:152892,
J:152525,
J:152749
|
| abnormal skeletal muscle morphology
|
J:152892
|
| abnormal skeletal muscle satellite cell proliferation
|
J:152892
|
| centrally nucleated skeletal muscle fibers
|
J:19034,
J:152525
|
| dilated sarcoplasmic reticulum
|
J:152892
|
| increased skeletal muscle fiber diameter
|
J:19034,
J:152749
|
| increased skeletal muscle mass
|
J:19034
|
| skeletal muscle endomysial fibrosis
|
J:19034
|
| skeletal muscle fiber necrosis
|
J:152892,
J:19034,
J:152525
|
| skeletal muscle hypertrophy
|
J:19034
|
| skeletal muscle necrosis
|
J:152892
|
Dmdmdx/Dmdmdx
(C57BL/10ScSn-Dmdmdx/J)
|
abnormal muscle morphology
|
J:7361
|
| abnormal muscle physiology
|
J:3666
|
| abnormal skeletal muscle fiber morphology
|
J:7361
|
| abnormal skeletal muscle regeneration
|
J:226314
|
| calcified muscle
|
J:226314
|
| cardiomyopathy
|
J:226314
|
| centrally nucleated skeletal muscle fibers
|
J:226314
|
| decreased cardiac muscle contractility
|
J:226314
|
| dilated sarcoplasmic reticulum
|
J:7361
|
| dystrophic muscle
|
J:7361,
J:226314
|
| impaired skeletal muscle contractility
|
J:226314
|
| increased skeletal muscle fiber diameter
|
J:226314
|
| increased skeletal muscle mass
|
J:226314
|
| increased variability of skeletal muscle fiber size
|
J:7361
|
| muscle degeneration
|
J:7361
|
| muscular atrophy
|
J:7361
|
| myopathy
|
J:7361
|
| myositis
|
J:226314
|
| skeletal muscle degeneration
|
J:226314
|
| skeletal muscle fibrosis
|
J:7361
|
| skeletal muscle hypertrophy
|
J:226314
|
| skeletal muscle necrosis
|
J:7361
|
Dmdmdx/Dmdmdx
(C57BL/10ScSn-Dmdmdx)
|
abnormal atrium myocardial trabeculae morphology
|
J:150127
|
| abnormal intercostal muscle morphology
|
J:150127
|
| abnormal muscle development
|
J:150127
|
| abnormal muscle morphology
|
J:7361
|
| abnormal myotube morphology
|
J:150127
|
| abnormal skeletal muscle fiber morphology
|
J:7361,
J:152524
|
| centrally nucleated skeletal muscle fibers
|
J:150127,
J:152524
|
| dilated sarcoplasmic reticulum
|
J:7361
|
| dystrophic muscle
|
J:7361
|
| increased quadriceps weight
|
J:160773
|
| increased skeletal muscle fiber number
|
J:160773
|
| increased skeletal muscle mass
|
J:160773
|
| increased skeletal muscle weight
|
J:160773
|
| increased variability of skeletal muscle fiber size
|
J:7361
|
| muscle degeneration
|
J:7361
|
| muscle phenotype
|
J:160773
|
| muscular atrophy
|
J:7361
|
| myocardial fiber disarray
|
J:150127
|
| myocardium necrosis
|
J:152524
|
| myopathy
|
J:7361
|
| skeletal muscle fiber necrosis
|
J:152524
|
| skeletal muscle fibrosis
|
J:7361
|
| skeletal muscle necrosis
|
J:7361
|
Dmdmdx/Dmdmdx
(involves: BALB/c * C57BL/10ScSn * C57BL/Ka)
|
centrally nucleated skeletal muscle fibers
|
J:125527
|
| impaired skeletal muscle contractility
|
J:125527
|
| increased skeletal muscle fiber diameter
|
J:125527
|
| skeletal muscle fiber degeneration
|
J:125527
|
| skeletal muscle fibrosis
|
J:125527
|
Dmdmdx/Dmdmdx
(D2.B10-Dmdmdx)
|
decreased quadriceps weight
|
J:160773
|
| decreased skeletal muscle fiber number
|
J:160773
|
| decreased skeletal muscle mass
|
J:160773
|
| decreased skeletal muscle weight
|
J:160773
|
| muscle weakness
|
J:160773
|
| skeletal muscle fibrosis
|
J:160773
|
Dmdmdx/Dmdmdx
(D2.B10-Dmdmdx/J)
|
abnormal skeletal muscle fiber morphology
|
J:226314
|
| abnormal skeletal muscle regeneration
|
J:226314
|
| calcified muscle
|
J:226314
|
| cardiac muscle degeneration
|
J:226314
|
| cardiomyopathy
|
J:226314
|
| centrally nucleated skeletal muscle fibers
|
J:226314
|
| decreased cardiac muscle contractility
|
J:226314
|
| decreased skeletal muscle fiber diameter
|
J:226314
|
| decreased skeletal muscle fiber size
|
J:226314
|
| decreased skeletal muscle mass
|
J:226314
|
| dystrophic muscle
|
J:226314
|
| impaired skeletal muscle contractility
|
J:226314
|
| myositis
|
J:226314
|
| skeletal muscle atrophy
|
J:226314
|
| skeletal muscle degeneration
|
J:226314
|
| skeletal muscle fiber atrophy
|
J:226314
|
Dmdmdx/Dmdmdx
Dusp1tm1Brv/Dusp1tm1Brv
(involves: 129S2/SvPas * C57BL/6 * C57BL/10ScSn)
|
decreased skeletal muscle fiber diameter
|
J:162340
|
| decreased skeletal muscle fiber size
|
J:162340
|
| decreased skeletal muscle weight
|
J:162340
|
| dystrophic muscle
|
J:162340
|
| myositis
|
J:162340
|
| skeletal muscle fiber degeneration
|
J:162340
|
Dmdmdx/Dmdmdx
Foxk1tm1Djg/Foxk1tm1Djg
(involves: 129S4/SvJae * C57BL/10ScSn)
|
skeletal muscle fibrosis
|
J:62225
|
| skeletal muscle necrosis
|
J:62225
|
Dmdmdx/Dmdmdx
Mamstrtm1.2Eno/Mamstrtm1.2Eno
(involves: 129 * C57BL/6 * C57BL/10ScSn)
|
abnormal skeletal muscle satellite cell proliferation
|
J:179880
|
| decreased skeletal muscle weight
|
J:179880
|
| muscle degeneration
|
J:179880
|
| skeletal muscle fibrosis
|
J:179880
|
Dmdmdx/Dmdmdx
Mmp9tm1Tvu/Mmp9+
(B10.Cg-Mmp9tm1Tvu Dmdmdx)
|
abnormal muscle morphology
|
J:150030
|
| abnormal muscle physiology
|
J:150030
|
| enhanced skeletal muscle regeneration
|
J:150030
|
Dmdmdx/Dmdmdx
Mmp9tm1Tvu/Mmp9tm1Tvu
(B10.Cg-Mmp9tm1Tvu Dmdmdx)
|
abnormal muscle morphology
|
J:150030
|
| enhanced skeletal muscle regeneration
|
J:150030
|
Dmdmdx/Dmdmdx
Prkdcscid/Prkdcscid
(involves: BALB/c * C57BL/10ScSn * C57BL/Ka)
|
centrally nucleated skeletal muscle fibers
|
J:125527
|
| impaired skeletal muscle contractility
|
J:125527
|
| increased skeletal muscle fiber diameter
|
J:125527
|
| skeletal muscle fiber degeneration
|
J:125527
|
| skeletal muscle fibrosis
|
J:125527
|
Dmdmdx/Dmdmdx
Selenostm1.1Sfa/Selenos+
(involves: C57BL/6 * C57BL/10ScSn)
|
abnormal skeletal muscle fiber type ratio
|
J:266872
|
| muscle phenotype
|
J:266872
|
Dmdmdx/Dmdmdx
Snhg15tm1Nju/Snhg15tm1Nju
(involves: C57BL/6J * C57BL/10ScSn)
|
impaired skeletal muscle regeneration
|
J:291983
|
| increased variability of skeletal muscle fiber size
|
J:291983
|
| muscle phenotype
|
J:291983
|
| skeletal muscle fibrosis
|
J:291983
|
Dmdmdx/Dmdmdx
Spp1tm1Blh/Spp1tm1Blh
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/10 * C57BL/10ScSn)
|
abnormal muscle physiology
|
J:150572
|
Dmdmdx/Dmdmdx
Tg(ACTA1-SSPN)3.0Rcros/0
(involves: C57BL/10ScSn)
|
abnormal sarcolemma morphology
|
J:185346
|
| centrally nucleated skeletal muscle fibers
|
J:185346
|
| dystrophic muscle
|
J:185346
|
Dmdmdx/Dmdmdx
Utrntm1Jrs/Utrntm1Jrs
(involves: 129S1/Sv * 129X1/SvJ * C57BL/10ScSn)
|
abnormal muscle physiology
|
J:42389
|
| abnormal muscle relaxation
|
J:42389
|
| cardiomyopathy
|
J:59675,
J:42389
|
| dystrophic muscle
|
J:59675,
J:42389
|
| muscle degeneration
|
J:42389
|
| muscle weakness
|
J:42389
|
| myocardium necrosis
|
J:42389
|
| skeletal muscle interstitial fibrosis
|
J:42389
|
| skeletal muscle necrosis
|
J:42389
|
Dmdmdx/Dmdmdx
Utrntm1Ked/Utrntm1Ked
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/10ScSn * DBA)
|
abnormal skeletal muscle fiber morphology
|
J:42388
|
| abnormal skeletal muscle fiber size
|
J:42388
|
| centrally nucleated skeletal muscle fibers
|
J:42388
|
| dystrophic muscle
|
J:42388
|
| progressive muscle weakness
|
J:42388
|
| skeletal muscle interstitial fibrosis
|
J:42388
|
| skeletal muscle necrosis
|
J:42388
|
Dmdtm1.1Khan/Y
(involves: C57BL/6 * CBA)
|
increased skeletal muscle fiber size
|
J:96210
|
| skeletal muscle fiber degeneration
|
J:96210
|
| skeletal muscle fiber necrosis
|
J:96210
|
Dmdtm1.1Know/Dmdtm1.1Know
(involves: C3H)
|
abnormal sarcolemma morphology
|
J:207775
|
Dmdtm1.1Know/Dmdtm1.1Know
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
Tg(Myh6-2A)#Know/0
(involves: BALB/c * C3H * C57BL/6 * FVB/N)
|
cardiomyopathy
|
J:207775
|
| increased cardiac muscle contractility
|
J:207775
|
Dmdtm1Kmf/Y
(involves: C57BL/6)
|
dystrophic muscle
|
J:233298
|
| muscle degeneration
|
J:233298
|
| myositis
|
J:233298
|
| skeletal muscle fiber necrosis
|
J:233298
|
| skeletal muscle fibrosis
|
J:233298
|
Dmdtm1Mok/Y
(involves: 129S/SvEv)
|
abnormal diaphragm morphology
|
J:43164
|
| muscle degeneration
|
J:43164
|
Dmpkem1Sws/Dmpkem1Sws
(C57BL/6J-Dmpkem1Sws)
|
muscle phenotype
|
J:284198
|
Dmpkem2Sws/Dmpkem2Sws
(involves: C57BL/6J * FVB/NJ)
|
muscle phenotype
|
J:284198
|
Dmpktm1Bew/Dmpktm1Bew
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal muscle physiology
|
J:43052,
J:33711
|
Dmpktm1Rdd/Dmpk+
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal sarcomere morphology
|
J:53077
|
| decreased skeletal muscle fiber diameter
|
J:33714
|
| enhanced skeletal muscle regeneration
|
J:33714
|
| impaired skeletal muscle contractility
|
J:33714
|
| myopathy
|
J:33714
|
Dmpktm1Rdd/Dmpktm1Rdd
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal sarcomere morphology
|
J:33714
|
| absent Z line
|
J:33714
|
| dilated sarcoplasmic reticulum
|
J:33714
|
| enhanced skeletal muscle regeneration
|
J:33714
|
| impaired skeletal muscle contractility
|
J:33714
|
| increased variability of skeletal muscle fiber size
|
J:33714
|
| myopathy
|
J:33714
|
| progressive muscle weakness
|
J:33714
|
Dmrt2tm1Rjo/Dmrt2tm1Rjo
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal dermomyotome development
|
J:104893
|
| abnormal myotome development
|
J:104893
|
| abnormal myotome morphology
|
J:104893
|
Dnah5b2b2395Clo/Dnah5b2b2395Clo
(C57BL/6J-Dnah5b2b2395Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
Dnah11b2b1279Clo/Dnah11b2b1279Clo
(C57BL/6J-Dnah11b2b1279Clo)
|
abnormal myocardial trabeculae morphology
|
J:175213
|
Dnah11b2b1289Clo/Dnah11b2b1289Clo
(C57BL/6J-Dnah11b2b1289Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
Dnaja3tm1.1Jdl/Dnaja3tm1.1Jdl
Tg(Myhca-cre)1Abel/0
(involves: 129X1/SvJ * C57BL/6J * FVB)
|
abnormal myocardial fiber morphology
|
J:104462
|
| abnormal sarcomere morphology
|
J:104462
|
| decreased myocardial fiber mitochondrial DNA content
|
J:104462
|
| decreased ventricle muscle contractility
|
J:104462
|
| dilated cardiomyopathy
|
J:104462
|
| increased cardiomyocyte apoptosis
|
J:104462
|
| trabecula carnea hypoplasia
|
J:104462
|
Dnajb4em1Sngi/Dnajb4+
(involves: C57BL/6J)
|
abnormal skeletal muscle fiber morphology
|
J:333950
|
| abnormal skeletal muscle morphology
|
J:333950
|
| decreased skeletal muscle fiber size
|
J:333950
|
| impaired skeletal muscle contractility
|
J:333950
|
| increased variability of skeletal muscle fiber size
|
J:333950
|
| muscle weakness
|
J:333950
|
| skeletal muscle atrophy
|
J:333950
|
| skeletal muscle fibrosis
|
J:333950
|
Dnajb4em1Sngi/Dnajb4em1Sngi
(involves: C57BL/6J)
|
abnormal diaphragm morphology
|
J:333950
|
| abnormal sarcomere morphology
|
J:333950
|
| abnormal skeletal muscle fiber morphology
|
J:333950
|
| abnormal skeletal muscle morphology
|
J:333950
|
Dnajb4em2Sngi/Dnajb4em2Sngi
(involves: C57BL/6J)
|
abnormal diaphragm morphology
|
J:333950
|
| abnormal sarcomere morphology
|
J:333950
|
| abnormal skeletal muscle fiber morphology
|
J:333950
|
| decreased skeletal muscle mass
|
J:333950
|
| impaired skeletal muscle contractility
|
J:333950
|
| increased variability of skeletal muscle fiber size
|
J:333950
|
| muscle weakness
|
J:333950
|
| skeletal muscle fibrosis
|
J:333950
|
Dnajc5tm1Sud/Dnajc5tm1Sud
(involves: 129S6/SvEvTac)
|
decreased skeletal muscle mass
|
J:91702
|
| progressive muscle weakness
|
J:91702
|
Dnajc11spc/Dnajc11spc
(B6.Cg-Dnajc11spc)
|
progressive muscle weakness
|
J:221543
|
Dnase2atm1Aea/Dnase2atm1Aea
(involves: 129 * C57BL/6)
|
diaphragmatic hernia
|
J:89469
|
| thin diaphragm muscle
|
J:89469
|
Dnm1lPy/Dnm1l+
(involves: BALB/cAnNCrl * C3H/HeH)
|
abnormal cardiac muscle relaxation
|
J:161510
|
| abnormal myocardial fiber mitochondrial morphology
|
J:161510
|
| decreased ventricle muscle contractility
|
J:161510
|
| increased myocardial fiber size
|
J:161510
|
| thin myocardium
|
J:161510
|
Dnm2tm1.1Ics/Dnm2+
(involves: 129S2/SvPas * C57BL/6)
|
abnormal muscle contractility
|
J:237196
|
| abnormal skeletal muscle fiber morphology
|
J:166364
|
| decreased skeletal muscle fiber diameter
|
J:166364
|
| decreased skeletal muscle fiber size
|
J:166364
|
| decreased skeletal muscle mass
|
J:166364
|
| increased skeletal muscle fiber size
|
J:166364
|
| increased skeletal muscle mass
|
J:166364
|
| muscle weakness
|
J:166364
|
| muscular atrophy
|
J:166364
|
Dnm2tm1.1Ics/Dnm2tm1.1Ics
(involves: 129S2/SvPas * C57BL/6)
|
abnormal skeletal muscle fiber morphology
|
J:166364
|
| centrally nucleated skeletal muscle fibers
|
J:166364
|
| decreased skeletal muscle fiber size
|
J:166364
|
Dnm2tm2.1Ics/Dnm2+
(involves: C57BL/6J)
|
abnormal muscle electrophysiology
|
J:288372
|
| abnormal skeletal muscle fiber morphology
|
J:288372
|
| abnormal skeletal muscle fiber type ratio
|
J:288372
|
| decreased skeletal muscle fiber diameter
|
J:288372
|
| decreased skeletal muscle weight
|
J:288372
|
| myopathy
|
J:288372
|
Dnm2tm4.1Ics/Dnm2+
(involves: C57BL/6N)
|
abnormal skeletal muscle fiber morphology
|
J:329580
|
| decreased skeletal muscle fiber size
|
J:329580
|
Dnm2tm4.1Ics/Dnm2tm4.1Ics
(involves: C57BL/6N)
|
abnormal skeletal muscle fiber morphology
|
J:329580
|
Dnm3ostm1Tkk/Dnm3ostm1Tkk
(involves: 129 * C57BL/6 * ICR)
|
abnormal muscle morphology
|
J:143209
|
Dnmt3atm1Jae/Dnmt3atm1Jae
Tg(Nes-cre)1Atp/0
(involves: 129S4/SvJae * C57BL/6 * FVB/N)
|
muscle phenotype
|
J:121563
|
Dock1tm1.1Ysfk/Dock1tm1.1Ysfk
(B6(Cg)-Dock1tm1.1Ysfk)
|
abnormal myogenesis
|
J:178190
|
Dock1tm1Jfco/Dock1+
Dock5Gt(AN0268)Wtsi/Dock5+
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
muscle phenotype
|
J:143342
|
Dock1tm1Jfco/Dock1+
Dock5Gt(AN0268)Wtsi/Dock5Gt(AN0268)Wtsi
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
decreased skeletal muscle fiber diameter
|
J:143342
|
Dock1tm1Jfco/Dock1tm1Jfco
(involves: 129/Sv * C57BL/6)
|
abnormal diaphragm morphology
|
J:143342
|
| abnormal intercostal muscle morphology
|
J:143342
|
| abnormal muscle development
|
J:143342
|
| abnormal muscle physiology
|
J:143342
|
| decreased skeletal muscle fiber diameter
|
J:143342
|
| decreased skeletal muscle mass
|
J:143342
|
| thin diaphragm muscle
|
J:143342
|
Dock1tm1Jfco/Dock1tm1Jfco
(involves: 129)
|
abnormal myogenesis
|
J:178190
|
Dock3tm1Dasc/Dock3tm1Dasc
(B6.Cg-Dock3tm1Dasc)
|
muscular atrophy
|
J:144341
|
Dock5Gt(AN0268)Wtsi/Dock5Gt(AN0268)Wtsi
(involves: 129P2/OlaHsd * C57BL/6)
|
muscle phenotype
|
J:143342
|
Dok7tm2Yyam/Dok7tm2Yyam
(involves: 129P2/OlaHsd * C57BL/6J)
|
muscle weakness
|
J:213767
|
Dot1ltm1Tche/Dot1ltm1.1Tche
Tg(Myhca-cre)1Abel/0
(Not Specified)
|
abnormal muscle physiology
|
J:168140
|
| dilated cardiomyopathy
|
J:168140
|
| increased cardiomyocyte apoptosis
|
J:168140
|
| increased fetal cardiomyocyte proliferation
|
J:168140
|
Dp(16Hspa13-App)2Yah/0
(B6J.129P2-Dp(16Hspa13-App)2Yah)
|
abnormal skeletal muscle fiber type ratio
|
J:223518
|
| abnormal skeletal muscle morphology
|
J:223518
|
| decreased muscle fiber mitochondrial DNA content
|
J:223518
|
| increased skeletal muscle mass
|
J:223518
|
Dpmy/Dpmy+
(B6NJ;CBA-Dpmy/GrsrJ)
|
muscular atrophy
|
J:226382
|
Dpp9tm1.1Npa/Dpp9tm1.1Npa
(involves: C57BL/6)
|
abnormal tongue muscle morphology
|
J:251322
|
Drd1tm1Jcd/Drd1tm1Jcd
Drd2tm1Ebo/Drd2tm1Ebo
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6)
|
abnormal intestinal smooth muscle morphology
|
J:91781
|
Drd1tm2Jcd/Drd1+
Tg(Camk2a-cre)2Gsc/0
(involves: 129S4/SvJae * FVB/N)
|
dystonia
|
J:120070
|
Drd1tm2Jcd/Drd1+
Tg(EIIa-cre)C5379Lmgd/0
(involves: 129S4/SvJae * BALB/c * CD-1 * FVB/N)
|
dystonia
|
J:120582
|
| myoclonus
|
J:120582
|
Droshatm1Litt/Droshatm1.1Litt
Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2 * FVB/N)
|
decreased skeletal muscle mass
|
J:138683
|
Dsc2tm1.2Leu/Dsc2tm1.2Leu
(involves: C57BL/6)
|
decreased ventricle muscle contractility
|
J:302593
|
| heart left ventricle hypertrophy
|
J:302593
|
Dscam3J/Dscam3J
(involves: BALB/c * C3H/HeSnSmn * C57BL/Ka)
|
muscle hypertonia
|
J:195831
|
Dsg2em1Spin/Dsg2+
(involves: C57BL/6J)
|
abnormal intercalated disk morphology
|
J:342765
|
Dsg2em1Spin/Dsg2em1Spin
(involves: C57BL/6J)
|
abnormal intercalated disk morphology
|
J:342765
|
| decreased ventricle muscle contractility
|
J:342765
|
Dsg2tm1a(EUCOMM)Wtsi/Dsg2tm1a(EUCOMM)Wtsi
(C57BL/6-Dsg2tm1a(EUCOMM)Wtsi)
|
cardiomyopathy
|
J:235770
|
Dsg2tm1b(EUCOMM)Wtsi/Dsg2tm1b(EUCOMM)Wtsi
(C57BL/6N-Dsg2tm1b(EUCOMM)Wtsi/Bay)
|
decreased cardiac muscle contractility
|
J:211773
|
Dsg2tm1d(EUCOMM)Wtsi/Dsg2tm1d(EUCOMM)Wtsi
(involves: C57BL/6J * C57BL/6N)
|
cardiomyopathy
|
J:235770
|
| decreased cardiac muscle contractility
|
J:235770
|
| increased cardiomyocyte apoptosis
|
J:235770
|
Dsg2tm1d(EUCOMM)Wtsi/Dsg2tm1d(EUCOMM)Wtsi
Gsk3btm1Dral/Gsk3b+
(involves: 129P2/OlaHsd * C57BL/6J * C57BL/6N)
|
decreased cardiac muscle contractility
|
J:235770
|
Dsg2tm1d(EUCOMM)Wtsi/Dsg2tm1d(EUCOMM)Wtsi
Gsk3btm1Dral/Gsk3btm1Dral
(involves: 129P2/OlaHsd * C57BL/6J * C57BL/6N)
|
decreased cardiac muscle contractility
|
J:235770
|
Dsptm1Efu/Dsptm1Efu
Myl2tm1(cre)Krc/Myl2+
(involves: 129 * 129S4/SvJae * C57BL/6)
|
abnormal intercalated disk morphology
|
J:205990
|
| abnormal myocardial fiber morphology
|
J:205990
|
| abnormal myocardium layer morphology
|
J:205990
|
| abnormal Z line morphology
|
J:205990
|
| decreased ventricle muscle contractility
|
J:205990
|
| ventricular cardiomyopathy
|
J:205990
|
Dstdt-23Rbrc/Dstdt-23Rbrc
(involves: C3H/HeN * C57BL/6)
|
abnormal muscle physiology
|
J:251779
|
| dystonia
|
J:251779
|
| muscular atrophy
|
J:251779
|
Dstdt-30J/Dstdt-30J
(C57BL/6J-Dstdt-30J/J)
|
dystonia
|
J:155853
|
Dstdt-31J/Dstdt-31J
(involves: DBA/1LacJ)
|
dystonia
|
J:155854
|
Dstdt-37J/Dstdt-37J
(C57BL/6J-Dstdt-37J/J)
|
decreased skeletal muscle fiber size
|
J:82238
|
| dystonia
|
J:82238
|
Dstdt-38J/Dstdt-38J
(involves: BALB/cByJ * C57BL/6J)
|
muscle spasm
|
J:82238
|
Dstdt-39J/Dstdt-39J
(involves: NOD)
|
dystonia
|
J:157224
|
Dstdt-alb/Dstdt-alb
(BALB/cByJ-Dstdt-alb)
|
dystonia
|
J:64441
|
Dstdt/Dstdt
(Q-Dstdt)
|
dystonia
|
J:64095
|
Dstdt/Dstdt
(involves: Q)
|
dystonia
|
J:5674
|
DstGt(E182H05)Wrst/DstGt(E182H05)Wrst
(B6NCrj.129P2-DstGt(E182H05)Wrst)
|
dystonia
|
J:228781,
J:251779
|
DstGt(E182H05)Wrst/DstGt(E182H05)Wrst
(involves: 129P2/OlaHsd * ICR)
|
abnormal muscle electrophysiology
|
J:228781,
J:251779
|
DstTg4/DstTg4
(involves: CD-1)
|
abnormal muscle physiology
|
J:55704
|
| abnormal skeletal muscle fiber mitochondrial morphology
|
J:55704
|
| abnormal skeletal muscle fiber morphology
|
J:55704
|
| abnormal Z line morphology
|
J:55704
|
| impaired skeletal muscle contractility
|
J:55704
|
| muscle weakness
|
J:55704
|
DstTg4/DstTg4
(involves: C57BL/6 * CD-1)
|
abnormal muscle spindle morphology
|
J:209161
|
Dsttm1Efu/Dsttm1Efu
(involves: C57BL/6)
|
dystonia
|
J:24974
|
| muscular atrophy
|
J:24974
|
Dtnatm1Jrs/Dtnatm1Jrs
(involves: 129X1/SvJ * C57BL/6)
|
cardiomyopathy
|
J:59675
|
| dystrophic muscle
|
J:60776,
J:59675
|
| myocardial fiber degeneration
|
J:59675
|
Dtnatm1Jrs/Dtnatm1Jrs
Utrntm1Jrs/Utrntm1Jrs
(involves: 129S1/Sv * 129X1/SvJ)
|
cardiomyopathy
|
J:59675
|
| dystrophic muscle
|
J:59675
|
Dtnbp1sdy/Dtnbp1sdy
(involves: DBA/2J)
|
muscle phenotype
|
J:85123
|
Dusp1tm1Brv/Dusp1tm1Brv
(involves: 129S2/SvPas * C57BL/6)
|
abnormal muscle development
|
J:162340
|
| abnormal muscle regeneration
|
J:162340
|
| abnormal myoblast differentiation
|
J:162340
|
| decreased myoblast proliferation
|
J:162340
|
| decreased skeletal muscle fiber diameter
|
J:162340
|
| decreased skeletal muscle fiber size
|
J:162340
|
Dusp6tm1Jmol/Dusp6tm1Jmol
(involves: 129 * C57BL/6)
|
abnormal muscle physiology
|
J:190460
|
| increased satellite cell number
|
J:190460
|
| muscle phenotype
|
J:190460
|
Dusp8tm1Jmol/Dusp8tm1Jmol
(involves: 129/SvJ * C57BL/6)
|
abnormal cardiac muscle relaxation
|
J:233947
|
| abnormal myocardial fiber morphology
|
J:233947
|
| increased cardiac muscle contractility
|
J:233947
|
Dusp14em1Lyg/Dusp14em1Lyg
(Not Specified)
|
decreased cardiac muscle contractility
|
J:263251
|
| increased myocardial fiber size
|
J:263251
|
| myocardium hypertrophy
|
J:263251
|
Dync1h1Cra1/Dync1h1+
(C3HeB/FeJ-Dync1h1Cra1)
|
muscle spasm
|
J:83128
|
Dync1h1Cra1/Dync1h1+
(involves: C3HeB/FeJ * C57BL/6)
|
muscle spasm
|
J:83128
|
Dync1h1Loa/Dync1h1+
(C3H/HeH-Dync1h1Loa)
|
muscle spasm
|
J:83128
|
Dync1h1Loa/Dync1h1+
(involves: C3H/HeH * C57BL/6)
|
muscle spasm
|
J:83128
|
Dync1h1tm1.1Sjki/Dync1h1+
(involves: 129 * 129S1/SvImJ * C57BL/6 * C57BL/6J)
|
muscle phenotype
|
J:264493
|
Dysfim/Dysf+
Fktntm1Ttd/Fktntm2(FCMD)Ttd
(involves: 129S7/SvEvBrd * C57BL/6 * SJL/J)
|
muscle phenotype
|
J:221523
|
Dysfim/Dysf+
Large1myd/Large1myd
(involves: C57BL/6 * SJL/J)
|
abnormal skeletal muscle fiber morphology
|
J:221523
|
| centrally nucleated skeletal muscle fibers
|
J:221523
|
| dystrophic muscle
|
J:221523
|
| increased variability of skeletal muscle fiber size
|
J:221523
|
| myositis
|
J:221523
|
| skeletal muscle fiber degeneration
|
J:221523
|
| skeletal muscle fiber necrosis
|
J:221523
|
Dysfim/Dysfim
(involves: SJL)
|
dystrophic muscle
|
J:57764
|
| progressive muscle weakness
|
J:57764
|
Dysfim/Dysfim
Fktntm1Ttd/Fktntm2(FCMD)Ttd
(involves: 129S7/SvEvBrd * C57BL/6 * SJL/J)
|
abnormal skeletal muscle fiber morphology
|
J:221523
|
| abnormal skeletal muscle morphology
|
J:221523
|
| centrally nucleated skeletal muscle fibers
|
J:221523
|
| dystrophic muscle
|
J:221523
|
| myositis
|
J:221523
|
| skeletal muscle fiber degeneration
|
J:221523
|
| skeletal muscle fibrosis
|
J:221523
|
Dysfim/Dysfim
Fktntm2(FCMD)Ttd/Fktn+
(involves: C57BL/6 * SJL/J)
|
abnormal skeletal muscle fiber morphology
|
J:221523
|
| centrally nucleated skeletal muscle fibers
|
J:221523
|
| dystrophic muscle
|
J:221523
|
| skeletal muscle fiber necrosis
|
J:221523
|
Dysfim/Dysfim
Large1myd/Large1myd
(involves: C57BL/6 * SJL/J)
|
abnormal skeletal muscle fiber morphology
|
J:221523
|
| dystrophic muscle
|
J:221523
|
| increased variability of skeletal muscle fiber size
|
J:221523
|
| myositis
|
J:221523
|
Dysfprmd/Dysfprmd
(A/J)
|
abnormal skeletal muscle fiber morphology
|
J:92838
|
| abnormal skeletal muscle morphology
|
J:92838
|
| centrally nucleated skeletal muscle fibers
|
J:92838
|
| skeletal muscle endomysial fibrosis
|
J:92838
|
| skeletal muscle fiber degeneration
|
J:92838
|
| skeletal muscle fiber necrosis
|
J:92838
|
Dysfprmd/Dysfprmd
(involves: 129 * A/J * C57BL/6)
|
impaired skeletal muscle regeneration
|
J:331473
|
Dysfprmd/Dysfprmd
Elmo2tm2.1Jfco/Elmo2tm2.1Jfco
(involves: 129 * A/J * C57BL/6)
|
muscle phenotype
|
J:331473
|
Dysfprmd/Dysfprmd
Hprt1tm2(CAG-Myof)Isrd/Y
(involves: 129 * A/J * C57BL/6)
|
dystrophic muscle
|
J:187293
|
| muscle phenotype
|
J:187293
|
Dysfprmd/Dysfprmd
Hprt1tm2(CAG-Myof)Isrd/Hprt1tm2(CAG-Myof)Isrd
(involves: 129 * A/J * C57BL/6)
|
dystrophic muscle
|
J:187293
|
| muscle phenotype
|
J:187293
|
Dysftm1.1Mdcb/Dysftm1.1Mdcb
(B6.129P2(Cg)-Dysftm1.1Mdcb)
|
abnormal muscle physiology
|
J:302056
|
| dystrophic muscle
|
J:302056
|
| skeletal muscle fiber necrosis
|
J:302056
|
| skeletal muscle fibrosis
|
J:302056
|
Dysftm1Kcam/Dysftm1Kcam
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal sarcolemma morphology
|
J:83126
|
| centrally nucleated skeletal muscle fibers
|
J:83126,
J:171870
|
| dystrophic muscle
|
J:83126
|
| impaired skeletal muscle regeneration
|
J:83126
|
| increased variability of skeletal muscle fiber size
|
J:83126,
J:171870
|
| myositis
|
J:171870
|
| skeletal muscle fiber degeneration
|
J:83126
|
| skeletal muscle fiber necrosis
|
J:83126
|
| skeletal muscle fibrosis
|
J:171870
|
| skeletal muscle necrosis
|
J:171870
|
Dysftm1Meho/Dysftm1Meho
(involves: 129S4/SvJae * C57BL/6)
|
abnormal skeletal muscle fiber morphology
|
J:92838
|
| abnormal skeletal muscle morphology
|
J:92838
|
| centrally nucleated skeletal muscle fibers
|
J:92838
|
| increased skeletal muscle fiber size
|
J:92838
|
| skeletal muscle endomysial fibrosis
|
J:92838
|
| skeletal muscle fiber necrosis
|
J:92838
|
E2f1tm1Meg/E2f1tm1Meg
Rb1tm1Tyj/Rb1tm1Tyj
Tg(Rb1)1Blg/0
(involves: 129S2/SvPas * 129S4/SvJae)
|
abnormal muscle physiology
|
J:65679
|
| abnormal skeletal muscle fiber morphology
|
J:65679
|
Ece1tm1Reh/Ece1tm1Reh
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal vasodilation
|
J:46640
|
Ecel1tm1Hiki/Ecel1tm1Hiki
(B6.129-Ecel1tm1Hiki)
|
thin diaphragm muscle
|
J:160510
|
Ecsitmpc178H/Ecsitmpc178H
(involves: BALB/c * C3H/HeH * C57BL/6J)
|
cardiomyopathy
|
J:234901
|
Edn1tm1Utj/Edn1tm1Utj
(either: (involves: 129X1/SvJ * C57BL/6J) or (involves: 129X1/SvJ * ICR))
|
abnormal neck muscle morphology
|
J:17694
|
| abnormal tongue muscle morphology
|
J:17694
|
Ednratm1Ywa/Ednratm1Ywa
(129S/SvEv-Ednratm1Ywa)
|
abnormal muscle morphology
|
J:46639
|
Ednratm6(Edn1)Hku/Ednra+
(involves: 129 * C57BL/6 * ICR)
|
abnormal masseter muscle morphology
|
J:224515
|
Ednrbs-1Acrg/Ednrbs-9ThW
(involves: 101/Rl * C3H/Rl * C57BL/6J)
|
abnormal diaphragm morphology
|
J:87686
|
Ednrbs-1Acrg/Ednrbs-48UThc
(involves: 101/Rl * C3H/Rl * C57BL/6J)
|
muscle phenotype
|
J:87686
|
Ednrbs-15DttMb/Ednrbs-15DttMb
(involves: 101/Rl * C3H/Rl * C57BL/6J)
|
abnormal diaphragm morphology
|
J:87686
|
Ednrbtm1.1Nrd/Ednrb+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased cardiac muscle contractility
|
J:226561
|
Ednrbtm1.1Yko/Ednrbtm1.1Yko
(involves: 129P2/OlaHsd * Bkl:BKW * C57BL/6 * SJL)
|
decreased vasodilation
|
J:135711
|
Ednrbtm1Yko/Ednrbtm1Yko
Tg(Tek-cre)1Ywa/0
(involves: 129P2/OlaHsd * Bkl:BKW * C57BL/6 * SJL)
|
decreased vasodilation
|
J:135711
|
Eef1a2em#Abb/Eef1a2+
(C57BL/6JCrl-Eef1a2em#Abb)
|
decreased skeletal muscle mass
|
J:296080
|
Eef1a2wst/Eef1a2wst
(involves: HRS/J)
|
abnormal muscle morphology
|
J:104855
|
Efemp1tm2Lmar/Efemp1tm2Lmar
(involves: 129X1/SvJ * C57BL/6)
|
decreased skeletal muscle weight
|
J:132043
|
Efemp2tm1.1Chu/Efemp2tm1.1Chu
(B6(SJL)-Efemp2tm1.1Chu)
|
abnormal aorta smooth muscle morphology
|
J:223792
|
| abnormal hypodermis muscle layer morphology
|
J:223792
|
| abnormal tendon collagen fibril morphology
|
J:223792
|
Efemp2tm1.1Hiya/Efemp2tm1.2Hiya
Tg(Tagln-cre)1Her/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
abnormal aorta smooth muscle morphology
|
J:213282
|
| abnormal vascular smooth muscle morphology
|
J:170883
|
Efemp2tm1.1Tynk/Efemp2tm1.2Tynk
Tg(Tagln-cre)1Her/0
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
heart left ventricle hypertrophy
|
J:154659
|
Efemp2tm1.2Hiya/Efemp2tm1.2Hiya
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
abnormal vascular smooth muscle morphology
|
J:170883
|
| abnormal vascular smooth muscle physiology
|
J:170883
|
| increased vascular smooth muscle cell proliferation
|
J:170883
|
| vascular smooth muscle hyperplasia
|
J:170883
|
Efemp2tm1.2Tynk/Efemp2tm1.2Tynk
(involves: C57BL/6)
|
diaphragmatic hernia
|
J:154659
|
Efemp2tm1Dgen/Efemp2tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal aorta smooth muscle morphology
|
J:106902
|
Efhc1tm1Kzy/Efhc1+
(B6.129P2-Efhc1tm1Kzy)
|
myoclonus
|
J:145858
|
Efhc1tm1Kzy/Efhc1tm1Kzy
(B6.129P2-Efhc1tm1Kzy)
|
myoclonus
|
J:145858
|
Efna1tm1Jinc/Efna1tm1Jinc
(involves: 129X1/SvJ * C57BL/6)
|
decreased cardiac muscle contractility
|
J:166527
|
Efnb2tm1And/Efnb2tm1And
(involves: 129S7/SvEvBrd)
|
abnormal myocardium layer morphology
|
J:119151
|
| absent myocardial trabeculae
|
J:75288
|
Efnb2tm1And/Efnb2tm1And
(involves: 129S7/SvEvBrd * C57BL/6)
|
absent myocardial trabeculae
|
J:74909
|
Efnb2tm1And/Efnb2tm2And
Tg(Tek-cre)12Flv/0
(involves: 129S7/SvEvBrd * C57BL/6)
|
absent myocardial trabeculae
|
J:74909
|
Eftud2tm1b(KOMP)Wtsi/Eftud2+
(C57BL/6N-Eftud2tm1b(KOMP)Wtsi/Ics)
|
increased cardiac muscle contractility
|
J:211773
|
Egfrtm2(EGFR)Wag/Egfrtm2(EGFR)Wag
(involves: 129/Sv * C57BL/6)
|
heart left ventricle hypertrophy
|
J:84870
|
Egfrwa2/Egfrwa2
(involves: C57BL/6)
|
abnormal myocardial fiber morphology
|
J:241813
|
| decreased ventricle muscle contractility
|
J:241813
|
| heart left ventricle hypertrophy
|
J:241813
|
Egfrwa2/Egfrwa2
Ptpn11tm1Paw/Ptpn11+
(involves: 129S1/Sv * 129X1/SvJ * B6EiC3Sn a/A-Egfrwa2 Wnt3avt * C57BL/6)
|
abnormal muscle morphology
|
J:75413
|
| intestinal hypoperistalsis
|
J:75413
|
Egfrwa2/Egfrwa2
Ptpn11tm1Rbn/Ptpn11+
(involves: 129 * B6EiC3Sn-a/A-Egfrwa2 Wnt3avt)
|
myocardium hypertrophy
|
J:60750
|
Egln1tm1.1Brei/Egln1tm1.1Brei
Myl2tm1(cre)Krc/Myl2+
(B6.Cg-Myl2tm1(cre)Krc Egln1tm1.1Brei)
|
decreased cardiomyocyte apoptosis
|
J:170943
|
Egln1tm1Fong/Egln1+
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N)
|
muscle phenotype
|
J:132630
|
Egln1tm1Fong/Egln1tm1Fong
(involves: 129S6/SvEvTac * C57BL/6 * CD-1 * FVB/N * SJL)
|
abnormal trabecula carnea morphology
|
J:114669
|
| thin ventricle myocardium compact layer
|
J:114669
|
Egln1tm1Kael/Egln1tm1Kael
Egln3tm1Vlcg/Egln3tm1Vlcg
Tg(Myh6-cre)2182Mds/0
(involves: 129S6/SvEvTac * FVB/N)
|
cardiomyopathy
|
J:179490
|
| decreased ventricle muscle contractility
|
J:179490
|
| myocardial fiber degeneration
|
J:179490
|
Egln1tm1Kael/Egln1tm1Kael
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA)
|
abnormal myocardium layer morphology
|
J:132718
|
| dilated cardiomyopathy
|
J:132718
|
| increased myocardial fiber size
|
J:132718
|
Egln1tm1Kael/Egln1tm1Kael
Tg(Myh6-cre)2182Mds/0
(involves: 129S6/SvEvTac * FVB/N)
|
decreased ventricle muscle contractility
|
J:179490
|
| increased myocardial fiber size
|
J:179490
|
| myocardial fiber degeneration
|
J:179490
|
Egln2tm1Pec/Egln2tm1Pec
(involves: 129S/SvEv * Swiss)
|
abnormal muscle physiology
|
J:132630
|
| skeletal muscle necrosis
|
J:132630
|
Egln2tm1Pec/Egln2tm1Pec
Epas1tm1Pec/Epas1+
(involves: 129S/SvEv * Swiss)
|
muscle phenotype
|
J:132630
|
Egln2tm1Pec/Egln2tm1Pec
Hif1atm1Pec/Hif1a+
(involves: 129S/SvEv * Swiss)
|
muscle phenotype
|
J:132630
|
Egln3tm1Fong/Egln3tm1Fong
(involves: 129S6/SvEvTac * C57BL/6)
|
muscle phenotype
|
J:132630
|
Egr2tm3Pch/Egr2tm3Pch
Tg(Tek-cre)1Ywa/0
(involves: 129S2/SvPas * C57BL/6 * SJL)
|
heart left ventricle hypertrophy
|
J:230306
|
Egr3tm1Jmi/Egr3tm1Jmi
(Not Specified)
|
abnormal muscle spindle morphology
|
J:76256
|
| absent muscle spindles
|
J:49575
|
Ehbp1l1tm1a(EUCOMM)Wtsi/Ehbp1l1tm1a(EUCOMM)Wtsi
(C57BL/6N-Ehbp1l1tm1a(EUCOMM)Wtsi/Wtsi)
|
abnormal eye muscle morphology
|
J:239583
|
| thin myocardium
|
J:239583
|
Ehhadhtm1Jkr/Ehhadhtm1Jkr
Hsd17b4tm1Baes/Hsd17b4tm1Baes
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
hypotonia
|
J:104835
|
Eif2ak4tm1Drc/Eif2ak4tm1Drc
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased skeletal muscle mass
|
J:92545
|
Eif2ak4tm1Drc/Eif2ak4tm1Drc
(B6.129S6-Eif2ak4tm1Drc)
|
decreased skeletal muscle mass
|
J:92545
|
Eif3ftm1(KOMP)Vlcg/Eif3f+
(B6J.B6N-Eif3ftm1(KOMP)Vlcg)
|
abnormal muscle physiology
|
J:294674
|
| decreased skeletal muscle fiber size
|
J:294674
|
| decreased skeletal muscle mass
|
J:294674
|
| increased susceptibility to induced muscular atrophy
|
J:294674
|
Eif4ebp1tm1Nso/Eif4ebp1tm1Nso
(involves: 129S4/SvJae * C57BL/6)
|
increased cardiac muscle contractility
|
J:163763
|
Eif4ebp1tm1Nso/Eif4ebp1tm1Nso
Mtortm1.1Gcon/Mtortm1.1Gcon
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: 129S4/SvJae * C57BL/6 * FVB/N)
|
decreased cardiomyocyte apoptosis
|
J:163763
|
Eif4hGt(Ex279)Byg/Eif4hGt(Ex279)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal muscle morphology
|
J:181945
|
| increased muscle fatigability
|
J:181945
|
Elac2tm1c(EUCOMM)Wtsi/Elac2tm1c(EUCOMM)Wtsi
Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6N * FVB)
|
decreased cardiac muscle contractility
|
J:265839
|
| dilated cardiomyopathy
|
J:265839
|
Elavl1tm1.1Dkon/Elavl1tm1.1Dkon
Tg(MYOD1-cre)M23Glh/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal muscle contractility
|
J:279284
|
| abnormal skeletal muscle fiber type ratio
|
J:279284
|
| decreased susceptibility to induced muscular atrophy
|
J:279284
|
Elmo1tm1.2Ravi/Elmo1tm1.2Ravi
Elmo2tm1.1Jfco/Elmo2tm1.1Jfco
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal muscle development
|
J:331473
|
| decreased skeletal muscle fiber size
|
J:331473
|
| impaired skeletal muscle regeneration
|
J:331473
|
Elmo1tm1.2Ravi/Elmo1tm1.2Ravi
Elmo2tm1c(EUCOMM)Hmgu/Elmo2tm1c(EUCOMM)Hmgu
Myf5tm3(cre)Sor/Myf5+
(involves: 129P2/OlaHsd * C57BL/6N)
|
abnormal muscle development
|
J:331473
|
Elmo1tm1.2Ravi/Elmo1tm1.2Ravi
Elmo2tm1c(EUCOMM)Hmgu/Elmo2tm1c(EUCOMM)Hmgu
Pax3tm1(cre)Joe/Pax3+
(involves: 129P2/OlaHsd * C57BL/6N)
|
abnormal diaphragm development
|
J:331473
|
| abnormal muscle development
|
J:331473
|
Elmo2tm2.1Jfco/Elmo2tm2.1Jfco
(involves: 129 * C57BL/6)
|
enhanced skeletal muscle regeneration
|
J:331473
|
| increased skeletal muscle fiber size
|
J:331473
|
Elntm1Dyl/Eln+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal vascular smooth muscle morphology
|
J:51109
|
Elntm1Dyl/Elntm1Dyl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal vascular smooth muscle morphology
|
J:47771
|
Elp1tm1.1Gilas/Elp1tm1.1Gilas
Tg(Dct-cre)1Apdn/0
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal intestinal peristalsis
|
J:237480
|
Elp1tm1Id/Elp1tm1Id
Tg(Hsp70-1-cre)6Arge/0
(involves: 129S1/Sv * C57BL/6 * C57BL/6J * CBA)
|
abnormal muscle spindle morphology
|
J:188923
|
Elp2em2Bjw/Elp2em2Bjw
(involves: C57BL/6)
|
hypotonia
|
J:306113
|
Elp2em2Bjw/Elp2em2Bjw
(involves: C57BL/6 * DBA/2J)
|
hypotonia
|
J:306113
|
Elp2em2Bjw/Elp2em3Bjw
(involves: C57BL/6 * DBA/2J)
|
hypotonia
|
J:306113
|
Emdtm1.1Stw/Y
(involves: 129S1/Sv * FVB/N)
|
abnormal gastrocnemius morphology
|
J:106760
|
Emdtm1.1Stw/Y
(involves: 129S1/Sv * C57BL/6)
|
abnormal myocardial fiber morphology
|
J:218095
|
| decreased myocardial fiber size
|
J:218095
|
| decreased ventricle muscle contractility
|
J:218095
|
| increased myocardial fiber number
|
J:218095
|
Emdtm1.1Stw/Emdtm1.1Stw
(involves: 129S1/Sv * FVB/N)
|
muscle phenotype
|
J:106760
|
Emdtm1Ykh/Y
(B6.129X1-Emdtm1Ykh)
|
abnormal myocardial fiber morphology
|
J:106563
|
| abnormal skeletal muscle fiber morphology
|
J:106563
|
Emdtm1Ykh/Emdtm1Ykh
(B6.129X1-Emdtm1Ykh)
|
abnormal myocardial fiber morphology
|
J:106563
|
| abnormal skeletal muscle fiber morphology
|
J:106563
|
Eml1heco/Eml1heco
(involves: NOR)
|
myoclonus
|
J:208031
|
En1tm2(cre)Wrst/En1+
Tor1atm1Wtd/Tor1atm3.1Wtd
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J)
|
dystonia
|
J:213785
|
En1tm2(cre)Wrst/En1+
Tor1atm2Wtd/Tor1atm3.1Wtd
(involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6J * SJL)
|
dystonia
|
J:213785
|
Engtm1Dyl/Engtm1Dyl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal vascular smooth muscle morphology
|
J:55403
|
Engtm1Hma/Eng+
(129P2/OlaHsd-Engtm1Hma)
|
abnormal vascular smooth muscle morphology
|
J:73415
|
Engtm1Hma/Engtm1Hma
(involves: 129P2/OlaHsd * C57BL/6J)
|
thin myocardium
|
J:73415
|
Engtm1Hma/Engtm1Hma
(involves: 129P2/OlaHsd)
|
abnormal vascular smooth muscle morphology
|
J:98373
|
Engtm1Mle/Eng+
(involves: 129P2/OlaHsd * C57BL/6)
|
ear telangiectasia
|
J:58502
|
| neck telangiectasia
|
J:58502
|
| tail telangiectasia
|
J:58502
|
Engtm1Mle/Eng+
(129P2/OlaHsd-Engtm1Mle)
|
ear telangiectasia
|
J:58502
|
| tail telangiectasia
|
J:58502
|
Enhotm1.1Butl/Enhotm1.1Butl
(B6.Cg-Enhotm1.1Butl)
|
decreased muscle cell glucose uptake
|
J:225402
|
Enpp1m1Amgn/Enpp1m1Amgn
(involves: C3H/HeSnJ * C57BL/6J * Swiss)
|
calcified calcaneal tendon
|
J:168664
|
| calcified tendon
|
J:168664
|
Enpp1tm1Gdg/Enpp1tm1Gdg
(involves: 129S1/Sv * C57BL/6)
|
abnormal vascular smooth muscle morphology
|
J:110028
|
Enpp1tm1Gdg/Enpp1tm1Gdg
(involves: 129S1/Sv)
|
calcified calcaneal tendon
|
J:111462
|
Enpp1ttw/Enpp1ttw
(involves: ICR)
|
calcified calcaneal tendon
|
J:37369
|
Entpd1tm1Djp/Entpd1tm1Djp
(B6.129-Entpd1tm1Djp)
|
abnormal muscle electrophysiology
|
J:143010
|
| impaired smooth muscle contractility
|
J:143010
|
Ep300tm1Dli/Ep300tm1Dli
(either: 129S4/SvJae or (involves: 129S4/SvJae * C57BL/6))
|
absent trabeculae carneae
|
J:47301
|
| decreased cardiac muscle contractility
|
J:47301
|
Ep300tm1Reck/Ep300+
(involves: 129P2/OlaHsd)
|
abnormal muscle fiber morphology
|
J:85950
|
| abnormal muscle morphology
|
J:85950
|
| abnormal myogenesis
|
J:85950
|
| decreased skeletal muscle fiber size
|
J:85950
|
| myocardium hypoplasia
|
J:85949
|
| thin myocardium
|
J:85949
|
| thin ventricle myocardium compact layer
|
J:85949
|
Epas1tm1Mcs/Epas1tm1.1Mcs
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129X1/SvJ * C57BL/6 * CBA)
|
heart left ventricle hypertrophy
|
J:302384
|
Epc1Gt(XB645)Byg/Epc1+
(B6.129P2-Epc1Gt(XB645)Byg)
|
abnormal muscle development
|
J:151355
|
epf/epf
(Not Specified)
|
emprosthotonos
|
J:6309
|
Epg5tm1Ygz/Epg5tm1Ygz
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6N)
|
abnormal muscle fiber morphology
|
J:196603
|
| abnormal Z line morphology
|
J:196603
|
| centrally nucleated skeletal muscle fibers
|
J:196603
|
| decreased skeletal muscle fiber size
|
J:196603
|
| muscular atrophy
|
J:196603
|
| skeletal muscle fiber degeneration
|
J:196603
|
Ephb4tm1And/Ephb4tm1And
(involves: 129S7/SvEvBrd * C57BL/6J)
|
absent myocardial trabeculae
|
J:57908
|
Epm2atm1Kzy/Epm2atm1Kzy
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased cardiac muscle cell glucose uptake
|
J:173769
|
| increased cardiac muscle glycogen level
|
J:173769
|
| muscle weakness
|
J:76688
|
| myoclonus
|
J:76688
|
Epm2aip1Gt(BA0314)Wtsi/Epm2aip1Gt(BA0314)Wtsi
(involves: 129P2/OlaHsd * C57BL/6)
|
muscle phenotype
|
J:204966
|
EpoTg(TAg/Epo)134.3LCPjr/EpoTg(TAg/Epo)134.3LCPjr
(involves: C57BL/6 * CBA)
|
increased myocardial fiber size
|
J:79374
|
Eportm1Lizon/Eportm1Lizon
Tg(Gata1-Epor)AMym/0
(involves: 129S4/SvJae * C57BL/6 * DBA)
|
heart right ventricle hypertrophy
|
J:121500
|
Erbb2l11Jus8/Erbb2l11Jus8
(129S5.B6(129S7)-Erbb2l11Jus8)
|
abnormal atrium myocardium morphology
|
J:222460
|
Erbb2tm1Cbm/Erbb2tm1Cbm
(involves: 129P2/OlaHsd * C57BL/6)
|
absent trabeculae carneae
|
J:48515
|
Erbb2tm1Cbm/Erbb2tm2.1Cbm
(involves: 129P2/OlaHsd * C57BL/6)
|
absent trabeculae carneae
|
J:75421
|
Erbb2tm1Cbm/Erbb2tm2Cbm
Myl2tm1(cre)Krc/Myl2+
(involves: 129P2/OlaHsd * 129S4/SvJae)
|
abnormal myocardial fiber morphology
|
J:77347
|
| decreased ventricle muscle contractility
|
J:77347
|
| dilated cardiomyopathy
|
J:77347
|
Erbb2tm1Gne/Erbb2tm1Gne
(either: (involves: 129S2/SvPas * BALB/c) or (involves: 129S2/SvPas * C57BL/6J))
|
absent myocardial trabeculae
|
J:45302
|
Erbb2tm1Haus/Erbb2tm1Haus
(involves: 129S4/SvJae * C57BL/6)
|
absent myocardial trabeculae
|
J:29973
|
Erbb2tm1Haus/Erbb2tm1Klee
Myf5tm3(cre)Sor/Myf5+
(involves: 129S4/SvJae * C57BL/6)
|
abnormal muscle spindle morphology
|
J:147957
|
| decreased muscle spindle number
|
J:147957
|
Erbb2tm1Klee/Erbb2tm1Klee
Myl2tm1(cre)Krc/Myl2+
(involves: 129S4/SvJae)
|
abnormal cardiac muscle relaxation
|
J:76196
|
| abnormal myocardial fiber morphology
|
J:76196
|
| decreased ventricle muscle contractility
|
J:76196
|
| dilated cardiomyopathy
|
J:76196
|
Erbb2tm1Klee/Erbb2tm1Klee
Tg(Ckmm-cre)1Lrsn/0
(Not Specified)
|
abnormal cardiac muscle relaxation
|
J:76196
|
| abnormal myocardial fiber morphology
|
J:76196
|
| decreased ventricle muscle contractility
|
J:76196
|
| dilated cardiomyopathy
|
J:76196
|
Erbb2tm1Mul/Erbb2tm1Mul
(involves: 129S1/Sv * 129X1/SvJ * BALB/c)
|
absent trabeculae carneae
|
J:74283
|
Erbb2tm3(Erbb2)Mul/Erbb2tm1Mll
Tg(ACTA1-cre)1Mll/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal muscle spindle morphology
|
J:82801
|
| absent muscle spindles
|
J:82801
|
Erbb2tm3(Erbb2)Mul/Erbb2tm3(Erbb2)Mul
(involves: 129S1/Sv * 129X1/SvJ)
|
absent primary muscle spindle
|
J:81565
|
| partial loss of secondary muscle spindle
|
J:81565
|
Erbb2tm3(Erbb2)Mul/Erbb2tm3(Erbb2)Mul
Tg(Ckmm-cre)5Khn/0
(involves: 129S1/Sv * 129X1/SvJ * BALB/c * FVB)
|
absent primary muscle spindle
|
J:81565
|
| absent secondary muscle spindle
|
J:81565
|
| impaired skeletal muscle regeneration
|
J:81565
|
| increased myoblast apoptosis
|
J:81565
|
Erbb2tm8.1(Erbb2)Mul/Erbb2tm8.1(Erbb2)Mul
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal myocardial trabeculae morphology
|
J:89255
|
Erbb3tm1Gne/Erbb3tm1Gne
(involves: 129S2/SvPas * C57BL/6)
|
abnormal myocardial trabeculae morphology
|
J:45302
|
| abnormal myocardium layer morphology
|
J:45302
|
Erbb4tm1Grl/Erbb4tm1Grl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
absent trabeculae carneae
|
J:29972
|
Erbb4tm1Htig/Erbb4tm1Htig
Myl2tm1(cre)Krc/Myl2+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6)
|
abnormal intercalated disk morphology
|
J:101252
|
| abnormal myocardial fiber morphology
|
J:101252
|
| decreased cardiac muscle contractility
|
J:101252
|
| decreased myocardial fiber number
|
J:101252
|
| dilated cardiomyopathy
|
J:101252
|
Ercc1tm1Jhjh/Ercc1tm1Jhjh
(involves: 129P2/OlaHsd * C57BL/6 * FVB)
|
decreased skeletal muscle mass
|
J:117488
|
| dystonia
|
J:117488
|
Ercc3tm2Jhjh/Ercc3tm2Jhjh
Xpatm1Hvs/Xpatm1Hvs
(involves: 129P2/OlaHsd * C57BL/6)
|
muscle hypertonia
|
J:145759
|
Ercc6tm1Gvh/Ercc6tm1Gvh
Xpatm1Hvs/Xpatm1Hvs
(B6.129P2-Xpatm1Hvs Ercc6tm1Gvh)
|
dystonia
|
J:122013
|
Ergtm1.1Path/Ergtm1.1Path
(Not Specified)
|
heart right ventricle hypertrophy
|
J:227456
|
Ergic2tm1.1Bcgen/Ergic2tm1.1Bcgen
(Not Specified)
|
abnormal ventricle myocardium morphology
|
J:345070
|
| decreased cardiac muscle contractility
|
J:345070
|
| decreased ventricle muscle contractility
|
J:345070
|
Ergic3tm1.1Bcgen/Ergic3tm1.1Bcgen
(Not Specified)
|
abnormal ventricle myocardium morphology
|
J:345070
|
| decreased cardiac muscle contractility
|
J:345070
|
| decreased ventricle muscle contractility
|
J:345070
|
Esr1tm1.1Ics/Esr1tm1.1Ics
(involves: C57BL/6NTac)
|
abnormal vasodilation
|
J:206373
|
Esr1tm1.1Mma/Esr1tm1.1Mma
(involves: 129S2/SvPas)
|
abnormal vasodilation
|
J:206373
|
Esr1tm1Ksk/Esr1+
(involves: 129P2/OlaHsd)
|
abnormal cremaster muscle morphology
|
J:112350
|
Esr1tm1Ksk/Esr1tm1Ksk
(involves: 129P2/OlaHsd)
|
abnormal cremaster muscle morphology
|
J:112350
|
Esr1tm4.2Ksk/Esr1tm4.2Ksk
Mir22tm1Boet/Mir22tm1Boet
Tg(Ckmm-cre)5Khn/0
(involves: 129S2/SvPas * C57BL/6 * FVB)
|
muscle phenotype
|
J:266382
|
Esr2tm1Unc/Esr2tm1Unc
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal muscle electrophysiology
|
J:73898
|
| abnormal vascular smooth muscle morphology
|
J:73898
|
| abnormal vascular smooth muscle physiology
|
J:73898
|
| increased vasoconstriction
|
J:73898
|
Esr2tm1Unc/Esr2tm1Unc
(involves: 129P2/OlaHsd)
|
abnormal intercalated disk morphology
|
J:93438
|
| abnormal muscle contractility
|
J:95398
|
| abnormal myocardial fiber morphology
|
J:93438
|
| increased myocardial fiber size
|
J:93438
|
| increased vasodilation
|
J:64165
|
Esrrbtm1.1Nat/Esrrbtm1.1Nat
Tg(Myh6-cre)2182Mds/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6N * FVB/N)
|
abnormal sarcomere morphology
|
J:241078
|
| decreased cardiac muscle contractility
|
J:241078
|
| decreased ventricle muscle contractility
|
J:241078
|
| dilated cardiomyopathy
|
J:241078
|
Etfdhtm1c(EUCOMM)Hmgu/Etfdhtm1c(EUCOMM)Hmgu
Tg(ACTA1-rtTA,tetO-cre)102Monk/0
(involves: C3H * C57BL/6 * C57BL/6N)
|
abnormal muscle physiology
|
J:345923
|
| abnormal skeletal muscle fiber mitochondrial morphology
|
J:345923
|
| myopathy
|
J:345923
|
Etv1tm1Tmj/Etv1+
(involves: 129S1/Sv)
|
abnormal golgi tendon organ morphology
|
J:75311
|
| increased muscle spindle number
|
J:75311
|
Etv1tm1Tmj/Etv1tm1Tmj
(involves: 129S1/Sv * C57BL/6J)
|
abnormal muscle spindle morphology
|
J:78232
|
Etv1tm1Tmj/Etv1tm1Tmj
(involves: 129S1/Sv)
|
abnormal golgi tendon organ morphology
|
J:75311
|
| abnormal muscle spindle morphology
|
J:75311
|
| absent golgi tendon organ
|
J:75311
|
Etv1tm1Tmj/Etv1tm1Tmj
Etv4tm1Arbr/Etv4+
(involves: 129S1/Sv)
|
decreased muscle spindle number
|
J:197913
|
Etv1tm1Tmj/Etv1tm1Tmj
Ntf3tm1Lfr/Ntf3tm1Lfr
(involves: 129S1/Sv * 129S2/SvPas)
|
absent golgi tendon organ
|
J:75311
|
| absent muscle spindles
|
J:75311
|
Etv1tm1Tmj/Etv1tm2Tmj
Tg(EGR3-WGA)1Tmj/0
(involves: 129S1/Sv)
|
decreased muscle spindle number
|
J:197913
|
Etv1tm2Tmj/Etv1+
(involves: 129S1/Sv)
|
abnormal golgi tendon organ morphology
|
J:75311
|
| increased muscle spindle number
|
J:75311
|
Etv1tm2Tmj/Etv1tm2Tmj
(involves: 129S1/Sv)
|
abnormal golgi tendon organ morphology
|
J:75311
|
| abnormal muscle spindle morphology
|
J:75311
|
| absent golgi tendon organ
|
J:75311
|
Etv1tm2Tmj/Etv1tm2Tmj
Ntf3tm1Lfr/Ntf3tm1Lfr
(involves: 129S1/Sv * 129S2/SvPas)
|
absent golgi tendon organ
|
J:75311
|
| absent muscle spindles
|
J:75311
|
Evlb2b2600Clo/Evlb2b2600Clo
(C57BL/6J-Evlb2b2600Clo)
|
abnormal myocardium compact layer morphology
|
J:175213
|
Ewsr1tm1Sblee/Ewsr1tm1Sblee
(involves: 129S6/SvEvTac * Black Swiss)
|
muscular atrophy
|
J:122058
|
Eya1tm1Rilm/Eya1tm1Rilm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal skeletal muscle morphology
|
J:172023
|
Eya1tm1Rilm/Eya1tm1Rilm
Six1tm1Mair/Six1tm1Mair
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal extraocular muscle morphology
|
J:172023
|
| abnormal skeletal muscle morphology
|
J:172023
|
| facial muscle hypoplasia
|
J:172023
|
| tongue muscle hypoplasia
|
J:172023
|
Eya1tm1Rilm/Eya1tm1Rilm
Six1tm1Rsd/Six1tm1Rsd
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal epaxial muscle morphology
|
J:86619
|
| absent hypaxial muscle
|
J:86619
|
Ezh2tm2Sho/Ezh2tm2Sho
(involves: 129S1/Sv * 129S7/SvEvBrd)
|
abnormal myocardial trabeculae morphology
|
J:179371
|
| thin myocardium compact layer
|
J:179371
|
F2tm1Jld/F2tm1Sjd
Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * CBA)
|
muscle hemorrhage
|
J:144572
|
F3tm1.1Dwr/F3tm1.1Dwr
(involves: 129S1/Sv * 129X1/SvJ * MF1 * Swiss)
|
abnormal vascular smooth muscle physiology
|
J:111390
|
| increased vascular smooth muscle cell proliferation
|
J:111390
|
F11tm1Gjb/F11tm1Gjb
Proctm1Fjc/Proctm1Fjc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
myocardial fiber degeneration
|
J:67398
|
| myocardium necrosis
|
J:67398
|
Faahtm1Crv/Faahtm1Crv
Tg(SOD1*G93A)1Gur/0
(involves: 129X1/SvJ * ABH * C57BL/6 * SJL)
|
abnormal muscle physiology
|
J:111498
|
Fabp3tm1Bin/Fabp3tm1Bin
(involves: 129P2/OlaHsd * BALB/c)
|
increased cardiac muscle cell glucose uptake
|
J:54614
|
Fabp4tm1Brsp/Fabp4tm1Brsp
Fabp5tm1Hota/Fabp5tm1Hota
(involves: 129S7/SvEvBrd * C57BL/6J * SJL)
|
decreased skeletal muscle glycogen level
|
J:217245
|
| muscle phenotype
|
J:217245
|
Fabp4tm1Brsp/Fabp4tm1Brsp
Fabp5tm1Hota/Fabp5tm1Hota
Lepob/Lepob
(B6.Cg-Fabp4tm1Brsp Fabp5tm1Hota Lepob)
|
increased muscle cell glucose uptake
|
J:111878
|
Faddtm1Mak/Faddtm1Mak
(either: (involves: 129P2/OlaHsd * C57BL/6J) or (involves: 129P2/OlaHsd * CD-1))
|
abnormal myocardium layer morphology
|
J:46527
|
| thin myocardium
|
J:46527
|
| trabecula carnea hypoplasia
|
J:46527
|
Fam120bem1Qqlg/Fam120bem1Qqlg
(C57BL/6-Fam120bem1Qqlg)
|
decreased fetal cardiomyocyte proliferation
|
J:318650
|
| decreased ventricle muscle contractility
|
J:318650
|
| increased myocardial fiber size
|
J:318650
|
| myocardial fiber disarray
|
J:318650
|
Fam161bem1(IMPC)Ccpcz/Fam161bem1(IMPC)Ccpcz
(C57BL/6N-Fam161bem1(IMPC)Ccpcz/Ccpcz)
|
abnormal skeletal muscle morphology
|
J:211773
|
Fam227bem1(IMPC)Ccpcz/Fam227bem1(IMPC)Ccpcz
(C57BL/6NCrl-Fam227bem1(IMPC)Ccpcz/Ccpcz)
|
abnormal skeletal muscle morphology
|
J:211773
|
Faslpr/Faslpr
(MRL/MpJ-Faslpr/J)
|
abnormal myocardium layer morphology
|
J:14151
|
Fat1Gt(KST249)Byg/Fat1Gt(KST249)Byg
Tg(Myl1-lacZ)1Ibdml/0
(involves: 129P2/OlaHsd)
|
abnormal muscle development
|
J:199157
|
| abnormal skeletal muscle morphology
|
J:199157
|
| decreased skeletal muscle fiber diameter
|
J:199157
|
| decreased skeletal muscle mass
|
J:199157
|
| ectopic skeletal muscle
|
J:199157
|
| myositis
|
J:199157
|
| skeletal muscle atrophy
|
J:199157
|
| skeletal muscle fiber necrosis
|
J:199157
|
Fat1tm1.2Fhel/Fat1tm1.2Fhel
Tg(Myl1-lacZ)1Ibdml/0
(involves: 129S6/SvEvTac * BALB/cJ * C57BL/6J * SJL)
|
abnormal facial muscle morphology
|
J:199157
|
| abnormal muscle development
|
J:199157
|
| abnormal skeletal muscle morphology
|
J:199157
|
| decreased skeletal muscle fiber diameter
|
J:199157
|
| ectopic skeletal muscle
|
J:199157
|
| myositis
|
J:199157
|
| skeletal muscle fiber necrosis
|
J:199157
|
Fat1tm1Fhel/Fat1tm1Fhel
Pax3tm1(cre)Joe/Pax3+
Tg(Myl1-lacZ)1Ibdml/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * SJL)
|
abnormal muscle development
|
J:199157
|
| abnormal skeletal muscle morphology
|
J:199157
|
| ectopic skeletal muscle
|
J:199157
|
Fat1tm1Fhel/Fat1tm1Fhel
Tg(Myl1-lacZ)1Ibdml/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * SJL)
|
abnormal muscle development
|
J:199157
|
| abnormal skeletal muscle morphology
|
J:199157
|
| ectopic skeletal muscle
|
J:199157
|
Fbln1Gt(XST011)Byg/Fbln1Gt(XST011)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
ventricle myocardium hypoplasia
|
J:137690
|
Fbln5tm1Eno/Fbln5tm1Eno
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal vascular smooth muscle physiology
|
J:96831
|
Fbn1tm1.2Lysa/Fbn1+
(involves: C57BL/6)
|
abnormal skeletal muscle fiber morphology
|
J:165897
|
| abnormal tendon morphology
|
J:165897
|
Fbn1tm1.2Lysa/Fbn1tm1.2Lysa
(involves: C57BL/6)
|
abnormal skeletal muscle fiber morphology
|
J:165897
|
| abnormal tendon morphology
|
J:165897
|
Fbn1tm2Rmz/Fbn1tm2Rmz
(involves: 129S1/Sv * 129X1/SvJ)
|
diaphragmatic hernia
|
J:54081
|
Fbn1tm3Rmz/Fbn1tm3Rmz
(Not Specified)
|
abnormal diaphragm morphology
|
J:110586
|
| abnormal intercostal muscle morphology
|
J:110586
|
| diaphragmatic hernia
|
J:110586
|
Fbn1Tsk Bloc1s6+/Fbn1+ Bloc1s6pa
(B6.Cg-Fbn1Tsk +/+ Bloc1s6pa/J)
|
abnormal vasodilation
|
J:81020
|
Fbn1Tsk/Fbn1+
(B10.D2/(58N)Sn)
|
abnormal tendon morphology
|
J:5629
|
| abnormal tendon sheath morphology
|
J:5629
|
Fbn1Tsk/Fbn1+
(B6.Cg-Fbn1Tsk)
|
heart right ventricle hypertrophy
|
J:20724
|
Fbn2fp/Fbn2fp
(C3Fe(B6)-Fbn2fp/J)
|
muscle weakness
|
J:157998
|
Fbn2fp/Fbn2mz
(involves: BALB/cAnNCrl * C3H/HeH * C3HeB/FeHu * C57BL/6J)
|
muscle weakness
|
J:157998
|
Fbn2mz/Fbn2mz
(involves: BALB/cAnNCrl * C3H/HeH)
|
abnormal muscle electrophysiology
|
J:157998
|
| centrally nucleated skeletal muscle fibers
|
J:157998
|
| decreased skeletal muscle fiber diameter
|
J:157998
|
| increased skeletal muscle mass
|
J:157998
|
| muscle weakness
|
J:157998
|
Fbxl3em1(IMPC)Ccpcz/Fbxl3em1(IMPC)Ccpcz
(C57BL/6NCrl-Fbxl3em1(IMPC)Ccpcz/Ccpcz)
|
abnormal skeletal muscle morphology
|
J:211773
|
Fbxo10tm1b(KOMP)Wtsi/Fbxo10tm1b(KOMP)Wtsi
(C57BL/6N-Fbxo10tm1b(KOMP)Wtsi/Nju)
|
decreased cardiac muscle contractility
|
J:211773
|
Fbxo32tm1Glas/Fbxo32tm1Glas
(involves: 129S1/Sv)
|
decreased susceptibility to induced muscular atrophy
|
J:77660
|
Fbxw5em1Syli/Fbxw5em1Syli
(C57BL/6-Fbxw5em1Syli)
|
decreased cardiac muscle contractility
|
J:298305
|
Fdpstm1Jiy/Fdpstm1Jiy
Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6 * FVB/N)
|
decreased cardiac muscle contractility
|
J:317808
|
| increased myocardial fiber size
|
J:317808
|
Fendrrtm1Bgh/Fendrrtm2Bgh
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased fetal cardiomyocyte proliferation
|
J:191565
|
| ventricle myocardium hypoplasia
|
J:191565
|
Fendrrtm1Vlcg/Fendrrtm1Vlcg
(involves: 129S6/SvEvTac * C57BL/6J * C57BL/6N)
|
abnormal esophageal smooth muscle morphology
|
J:204277
|
Festm2Mcs/Fes+
(chimera involves: 129X1/SvJ * C57BL/6)
|
abnormal myocardial trabeculae morphology
|
J:76509
|
| thin myocardium compact layer
|
J:76509
|
Fgf2tm1Doe/Fgf2tm1Doe
(involves: 129P2/OlaHsd * Black Swiss)
|
abnormal cardiac muscle relaxation
|
J:119652
|
| decreased cardiac muscle contractility
|
J:119652
|
| decreased vasoconstriction
|
J:45775
|
| increased cardiomyocyte apoptosis
|
J:119652
|
Fgf2tm1Zllr/Fgf2tm1Zllr
(involves: 129S1/Sv * 129X1/SvJ)
|
muscle phenotype
|
J:85088
|
Fgf2tm1Zllr/Fgf2tm1Zllr
Fgf6tm1Thbr/Fgf6tm1Thbr
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)
|
abnormal myoblast migration
|
J:85088
|
| muscle phenotype
|
J:85088
|
Fgf2tm2Doe/Fgf2tm2Doe
(involves: 129P2/OlaHsd * Black Swiss)
|
abnormal cardiac muscle relaxation
|
J:119652
|
| decreased cardiac muscle contractility
|
J:119652
|
| increased cardiomyocyte apoptosis
|
J:119652
|
Fgf6tm1Thbr/Fgf6tm1Thbr
(either: (involves: 129S4/SvJae-Fgf6tm1Thbr) or (involves: 129S4/SvJae * C57BL/6))
|
impaired skeletal muscle regeneration
|
J:42574
|
| increased satellite cell number
|
J:42574
|
Fgf8tm1.3Mrt/Fgf8tm1.4Mrt
Tg(Tbx1-cre)1Joe/0
(involves: 129P2/OlaHsd)
|
abnormal vascular smooth muscle morphology
|
J:88814
|
Fgf9tm1Dor/Fgf9tm1Dor
(involves: C57BL/6J)
|
abnormal fetal cardiomyocyte proliferation
|
J:95803
|
Fgf10tm1Ska/Fgf10tm1Ska
(involves: C57BL/6 * CBA)
|
abnormal limb muscle morphology
|
J:80685
|
| diaphragmatic hernia
|
J:80685
|
| muscle phenotype
|
J:80685
|
Fgf16tm1Nit/Y
(C57BL/6-Fgf16tm1Nit)
|
abnormal fetal cardiomyocyte proliferation
|
J:139637
|
Fgf16tm1Paca/Y
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss)
|
trabecula carnea hypoplasia
|
J:138004
|
Fgfr1tm1Upir/Fgfr1tm1.1Upir
(involves: C57BL/6J)
|
abnormal fetal cardiomyocyte proliferation
|
J:95803
|
| abnormal myocardial fiber morphology
|
J:95803
|
| thin myocardium
|
J:95803
|
Fgfr2tm1.1Dsn/Fgfr2tm1.1Dsn
(involves: 129P2/OlaHsd * C57BL/6)
|
absent hypodermis muscle layer
|
J:59285
|
Fgfr2tm1Ewj/Fgfr2+
Tg(EIIa-cre)C5379Lmgd/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)
|
abnormal vasodilation
|
J:101174
|
Fgfr2tm3Dsn/Fgfr2tm3Dsn
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal trabecula carnea morphology
|
J:111148
|
| thin left ventricle myocardium compact layer
|
J:111148
|
Fgfrl1tm1.1Ptew/Fgfrl1tm1.1Ptew
(B6.129-Fgfrl1tm1.1Ptew)
|
abnormal diaphragm development
|
J:149673
|
| thin myocardium
|
J:149673
|
Fgfrl1tm1True/Fgfrl1tm1True
(B6.129S6-Fgfrl1tm1True)
|
abnormal diaphragm development
|
J:130254
|
| diaphragmatic hernia
|
J:130254
|
| muscle hypoplasia
|
J:130254
|
| thin diaphragm muscle
|
J:130254,
J:218981
|
Fgfrl1tm2.1True/Fgfrl1tm2.1True
(B6.Cg-Fgfrl1tm2.1True)
|
muscle phenotype
|
J:218981
|
Fhl1tm1.1Mihi/Y
(involves: 129S/SvEv * C57BL/6J * C57BL/6NJ)
|
centrally nucleated skeletal muscle fibers
|
J:218097
|
| decreased skeletal muscle fiber diameter
|
J:218097
|
| myopathy
|
J:218097
|
Fhod3tm1Hsum/Fhod3+
Tg(Myh6-Fhod3*I1127A)#Hsum/0
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal myocardium layer morphology
|
J:187358
|
Fhod3tm1Hsum/Fhod3tm1Hsum
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal myocardial trabeculae morphology
|
J:187358
|
| decreased ventricle muscle contractility
|
J:187358
|
Fig4plt1/Fig4plt1
(involves: 129P2/OlaHsd * C3H * C57BL/6 * CAST/Ei * SJL)
|
muscle weakness
|
J:122737
|
Fis1tm1.1Itl/Fis1tm1.1Itl
Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6NTac * FVB)
|
abnormal skeletal muscle morphology
|
J:290485
|
| abnormal Z line morphology
|
J:290485
|
Fkbp1atm1.1Shou/Fkbp1atm1Zuk
Tg(Tek-cre)1Ywa/0
(involves: 129S7/SvEvBrd * C57BL/6 * SJL)
|
thin ventricle myocardium compact layer
|
J:195489
|
Fkbp1atm1Slh/Fkbp1atm1Slh
Tg(Ckmm-cre)5Khn/0
(involves: 129S7/SvEvBrd * FVB)
|
abnormal muscle contractility
|
J:176731
|
| abnormal muscle physiology
|
J:176731
|
| abnormal skeletal muscle morphology
|
J:176731
|
Fkbp1atm1Zuk/Fkbp1atm1Slh
Tg(Ckmm-cre)5Khn/0
(involves: 129S7/SvEvBrd * FVB)
|
abnormal muscle contractility
|
J:94747
|
| abnormal muscle physiology
|
J:94747
|
| abnormal skeletal muscle fiber morphology
|
J:94747
|
| abnormal skeletal muscle fiber type ratio
|
J:94747
|
| centrally nucleated skeletal muscle fibers
|
J:94747
|
Fkbp1atm1Zuk/Fkbp1atm1Zuk
(either: (involves: 129S7/SvEvBrd) or (involves: 129S7/SvEvBrd * C57BL/6J))
|
abnormal muscle physiology
|
J:45536
|
| abnormal myocardium layer morphology
|
J:45536
|
| abnormal trabecula carnea morphology
|
J:45536
|
| decreased ventricle muscle contractility
|
J:45536
|
| dilated cardiomyopathy
|
J:45536
|
Fkrptm1.1Pg/Fkrptm1.1Pg
(involves: 129P2/OlaHsd)
|
abnormal skeletal muscle fiber morphology
|
J:285924
|
| abnormal skeletal muscle fiber type ratio
|
J:285924
|
| increased skeletal muscle fiber diameter
|
J:285924
|
| increased skeletal muscle fiber size
|
J:285924
|
| myopathy
|
J:285924
|
| skeletal muscle fibrosis
|
J:285924
|
Fkrptm1.1Pg/Fkrptm1.2Pg
(involves: 129P2/OlaHsd * FVB/N)
|
abnormal skeletal muscle fiber morphology
|
J:285924
|
Fkrptm1Itl/Fkrptm1Itl
(involves: 129S6/SvEvTac * C57BL/6N)
|
abnormal skeletal muscle fiber morphology
|
J:164448
|
| centrally nucleated skeletal muscle fibers
|
J:164448
|
| dystrophic muscle
|
J:164448
|
| increased variability of skeletal muscle fiber size
|
J:164448
|
| muscle weakness
|
J:164448
|
| skeletal muscle fiber degeneration
|
J:164448
|
| skeletal muscle fiber necrosis
|
J:164448
|
| skeletal muscle fibrosis
|
J:164448
|
Fkrptm1Scbr/Fkrptm1Scbr
(involves: C57BL/6)
|
abnormal extensor digitorum longus morphology
|
J:164634
|
| abnormal tibialis anterior morphology
|
J:164634
|
| centrally nucleated skeletal muscle fibers
|
J:164634
|
| decreased skeletal muscle fiber number
|
J:164634
|
Fkrptm1Scbr/Fkrptm1Scbr
Sox1tm1(cre)Take/Sox1+
(involves: C57BL/6NCrlj * CBA/JNCrlj)
|
centrally nucleated skeletal muscle fibers
|
J:207119
|
| dystrophic muscle
|
J:207119
|
| muscle degeneration
|
J:207119
|
| myositis
|
J:207119
|
Fkrptm1Scbr/Fkrptm1Scbr
Sox1tm1(cre)Take/Sox1+
Tg(CAG-LARGE)126Fmu/0
(involves: C57BL/6NCrlj * C57BL/10 * CBA/Ca * CBA/JNCrlj)
|
abnormal muscle morphology
|
J:207119
|
| abnormal muscle physiology
|
J:207119
|
| calcified muscle
|
J:207119
|
| centrally nucleated skeletal muscle fibers
|
J:207119
|
| dystrophic muscle
|
J:207119
|
| myositis
|
J:207119
|
| skeletal muscle fibrosis
|
J:207119
|
| skeletal muscle hypertrophy
|
J:207119
|
Fkrptvrm53/Fkrptvrm53
(C57BL/6J-Fkrptvrm53/Pjn)
|
centrally nucleated skeletal muscle fibers
|
J:243745
|
| dystrophic muscle
|
J:243745
|
Fktntm1Kcam/Fktntm1Kcam
Myf5tm3(cre)Sor/Myf5+
(involves: 129S/SvEv * 129S4/SvJaeSor)
|
dystrophic muscle
|
J:187144
|
Fktntm1Kcam/Fktntm1Kcam
Tg(CAG-cre/Esr1*)5Amc/?
(involves: 129S/SvEv * C57BL/6 * CBA)
|
dystrophic muscle
|
J:187144
|
Fktntm1Kcam/Fktntm1Kcam
Tg(Ckmm-cre)5Khn/?
(involves: 129S/SvEv * FVB)
|
dystrophic muscle
|
J:187144
|
Fktntm1Ttd/Fktntm2(FCMD)Ttd
(involves: 129S7/SvEvBrd)
|
muscle phenotype
|
J:144746
|
Fktntm2(FCMD)Ttd/Fktntm2(FCMD)Ttd
(Not Specified)
|
muscle phenotype
|
J:144746
|
Fktntm3.1Ttd/Fktntm3.1Ttd
Myf5tm3(cre)Sor/Myf5+
(involves: 129S4/SvJaeSor * C57BL/6)
|
abnormal muscle precursor cell morphology
|
J:198535
|
| abnormal muscle precursor cell physiology
|
J:198535
|
| centrally nucleated skeletal muscle fibers
|
J:198535
|
| decreased satellite cell number
|
J:198535
|
| decreased skeletal muscle weight
|
J:198535
|
| impaired skeletal muscle regeneration
|
J:198535
|
| increased collagen deposition in the muscles
|
J:198535
|
| increased variability of skeletal muscle fiber size
|
J:198535
|
| skeletal muscle atrophy
|
J:198535
|
| skeletal muscle fibrosis
|
J:198535
|
| skeletal muscle necrosis
|
J:198535
|
Fktntm3.1Ttd/Fktntm3.1Ttd
Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6 * FVB)
|
abnormal skeletal muscle fiber morphology
|
J:198535
|
| centrally nucleated skeletal muscle fibers
|
J:198535
|
| dystrophic muscle
|
J:198535
|
| skeletal muscle necrosis
|
J:198535
|
Fli1tm1Matr/Fli1tm1Matr
Tg(Tek-cre)12Flv/0
(B6.Cg-Fli1tm1Matr Tg(Tek-cre)12Flv)
|
abnormal vascular smooth muscle morphology
|
J:158658
|
Flnctm1.1Rsdf/Flnc+
(involves: C57BL/6)
|
abnormal muscle fiber morphology
|
J:226976
|
| abnormal sarcomere morphology
|
J:226976
|
| abnormal Z line morphology
|
J:226976
|
| muscle phenotype
|
J:226976
|
| skeletal muscle fiber degeneration
|
J:226976
|
Flnctm1Lmk/Flnctm1Lmk
(involves: 129X1/SvJ * C57BL/6)
|
abnormal diaphragm morphology
|
J:112170
|
| abnormal extensor digitorum longus morphology
|
J:112170
|
| abnormal intercostal muscle morphology
|
J:112170
|
| abnormal myogenesis
|
J:112170
|
| abnormal skeletal muscle fiber morphology
|
J:112170
|
| abnormal skeletal muscle morphology
|
J:112170
|
| abnormal soleus morphology
|
J:112170
|
| abnormal tibialis anterior morphology
|
J:112170
|
| centrally nucleated skeletal muscle fibers
|
J:112170
|
| decreased skeletal muscle fiber number
|
J:112170
|
| decreased skeletal muscle mass
|
J:112170
|
| increased variability of skeletal muscle fiber size
|
J:112170
|
Flrt2tm1Rob/Flrt2tm1Rob
(involves: 129S/SvEv * C57BL/6J)
|
thin ventricle myocardium compact layer
|
J:171515
|
Flt3em1(IMPC)Ccpcz/Flt3em1(IMPC)Ccpcz
(C57BL/6NCrl-Flt3em1(IMPC)Ccpcz/Ccpcz)
|
abnormal skeletal muscle morphology
|
J:211773
|
Flt4tm1Ali/Flt4+
Tmem204tm1.1Ali/Tmem204tm1.1Ali
(involves: BALB/c * C57BL/6)
|
abnormal lymphatic vessel smooth muscle morphology
|
J:159519
|
Fmodtm1Aol/Fmod+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal tendon morphology
|
J:54069
|
Fmodtm1Aol/Fmodtm1Aol
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
abnormal tendon morphology
|
J:65867
|
| decreased tendon stiffness
|
J:79115
|
Fmodtm1Aol/Fmodtm1Aol
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal tendon morphology
|
J:54069
|
Fmodtm1Aol/Fmodtm1Aol
Lumtm1Chak/Lum+
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
decreased tendon stiffness
|
J:83544
|
Fmodtm1Aol/Fmodtm1Aol
Lumtm1Chak/Lumtm1Chak
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
abnormal myocardial fiber morphology
|
J:79115
|
| abnormal tendon morphology
|
J:79115
|
| decreased tendon stiffness
|
J:83544
|
| muscle weakness
|
J:79115
|
Fn1tm1Hyn/Fn1tm1Hyn
(involves: 129S2/SvPas * C57BL/6J)
|
thick myocardium
|
J:16247
|
Fn1tm4Hyn/Fn1tm4Hyn
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal vascular smooth muscle morphology
|
J:126737
|
Fnip1LPAB.1/Fnip1LPAB.1
(C57BL/6J-Fnip1LPAB.1)
|
abnormal skeletal muscle morphology
|
J:187318
|
| cardiomyopathy
|
J:187318
|
Fnip1m1Btlr/Fnip1m1Btlr
(C57BL/6J-Fnip1m1Btlr)
|
abnormal skeletal muscle morphology
|
J:234285
|
| increased cardiac muscle glycogen level
|
J:234285
|
Fnip1tm1.1Baba/Fnip1tm1.1Baba
Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6 * FVB)
|
abnormal muscle morphology
|
J:220672
|
| abnormal muscle physiology
|
J:220672
|
Fostm1Wag/Fostm1Wag
Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas * C57BL/6)
|
increased rhabdomyosarcoma incidence
|
J:89283
|
Fostm1Wag/Fostm1Wag
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * C57BL/6)
|
increased rhabdomyosarcoma incidence
|
J:89283
|
Foxc1tm1Blh/Foxc1+
Foxc2tm1Blh/Foxc2+
(involves: 129S6/SvEvTac * Black Swiss)
|
trabecula carnea hypoplasia
|
J:57677
|
| ventricle myocardium hypoplasia
|
J:57677
|
Foxc1tm1Blh/Foxc1tm1Blh
Foxc2tm1Blh/Foxc2tm1Blh
(involves: 129S6/SvEvTac * Black Swiss)
|
disorganized myocardium
|
J:71693
|
Foxc2tm1.2Tsku/Foxc2tm1.2Tsku
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N * SJL * Tac:NIHBS)
|
thin myocardium
|
J:188816
|
Foxc2tm1Miu/Foxc2tm1Miu
Pax1tm2Neu/Pax1tm2Neu
(involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6)
|
abnormal dermomyotome development
|
J:55575
|
| abnormal muscle development
|
J:55575
|
Foxe3tm1Mjam/Foxe3tm1Mjam
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal vascular smooth muscle physiology
|
J:232427
|
Foxf1tm2Rhc/Foxf1+
Tg(Myh11-cre,-EGFP)2Mik/0
(involves: C57BL/6 * DBA/2)
|
abnormal intestinal smooth muscle morphology
|
J:203847
|
| impaired contractility of intestinal smooth muscle
|
J:203847
|
Foxf1tm2Rhc/Foxf1tm2Rhc
Tg(Myh11-cre,-EGFP)2Mik/0
(involves: C57BL/6 * DBA/2)
|
abnormal esophageal smooth muscle morphology
|
J:203847
|
Foxf2W174R/Foxf2+
(involves: BALB/c * C3H/HeH)
|
abnormal ciliary muscle morphology
|
J:178103
|
Foxh1b2b2662Clo/Foxh1b2b2662Clo
(C57BL/6J-Foxh1b2b2662Clo)
|
diaphragmatic hernia
|
J:175213
|
Foxh1tm1Jlw/Foxh1tm1Jlw
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
disorganized myocardium
|
J:93034
|
| trabecula carnea hypoplasia
|
J:93034
|
Foxj1b2b774Clo/Foxj1b2b774Clo
(C57BL/6J-Foxj1b2b774Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
Foxj3Gt(XL913)Byg/Foxj3Gt(XL913)Byg
(either: 129P2/OlaHsd-Foxj3Gt(XL913)Byg or B6.129P2-Foxj3 |
abnormal extensor digitorum longus morphology
|
J:157260
|
| abnormal muscle physiology
|
J:157260
|
| abnormal skeletal muscle fiber type ratio
|
J:157260
|
| abnormal skeletal muscle satellite cell proliferation
|
J:157260
|
| abnormal soleus morphology
|
J:157260
|
| impaired skeletal muscle contractility
|
J:157260
|
| impaired skeletal muscle regeneration
|
J:157260
|
| skeletal muscle necrosis
|
J:157260
|
Foxk1tm1Djg/Foxk1tm1Djg
(involves: 129S4/SvJae)
|
abnormal muscle precursor cell morphology
|
J:81688
|
| abnormal myogenesis
|
J:81688
|
| impaired skeletal muscle regeneration
|
J:62225
|
Foxm1tm1.1Rhc/Foxm1tm1.1Rhc
(involves: 129X1/SvJ)
|
increased myocardial fiber size
|
J:94883
|
Foxm1tm1.1Rhc/Foxm1tm1.1Rhc
(involves: 129X1/SvJ * C57BL/6)
|
vascular smooth muscle hypertrophy
|
J:100263
|
Foxm1tm1.1Rhc/Foxm1tm1.1Rhc
(B6.129X1-Foxm1tm1.1Rhc)
|
abnormal ventricle myocardium morphology
|
J:119481
|
| decreased fetal cardiomyocyte proliferation
|
J:119481
|
Foxm1tm1Cle/Foxm1tm1Cle
(Not Specified)
|
abnormal myocardial fiber morphology
|
J:95612
|
| myocardial fiber disarray
|
J:95612
|
| thin myocardium
|
J:95612
|
Foxn1nu/Foxn1nu
(involves: C57BL/10)
|
abnormal muscle morphology
|
J:95776
|
| decreased skeletal muscle fiber size
|
J:95776
|
| decreased skeletal muscle mass
|
J:95776
|
Foxo1tm1.1Dac/Foxo1tm1.1Dac
(Not Specified)
|
abnormal myocardial trabeculae morphology
|
J:179687
|
Foxp1Gt(S17-4A1)Sor/Foxp1+
Ncor2tm1Rsd/Ncor2+
(involves: 129/Sv * 129S4/SvJaeSor)
|
thin myocardium
|
J:132982
|
Foxp1tm1Eem/Foxp1+
Foxp2tm1Bux/Foxp2tm1Bux
(involves: 129X1/SvJ * C57BL/6)
|
abnormal esophageal smooth muscle morphology
|
J:121421
|
Foxp1tm1Eem/Foxp1tm1Eem
(involves: 129S6/SvEvTac * C57BL/6)
|
disorganized myocardium
|
J:93182
|
| thin ventricle myocardium compact layer
|
J:93182
|
Foxp1tm2.1Eem/Foxp1tm2.1Eem
Nkx2-5tm1(cre)Rjs/Nkx2-5+
(involves: 129 * C57BL/6 * SJL)
|
abnormal sarcomere morphology
|
J:163662
|
| increased fetal cardiomyocyte proliferation
|
J:163662
|
Foxp1tm2.1Eem/Foxp1tm2.1Eem
Tg(Tek-cre)1Ywa/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
abnormal fetal cardiomyocyte proliferation
|
J:163662
|
Frem1eyes2/Frem1eyes2
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal diaphragm development
|
J:192553
|
| diaphragmatic hernia
|
J:192553
|
Frem1eyes2/Frem1eyes2
(C57BL/6J-Frem1eyes2)
|
diaphragmatic hernia
|
J:192553
|
Frem2b2b3270Clo/Frem2b2b3270Clo
(C57BL/6J-Frem2b2b3270Clo)
|
diaphragmatic hernia
|
J:175213
|
fsq/fsq
(KK(Cg)-fsq/J)
|
muscle hypertonia
|
J:137888
|
| muscle phenotype
|
J:137888
|
Fsttm1Zuk/Fst+
(B6.129S7-Fsttm1Zuk)
|
abnormal extensor digitorum longus morphology
|
J:182827
|
| abnormal gastrocnemius morphology
|
J:182827
|
| abnormal muscle physiology
|
J:182827
|
| abnormal pectoral muscle morphology
|
J:182827
|
| abnormal skeletal muscle fiber morphology
|
J:182827
|
| decreased gastrocnemius weight
|
J:182827
|
| decreased quadriceps weight
|
J:182827
|
| decreased skeletal muscle weight
|
J:182827
|
Fsttm1Zuk/Fst+
Fstl3tm1.1Sjl/Fstl3tm1.1Sjl
(B6.129-Fsttm1Zuk Fstl3tm1.1Sjl)
|
decreased skeletal muscle weight
|
J:182827
|
Fsttm1Zuk/Fst+
Mstntm1Sjl/Mstn+
(B6.129-Mstntm1Sjl Fsttm1Zuk)
|
decreased skeletal muscle weight
|
J:182827
|
Fsttm1Zuk/Fst+
Mstntm1Sjl/Mstntm1Sjl
(B6.129-Mstntm1Sjl Fsttm1Zuk)
|
decreased skeletal muscle weight
|
J:182827
|
Fsttm1Zuk/Fsttm1Zuk
(involves: 129S7/SvEvBrd)
|
decreased skeletal muscle mass
|
J:23925
|
Fsttm1Zuk/Fsttm1Zuk
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased skeletal muscle mass
|
J:23925
|
Fstl1tm1.1Mvdh/Fstl1tm1.1Mvdh
Tg(Myh6-cre)2182Mds/0
(involves: 129S4/SvJae * C57BL/6 * FVB/N)
|
decreased cardiac muscle contractility
|
J:177416
|
| increased myocardial fiber size
|
J:177416
|
Fuzb2b1273Clo/Fuzb2b1273Clo
(C57BL/6J-Fuzb2b1273Clo)
|
diaphragmatic hernia
|
J:175213
|
Fxnem2Lutzy/Fxnem2.1Lutzy
Tg(Ckmm-cre)5Khn/?
(B6.Cg-Fxnem2Lutzy Fxnem2.1Lutzy Tg(Ckmm-cre)5Khn/J)
|
cardiomyopathy
|
J:101977
|
| decreased cardiac muscle contractility
|
J:101977
|
Fxntm1Mkn/Fxntm1Mkn
Tg(FXN)YG8Pook/0
(involves: 129/Sv * C57BL/6 * CBA)
|
abnormal myocardial fiber morphology
|
J:114840
|
Fxntm2Mkn/Fxntm2.1Mkn
Tg(Ckmm-cre)1Lrsn/0
(involves: 129 * C57BL/6J)
|
abnormal myocardial fiber mitochondrial morphology
|
J:75420
|
| abnormal myocardial fiber morphology
|
J:75420,
J:90401
|
| decreased ventricle muscle contractility
|
J:90401
|
| dilated cardiomyopathy
|
J:75420,
J:90401
|
| heart left ventricle hypertrophy
|
J:75420
|
| myocardium necrosis
|
J:75420
|
Fxntm2Mkn/Fxntm2.1Mkn
Tg(Eno2-cre)39Jme/0
(involves: 129 * C57BL/6J)
|
abnormal myocardial fiber morphology
|
J:75420
|
| dilated cardiomyopathy
|
J:75420
|
| muscle phenotype
|
J:75420
|
| myocardium necrosis
|
J:75420
|
Fxr1tm1.2Dln/Fxr1tm1.2Dln
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal muscle development
|
J:91191
|
| abnormal myocardial fiber morphology
|
J:91191
|
Fxr1tm1Dln/Fxr1tm1Dln
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal muscle development
|
J:91191
|
| disorganized myocardium
|
J:91191
|
Fxyd1tm1Atck/Fxyd1tm1Atck
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased cardiac muscle contractility
|
J:97365
|
Fzd4tm1Nat/Fzd4tm1Nat
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased skeletal muscle fiber diameter
|
J:70078
|
Fzd8em1(IMPC)Bay/Fzd8em1(IMPC)Bay
(C57BL/6N-Fzd8em1(IMPC)Bay/Bay)
|
increased cardiac muscle contractility
|
J:211773
|
Gaatm1.1Rabn/Gaatm1.1Rabn
(involves: 129X1/SvJ * C57BL/6 * FVB/N)
|
increased cardiac muscle glycogen level
|
J:76435,
J:48839
|
| increased skeletal muscle glycogen level
|
J:76435,
J:48839
|
| myopathy
|
J:76435
|
| progressive muscle weakness
|
J:76435
|
Gaatm1Rabn/Gaatm1Rabn
(involves: 129X1/SvJ * C57BL/6)
|
abnormal muscle fiber morphology
|
J:48839
|
| abnormal sarcomere morphology
|
J:48839
|
| abnormal Z line morphology
|
J:48839
|
| cardiomyopathy
|
J:76435,
J:48839
|
| increased cardiac muscle glycogen level
|
J:235790,
J:76435,
J:48839
|
| increased skeletal muscle glycogen level
|
J:235790,
J:48839,
J:73924
|
| muscle weakness
|
J:48839
|
| myopathy
|
J:76435
|
| progressive muscle weakness
|
J:76435,
J:48839
|
Gaatm1Rabn/Gaatm1Rabn
Stbd1tm1Bsn/Stbd1tm1Bsn
(involves: 129X1/SvJ * C57BL/6)
|
increased cardiac muscle glycogen level
|
J:235790
|
| increased skeletal muscle glycogen level
|
J:235790
|
Gaatm1Rabn/Gaatm1Rabn
Tg(CMV-GAA*P545L)#Kjv/0
(involves: 129X1/SvJ * C57BL/6)
|
increased skeletal muscle glycogen level
|
J:219022
|
Gaatm1Vdp/Gaatm1Vdp
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * FVB))
|
abnormal myocardial fiber morphology
|
J:45386
|
| abnormal skeletal muscle fiber morphology
|
J:45386
|
| cardiomyopathy
|
J:45386
|
| heart left ventricle hypertrophy
|
J:45386
|
| heart right ventricle hypertrophy
|
J:45386
|
Gaatm1Vdp/Gaatm1Vdp
(B6.129P2-Gaatm1Vdp)
|
abnormal muscle physiology
|
J:105167
|
| decreased skeletal muscle mass
|
J:105167
|
| muscular atrophy
|
J:105167
|
| progressive muscle weakness
|
J:105167
|
Gaatm2Rabn/Gaatm2Rabn
(involves: 129X1/SvJ * C57BL/6)
|
cardiomyopathy
|
J:76435
|
| increased cardiac muscle glycogen level
|
J:76435
|
| increased skeletal muscle glycogen level
|
J:76435
|
| myopathy
|
J:76435
|
| progressive muscle weakness
|
J:76435
|
Gab1tm1Nmoc/Gab1tm1Nmoc
Gab2tm1Thir/Gab2tm1Thir
Tg(Myh6-cre)2182Mds/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)
|
abnormal cardiac muscle relaxation
|
J:124033
|
| decreased cardiac muscle contractility
|
J:124033
|
Gab1tm1Wbm/Gab1tm1Wbm
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal diaphragm development
|
J:68751
|
| abnormal muscle precursor cell migration
|
J:68751
|
| hypaxial muscle hypoplasia
|
J:68751
|
Gab1tm1Wbm/Gab1tm1Wbm
(involves: 129P2/OlaHsd)
|
abnormal intrinsic tongue muscle morphology
|
J:100909
|
| abnormal muscle precursor cell migration
|
J:100909
|
| hypaxial muscle hypoplasia
|
J:100909
|
Gab1tm1Wbm/Gab1tm1Wbm
(involves: 129P2/OlaHsd * C57BL/6 * CD-1)
|
abnormal skeletal muscle morphology
|
J:125303
|
| decreased skeletal muscle mass
|
J:125303
|
Gab1tm1Wbm/Gab1tm1Wbm
Mettm1Cbm/Mettm1Cbm
(involves: 129P2/OlaHsd * C57BL/6)
|
hypaxial muscle hypoplasia
|
J:68751
|
Gab1tm2Wbm/Gab1tm2Wbm
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6 * CD-1)
|
muscle phenotype
|
J:125303
|
Gab1tm3Wbm/Gab1tm3Wbm
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6 * CD-1)
|
muscle phenotype
|
J:125303
|
Gab1tm5Wbm/Gab1tm5Wbm
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6 * CD-1)
|
abnormal muscle precursor cell morphology
|
J:125303
|
| abnormal myogenesis
|
J:125303
|
Gabpatm1Pjh/Gabpatm1Pjh
Tg(ACTA1-cre)79Jme/0
(involves: 129X1/SvJ * C57BL/6 * SJL)
|
muscle phenotype
|
J:121356
|
Gabpb1tm1Hhx/Gabpb1tm1Hhx
(involves: 129 * C57BL/6)
|
muscle phenotype
|
J:137300
|
Gabra1tm1.1Geh/Gabra1+
(B6.129(Cg)-Gabra1tm1.1Geh)
|
myoclonus
|
J:227437
|
Gabra1tm1.1Mjga/Gabra1+
(B6J.Cg-Gabra1tm1.1Mjga)
|
myoclonus
|
J:227437
|
Gabrg2tm1.2Rmac/Gabrg2+
(involves: C57BL/6 * C57BL/6J * SJL)
|
myoclonus
|
J:306976
|
Gad2tm1Oba/Gad2tm1Oba
(involves: C57BL/6 * CBA)
|
myoclonus
|
J:62320
|
Galctwi/Galctwi
(B6.CE-Galctwi/J)
|
muscle twitch
|
J:170081
|
Galctwi/Galctwi
(involves: C57BL/6J * CE/J)
|
progressive muscle weakness
|
J:6390
|
Galnt1tm1.1Jxm/Galnt1tm1.1Jxm
(B6NHsd.Cg-Galnt1tm1.1Jxm)
|
decreased ventricle muscle contractility
|
J:242253
|
Galnt3tcal/Galnt3tcal
(involves: C3H * C57BL/6J)
|
calcified muscle
|
J:187064
|
Gantm1Jpj/Gantm1Jpj
(involves: C57BL/6)
|
muscular atrophy
|
J:140136
|
Gantm1Yany/Gantm1Yany
(Not Specified)
|
muscle spasm
|
J:108239
|
| muscular atrophy
|
J:108239
|
| progressive muscle weakness
|
J:108239
|
Gars1C201R/Gars1+
(involves: BALB/cAnN * C3H/HeH * C57BL/6J)
|
abnormal tibialis anterior morphology
|
J:149830
|
| decreased skeletal muscle fiber number
|
J:149830
|
| decreased tibialis anterior weight
|
J:149830
|
| muscle weakness
|
J:149830
|
Gars1C201R/Gars1+
Nrcamm1J/Nrcamm1J
(involves: BALB/cAnN * C3H/HeH * C57BL/6J)
|
muscle hypoplasia
|
J:240096
|
Gars1em1Rwb/Gars1em2Rwb
(involves: C57BL/6NJ * FVB/NJ)
|
muscular atrophy
|
J:284948
|
Gars1Nmf249/Gars1+
(C57BL/6J-Gars1Nmf249/J)
|
decreased muscle weight
|
J:112221
|
| muscular atrophy
|
J:112221
|
Gars1Nmf249/Gars1+
Scn8am10J/Scn8a+
(involves: C57BL/6J * FVB/NJ)
|
skeletal muscle atrophy
|
J:240096
|
Gas2l2tm1a(KOMP)Wtsi/Gas2l2tm1a(KOMP)Wtsi
(C57BL/6N-Gas2l2tm1a(KOMP)Wtsi/Wtsi)
|
abnormal eye muscle morphology
|
J:239583
|
Gas2l3tm1c(EUCOMM)Hmgu/Gas2l3tm1c(EUCOMM)Hmgu
Gt(ROSA)26Sortm2(cre/ERT2)Brn/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6N)
|
abnormal fetal cardiomyocyte proliferation
|
J:244087
|
Gas2l3tm1c(EUCOMM)Hmgu/Gas2l3tm1c(EUCOMM)Hmgu
Nkx2-5tm2(cre)Rph/Nkx2-5+
(involves: 129S1/Sv * 129S4/SvJaeSor * C57BL/6N)
|
dilated cardiomyopathy
|
J:244087
|
Gas2l3tm1d(EUCOMM)Hmgu/Gas2l3tm1d(EUCOMM)Hmgu
(involves: 129S4/SvJaeSor * C57BL/6J * C57BL/6N)
|
abnormal fetal cardiomyocyte proliferation
|
J:244087
|
| abnormal myocardial fiber morphology
|
J:244087
|
| decreased cardiac muscle contractility
|
J:244087
|
| decreased myocardial fiber number
|
J:244087
|
| dilated cardiomyopathy
|
J:244087
|
| increased myocardial fiber size
|
J:244087
|
Gas7tm1Slch/Gas7tm1Slch
(B6.129-Gas7tm1Slch)
|
abnormal skeletal muscle fiber type ratio
|
J:227375
|
| abnormal soleus morphology
|
J:227375
|
| increased skeletal muscle fiber diameter
|
J:227375
|
| progressive muscle weakness
|
J:227375
|
Gata3tm1Gsv/Gata3tm1Gsv
(involves: 129)
|
abnormal pyloric sphincter morphology
|
J:228275
|
| abnormal stomach smooth muscle circular layer morphology
|
J:228275
|
| abnormal stomach smooth muscle outer longitudinal layer morphology
|
J:228275
|
Gata4tm1.1Sad/Gata4tm1.1Sad
Gata6tm2.1Sad/Gata6tm2.1Sad
Tg(Wt1-cre)1Jbeb/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased fetal cardiomyocyte proliferation
|
J:206877
|
| thin myocardium
|
J:206877
|
Gata4tm1.1Sad/Gata4tm1.1Sad
Nkx2-5tm1(cre)Rjs/Nkx2-5+
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
increased cardiomyocyte apoptosis
|
J:121367
|
Gata4tm1.1Sad/Gata4tm1.1Sad
Tg(Myh6-cre)1Jmk/0
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
abnormal myocardial fiber morphology
|
J:121367
|
| decreased cardiac muscle contractility
|
J:121367
|
Gata4tm1.1Sad/Gata4tm1.1Sad
Tg(Myh7-cre)1Jmk/0
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
abnormal myocardial fiber morphology
|
J:121367
|
| decreased cardiac muscle contractility
|
J:121367
|
| increased cardiomyocyte apoptosis
|
J:121367
|
Gata4tm1.1Sad/Gata4tm1.2Sad
Pax3Sp-d/Pax3Sp-d
Tg(Prrx1-cre)1Cjt/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * SJL/J)
|
muscle phenotype
|
J:231793
|
Gata4tm1.1Sad/Gata4tm1.2Sad
Pax3tm1(cre)Joe/Pax3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
muscle phenotype
|
J:231793
|
Gata4tm1.1Sad/Gata4tm1.2Sad
Tg(Prrx1-cre)1Cjt/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * SJL/J)
|
abnormal diaphragm development
|
J:231793
|
| abnormal muscle precursor cell morphology
|
J:231793
|
| abnormal muscle precursor cell physiology
|
J:231793
|
| diaphragmatic hernia
|
J:231793
|
Gata4tm1.1Wtp/Gata4tm1.1Wtp
Nkx2-5tm1(cre)Rjs/Nkx2-5+
(involves: 129S7/SvEvBrd)
|
abnormal fetal cardiomyocyte proliferation
|
J:99203
|
Gata4tm1.1Wtp/Gata4tm1.1Wtp
Tg(Myh6-cre)2182Mds/0
(involves: FVB/N)
|
abnormal fetal cardiomyocyte proliferation
|
J:99203
|
Gata4tm1.2Wtp/Gata4+
(B6.Cg-Gata4tm1.2Wtp)
|
abnormal diaphragm central tendon morphology
|
J:117367
|
| diaphragmatic hernia
|
J:117367
|
Gata4tm1Eno/Gata4+
(B6.129S7-Gata4tm1Eno)
|
diaphragmatic hernia
|
J:187416
|
Gata4tm1Eno/Gata4+
Gata6tm1Eno/Gata6+
(involves: 129/Sv * 129S7/SvEvBrd * C57BL/6)
|
abnormal aorta smooth muscle morphology
|
J:111824
|
| abnormal fetal cardiomyocyte proliferation
|
J:111824
|
| abnormal vascular smooth muscle morphology
|
J:111824
|
| thin myocardium
|
J:111824
|
| thin myocardium compact layer
|
J:111824
|
Gata4tm1Grg/Gata4+
(involves: 129 * C57BL/6)
|
decreased fetal cardiomyocyte proliferation
|
J:185124
|
| thin ventricle myocardium compact layer
|
J:185124
|
Gata4tm1Grg/Gata4tm1.1Wtp
Tg(Nkx2-5-cre)9Eno/0
(involves: 129 * C57BL/6)
|
thin myocardium
|
J:185124
|
Gata4tm1Grg/Gata4tm1Grg
(involves: 129 * C57BL/6)
|
decreased fetal cardiomyocyte proliferation
|
J:185124
|
| thin myocardium
|
J:185124
|
Gata4tm1Jml/Gata4+
Gata5tm1Eem/Gata5+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
thin myocardium compact layer
|
J:155855
|
| thin ventricle myocardium compact layer
|
J:155855
|
Gata4tm1Jml/Gata4+
Gata5tm1Eem/Gata5tm1Eem
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal trabecula carnea morphology
|
J:155855
|
| decreased fetal cardiomyocyte proliferation
|
J:155855
|
| thin ventricle myocardium compact layer
|
J:155855
|
| ventricular myocardium compact layer hypoplasia
|
J:155855
|
Gata4tm1Sho/Gata4tm1.1Wtp
Nkx2-5tm1(cre)Rjs/Nkx2-5+
(involves: 129S6/SvEvTac * 129S7/SvEvBrd)
|
thin myocardium compact layer
|
J:150452
|
Gata4tm1Sho/Gata4tm1Sho
(involves: 129S6/SvEvTac)
|
thin myocardium
|
J:77392
|
Gata4tm1Wtp/Gata4tm1Wtp
(involves: 129 * C57BL/6)
|
abnormal myocardium compact layer morphology
|
J:94637
|
| decreased fetal cardiomyocyte proliferation
|
J:94637
|
| myocardial trabeculae hypoplasia
|
J:94637
|
Gata5tm1.2Nemr/Gata5tm1.2Nemr
(involves: 129 * C57BL/6)
|
decreased myocardial fiber number
|
J:175663
|
| increased myocardial fiber size
|
J:175663
|
| increased ventricle muscle contractility
|
J:175663
|
| myocardial trabeculae hypoplasia
|
J:175663
|
Gata5tm1.2Nemr/Gata5tm1.2Nemr
(Not Specified)
|
abnormal vasodilation
|
J:227997
|
Gatmtm1.1Isb/Gatmtm1.1Isb
(B6.129-Gatmtm1.1Isb)
|
hypotonia
|
J:191142
|
| increased muscle cell glucose uptake
|
J:191142
|
Gbe1m1Yty/Gbe1m1Yty
(C3HeB/FeJ-Gbe1m1Yty)
|
abnormal fetal cardiomyocyte proliferation
|
J:167233
|
| decreased cardiac muscle glycogen level
|
J:167233
|
| thin myocardium
|
J:167233
|
Gbe1tm1.1Hoa/Gbe1tm1.1Hoa
(involves: 129S7/SvEvBrd)
|
abnormal muscle physiology
|
J:176889
|
| decreased skeletal muscle glycogen level
|
J:176889
|
Gbe1tm1Hoa/Gbe1tm1Hoa
(involves: 129S7/SvEvBrd)
|
abnormal skeletal muscle morphology
|
J:176889
|
| increased skeletal muscle glycogen level
|
J:176889
|
Gbe1tm2.1Hoa/Gbe1tm2.1Hoa
(involves: 129S7/SvEvBrd)
|
abnormal muscle glycogen level
|
J:226481
|
Gbe1tm2Hoa/Gbe1tm2Hoa
(involves: 129S7/SvEvBrd)
|
abnormal muscle glycogen level
|
J:226481
|
Gdf11tm1Sjl/Gdf11tm2.1Sjl
Tg(Myl1-cre)1Sjl/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6N * FVB * SJL/J)
|
muscle phenotype
|
J:158173
|
Gdnftm1.1Neas/Gdnftm1.1Neas
Egr3tm1(cre)Mod/Egr3tm1(cre)Mod
(involves: 129S1/Sv * C57BL/6 * C57BL/6J * SJL)
|
muscle phenotype
|
J:160727
|
Gdnftm1Lmgd/Gdnf+
(either: (involves: 129/Sv) or (involves: 129/Sv * C57BL/6) or (involves: 129/Sv * CD-1))
|
intestinal hypoperistalsis
|
J:73922
|
Gdnftm1Lmgd/Gdnftm1Lmgd
(either: (involves: 129S4/SvJae) or (involves: 129S1/Sv * 129X1/SvJ))
|
intestinal hypoperistalsis
|
J:33810
|
Gdnftm1Rosl/Gdnf+
(involves: 129S2/SvPas * C57BL/6)
|
intestinal hypoperistalsis
|
J:82456
|
Gdnftm1Rosl/Gdnf+
Nrtntm1Jmi/Nrtntm1Jmi
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6)
|
intestinal hypoperistalsis
|
J:82456
|
Gdnftm1Rosl/Gdnftm1Rosl
(involves: 129S2/SvPas)
|
abnormal muscle spindle morphology
|
J:132854
|
Gena26/Gena26+
(involves: BALB/c * C3H/HeH)
|
abnormal muscle tone
|
J:169366
|
Gena323/Gena323+
(involves: BALB/c * C3H/HeH)
|
abnormal muscle tone
|
J:169366
|
Gfaptm1Pkny/Gfaptm1Pkny
Vimtm1Cba/Vimtm1Cba
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
increased vasodilation
|
J:124385
|
Gfpt1tm1c(EUCOMM)Wtsi/Gfpt1tm1c(EUCOMM)Wtsi
Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6J * C57BL/6N * SJL/J)
|
abnormal muscle electrophysiology
|
J:265013
|
| abnormal sarcolemma morphology
|
J:265013
|
| abnormal sarcoplasmic reticulum morphology
|
J:265013
|
| abnormal skeletal muscle fiber morphology
|
J:265013
|
| centrally nucleated skeletal muscle fibers
|
J:265013
|
| decreased skeletal muscle fiber size
|
J:265013
|
| impaired skeletal muscle contractility
|
J:265013
|
| increased muscle fatigability
|
J:265013
|
| increased skeletal muscle fiber size
|
J:265013
|
| increased variability of skeletal muscle fiber size
|
J:265013
|
| muscle phenotype
|
J:265013
|
| muscle weakness
|
J:265013
|
| myopathy
|
J:265013
|
| skeletal muscle fiber atrophy
|
J:265013
|
| skeletal muscle fiber necrosis
|
J:265013
|
Gfra1tm1Jmi/Gfra1+
(involves: 129X1/SvJ * C57BL/6)
|
intestinal hypoperistalsis
|
J:82456
|
Gfra1tm3Jmi/Gfra1tm3Jmi
(involves: 129X1/SvJ)
|
abnormal muscle spindle morphology
|
J:132854
|
Gfra2tm1Msa/Gfra2tm1Msa
(either: B6.129-Gfra2tm1Msa or 129S2.129-Gfra2tm1Msa)
|
intestinal hypoperistalsis
|
J:93911
|
Ghitmem1Ltk/Ghitmem1Ltk
(C57BL6J-Ghitmem1Ltk)
|
abnormal skeletal muscle fiber morphology
|
J:327550
|
Ghrtm1c(KOMP)Wtsi/Ghrtm1c(KOMP)Wtsi
Tg(Fabp4-cre)1Rev/0
(involves: C57BL/6N)
|
increased soleus weight
|
J:206358
|
Gipc1Gt(OST93079)Lex/Gipc1Gt(OST93079)Lex
(B6.129S-Gipc1Gt(OST93079)Lex)
|
decreased ventricle muscle contractility
|
J:122652
|
Gja1M1Jrt/Gja1+
(involves: C3H/HeJ * C57BL/6J)
|
abnormal cardiac muscle contractility
|
J:101733
|
| abnormal myocardium layer morphology
|
J:101733
|
| decreased ventricle muscle contractility
|
J:101733
|
Gja1tm1.1Gfi/Gja1tm1.1Gfi
(Not Specified)
|
abnormal trabecula carnea morphology
|
J:108525
|
Gja1tm1Gfi/Gja1tm1.1Gfi
Tg(Pax3-cre)1Joe/0
(involves: 129/Sv * C57BL/6 * FVB/N * SJL)
|
abnormal trabecula carnea morphology
|
J:108525
|
Gja1tm1Kdr/Gja1tm1Kdr
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal trabecula carnea morphology
|
J:24121
|
| abnormal vascular smooth muscle physiology
|
J:212895
|
Gja1tm1Kdr/Gja1tm1Kdr
Tg(CMV-Gja1)BClo/0
(involves: 129S1/Sv * 129X1/SvJ * SJL/J * SWR/J)
|
heart right ventricle hypertrophy
|
J:40388
|
Gja1tm1Kwi/Gja1tm1Kwi
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal muscle regeneration
|
J:94694
|
Gja1tm2(Gjb1)Kwi/Gja1tm2(Gjb1)Kwi
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal trabecula carnea morphology
|
J:65112
|
Gja1tm3.1Clo/Gja1tm3.1Clo
(B6.Cg-Gja1tm1.1Clo)
|
abnormal vascular smooth muscle cell proliferation
|
J:212895
|
Gja1tm5Gfi/Gja1tm5Gfi
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
abnormal cardiac muscle contractility
|
J:185692
|
Gja1tm6.1(Gjb3)Kwi/Gja1tm6.1(Gjb3)Kwi
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
decreased cardiac muscle contractility
|
J:106509
|
Gja1tm10Kwi/Gja1tm10Kwi
Tg(Myh6-cre)2182Mds/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
abnormal myocardial trabeculae morphology
|
J:194957
|
Gja1W45X/Gja1W45X
(C57BL/6J-Gja1W45X)
|
thin myocardium compact layer
|
J:94456
|
| thin right ventricle myocardium compact layer
|
J:94456
|
Gja4tm1Paul/Gja4tm1Paul
Gja5tm1Paul/Gja5tm1Paul
(involves: 129S4/SvJae * C57BL/6)
|
increased vasodilation
|
J:80178
|
Gja5tm1Paul/Gja5tm1Paul
(involves: 129S4/SvJae * C57BL/6)
|
dilated cardiomyopathy
|
J:109301
|
Gjc1tm1.1(Gjd2)Kwi/Gjc1tm1.1(Gjd2)Kwi
Tg(Myh6-cre)2182Mds/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL)
|
decreased cardiac muscle contractility
|
J:182927
|
Gjc1tm1.1Kni/Gjc1tm1.1Kni
(involves: 129S/SvEv * C57BL/6)
|
absent trabeculae carneae
|
J:63214
|
| decreased cardiac muscle contractility
|
J:63214
|
Gjc1tm1.2(Gjd2)Kwi/Gjc1tm1.2(Gjd2)Kwi
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * SJL)
|
decreased cardiac muscle contractility
|
J:182927
|
Gjc1tm1Kni/Gjc1tm1Kni
(involves: 129S/SvEv * C57BL/6)
|
absent trabeculae carneae
|
J:63214
|
| decreased cardiac muscle contractility
|
J:63214
|
Gjc1tm2.1Kni/Gjc1tm2.1Kni
(Not Specified)
|
thin myocardium
|
J:103078
|
Gjc1tm2Kni/Gjc1tm2Kni
Tg(ACTC1-cre)1Miwa/0
(involves: C57BL/6 * DBA)
|
thin myocardium
|
J:103078
|
Gjd4tm1.1Malt/Gjd4tm1.1Malt
(involves: 129S2/SvPas * C57BL/6 * SJL)
|
enhanced skeletal muscle regeneration
|
J:172698
|
| increased satellite cell number
|
J:172698
|
| muscle phenotype
|
J:172698
|
Glatm1Kul/Y
(involves: 129S4/SvJae * C57BL/6)
|
cardiomyopathy
|
J:187258
|
| heart left ventricle hypertrophy
|
J:187258
|
Gli2tm1Alj/Gli2tm1Alj
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
abnormal esophageal smooth muscle morphology
|
J:49603
|
Glra1m1Cpai/Glra1m1Cpai
(involves: 129 * C57BL/6)
|
muscle spasm
|
J:248717
|
Glra1spd-ot/Glra1spd-ot
(involves: C57BL/6J)
|
muscle spasm
|
J:107942
|
Glra1spd/Glra1spd
(B6C3Fe a/a-Glra1spd/J)
|
muscle hypertonia
|
J:20373
|
Glra1tm1Betz/Glra1tm1Betz
(B6.129P2-Glra1tm1Betz)
|
muscle hypertonia
|
J:117236
|
Glrbspa-Alb/Glrbspa-Alb
(C57BL/6Fla-H2-T18a)
|
muscle hypertonia
|
J:64454
|
Glrbspa/Glrbspa
(Not Specified)
|
muscle spasm
|
J:13079,
J:5196
|
Glrbspa/Glrbspa
(involves: C3HeB/FeLe * C57BL/6 * C57BL/6J * DBA/2)
|
muscle hypertonia
|
J:60037
|
Glrbspa/Glrbspa
Tg(Eno2-Glrb)456Wha/0
(involves: C3HeB/FeLe * C57BL/6 * C57BL/6J * DBA/2)
|
muscle hypertonia
|
J:60037
|
Glrx3Gt(RRF094)Byg/Glrx3+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal cardiac muscle relaxation
|
J:143577
|
| decreased cardiac muscle contractility
|
J:143577
|
Gm5544tm1a(KOMP)Wtsi/Gm5544tm1a(KOMP)Wtsi
(C57BL/6N-Gm5544tm1a(KOMP)Wtsi/Wtsi)
|
abnormal eye muscle morphology
|
J:239583
|
Gmppatm1d(EUCOMM)Wtsi/Gmppatm1d(EUCOMM)Wtsi
(involves: C57BL/6N)
|
abnormal skeletal muscle fiber morphology
|
J:305791
|
| abnormal skeletal muscle morphology
|
J:305791
|
| abnormal Z line morphology
|
J:305791
|
| centrally nucleated skeletal muscle fibers
|
J:305791
|
| decreased skeletal muscle fiber diameter
|
J:305791
|
| decreased skeletal muscle mass
|
J:305791
|
| increased skeletal muscle cell apoptosis
|
J:305791
|
| myopathy
|
J:305791
|
| progressive muscle weakness
|
J:305791
|
Gna11tm1Soff/Gna11tm1Soff
Gnaqtm1Soff/Gnaqtm1Soff
(involves: 129S1/Sv * 129S7/SvEvBrd * C57BL/6)
|
trabecula carnea hypoplasia
|
J:49140
|
| ventricular myocardium compact layer hypoplasia
|
J:49140
|
Gna11tm1Soff/Gna11tm1Soff
Gnaqtm2Soff/Gnaqtm2Soff
X/Tg(Myh11-icre/ERT2)1Soff
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * FVB/N)
|
decreased vasoconstriction
|
J:141641
|
Gna11tm1Soff/Gna11tm1Soff
Gnaqtm2Soff/Gnaqtm2Soff
Tg(Tek-icre/ERT2)1Soff/0
(B6N.Cg-Gna11tm1Soff Gnaqtm2Soff Tg(Tek-icre/ERT2)1Soff)
|
decreased vasodilation
|
J:224523
|
Gna12tm1Citb/Gna12tm1Citb
Gna13tm2.1Soff/Gna13tm2.1Soff
X/Tg(Myh11-icre/ERT2)1Soff
(involves: 129S1/Sv * FVB/N)
|
decreased vasoconstriction
|
J:141641
|
Gnastm1Lsw/Gnas+
(involves: 129S4/SvJae * CD-1)
|
increased muscle cell glucose uptake
|
J:106729
|
Gnastm5.1Lsw/Gnastm5.1Lsw
Tg(Fabp4-cre)1Abel/0
(involves: FVB)
|
decreased skeletal muscle triglyceride level
|
J:159612
|
Gnb5flr/Gnb5flr
Myo5aflr/Myo5aflr
(involves: C57BL/6J * C57BL/10J * CBA/Ca)
|
opisthotonus
|
J:61324
|
Gnetm1Dar/Gnetm1Dar
(involves: C57BL/6J)
|
muscle phenotype
|
J:122172
|
Gnetm1Sngi/Gnetm1Sngi
Tg(ACTB-GNE*D176V)9Sngi/0
(involves: C57BL/6)
|
abnormal diaphragm morphology
|
J:117854
|
| abnormal muscle physiology
|
J:117854
|
| abnormal myocardium layer morphology
|
J:117854
|
| abnormal skeletal muscle fiber morphology
|
J:117854
|
| abnormal skeletal muscle morphology
|
J:117854
|
| increased variability of skeletal muscle fiber size
|
J:117854
|
| muscle weakness
|
J:117854
|
| muscular atrophy
|
J:117854
|
| skeletal muscle fiber atrophy
|
J:117854
|
Gng5tm1.1Rbs/Gng5tm1.1Rbs
(B6J.Cg-Gng5tm1.1Rbs)
|
decreased fetal cardiomyocyte proliferation
|
J:215128
|
Gnptabnym/Gnptabnym
(involves: BALB/cAnNHsd * C3H/HeNHsd)
|
progressive muscle weakness
|
J:218156
|
Gpcpd1tm1c(EUCOMM)Hmgu/Gpcpd1tm1c(EUCOMM)Hmgu
Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6J * C57BL/6N * FVB)
|
abnormal muscle glycogen level
|
J:345630
|
| increased cardiac muscle cell glucose uptake
|
J:345630
|
| increased muscle cell glucose uptake
|
J:345630
|
| muscle phenotype
|
J:345630
|
Gpm6btm1KanPlp1tm1Kan/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
muscle hypertonia
|
J:193310
|
| muscle spasm
|
J:193310
|
Gpr4tm1Witt/Gpr4tm1Witt
(either: B6.129X1-Gpr4tm1Witt or (involves: 129X1/SvJ * C57BL/6))
|
abnormal vascular smooth muscle morphology
|
J:118276
|
Gpsm1tm1.1Lajb/Gpsm1tm1.1Lajb
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N * SJL)
|
increased vasodilation
|
J:138126
|
Grb10GT(XC302)Byg/Grb10GT(XC302)Byg
(involves: 129P2/OlaHsd * Black Swiss * C57BL/6)
|
increased muscle weight
|
J:125128
|
Grem2tm1Akh/Grem2tm1Akh
(involves: 129/Sv * C57BL/6)
|
decreased cardiac muscle contractility
|
J:250034
|
Grid2ho-8J/Grid2ho-8J
(B10.D2/nSnJ)
|
muscle spasm
|
J:155927
|
Grid2ho-16J/Grid2ho-16J
(C57BL/6J-Grid2ho-16J/J)
|
muscle spasm
|
J:87349
|
Grk2tm1Mca/Grk2tm1Mca
(involves: 129)
|
abnormal myocardial trabeculae morphology
|
J:36567
|
| decreased ventricle muscle contractility
|
J:36567
|
| disorganized myocardium
|
J:36567
|
| thin myocardium
|
J:36567
|
| thin myocardium compact layer
|
J:36567
|
| trabecula carnea hypoplasia
|
J:36567
|
Grk5tm1Rjl/Grk5tm1Rjl
(involves: 129S4/SvJaeSor * C57BL/6)
|
abnormal muscle contractility
|
J:96208
|
Grm1crv4/Grm1crv4
(BALB/cPas-Grm1crv4)
|
muscle spasm
|
J:112290
|
Grpel1tm1c(EUCOMM)Wtsi/Grpel1tm1c(EUCOMM)Wtsi
Tg(ACTA1-cre/ERT2)97.16Mtz/0
(involves: C57BL/6N)
|
abnormal muscle physiology
|
J:330869
|
| abnormal skeletal muscle morphology
|
J:330869
|
| decreased skeletal muscle fiber diameter
|
J:330869
|
| skeletal muscle atrophy
|
J:330869
|
| skeletal muscle fibrosis
|
J:330869
|
Gsctm1Bhr/Gsctm1Bhr
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal extrinsic tongue muscle morphology
|
J:28702
|
| abnormal genioglossus muscle morphology
|
J:28702
|
Gsctm1Pgr/Gsctm1Pgr
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal intrinsic tongue muscle morphology
|
J:29421
|
| abnormal masticatory muscle morphology
|
J:29421
|
Gt(ROSA)26Sorem1(CAG-Zfas1)Cya/Gt(ROSA)26Sor+
Tg(Myh6-cre)#Cya/0
(involves: C57BL/6J)
|
decreased cardiac muscle contractility
|
J:294533
|
| increased cardiomyocyte apoptosis
|
J:294533
|
Gt(ROSA)26Sortm1(Akt1/EGFP)Glas/Gt(ROSA)26Sor+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased muscle weight
|
J:94134
|
| increased skeletal muscle fiber size
|
J:94134
|
| increased skeletal muscle size
|
J:94134
|
Gt(ROSA)26Sortm1(CAG-GCaMP5)Ryba/Gt(ROSA)26Sor+
Hnrnputm1.1Tman/Hnrnputm1.1Tman
Tg(Ckmm-cre)5Khn/0
(involves: 129S4/SvJaeSor * FVB)
|
decreased cardiac muscle contractility
|
J:223139
|
Gt(ROSA)26Sortm1(CAG-LMNA*)Cyh/Gt(ROSA)26Sor+
Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6JNarl * FVB)
|
abnormal skeletal muscle morphology
|
J:284048
|
| centrally nucleated skeletal muscle fibers
|
J:284048
|
| decreased skeletal muscle fiber diameter
|
J:284048
|
| decreased skeletal muscle mass
|
J:284048
|
| dystrophic muscle
|
J:284048
|
Gt(ROSA)26Sortm1(CAG-Lmx1b,ALPP)Rjo/Gt(ROSA)26Sor+
Sox9tm3(cre)Crm/Sox9+
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6)
|
abnormal tendon morphology
|
J:158676
|
| decreased skeletal muscle mass
|
J:158676
|
Gt(ROSA)26Sortm1(CAG-Lmx1b,ALPP)Rjo/Gt(ROSA)26Sor+
Tg(Prrx1-cre)1Cjt/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * SJL/J)
|
abnormal tendon morphology
|
J:158676
|
| decreased skeletal muscle mass
|
J:158676
|
Gt(ROSA)26Sortm1(CAG-MFN2*T105M)Dple/Gt(ROSA)26Sor+
Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * SJL)
|
abnormal skeletal muscle fiber morphology
|
J:251584
|
| abnormal skeletal muscle fiber type ratio
|
J:251584
|
| abnormal soleus morphology
|
J:251584
|
| decreased skeletal muscle fiber diameter
|
J:251584
|
| skeletal muscle fiber atrophy
|
J:251584
|
Gt(ROSA)26Sortm1(CAG-Nr2f2)Tsa/Gt(ROSA)26Sor+
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
decreased cardiac muscle contractility
|
J:227012
|
| dilated cardiomyopathy
|
J:227012
|
Gt(ROSA)26Sortm1(CAG-PLS3,-GFP)Bwir/Gt(ROSA)26Sor+
Mnx1tm4(cre)Tmj/Mnx1+
(involves: 129S1/Sv * 129S4/SvJae * BALB/cJ * C57BL/6)
|
muscle phenotype
|
J:193844
|
Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sor+
Rdh10tm1c(KOMP)Wtsi/Rdh10tm1d(KOMP)Wtsi
(involves: 129S4/SvJae * C57BL/6N * FVB/NJ)
|
abnormal tongue muscle morphology
|
J:278485
|
Gt(ROSA)26Sortm1(cre/ERT)Nat/Gt(ROSA)26Sor+
Pdgfratm12Sor/Pdgfra+
(involves: 129 * C57BL/6)
|
skeletal muscle interstitial fibrosis
|
J:146617
|
Gt(ROSA)26Sortm1(cre/ERT)Nat/Gt(ROSA)26Sor+
Pdgfratm13Sor/Pdgfra+
(involves: 129S4/SvJaeSor * C57BL/6)
|
skeletal muscle interstitial fibrosis
|
J:146617
|
Gt(ROSA)26Sortm1(DTA)Jpmb/Gt(ROSA)26Sor+
Hcn4tm1(cre/ERT2)Anlu/Hcn4+
(involves: 129S/SvEv)
|
abnormal sinoatrial node morphology
|
J:186021
|
Gt(ROSA)26Sortm1(DTA)Jpmb/Gt(ROSA)26Sor+
Kittm1(cre/ERT2)Dsa/Kit+
(involves: 129S/SvEv * 129S6/SvEvTac * C57BL/6)
|
abnormal intestinal peristalsis
|
J:204737
|
Gt(ROSA)26Sortm1(DTA)Lky/Gt(ROSA)26Sor+
Myf5tm3(cre)Sor/Myf5+
(involves: 129P2/OlaHsd * 129S4/SvJaeSor)
|
abnormal levator veli palatini muscle morphology
|
J:310908
|
| abnormal palatopharyngeus muscle morphology
|
J:310908
|
| abnormal soft palate muscle morphology
|
J:310908
|
| abnormal superior pharyngeal constrictor muscle morphology
|
J:310908
|
| abnormal tensor veli palatini muscle morphology
|
J:310908
|
Gt(ROSA)26Sortm1(DTA)Mrc/Gt(ROSA)26Sor+
Myf5tm1.1(cre)Mrc/Myf5+
(involves: 129S1/Sv * 129X1/SvJ)
|
muscle phenotype
|
J:133338
|
Gt(ROSA)26Sortm1(DTA)Mrc/Gt(ROSA)26Sor+
Myf6tm1(cre)Mrc/Myf6+
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal myogenesis
|
J:133338
|
| abnormal skeletal muscle fiber morphology
|
J:133338
|
Gt(ROSA)26Sortm1(DUX4)Sqh/Gt(ROSA)26Sor+
Tg(ACTA1-cre/Esr1*)2Kesr/0
(involves: 129S6/SvEvTac * C3H * C57BL/6)
|
centrally nucleated skeletal muscle fibers
|
J:268959
|
| decreased skeletal muscle fiber diameter
|
J:268959
|
| decreased skeletal muscle mass
|
J:268959
|
| muscle weakness
|
J:268959
|
| skeletal muscle fiber degeneration
|
J:268959
|
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sortm1(EYFP)Cos
Pax7tm1(cre/ERT2)Gaka/Pax7tm1(cre/ERT2)Gaka
Paxbp1tm1.1Nju/Paxbp1tm1.1Nju
(involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6NCr)
|
impaired skeletal muscle regeneration
|
J:304562
|
Gt(ROSA)26Sortm1(H1/tetO-RNAi:Fxn)Dhg/Gt(ROSA)26Sor+
(B6.129-Gt(ROSA)26Sortm1(H1/tetO-RNAi:Fxn)Dhg)
|
abnormal myocardial fiber morphology
|
J:254962
|
| abnormal sarcomere morphology
|
J:254962
|
| cardiomyopathy
|
J:254962
|
Gt(ROSA)26Sortm1(Kcnj11*V59M)Fmas/Gt(ROSA)26Sor+
Tg(Nes-cre)1Kln/0
(involves: 129S4/SvJae * C57BL/6 * SJL)
|
muscle weakness
|
J:162008
|
Gt(ROSA)26Sortm1(Mib1*V943F)Jlp/Gt(ROSA)26Sor+
Tg(Myh6-cre)2182Mds/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
thin ventricle myocardium compact layer
|
J:338889
|
Gt(ROSA)26Sortm1(Notch1)Dam/Gt(ROSA)26Sor+
Tg(Wt1-cre)#Jbeb/0
(involves: 129S4/SvJaeSor)
|
thin myocardium compact layer
|
J:178290
|
Gt(ROSA)26Sortm1(RNAi:Bmpr2)Dliu/Gt(ROSA)26Sor+
(involves: 129 * C57BL/6J)
|
vascular smooth muscle hypoplasia
|
J:145514
|
Gt(ROSA)26Sortm1(sb11)Njen/Gt(ROSA)26Sor+
Hprt1tm1(sb-Onco-Array)Peli/Y
(involves: 129S7/SvEvBrd)
|
increased rhabdomyosarcoma incidence
|
J:166283
|
Gt(ROSA)26Sortm1(sb11)Njen/Gt(ROSA)26Sor+
Hprt1tm1(sb-Onco-Array)Peli/Hprt1+
(involves: 129S7/SvEvBrd)
|
increased rhabdomyosarcoma incidence
|
J:166283
|
Gt(ROSA)26Sortm1(Smo/EYFP)Amc/?
Tg(CAG-cre/Esr1*)5Amc/?
(involves: 129X1/SvJ * C57BL/6 * CBA)
|
increased rhabdomyosarcoma incidence
|
J:114992
|
Gt(ROSA)26Sortm1(Tgfbr1*)Crm/Gt(ROSA)26Sor+
Tg(Col1a2-cre/ERT,-ALPP)7Cpd/0
(involves: 129S7/SvEvBrd * C57BL/6 * DBA/2)
|
vascular smooth muscle hypertrophy
|
J:134135
|
Gt(ROSA)26Sortm1.1(CAG-Mirc20)Eem/Gt(ROSA)26Sor+
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: 129 * C57BL/6 * FVB/N)
|
abnormal myocardial fiber morphology
|
J:233994
|
| decreased cardiomyocyte apoptosis
|
J:233994
|
| decreased myocardial fiber size
|
J:233994
|
| increased myocardial fiber number
|
J:233994
|
Gt(ROSA)26Sortm1.1(CAG-Mirc20)Eem/Gt(ROSA)26Sor+
Nkx2-5tm1(cre)Rjs/Nkx2-5+
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal myocardial fiber morphology
|
J:233994
|
| decreased cardiac muscle contractility
|
J:233994
|
| decreased myocardial fiber size
|
J:233994
|
| increased cardiomyocyte apoptosis
|
J:233994
|
| increased fetal cardiomyocyte proliferation
|
J:233994
|
Gt(ROSA)26Sortm1.1(CAG-PLS3,-GFP)Bwir/Gt(ROSA)26Sor+
Smn1tm1Hung/Smn1tm1Hung
Tg(SMN2)2Hung/0
(B6N.Cg-Gt(ROSA)26Sortm1.1(CAG-PLS3,-GFP)Bwir Smn1tm1Hung Tg(SMN2)2Hung)
|
increased skeletal muscle fiber size
|
J:193844
|
Gt(ROSA)26Sortm1.1(DUX4*)Plj/Gt(ROSA)26Sor+
(B6(Cg)-Gt(ROSA)26Sortm1.1(DUX4*)Plj)
|
muscle phenotype
|
J:256652
|
Gt(ROSA)26Sortm1.1(DUX4*)Plj/Gt(ROSA)26Sor+
Tg(ACTA1-cre/Esr1*)2Kesr/0
(involves: C3H * C57BL/6)
|
centrally nucleated skeletal muscle fibers
|
J:256652
|
| decreased skeletal muscle fiber size
|
J:256652
|
| dystrophic muscle
|
J:256652
|
| increased variability of skeletal muscle fiber size
|
J:256652
|
| myopathy
|
J:256652
|
| skeletal muscle fibrosis
|
J:256652
|
| skeletal muscle necrosis
|
J:256652
|
Gt(ROSA)26Sortm1.1(DUX4*)Plj/Gt(ROSA)26Sortm1.1(DUX4*)Plj
(B6(Cg)-Gt(ROSA)26Sortm1.1(DUX4*)Plj)
|
muscle phenotype
|
J:256652
|
Gt(ROSA)26Sortm1Lrsn/Gt(ROSA)26Sor+
Slc6a3tm1(cre)Lrsn/Slc6a3+
Tfamtm1Lrsn/Tfamtm1Lrsn
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
muscle hypertonia
|
J:176022
|
Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sor+
Meis2tm1.1Zkoz/Meis2tm1.1Zkoz
Tfap2atm1(cre)Moon/Tfap2a+
(involves: 129 * C57BL/6J)
|
abnormal tongue muscle morphology
|
J:229604
|
Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sor+
Pax3Sp-d/Pax3Sp-d
Tg(Prrx1-cre)1Cjt/0
(involves: 129S4/SvJaeSor * C57BL/6J * SJL/J)
|
abnormal diaphragm morphology
|
J:231793
|
Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sor+
Pax7tm1.1Fan/Pax7tm2.1(cre/ERT2)Fan
(involves: 129 * C57BL/6 * SJL)
|
abnormal muscle regeneration
|
J:150962
|
| abnormal myogenesis
|
J:150962
|
| muscle phenotype
|
J:150962
|
Gt(ROSA)26Sortm2(ATF4)Myz/Gt(ROSA)26Sortm2(ATF4)Myz
Tg(Myh11-icre/ERT2)1Soff/?
(either: D2.Cg-Atf4tm1.1Cmad Tg(Myh11-icre/ERT2)1Soff or B6.Cg-Atf4tm1.1Cmad Tg(Myh11-icre/ERT2)1Soff)
|
increased cardiomyocyte apoptosis
|
J:237331
|
Gt(ROSA)26Sortm2(NOTCH3*C455R)Sat/Gt(ROSA)26Sor+
Notch3Gt(PST033)Byg/Notch3Gt(PST033)Byg
Tg(Tagln-cre)1Her/0
(involves: 129 * C57BL/6 * SJL)
|
abnormal vascular smooth muscle morphology
|
J:171887
|
Gt(ROSA)26Sortm2(Pax3)Joe/Gt(ROSA)26Sor+
Pax3tm1(cre)Joe/Pax3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
muscle phenotype
|
J:137730
|
Gt(ROSA)26Sortm2(Pax3)Joe/Gt(ROSA)26Sortm2(Pax3)Joe
Pax3tm1(cre)Joe/Pax3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
hypaxial muscle hypoplasia
|
J:137730
|
| muscle phenotype
|
J:137730
|
Gt(ROSA)26Sortm2(sb11)Njen/Gt(ROSA)26Sor+
TgTn(sb-T2/Onc2)6070Njen/0
(involves: 129 * C57BL/6 * C57BL/6J)
|
muscle degeneration
|
J:153656
|
Gt(ROSA)26Sortm2(SS18)Mrc/Gt(ROSA)26Sortm2(SS18)Mrc
Myf6tm1(cre)Mrc/Myf6tm1(cre)Mrc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal skeletal muscle morphology
|
J:120967
|
| centrally nucleated skeletal muscle fibers
|
J:120967
|
| myopathy
|
J:120967
|
Gt(ROSA)26Sortm3(CAG-EYFP)Hze/Gt(ROSA)26Sor+
Hiratm1c(EUCOMM)Wtsi/Hiratm1d(EUCOMM)Wtsi
Tg(Myh6-cre)2182Mds/0
(B6.Cg-Gt(ROSA)26Sortm3(CAG-EYFP)Hze Hiratm1c(EUCOMM)Wtsi/Hiratm1d(EUCOMM)Wtsi Tg(Myh6-cre)2182Mds)
|
abnormal cardiac muscle contractility
|
J:231593
|
| abnormal myocardial fiber morphology
|
J:231593
|
| abnormal sarcolemma morphology
|
J:231593
|
| myocardial fiber degeneration
|
J:231593
|
Gt(ROSA)26Sortm3(NOTCH3*R1031C)Sat/Gt(ROSA)26Sor+
Tg(Tagln-cre)1Her/0
(involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6 * SJL)
|
abnormal vascular smooth muscle morphology
|
J:171887
|
Gt(ROSA)26Sortm3(SS18/EGFP)Mrc/Gt(ROSA)26Sortm3(SS18/EGFP)Mrc
Myf5tm1(cre)Mrc/Myf5tm1(cre)Mrc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal muscle development
|
J:120967
|
Gt(ROSA)26Sortm3(SS18/EGFP)Mrc/Gt(ROSA)26Sortm3(SS18/EGFP)Mrc
Myf6tm1(cre)Mrc/Myf6tm1(cre)Mrc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
myopathy
|
J:120967
|
Gt(ROSA)26Sortm3(SS18/EGFP)Mrc/Gt(ROSA)26Sortm3(SS18/EGFP)Mrc
Pax7tm1(cre)Mrc/Pax7tm1(cre)Mrc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal muscle development
|
J:120967
|
Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/Gt(ROSA)26Sor+
Kdm6atm1.1Kaig/Y
Pax7tm2.1(cre/ERT2)Fan/Pax7+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
impaired skeletal muscle regeneration
|
J:232700
|
Gt(ROSA)26Sortm4(EWSR1/ATF1)Mrc/Gt(ROSA)26Sor+
Myf5tm1(cre)Mrc/Myf5+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
myopathy
|
J:194308
|
Gt(ROSA)26Sortm4(EWSR1/ATF1)Mrc/Gt(ROSA)26Sor+
Pax7tm1(cre/ERT2)Gaka/Pax7+
(involves: 129S6/SvEvTac * C57BL/6)
|
myopathy
|
J:194308
|
Gt(ROSA)26Sortm4(EWSR1/ATF1)Mrc/Gt(ROSA)26Sor+
Tg(Prrx1-cre/ERT2)1Mlgn/?
(involves: C57BL/6)
|
myopathy
|
J:194308
|
Gt(ROSA)26Sortm4(HIF2A*)Kael/Gt(ROSA)26Sor+
Tg(Myh6-cre)2182Mds/0
(involves: 129S6/SvEvTac * FVB/N)
|
decreased ventricle muscle contractility
|
J:179490
|
| dilated cardiomyopathy
|
J:179490
|
Gt(ROSA)26Sortm7(Pik3ca*,EGFP)Rsky/Gt(ROSA)26Sor+
Tg(CAG-cre/Esr1*)5Amc/0
(B6.Cg-Gt(ROSA)26Sortm7(Pik3ca*,EGFP)Rsky Tg(CAG-cre/Esr1*)5Amc)
|
skeletal muscle hypertrophy
|
J:264410
|
Gt(ROSA)26Sortm37(H1/tetO-RNAi:Tafazzin)Arte/?
(Not Specified)
|
decreased ventricle muscle contractility
|
J:176041
|
| impaired skeletal muscle contractility
|
J:176041
|
Gt(ROSA)26Sortm37(H1/tetO-RNAi:Tafazzin)Arte/Gt(ROSA)26Sor+
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal myocardial fiber morphology
|
J:167527
|
| abnormal sarcomere morphology
|
J:167527
|
| abnormal skeletal muscle fiber morphology
|
J:167527
|
| decreased cardiac muscle contractility
|
J:167527
|
Gt(ROSA)26Sortm407(H1/tetO-RNAi:Large)Arte/Gt(ROSA)26Sor+
(B6.Cg-Gt(ROSA)26Sortm407(H1/tetO-RNAi:Large)Arte)
|
centrally nucleated skeletal muscle fibers
|
J:206057
|
| dystrophic muscle
|
J:206057
|
| enhanced skeletal muscle regeneration
|
J:206057
|
| muscle phenotype
|
J:206057
|
| skeletal muscle endomysial fibrosis
|
J:206057
|
| skeletal muscle necrosis
|
J:206057
|
Gtf2ird1tm1Hrd/Gtf2ird1tm1Hrd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal laryngeal muscle morphology
|
J:182346
|
Gucy1a1tm1.1Brou/Gucy1a1tm1.1Brou
(involves: 129S1/Sv * 129X1/SvJ)
|
heart right ventricle hypertrophy
|
J:139850
|
Gucy1a1tm1.1Dko/Gucy1a1tm1.1Dko
(involves: C57BL/6)
|
abnormal vasodilation
|
J:110362
|
Gucy1b1tm1.1Frb/Gucy1b1tm1.1Frb
(involves: 129 * C57BL/6 * FVB/N)
|
abnormal vasodilation
|
J:121321
|
| intestinal hypoperistalsis
|
J:121321
|
Gucy1b1tm1.2Frb/Gucy1b1tm1.2Frb
X/Tg(Myh11-icre/ERT2)1Soff
(B6.Cg-Gucy1b1tm1.2Frb Tg(Myh11-icre/ERT2)1Soff)
|
decreased vasodilation
|
J:186053
|
Gulotm1Mae/Gulotm1Mae
(involves: 129 * C57BL/6)
|
abnormal aorta smooth muscle morphology
|
J:59931
|
Gyg1tm1a(KOMP)Wtsi/Gyg1+
(involves: C57BL/6N)
|
increased cardiac muscle glycogen level
|
J:244440
|
| increased skeletal muscle glycogen level
|
J:244440
|
Gyg1tm1a(KOMP)Wtsi/Gyg1tm1a(KOMP)Wtsi
(involves: C57BL/6N)
|
abnormal muscle electrophysiology
|
J:244440
|
| increased cardiac muscle glycogen level
|
J:244440
|
| increased skeletal muscle glycogen level
|
J:244440
|
Gys1Gt(OST33395)Lex/Gys1Gt(OST33395)Lex
(involves: 129S5/SvEvBrd * 129X1/SvJ * C57BL/6J)
|
abnormal fetal cardiomyocyte proliferation
|
J:92245
|
| trabecula carnea hypoplasia
|
J:92245
|
Gys1tm1.1Arte/Gys1+
(involves: C57BL/6J)
|
decreased skeletal muscle glycogen level
|
J:167911
|
Gys1tm1.1Arte/Gys1tm1.1Arte
(involves: C57BL/6J)
|
abnormal muscle cell glucose uptake
|
J:167911
|
| decreased skeletal muscle glycogen level
|
J:167911
|
Gys2tm1.1Pro/Gys2tm1.1Pro
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * DBA)
|
decreased cardiac muscle cell glucose uptake
|
J:162043
|
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru
Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell/Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell
(NOD.Cg-H2-Ab1b-tm1Gru Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell)
|
decreased ventricle muscle contractility
|
J:86540
|
| dilated cardiomyopathy
|
J:86540
|
| myocardium necrosis
|
J:86540
|
| myositis
|
J:86540
|
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru
Tg(HLA-DQA1,HLA-DQB1)70Myl/0
(NOD.Cg-H2-Ab1b-tm1Gru Tg(HLA-DQA1,HLA-DQB1)70Myl)
|
myocardium necrosis
|
J:88055
|
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru
Tg(HLA-DQA1,HLA-DQB1)73Myl/0
(NOD.Cg-H2-Ab1b-tm1Gru Tg(HLA-DQA1,HLA-DQB1)73Myl)
|
abnormal myocardial fiber morphology
|
J:88055
|
| myocardial fiber degeneration
|
J:88055
|
| myocardium necrosis
|
J:88055
|
H2az2Tg(Wnt1-cre)11Rth/H2az2+
Meis2tm1.1Zkoz/Meis2tm1.1Zkoz
(involves: 129S6/SvEvTac * C57BL/6J * CBA/J)
|
abnormal tongue muscle morphology
|
J:286823
|
H6pdtm1Pmst/H6pdtm1Pmst
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal skeletal muscle fiber morphology
|
J:189132
|
| centrally nucleated skeletal muscle fibers
|
J:189132
|
| decreased quadriceps weight
|
J:189132
|
| decreased tibialis anterior weight
|
J:189132
|
| increased skeletal muscle glycogen level
|
J:189132
|
| skeletal muscle atrophy
|
J:189132
|
H6pdtm1Pmst/H6pdtm1Pmst
Hsd11b1tm1.1Ggla/Hsd11b1tm1.1Ggla
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
abnormal skeletal muscle fiber morphology
|
J:189132
|
| centrally nucleated skeletal muscle fibers
|
J:189132
|
| decreased quadriceps weight
|
J:189132
|
| decreased tibialis anterior weight
|
J:189132
|
| increased skeletal muscle glycogen level
|
J:189132
|
| skeletal muscle atrophy
|
J:189132
|
H13tm1b(KOMP)Wtsi/H13tm1b(KOMP)Wtsi
(C57BL/6N-H13tm1b(KOMP)Wtsi/Wtsi)
|
abnormal eye muscle morphology
|
J:239583
|
| abnormal infrahyoid muscle connection
|
J:239583
|
| abnormal infrahyoid muscle morphology
|
J:239583
|
Hacd1tm1Akih/Hacd1tm1Akih
(B6.129P2-Hacd1tm1Akih/Akih)
|
decreased gastrocnemius weight
|
J:247117
|
Hacd2tm1b(EUCOMM)Hmgu/Hacd2tm1b(EUCOMM)Hmgu
(involves: C57BL/6N)
|
thin myocardium
|
J:333944
|
Hadhatm1Jib/Hadhatm1Jib
(involves: 129X1/SvJ * NIH Black Swiss)
|
abnormal diaphragm morphology
|
J:69846
|
| abnormal myocardium layer morphology
|
J:69846
|
Hadhbm1Ytc/Hadhbm1Ytc
(C57BL/6J-Hadhbm1Yuan)
|
abnormal myocardial fiber morphology
|
J:117738
|
| abnormal skeletal muscle morphology
|
J:117738
|
| cardiomyopathy
|
J:117738
|
Hand1tm1(tTA)Prri/Hand1+
Tg(tetO-Hand1)1Prri/0
(involves: 129/Sv * C57BL/6)
|
abnormal fetal cardiomyocyte proliferation
|
J:116090
|
| abnormal myocardial fiber morphology
|
J:116090
|
Hand1tm1Eno/Hand1+
Rr133tm1Eno/Rr133tm1Eno
(Not Specified)
|
abnormal myocardium layer morphology
|
J:94514
|
Hand1tm1Eno/Hand1tm2Eno
Rr133tm1Eno/Rr133+
Tg(Nkx2-5-cre)9Eno/0
(either: (involves: 129S6/SvEvTac * Black Swiss) or (involves: 129S6/SvEvTac * C57BL/6))
|
abnormal myocardial trabeculae morphology
|
J:94514
|
| thin myocardium
|
J:94514
|
Hand1tm1Eno/Hand1tm2Eno
Rr133tm1Eno/Rr133tm1Eno
Tg(Nkx2-5-cre)9Eno/0
(either: (involves: 129S6/SvEvTac * Black Swiss) or (involves: 129S6/SvEvTac * C57BL/6))
|
abnormal myocardium layer morphology
|
J:94514
|
| trabecula carnea hypoplasia
|
J:94514
|
Hand1tm2(Hand1)Abfi/Hand1tm2(Hand1)Abfi
(Not Specified)
|
abnormal myocardial trabeculae morphology
|
J:164028
|
Hand1tm5Abfi/Hand1+
Nkx2-5tm1(cre)Rjs/Nkx2-5+
(involves: 129S7/SvEvBrd)
|
abnormal myocardial trabeculae morphology
|
J:311466
|
| thin left ventricle myocardium compact layer
|
J:311466
|
| thin myocardium
|
J:311466
|
Hand2tm1Cse/Hand2+
H2az2Tg(Wnt1-cre)11Rth/H2az2+
(involves: 129S1/Sv * C57BL/6J * CBA/J)
|
abnormal fetal cardiomyocyte proliferation
|
J:155265
|
| abnormal myocardial trabeculae morphology
|
J:155265
|
| heart right ventricle hypertrophy
|
J:155265
|
Hand2tm1Dsr/Hand2tm1Dsr
(involves: 129S7/SvEvBrd)
|
absent myocardial trabeculae
|
J:40768
|
| absent trabeculae carneae
|
J:40768
|
| decreased cardiac muscle contractility
|
J:40768
|
| thin myocardium
|
J:40768
|
Hand2tm1Dsr/Hand2tm1Dsr
Nkx2-5tm1Wehi/Nkx2-5tm1Wehi
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)
|
absent myocardial trabeculae
|
J:72600
|
Hand2tm1Dsr/Hand2tm2.1Dsr
Tg(Mef2c-cre)#Blk/0
(involves: 129 * 129S7/SvEvBrd * C57BL/6)
|
thin myocardium
|
J:169213
|
Has2tm1Jam/Has2tm1Jam
(involves: 129P2/OlaHsd * C57BL/6J)
|
absent trabeculae carneae
|
J:63748
|
Hat1tm1.1Mrpa/Hat1+
(B6.Cg-Hat1tm1.1Mrpa)
|
decreased skeletal muscle mass
|
J:296531
|
| muscle degeneration
|
J:296531
|
| muscular atrophy
|
J:296531
|
| skeletal muscle atrophy
|
J:296531
|
| skeletal muscle degeneration
|
J:296531
|
Hba-a1tm1Shs/Hba-a1+
(involves: C57BL/6CrSlc)
|
abnormal skeletal muscle fiber type ratio
|
J:81902
|
Hbb-b1tm1Shs/Hbb-b1+
(involves: C57BL/6CrSlc)
|
abnormal skeletal muscle fiber type ratio
|
J:81902
|
Hbegftm1.1Mek/Hbegftm1.1Mek
(involves: C57BL/6 * C57BL/6J * CBA)
|
decreased ventricle muscle contractility
|
J:82728
|
| increased myocardial fiber size
|
J:82728
|
Hbegftm1Dcl/Hbegftm1Dcl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased ventricle muscle contractility
|
J:83820
|
Hbegftm2Mek/Hbegftm2Mek
(involves: 129/Sv * C57BL/6 * CBA)
|
decreased cardiac muscle contractility
|
J:86547
|
| dilated cardiomyopathy
|
J:86547
|
| thin myocardium
|
J:86547
|
Hbegftm3Mek/Hbegf+
(involves: 129/Sv * C57BL/6 * CBA)
|
abnormal myocardial fiber morphology
|
J:86547
|
Hccstm1Tcc/Y
Nkx2-5tm2(cre)Rph/Nkx2-5+
(involves: 129S1/Sv)
|
decreased cardiac muscle glycogen level
|
J:143285
|
| decreased fetal cardiomyocyte proliferation
|
J:143285
|
Hccstm1Tcc/Hccs+
Nkx2-5tm2(cre)Rph/Nkx2-5+
(involves: 129S1/Sv)
|
abnormal myocardium layer morphology
|
J:143285
|
| dilated cardiomyopathy
|
J:143285
|
Hccstm1Tcc/Hccs+
Nkx2-5tm2(cre)Rph/Nkx2-5+
Tg(CAG-EGFP)D4Nagy/0
Tg(Hmgcr-lacZ)H253Sest/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal fetal cardiomyocyte proliferation
|
J:143285
|
Hcfc1em1Poche/Y
(C57BL/6J-Hcfc1em1Poche)
|
abnormal ventricle myocardium morphology
|
J:317822
|
Hcn4tm1Rsei/Hcn4tm1Rsei
(B6.Cg-Hcn4tm1Rsei)
|
decreased cardiac muscle contractility
|
J:131820
|
Hcrttm1Ywa/Hcrttm1Ywa
(involves: 129S6/SvEvTac)
|
abnormal muscle tone
|
J:170824
|
Hcrtr2tm1Tesc/Hcrtr2tm1Tesc
(B6.Cg-Hcrtr2tm1Tesc)
|
abnormal muscle tone
|
J:170824
|
Hdac1tm1.1Eno/Hdac1tm1.1Eno
Hdac2tm1.1Eno/Hdac2tm1.1Eno
Tg(Myh6-cre)2182Mds/?
(involves: 129S/SvEv * C57BL/6 * CD-1 * FVB/N)
|
increased cardiomyocyte apoptosis
|
J:123173
|
Hdac2Gt(W035F03)Joe/Hdac2Gt(W035F03)Joe
(Not Specified)
|
abnormal myocardial fiber morphology
|
J:121697
|
| abnormal myocardial trabeculae morphology
|
J:121697
|
| abnormal myocardium layer morphology
|
J:121697
|
| diffuse Z line
|
J:121697
|
| increased fetal cardiomyocyte proliferation
|
J:121697
|
| thick myocardium compact layer
|
J:121697
|
Hdac2tm1.2Eno/Hdac2tm1.2Eno
(involves: 129S/SvEv * C57BL/6 * CD-1)
|
abnormal fetal cardiomyocyte proliferation
|
J:123173
|
| increased cardiomyocyte apoptosis
|
J:123173
|
Hdac3tm1.1Eno/Hdac3tm1.1Eno
Tg(Myh6-cre)2182Mds/?
(involves: 129S/SvEv * C57BL/6)
|
abnormal myocardial fiber mitochondrial morphology
|
J:144604
|
| decreased ventricle muscle contractility
|
J:144604
|
| increased cardiac muscle triglyceride level
|
J:144604
|
Hdac4tm1Eno/Hdac4+
Hdac5tm1Eno/Hdac5tm1Eno
Hdac9tm1Eno/Hdac9+
(involves: 129 * 129S1/Sv * 129S2/SvPas * 129X1/SvJ)
|
abnormal skeletal muscle fiber type ratio
|
J:127416
|
Hdac4tm1Eno/Hdac4tm1Eno
(involves: 129)
|
muscle phenotype
|
J:127416
|
Hdac4tm1Eno/Hdac4tm2.1Eno
Hdac5tm1Eno/Hdac5tm1Eno
Tg(Myog-cre)1Eno/0
(involves: 129 * 129S/SvEv * 129S2/SvPas)
|
abnormal skeletal muscle fiber type ratio
|
J:127416
|
Hdac4tm2.1Eno/Hdac4tm2.1Eno
(involves: 129S/SvEv)
|
muscle phenotype
|
J:127416
|
Hdac5tm1Eno/Hdac5tm1Eno
(involves: 129S2/SvPas)
|
muscle phenotype
|
J:127416
|
Hdac5tm1Eno/Hdac5tm1Eno
Hdac9tm1Eno/Hdac9tm1Eno
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ)
|
abnormal skeletal muscle fiber type ratio
|
J:127416
|
Hdac7tm1Eno/Hdac7tm2Eno
Tg(Tek-cre)1Ywa/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
abnormal vascular smooth muscle morphology
|
J:116008
|
Hdac9tm1Eno/Hdac9tm1Eno
(involves: 129S1/Sv * 129X1/SvJ)
|
heart left ventricle hypertrophy
|
J:78734
|
| muscle phenotype
|
J:127416
|
Hdac9tm1Eno/Hdac9tm1Eno
Tg(Myh6-Ppp3ca)37Eno/?
(involves: 129S1/Sv * 129X1/SvJ * FVB)
|
abnormal myocardium layer morphology
|
J:78734
|
Hdnrem1Bbr/Hdnrem1Bbr
(C57BL/6J-Hdnrem1Bbr)
|
increased cardiac muscle contractility
|
J:284183
|
Hectd3tm1(NCOM)Cmhd/Hectd3tm1(NCOM)Cmhd
(C57BL/6N-Hectd3tm1(NCOM)Cmhd/Nju)
|
increased cardiac muscle contractility
|
J:211773
|
Hexbtm1Grv/Hexbtm1Grv
(either: (involves: 129P2/Ola * C57BL/6J) or (involves: 129S1/Sv * 129X1/SvJ * C57L/6J))
|
muscle weakness
|
J:30899
|
Hexbtm1Rlp/Hexbtm1Rlp
(involves: 129S4/SvJae * C57BL/6)
|
muscular atrophy
|
J:29268
|
Hexbtm1Rlp/Hexbtm1Rlp
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
muscular atrophy
|
J:87617
|
Hexbtm1Rlp/Hexbtm1Rlp
Tg(Hexb-tTA2S,tetO-Hexb)#Tjsa/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
muscle hypertonia
|
J:190450
|
Hexbtm1Rlp/Hexbtm1Rlp
Tg(SYN1-tTA2S,tetO-Hexb)#Tjsa/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
muscle hypertonia
|
J:190450
|
Hexim1Gt(XB322)Byg/Hexim1Gt(XB322)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
dilated cardiomyopathy
|
J:141643
|
| thin myocardium compact layer
|
J:141643
|
Hey1tm1Gess/Hey1tm1Gess
Hey2tm1Gess/Hey2tm1Gess
(involves: 129 * C57BL/6)
|
absent myocardial trabeculae
|
J:89444
|
| thin myocardium
|
J:89444
|
Hey1tm1Kkb/Hey1tm1Kkb
(involves: 129S7/SvEvBrd)
|
muscle phenotype
|
J:178310
|
Hey1tm1Kkb/Hey1tm1Kkb
Hey2tm1Kkb/Hey2tm1Kkb
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal myocardial fiber morphology
|
J:96337
|
| trabecula carnea hypoplasia
|
J:96337
|
Hey1tm1Kkb/Hey1tm1Kkb
Heyltm1Kkb/Heyltm1Kkb
(B6.Cg-Hey1tm1Kkb Heyltm1Kkb)
|
abnormal skeletal muscle morphology
|
J:178310
|
| abnormal skeletal muscle satellite cell proliferation
|
J:178310
|
| decreased muscle weight
|
J:178310
|
| decreased satellite cell number
|
J:178310
|
| decreased skeletal muscle fiber number
|
J:178310
|
| decreased skeletal muscle fiber size
|
J:178310
|
| impaired skeletal muscle regeneration
|
J:178310
|
Hey1tm1Kkb/Hey1tm1Kkb
Mesp1tm2(cre)Ysa/Mesp1+
Tg(CAG-cat,-Notch1)1Ysa/0
(involves: 129S7/SvEvBrd * C3H * C57BL/6 * CBA)
|
abnormal myocardial trabeculae morphology
|
J:108444
|
Hey2tm1Eno/Hey2tm2Eno
Tg(Nkx2-5-cre)9Eno/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
decreased cardiac muscle contractility
|
J:121577
|
Hey2tm1Eno/Hey2tm2Eno
Tg(Tagln-cre)1Her/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
decreased cardiac muscle contractility
|
J:121577
|
Hey2tm1Gess/Hey2tm1Gess
(involves: 129P2/OlaHsd * C57BL/6)
|
heart left ventricle hypertrophy
|
J:79024
|
| heart right ventricle hypertrophy
|
J:79024
|
| myocardial fiber disarray
|
J:79024
|
Hey2tm1Kkb/Hey2tm1Kkb
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal myocardial fiber morphology
|
J:97120,
J:216895
|
| abnormal myocardium layer morphology
|
J:216895
|
| abnormal ventricle myocardium morphology
|
J:216895
|
| abnormal Z line morphology
|
J:216895
|
| decreased ventricle muscle contractility
|
J:97120,
J:216895
|
Hey2tm1Mtc/Hey2tm1Mtc
(involves: 129X1/SvJ * C57BL/6)
|
cardiomyopathy
|
J:80681
|
| decreased cardiac muscle contractility
|
J:80681
|
Hey2tm1Uts/Hey2tm1Uts
(either: (involves: 129X1/SvJ) or (involves: C57BL/6))
|
heart left ventricle hypertrophy
|
J:79025
|
| heart right ventricle hypertrophy
|
J:79025
|
Hey2tm2.1Mtc/Hey2tm2.1Mtc
Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6 * FVB/N * SJL)
|
decreased cardiac muscle contractility
|
J:186570
|
Heyltm1Kkb/Heyltm1Kkb
(Not Specified)
|
muscle phenotype
|
J:178310
|
Hgstn/Hgstn
(B6.C3-Hgstn)
|
muscular atrophy
|
J:5025
|
| opisthotonus
|
J:5025
|
Hgsnattm1a(EUCOMM)Wtsi/Hgsnattm1a(EUCOMM)Wtsi
(involves: C57BL/6N * C57BL/6NTac)
|
abnormal ventricle myocardium morphology
|
J:235361
|
Hhextm1Cwb/Hhextm1Cwb
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal myocardial trabeculae morphology
|
J:93580
|
| thin myocardium compact layer
|
J:93580
|
| vascular smooth muscle hypoplasia
|
J:93580
|
Hhipl1tm1a(KOMP)Wtsi/Hhipl1tm1a(KOMP)Wtsi
(B6J.B6N-Hhipl1tm1a(KOMP)Wtsi)
|
abnormal vascular smooth muscle physiology
|
J:280707
|
| decreased vascular smooth muscle cell proliferation
|
J:280707
|
Hic2Gt(E225A08)1.1Wrst/Hic2Gt(E225A08)1.1Wrst
Mesp1tm2(cre)Ysa/Mesp1+
(involves: 129P2/OlaHsd * C57BL/6NCrlj * CBA/JNCrlj)
|
thin myocardium
|
J:225226
|
Hic2Gt(E225A08)1.1Wrst/Hic2Gt(E225A08)1.1Wrst
Nkx2-5tm1(cre)Rjs/Nkx2-5+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd)
|
thin myocardium
|
J:225226
|
Hic2Gt(RRN127)Byg/Hic2+
(B6.129P2-Hic2Gt(RRN127)Byg)
|
abnormal myocardial trabeculae morphology
|
J:225226
|
| abnormal myocardium layer morphology
|
J:225226
|
| thin myocardium
|
J:225226
|
Hif1atm1Jhu/Hif1atm1Jhu
(involves: 129S4/SvJae * C57BL/6)
|
abnormal myocardium layer morphology
|
J:45554
|
| disorganized myocardium
|
J:45554
|
Hif1atm1Pec/Hif1atm1Pec
(involves: 129X1/SvJ * Swiss)
|
abnormal myocardial trabeculae morphology
|
J:102537
|
| absent myocardial trabeculae
|
J:102537
|
Hif1atm3Rsjo/Hif1atm3Rsjo
Hprt1tm1(Pck1-cre)Vhh/Y
Vhltm1Jae/Vhltm1Jae
(involves: 129 * BALB/c * C57BL/6)
|
abnormal vasodilation
|
J:97652
|
Hif1atm3Rsjo/Hif1atm3Rsjo
Myl2tm1(cre)Krc/Myl2+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6)
|
abnormal cardiac muscle relaxation
|
J:118455
|
| decreased cardiac muscle contractility
|
J:118455
|
Hif1atm3Rsjo/Hif1atm3Rsjo
Tg(Ckmm-cre)5Khn/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)
|
abnormal muscle physiology
|
J:97761
|
Hif1atm3Rsjo/Hif1atm3Rsjo
Vhltm1Jae/Vhltm1Jae
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129 * BALB/c * C57BL/6 * DBA)
|
abnormal vasodilation
|
J:97652
|
Hif1antm1.2Rsjo/Hif1antm1.2Rsjo
(B6.129-Hif1antm1.2Rsjo)
|
decreased quadriceps weight
|
J:160941
|
Hif3atm1Mym/Hif3atm1Mym
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal myocardium layer morphology
|
J:132655
|
| myocardial fiber degeneration
|
J:132655
|
Hilpdaem1(IMPC)Mhzh/Hilpdaem1(IMPC)Mhzh
(C57BL/6N-Hilpdaem1(IMPC)Mhzh/Mhzh)
|
decreased cardiac muscle contractility
|
J:211773
|
Hip1tm1Hay/Hip1tm1Hay
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal muscle morphology
|
J:84278
|
Hipk2tm1Ejh/Hipk2tm1Ejh
(involves: 129X1/SvJ * C57BL/6)
|
dystonia
|
J:117465
|
hle/hle
(involves: C3H/HeH * C57BL/6J)
|
abnormal smooth muscle morphology
|
J:171107
|
Hlxtm1Rph/Hlxtm1Rph
(involves: 129P2/OlaHsd)
|
abnormal diaphragm morphology
|
J:31553
|
| diaphragmatic hernia
|
J:31553
|
Hmbstm2Uam/Hmbstm3Uam
(C57BL/6-Hmbstm2Uam/Hmbstm3Uam)
|
skeletal muscle degeneration
|
J:31572
|
Hmga1tm1Afus/Hmga1tm1Afus
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal myocardium layer morphology
|
J:106702
|
| heart left ventricle hypertrophy
|
J:106702
|
Hmgxb3tm1a(EUCOMM)Wtsi/Hmgxb3tm1a(EUCOMM)Wtsi
(C57BL/6N-Hmgxb3tm1a(EUCOMM)Wtsi/Wtsi)
|
abnormal eye muscle morphology
|
J:239583
|
Hmox1tm1Mlee/Hmox1tm1Mlee
(involves: 129S2/SvPas * BALB/c)
|
increased cardiomyocyte apoptosis
|
J:54684
|
| myocardium necrosis
|
J:54684
|
Hmox1tm1Mlee/Hmox1tm1Mlee
(B6.129S2-Hmox1tm1Mlee)
|
abnormal vascular smooth muscle physiology
|
J:106600
|
| increased vascular smooth muscle cell proliferation
|
J:106600
|
Hmox1tm1Ysh/Hmox1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal cardiac muscle contractility
|
J:95461
|
| myocardium necrosis
|
J:95461
|
Hmox2tm1Poss/Hmox2tm1Poss
(involves: 129S2/SvPas)
|
abnormal muscle physiology
|
J:89581
|
| abnormal muscle relaxation
|
J:89581
|
Hmox2tm1Poss/Hmox2tm1Poss
Nos1tm1Plh/Nos1tm1Plh
(involves: 129S2/SvPas * 129S4/SvJae)
|
abnormal muscle physiology
|
J:89581
|
| abnormal muscle relaxation
|
J:89581
|
Hmx3/Hmx2tm3Tlu/Hmx3/Hmx2tm3Tlu
(either: (involves: 129) or (involves: 129 * C57BL/6J))
|
muscle spasm
|
J:92940
|
Hmx3/Hmx2tm3Tlu/Hmx3/Hmx2tm3Tlu
(either: (involves: 129) or (involves: 129 * C57BL/6J))
|
muscle spasm
|
J:92940
|
Hnf1atm1Mya/Hnf1atm1Mya
(involves: 129S2/SvPas)
|
muscular atrophy
|
J:31627
|
Hnf1atm2Mya/Hnf1atm2Mya
(involves: 129S2/SvPas)
|
muscular atrophy
|
J:31627
|
Hnf1btm1Mya/Hnf1btm3Mya
Tg(Alb1-cre)7Gsc/0
(involves: 129S2/SvPas * C57BL/6 * FVB/N)
|
muscular atrophy
|
J:75935
|
Hnrnpa1tm1.1Cyf/Hnrnpa1tm1.1Cyf
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6JNarl)
|
abnormal intercostal muscle morphology
|
J:238260
|
| abnormal tongue muscle morphology
|
J:238260
|
| dilated cardiomyopathy
|
J:238260
|
| tongue muscle hypoplasia
|
J:238260
|
Hnrnputm1.1Tman/Hnrnputm1.1Tman
Tg(Ckmm-cre)5Khn/0
(involves: 129S4/SvJaeSor * FVB)
|
abnormal I band morphology
|
J:223139
|
| abnormal myocardial fiber morphology
|
J:223139
|
| abnormal sarcomere morphology
|
J:223139
|
| decreased cardiac muscle relaxation
|
J:223139
|
| decreased myocardial fiber number
|
J:223139
|
| decreased ventricle muscle contractility
|
J:223139
|
| dilated cardiomyopathy
|
J:223139
|
| increased cardiomyocyte apoptosis
|
J:223139
|
| increased myocardial fiber size
|
J:223139
|
Hnrnputm1.1Tman/Hnrnputm1.1Tman
Tg(Myh6-cre)2182Mds/0
(involves: 129S4/SvJaeSor * FVB/N)
|
dilated cardiomyopathy
|
J:223139
|
Hopxtm1.1Joe/Hopxtm1.1Joe
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal myocardium layer morphology
|
J:79153
|
| thin myocardium
|
J:79153
|
| thin myocardium compact layer
|
J:79153
|
Hopxtm1.1Joe/Hopxtm1.1Joe
(involves: 129S6/SvEvTac)
|
abnormal myocardium layer morphology
|
J:121995
|
| increased myocardial fiber number
|
J:121995
|
Hopxtm1Eno/Hopxtm1Eno
(involves: 129S6/SvEvTac)
|
abnormal fetal cardiomyocyte proliferation
|
J:79152
|
| abnormal muscle physiology
|
J:79152
|
| decreased cardiac muscle contractility
|
J:79152
|
| thin myocardium
|
J:79152
|
Hottiptm1Vlcg/Hottiptm1Vlcg
(involves: 129S6/SvEvTac * C57BL/6NTac)
|
abnormal gastrocnemius morphology
|
J:233815
|
| decreased gastrocnemius weight
|
J:233815
|
| decreased skeletal muscle fiber number
|
J:233815
|
| muscle weakness
|
J:233815
|
Hoxa1tm1Ipc/Hoxa1tm1Ipc
(involves: 129S2/SvPas * C57BL/6)
|
muscle spasm
|
J:23837
|
Hoxa1tm1Ipc/Hoxa1tm1Ipc
Hoxb1tm1Ipc/Hoxb1tm1Ipc
(involves: 129S2/SvPas * 129S7/SvEvBrd)
|
muscle phenotype
|
J:124278
|
Hoxa1tm3.1Mrc/Hoxa1tm3.1Mrc
(involves: 129S1/Sv * 129X1/SvJ)
|
heart right ventricle hypertrophy
|
J:178887
|
Hoxa1tm3.1Mrc/Hoxa1tm3.1Mrc
Hoxb1tm3Mrc/Hoxb1tm3Mrc
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal digastric posterior belly morphology
|
J:41540
|
| abnormal stylohyoid muscle morphology
|
J:41540
|
| absent facial muscle
|
J:41540
|
| absent levator labii superioris muscle
|
J:41540
|
| absent orbicularis oculi muscle
|
J:41540
|
| absent zygomaticus muscle
|
J:41540
|
Hoxa2tm1(tetO)Mllo/Hoxa2tm1(tetO)Mllo
(involves: 129S1/Sv * C57BL/6J)
|
abnormal tongue muscle morphology
|
J:71951
|
Hoxa2tm1(tetO)Mllo/Hoxa2tm1Grid
(involves: 129S1/Sv * C57BL/6J)
|
abnormal tongue muscle morphology
|
J:71951
|
Hoxa2tm1Ipc/Hoxa2tm1Ipc
(involves: 129S2/SvPas)
|
abnormal tensor tympani muscle morphology
|
J:16388
|
| absent stapedius muscle
|
J:16388
|
| absent stylohyoid muscle
|
J:16388
|
Hoxa2tm1Mrc/Hoxa2tm1Mrc
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal styloglossus muscle morphology
|
J:58093
|
| abnormal tongue muscle morphology
|
J:58093
|
Hoxa3tm1Mrc/Hoxa3tm1Mrc
(involves: 129S7/SvEvBrd)
|
abnormal muscle morphology
|
J:17753
|
| abnormal tongue muscle morphology
|
J:17753
|
Hoxb1tm1Mrc/Hoxb1tm1Mrc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal buccinator muscle morphology
|
J:36235
|
| abnormal depressor anguli oris muscle morphology
|
J:36235
|
| abnormal digastric posterior belly morphology
|
J:36235
|
| abnormal masseter muscle morphology
|
J:36235
|
| abnormal temporalis muscle morphology
|
J:36235
|
| abnormal zygomaticus muscle morphology
|
J:36235
|
| absent facial muscle
|
J:36235
|
| absent levator nasolabialis muscle
|
J:36235
|
| facial muscle degeneration
|
J:36235
|
Hoxb1tm2Mrc/Hoxb1tm2Mrc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal buccinator muscle morphology
|
J:36235
|
| abnormal depressor anguli oris muscle morphology
|
J:36235
|
| abnormal digastric posterior belly morphology
|
J:36235
|
| abnormal masseter muscle morphology
|
J:36235
|
| abnormal temporalis muscle morphology
|
J:36235
|
| abnormal zygomaticus muscle morphology
|
J:36235
|
| absent facial muscle
|
J:36235
|
| absent levator nasolabialis muscle
|
J:36235
|
| facial muscle degeneration
|
J:36235
|
Hoxb2tm1Mrc/Hoxb2tm1Mrc
(involves: 129S1/Sv * 129X1/SvJ)
|
absent levator nasolabialis muscle
|
J:37682
|
| facial muscle atrophy
|
J:37682
|
Hoxb4tm1Bay/Hoxb4tm1Bay
(involves: 129S7/SvEvBrd * C57BL/6J)
|
diaphragmatic hernia
|
J:4612
|
Hoxb4tm1Nrm/Hoxb4tm1Nrm
(involves: 129S7/SvEvBrd * C57BL/6)
|
diaphragmatic hernia
|
J:71389
|
Hoxb4tm2Bay/Hoxb4tm2Bay
(involves: 129S7/SvEvBrd * C57BL/6J)
|
muscle phenotype
|
J:4612
|
Hoxc4tm1Mrc/Hoxc4tm1Mrc
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal esophageal smooth muscle morphology
|
J:34198
|
Hoxc8tm1Phb/Hoxc8tm1Phb
(either: (involves: 129) or (involves: 129S2/SvPas * C57BL/6 * DBA/2))
|
muscle spasm
|
J:590
|
Hoxc10tm1Emca/Hoxc10tm1Emca
(involves: 129S7/SvEvBrd * C57BL/6J)
|
decreased skeletal muscle size
|
J:161095
|
| decreased skeletal muscle weight
|
J:161095
|
| skeletal muscle atrophy
|
J:161095
|
Hoxc13N/Hoxc13N
(Not Specified)
|
muscle degeneration
|
J:30359
|
Hoxd9tm1Emca/Hoxd9tm1Emca
Hoxd10tm1Emca/Hoxd10tm1Emca
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal skeletal muscle morphology
|
J:59070
|
| abnormal tendon morphology
|
J:59070
|
Hoxd12tm2Ddu/Hoxd12tm2Ddu
(involves: 129S2/SvPas)
|
abnormal internal anal sphincter morphology
|
J:36770
|
| abnormal smooth muscle morphology
|
J:36770
|
Hoxd13tm1Ddu/Hoxd13+
(involves: 129S2/SvPas)
|
abnormal internal anal sphincter morphology
|
J:36770
|
Hoxd13tm1Ddu/Hoxd13tm1Ddu
(involves: 129S2/SvPas)
|
abnormal internal anal sphincter morphology
|
J:36770
|
| abnormal smooth muscle morphology
|
J:36770
|
hph1/hph1
(involves: C57BL/6 * CBA/Ca)
|
abnormal smooth muscle morphology
|
J:101792
|
hpld/hpld
(Not Specified)
|
abnormal diaphragm morphology
|
J:75360
|
Hprt1tm1(CAG-Gys1*)Jjg/?
Myl1tm1(cre)Sjb/Myl1+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)
|
increased skeletal muscle glycogen level
|
J:244440
|
Hprt1tm1(MAPT)Dph/Y
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal skeletal muscle fiber morphology
|
J:263643
|
| skeletal muscle fiber degeneration
|
J:263643
|
Hprt1tm1(Pck1-cre)Vhh/Y
Vhltm1Jae/Vhltm1Jae
(involves: 129P2/OlaHsd * 129S4/SvJae * BALB/c * C57BL/6)
|
abnormal vasodilation
|
J:97652
|
Hprt1tm1Dhm/Y
(involves: 129P2/OlaHsd)
|
abnormal cardiac muscle relaxation
|
J:106044
|
| decreased cardiac muscle contractility
|
J:106044
|
| decreased ventricle muscle contractility
|
J:91410
|
Hprt1tm1Dhm/Y
Plntm1Egk/Plntm1Egk
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
abnormal cardiac muscle relaxation
|
J:106044
|
| increased cardiac muscle contractility
|
J:106044
|
Hprt1tm1Dhm/Hprt1tm1Dhm
(involves: 129P2/OlaHsd)
|
abnormal cardiac muscle relaxation
|
J:106044
|
| decreased cardiac muscle contractility
|
J:106044
|
| decreased ventricle muscle contractility
|
J:91410
|
Hprt1tm1Dhm/Hprt1tm1Dhm
Plntm1Egk/Plntm1Egk
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
abnormal cardiac muscle relaxation
|
J:106044
|
| increased cardiac muscle contractility
|
J:106044
|
Hprt1tm2(CAG-Myof)Isrd/Y
(involves: 129 * C57BL/6)
|
muscle phenotype
|
J:187293
|
Hprt1tm2(CAG-Myof)Isrd/Hprt1tm2(CAG-Myof)Isrd
(involves: 129 * C57BL/6)
|
muscle phenotype
|
J:187293
|
Hprt1tm4(CAG-Tbx18*,-Venus)Akis/Y
Tbx18tm4(cre)Akis/Tbx18+
(involves: 129S1/SvImJ * NMRI)
|
decreased fetal cardiomyocyte proliferation
|
J:210076
|
| thin ventricle myocardium compact layer
|
J:210076
|
Hprt1tm4(Tek-IGF1R)Geno/Y
(B6.129P2-Hprt1tm4(Tek-IGF1R)Geno)
|
increased vasoconstriction
|
J:208523
|
Hrastm2Xbr/Hrastm2Xbr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
heart left ventricle hypertrophy
|
J:137729
|
| heart right ventricle hypertrophy
|
J:137729
|
Hrctm1.1Desa/Hrctm1.1Desa
(Not Specified)
|
decreased cardiac muscle contractility
|
J:243733
|
| decreased cardiac muscle relaxation
|
J:243733
|
Hrctm1Blk/Hrctm1Blk
(B6.129S6-Hrctm1Blk)
|
decreased skeletal muscle mass
|
J:117648
|
Hrh1tm1Wtn/Hrh1tm1Wtn
(B6.129P2-Hrh1tm1Wtn)
|
increased skeletal muscle triglyceride level
|
J:107191
|
Hrtfm2DBA/2J/Hrtfm2DBA/2J
(involves: C57BL/6J * DBA/2J)
|
dilated cardiomyopathy
|
J:100634
|
Hrtfm4AKR/J/Hrtfm4AKR/J
Tg(Myh6-CASQ2)1Mord/0
(involves: AKR/J * DBA/2J)
|
dilated cardiomyopathy
|
J:86767
|
Hrtfm5AKR/J/?
Tg(Myh6-CASQ2)1Mord/0
(involves: AKR/J * DBA/2J)
|
dilated cardiomyopathy
|
J:86767
|
Hrtfm6AKR/J/?
Tg(Myh6-CASQ2)1Mord/0
(involves: AKR/J * DBA/2J)
|
dilated cardiomyopathy
|
J:86767
|
Hrtfm7AKR/J/Hrtfm7DBA/2J
(involves: C57BL/6J * DBA/2J)
|
dilated cardiomyopathy
|
J:100634
|
Hsd11b1tm1.1Ggla/Hsd11b1tm1.1Ggla
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
muscle phenotype
|
J:189132
|
Hsd11b2tm1Yko/Hsd11b2tm1Yko
(involves: 129P2/OlaHsd * MF1)
|
abnormal fetal cardiomyocyte proliferation
|
J:53391
|
Hsd17b3tm1.2Mpo/Hsd17b3tm1.2Mpo
(involves: 129S6/SvEvTac * C57BL/6N * C57BL/6NCrl)
|
abnormal muscle morphology
|
J:301756
|
Hsd17b7tm1Mpo/Hsd17b7tm1Mpo
(involves: 129S7/SvEvBrd)
|
decreased myocardial fiber number
|
J:160004
|
| thick myocardium
|
J:160004
|
Hspb7tm1.1Yty/Hspb7tm1.1Yty
Tg(ACTA1-cre)79Jme/0
(involves: 129 * C57BL/6J * SJL)
|
abnormal diaphragm morphology
|
J:246267
|
| abnormal sarcomere morphology
|
J:246267
|
| abnormal Z line morphology
|
J:246267
|
| centrally nucleated skeletal muscle fibers
|
J:246267
|
| myopathy
|
J:246267
|
| skeletal muscle fibrosis
|
J:246267
|
Hspb7tm1.2Chen/Hspb7tm1.2Chen
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
abnormal sarcomere morphology
|
J:256653
|
| abnormal trabecula carnea morphology
|
J:256653
|
| abnormal Z line morphology
|
J:256653
|
| decreased fetal cardiomyocyte proliferation
|
J:256653
|
Hspb7tm1.2Chen/Hspb7tm1.2Chen
Lmod2tm1(KOMP)Vlcg/Lmod2tm1(KOMP)Vlcg
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/6NTac * CBA)
|
abnormal sarcomere morphology
|
J:256653
|
Hspb7tm1.2Chen/Hspb7tm1.2Chen
Tg(Myh6-Tmod1)65Msus/Tg(Myh6-Tmod1)65Msus
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * FVB/N)
|
abnormal sarcomere morphology
|
J:256653
|
Hspb8tm1.1Depr/Hspb8tm1.1Depr
(B.129-Hspb8tm1.1Depr)
|
abnormal myocardium layer morphology
|
J:186292
|
| decreased ventricle muscle contractility
|
J:186292
|
Hspb8tm1.1Vti/Hspb8tm1.1Vti
(involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NCrl)
|
abnormal skeletal muscle morphology
|
J:284796
|
Hspb8tm1Vti/Hspb8+
(involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NCrl)
|
abnormal muscle fiber morphology
|
J:284796
|
| abnormal Z line morphology
|
J:284796
|
Hspb8tm1Vti/Hspb8tm1Vti
(involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NCrl)
|
abnormal skeletal muscle fiber morphology
|
J:284796
|
| abnormal Z line morphology
|
J:284796
|
| muscular atrophy
|
J:284796
|
| myopathy
|
J:284796
|
| skeletal muscle fiber degeneration
|
J:284796
|
Hspd1Gt(OST171441)Lex/Hspd1+
(B6.129S5-Hspd1Gt(OST171441)Lex)
|
decreased skeletal muscle fiber size
|
J:197946
|
Hspd1tm1c(EUCOMM)Hmgu/Hspd1tm1c(EUCOMM)Hmgu
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: Black Swiss * C57BL/6 * C57BL/6N * FVB/N)
|
decreased ventricle muscle contractility
|
J:283049
|
| dilated cardiomyopathy
|
J:283049
|
Hspg2tm1.1Soni/Hspg2tm1.1Soni
(involves: 129S/SvEv * C57BL/6)
|
abnormal muscle electrophysiology
|
J:139975
|
| abnormal skeletal muscle fiber morphology
|
J:139975
|
| abnormal skeletal muscle fiber type ratio
|
J:139975
|
| centrally nucleated skeletal muscle fibers
|
J:139975
|
| increased variability of skeletal muscle fiber size
|
J:139975
|
Hspg2tm1Rdgr/Hspg2tm1Rdgr
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal muscle morphology
|
J:121855
|
| skeletal muscle hyperplasia
|
J:121855
|
Hspg2tm1Ref/Hspg2tm1Ref
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal myocardium compact layer morphology
|
J:58700
|
| abnormal myocardium layer morphology
|
J:80720
|
Htatip2tm1Hx/Htatip2tm1Hx
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased uterus leiomyoma incidence
|
J:87066
|
Htr1btm1Rhn/Htr1btm1Rhn
Slc6a4tm1Kpl/Slc6a4tm1Kpl
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6)
|
decreased cardiac muscle contractility
|
J:121505
|
| dilated cardiomyopathy
|
J:121505
|
Htr2atm1Rhn/Htr2atm1Rhn
(involves: 129S1/Sv * C57BL/6)
|
abnormal intestinal smooth muscle morphology
|
J:108058
|
Htr2btm1Lum/Htr2btm1Lum
(129S2/SvPas-Htr2btm1Lum)
|
abnormal fetal cardiomyocyte proliferation
|
J:64067
|
| absent trabeculae carneae
|
J:64067
|
| disorganized myocardium
|
J:64067
|
Htr2ctm1.1Eme/Y
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6)
|
hypotonia
|
J:163043
|
Htr3atm1Ckn/Htr3atm1Ckn
(involves: 129S1/Sv * C57BL/6J * DBA/2)
|
abnormal urinary bladder detrusor smooth muscle morphology
|
J:90942
|
Htra2mnd2/Htra2mnd2
(involves: C3H/He * C57BL/6J)
|
dystrophic muscle
|
J:12780
|
Htra2mnd2/Htra2mnd2
(involves: C3H/HeJ * C57BL/6J * CAST/Ei)
|
muscular atrophy
|
J:50420
|
Htra2mnd2/Htra2mnd2
(B6.Cg-Htra2mnd2)
|
dystonia
|
J:76481
|
| muscle spasm
|
J:76481
|
Htra2tm1.1Hohj/Htra2tm1.1Hohj
Tg(Nes-cre)1Kln/0
(involves: C57BL/6J)
|
muscle weakness
|
J:225666
|
Htra2tm1.2Hohj/Htra2tm1.2Hohj
(involves: C57BL/6 * C57BL/6J)
|
muscle weakness
|
J:225666
|
Htttm1Mem/Htttm6Mem
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * Swiss Webster)
|
muscular atrophy
|
J:260244
|
Hydinhy3/Hydinhy3
(involves: CBA)
|
muscle spasm
|
J:13103
|
Icam1tm1Jcgr/Icam1tm1Jcgr
(B6.129S4-Icam1tm1Jcgr/J)
|
abnormal cardiac muscle contractility
|
J:114093
|
Id1tm1Zhu/Id1tm1Zhu
(either: 129/Sv-Id1tm1Zhu or (involves: 129S1/Sv * C57BL/6))
|
muscle phenotype
|
J:44278
|
Ido1tm1.1Mkks/Ido1tm1.1Mkks
(B6.Cg-Ido1tm1.1Mkks)
|
abnormal vasodilation
|
J:229059
|
Idstm1Muen/Y
(involves: C57BL/6)
|
abnormal tendon morphology
|
J:259752
|
| calcified calcaneal tendon
|
J:259752
|
Iduatm1Efn/Iduatm1Efn
(involves: C57BL/6)
|
abnormal aorta smooth muscle morphology
|
J:101932
|
| abnormal cardiac muscle relaxation
|
J:101932
|
| abnormal myocardial fiber morphology
|
J:101932
|
| abnormal myocardium layer morphology
|
J:101932
|
| decreased ventricle muscle contractility
|
J:101932
|
| increased collagen deposition in the muscles
|
J:101932
|
Ier3tm1Mxw/Ier3tm1Mxw
(involves: 129 * C57BL/6)
|
decreased vasodilation
|
J:157504
|
Ier3tm1Raku/Ier3tm1Raku
(involves: 129S6/SvEvTac)
|
decreased cardiac muscle contractility
|
J:131099
|
| heart left ventricle hypertrophy
|
J:131099
|
| increased myocardial fiber size
|
J:131099
|
Ifngtm1Ts/Ifngtm1Ts
(B6.129S7-Ifngtm1Ts/J)
|
impaired skeletal muscle regeneration
|
J:136628
|
| skeletal muscle fibrosis
|
J:136628
|
Ifrd1tm1Lah/Ifrd1tm1Lah
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal muscle regeneration
|
J:89917
|
| abnormal skeletal muscle morphology
|
J:89917
|
| decreased soleus weight
|
J:89917
|
Igf1tm1Arge/Igf1tm1Arge
(involves: 129S/SvEv * MF1)
|
muscle hypoplasia
|
J:82113
|
Igf1tm1Arge/Igf1tm1Arge
Liftm1Stw/Liftm1Stw
(involves: 129S/SvEv * 129S1/Sv * BALB/c * C57BL/6J * MF1)
|
muscle hypoplasia
|
J:82113
|
Igf1tm1Ts/Igf1tm1Ts
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal muscle morphology
|
J:16214
|
Igf1tm2Ts/Igf1tm2Ts
(involves: 129S7/SvEvBrd * C57BL/6J)
|
increased ventricle muscle contractility
|
J:37969
|
Igf1rtm1.1Mhz/Igf1r+
Insrtm1Khn/Insrtm1Khn
Tg(Ckmm-cre)5Khn/0
(involves: 129/Sv * 129S4/SvJae * C57BL/6 * FVB)
|
decreased ventricle muscle contractility
|
J:118987
|
Igf1rtm1.1Mhz/Igf1rtm1.1Mhz
Insrtm1Khn/Insrtm1Khn
Tg(Ckmm-cre)5Khn/0
(involves: 129/Sv * 129S4/SvJae * C57BL/6 * FVB)
|
abnormal myocardial fiber morphology
|
J:118987
|
| decreased myocardial fiber size
|
J:118987
|
| decreased ventricle muscle contractility
|
J:118987
|
| dilated cardiomyopathy
|
J:118987
|
Igf1rtm1.2Mhz/Igf1rtm1.2Mhz
(involves: 129/Sv * C57BL/6 * FVB/N)
|
abnormal muscle morphology
|
J:63460
|
Igf1rtm1Arge/Igf1rtm1Arge
(involves: 129S/SvEv)
|
muscle hypoplasia
|
J:15108
|
Igf2tm1Rob/Igf2+
(involves: 129S/SvEv * C57BL/6J)
|
abnormal fetal cardiomyocyte proliferation
|
J:77413
|
Igf2bp1Gt(OST33739)Lex/Igf2bp1Gt(OST33739)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal intestinal smooth muscle morphology
|
J:89882
|
Igf2rtm1Stw/Igf2r+
(involves: 129S1/Sv * C57BL/6)
|
abnormal myocardium layer morphology
|
J:22124
|
Igf2rtm1Wag/Igf2r+
(involves: 129S2/SvPas)
|
disorganized myocardium
|
J:20763
|
Igf2rtm1Wag/Igf2rtm1Wag
(involves: 129S2/SvPas)
|
disorganized myocardium
|
J:20763
|
Igfbp3tm1Jep/Igfbp3tm1Jep
Igfbp4tm1Jep/Igfbp4tm1Jep
Igfbp5tm1Jep/Igfbp5tm1Jep
(involves: 129S/SvEv * C57BL/6J)
|
decreased quadriceps weight
|
J:112029
|
Igfbp3tm1Lex/Igfbp3tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
increased quadriceps weight
|
J:168345
|
| increased tibialis anterior weight
|
J:168345
|
Igh-Jtm1Aigl/Igh-J+
Mogtm1Dpd/Mogtm1Dpd
Tg(Tcra2D2,Tcrb2D2)1Kuch/0
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6)
|
muscle hypertonia
|
J:151335
|
Igh-Jtm1Aigl/Igh-J+
Tg(Tcra2D2,Tcrb2D2)1Kuch/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
muscle hypertonia
|
J:151335
|
Ighmbp2em1Cll/Ighmbp2em1Cll
(FVB/NJ-Ighmbp2em1Cll)
|
decreased skeletal muscle fiber size
|
J:326540
|
| muscular atrophy
|
J:326540
|
Ighmbp2em1Cx/Ighmbp2em1Cx
(C57BL/6J-Ighmbp2em1Cx/Cx)
|
decreased skeletal muscle weight
|
J:337488
|
| muscular atrophy
|
J:337488
|
| skeletal muscle fiber atrophy
|
J:337488
|
Ighmbp2em5Cx/Ighmbp2em5Cx
(C57BL/6J-Ighmbp2em5Cx/Cx)
|
muscular atrophy
|
J:337488
|
Ighmbp2nmd-2J/Ighmbp2nmd-2J
(BKS.Cg Dock7m +/+ Leprdb-Ighmbp2nmd-2J)
|
abnormal masseter muscle morphology
|
J:23584
|
| abnormal skeletal muscle fiber morphology
|
J:23584
|
| abnormal temporalis muscle morphology
|
J:23584
|
Ighmbp2nmd-2J/Ighmbp2nmd-2J
(B6.BKS-Ighmbp2nmd-2J/J)
|
abnormal diaphragm morphology
|
J:92862
|
| abnormal intercalated disk morphology
|
J:90418
|
| abnormal myocardial fiber morphology
|
J:90418
|
| centrally nucleated skeletal muscle fibers
|
J:90418
|
| dilated cardiomyopathy
|
J:90418
|
| increased variability of skeletal muscle fiber size
|
J:90418
|
| muscle degeneration
|
J:90418
|
| myocardial fiber degeneration
|
J:90418
|
| myocardium necrosis
|
J:90418
|
| skeletal muscle fiber atrophy
|
J:90418
|
| skeletal muscle interstitial fibrosis
|
J:90418
|
Ighmbp2nmd-2J/Ighmbp2nmd-2J
MnmC/MnmC
(involves: C57BL/6J * C57BLKS/J * CAST/Ei * DBA/J)
|
dilated cardiomyopathy
|
J:90418
|
| muscle degeneration
|
J:90418
|
| muscular atrophy
|
J:51890
|
Ighmbp2nmd-2J/Ighmbp2nmd-2J
Tg(Eno2-Ighmbp2)17Cx/?
(involves: C57BL/6J * C57BLKS/J)
|
dilated cardiomyopathy
|
J:90418
|
| muscle degeneration
|
J:90418
|
| muscle phenotype
|
J:90418
|
Ighmbp2nmd-2J/Ighmbp2nmd-2J
Tg(Eno2-Ighmbp2)90Cx/?
(involves: C57BL/6J * C57BLKS/J)
|
dilated cardiomyopathy
|
J:90418
|
| muscle degeneration
|
J:90418
|
| muscle phenotype
|
J:90418
|
Ighmbp2nmd-2J/Ighmbp2nmd-2J
Tg(Ttn-Ighmbp2)45Cx/?
(involves: C57BL/6J * C57BLKS/J)
|
muscle degeneration
|
J:102748
|
Ighmbp2nmd-2J/Ighmbp2nmd-2J
Tg(Ttn-Ighmbp2)108Cx/?
(involves: C57BL/6J * C57BLKS/J)
|
muscle degeneration
|
J:102748
|
Ighmbp2nmd/Ighmbp2nmd
(CBA/J-Ighmbp2nmd)
|
muscle degeneration
|
J:23584
|
Igs1tm2(CAG-Bgeo,-Ndp,-EGFP)Nat/Igs1tm2(CAG-Bgeo,-Ndp,-EGFP)Nat
Edil3Tg(Sox2-cre)1Amc/?
(involves: 129 * C57BL/6 * CBA)
|
abnormal aorta smooth muscle morphology
|
J:154020
|
Igs2em53(Myh6-cre/ERT2)Gpt/Igs2+
Stx17em1Gpt/Stx17em1Gpt
(involves: C57BL/6JGpt)
|
abnormal cardiac muscle contractility
|
J:345305
|
| abnormal myocardial fiber morphology
|
J:345305
|
Igsf3em1Laap/Igsf3em1Laap
(FVB/NRj-Igsf3em1Laap)
|
abnormal intestinal smooth muscle morphology
|
J:341537
|
Ihhtm1Amc/Ihhtm1Amc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CBA/J)
|
abnormal smooth muscle morphology
|
J:62158
|
Ikbkbtm2Mka/Ikbkbtm2Mka
Tg(Ckmm-cre)1Lrsn/0
(involves: 129)
|
abnormal myotube morphology
|
J:135692
|
| increased skeletal muscle fiber number
|
J:135692
|
Il6tm1Kopf/Il6tm1Kopf
(involves: 129S2/SvPas * C57BL/6)
|
abnormal myoblast migration
|
J:131016
|
| abnormal skeletal muscle fiber morphology
|
J:131016
|
| abnormal skeletal muscle satellite cell proliferation
|
J:131016
|
| decreased cardiac muscle contractility
|
J:150895
|
Il10tm1Cgn/Il10tm1Cgn
(B6.129P2-Il10tm1Cgn/J)
|
decreased vasoconstriction
|
J:59742
|
| increased vasoconstriction
|
J:146372
|
Il10tm1Cgn/Il10tm1Cgn
(129S.Cg-Il10tm1Cgn)
|
decreased vasoconstriction
|
J:59742
|
Il13tm2Anjm/Il13tm2Anjm
Tg(SFTPC-Il18)AThos/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N * DBA/2)
|
decreased skeletal muscle weight
|
J:219136
|
Il18tm1Aki/Il18tm1Aki
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased ventricle muscle contractility
|
J:118183
|
Ilf3tm1Pnk/Ilf3tm1Pnk
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal intercostal muscle morphology
|
J:99935
|
| abnormal skeletal muscle fiber morphology
|
J:99935
|
| abnormal skeletal muscle morphology
|
J:99935
|
| thin diaphragm muscle
|
J:99935
|
Ilktm1Star/Ilktm1Star
Tg(Ckmm-cre)1Lrsn/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
decreased cardiac muscle contractility
|
J:112174
|
| dilated cardiomyopathy
|
J:112174
|
ImmtGt(AW0256)Wtsi/Immt+
(involves: 129P2/OlaHsd)
|
abnormal muscle fiber mitochondrial morphology
|
J:344896
|
In(7Oca2;7Sox6)100H/In(7Oca2;7Sox6)100H
(Not Specified)
|
abnormal myocardial fiber morphology
|
J:61682
|
| abnormal skeletal muscle morphology
|
J:61682
|
Inhbatm1Zuk/Inhba+
(B6.129S7-Inhbatm1Zuk)
|
abnormal pectoral muscle morphology
|
J:182827
|
| increased gastrocnemius weight
|
J:182827
|
| increased quadriceps weight
|
J:182827
|
| increased skeletal muscle weight
|
J:182827
|
Inhbbtm1Jae/Inhbbtm1Jae
(B6.129S4-Inhbbtm1Jae)
|
abnormal pectoral muscle morphology
|
J:182827
|
| increased skeletal muscle weight
|
J:182827
|
Inpp4atm1Tsak/Inpp4atm1Tsak
(involves: 129P2/OlaHsd * C57BL/6)
|
dystonia
|
J:161963
|
Inpp5dtm1Rkh/Inpp5dtm1Rkh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal intestinal smooth muscle morphology
|
J:173301
|
Inpp5fGt(XL571)Byg/Inpp5fGt(XL571)Byg
(involves: 129P2/OlaHsd)
|
increased cardiomyocyte apoptosis
|
J:170072
|
Inpp5ktm1Brd/Inpp5k+
(B6.Cg-Inpp5ktm1Brd)
|
increased muscle cell glucose uptake
|
J:139745
|
| increased skeletal muscle mass
|
J:139745
|
Ins2Akita/?
(involves: C57BL/6NSlc)
|
abnormal cardiac muscle contractility
|
J:130021
|
| decreased muscle cell glucose uptake
|
J:130021
|
| decreased skeletal muscle triglyceride level
|
J:130021
|
| heart left ventricle hypertrophy
|
J:130021
|
Insrtm1Jja/Insrtm1Jja
(involves: 129S2/SvPas * C57BL/6 * DBA/2)
|
skeletal muscle hypotrophy
|
J:32538
|
Insrtm1Khn/Insrtm1Khn
Tg(Myhca-cre)1Abel/0
(involves: 129S4/SvJae * FVB)
|
abnormal cardiac muscle cell glucose uptake
|
J:75348
|
| decreased cardiac muscle cell glucose uptake
|
J:75348
|
| decreased cardiac muscle contractility
|
J:75348
|
| decreased myocardial fiber size
|
J:75348
|
| increased cardiac muscle cell glucose uptake
|
J:75348
|
| increased cardiac muscle glycogen level
|
J:75348
|
Irag1tm1Jens/Irag1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
impaired smooth muscle contractility
|
J:94387
|
Irag1tm1Jens/Irag1tm1Jens
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
impaired smooth muscle contractility
|
J:94387
|
Irag1tm2.1Jens/Irag1tm2.1Jens
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal vascular smooth muscle physiology
|
J:175887
|
| impaired muscle relaxation
|
J:175887
|
Irag1tm2.1Jens/Irag1tm2.1Jens
Taglntm2(PRKG1*)Hfm/Taglntm2(PRKG1*)Hfm
(involves: 129S1/Sv * 129X1/SvJ)
|
impaired muscle relaxation
|
J:175887
|
Irak1tm1Jth/Y
Tg(Myh6-Tnf)1Brgi/?
(involves: 129/Sv * C57BL/6J * SJL)
|
myocardial fiber degeneration
|
J:84829
|
Irak1tm1Jth/Irak1tm1Jth
Tg(Myh6-Tnf)1Brgi/?
(involves: 129/Sv * C57BL/6J * SJL)
|
myocardial fiber degeneration
|
J:84829
|
Irs1smla/Irs1smla
Serpinb2tm2Dgi/Serpinb2tm2Dgi
(involves: 129S2/SvPas * C57BL/6J * DBA/2J)
|
muscular atrophy
|
J:164568
|
Irs1tm1Tka/Irs1tm1Tka
(involves: C57BL/6 * CBA)
|
decreased vasodilation
|
J:99746
|
Irs2tm1Mfw/Irs2tm1Mfw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased skeletal muscle glycogen level
|
J:74303
|
Irs2tm1Tka/Irs2tm1Tka
(involves: C57BL/6 * CBA)
|
decreased vasodilation
|
J:99746
|
Irx4tm1Jse/Irx4+
(involves: 129X1/SvJ * Black Swiss)
|
heart left ventricle hypertrophy
|
J:67359
|
Irx4tm1Jse/Irx4tm1Jse
(involves: 129X1/SvJ * Black Swiss)
|
cardiomyopathy
|
J:67359
|
| decreased ventricle muscle contractility
|
J:67359
|
| dilated cardiomyopathy
|
J:67359
|
| heart left ventricle hypertrophy
|
J:67359
|
Isl1tm1(cre)Tmj/Isl1+
Mapttm1(Ewsr1/Etv4)Arbr/Mapt+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased muscle spindle number
|
J:100886
|
Itga7tm1Burk/Itga7tm1Burk
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal vascular smooth muscle morphology
|
J:100236
|
| myopathy
|
J:100236
|
| vascular smooth muscle hyperplasia
|
J:100236
|
| vascular smooth muscle hypertrophy
|
J:100236
|
Itga7tm1Burk/Itga7tm1Burk
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal diaphragm morphology
|
J:187752
|
| abnormal muscle physiology
|
J:187752
|
| abnormal skeletal muscle fiber type ratio
|
J:187752
|
| centrally nucleated skeletal muscle fibers
|
J:187752
|
| myopathy
|
J:187752
|
| skeletal muscle necrosis
|
J:187752
|
Itga7tm1Burk/Itga7tm1Burk
Sspntm1Kcam/Sspntm1Kcam
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal diaphragm morphology
|
J:187752
|
| abnormal muscle physiology
|
J:187752
|
| abnormal quadriceps morphology
|
J:187752
|
| abnormal sarcolemma morphology
|
J:187752
|
| abnormal skeletal muscle fiber type ratio
|
J:187752
|
| centrally nucleated skeletal muscle fibers
|
J:187752
|
| decreased quadriceps weight
|
J:187752
|
| decreased skeletal muscle mass
|
J:187752
|
| enhanced skeletal muscle regeneration
|
J:187752
|
| myopathy
|
J:187752
|
| skeletal muscle atrophy
|
J:187752
|
| skeletal muscle fibrosis
|
J:187752
|
Itga7tm1Umr/Itga7tm1Umr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal diaphragm morphology
|
J:43840
|
| abnormal skeletal muscle morphology
|
J:43840,
J:82116
|
| abnormal soleus morphology
|
J:43840
|
| centrally nucleated skeletal muscle fibers
|
J:43840
|
| dystrophic muscle
|
J:43840
|
| increased skeletal muscle fiber size
|
J:43840
|
| increased variability of skeletal muscle fiber size
|
J:43840
|
| muscle degeneration
|
J:43840
|
| skeletal muscle fiber atrophy
|
J:43840
|
Itga7tm1Umr/Itga7tm1Umr
Sgcgtm1Mcn/Sgcgtm1Mcn
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
muscle degeneration
|
J:91880
|
Itgavtm1Hyn/Itgavtm1Hyn
(either: (involves: 129/Sv * 129S2/SvPas) or (involves: 129S2/SvPas * C57BL/6J))
|
thin myocardium
|
J:50951
|
| trabecula carnea hypoplasia
|
J:50951
|
Itgavtm2Hyn/Itgavtm2.1Hyn
Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * FVB * SJL)
|
muscle hypertonia
|
J:94376
|
| muscle phenotype
|
J:94376
|
Itgb1tm1Lscd/Itgb1tm1Ref
Tg(PLAT-cre)116Sdu/0
(Not Specified)
|
muscular atrophy
|
J:92060
|
| progressive muscle weakness
|
J:92060
|
Itgb1tm1Ross/Itgb1tm1Ross
Myl2tm1(cre)Krc/Myl2+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * Black Swiss)
|
abnormal cardiac muscle cell glucose uptake
|
J:82534
|
| abnormal cardiac muscle relaxation
|
J:82534
|
| abnormal myocardial fiber morphology
|
J:82534
|
| abnormal myocardium layer morphology
|
J:82534
|
| decreased ventricle muscle contractility
|
J:82534
|
| dilated cardiomyopathy
|
J:82534
|
Itgb1tm1Son/Itgb1tm1Son
(either: 129P2/OlaHsd-Itgb1tm1Son or (involves: 129P2/OlaHsd * FVB))
|
muscle phenotype
|
J:47279
|
Itgb1tm2Son/Itgb1tm2Son
(FVB.129P2-Itgb1tm2Son)
|
abnormal myogenesis
|
J:82463
|
| abnormal myotube morphology
|
J:82463
|
| abnormal skeletal muscle morphology
|
J:82463
|
| decreased skeletal muscle fiber number
|
J:82463
|
| decreased skeletal muscle mass
|
J:82463
|
Itgb3tm1Hyn/Itgb3+
(involves: 129S2/SvPas * C57BL/6)
|
heart left ventricle hypertrophy
|
J:119666
|
Itgb3tm1Hyn/Itgb3tm1Hyn
(involves: 129S2/SvPas * C57BL/6)
|
abnormal cardiac muscle relaxation
|
J:119666
|
| decreased cardiac muscle contractility
|
J:119666
|
| heart left ventricle hypertrophy
|
J:119666
|
| myositis
|
J:119666
|
Itpatm1Skmi/Itpatm1Skmi
(involves: 129S/SvEv * C57BL/6J)
|
abnormal myocardial fiber morphology
|
J:169285
|
| abnormal sarcomere morphology
|
J:169285
|
| absent Z line
|
J:169285
|
Itpr1opt/Itpr1opt
(involves: C57BLKS)
|
opisthotonus
|
J:13536
|
Itpr3tf/Itpr3tf
Prkralear-5J/Prkralear-5J
(BTBR-Prkralear-5J Itpr3tf/GrsrJ)
|
dystonia
|
J:223062
|
Itprid2tm1Sawa/Itprid2tm1Sawa
(B6.Cg-Itprid2tm1Sawa)
|
decreased skeletal muscle triglyceride level
|
J:144968
|
Ivns1abptm1Htno/Ivns1abptm1Htno
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased cardiac muscle contractility
|
J:162743
|
| increased cardiomyocyte apoptosis
|
J:162743
|
Izumo2em1(IMPC)Bay/Izumo2em1(IMPC)Bay
(C57BL/6N-Izumo2em1(IMPC)Bay/BayMmucd)
|
increased cardiac muscle contractility
|
J:211773
|
Jag1tm1Frad/Jag1tm1Frad
Tg(Cdh5-cre)7Mlia/0
(B6.Cg-Jag1tm1Frad Tg(Cdh5-cre)7Mlia)
|
heart right ventricle hypertrophy
|
J:189213
|
Jag1tm1Grid/Jag1tm2Grid
Tg(Tagln-cre)1Her/0
(involves: 129S1/Sv * C57BL/6 * SJL)
|
abnormal vascular smooth muscle morphology
|
J:166769
|
Jag1tm2Grid/Jag1tm2Grid
Tg(Tek-cre)12Flv/0
(involves: C3H * C57BL/6)
|
abnormal vascular smooth muscle morphology
|
J:166769
|
Jam3tm1.1(KOMP)Vlcg/Jam3+
(C57BL/6N-Jam3tm1.1(KOMP)Vlcg/J)
|
abnormal skeletal muscle morphology
|
J:211773
|
Jarid2Gt(ROSA)1Gel/Jarid2Gt(ROSA)1Gel
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal fetal cardiomyocyte proliferation
|
J:100923
|
| abnormal myocardium compact layer morphology
|
J:63359
|
| abnormal myocardium layer morphology
|
J:63359
|
| thin myocardium
|
J:63359
|
| trabecula carnea hypoplasia
|
J:63359
|
Jarid2jumonji/Jarid2jumonji
(C3.129P2-Jarid2jumonji)
|
abnormal myocardial fiber morphology
|
J:57069
|
| abnormal myocardial trabeculae morphology
|
J:57069
|
Jmjd6tm1Gbf/Jmjd6tm1Gbf
(C57BL/6-Ptdsrtm1Gbf)
|
myocardial trabeculae hypoplasia
|
J:102098
|
| thin myocardium compact layer
|
J:102098
|
Jph1tm1Hta/Jph1tm1Hta
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal sarcoplasmic reticulum morphology
|
J:77652
|
| abnormal skeletal muscle fiber triad morphology
|
J:77652
|
| impaired skeletal muscle contractility
|
J:77652
|
Jph2tm1Hta/Jph2tm1Hta
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal myocardial fiber morphology
|
J:63879
|
Jsrp1tm1Zor/Jsrp1tm1Zor
(involves: 129S4/SvJae * C57BL/6)
|
abnormal muscle physiology
|
J:128603
|
| muscle weakness
|
J:128603
|
Juntm4Wag/Juntm4Wag
Tg(Tek-cre)1Ywa/0
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
thin right ventricle myocardium compact layer
|
J:199412
|
Jundtm1Mya/Jundtm1Mya
Tg(H2-K-Fosl1)1Wag/0
(involves: 129S2/SvPas * C57BL/6 * CBA)
|
abnormal myocardial fiber morphology
|
J:95691
|
| dilated cardiomyopathy
|
J:95691
|
Juptm1.1Glr/Juptm1.1Glr
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N * SJL)
|
abnormal intercalated disk morphology
|
J:170618
|
| abnormal myocardial fiber morphology
|
J:170618
|
| abnormal sarcomere morphology
|
J:170618
|
| decreased ventricle muscle contractility
|
J:170618
|
| diffuse Z line
|
J:170618
|
| heart left ventricle hypertrophy
|
J:170618
|
| increased myocardial fiber size
|
J:170618
|
Juptm1.1Shou/Juptm1.1Shou
Tg(Myh6-cre)2182Mds/0
(involves: 129 * C57BL/6J)
|
abnormal myocardial fiber morphology
|
J:177567
|
| calcified myocardium
|
J:177567
|
| cardiac muscle necrosis
|
J:177567
|
| cardiomyopathy
|
J:177567
|
| decreased cardiac muscle contractility
|
J:177567
|
| increased cardiomyocyte apoptosis
|
J:177567
|
Juptm1Kem/Juptm1Kem
(involves: 129S1/Sv * 129X1/SvJ)
|
absent cardiac desmosomes
|
J:38047
|
| thin myocardium
|
J:38047
|
| trabecula carnea hypoplasia
|
J:38047
|
Juptm1Kem/Juptm1Kem
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
absent cardiac desmosomes
|
J:38047
|
| thin myocardium
|
J:38047
|
| trabecula carnea hypoplasia
|
J:38047
|
Juptm1Ruiz/Jup+
Tg(Myh6-Jup*)1Ajm/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
decreased ventricle muscle contractility
|
J:192719
|
Juptm1Ruiz/Juptm1Ruiz
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal cardiac muscle contractility
|
J:64280
|
| abnormal intercalated disk morphology
|
J:64280
|
| absent cardiac desmosomes
|
J:64280
|
Kalrntm2.1Npl/Kalrntm2.1Npl
(B6.Cg-Kalrntm2.1Npl)
|
abnormal I band morphology
|
J:206512
|
| abnormal sarcomere morphology
|
J:206512
|
| abnormal Z line morphology
|
J:206512
|
Kat6bGt(pKC199)1Pgr/Kat6bGt(pKC199)1Pgr
(involves: 129S2/SvPas)
|
abnormal muscle morphology
|
J:178264
|
Kbtbd13em1Coeo/Kbtbd13em1Coeo
(involves: C57BL/6J)
|
abnormal skeletal muscle fiber morphology
|
J:295442
|
| abnormal soleus morphology
|
J:295442
|
| impaired muscle relaxation
|
J:295442
|
| increased soleus weight
|
J:295442
|
| thick diaphragm muscle
|
J:295442
|
Kbtbd13tm1.1Coeo/Kbtbd13tm1.1Coeo
(involves: C57BL/6J)
|
decreased soleus weight
|
J:295442
|
| increased quadriceps weight
|
J:295442
|
| muscle phenotype
|
J:295442
|
Kcna1tm1Tem/Kcna1tm1Tem
(involves: 129S7/SvEvBrd)
|
myoclonus
|
J:164091
|
Kcna3tm1Gvd/Kcna3tm1Gvd
(involves: 129S1/Sv * C57BL/6)
|
increased muscle cell glucose uptake
|
J:88651
|
Kcna5tm1(Kcna1)Lndn/Kcna5tm1(Kcna1)Lndn
(involves: C57BL/6)
|
abnormal vascular smooth muscle physiology
|
J:70694
|
| decreased vasoconstriction
|
J:70694
|
Kcnc1tm1Joho/Kcnc1tm1Joho
Kcnc3tm1Echa/Kcnc3tm1Echa
(involves: 129/Sv * C57BL/6)
|
myoclonus
|
J:71179
|
Kcnc2tm1Rudy/Kcnc2tm1Rudy
(B6.129S1-Kcnc2tm1Rudy)
|
myoclonus
|
J:66730
|
Kcne1tm1Rdn/Kcne1+
Lamp2tm1.2Ces/Y
(involves: 129 * 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * SJL)
|
abnormal atrioventricular bundle morphology
|
J:328713
|
| abnormal atrioventricular node morphology
|
J:328713
|
Kcne4tm1Gwab/Kcne4tm1Gwab
(B6.129-Kcne4tm1Gwab)
|
increased cardiac muscle relaxation
|
J:227222
|
Kcng2em1(IMPC)Bay/Kcng2em1(IMPC)Bay
(C57BL/6N-Kcng2em1(IMPC)Bay/Bay)
|
decreased cardiac muscle contractility
|
J:211773
|
Kcnh2tm1.1Hjd/Kcnh2tm1.1Hjd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal muscle electrophysiology
|
J:155273
|
Kcnj2tm1Swz/Kcnj2tm1Swz
(involves: 129S1/Sv * 129X1/SvJ * FVB)
|
abnormal vasodilation
|
J:78077
|
Kcnj6wv/Kcnj6wv
(involves: C57BL/6 * CBA/CaGnLe)
|
hypotonia
|
J:18348
|
Kcnj8em1Nich/Kcnj8+
(involves: C57BL/6J * CBA/J)
|
abnormal vascular smooth muscle physiology
|
J:281903
|
| increased myocardial fiber size
|
J:281903
|
| increased vasodilation
|
J:281903
|
Kcnj8tm1Sse/Kcnj8tm1Sse
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal vascular smooth muscle physiology
|
J:202037
|
Kcnj11tm1Sse/Kcnj11tm1Sse
(involves: 129P2/OlaHsd)
|
abnormal muscle relaxation
|
J:105244
|
| impaired skeletal muscle contractility
|
J:105244,
J:140833
|
| increased muscle fatigability
|
J:140833
|
| myoclonus
|
J:69832
|
Kcnk6tm1Tigm/Kcnk6tm1Tigm
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal vascular smooth muscle physiology
|
J:194443
|
| abnormal vasoconstriction
|
J:194443
|
Kcnma1tm1Ruth/Kcnma1tm1Ruth
(involves: 129/Sv * C57BL/6)
|
abnormal muscle contractility
|
J:148424
|
| increased muscle relaxation
|
J:148424
|
Kcnma1tm1Ruth/Kcnma1tm2.1Ruth
X/Tg(Myh11-icre/ERT2)1Soff
(involves: 129/Sv * C57BL/6 * FVB/N)
|
abnormal muscle contractility
|
J:148424
|
Kcnmb1tm1Ltor/Kcnmb1tm1Ltor
(Not Specified)
|
increased vasoconstriction
|
J:195657
|
Kcnmb1tm1Pong/Kcnmb1tm1Pong
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal vascular smooth muscle physiology
|
J:82471
|
| increased vasoconstriction
|
J:82471
|
Kcnmb1tm1Rwa/Kcnmb1tm1Rwa
(involves: 129X1/SvJ * C57BL/6)
|
abnormal muscle contractility
|
J:106302
|
| abnormal vasoconstriction
|
J:65415
|
Kcnn4tm1Rklr/Kcnn4tm1Rklr
(involves: 129S/SvEv * C57BL/6)
|
decreased vasodilation
|
J:124858
|
Kcnq1m1Anu/?
(involves: BALB/c * C57BL/6 * DBA/2)
|
opisthotonus
|
J:196547
|
Kcnv1vibe/Kcnv1vibe
(C57BL/6JSfdAnu-Kcnv1vibe/Anu)
|
muscle spasm
|
J:104190
|
Kctd10tm1.2Zji/Kctd10tm1.2Zji
(involves: 129S * 129X1/SvJ * C57BL/6J * FVB/N)
|
thin myocardium
|
J:225134
|
Kdm1atm1.1Tche/Kdm1atm1.1Tche
(Not Specified)
|
cardiac muscle degeneration
|
J:270116
|
Kdm3atm1.1Yzha/Kdm3atm1.1Yzha
(B6.129P2-Kdm3atm1.1Yzha)
|
abnormal muscle morphology
|
J:147295
|
| abnormal muscle physiology
|
J:147295
|
Kdm4atm1Zpl/Kdm4atm1Zpl
Tg(Myh6-cre)1Jmk/0
(involves: 129S6/SvEv * C57BL/6)
|
decreased myocardial fiber size
|
J:173908
|
| increased cardiac muscle contractility
|
J:173908
|
Kdm6aGt(RRA094)Byg/Y
X/UtyGt(XS0378)Wtsi
(either: (involves: 129 * CD-1) or (involves: 129P2/OlaHsd * CD-1) or (involves: 129P2/OlaHsd * C57BL/6 * CD-1))
|
myocardial trabeculae hypoplasia
|
J:201868
|
Kdm6aGt(RRA094)Byg/Kdm6aGt(RRA094)Byg
(either: (involves: 129 * CD-1) or (involves: 129P2/OlaHsd * CD-1) or (involves: 129P2/OlaHsd * C57BL/6 * CD-1))
|
myocardial trabeculae hypoplasia
|
J:201868
|
Kdm6atm1.1Kaig/Y
Pax7tm2.1(cre/ERT2)Fan/Pax7+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal muscle precursor cell morphology
|
J:232700
|
| impaired skeletal muscle regeneration
|
J:232700
|
Kdm6atm1.1Kaig/Kdm6atm1.1Kaig
Pax7tm2.1(cre/ERT2)Fan/Pax7+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal muscle precursor cell morphology
|
J:232700
|
| impaired skeletal muscle regeneration
|
J:232700
|
Kdm6atm1b(EUCOMM)Wtsi/Kdm6atm1b(EUCOMM)Wtsi
(either: (involves: C57BL/6 * CD-1) or (involves: 129 * C57BL/6 * CD-1))
|
myocardial trabeculae hypoplasia
|
J:201868
|
Kdm6atm2.1Kaig/Y
(involves: 129 * C57BL/6)
|
abnormal muscle precursor cell morphology
|
J:232700
|
| impaired skeletal muscle regeneration
|
J:232700
|
| muscle phenotype
|
J:232700
|
Kdm6atm2.1Kaig/Kdm6atm2.1Kaig
(involves: 129 * C57BL/6)
|
abnormal muscle precursor cell morphology
|
J:232700
|
| impaired skeletal muscle regeneration
|
J:232700
|
| muscle phenotype
|
J:232700
|
Kdm6btm1.1Rbo/Kdm6btm1.1Rbo
H2az2Tg(Wnt1-cre)11Rth/H2az2+
(involves: 129S4/SvJae * C57BL/6J * CBA/J)
|
abnormal soft palate muscle morphology
|
J:323190
|
Kdrtm1Jrt/Kdr+
Tmem204tm1.1Ali/Tmem204tm1.1Ali
(involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6)
|
abnormal lymphatic vessel smooth muscle morphology
|
J:159519
|
Keltm1Slee/Keltm1Slee
Xktm1Ariv/Xktm1Ariv
(B6.Cg-Keltm1Slee Xktm1Ariv)
|
abnormal skeletal muscle fiber morphology
|
J:206464
|
| centrally nucleated skeletal muscle fibers
|
J:206464
|
| increased variability of skeletal muscle fiber size
|
J:206464
|
| muscle phenotype
|
J:206464
|
Kif1btm1Noh/Kif1b+
(involves: 129S4/SvJae * C57BL/6J)
|
progressive muscle weakness
|
J:69772
|
Kif3atm1Noh/Kif3atm1Noh
(involves: 129S4/SvJae * C57BL/6J)
|
myocardium hypoplasia
|
J:55332
|
Kif7dda/Kif7dda
(FVB.A-Kif7dda)
|
abnormal diaphragm central tendon morphology
|
J:197449
|
| abnormal diaphragm development
|
J:197449
|
| diaphragm muscle hyperplasia
|
J:197449
|
| diaphragmatic hernia
|
J:197449
|
| thick diaphragm muscle
|
J:197449
|
Kif7maki/Kif7maki
(involves: C57BL/6J)
|
abnormal diaphragm central tendon morphology
|
J:197449
|
| diaphragmatic hernia
|
J:197449
|
Kif16bem1(IMPC)Ccpcz/Kif16bem1(IMPC)Ccpcz
(C57BL/6NCrl-Kif16bem1(IMPC)Ccpcz/Ccpcz)
|
abnormal skeletal muscle morphology
|
J:211773
|
Kif21atm1.1Ece/Kif21atm1.1Ece
(involves: 129S1/Sv * 129S4/SvJae)
|
abnormal extraocular muscle morphology
|
J:213171
|
Kif21atm1.1Ece/Kif21atm1.1Ece
Tg(Isl1-EGFP*)1Slp/0
(involves: 129S1/Sv * 129S4/SvJae * BALB/c * C57BL/6)
|
abnormal extraocular muscle morphology
|
J:213171
|
Kif21atm1.1Ece/Kif21atm3Ece
(involves: 129S1/Sv * 129S4/SvJae)
|
abnormal extraocular muscle morphology
|
J:213171
|
Kif26atm1.1Noh/Kif26atm1.1Noh
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J)
|
abnormal intestinal peristalsis
|
J:154859
|
Kifbptm1a(KOMP)Wtsi/Kifbptm1a(KOMP)Wtsi
(C57BL/6N-Kifbptm1a(KOMP)Wtsi/Wtsi)
|
abnormal eye muscle morphology
|
J:239583
|
Kittm1(cre/ERT2)Dsa/Kit+
Prkg1tm2Naw/Prkg1tm2Naw
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6)
|
abnormal intestinal peristalsis
|
J:204737
|
KitW/KitW-v
(involves: C57BL)
|
abnormal muscle physiology
|
J:70182
|
Klkl/Klkl
(either: C.Cg-Klkl or (involves: C3H/HeJ * C57BL/6J))
|
calcified muscle
|
J:44109
|
Klm1Anu/Klm1Anu
(C57BL/6NCrlAnu-Klm1Anu)
|
abnormal smooth muscle morphology
|
J:104190
|
| diaphragmatic hernia
|
J:104190
|
Klf2tm1Jml/Klf2tm1Jml
(either: (involves: 129X1/SvJ * C57BL/6) or (involves: 129X1/SvJ * C57BL/6 * CD-1))
|
abnormal vascular smooth muscle morphology
|
J:44352
|
Klf2tm1Mlkn/Klf2tm1Mlkn
Tg(Tek-cre)12Flv/?
(involves: C3H * C57BL/6)
|
thin myocardium
|
J:127228
|
Klf3m1Cmhd/Klf3+
(involves: C3H/HeJ * C57BL/6J)
|
abnormal ventricle myocardium morphology
|
J:206507
|
| increased cardiac muscle contractility
|
J:206507
|
Klf3m1Cmhd/Klf3m1Cmhd
(involves: C3H/HeJ * C57BL/6J)
|
abnormal ventricle myocardium morphology
|
J:206507
|
Klf5tm1Jaw/Klf5tm1Jaw
Tg(Pax6-cre,GFP)1Pgr/0
(involves: FVB)
|
abnormal extraocular muscle morphology
|
J:175263
|
Klf5tm1Rng/Klf5+
(involves: 129/Sv * C57BL/6)
|
abnormal vascular smooth muscle physiology
|
J:78275
|
Klf5tm2.1Rng/Klf5tm2.1Rng
Tg(Postn-cre)1Sjc/0
(involves: C57BL/6)
|
abnormal myocardial fiber morphology
|
J:156696
|
Klf15tm1Jain/Klf15tm1Jain
(B6.129X1-Klf15tm1Jain)
|
cardiomyopathy
|
J:167880
|
| decreased ventricle muscle contractility
|
J:121109
|
| heart left ventricle hypertrophy
|
J:167880
|
| increased myocardial fiber size
|
J:121109
|
Klhl29tm1b(EUCOMM)Hmgu/Klhl29tm1b(EUCOMM)Hmgu
(C57BL/6N-Klhl29tm1b(EUCOMM)Hmgu/Ics)
|
increased cardiac muscle contractility
|
J:211773
|
Klhl31em1Eno/Klhl31em1Eno
(involves: C57BL/6)
|
abnormal muscle fiber morphology
|
J:247651
|
| abnormal quadriceps morphology
|
J:247651
|
| abnormal sarcomere morphology
|
J:247651
|
| abnormal Z line morphology
|
J:247651
|
| centrally nucleated skeletal muscle fibers
|
J:247651
|
| decreased muscle weight
|
J:247651
|
| dilated sarcoplasmic reticulum
|
J:247651
|
| myopathy
|
J:247651
|
| skeletal muscle fiber degeneration
|
J:247651
|
Klhl40tm1(KOMP)Vlcg/Klhl40tm1(KOMP)Vlcg
(C57BL/6-Klhl40tm1(KOMP)Vlcg)
|
abnormal muscle physiology
|
J:213780
|
| abnormal sarcomere morphology
|
J:213780
|
| abnormal skeletal muscle morphology
|
J:213780
|
| abnormal Z line morphology
|
J:213780
|
| impaired skeletal muscle contractility
|
J:213780
|
| muscle weakness
|
J:213780
|
| myopathy
|
J:213780
|
Klhl40tm1.1Itl/Klhl40tm1.1Itl
(involves: 129S6/SvEvTac * C57BL/6N)
|
abnormal sarcomere morphology
|
J:227534
|
| decreased skeletal muscle fiber size
|
J:227534
|
| increased skeletal muscle cell apoptosis
|
J:227534
|
Klhl41tm1a(KOMP)Wtsi/Klhl41tm1a(KOMP)Wtsi
(C57BL/6-Klhl41tm1a(KOMP)Wtsi)
|
abnormal diaphragm morphology
|
J:255305
|
| myopathy
|
J:255305
|
Klk1tm1Pmtn/Klk1tm1Pmtn
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased vasodilation
|
J:67868
|
| decreased ventricle muscle contractility
|
J:67868
|
Klk1tm1Pmtn/Klk1tm1Pmtn
(involves: 129/Sv * C57BL/6)
|
decreased vasodilation
|
J:103928
|
Kmt2atm1Sjk/Kmt2atm1Sjk
(involves: 129S2/SvPas * CD-1)
|
abnormal myoblast differentiation
|
J:201612
|
Kmt2dtm1.1Kaig/Kmt2dtm1.1Kaig
Myf5tm3(cre)Sor/Myf5+
(involves: 129S4/SvJaeSor * C57BL/6J)
|
abnormal muscle morphology
|
J:207891
|
| decreased muscle weight
|
J:207891
|
Kmt2dtm1.1Kaig/Kmt2dtm1.1Kaig
Tg(Tnnt2-cre)5Blh/0
(B6.Cg-Kmt2dtm1.1Kaig Tg(Tnnt2-cre)5Blh)
|
decreased fetal cardiomyocyte proliferation
|
J:229890
|
| thin myocardium compact layer
|
J:229890
|
Knk/Knk+
(involves: C57BL/6J * FVB/N)
|
abnormal myotome development
|
J:154368
|
Krastm1(Hras)Rdl/Krastm1(Hras)Rdl
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
decreased cardiac muscle contractility
|
J:98940
|
| dilated cardiomyopathy
|
J:98940
|
| increased myocardial fiber size
|
J:98940
|
Krastm1Mok/Krastm1Mok
(involves: 129S/SvEv * C57BL/6J)
|
abnormal fetal cardiomyocyte proliferation
|
J:42943
|
| thin myocardium
|
J:42943
|
Krastm4.1Bbd/Krastm4.1Bbd
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6J * FVB/N)
|
increased cardiac muscle contractility
|
J:223433
|
| increased myocardial fiber number
|
J:223433
|
Krit1tm1Kwhi/Krit1tm1.1Kwhi
Tg(Pdgfb-icre/ERT2,-EGFP)1Frut/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NCrl * CBA)
|
telangiectasia
|
J:215458
|
Krit1tm1Kwhi/Krit1tm1Kwhi
Nfatc1tm1.1(cre)Bz/Nfatc1+
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6NCrl)
|
abnormal myocardial trabeculae morphology
|
J:238897
|
| thin myocardium
|
J:238897
|
Kyky/Kyky
(Not Specified)
|
abnormal skeletal muscle morphology
|
J:116344
|
| decreased extensor digitorum longus weight
|
J:22972
|
| decreased soleus weight
|
J:22972
|
| impaired skeletal muscle contractility
|
J:22972
|
| muscle degeneration
|
J:116344
|
| muscular atrophy
|
J:116344
|
| skeletal muscle necrosis
|
J:116344
|
Lama2dy-2J/Lama2dy-2J
(involves: C57BL/6 * FVB/N)
|
dystrophic muscle
|
J:49435
|
Lama2dy-2J/Lama2dy-2J
(B6.WK-Lama2dy-2J/J)
|
enhanced skeletal muscle regeneration
|
J:134367
|
| increased variability of skeletal muscle fiber size
|
J:134367
|
Lama2dy-2J/Lama2dy-2J
(involves: WK/ReJ)
|
dystrophic muscle
|
J:5151
|
| opisthotonus
|
J:5151
|
Lama2dy-6J/Lama2dy-6J
(involves: C57BL/6JEi * DBA/2J)
|
dystrophic muscle
|
J:56803
|
| progressive muscle weakness
|
J:56803
|
Lama2dy-7J/Lama2dy-7J
(C57BL/6J-Lama2dy-7J/J)
|
dystrophic muscle
|
J:134367
|
| enhanced skeletal muscle regeneration
|
J:134367
|
| increased variability of skeletal muscle fiber size
|
J:134367
|
| muscle spasm
|
J:82238
|
| myopathy
|
J:134367,
J:82238
|
| skeletal muscle endomysial fibrosis
|
J:134367
|
Lama2dy-8J/Lama2dy-8J
(C57BL/6J-Lama2dy-8J/GrsrJ)
|
myopathy
|
J:149729
|
Lama2dy-Pas/Lama2dy-Pas
(involves: non-inbred stock)
|
abnormal skeletal muscle morphology
|
J:102806
|
| centrally nucleated skeletal muscle fibers
|
J:102806
|
| dystrophic muscle
|
J:102806
|
| increased variability of skeletal muscle fiber size
|
J:102806
|
| skeletal muscle fiber necrosis
|
J:102806
|
Lama2dy/Lama2dy
(involves: 129P1/Re * C57BL/6)
|
abnormal skeletal muscle fiber morphology
|
J:152525
|
| centrally nucleated skeletal muscle fibers
|
J:152525
|
| decreased skeletal muscle fiber number
|
J:152525
|
| impaired skeletal muscle regeneration
|
J:134367
|
| increased variability of skeletal muscle fiber size
|
J:134367,
J:152525
|
| myopathy
|
J:134367
|
| skeletal muscle fiber necrosis
|
J:152525
|
| skeletal muscle interstitial fibrosis
|
J:134367,
J:152525
|
Lama2dy/Lama2dy
(involves: 129P1/Re)
|
abnormal sarcolemma morphology
|
J:13125
|
| abnormal skeletal muscle fiber morphology
|
J:13125
|
| centrally nucleated skeletal muscle fibers
|
J:13125
|
| dystrophic muscle
|
J:13125
|
| increased variability of skeletal muscle fiber size
|
J:13125
|
| progressive muscle weakness
|
J:13125
|
Lama2dy/Lama2dy
(B6.129P1-Lama2dy/J)
|
muscle weakness
|
J:101670
|
Lama2dy/Lama2dy
(involves: 129P1/ReJ)
|
abnormal muscle physiology
|
J:102959
|
| dystrophic muscle
|
J:102959
|
| muscle weakness
|
J:102959
|
| skeletal muscle interstitial fibrosis
|
J:102959
|
Lama2tm1Eeng/Lama2tm1Eeng
(involves: 129S1/Sv * Black Swiss)
|
dystrophic muscle
|
J:59089
|
| impaired skeletal muscle regeneration
|
J:59089
|
Lama2tm1Eeng/Lama2tm1Eeng
(involves: 129S1/Sv * Black Swiss * FVB/N)
|
dystrophic muscle
|
J:49435
|
Lama2tm1Eeng/Lama2tm1Eeng
(involves: 129S1/Sv)
|
dystrophic muscle
|
J:170192
|
| muscle degeneration
|
J:170192
|
| muscle weakness
|
J:170192
|
| myositis
|
J:170192
|
Lama2tm1Stk/Lama2tm1Stk
(involves: 129/Sv * 129P2/OlaHsd * BALB/c * ICR)
|
abnormal skeletal muscle fiber morphology
|
J:43145
|
| abnormal skeletal muscle morphology
|
J:43145
|
| dystrophic muscle
|
J:43145
|
| increased variability of skeletal muscle fiber size
|
J:43145
|
| muscle spasm
|
J:43145
|
| myopathy
|
J:43145
|
Lama4tm1Ktry/Lama4tm1Ktry
(B6.129X1-Lama4tm1Ktry)
|
abnormal myocardial fiber morphology
|
J:105789
|
| cardiomyopathy
|
J:105789
|
| decreased ventricle muscle contractility
|
J:105789
|
| heart left ventricle hypertrophy
|
J:105789
|
| increased myocardial fiber size
|
J:105789
|
| myocardial fiber degeneration
|
J:105789
|
Lamb1Lt/Lamb1+
(B6N.Cg-Lamb1Lt)
|
dystonia
|
J:247484
|
Lamc1tm1Strl/Lamc1tm1.2Strl
(either: (involves: 129P2/OlaHsd * C57BL/6 * CBA) or (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * CBA))
|
abnormal quadriceps morphology
|
J:199683
|
| centrally nucleated skeletal muscle fibers
|
J:199683
|
| decreased skeletal muscle fiber diameter
|
J:199683
|
| decreased skeletal muscle mass
|
J:199683
|
| skeletal muscle fiber atrophy
|
J:199683
|
Lamc1tm1Strl/Lamc1tm1Strl
Tg(Camk2a-cre)2Szi/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
muscular atrophy
|
J:86714
|
Lamp2tm1.2Ces/Y
(involves: 129 * 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * SJL)
|
abnormal myocardial fiber morphology
|
J:328713
|
| cardiomyopathy
|
J:328713
|
| decreased cardiac muscle contractility
|
J:328713
|
| heart left ventricle hypertrophy
|
J:328713
|
| increased cardiac muscle glycogen level
|
J:328713
|
Lamp2tm1Psa/Lamp2tm1Psa
(either: (involves: 129P2/OlaHsd * 129/Sv * C57BL/6J) or (involves: 129P2/OlaHsd * 129/Sv))
|
decreased cardiac muscle contractility
|
J:64151
|
Lamp2tm1Psa/Lamp2tm1Psa
(involves: 129P2/OlaHsd)
|
increased myocardial fiber size
|
J:253728
|
Large1enr-Tg(MbpReg)36Pop/Large1enr-Tg(MbpReg)36Pop
(involves: C57BL/6J * DBA/2J)
|
abnormal skeletal muscle fiber morphology
|
J:16281
|
| abnormal skeletal muscle morphology
|
J:16281
|
| skeletal muscle endomysial fibrosis
|
J:16281
|
| skeletal muscle fiber necrosis
|
J:16281
|
Large1myd-3J/Large1myd-3J
(STOCK Large1myd-3J/GrsrJ)
|
muscle phenotype
|
J:160357
|
| myopathy
|
J:160357
|
| skeletal muscle degeneration
|
J:160357
|
Large1myd/Large1myd
(MYD/Le-Os +/+ Largemyd/J)
|
abnormal muscle morphology
|
J:5670
|
| abnormal muscle physiology
|
J:5670
|
| abnormal skeletal muscle fiber morphology
|
J:5670
|
| calcified muscle
|
J:12034
|
| dystrophic muscle
|
J:5670
|
| muscle degeneration
|
J:5670
|
| myopathy
|
J:5670
|
| myositis
|
J:5670
|
Large1myd/Large1myd
(B6.Cg-Large1myd/Pjn)
|
abnormal diaphragm morphology
|
J:100214
|
| abnormal myocardium layer morphology
|
J:100214
|
| abnormal soleus morphology
|
J:100214
|
| dilated cardiomyopathy
|
J:100214
|
Large1myd/Large1myd
(B6C3Fe a/a-Large1myd/J)
|
abnormal myocardial fiber morphology
|
J:169951
|
| abnormal myocardium layer morphology
|
J:169951
|
| abnormal skeletal muscle fiber morphology
|
J:27793
|
| calcified muscle
|
J:27793
|
| centrally nucleated skeletal muscle fibers
|
J:27793
|
| dystrophic muscle
|
J:144746
|
| increased variability of skeletal muscle fiber size
|
J:27793
|
| myositis
|
J:27793
|
| skeletal muscle fiber degeneration
|
J:27793
|
| skeletal muscle fiber necrosis
|
J:27793
|
Large1vls/Large1vls
(B6.CAST(Cg)-Large1vls/Pjn)
|
abnormal diaphragm morphology
|
J:100214
|
| abnormal myocardium layer morphology
|
J:100214
|
| abnormal soleus morphology
|
J:100214
|
| dilated cardiomyopathy
|
J:100214
|
Lats2tm1Noj/Lats2tm1Noj
(involves: 129S2/SvPas * C57BL/6)
|
delayed muscle development
|
J:123480
|
Lats2tm1Raz/Lats2tm1Raz
(involves: 129P2/OlaHsd * C57BL/6)
|
trabecula carnea hypoplasia
|
J:93191
|
Lbx1tm1.1Khan/Lbx1tm1.1Khan
Myf5tm3(cre)Sor/Myf5+
(involves: 129S4/SvJaeSor * C57BL/6JJcl * C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal muscle precursor cell migration
|
J:178868
|
| abnormal skeletal muscle morphology
|
J:178868
|
Lbx1tm1.1Khan/Lbx1tm1.1Khan
Tg(CAG-cre/Esr1*)5Amc/0
(involves: C57BL/6 * CBA)
|
abnormal skeletal muscle morphology
|
J:178868
|
Lbx1tm1Gld/Lbx1tm1Gld
(involves: 129S1/Sv * C57BL/6)
|
abnormal limb muscle morphology
|
J:56498
|
| abnormal muscle precursor cell migration
|
J:56498
|
| abnormal myogenesis
|
J:56498
|
| absent hypaxial muscle
|
J:56498
|
| decreased skeletal muscle mass
|
J:56498
|
| muscle phenotype
|
J:56498
|
Lbx1tm1Gld/Lbx1tm1Gld
(involves: 129S1/Sv)
|
abnormal skeletal muscle morphology
|
J:98439
|
| muscle phenotype
|
J:98439
|
Lbx1tm1Thbr/Lbx1tm1Thbr
(involves: 129S4/SvJae)
|
abnormal limb muscle morphology
|
J:57891
|
| abnormal muscle precursor cell migration
|
J:57891
|
| muscle phenotype
|
J:57891
|
Ldb3tm1Chen/Ldb3tm1Chen
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss)
|
abnormal myocardium layer morphology
|
J:72799
|
| abnormal skeletal muscle morphology
|
J:72799
|
| muscle weakness
|
J:72799
|
| myopathy
|
J:72799
|
Ldb3tm2Chen/Ldb3tm2Chen
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss)
|
abnormal skeletal muscle morphology
|
J:82141
|
| increased variability of skeletal muscle fiber size
|
J:82141
|
| myopathy
|
J:82141
|
| skeletal muscle fiber atrophy
|
J:82141
|
Ldb3tm3Chen/Ldb3tm3Chen
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss)
|
abnormal skeletal muscle morphology
|
J:82141
|
| increased variability of skeletal muscle fiber size
|
J:82141
|
| myopathy
|
J:82141
|
| skeletal muscle fiber atrophy
|
J:82141
|
Ldb3tm4Chen/Ldb3tm4Chen
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss * FVB/N)
|
dilated cardiomyopathy
|
J:144739
|
Ldb3tm4Chen/Ldb3tm4Chen
Myl2tm1(cre)Krc/Myl2+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * Black Swiss)
|
abnormal myocardial fiber morphology
|
J:144739
|
| dilated cardiomyopathy
|
J:144739
|
Ldb3tm6.2Chen/Ldb3tm6.2Chen
(involves: 129/Sv * Black Swiss * C57BL/6 * SJL)
|
abnormal Z line morphology
|
J:170494
|
| decreased cardiac muscle contractility
|
J:170494
|
| dilated cardiomyopathy
|
J:170494
|
Ldlrtm1Her/Ldlrtm1Her
Lrp1tm2Her/Lrp1tm2Her
Tg(Tagln-cre)1Her/0
(involves: 129S7/SvEvBrd * C57BL/6J * SJL)
|
increased vascular smooth muscle cell proliferation
|
J:82871
|
Lemd2em1Eno/Lemd2em1Eno
(involves: C3H * C57BL/6 * C57BL/6N)
|
abnormal myocardial fiber morphology
|
J:331716
|
| decreased cardiac muscle contractility
|
J:331716
|
| dilated cardiomyopathy
|
J:331716
|
| increased myocardial fiber size
|
J:331716
|
| muscle phenotype
|
J:331716
|
Lemd2em2Eno/Lemd2em2Eno
Tg(Myh6-cre)2182Mds/0
(involves: C3H * C57BL/6 * C57BL/6N * FVB/N)
|
abnormal myocardial fiber morphology
|
J:331716
|
| dilated cardiomyopathy
|
J:331716
|
Lemd2Gt(DD0639)Wtsi/Lemd2+
(B6.129P2-Lemd2Gt(DD0639)Wtsi)
|
delayed skeletal muscle regeneration
|
J:221495
|
| muscle phenotype
|
J:221495
|
Lemd2Gt(DD0639)Wtsi/Lemd2Gt(DD0639)Wtsi
(B6.129P2-Lemd2Gt(DD0639)Wtsi)
|
myocardial trabeculae hypoplasia
|
J:221495
|
| thin myocardium
|
J:221495
|
Lepob/Lepob
(involves: C57BL/6J)
|
abnormal muscle contractility
|
J:106205
|
Lepob/Lepob
(B6.Cg-Lepob/J)
|
abnormal muscle morphology
|
J:151518
|
| abnormal myocardial fiber morphology
|
J:103063,
J:111488,
J:104171
|
| abnormal skeletal muscle fiber type ratio
|
J:151518
|
| decreased cardiac muscle contractility
|
J:111488,
J:104171
|
| decreased skeletal muscle fiber size
|
J:151518
|
| decreased skeletal muscle mass
|
J:151518
|
| heart left ventricle hypertrophy
|
J:103063
|
| increased myocardial fiber size
|
J:104171
|
Lepob/Lepob
Plin4tm1Vlcg/Plin4tm1Vlcg
(involves: C57BL/6J)
|
decreased cardiac muscle triglyceride level
|
J:195987
|
Lepob/Lepob
Ppargtm1Avp/Pparg+
(involves: 129S2/SvPas * C57BL/6)
|
abnormal skeletal muscle morphology
|
J:116568
|
Lepob/Lepob
Ppargtm2Avp/Ppargtm2Avp
(involves: 129 * C57BL/6)
|
abnormal skeletal muscle morphology
|
J:121534
|
Leprdb-Pas/Leprdb-Pas
(involves: DW/Pas)
|
decreased muscle weight
|
J:174584
|
Leprdb/Leprdb
(involves: C57BLKS/J)
|
abnormal myocardium layer morphology
|
J:107138
|
| decreased cardiac muscle contractility
|
J:106871
|
| increased vasoconstriction
|
J:106597
|
Leprdb/Leprdb
(B6.Cg-Dock7m +/+ Leprdb/J)
|
abnormal myocardial fiber morphology
|
J:103063
|
| heart left ventricle hypertrophy
|
J:103063
|
Leprdb/Leprdb
(BKS.Cg-Dock7m +/+ Leprdb/J)
|
abnormal myocardial fiber morphology
|
J:6115
|
Leprotl1tm1b(EUCOMM)Hmgu/Leprotl1tm1b(EUCOMM)Hmgu
(C57BL/6N-Leprotl1tm1b(EUCOMM)Hmgu/H)
|
increased cardiac muscle contractility
|
J:211773
|
Lfngtm1Rjo/Lfngtm1Rjo
(B6.129S7-Lfngtm1Rjo)
|
abnormal multifidus muscle morphology
|
J:324821
|
Lgals1tm1Rob/Lgals1tm1Rob
(involves: 129S/SvEv)
|
delayed muscle development
|
J:119480
|
Lgals1tm1Rob/Lgals1tm1Rob
Myf5tm2Pas/Myf5+
(involves: 129S/SvEv * 129S2/SvPas)
|
abnormal skeletal muscle fiber morphology
|
J:119480
|
| decreased skeletal muscle fiber diameter
|
J:119480
|
| delayed muscle development
|
J:119480
|
| delayed skeletal muscle regeneration
|
J:119480
|
Lgi4clp/Lgi4clp
(C57BL/6J-Lgi4clp/J)
|
muscle phenotype
|
J:11392
|
Lig3tm1.1Pmc/Lig3tm1.1Pmc
Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6 * FVB)
|
abnormal myocardial fiber morphology
|
J:170077
|
| decreased cardiac muscle contractility
|
J:170077
|
Limch1em1Coop/Limch1em1Coop
(FVB-Limch1em1Coop)
|
abnormal skeletal muscle fiber morphology
|
J:336773
|
| impaired muscle relaxation
|
J:336773
|
| impaired skeletal muscle contractility
|
J:336773
|
| muscle phenotype
|
J:336773
|
| muscle weakness
|
J:336773
|
Lims1tm1.1Chen/Lims1tm1.1Chen
Lims2tm1.1Chen/Lims2tm1.1Chen
Tg(Tnnt2-cre)5Blh/0
(involves: 129/Sv * C57BL/6 * DBA/2)
|
abnormal pectinate muscle morphology
|
J:167114
|
| abnormal ventricle myocardium morphology
|
J:167114
|
| decreased myocardial fiber size
|
J:167114
|
| thin myocardium compact layer
|
J:167114
|
Lims1tm1.1Chen/Lims1tm1.1Chen
Tg(Tnnt2-cre)5Blh/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
decreased cardiac muscle contractility
|
J:167114
|
Lims2tm1.1Chen/Lims2tm1.1Chen
(involves: 129S4/SvJae)
|
decreased cardiac muscle contractility
|
J:167114
|
Lin28atm1.1Gqda/Lin28atm1.1Gqda
(involves: 129S4/SvJae * C57BL/6)
|
muscle phenotype
|
J:199720
|
Lin28btm1Gqda/Lin28btm1Gqda
Myf5tm1(cre)Mrc/Myf5+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6)
|
muscle phenotype
|
J:199720
|
Lipetm1Land/Lipetm1Land
(involves: 129 * C57BL/6J)
|
decreased muscle cell glucose uptake
|
J:85540
|
Lipetm1Land/Lipetm1Land
(involves: 129)
|
decreased skeletal muscle glycogen level
|
J:106148
|
Lipetm1Rze/Lipetm1Rze
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased cardiac muscle triglyceride level
|
J:74644
|
Lmbrd1tm1.1Ntum/Lmbrd1+
(B6.Cg-Lmbrd1tm1.1Ntum)
|
abnormal cardiac muscle cell glucose uptake
|
J:204994
|
| increased cardiac muscle cell glucose uptake
|
J:204994
|
LmnaGt(S7-1F1)Sor/LmnaGt(S7-1F1)Sor
(involves: 129S4/SvJaeSor * C57BL/6)
|
decreased myocardial fiber size
|
J:221850
|
| decreased quadriceps weight
|
J:221850
|
| decreased skeletal muscle fiber diameter
|
J:221850
|
| decreased skeletal muscle fiber size
|
J:221850
|
| muscle weakness
|
J:221850
|
Lmnatm1.1Bliu/Lmna+
(involves: C57BL/6 * FVB/N)
|
abnormal vasodilation
|
J:287256
|
Lmnatm1.1Bliu/Lmnatm1.1Bliu
(involves: C57BL/6 * FVB/N)
|
abnormal vasodilation
|
J:287256
|
Lmnatm1.1Otin/Lmna+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal vascular smooth muscle physiology
|
J:211388
|
Lmnatm1.1Otin/Lmnatm1.1Otin
(involves: 129P2/OlaHsd * C57BL/6)
|
vascular smooth muscle hypoplasia
|
J:177632
|
Lmnatm1.1Vde/Lmnatm1.1Vde
(B6.129(Cg)-Lmnatm1.1Vde)
|
abnormal muscle tone
|
J:322912
|
Lmnatm1.2Yxz/Lmnatm1.2Yxz
(involves: 129S * BALB/cJ * C57BL/6 * CD-1 * SJL)
|
decreased skeletal muscle fiber size
|
J:211369
|
Lmnatm1Bliu/Lmna+
Tg(Tek-cre)1Ywa/0
(involves: C57BL/6 * SJL)
|
abnormal vasodilation
|
J:287256
|
| decreased ventricle muscle contractility
|
J:287256
|
| dilated cardiomyopathy
|
J:287256
|
Lmnatm1Gbon/Lmnatm1Gbon
(involves: 129S2/SvPas * C57BL/6)
|
abnormal diaphragm morphology
|
J:95528
|
| abnormal gastrocnemius morphology
|
J:95528
|
| abnormal hypaxial muscle morphology
|
J:95528
|
| abnormal myocardial fiber morphology
|
J:95528
|
| abnormal soleus morphology
|
J:95528
|
| abnormal tibialis anterior morphology
|
J:95528
|
| decreased cardiac muscle contractility
|
J:95528,
J:187399
|
| dilated cardiomyopathy
|
J:187399
|
| dystrophic muscle
|
J:95528
|
| myocardium necrosis
|
J:95528
|
| progressive muscle weakness
|
J:95528
|
| skeletal muscle fibrosis
|
J:95528
|
Lmnatm1Stw/Lmna+
Mliptm1.1(cre)Dzw/Mliptm1.1(cre)Dzw
(involves: 129S1/Sv * C57BL/6)
|
decreased cardiac muscle contractility
|
J:227485
|
| dilated cardiomyopathy
|
J:227485
|
Lmnatm1Stw/Lmna+
Zmpste24tm1Sgy/Zmpste24tm1Sgy
(involves: 129S1/Sv * 129S4/SvJae * C57BL/6)
|
muscle phenotype
|
J:95274
|
Lmnatm1Stw/Lmnatm1Stw
(involves: 129S1/Sv)
|
dystrophic muscle
|
J:58702
|
| muscle degeneration
|
J:58702
|
Lmnatm1Stw/Lmnatm1Stw
(involves: 129S1/Sv * C57BL/6)
|
muscle weakness
|
J:95274
|
Lmnatm1Stw/Lmnatm1Stw
Mliptm1.1(cre)Dzw/Mliptm1.1(cre)Dzw
(involves: 129S1/Sv * C57BL/6)
|
decreased cardiac muscle contractility
|
J:227485
|
Lmnatm1Stw/Lmnatm1Stw
Zmpste24tm1Sgy/Zmpste24+
(involves: 129S1/Sv * 129S4/SvJae * C57BL/6)
|
muscle weakness
|
J:95274
|
Lmnatm1Stw/Lmnatm1Stw
Zmpste24tm1Sgy/Zmpste24tm1Sgy
(involves: 129S1/Sv * 129S4/SvJae * C57BL/6)
|
muscle weakness
|
J:95274
|
Lmnatm2.1Gbon/Lmna+
(involves: 129 * C57BL/6)
|
abnormal sarcomere morphology
|
J:198526
|
| cardiac muscle degeneration
|
J:198526
|
| decreased cardiac muscle contractility
|
J:198526
|
| dilated cardiomyopathy
|
J:198526
|
| muscle phenotype
|
J:198526
|
Lmnatm2.1Gbon/Lmnatm2.1Gbon
(involves: 129 * C57BL/6)
|
abnormal muscle development
|
J:180603
|
| abnormal myocardial fiber morphology
|
J:180603
|
| centrally nucleated skeletal muscle fibers
|
J:180603
|
| decreased skeletal muscle fiber size
|
J:180603
|
Lmnatm2Lgf/Lmna+
Zmpste24tm1Sgy/Zmpste24tm1Sgy
(involves: 129S4/SvJae * C57BL/6)
|
muscle phenotype
|
J:106473
|
Lmnatm2Stw/Lmnatm2Stw
(involves: 129S1/Sv)
|
abnormal esophageal smooth muscle morphology
|
J:83382
|
| cardiac muscle degeneration
|
J:83382
|
| decreased myocardial fiber number
|
J:83382
|
| decreased myocardial fiber size
|
J:83382
|
| muscular atrophy
|
J:83382
|
| skeletal muscle degeneration
|
J:83382
|
Lmnatm3Stw/Lmnatm3Stw
(involves: 129S1/Sv * 129S4/SvJaeSor * C57BL)
|
abnormal myocardial fiber morphology
|
J:100393
|
| cardiac muscle degeneration
|
J:100393
|
| decreased ventricle muscle contractility
|
J:100393
|
| dilated cardiomyopathy
|
J:100393
|
| myocardial fiber degeneration
|
J:100393
|
| thin myocardium
|
J:100393
|
Lmnatm4Stw/Lmnatm4Stw
Tg(Zp3-cre)93Knw/0
(involves: C57BL/6J)
|
centrally nucleated skeletal muscle fibers
|
J:220874
|
| decreased skeletal muscle fiber diameter
|
J:220874
|
| dystrophic muscle
|
J:220874
|
Lmnatm5Lgf/Lmnatm5Lgf
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased ventricle muscle contractility
|
J:160705
|
| dilated cardiomyopathy
|
J:160705
|
Lmnatm8Lgf/Lmnatm8Lgf
(involves: 129P2/OlaHsd)
|
decreased ventricle muscle contractility
|
J:167229
|
Lmnatm10Lgf/Lmnatm10Lgf
Zmpste24tm1Sgy/Zmpste24tm1Sgy
(involves: 129P2/OlaHsd * 129S4/SvJae)
|
esophageal achalasia
|
J:220988
|
Lmnatm11Lgf/Lmna+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal esophageal smooth muscle morphology
|
J:220988
|
| esophageal achalasia
|
J:220988
|
Lmnatm12Lgf/Lmnatm12Lgf
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal aorta smooth muscle morphology
|
J:234711
|
Lmnb1tm1Yxz/Lmnb1tm1Yxz
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6)
|
thin diaphragm muscle
|
J:178993
|
Lmnb1tm1Yxz/Lmnb1tm1Yxz
Lmnb2tm1Yxz/Lmnb2tm1Yxz
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6)
|
thin diaphragm muscle
|
J:178993
|
Lmo7tm1Tilg/Lmo7tm1Tilg
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal skeletal muscle fiber morphology
|
J:83810
|
Lmod2tm1(KOMP)Vlcg/Lmod2tm1(KOMP)Vlcg
(involves: C57BL/6J * C57BL/6NTac)
|
abnormal intercalated disk morphology
|
J:227272
|
| abnormal myocardial fiber morphology
|
J:227272
|
| abnormal sarcomere morphology
|
J:227272
|
| abnormal Z line morphology
|
J:227272
|
| decreased cardiac muscle contractility
|
J:227272
|
| dilated cardiomyopathy
|
J:227272
|
Lmod2Tn(pb-Act-RFP)1.1Zhu/Lmod2Tn(pb-Act-RFP)1.1Zhu
(involves: FVB/N)
|
abnormal intercalated disk morphology
|
J:233669
|
| abnormal myocardial fiber morphology
|
J:233669
|
| abnormal sarcomere morphology
|
J:233669
|
| abnormal Z line morphology
|
J:233669
|
| absent M line
|
J:233669
|
| decreased cardiac muscle contractility
|
J:233669
|
| dilated cardiomyopathy
|
J:233669
|
Lmod3em1(IMPC)Mbp/Lmod3em1(IMPC)Mbp
(C57BL/6N-Lmod3em1(IMPC)Mbp/Ucd)
|
abnormal skeletal muscle morphology
|
J:211773
|
Lmod3em1Eno/Lmod3em1Eno
(involves: C3H * C57BL/6)
|
abnormal sarcomere morphology
|
J:222174
|
| abnormal Z line morphology
|
J:222174
|
| centrally nucleated skeletal muscle fibers
|
J:222174
|
| decreased cardiac muscle contractility
|
J:222174
|
| decreased skeletal muscle fiber size
|
J:222174
|
| decreased skeletal muscle size
|
J:222174
|
| increased skeletal muscle glycogen level
|
J:222174
|
Lmod3Tn(pb-Act-RFP)1.1Zhu/Lmod3Tn(pb-Act-RFP)1.1Zhu
(involves: C57BL/6J)
|
abnormal sarcomere morphology
|
J:223382
|
| abnormal skeletal muscle fiber morphology
|
J:223382
|
| abnormal Z line morphology
|
J:223382
|
| muscle weakness
|
J:223382
|
| skeletal muscle fiber atrophy
|
J:223382
|
Lmx1btm1Rjo/Lmx1btm1Zfc
Tg(Prrx1-cre)1Cjt/0
(involves: 129S7/SvEvBrd * C57BL/6J * SJL/J)
|
abnormal tendon morphology
|
J:158676
|
Lmx1btm1Rjo/Lmx1btm4.1Rjo
Pitx2tm4(cre)Jfm/Pitx2+
(involves: 129S7/SvEvBrd)
|
abnormal intraocular muscle morphology
|
J:161793
|
Lncpinttm1Vlcg/Lncpinttm1Vlcg
(involves: 129S6/SvEvTac * C57BL/6NTac)
|
decreased gastrocnemius weight
|
J:233815
|
| decreased skeletal muscle mass
|
J:233815
|
| decreased tibialis anterior weight
|
J:233815
|
| progressive muscle weakness
|
J:233815
|
Lnhrttm1.1Koho/Lnhrttm1.1Koho
(involves: C57BL/6 * DBA/2)
|
decreased myocardial fiber size
|
J:293789
|
| decreased susceptibility to induced muscular atrophy
|
J:293789
|
| decreased ventricle muscle contractility
|
J:293789
|
Loxb2b370.2Clo/Loxb2b370.2Clo
(C57BL/6J-Loxb2b370.2Clo)
|
diaphragmatic hernia
|
J:175213
|
| heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
Loxtm1Ikh/Loxtm1Ikh
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal aorta smooth muscle morphology
|
J:82926
|
| abnormal diaphragm central tendon morphology
|
J:82926
|
| abnormal diaphragm development
|
J:82926
|
| diaphragmatic hernia
|
J:82926
|
Loxtm1Soin/Loxtm1Soin
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal aorta smooth muscle morphology
|
J:103389
|
| abnormal diaphragm morphology
|
J:101687
|
| diaphragmatic hernia
|
J:101687
|
Lpar4tm1Sati/Y
(involves: C57BL/6)
|
vascular smooth muscle hypoplasia
|
J:167262
|
Lpar4tm1Sati/Lpar4tm1Sati
(involves: C57BL/6)
|
vascular smooth muscle hypoplasia
|
J:167262
|
Lpin120884/Lpin120884
Nrcam20884/Nrcam20884
(involves: C57BL/6J)
|
skeletal muscle fiber atrophy
|
J:153042
|
Lpin1fld/Lpin1fld
Nrcam20884/Nrcam20884
(involves: BALB/cByJ * C57BL/6J)
|
skeletal muscle fiber atrophy
|
J:153042
|
Lpltm1Bres/Lpl+
Tg(Myh6-LPL*)357Ijg/0
(involves: 129S4/SvJae)
|
abnormal cardiac muscle tissue morphology
|
J:134550
|
| abnormal myocardial fiber morphology
|
J:134550
|
| cardiomyopathy
|
J:134550
|
| decreased ventricle muscle contractility
|
J:134550
|
Lpltm1Bres/Lpltm1Bres
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal skeletal muscle morphology
|
J:30062
|
Lpltm1Ijg/Lpltm1Ijg
Tg(Myh6-cre)2182Mds/?
(involves: C57BL/6)
|
decreased cardiac muscle triglyceride level
|
J:90737
|
| increased cardiac muscle cell glucose uptake
|
J:90737
|
Lpltm1Ijg/Lpltm1Ijg
Tg(Myh6-cre)2182Mds/0
(involves: FVB/N)
|
decreased cardiac muscle contractility
|
J:110484
|
| increased cardiac muscle cell glucose uptake
|
J:110484
|
Lpoem1Zlu/Lpoem1Zlu
(involves: C57BL/6 * SJL)
|
dilated cardiomyopathy
|
J:307289
|
| myositis
|
J:307289
|
Lrig3em1(IMPC)Ccpcz/Lrig3em1(IMPC)Ccpcz
(C57BL/6NCrl-Lrig3em1(IMPC)Ccpcz/Ccpcz)
|
abnormal skeletal muscle morphology
|
J:211773
|
Lrp1b2b1554Clo/Lrp1b2b1554Clo
(C57BL/6J-Lrp1b2b1554Clo)
|
diaphragmatic hernia
|
J:175213
|
Lrp1tm2Her/Lrp1tm2Her
Tg(Fabp4-cre)1Rev/0
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased muscle cell glucose uptake
|
J:127398
|
Lrp1tm2Her/Lrp1tm2Her
Tg(Tagln-cre)1Her/0
(B6.Cg-Lrp1tm2Her Tg(Tagln-cre)1Her)
|
abnormal aorta smooth muscle morphology
|
J:167799
|
| abnormal vascular smooth muscle physiology
|
J:167799
|
| decreased vasoconstriction
|
J:167799
|
Lrp1tm2Her/Lrp1tm2Her
Tg(Tagln-cre)1Her/0
(involves: 129S7/SvEvBrd * C57BL/6 * SJL)
|
abnormal myocardial fiber morphology
|
J:209752
|
| decreased cardiac muscle contractility
|
J:209752
|
| dilated cardiomyopathy
|
J:209752
|
Lrp2b2b2671Clo/Lrp2b2b2671Clo
(C57BL/6J-Lrp2b2b2671Clo)
|
abnormal myocardium compact layer morphology
|
J:175213
|
| heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
Lrp4tm1.1Pg/Lrp4tm1.1Pg
(involves: C57BL/6N)
|
muscle phenotype
|
J:277372
|
Lrrc8atm1.1Geha/Lrrc8atm1.1Geha
(B6.129S1(Cg)-Lrrc8atm1.1Geha)
|
abnormal skeletal muscle morphology
|
J:211308
|
Lrrc10tm1Sgt/Lrrc10tm1Sgt
(B6.129P2-Lrrc10tm1Sgt)
|
abnormal myocardial fiber morphology
|
J:195548
|
| decreased cardiac muscle contractility
|
J:195548
|
| dilated cardiomyopathy
|
J:195548
|
Lrrc25em1Cya/Lrrc25em1Cya
(C57BL/6J-Lrrc25em1Cya/Cya)
|
decreased cardiac muscle contractility
|
J:270157
|
Lsq1BALB/cJ/Lsq1C57BL/6J
(involves: BALB/cJ * C57BL/6J)
|
skeletal muscle necrosis
|
J:135427
|
Lsq1C57BL/6J/Lsq1C57BL/6J
(involves: BALB/cJ * C57BL/6J)
|
skeletal muscle necrosis
|
J:135427
|
Ltbp1tm1Veto/Ltbp1tm1Veto
(involves: 129 * C57BL/6)
|
abnormal vascular smooth muscle morphology
|
J:128012
|
Ltbp1tm2Veto/Ltbp1tm2Veto
(involves: 129 * C57BL/6)
|
abnormal vascular smooth muscle morphology
|
J:128012
|
Ltbp4dmod1-129T2/SvEmsJ/Ltbp4dmod1-129T2/SvEmsJ
Sgcgtm1Mcn/Sgcgtm1Mcn
(129T2.Cg-Ltbp4dmod1-129T2/SvEmsJ Sgcgtm1Mcn)
|
abnormal muscle physiology
|
J:155107
|
| skeletal muscle fibrosis
|
J:155107
|
Ltbp4dmod1-DBA/2J/Ltbp4dmod1-DBA/2J
Sgcgtm1Mcn/Sgcgtm1Mcn
(D2.Cg-Ltbp4dmod1-DBA/2J Sgcgtm1Mcn)
|
abnormal muscle physiology
|
J:155107
|
| skeletal muscle fibrosis
|
J:155107
|
Ltbp4Gt(E301B04)Wrst/Ltbp4Gt(E301B04)Wrst
(B6N.129P2-Ltbp4Gt(E301B04)Wrst)
|
heart right ventricle hypertrophy
|
J:221200
|
Ltbp4Gt(U3Cre)1Vmel/Ltbp4Gt(U3Cre)1Vmel
(involves: 129S2/SvPas * C57BL/6)
|
cardiomyopathy
|
J:85162
|
Ltbp4Gt(U3Cre)1Vmel/Ltbp4Gt(U3Cre)1Vmel
(B6.129S2-Ltbp4Gt(U3Cre)1Vmel)
|
increased myocardial fiber size
|
J:78819
|
| ventricular cardiomyopathy
|
J:78819
|
Ltn1lister/Ltn1lister
(C57BL/6-Ltn1lister)
|
abnormal muscle regeneration
|
J:146493
|
| decreased skeletal muscle fiber size
|
J:146493
|
| muscular atrophy
|
J:146493
|
Lumtm1Chak/Lumtm1Chak
(involves: 129S/Sv * CD-1)
|
abnormal tendon morphology
|
J:65867
|
Ly6etm1Zmt/Ly6etm1Zmt
(involves: 129S1/Sv)
|
dilated cardiomyopathy
|
J:73972
|
Lztr1tm1a(EUCOMM)Wtsi/Lztr1+
(involves: C57BL/6N)
|
decreased cardiac muscle contractility
|
J:268690
|
| increased myocardial fiber size
|
J:268690
|
Mad1l1tm1.1Ktj/Mad1l1+
(involves: BALB/c * C57BL/6J)
|
increased rhabdomyosarcoma incidence
|
J:117337
|
Mad2l1bptm1.2Itl/Mad2l1bptm1.2Itl
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac)
|
muscle phenotype
|
J:234643
|
Mafgtm1Jeng/Mafgtm1Jeng
Mafktm1Jeng/Mafk+
(involves: 129S1/Sv * 129X1/SvJ)
|
myoclonus
|
J:81813
|
Magel2tm1Stw/Magel2tm1Stw
(C57BL/6-Magel2tm1Stw/J)
|
decreased skeletal muscle fiber size
|
J:233299
|
| decreased skeletal muscle weight
|
J:233299
|
| increased skeletal muscle fiber size
|
J:233299
|
| skeletal muscle atrophy
|
J:233299
|
Maml1tm1Lizw/Maml1tm1Lizw
(involves: 129)
|
increased variability of skeletal muscle fiber size
|
J:106711
|
| skeletal muscle fiber necrosis
|
J:106711
|
Maml1tm1Mkit/Maml1tm1Mkit
(involves: 129P2/OlaHsd * C57BL/6)
|
dystrophic muscle
|
J:122286
|
Mamstrtm1.1Eno/Mamstrtm1.1Eno
Pax7tm2.1(cre/ERT2)Fan/Pax7+
(involves: 129 * C57BL/6)
|
impaired skeletal muscle regeneration
|
J:179880
|
Mamstrtm1.2Eno/Mamstrtm1.2Eno
(involves: 129 * C57BL/6)
|
impaired skeletal muscle regeneration
|
J:179880
|
Mamstrtm1.2Eno/Mamstrtm1.2Eno
Mrtfatm1Eno/Mrtfatm1Eno
(involves: 129 * C57BL/6)
|
abnormal muscle physiology
|
J:179880
|
| abnormal skeletal muscle satellite cell proliferation
|
J:179880
|
| decreased skeletal muscle weight
|
J:179880
|
| impaired skeletal muscle regeneration
|
J:179880
|
| muscular atrophy
|
J:179880
|
Man2b1tm1Psa/Man2b1tm1Psa
(involves: 129 * C57BL/6J)
|
abnormal eye muscle morphology
|
J:56659
|
Map1stm1.1Lliu/Map1stm1.1Lliu
(involves: 129S4/SvJaeSor * C57BL/6)
|
abnormal myocardial fiber morphology
|
J:170757
|
Map2k5tm1Ctr/Map2k5tm1Ctr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal myocardial trabeculae morphology
|
J:95388
|
Map3k1tm1Glj/Map3k1tm1Glj
(involves: 129S/SvEv)
|
abnormal vascular smooth muscle physiology
|
J:108989
|
| decreased ventricle muscle contractility
|
J:78068
|
| increased cardiomyocyte apoptosis
|
J:78068
|
Map3k3tm1.1Mlkn/Map3k3tm1.2Mlkn
Nfatc1tm1.1(cre)Bz/Nfatc1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6NTac)
|
thin myocardium
|
J:238897
|
Map3k3tm1Bisu/Map3k3tm1Bisu
(Not Specified)
|
abnormal myocardium layer morphology
|
J:60748
|
| trabecula carnea hypoplasia
|
J:60748
|
Map3k7Gt(XB444)Byg/Map3k7Gt(XB444)Byg
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal myocardial trabeculae morphology
|
J:107401
|
| abnormal vascular smooth muscle morphology
|
J:107401
|
| thin myocardium compact layer
|
J:107401
|
Map3k10tm1Lex/Map3k10tm1Lex
Map3k9tm1Lex/Map3k9tm1Lex
(either: 129S-Map3k10tm1Lex Map3k9tm1Lex or B6.129S-Map3k10tm1Lex Map3k9tm1Lex)
|
muscle phenotype
|
J:137358
|
Mapk1tm1Gela/Mapk1tm1Gela
H2az2Tg(Wnt1-cre)11Rth/H2az2+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/6J * CBA/J)
|
abnormal extrinsic tongue muscle morphology
|
J:239772
|
| abnormal tongue muscle morphology
|
J:239772
|
Mapk1tm1Melo/Mapk1+
(involves: C57BL/6)
|
decreased cardiac muscle contractility
|
J:127872
|
| increased cardiomyocyte apoptosis
|
J:127872
|
Mapk1tm1Melo/Mapk1+
(involves: 129S2/SvPas)
|
decreased cardiac muscle contractility
|
J:124903
|
Mapk1tm1Moga/Mapk1tm1Moga
(involves: 129P2/OlaHsd * C57BL/6)
|
thin myocardium
|
J:89903
|
Mapk3tm1Gpg/Mapk3tm1Gpg
(involves: 129/Sv * C57BL/6)
|
muscle phenotype
|
J:190460
|
Mapk7b2b2346Clo/Mapk7b2b2346Clo
(C57BL/6J-Mapk7b2b2346Clo)
|
abnormal myocardium compact layer morphology
|
J:175213
|
Mapk7tm1Jdl/Mapk7tm1Jdl
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
myocardial fiber degeneration
|
J:89215
|
Mapk7tm1Jdl/Mapk7tm1Jdl
Tg(Tek-cre)12Flv/0
(Not Specified)
|
trabecula carnea hypoplasia
|
J:89215
|
Mapk7tm1Jsca/Mapk7tm1Jsca
(either: (involves: BALB/c) or (involves: C57BL/6))
|
thin myocardium
|
J:107620
|
Mapk7tm1Kda/Mapk7tm1Kda
(involves: 129S6/SvEvTac)
|
abnormal vascular smooth muscle morphology
|
J:77725
|
| trabecula carnea hypoplasia
|
J:77725
|
Mapk7tm1Wnt/Mapk7tm1Wnt
(involves: C57BL/6)
|
heart left ventricle hypertrophy
|
J:80044
|
| thin myocardium
|
J:80044
|
| trabecula carnea hypoplasia
|
J:80044
|
Mapk8tm1Flv/Mapk8tm1Flv
(involves: 129S1/Sv * C57BL/6)
|
abnormal myocardium layer morphology
|
J:102152
|
| decreased cardiomyocyte apoptosis
|
J:102152
|
Mapk8tm1Flv/Mapk8tm1Flv
(involves: 129S1/Sv)
|
decreased cardiac muscle contractility
|
J:108253
|
| increased cardiomyocyte apoptosis
|
J:108253
|
Mapk9tm1Mka/Mapk9tm1Mka
(involves: 129/Sv * C57BL/6)
|
abnormal myocardium layer morphology
|
J:102152
|
| decreased cardiomyocyte apoptosis
|
J:102152
|
Mapk11tm1Jsca/Mapk11tm1Jsca
(involves: 129P2/OlaHsd)
|
increased fetal cardiomyocyte proliferation
|
J:176023
|
| thin right ventricle myocardium compact layer
|
J:176023
|
Mapk11tm1Jsca/Mapk11tm1Jsca
Mapk14tm2Nbr/Mapk14tm2Nbr
Edil3Tg(Sox2-cre)1Amc/Edil3+
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal fetal cardiomyocyte proliferation
|
J:176023
|
Mapk11tm2.1Lex/Mapk11tm2.1Lex
(involves: 129 * C57BL * C57BL/6J * DBA)
|
muscle phenotype
|
J:119724
|
Mapk11tm2Lex/Mapk11tm2Lex
Tg(Myog-cre)1Eno/0
(involves: 129S/SvEvBrd)
|
muscle phenotype
|
J:155408
|
Mapk12tm1.1Lex/Mapk12tm1.1Lex
(involves: 129S/SvEvBrd * C57BL * C57BL/6J * DBA)
|
muscle phenotype
|
J:119724
|
Mapk12tm1Lex/Mapk12tm1Lex
Tg(Myog-cre)1Eno/0
(involves: 129S/SvEvBrd)
|
muscle phenotype
|
J:155408
|
Mapk13tm2.1Lex/Mapk13tm2.1Lex
(involves: 129S5/SvEvBrd * C57BL * C57BL/6J * DBA)
|
muscle phenotype
|
J:119724
|
Mapk14tm1.1Lex/Mapk14tm1.1Lex
(involves: 129S4/SvJaeSor * 129S5/SvEvBrd * C57BL/6J)
|
abnormal muscle fiber morphology
|
J:119724
|
| abnormal myoblast differentiation
|
J:119724
|
| abnormal myoblast fusion
|
J:119724
|
| increased myoblast proliferation
|
J:119724
|
Mapk14tm1.2Otsu/Mapk14tm1.2Otsu
Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6J)
|
decreased cardiac muscle contractility
|
J:95116
|
| increased cardiomyocyte apoptosis
|
J:95116
|
Mapk14tm1Lex/Mapk14tm1Lex
Myl7tm1(cre)Krc/Myl7+
(involves: 129S1/Sv * 129S5/SvEvBrd * 129X1/SvJ * C57BL/6)
|
abnormal fetal cardiomyocyte proliferation
|
J:98514
|
Mapk14tm1Lex/Mapk14tm1Lex
Tg(Myog-cre)1Eno/0
(involves: 129S5/SvEvBrd)
|
muscle phenotype
|
J:155408
|
Mapk14tm1Nbr/Mapk14tm1Nbr
(either: (involves: 129S/SvEv * 129S1/Sv * 129X1/SvJ * C57BL/6) or (involves: 129S/SvEv * 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1))
|
absent myocardial trabeculae
|
J:63877
|
| decreased cardiac muscle contractility
|
J:63877
|
| thin myocardium
|
J:63877
|
Mapkapk2tm1Mgl/Mapkapk2tm1Mgl
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased cardiomyocyte apoptosis
|
J:101888
|
Mapttm3.1(FUS)Neas/Mapt+
(B6J.129P2(129S)-Mapttm3.1(FUS)Neas)
|
abnormal sarcomere morphology
|
J:232167
|
| abnormal tibialis anterior morphology
|
J:232167
|
Marveld2tm1.1Sria/Marveld2+
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal myocardial fiber morphology
|
J:201580
|
Marveld2tm1.1Sria/Marveld2tm1.1Sria
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal myocardial fiber morphology
|
J:201580
|
Matr3em1Tcp/Matr3em1Tcp
(C57BL/6J-Matr3em1Tcp)
|
decreased skeletal muscle fiber size
|
J:298091
|
Mavstm1Itl/Mavstm1Itl
Trex1tm1Tld/Trex1tm1Tld
(involves: 129P2/OlaHsd * C57BL/6)
|
myositis
|
J:181257
|
Mbem1Shad/Mbem1Shad
(B6N-Mbem1Shad)
|
muscle phenotype
|
J:307655
|
Mbtm1Wlm/Mbtm1Wlm
(Not Specified)
|
abnormal myocardium layer morphology
|
J:50584
|
| abnormal skeletal muscle fiber type ratio
|
J:72560
|
| abnormal soleus morphology
|
J:72560,
J:50584
|
| increased muscle fatigability
|
J:72560
|
| muscle phenotype
|
J:50584
|
Mbtm1Wlm/Mbtm1Wlm
(either: (involves: 129/Sv) or (involves: C57BL/6))
|
thin myocardium
|
J:74121
|
Mbtm1Wlm/Mbtm1Wlm
(B6.Cg-Mbtm1Wlm)
|
decreased ventricle muscle contractility
|
J:86546
|
| heart left ventricle hypertrophy
|
J:86546
|
Mbnl1tm1Sws/Mbnl1tm1Sws
(involves: 129S1/Sv * C57BL/6J)
|
abnormal muscle physiology
|
J:86903
|
| abnormal skeletal muscle fiber morphology
|
J:86903
|
| centrally nucleated skeletal muscle fibers
|
J:86903
|
Mbnl1tm1Sws/Mbnl1tm1Sws
Mbnl2tm1.1Sws/Mbnl2+
(involves: 129S1/Sv * 129S1/SvImJ * C57BL)
|
heart left ventricle hypertrophy
|
J:218011
|
| impaired muscle relaxation
|
J:218011
|
| muscle degeneration
|
J:218011
|
| progressive muscle weakness
|
J:218011
|
Mbnl1tm1Sws/Mbnl1tm1Sws
Mbnl2tm1Sws/Mbnl2tm1Sws
Tg(Myog-cre)1Eno/0
(involves: 129S1/Sv * 129S1/SvImJ * C57BL)
|
centrally nucleated skeletal muscle fibers
|
J:218011
|
| decreased skeletal muscle fiber size
|
J:218011
|
| increased variability of skeletal muscle fiber size
|
J:218011
|
| skeletal muscle degeneration
|
J:218011
|
Mbnl2Gt(RRK149)Byg/Mbnl2Gt(RRK149)Byg
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal skeletal muscle fiber morphology
|
J:130160
|
| centrally nucleated skeletal muscle fibers
|
J:130160
|
| decreased skeletal muscle fiber size
|
J:130160
|
| impaired muscle relaxation
|
J:130160
|
| skeletal muscle interstitial fibrosis
|
J:130160
|
Mbnl2Gt(XB595)Byg/Mbnl2Gt(XB595)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
muscle phenotype
|
J:112061
|
Mbnl2tm1.1Sws/Mbnl2tm1.1Sws
(involves: 129S1/SvImJ * BALB/cJ * C57BL/6J)
|
muscle phenotype
|
J:218010
|
Mbnl3tm1.1Sws/Y
(involves: BALB/c * C57BL/6 * C57BL/6J)
|
decreased skeletal muscle fiber number
|
J:199127
|
| decreased skeletal muscle fiber size
|
J:199127
|
| impaired skeletal muscle regeneration
|
J:199127
|
Mbnl3tm1.1Sws/Mbnl3tm1.1Sws
(involves: BALB/c * C57BL/6 * C57BL/6J)
|
decreased skeletal muscle fiber number
|
J:199127
|
| decreased skeletal muscle fiber size
|
J:199127
|
| impaired skeletal muscle regeneration
|
J:199127
|
Mcattm1.1Ssmi/Mcattm1.1Ssmi
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * CBA)
|
abnormal muscle physiology
|
J:192213
|
| increased skeletal muscle glycogen level
|
J:192213
|
Mcm2tm1(cre/ERT2)Scpr/Mcm2tm1(cre/ERT2)Scpr
(involves: 129S6/SvEvTac)
|
muscle weakness
|
J:141493
|
Mcoln1tm1Sasl/Mcoln1tm1Sasl
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased skeletal muscle mass
|
J:135368
|
| dilated cardiomyopathy
|
J:135368
|
Mcrip2em1Eno/Mcrip2em1Eno
(C57BL/6N-Mcrip2em1Eno)
|
muscle phenotype
|
J:316902
|
Mcutm1.1Jmol/Mcutm1.1Jmol
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6J * FVB/N)
|
abnormal myocardial fiber morphology
|
J:224853
|
| decreased cardiomyocyte apoptosis
|
J:224853
|
| decreased ventricle muscle contractility
|
J:224853
|
Mdga2Tg(Prnp-PFN1*G118V)838Kiaei/Mdga2+
(involves: C57BL/6N)
|
progressive muscle weakness
|
J:241428
|
| skeletal muscle atrophy
|
J:241428
|
Mdm2tm1Glo/Mdm2tm2.1Glo
Tg(Myh6-cre)2182Mds/0
(involves: 129S7/SvEvBrd * FVB/N)
|
increased cardiomyocyte apoptosis
|
J:104114
|
| thin myocardium
|
J:104114
|
Mdm2tm3.1Glo/Mdm2tm3.1Glo
Trp53tm3.1Glo/Trp53+
(B6.129S-Mdm2tm3.1Glo Trp53tm3.1Glo)
|
increased leiomyosarcoma incidence
|
J:164201
|
Mdm4tm2Glo/Mdm4tm2.1Glo
Tg(Myh6-cre)2182Mds/0
(involves: 129S4/SvJaeSor * 129S7/SvEvBrd * C57BL/6J * FVB/N)
|
decreased myocardial fiber number
|
J:137114
|
| dilated cardiomyopathy
|
J:137114
|
| increased cardiomyocyte apoptosis
|
J:137114
|
| increased myocardial fiber size
|
J:137114
|
Mdmsc1Comp9/?
(involves: CAST/Ei * Comp9)
|
abnormal muscle morphology
|
J:85812
|
Mdmsc2Comp9/?
(involves: CAST/Ei * Comp9)
|
abnormal muscle morphology
|
J:85812
|
Mdmsc3Comp9/?
(involves: CAST/Ei * Comp9)
|
abnormal muscle morphology
|
J:85812
|
Mdmsc4Comp9/?
(involves: CAST/Ei * Comp9)
|
abnormal muscle morphology
|
J:85812
|
Mdmsc5Comp9/?
(involves: CAST/Ei * Comp9)
|
abnormal muscle morphology
|
J:85812
|
Mdmsc6Comp9/?
(involves: CAST/Ei * Comp9)
|
abnormal muscle morphology
|
J:85812
|
Mecomtm1Aspe/Mecomtm1Aspe
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal tendon collagen fibril morphology
|
J:207915
|
Mecomtm1Mmor/Mecomtm1Mmor
(involves: 129S2/SvPas * CF-1)
|
abnormal myotome development
|
J:42030
|
| absent myotome
|
J:42030
|
| trabecula carnea hypoplasia
|
J:42030
|
Mecp2tm1.1Bird/Y
(involves: 129P2/OlaHsd * CD-1)
|
increased muscle fatigability
|
J:268051
|
Mecp2tm1Nlnd/Y
(involves: 129 * CD-1)
|
increased muscle fatigability
|
J:268051
|
Med1tm1.1Mpk/Med1tm1.1Mpk
(involves: 129P2/OlaHsd * C57BL/6J)
|
trabecula carnea hypoplasia
|
J:86857
|
Med1tm1Jkr/Med1tm1Jkr
(involves: 129P2/OlaHsd * C57BL/6)
|
myocardial trabeculae hypoplasia
|
J:74328
|
| myocardium hypoplasia
|
J:74328
|
| thin myocardium
|
J:62272
|
| trabecula carnea hypoplasia
|
J:74328
|
Med1tm1Mpk/Med1tm1Mpk
(involves: 129P2/OlaHsd * C57BL/6J)
|
trabecula carnea hypoplasia
|
J:86857
|
Med1tm1Rgr/Med1tm1Rgr
(either: (involves: 129P2/OlaHsd * C57BL/6J) or (involves: 129P2/OlaHsd * 129X1/SvJ))
|
abnormal myocardial trabeculae morphology
|
J:61840
|
| thin myocardium compact layer
|
J:61840
|
| trabecula carnea hypoplasia
|
J:61840
|
Med1tm2Jkr/Med1tm2Jkr
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: 129P2/OlaHsd * FVB/N)
|
decreased cardiac muscle contractility
|
J:243730
|
| dilated cardiomyopathy
|
J:243730
|
| increased cardiomyocyte apoptosis
|
J:243730
|
Med1tm2Jkr/Med1tm2Jkr
Tg(Myh6-cre)2182Mds/0
(involves: 129P2/OlaHsd * FVB/N)
|
abnormal myocardial fiber morphology
|
J:243730
|
| abnormal Z line morphology
|
J:243730
|
| decreased cardiac muscle contractility
|
J:243730
|
| decreased myocardial fiber mitochondrial DNA content
|
J:243730
|
| dilated cardiomyopathy
|
J:243730
|
| increased cardiomyocyte apoptosis
|
J:243730
|
Med24tm1Rgr/Med24tm1Rgr
(involves: 129X1/SvJ * C57BL/6 * CD-1)
|
trabecula carnea hypoplasia
|
J:77765
|
Med30m1Btlr/Med30m1Btlr
(involves: C57BL/6J)
|
abnormal I band morphology
|
J:180728
|
| abnormal myocardial fiber morphology
|
J:180728
|
| abnormal sarcomere morphology
|
J:180728
|
| abnormal Z line morphology
|
J:180728
|
| cardiomyopathy
|
J:180728
|
| decreased cardiac muscle contractility
|
J:180728
|
| myocardium necrosis
|
J:180728
|
Mef2atm1Eno/Mef2atm1Eno
(involves: 129S6/SvEvTac)
|
muscle phenotype
|
J:127416
|
Mef2ctm1.1Jjs/Mef2ctm1.1Jjs
(involves: 129S4/SvJaeSor * 129S6/SvEvTac)
|
increased sinoatrial node size
|
J:100949
|
Mef2ctm1Eno/Mef2ctm1Eno
(involves: 129S7/SvEvBrd)
|
decreased cardiac muscle contractility
|
J:40724
|
| decreased ventricle muscle contractility
|
J:40724
|
| trabecula carnea hypoplasia
|
J:40724
|
Mef2ctm1Eno/Mef2ctm2Eno
Tg(Myog-cre)1Eno/0
(involves: 129S/SvEv * 129S7/SvEvBrd)
|
abnormal skeletal muscle fiber type ratio
|
J:127416
|
Mef2dtm1Eno/Mef2dtm1Eno
Tg(Myog-cre)1Eno/0
(Not Specified)
|
abnormal skeletal muscle fiber type ratio
|
J:127416
|
Mef2dtm3Eno/Mef2dtm3Eno
Meox2tm1(cre)Sor/Meox2+
(involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6 * SJL)
|
abnormal myocardial fiber morphology
|
J:130825
|
| decreased cardiac muscle contractility
|
J:130825
|
Meg3tm1Itl/Meg3+
(B6.129S6-Meg3tm1Itl)
|
abnormal muscle development
|
J:166176
|
| abnormal skeletal muscle fiber morphology
|
J:166176
|
Megf8hlb611/Megf8hlb611
(involves: C57BL/6J * C3H/HeJ)
|
trabecula carnea hypoplasia
|
J:146957
|
Men1tm1Zqw/Men1tm1Zqw
(either: (involves: 129/Sv * 129P2/OlaHsd) or (involves: 129P2/OlaHsd * C57BL/6))
|
trabecula carnea hypoplasia
|
J:83882
|
Meox1Tg(Mx1-TAX)2627Arnh/Meox1Tg(Mx1-TAX)2627Arnh
Meox2tm1Vpa/Meox2tm1Vpa
(involves: 129P2/OlaHsd * C3H/HeJ * C57BL/6)
|
abnormal skeletal muscle morphology
|
J:84754
|
Meox1tm1Bmk/Meox1tm1Bmk
Meox2tm1Vpa/Meox2tm1Vpa
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal dermomyotome development
|
J:84754
|
| abnormal epaxial muscle morphology
|
J:84754
|
| abnormal hypaxial muscle morphology
|
J:84754
|
| abnormal myotome development
|
J:84754
|
| abnormal skeletal muscle morphology
|
J:84754
|
Meox2fla/Meox2fla
(involves: C3HeB/FeJ * C57BL/6J)
|
abnormal gastrocnemius morphology
|
J:123197
|
| abnormal skeletal muscle morphology
|
J:123197
|
| thin myocardium
|
J:123197
|
Meox2tm1(cre)Sor/Meox2+
Ptpn11tm6Bgn/Ptpn11+
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6)
|
thin myocardium
|
J:147154
|
Meox2tm1(cre)Sor/Meox2+
Ptrh2tm1Eruo/Ptrh2tm1.1Eruo
(B6.Cg-Ptrh2tm1Eruo Ptrh2tm1.1Eruo Meox2tm1(cre)Sor)
|
abnormal muscle fiber morphology
|
J:220518
|
| muscle weakness
|
J:220518
|
Meox2tm1(cre)Sor/Meox2+
Smad1tm2Rob/Smad1tm2Sor
(involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6)
|
abnormal stomach muscularis externa morphology
|
J:90769
|
Meox2tm1(cre)Sor/Meox2+
Tg(CAG-lacZ,-FUS*R521G,-EGFP)682Gyu/0
(involves: 129S4/SvJaeSor * C57BL/6)
|
muscular atrophy
|
J:216672
|
Meox2tm1(cre)Sor/Meox2+
Tg(CAG-lacZ,-FUS,-EGFP)629Gyu/0
(involves: 129S4/SvJaeSor * C57BL/6)
|
muscular atrophy
|
J:216672
|
Meox2tm1Vpa/Meox2tm1Vpa
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal muscle development
|
J:56172
|
| abnormal myogenesis
|
J:56172
|
| centrally nucleated skeletal muscle fibers
|
J:56172
|
| decreased skeletal muscle mass
|
J:56172
|
| increased variability of skeletal muscle fiber size
|
J:56172
|
Meox2tm1Vpa/Meox2tm1Vpa
(involves: 129P2/OlaHsd)
|
abnormal skeletal muscle morphology
|
J:98439
|
| muscle phenotype
|
J:98439
|
Mesp1tm2(cre)Ysa/Mesp1+
Pofut1tm1Ysa/Pofut1tm1Ysa
(involves: C57BL/6 * CBA * SJL)
|
myocardial trabeculae hypoplasia
|
J:139209
|
Mesp1tm2(cre)Ysa/Mesp1+
Tg(CAG-cat,-Notch1)1Ysa/0
(involves: C3H * C57BL/6 * CBA)
|
abnormal myocardial fiber morphology
|
J:108444
|
| abnormal myocardium layer morphology
|
J:108444
|
| abnormal sarcomere morphology
|
J:108444
|
| abnormal trabecula carnea morphology
|
J:108444
|
Mesp2tm1Ysa/Mesp2tm1Ysa
(either: (involves: C57BL/6 * CBA) or (involves: C57BL/6 * CBA * ICR))
|
abnormal dermomyotome development
|
J:42014
|
| muscle phenotype
|
J:42014
|
Mesttm1Masu/Mest+
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal myocardial trabeculae morphology
|
J:79223
|
| abnormal myocardium layer morphology
|
J:79223
|
Mettm1Cbm/Mettm1Cbm
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal diaphragm development
|
J:28570
|
| abnormal intrinsic tongue muscle morphology
|
J:28570
|
| abnormal muscle precursor cell migration
|
J:28570
|
| abnormal myogenesis
|
J:28570
|
| hypaxial muscle hypoplasia
|
J:28570
|
Mettm1Cbm/Mettm1Cbm
(involves: ICR)
|
abnormal diaphragm morphology
|
J:80685
|
| abnormal muscle precursor cell migration
|
J:80685
|
| diaphragmatic hernia
|
J:80685
|
| hypaxial muscle hypoplasia
|
J:80685
|
| thin diaphragm muscle
|
J:80685
|
Mettm1Cpo/Mettm1Cpo
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal muscle development
|
J:36244
|
| abnormal tongue muscle morphology
|
J:36244
|
| absent diaphragm
|
J:36244
|
Mettm1Cpo/Mettm1Cpo
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
absent skeletal muscle
|
J:98439
|
| muscle phenotype
|
J:98439
|
Mettm1Cpo/Mettm2Cpo
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased skeletal muscle mass
|
J:36244
|
Mettm1Kln/Mettm1Kln
(involves: 129/Sv * C57BL/6 * CD-1)
|
abnormal myoblast migration
|
J:94030
|
| abnormal myogenesis
|
J:94030
|
| decreased skeletal muscle mass
|
J:94030
|
Mettm2Cpo/Mettm2Cpo
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased skeletal muscle mass
|
J:36244
|
Mettm2Kln/Mettm2Kln
(involves: 129/Sv * C57BL/6 * CD-1)
|
abnormal diaphragm morphology
|
J:94030
|
| abnormal myoblast migration
|
J:94030
|
| abnormal myogenesis
|
J:94030
|
| decreased skeletal muscle mass
|
J:94030
|
Mettl21ctm1.1Krug/Mettl21ctm1.1Krug
(involves: 129 * C57BL/6)
|
abnormal muscle physiology
|
J:270838
|
| muscle weakness
|
J:270838
|
Mfn2tm1.1Mzhe/Mfn2tm1.1Mzhe
Myl2tm1(cre)Krc/Myl2+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6J)
|
abnormal myocardial fiber morphology
|
J:188865
|
| decreased ventricle muscle contractility
|
J:188865
|
Mfsd8tm1a(EUCOMM)Hmgu/Mfsd8tm1a(EUCOMM)Hmgu
(involves: C57BL/6N)
|
abnormal myocardial fiber morphology
|
J:211608
|
Mgat2tm1.1Jxm/Mgat2tm1.1Jxm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal muscle development
|
J:80661
|
mgb/mgb
(involves: FVB/N)
|
abnormal urinary bladder detrusor smooth muscle morphology
|
J:283803
|
Mgptm1Kry/Mgptm1Kry
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal aorta smooth muscle morphology
|
J:38867
|
Mgrn1md-2J/Mgrn1md-2J
(involves: 129S1/SvImJ * C3H/HeJ)
|
thin myocardium
|
J:116645
|
Mgrn1md-nc/Mgrn1md-nc
(involves: 101/H * C3H/HeH)
|
muscle weakness
|
J:81466
|
| thin myocardium
|
J:116645
|
Mib1em1Jlp/Mib1tm2Kong
Tg(Tnnt2-cre)5Blh/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
abnormal trabecula carnea morphology
|
J:338889
|
| decreased cardiac muscle contractility
|
J:338889
|
| thin left ventricle myocardium compact layer
|
J:338889
|
Micu1em#Fink/Micu1em#Fink
(C57BL/6N-Micu1em#Fink)
|
abnormal muscle physiology
|
J:238984
|
| decreased skeletal muscle fiber number
|
J:238984
|
Micu1em#Fink/Micu1em#Fink
Smdt1em1Fink/Smdt1+
(involves: C57BL/6J * C57BL/6N * CBA)
|
muscle phenotype
|
J:238984
|
Micu2Gt(OST409343)Lex/Micu2Gt(OST409343)Lex
(B6.129S5-Micu2Gt(OST409343)Lex)
|
abnormal myocardial fiber mitochondrial morphology
|
J:249367
|
| decreased cardiac muscle contractility
|
J:249367
|
| decreased cardiac muscle relaxation
|
J:249367
|
Mid1tm1Mero/Y
(B6.Cg-Mid1tm1Mero)
|
muscle phenotype
|
J:157828
|
Mir1a-1tm1Dsr/Mir1a-1tm1Dsr
Mir1a-2tm1Dsr/Mir1a-2tm1Dsr
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
abnormal sarcomere morphology
|
J:207845
|
| decreased cardiac muscle contractility
|
J:207845
|
Mir1a-2tm1Dsr/Mir1a-2tm1Dsr
(involves: 129/Sv * C57BL/6)
|
abnormal myocardium layer morphology
|
J:211548
|
Mir21atm1.1Zqy/Mir21atm1.1Zqy
Tg(Tek-cre)12Flv/0
(involves: 129S/SvEv * C3H * C57BL/6 * SJL)
|
decreased vasodilation
|
J:199907
|
Mir22tm1.1Arod/Mir22tm1.1Arod
(involves: 129S1/SvImJ * 129S7/SvEvBrd)
|
decreased cardiac muscle contractility
|
J:183005
|
Mir22tm1Boet/Mir22tm1Boet
(B6.129S2-Mir22tm1Boet)
|
muscle phenotype
|
J:266382
|
Mir92bem22Gpt/Mir92bem22Gpt
(involves: C57BL/6JGpt)
|
abnormal skeletal muscle morphology
|
J:346344
|
| increased skeletal muscle glycogen level
|
J:346344
|
| increased skeletal muscle weight
|
J:346344
|
| muscle phenotype
|
J:346344
|
Mir133a-1tm1.1Eno/Mir133a-1tm1.1Eno
Mir133a-2tm1.1Eno/Mir133a-2tm1.1Eno
(involves: 129S/SvEv * C57BL/6 * SJL)
|
abnormal myocardial fiber morphology
|
J:142220
|
| decreased cardiac muscle contractility
|
J:142220
|
| decreased ventricle muscle contractility
|
J:142220
|
| dilated cardiomyopathy
|
J:142220
|
| increased cardiomyocyte apoptosis
|
J:142220
|
Mir133a-1tm1Eno/Mir133a-1tm1Eno
Mir133a-2tm1Eno/Mir133a-2tm1Eno
(involves: 129S/SvEv * C57BL/6)
|
abnormal myocardial fiber morphology
|
J:142220
|
| decreased cardiac muscle contractility
|
J:142220
|
| decreased ventricle muscle contractility
|
J:142220
|
| dilated cardiomyopathy
|
J:142220
|
| increased cardiomyocyte apoptosis
|
J:142220
|
Mir145atm1Eno/Mir145atm1Eno
(involves: 129S/SvEv * C57BL/6)
|
abnormal vascular smooth muscle morphology
|
J:152458
|
| vascular smooth muscle hypotrophy
|
J:152458
|
Mir206tm1Eno/Mir206tm1Eno
Tg(SOD1*G93A)dl1Gur/0
(involves: 129S/SvEv * C57BL/6 * SJL)
|
skeletal muscle atrophy
|
J:155806
|
Mir208atm1.1Eno/Mir208atm1.1Eno
(involves: C57BL/6)
|
abnormal myocardium layer morphology
|
J:120908
|
| abnormal sarcomere morphology
|
J:120908
|
| decreased cardiac muscle contractility
|
J:120908
|
Mir208btm1.1Eno/Mir208btm1.1Eno
Mir499tm1.1Eno/Mir499tm1.1Eno
(involves: C57BL/6)
|
abnormal skeletal muscle fiber type ratio
|
J:155756
|
Mir214tm1.1Eno/Mir214tm1.1Eno
(involves: C57BL/6)
|
increased cardiomyocyte apoptosis
|
J:184550
|
| increased myocardial fiber size
|
J:184550
|
Mir503hgem1Jina/Mir503hgem1Jina
(C57BL/6J-Mir503hgem1Jina)
|
increased myocardial fiber size
|
J:336590
|
Mirc6tm1.1Mzhu/Mirc6+
(B6.129(Cg)-Mirc6tm1.1Mzhu)
|
abnormal muscle fiber morphology
|
J:227271
|
| skeletal muscle hypertrophy
|
J:227271
|
Mirc32tm1.2Eno/Mirc32tm1.2Eno
(involves: 129S/SvEv * C57BL/6)
|
abnormal vascular smooth muscle morphology
|
J:152458
|
| vascular smooth muscle hypotrophy
|
J:152458
|
Mirc32tm1Gcon/Mirc32tm1Gcon
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal aorta smooth muscle morphology
|
J:159593
|
| abnormal vascular smooth muscle physiology
|
J:159593
|
Mirc32tm1Thbr/Mirc32tm1Thbr
(involves: 129/Sv * C57BL/6)
|
abnormal vascular smooth muscle morphology
|
J:152702
|
| decreased vasoconstriction
|
J:152702
|
| vascular smooth muscle hypotrophy
|
J:152702
|
Mkxtm1.1Asah/Mkxtm1.1Asah
(involves: 129S4/SvJaeSor * C57BL/6 * CBA)
|
abnormal tendon morphology
|
J:161299
|
Mkxtm1.2Jian/Mkxtm1.2Jian
(involves: 129S1/Sv * 129S4/SvJae * C57BL/6 * FVB/N)
|
abnormal tendon morphology
|
J:175747
|
| abnormal tendon sheath morphology
|
J:175747
|
Mkxtm1Asah/Mkxtm1Asah
(involves: C57BL/6 * CBA)
|
abnormal tendon morphology
|
J:161299
|
Mkxtm1Miu/Mkxtm1Miu
(involves: 129 * C57BL/6)
|
abnormal tendon morphology
|
J:167977
|
Mliptm1.1(cre)Dzw/Mliptm1.1(cre)Dzw
(involves: C57BL/6)
|
decreased cardiac muscle contractility
|
J:227485
|
| increased myocardial fiber size
|
J:227485
|
Mliptm1.1(cre)Dzw/Mliptm1.1(cre)Dzw
Tg(Myh6-Ppp3ca)37Eno/0
(involves: C57BL/6 * FVB)
|
decreased cardiac muscle contractility
|
J:227485
|
Mlxtm1.2Rne/Mlxtm1.2Rne
(Not Specified)
|
impaired skeletal muscle regeneration
|
J:227117
|
Mlxiptm1.2Lchan/Mlxiptm1.2Lchan
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal muscle physiology
|
J:217834
|
Mmp2tm1Ito/Mmp2tm1Ito
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal vascular smooth muscle physiology
|
J:101783
|
Mmp9tm1Tvu/Mmp9tm1Tvu
(involves: 129S6/SvEvTac)
|
abnormal vascular smooth muscle physiology
|
J:109006
|
| decreased cardiac muscle contractility
|
J:148442
|
Mmp9tm1Tvu/Mmp9tm1Tvu
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal vascular smooth muscle physiology
|
J:101783
|
Mmp9tm1Tvu/Mmp9tm1Tvu
(FVB.129S6-Mmp9tm1Tvu)
|
increased ventricle muscle contractility
|
J:104786
|
Mmp9tm1Tvu/Mmp9tm1Tvu
(FVB.Cg-Mmp9tm1Tvu/J)
|
increased tibialis anterior weight
|
J:147593
|
Mmp14tm1Hbh/Mmp14tm1Hbh
(involves: 129P2/OlaHsd * Black Swiss)
|
skeletal muscle fibrosis
|
J:57969
|
Mmp14tm1Noda/Mmp14tm1Noda
Mmp2tm1Ito/Mmp2tm1Ito
(Not Specified)
|
abnormal skeletal muscle morphology
|
J:91198
|
| delayed muscle development
|
J:91198
|
| thin diaphragm muscle
|
J:91198
|
Mmp14tm1Ski/Mmp14tm1Ski
(B6.Cg-Mmp14tm1Ski)
|
abnormal skeletal muscle fiber morphology
|
J:113113,
J:165029
|
| centrally nucleated skeletal muscle fibers
|
J:113113
|
| increased skeletal muscle fiber size
|
J:113113
|
| skeletal muscle interstitial fibrosis
|
J:113113
|
Mnx1tm1Tmj/Mnx1tm1Tmj
(involves: 129S1/Sv)
|
thin diaphragm muscle
|
J:57340
|
Mnx1tm2Tmj/Mnx1tm2Tmj
(involves: 129S1/Sv)
|
thin diaphragm muscle
|
J:57340
|
Mnx1tm3Tmj/Mnx1tm3Tmj
(involves: 129S1/Sv)
|
thin diaphragm muscle
|
J:57340
|
Mnx1tm4(cre)Tmj/Mnx1+
(involves: 129S1/Sv)
|
decreased skeletal muscle fiber size
|
J:193844
|
Mnx1tm4(cre)Tmj/Mnx1+
Tardbptm1.1Ckjs/Tardbptm1.2Cjks
(involves: 129S1/Sv * C57BL/6J)
|
muscle weakness
|
J:190254
|
| muscular atrophy
|
J:190254
|
Mocs2tm1(KOMP)Vlcg/Mocs2tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
muscle weakness
|
J:242197
|
Mogtm1Dpd/Mogtm1Dpd
Tg(Tcra2D2,Tcrb2D2)1Kuch/0
(involves: 129S2/SvPas * C57BL/6)
|
muscle hypertonia
|
J:151335
|
Morc2aem1(IMPC)Wtsi/Morc2aem1(IMPC)Wtsi
(C57BL/6N-Morc2aem1(IMPC)Wtsi/WtsiOulu)
|
abnormal diaphragm morphology
|
J:239583
|
| abnormal eye muscle morphology
|
J:239583
|
| abnormal infrahyoid muscle connection
|
J:239583
|
| abnormal masticatory muscle morphology
|
J:239583
|
| abnormal pectinate muscle morphology
|
J:239583
|
| absent digastric muscle
|
J:239583
|
| absent eye muscles
|
J:239583
|
| diaphragmatic hernia
|
J:239583
|
Morc2aem1Snupy/Morc2a+
(involves: C57BL/6)
|
muscle phenotype
|
J:341847
|
| skeletal muscle atrophy
|
J:341847
|
| skeletal muscle fiber atrophy
|
J:341847
|
Morf4l1tm1Kto/Morf4l1tm1Kto
(involves: 129S7/SvEvBrd)
|
myocardial fiber disarray
|
J:97640
|
Mospd3Gt(PT1-ATG)124Wrst/Mospd3Gt(PT1-ATG)124Wrst
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal ventricle myocardium morphology
|
J:93956
|
| papillary muscle hypoplasia
|
J:93956
|
| trabecula carnea hypoplasia
|
J:93956
|
Mpotm1Lus/Mpotm1Lus
(B6.129X1-Mpotm1Lus)
|
abnormal muscle fiber morphology
|
J:112488
|
Mpp3tm1b(EUCOMM)Wtsi/Mpp3tm1b(EUCOMM)Wtsi
(C57BL/6N-Mpp3tm1b(EUCOMM)Wtsi/BayMmucd)
|
increased cardiac muscle contractility
|
J:211773
|
Mpv17/Mpv17
(CFW-Mpv17/J)
|
abnormal hypodermis muscle layer morphology
|
J:143355
|
| decreased muscle fiber mitochondrial DNA content
|
J:143355
|
Mpzl3rc/Mpzl3rc
(C57BL/6J-Mpzl3rc/J)
|
abnormal myocardial fiber morphology
|
J:93038
|
| myocardial fiber degeneration
|
J:93038
|
Mpzl3tm1Tacz/Mpzl3tm1Tacz
(B6.129P2-Mpzl3tm1Tacz)
|
abnormal muscle contractility
|
J:199257
|
| abnormal muscle morphology
|
J:199257
|
| abnormal muscle physiology
|
J:199257
|
Mregdsu/Mregdsu
Myo5ad-l20J/Myo5ad-l20J
(involves: C57BL/6J)
|
opisthotonus
|
J:20299
|
Mrgprdtm5Mjz/Mrgprdtm5Mjz
(B6.129S1-Mrgprdtm5Mjz/Mmnc)
|
abnormal myocardial fiber morphology
|
J:269603
|
| decreased cardiac muscle contractility
|
J:269603
|
| dilated cardiomyopathy
|
J:269603
|
| increased vasodilation
|
J:269603
|
Mrlnem1Eno/Mrlnem1Eno
(involves: C3H * C57BL/6)
|
abnormal muscle physiology
|
J:217579
|
Mrlntm1.1Nju/Mrlntm1.1Nju
(involves: C57BL/6)
|
decreased skeletal muscle fiber number
|
J:243999
|
| impaired skeletal muscle regeneration
|
J:243999
|
Mrps12em2.2Afi/Mrps12em2.2Afi
(B6N(Cg)-Mrps12em2.2Afi)
|
decreased cardiac muscle contractility
|
J:284101
|
| dilated cardiomyopathy
|
J:284101
|
Mrps34m1Anu/Mrps34m1Anu
(C57BL/6J-Mrps34m1Anu)
|
centrally nucleated skeletal muscle fibers
|
J:222643
|
| increased cardiac muscle contractility
|
J:222643
|
Mrtfatm1Swm/Mrtfatm1Swm
(involves: 129/Sv * C57BL/6)
|
abnormal muscle fiber mitochondrial morphology
|
J:111560
|
| myocardium necrosis
|
J:111560
|
Mrtfbem1Dsr/Mrtfb+
Myh7em1Dsr/Myh7+
(involves: C57BL/6J)
|
abnormal trabecula carnea morphology
|
J:277399
|
Mrtfbem1Dsr/Mrtfb+
Myh7em1Dsr/Myh7+
Nkx2-5em1Dsr/Nkx2-5+
(involves: C57BL/6J)
|
abnormal trabecula carnea morphology
|
J:277399
|
MrtfbGt(RRJ478)Byg/MrtfbGt(RRJ478)Byg
(involves: 129P2/OlaHsd * C57BL/6J)
|
thin myocardium
|
J:117226
|
Mrtfbtm1Eno/Mrtfbtm1Eno
(involves: 129S/SvEv * C57BL/6)
|
thin myocardium
|
J:102475
|
| vascular smooth muscle hypoplasia
|
J:102475
|
Msctm1Eno/Msc+
Tcf21tm2Eno/Tcf21tm2Eno
(involves: 129 * Black Swiss)
|
muscle phenotype
|
J:111337
|
Msctm1Eno/Msctm1Eno
Tcf21tm2Eno/Tcf21tm2Eno
(involves: 129 * Black Swiss)
|
abnormal masticatory muscle morphology
|
J:111337
|
| abnormal myogenesis
|
J:111337
|
| abnormal pterygoid muscle morphology
|
J:111337
|
| absent masseter muscle
|
J:111337
|
| absent pterygoid muscle
|
J:111337
|
| absent temporalis muscle
|
J:111337
|
| diaphragmatic hernia
|
J:111337
|
Msgn1tm1Wb/Msgn1tm1Wb
(involves: 129S1/Sv * C57BL/6)
|
abnormal myotome development
|
J:66514
|
Mskt2C57BL/6J/?
(involves: C57BL/6J * DBA/2J)
|
increased gastrocnemius weight
|
J:111262
|
Mskt4C57BL/6J/?
(involves: C57BL/6J * DBA/2J)
|
abnormal tibialis anterior morphology
|
J:111262
|
| increased gastrocnemius weight
|
J:111262
|
Mskt5DBA/2J/?
(involves: C57BL/6J * DBA/2J)
|
abnormal tibialis anterior morphology
|
J:111262
|
Mss51tm1(KOMP)Vlcg/Mss51tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
abnormal muscle morphology
|
J:280597
|
| increased skeletal muscle glycogen level
|
J:280597
|
MstnCmpt/Mstn+
(either: HCI or HCR)
|
abnormal muscle morphology
|
J:43299
|
| increased skeletal muscle mass
|
J:43299
|
MstnCmpt/MstnCmpt
(BEH)
|
impaired skeletal muscle contractility
|
J:119757
|
| increased skeletal muscle mass
|
J:119757
|
Mstnlean/Mstnlean
(C57BL/6J-Mstnlean)
|
increased gastrocnemius weight
|
J:146513
|
| increased quadriceps weight
|
J:146513
|
Mstntm1.1Mgs/Mstntm1.1Mgs
(involves: 129S1/Sv * 129X1/SvJ * C57BL * FVB/N)
|
abnormal muscle physiology
|
J:184622
|
| abnormal skeletal muscle morphology
|
J:184622
|
| increased skeletal muscle weight
|
J:184622
|
| skeletal muscle hypertrophy
|
J:184622
|
Mstntm1.1Swel/Mstntm1.1Swel
(involves: 129S7/SvEvBrd-Hprt1 * C57BL/6J * FVB/N)
|
abnormal muscle physiology
|
J:106054
|
| increased muscle weight
|
J:106054
|
Mstntm1Mgs/Mstntm1Mgs
Tg(Ckmm-cre)5Khn/?
(involves: 129S1/Sv * 129X1/SvJ * CD-1 * FVB)
|
abnormal muscle morphology
|
J:83122
|
| increased muscle weight
|
J:83122
|
| increased skeletal muscle fiber size
|
J:83122
|
| skeletal muscle hypertrophy
|
J:83122
|
Mstntm1Sjl/Mstntm1Sjl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased muscle weight
|
J:40054
|
| increased skeletal muscle fiber number
|
J:40054
|
| increased skeletal muscle fiber size
|
J:40054
|
| increased skeletal muscle mass
|
J:40054
|
| increased skeletal muscle size
|
J:75178
|
Mstntm1Sjl/Mstntm1Sjl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1)
|
increased quadriceps weight
|
J:105955
|
Mstntm1Sjl/Mstntm1Sjl
(B6N.129-Mstntm1Sjl)
|
increased skeletal muscle fiber diameter
|
J:132807
|
| increased skeletal muscle fiber number
|
J:132807
|
| increased skeletal muscle mass
|
J:132807
|
Mstntm1Sjl/Mstntm1Sjl
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal skeletal muscle fiber morphology
|
J:158173
|
| increased skeletal muscle fiber number
|
J:158173
|
Mstntm1Swel/Mstntm1Swel
Tg(CAG-cre/Esr1*)5Amc/?
(involves: 129S7/SvEvBrd-Hprt1 * C57BL/6 * CBA)
|
increased skeletal muscle fiber diameter
|
J:121233
|
| increased skeletal muscle mass
|
J:121233
|
Mstntm2Sjl/Mstn+
(B6.129-Mstntm2Sjl)
|
increased skeletal muscle mass
|
J:132807
|
Mstntm2Sjl/Mstntm2Sjl
(B6.129-Mstntm2Sjl)
|
increased skeletal muscle fiber diameter
|
J:132807
|
| increased skeletal muscle fiber number
|
J:132807
|
| increased skeletal muscle mass
|
J:132807
|
Mstntm3.1Sjl/Mstntm3.1Sjl
(B6N.129S6(FVB)-Mstntm3.1Sjl/Sjl)
|
muscle phenotype
|
J:240862
|
Mstntm3.1Sjl/Mstntm3.1Sjl
Tg(CDX2-cre)101Erf/0
(B6.Cg-Mstntm3.1Sjl Tg(CDX2-cre)101Erf/Sjl)
|
abnormal skeletal muscle morphology
|
J:240862
|
| increased skeletal muscle weight
|
J:240862
|
| skeletal muscle hyperplasia
|
J:240862
|
| skeletal muscle hypertrophy
|
J:240862
|
Mswtq1NMRI8/Fbn/?
(involves: DBA/2OlaHsd * NMRI8/Fbn)
|
decreased muscle weight
|
J:122125
|
Msx1tm1Bero/Msx1tm1Bero
Msx2tm1Bero/Msx2tm1Yvla
Taglntm2(cre)Yec/Tagln+
(involves: 129P2/OlaHsd * 129S2/SvPas * 129S6/SvEvTac * NMRI)
|
vascular smooth muscle hypoplasia
|
J:173525
|
Msx1tm1Bero/Msx1tm2.1(cre/ERT2)Bero
Msx2tm1Yvla/Msx2tm1Yvla
(involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6 * NMRI)
|
vascular smooth muscle hypoplasia
|
J:173525
|
Msx1tm1Rem/Msx1tm1Rem
Msx2tm1Yvla/Msx2tm1Yvla
Taglntm2(cre)Yec/Tagln+
(involves: 129S2/SvPas * 129S6/SvEvTac * NMRI)
|
vascular smooth muscle hypoplasia
|
J:173525
|
mt-Co1m1Jiha
(involves: C57BL/6J * M. m. domesticus)
|
abnormal myocardial fiber morphology
|
J:132659
|
| cardiomyopathy
|
J:132659
|
| myocardial fiber degeneration
|
J:132659
|
| myopathy
|
J:132659
|
mt-Nd6m1Jbst
mt-Tam1Jbst
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6NCrl)
|
cardiomyopathy
|
J:238994
|
mt-Rnr2m1Dwa
(C3H/An-mt-Rnr2m1Dwa)
|
abnormal myocardial fiber morphology
|
J:133576
|
| abnormal skeletal muscle fiber morphology
|
J:133576
|
| dilated cardiomyopathy
|
J:133576
|
| myopathy
|
J:133576
|
mt-Tkm1
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj)
|
muscle weakness
|
J:206827
|
mt-Tl1m1Jiha
(involves: C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal muscle fiber morphology
|
J:344247
|
Mtbcq2NMRI8/Fbn/?
(involves: DBA/2OlaHsd * NMRI8/Fbn)
|
increased muscle weight
|
J:122125
|
Mtbcq4NMRI8/Fbn/?
(involves: DBA/2OlaHsd * NMRI8/Fbn)
|
increased muscle weight
|
J:122125
|
Mtbcq7NMRI8/Fbn/?
(involves: DBA/2OlaHsd * NMRI8/Fbn)
|
decreased muscle weight
|
J:122125
|
Mterf2Gt(OST453159)Lex/Mterf2Gt(OST453159)Lex
(B6.129S5-Mterf2Gt(OST453159)Lex)
|
increased skeletal muscle fiber mitochondrial DNA content
|
J:149828
|
| muscle weakness
|
J:149828
|
Mterf3tm1.1Lrsn/Mterf3tm1.1Lrsn
Tg(Ckmm-cre)5Khn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB * SJL)
|
abnormal myocardial fiber morphology
|
J:145125
|
| cardiomyopathy
|
J:145125
|
Mterf4tm1.1Lrsn/Mterf4tm1.1Lrsn
Tg(Ckmm-cre)5Khn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB)
|
abnormal myocardial fiber morphology
|
J:175816
|
| cardiomyopathy
|
J:175816
|
Mtfp1tm1.2Wait/Mtfp1tm1.2Wait
Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6N * FVB/N)
|
decreased ventricle muscle contractility
|
J:330965
|
| dilated cardiomyopathy
|
J:330965
|
| increased cardiomyocyte apoptosis
|
J:330965
|
Mtg1em1Ywxu/Mtg1em1Ywxu
(Not Specified)
|
increased cardiac muscle contractility
|
J:271147
|
| increased myocardial fiber number
|
J:271147
|
Mtgq4NMRI8/Fbn/?
(involves: DBA/2OlaHsd * NMRI8/Fbn)
|
increased muscle weight
|
J:122125
|
Mtif3tm1c(EUCOMM)Wtsi/Mtif3tm1c(EUCOMM)Wtsi
Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6N)
|
cardiomyopathy
|
J:287609
|
| centrally nucleated skeletal muscle fibers
|
J:287609
|
| decreased cardiac muscle contractility
|
J:287609
|
| decreased skeletal muscle fiber size
|
J:287609
|
Mtlnem1Rlbd/Mtlnem1Rlbd
(involves: C57BL/6J * SJL/J)
|
abnormal cardiac muscle tissue morphology
|
J:263464
|
Mtm1Gt(OST290577)Lex/Y
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal Z line morphology
|
J:192845
|
| centrally nucleated skeletal muscle fibers
|
J:192845
|
| decreased muscle weight
|
J:192845
|
| decreased skeletal muscle fiber size
|
J:192845
|
| myopathy
|
J:192845
|
Mtm1tm1.1Jman/Y
(involves: 129T1/Sv * C57BL/6)
|
abnormal muscle physiology
|
J:81791
|
| abnormal skeletal muscle fiber morphology
|
J:81791
|
| decreased gastrocnemius weight
|
J:179741
|
| muscular atrophy
|
J:81791
|
| myopathy
|
J:81791
|
| progressive muscle weakness
|
J:81791,
J:179741
|
| skeletal muscle atrophy
|
J:179741
|
Mtm1tm1.2Jman/Y
Tg(ACTA1-cre)79Jme/?
(involves: 129T1/Sv * C57BL/6 * SJL)
|
centrally nucleated skeletal muscle fibers
|
J:81791
|
| myopathy
|
J:81791
|
| skeletal muscle fiber atrophy
|
J:81791
|
Mtm1tm1Itl/Y
(B6.Cg-Mtm1tm1Itl)
|
abnormal gastrocnemius morphology
|
J:179741
|
| centrally nucleated skeletal muscle fibers
|
J:179741
|
| decreased gastrocnemius weight
|
J:179741
|
| decreased quadriceps weight
|
J:179741
|
| decreased skeletal muscle fiber size
|
J:179741
|
| decreased skeletal muscle mass
|
J:179741
|
| decreased tibialis anterior weight
|
J:179741
|
| increased variability of skeletal muscle fiber size
|
J:179741
|
| progressive muscle weakness
|
J:179741
|
| skeletal muscle atrophy
|
J:179741
|
Mtmr14tm1Ckq/Mtmr14tm1Ckq
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal cardiac muscle contractility
|
J:155068
|
| abnormal muscle contractility
|
J:155068
|
| abnormal muscle physiology
|
J:155068
|
| abnormal muscle relaxation
|
J:155068
|
| dilated sarcoplasmic reticulum
|
J:155068
|
| impaired skeletal muscle contractility
|
J:155068
|
| impaired smooth muscle contractility
|
J:267733
|
| increased muscle fatigability
|
J:155068
|
| muscular atrophy
|
J:155068
|
Mto1Gt(G019A03)Wrst/Mto1Gt(G019A03)Wrst
(involves: 129S2/SvPas * C57BL/6J)
|
cardiac muscle necrosis
|
J:223246
|
| cardiomyopathy
|
J:223246
|
| decreased myocardial fiber mitochondrial DNA content
|
J:223246
|
| dilated sarcoplasmic reticulum
|
J:223246
|
| myocardial fiber degeneration
|
J:223246
|
Mtortm1.1Clyn/Mtor+
(involves: BALB/c * C57BL/6J)
|
abnormal muscle physiology
|
J:162945
|
| decreased skeletal muscle weight
|
J:162945
|
Mtortm1.1Gcon/Mtortm1.1Gcon
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
abnormal myocardial fiber morphology
|
J:163763
|
| abnormal sarcomere morphology
|
J:163763
|
| decreased cardiac muscle contractility
|
J:163763
|
| decreased myocardial fiber size
|
J:163763
|
| decreased ventricle muscle contractility
|
J:163763
|
| dilated cardiomyopathy
|
J:163763
|
| increased cardiomyocyte apoptosis
|
J:163763
|
Mtortm1.2Koz/Mtortm1.2Koz
Tg(ACTA1-cre)79Jme/?
(involves: 129S4/SvJae * C57BL/6J * SJL)
|
abnormal diaphragm morphology
|
J:162918
|
| abnormal gastrocnemius morphology
|
J:162918
|
| abnormal limb muscle morphology
|
J:162918
|
| abnormal muscle contractility
|
J:162918
|
| abnormal muscle morphology
|
J:162918
|
| abnormal muscle physiology
|
J:162918
|
| abnormal muscle relaxation
|
J:162918
|
| abnormal skeletal muscle fiber morphology
|
J:162918
|
| abnormal soleus morphology
|
J:162918
|
| abnormal tibialis anterior morphology
|
J:162918
|
| centrally nucleated skeletal muscle fibers
|
J:162918
|
| increased muscle fatigability
|
J:162918
|
| increased skeletal muscle glycogen level
|
J:162918
|
| skeletal muscle degeneration
|
J:162918
|
| skeletal muscle fiber degeneration
|
J:162918
|
Mus81tm1Esse/Mus81tm1Esse
(involves: 129P2/OlaHsd * C57BL/6)
|
heart left ventricle hypertrophy
|
J:133703
|
Musktm1.1Vwi/Musktm2Vwi
(Not Specified)
|
abnormal muscle electrophysiology
|
J:141024
|
| decreased skeletal muscle mass
|
J:141024
|
| muscle weakness
|
J:141024
|
| thin diaphragm muscle
|
J:141024
|
Musktm1.2Ics/Musktm1.2Ics
(involves: BALB/cN * C57BL/6NTac)
|
increased muscle fatigability
|
J:221340
|
| progressive muscle weakness
|
J:221340
|
Musktm1Vwi/Musktm1.1Vwi
Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6J * FVB)
|
muscle weakness
|
J:106867
|
Musktm1Vwi/Musktm1Vwi
Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6J * FVB)
|
muscle weakness
|
J:106867
|
Musktm2Vwi/Musktm2Vwi
(Not Specified)
|
muscle phenotype
|
J:141024
|
Mustn1tm1d(EUCOMM)Wtsi/Mustn1tm1d(EUCOMM)Wtsi
(involves: C57BL/6N * SJL)
|
skeletal muscle fibrosis
|
J:346460
|
Musz2MRL/MpJ/Musz2MRL/MpJ
Musz3SJL/J/Musz3SJL/J
(involves: MRL/MpJ * SJL/J)
|
abnormal muscle morphology
|
J:81605
|
Musz2SJL/J/Musz2SJL/J
Musz3SJL/J/Musz3SJL/J
(involves: MRL/MpJ * SJL/J)
|
abnormal muscle morphology
|
J:81605
|
Mwq1DBA/2J/Mwq1DU6i
(involves: DBA/2J * DU6i)
|
abnormal muscle morphology
|
J:66233
|
Mwq1DU6i/Mwq1DU6i
(involves: DBA/2J * DU6i)
|
abnormal muscle morphology
|
J:66233
|
Mwq2DBA/2J/Mwq2DU6i
(involves: DBA/2J * DU6i)
|
abnormal muscle morphology
|
J:66233
|
Mwq2DU6i/Mwq2DU6i
(involves: DBA/2J * DU6i)
|
abnormal muscle morphology
|
J:66233
|
Mwq3DBA/2J/Mwq3DU6i
(involves: DBA/2J * DU6i)
|
abnormal muscle morphology
|
J:66233
|
Mwq3DU6i/Mwq3DU6i
(involves: DBA/2J * DU6i)
|
abnormal muscle morphology
|
J:66233
|
Mwq4DBA/2J/Mwq4DU6i
(involves: DBA/2J * DU6i)
|
abnormal muscle morphology
|
J:66233
|
Mwq4DU6i/Mwq4DU6i
(involves: DBA/2J * DU6i)
|
abnormal muscle morphology
|
J:66233
|
Mwq5DBA/2J/Mwq5DU6i
(involves: DBA/2J * DU6i)
|
abnormal muscle morphology
|
J:66233
|
Mwq5DU6i/Mwq5DU6i
(involves: DBA/2J * DU6i)
|
abnormal muscle morphology
|
J:66233
|
Mybpc1em1Lbmc/Mybpc1+
(C57BL/6NTac-Mybpc1em1Lbmc/Lmcb)
|
abnormal sarcomere morphology
|
J:322115
|
| decreased skeletal muscle mass
|
J:322115
|
Mybpc3DBA/2J/Mybpc3DBA/2J
Myh7DBA/2J/Myh7DBA/2J
(DBA/2J)
|
increased myocardial fiber size
|
J:225492
|
Mybpc3tm1.1Jse/Mybpc3tm1.1Jse
(Not Specified)
|
abnormal M line morphology
|
J:58295
|
| abnormal myocardial fiber morphology
|
J:58295
|
| abnormal ventricle papillary muscle morphology
|
J:58295
|
| decreased ventricle muscle contractility
|
J:58295
|
| dilated cardiomyopathy
|
J:58295
|
| disorganized myocardium
|
J:58295
|
| heart left ventricle hypertrophy
|
J:58295
|
Mybpc3tm1Jse/Mybpc3tm1Jse
(Not Specified)
|
abnormal M line morphology
|
J:58295
|
| abnormal myocardial fiber morphology
|
J:58295
|
| abnormal ventricle papillary muscle morphology
|
J:58295
|
| decreased ventricle muscle contractility
|
J:58295
|
| dilated cardiomyopathy
|
J:58295
|
| heart left ventricle hypertrophy
|
J:58295
|
| myocardial fiber disarray
|
J:58295
|
Mybpc3tm1Jse/Mybpc3tm1Jse
(involves: 129S/SvEv)
|
abnormal cardiac muscle contractility
|
J:98868
|
| abnormal cardiac muscle relaxation
|
J:98868
|
| dilated cardiomyopathy
|
J:98868
|
| increased cardiac muscle contractility
|
J:98868
|
Mybpc3tm1Lcrr/Mybpc3+
(involves: 129S4/SvJae * Black Swiss)
|
heart left ventricle hypertrophy
|
J:101903
|
Mybpc3tm1Lcrr/Mybpc3tm1Lcrr
(involves: 129S4/SvJae * Black Swiss)
|
abnormal cardiac muscle contractility
|
J:105732
|
| decreased cardiac muscle contractility
|
J:101903
|
| heart left ventricle hypertrophy
|
J:101903
|
| impaired muscle relaxation
|
J:101903
|
Mybpc3tm1Rmos/Mybpc3tm1Rmos
(either: (involves: 129) or (involves: 129 * C57BL/6))
|
cardiomyopathy
|
J:95725
|
| decreased cardiac muscle contractility
|
J:95725
|
| decreased ventricle muscle contractility
|
J:95725
|
| myocardial fiber disarray
|
J:95725
|
Mybpc3tm1Rmos/Mybpc3tm1Rmos
(involves: 129)
|
decreased ventricle muscle contractility
|
J:202199
|
Mybpc3tm2.1Lcrr/Mybpc3+
(involves: 129S2/SvPasCrl * Black Swiss * C57BL/6 * CD-1 * DBA/2)
|
increased myocardial fiber size
|
J:164934
|
Mybpc3tm2.1Lcrr/Mybpc3+
(involves: 129S2/SvPasCrl * Black Swiss)
|
abnormal cardiac muscle relaxation
|
J:185726
|
Mybpc3tm2.1Lcrr/Mybpc3tm2.1Lcrr
(involves: 129S2/SvPasCrl * Black Swiss * C57BL/6 * CD-1 * DBA/2)
|
decreased cardiac muscle contractility
|
J:164934
|
| heart left ventricle hypertrophy
|
J:164934
|
| increased myocardial fiber size
|
J:164934
|
Mybpc3tm2.1Lcrr/Mybpc3tm2.1Lcrr
(involves: 129S2/SvPasCrl * Black Swiss)
|
abnormal cardiac muscle relaxation
|
J:185726
|
| decreased cardiac muscle contractility
|
J:185726
|
| heart left ventricle hypertrophy
|
J:185726
|
Mybpc3tm2.1Rmos/Mybpc3tm2.1Rmos
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: 129 * C57BL/6 * FVB/N)
|
decreased ventricle muscle contractility
|
J:202199
|
| increased myocardial fiber size
|
J:202199
|
| myocardial fiber disarray
|
J:202199
|
Mybphltm1a(KOMP)Wtsi/Mybphltm1a(KOMP)Wtsi
(C57BL/6N-Mybphltm1a(KOMP)Wtsi/Wtsi)
|
abnormal eye muscle morphology
|
J:239583
|
Mybphltm1b(KOMP)Wtsi/Mybphltm1b(KOMP)Wtsi
(C57BL/6N-Mybphltm1b(KOMP)Wtsi/Wtsi)
|
abnormal infrahyoid muscle connection
|
J:239583
|
Myctm1.1(Nmyc1)Fwa/Myctm1.1(Nmyc1)Fwa
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal skeletal muscle morphology
|
J:62573
|
Mycbp2tm1.1Adia/Mycbp2tm1.1Adia
(involves: C57BL/6 * FVB/N)
|
abnormal diaphragm morphology
|
J:125702
|
Mycntm1Fwa/Mycntm1Fwa
(involves: 129S/SvEv * MF1)
|
trabecula carnea hypoplasia
|
J:3413
|
Mycntm1Jrt/Mycntm1Par
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal fetal cardiomyocyte proliferation
|
J:15281
|
| thin myocardium
|
J:15281
|
| thin myocardium compact layer
|
J:15281
|
Mycntm1Knd/Mycntm1Knd
(involves: 129P2/OlaHsd * BALB/c)
|
thin myocardium
|
J:11859
|
| trabecula carnea hypoplasia
|
J:11859
|
Mycntm1Nagy/Mycntm2.1Nagy
(involves: 129S1/Sv * 129X1/SvJ)
|
thin myocardium
|
J:67930
|
Mycntm1Par/Mycntm1Par
(involves: 129S2/SvPas * C57BL/6J)
|
thin myocardium
|
J:3432
|
Myf5tm1(cre)Mrc/Myf5+
Myod1tm1Jae/Myod1tm1Jae
Pax7tm1.1Thbr/Pax7tm1.1Thbr
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)
|
decreased satellite cell number
|
J:202693
|
Myf5tm1Jae/Myf5+
Myf6tm1Eno/Myf6+
(involves: 129S4/SvJae * 129S7/SvEvBrd)
|
abnormal myotome development
|
J:42453
|
Myf5tm1Jae/Myf5+
Myf6tm1Wb/Myf6+
(involves: 129S1/Sv * 129S4/SvJae)
|
abnormal myotome development
|
J:42453
|
Myf5tm1Jae/Myf5tm1Jae
(involves: 129S4/SvJae)
|
absent myotome
|
J:42453
|
Myf5tm1Jae/Myf5tm1Jae
(either: 129-Myf5tm1Jae or (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6))
|
abnormal muscle morphology
|
J:3013
|
| abnormal myotome development
|
J:3013
|
Myf5tm1Jae/Myf5tm1Jae
Myod1tm1.1Glh/Myod1+
(involves: 129/Sv * 129S4/SvJae * C57BL/6J)
|
abnormal muscle development
|
J:87370
|
Myf5tm1Jae/Myf5tm1Jae
Myod1tm1.1Glh/Myod1tm1.1Glh
(involves: 129/Sv * 129S4/SvJae * C57BL/6J)
|
abnormal muscle development
|
J:87370
|
Myf5tm1Pas/Myf5tm1Pas
(Not Specified)
|
abnormal eye muscle development
|
J:150130
|
| absent extraocular muscles
|
J:150130
|
Myf5tm1Pas/Myf5tm1Pas
(involves: 129 * C57BL/6 * DBA/2)
|
abnormal muscle precursor cell migration
|
J:92799
|
| abnormal skeletal muscle morphology
|
J:92799
|
| absent myotome
|
J:92799
|
Myf5tm1Pas/Myf5tm1Pas
Myod1tm1Jae/Myod1tm1Jae
(involves: 129 * C57BL/6 * DBA/2)
|
abnormal myogenesis
|
J:92799
|
| absent skeletal muscle
|
J:92799
|
Myf5tm1Tajb/Myf5tm1Tajb
(involves: 129/Sv * C57BL/6 * DBA/2)
|
abnormal muscle precursor cell migration
|
J:92799
|
| abnormal skeletal muscle morphology
|
J:92799
|
| absent myotome
|
J:92799
|
Myf5tm1Tajb/Myf5tm1Tajb
(involves: 129S2/SvPas)
|
abnormal eye muscle development
|
J:150130
|
Myf5tm1Tajb/Myf5tm1Tajb
Myod1tm1Jae/Myod1tm1Jae
(involves: 129/Sv * C57BL/6 * DBA/2)
|
abnormal myogenesis
|
J:92799
|
| absent skeletal muscle
|
J:92799
|
Myf5tm1Tajb/Myf5tm1Tajb
Pax7tm1.1Tajb/Pax7tm1.1Tajb
(involves: 129S2/SvPas)
|
abnormal extraocular muscle morphology
|
J:150130
|
| muscle phenotype
|
J:150130
|
Myf5tm2(Myog)Jae/Myf5tm2(Myog)Jae
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal myotome development
|
J:65301
|
Myf5tm2(Pdgfa)Sor/Myf5tm2(Pdgfa)Sor
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal myotome development
|
J:65301
|
Myf5tm2Pas/Myf5tm2Tajb
(involves: 129S2/SvPas)
|
abnormal muscle regeneration
|
J:128921
|
Myf5tm2Tajb/Myf5+
Tbx1tm1Pa/Tbx1tm1Pa
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ)
|
abnormal pharyngeal muscle morphology
|
J:150130
|
Myf5tm2Tajb/Myf5tm2Tajb
(involves: 129/Sv * C57BL/6 * DBA/2)
|
abnormal muscle precursor cell migration
|
J:92799
|
| abnormal skeletal muscle morphology
|
J:92799
|
| absent myotome
|
J:92799
|
Myf5tm2Tajb/Myf5tm2Tajb
(involves: 129S2/SvPas)
|
abnormal eye muscle development
|
J:150130
|
| abnormal muscle regeneration
|
J:128921
|
| abnormal skeletal muscle morphology
|
J:128921
|
| abnormal skeletal muscle satellite cell proliferation
|
J:128921
|
| centrally nucleated skeletal muscle fibers
|
J:128921
|
| increased skeletal muscle fiber diameter
|
J:128921
|
| increased variability of skeletal muscle fiber size
|
J:128921
|
| muscle phenotype
|
J:168843
|
| skeletal muscle fibrosis
|
J:128921
|
Myf5tm2Tajb/Myf5tm2Tajb
Myf6tm1Tajb/Myf6+
(involves: 129S2/SvPas * BALB/c * C57BL/6)
|
abnormal muscle development
|
J:92799
|
Myf5tm2Tajb/Myf5tm2Tajb
Myf6tm1Tajb/Myf6tm1Tajb
(involves: 129S2/SvPas)
|
abnormal extraocular muscle morphology
|
J:150130
|
| abnormal eye muscle development
|
J:150130
|
Myf5tm2Tajb/Myf5tm2Tajb
Myod1tm1Jae/Myod1tm1Jae
(involves: 129/Sv * C57BL/6 * DBA/2)
|
abnormal myogenesis
|
J:92799
|
| absent skeletal muscle
|
J:92799
|
Myf5tm2Tajb/Myf5tm2Tajb
Tbx1tm1Pa/Tbx1tm1Pa
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ)
|
abnormal pharyngeal muscle morphology
|
J:150130
|
Myf5tm3(cre)Sor/Myf5+
Sik1tm1.1Berd/Sik1tm1.1Berd
(involves: 129S4/SvJaeSor * 129S7/SvEvBrd * C57BL/6J * SJL)
|
increased muscle cell glucose uptake
|
J:236223
|
| muscle phenotype
|
J:236223
|
Myf5tm3(cre)Sor/Myf5+
Spin1tm1.1Rosc/Spin1tm1.1Rosc
(involves: 129S4/SvJaeSor * C57BL/6N * C57BL/6NTac)
|
abnormal diaphragm morphology
|
J:302851
|
| abnormal M line morphology
|
J:302851
|
| abnormal myogenesis
|
J:302851
|
| abnormal skeletal muscle fiber morphology
|
J:302851
|
| abnormal skeletal muscle fiber type ratio
|
J:302851
|
| abnormal skeletal muscle morphology
|
J:302851
|
| abnormal soleus morphology
|
J:302851
|
| abnormal tibialis anterior morphology
|
J:302851
|
| decreased skeletal muscle fiber number
|
J:302851
|
| decreased skeletal muscle mass
|
J:302851
|
| increased skeletal muscle fiber size
|
J:302851
|
| skeletal muscle degeneration
|
J:302851
|
| skeletal muscle fiber degeneration
|
J:302851
|
| skeletal muscle fiber necrosis
|
J:302851
|
| skeletal muscle fibrosis
|
J:302851
|
Myf5tm3(cre)Sor/Myf5+
Tg(CAG-Nog)1Ych/0
(involves: 129S4/SvJaeSor)
|
abnormal levator veli palatini muscle morphology
|
J:310908
|
| abnormal palatopharyngeus muscle morphology
|
J:310908
|
| abnormal soft palate muscle morphology
|
J:310908
|
| abnormal superior pharyngeal constrictor muscle morphology
|
J:310908
|
| abnormal tensor veli palatini muscle morphology
|
J:310908
|
Myf5tm3(cre)Sor/Myf5tm3(cre)Sor
Myod1tm1Jae/Myod1tm1Jae
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal myogenesis
|
J:65301
|
| abnormal myotube morphology
|
J:65301
|
Myf5tm3.1Thbr/Myf5tm3.1Thbr
(Not Specified)
|
abnormal myotome development
|
J:63517
|
Myf5tm4(Myod1)Sor/Myf5tm4(Myod1)Sor
(involves: 129S4/SvJae * C57BL/6J)
|
muscle phenotype
|
J:65301
|
Myf6tm1(cre)Mrc/Myf6+
Pax3tm1Mrc/Pax3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
increased rhabdomyosarcoma incidence
|
J:93444
|
Myf6tm1(cre)Mrc/Myf6+
Pax3tm1Mrc/Pax3tm1Mrc
Trp53tm1Brn/Trp53+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
increased rhabdomyosarcoma incidence
|
J:93444
|
Myf6tm1(cre)Mrc/Myf6+
Pax3tm1Mrc/Pax3tm1Mrc
Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
increased rhabdomyosarcoma incidence
|
J:93444
|
Myf6tm1Eno/Myf6tm1Eno
(involves: 129S7/SvEvBrd)
|
abnormal extraocular muscle morphology
|
J:150130
|
| abnormal myotome development
|
J:42453
|
| muscle phenotype
|
J:26105
|
Myf6tm1Eno/Myf6tm1Eno
Myod1tm1Jae/Myod1tm1Jae
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6)
|
absent skeletal muscle
|
J:48809
|
| centrally nucleated skeletal muscle fibers
|
J:48809
|
| decreased skeletal muscle fiber number
|
J:48809
|
Myf6tm1Eno/Myf6tm1Eno
Myod1tm1Jae/Myod1tm1Jae
Myogtm1Whk/Myog+
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6)
|
abnormal myogenesis
|
J:48809
|
Myf6tm1Eno/Myf6tm1Eno
Myod1tm1Jae/Myod1tm1Jae
Myogtm1Whk/Myogtm1Whk
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6)
|
abnormal muscle development
|
J:61155
|
| muscle hypoplasia
|
J:61155
|
Myf6tm1Eno/Myf6tm1Eno
Myogtm1Whk/Myogtm1Whk
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal muscle fiber morphology
|
J:48809
|
| muscle hypoplasia
|
J:48809
|
Myf6tm1Thbr/Myf6tm1Thbr
(either: (involves: 129S4/SvJae-Myf6tm1Thbr) or (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6))
|
abnormal muscle morphology
|
J:24360
|
Myf6tm1Wb/Myf6tm1Wb
(involves: 129S1/Sv * C57BL/6)
|
abnormal intercostal muscle morphology
|
J:29279
|
| abnormal myotome development
|
J:29279
|
| abnormal myotome morphology
|
J:29279
|
Myh1tm1Lnwd/Myh1tm1Lnwd
(involves: 129/Ola * 129P2/OlaHsd * C57BL/6)
|
abnormal skeletal muscle fiber type ratio
|
J:48228
|
| abnormal skeletal muscle morphology
|
J:44448,
J:78284
|
| decreased skeletal muscle mass
|
J:44448
|
| impaired skeletal muscle contractility
|
J:44448
|
| muscle weakness
|
J:44448
|
Myh3tm1.2Sajm/Myh3tm1.1Sajm
Pax3tm1(cre)Joe/Pax3+
(involves: 129S1/Sv * 129S4/SvJaeSor * C57BL/6J)
|
abnormal muscle precursor cell morphology
|
J:287755
|
Myh3tm1.2Sajm/Myh3tm1.1Sajm
Pax7tm1(cre)Mrc/Pax7+
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6J)
|
abnormal muscle precursor cell morphology
|
J:287755
|
Myh3tm1.2Sajm/Myh3tm1.2Sajm
(involves: 129S1/Sv * 129S4/SvJaeSor * C57BL/6J)
|
abnormal muscle precursor cell morphology
|
J:287755
|
| abnormal skeletal muscle fiber type ratio
|
J:287755
|
| decreased skeletal muscle fiber diameter
|
J:287755
|
| decreased skeletal muscle weight
|
J:287755
|
| increased myoblast apoptosis
|
J:287755
|
| increased skeletal muscle fiber number
|
J:287755
|
Myh4arl/Myh4arl
(involves: C3H/HeH * C57BL/6J)
|
abnormal skeletal muscle fiber morphology
|
J:181892
|
| centrally nucleated skeletal muscle fibers
|
J:181892
|
| increased variability of skeletal muscle fiber size
|
J:181892
|
| muscular atrophy
|
J:181892
|
| myositis
|
J:181892
|
| skeletal muscle fiber degeneration
|
J:181892
|
Myh4tm1Lnwd/Myh4tm1Lnwd
(involves: 129/Ola * 129P2/OlaHsd * C57BL/6)
|
abnormal skeletal muscle fiber morphology
|
J:78886
|
| abnormal skeletal muscle fiber type ratio
|
J:78886
|
| abnormal skeletal muscle morphology
|
J:44448
|
| decreased skeletal muscle fiber number
|
J:78886
|
| decreased skeletal muscle mass
|
J:78886,
J:44448,
J:78284
|
| impaired skeletal muscle contractility
|
J:44448
|
| increased skeletal muscle fiber size
|
J:78886,
J:44448
|
| muscle weakness
|
J:44448
|
| skeletal muscle fiber atrophy
|
J:78886
|
Myh6tm1.1Jpsc/Myh6tm2Jse
(involves: 129)
|
abnormal cardiac muscle relaxation
|
J:247162
|
| decreased cardiac muscle contractility
|
J:247162
|
| increased myocardial fiber size
|
J:247162
|
| myocardium hypertrophy
|
J:247162
|
Myh6tm1Ces/Myh6+
(involves: 129S/SvEv * 129X1/SvJ)
|
abnormal cardiac muscle relaxation
|
J:114549
|
| decreased cardiac muscle contractility
|
J:114549
|
| dilated cardiomyopathy
|
J:114549
|
Myh6tm1Ces/Myh6tm1Ces
(involves: 129S/SvEv * 129X1/SvJ)
|
decreased cardiac muscle contractility
|
J:114549
|
| dilated cardiomyopathy
|
J:114549
|
Myh6tm1Jse/Myh6+
(involves: 129X1/SvJ)
|
abnormal myocardial fiber morphology
|
J:32960
|
| myocardial fiber disarray
|
J:32960,
J:95600
|
Myh6tm1Jse/Myh6+
(129S.129X1-Myh6tm1Jse)
|
increased cardiac muscle contractility
|
J:104363
|
| myocardial fiber disarray
|
J:104363
|
Myh6tm1Jse/Myh6+
Tg(Myh6-TNNI3*G203S)1Chs/0
(involves: 129X1/SvJ * C57BL/6)
|
abnormal cardiac muscle tissue morphology
|
J:153302
|
| abnormal myocardial fiber morphology
|
J:153302
|
| cardiac muscle necrosis
|
J:153302
|
| decreased cardiac muscle contractility
|
J:153302
|
| dilated cardiomyopathy
|
J:153302
|
| increased myocardial fiber size
|
J:153302
|
| myocardial fiber degeneration
|
J:153302
|
Myh6tm1Jse/Myh6+
Tg(Myh6/tetO-Tnnc1*I61Q)1Jmol/0
Tg(Myh6-tTA)55Rbns/0
(involves: 129X1/SvJ * FVB)
|
abnormal cardiac muscle contractility
|
J:234490
|
Myh6tm1Jse/Myh6tm1Jse
(involves: 129X1/SvJ * Black Swiss)
|
abnormal myocardial fiber morphology
|
J:51939
|
| decreased ventricle muscle contractility
|
J:51939
|
| dilated cardiomyopathy
|
J:51939
|
| disorganized myocardium
|
J:51939
|
| myocardial fiber disarray
|
J:51939
|
| myocardium necrosis
|
J:51939
|
Myh6tm1Rbns/Myh6+
(involves: 129P2/OlaHsd)
|
abnormal myocardial fiber morphology
|
J:36089
|
| abnormal myocardium layer morphology
|
J:36089
|
| decreased cardiac muscle contractility
|
J:36089
|
Myh6tm2Ces/Myh6+
(involves: 129S/SvEv * 129X1/SvJ)
|
decreased cardiac muscle contractility
|
J:114549
|
| dilated cardiomyopathy
|
J:114549
|
Myh6tm2Ces/Myh6tm2Ces
(involves: 129S/SvEv * 129X1/SvJ)
|
decreased cardiac muscle contractility
|
J:114549
|
| dilated cardiomyopathy
|
J:114549
|
Myh6tm2Jse/Myh6+
(involves: 129S1/Sv)
|
myocardial fiber disarray
|
J:95600
|
Myh6tm2Jse/Myh6+
(involves: 129)
|
increased cardiac muscle contractility
|
J:247162
|
| myocardial fiber disarray
|
J:247162
|
Myh6tm2Jse/Myh6tm2Jse
(involves: 129)
|
calcified myocardium
|
J:247162
|
| increased cardiomyocyte apoptosis
|
J:247162
|
| myocardial fiber disarray
|
J:247162
|
Myh6tm3.1Jse/Myh6+
(involves: 129X1/SvJ)
|
cardiomyopathy
|
J:165269
|
| heart left ventricle hypertrophy
|
J:165269
|
Myh6tm3.1Jse/Myh6+
(involves: 129)
|
increased cardiac muscle contractility
|
J:247162
|
| myocardial fiber disarray
|
J:247162
|
Myh6tm3.1Jse/Myh6tm3.1Jse
(involves: 129)
|
calcified myocardium
|
J:247162
|
| increased cardiomyocyte apoptosis
|
J:247162
|
| myocardial fiber disarray
|
J:247162
|
Myh10b2b2437Clo/Myh10b2b2437Clo
(C57BL/6J-Myh10b2b2437Clo)
|
abnormal myocardium compact layer morphology
|
J:175213
|
Myh10ehc/Myh10ehc
(involves: 129S5/SvEvBrd * 129S7/SvEvBrd * C57BL/6J)
|
abnormal myocardium compact layer morphology
|
J:248868
|
| abnormal ventricle myocardium morphology
|
J:248868
|
| myocardial trabeculae hypoplasia
|
J:248868
|
Myh10ehc/Myh10tm2Rsad
(involves: 129S4/SvJae * 129S5/SvEvBrd * 129S7/SvEvBrd * C57BL/6J)
|
abnormal myocardium compact layer morphology
|
J:248868
|
Myh10tm2Rsad/Myh10tm2Rsad
(involves: 129S4/SvJae)
|
abnormal myocardium compact layer morphology
|
J:248868
|
| decreased fetal cardiomyocyte proliferation
|
J:92230
|
| increased cardiomyocyte apoptosis
|
J:248868
|
Myh10tm2Rsad/Myh10tm2Rsad
Myh14tm1Rsad/Myh14tm1Rsad
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6)
|
cardiomyopathy
|
J:168304
|
Myh10tm3.1Rsad/Myh10+
(involves: 129S6/SvEvTac * BALB/c * C57BL/6)
|
abnormal diaphragm development
|
J:245570
|
| diaphragmatic hernia
|
J:245570
|
| thin diaphragm muscle
|
J:245570
|
Myh10tm3.1Rsad/Myh10tm3.1Rsad
(involves: 129S6/SvEvTac * BALB/c * C57BL/6)
|
abnormal diaphragm development
|
J:245570
|
| decreased cardiac muscle contractility
|
J:245570
|
| diaphragmatic hernia
|
J:245570
|
Myh10tm4Rsad/Myh10tm4Rsad
Myh14tm1Rsad/Myh14tm1Rsad
(involves: 129S6/SvEvTac * C57BL/6)
|
cardiomyopathy
|
J:168304
|
Myh10tm6(Myh9/GFP)Rsad/Myh10tm6(Myh9/GFP)Rsad
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased cardiac muscle contractility
|
J:124610
|
| dilated cardiomyopathy
|
J:124610
|
| increased myocardial fiber size
|
J:124610
|
Myh10tm7Rsad/Myh10tm7Rsad
Tg(Myh6-cre)2182Mds/0
(involves: 129S6/SvEvTac * C57BL/6J * FVB/N)
|
abnormal intercalated disk morphology
|
J:170148
|
| cardiomyopathy
|
J:170148
|
| decreased cardiac muscle contractility
|
J:170148
|
| increased cardiomyocyte apoptosis
|
J:170148
|
| increased myocardial fiber size
|
J:170148
|
Myh11tm1.1Dmmz/Myh11tm1.1Dmmz
(involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6)
|
abnormal vascular smooth muscle physiology
|
J:212664
|
| decreased vasoconstriction
|
J:212664
|
| increased vascular smooth muscle cell proliferation
|
J:212664
|
Myh11tm1Bdr/Myh11tm1Bdr
(Not Specified)
|
dilated cardiomyopathy
|
J:82859
|
| impaired contractility of urinary bladder detrusor smooth muscle
|
J:82859
|
| intestinal hypoperistalsis
|
J:82859
|
Myh11tm1Peri/Myh11+
(involves: 129 * C57BL/6)
|
impaired smooth muscle contractility
|
J:97927
|
Myh11tm1Peri/Myh11tm1Peri
(involves: 129 * C57BL/6)
|
impaired smooth muscle contractility
|
J:97927
|
Myh11tm2Peri/Myh11tm2Peri
(involves: 129 * C57BL/6)
|
abnormal muscle contractility
|
J:142230
|
| abnormal sarcomere morphology
|
J:142230
|
Myhastm1Bcgen/Myhastm1Bcgen
Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6J * FVB)
|
decreased extensor digitorum longus weight
|
J:240240
|
| decreased gastrocnemius weight
|
J:240240
|
| decreased skeletal muscle fiber diameter
|
J:240240
|
| decreased tibialis anterior weight
|
J:240240
|
| muscle weakness
|
J:240240
|
| skeletal muscle atrophy
|
J:240240
|
Myl1tm1(cre)Sjb/0
Ndufab1tm1Xiwa/Ndufab1tm1Xiwa
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6)
|
decreased skeletal muscle glycogen level
|
J:293657
|
| muscle phenotype
|
J:293657
|
Myl1tm1(cre)Sjb/Myl1+
Shc1tm3Paw/Shc1tm9Paw
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased muscle spindle number
|
J:122927
|
Myl1tm1(cre)Sjb/Myl1+
Shc1tm4Paw/Shc1tm9Paw
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal muscle spindle morphology
|
J:122927
|
Myl1tm1(cre)Sjb/Myl1+
Shc1tm7Paw/Shc1tm9Paw
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased muscle spindle number
|
J:122927
|
Myl1tm1(cre)Sjb/Myl1+
Shc1tm9Paw/Shc1tm9Paw
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased muscle spindle number
|
J:122927
|
Myl1tm1(cre)Sjb/Myl1+
Smarcd3tm1Jddl/Smarcd3tm1Jddl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal muscle physiology
|
J:256788
|
Myl1tm1(cre)Sjb/Myl1+
Tfamtm1Lrsn/Tfamtm1Lrsn
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
impaired skeletal muscle contractility
|
J:81561
|
| increased skeletal muscle fiber size
|
J:81561
|
Myl2tm1(cre)Krc/Myl2+
Nkx2-5tm1Krc/Nkx2-5tm1Krc
(either: (involves: 129/Sv * Black Swiss) or (involves: 129/Sv * C57BL/6))
|
abnormal atrioventricular bundle morphology
|
J:89404
|
| abnormal impulse conducting system morphology
|
J:89404
|
| abnormal myocardial fiber morphology
|
J:89404
|
| abnormal myocardial trabeculae morphology
|
J:89404
|
| atrioventricular node hypoplasia
|
J:89404
|
| dilated cardiomyopathy
|
J:89404
|
Myl2tm1(cre)Krc/Myl2+
Ptk2tm1.1Guan/Ptk2tm1.1Guan
(involves: 129P2/OlaHsd * 129S4/SvJae)
|
abnormal myocardial fiber morphology
|
J:105371
|
| abnormal myocardium layer morphology
|
J:105371
|
| disorganized myocardium
|
J:105371
|
Myl2tm1(cre)Krc/Myl2+
Slc8a1tm1Kdp/Slc8a1tm1Kdp
(involves: 129S4/SvJae)
|
decreased cardiac muscle contractility
|
J:101484
|
Myl2tm1(cre)Krc/Myl2+
Srsf1tm1Xdfu/Srsf1tm1Xdfu
(involves: 129S4/SvJae)
|
abnormal cardiac muscle contractility
|
J:96039
|
| abnormal myocardial fiber morphology
|
J:96039
|
| dilated cardiomyopathy
|
J:96039
|
Myl2tm1(cre)Krc/Myl2+
Srsf2tm1Xdfu/Srsf2tm1Xdfu
(involves: 129S4/SvJae)
|
decreased ventricle muscle contractility
|
J:88432
|
| dilated cardiomyopathy
|
J:88432
|
Myl2tm1(cre)Krc/Myl2+
Tsc1tm1Djk/Tsc1tm1Djk
(involves: 129S4/SvJae)
|
abnormal myocardial fiber morphology
|
J:96138
|
| decreased cardiac muscle contractility
|
J:96138
|
| dilated cardiomyopathy
|
J:96138
|
| increased myocardial fiber size
|
J:96138
|
Myl2tm1(cre)Krc/Myl2+
Txnrd2tm1Marc/Txnrd2tm1.1Marc
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal myocardial fiber morphology
|
J:94136
|
Myl2tm1(cre)Krc/Myl2+
Vcltm1Ross/Vcltm1Ross
(involves: 129S4/SvJae * Black Swiss * C57BL/6 * SJL)
|
abnormal cardiac muscle relaxation
|
J:129075
|
| abnormal intercalated disk morphology
|
J:129075
|
| abnormal myocardial fiber morphology
|
J:129075
|
| decreased cardiac muscle contractility
|
J:129075
|
| dilated cardiomyopathy
|
J:129075
|
Myl2tm1(Hand1)Tana/Myl2+
(involves: 129X1/SvJ * C57BL/6J)
|
thin myocardium compact layer
|
J:91082
|
Myl2tm2.1Chen/Myl2tm2.1Chen
(B6.129-Myl2tm2.1Chen)
|
abnormal Z line morphology
|
J:184548
|
| decreased ventricle muscle contractility
|
J:184548
|
| dilated cardiomyopathy
|
J:184548
|
| increased myocardial fiber size
|
J:184548
|
Myl7tm1(cre)Krc/Myl7+
Prkg1tm2Naw/Prkg1tm2Naw
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
abnormal cardiac muscle contractility
|
J:84611
|
Myl7tm1(cre)Krc/Myl7tm1(cre)Krc
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss)
|
abnormal myocardial fiber morphology
|
J:87043
|
| trabecula carnea hypoplasia
|
J:87043
|
| ventricle myocardium hypoplasia
|
J:87043
|
Myl9tm1Mzhu/Myl9tm1Mzhu
Tg(Acta2-cre)#Xya/0
(involves: C57BL/6 * CBA)
|
abnormal aorta smooth muscle morphology
|
J:308237
|
| abnormal intestinal peristalsis
|
J:308237
|
| abnormal vascular smooth muscle physiology
|
J:308237
|
| impaired contractility of jejunal smooth muscle
|
J:308237
|
| impaired smooth muscle contractility
|
J:308237
|
Mylk2tm1Jtst/Mylk2tm1Jtst
(involves: 129S6/SvEvTac * C57BL/6)
|
impaired skeletal muscle contractility
|
J:104384
|
Mylk3tm1.1Hkas/Mylk3tm1.1Hkas
(involves: 129 * C57BL/6 * FVB/N)
|
decreased cardiac muscle contractility
|
J:210147
|
| increased myocardial fiber size
|
J:210147
|
Mylk3tm1Jtst/Mylk3+
(involves: 129S/SvEv * C57BL/6)
|
cardiac muscle necrosis
|
J:167590
|
| decreased cardiac muscle contractility
|
J:167590
|
| increased myocardial fiber size
|
J:167590
|
Mylk3tm1Jtst/Mylk3tm1Jtst
(involves: 129S/SvEv * C57BL/6)
|
decreased cardiac muscle contractility
|
J:167590
|
| heart left ventricle hypertrophy
|
J:167590
|
| heart right ventricle hypertrophy
|
J:167590
|
| increased myocardial fiber size
|
J:167590
|
Mylktm1.1Bph/Mylktm1.1Bph
Tg(Myh11-cre,-EGFP)2Mik/0
(involves: C57BL/6 * C57BL/6N * DBA/2)
|
impaired smooth muscle contractility
|
J:204964
|
Mylktm1.1Bph/Mylktm1.2Bph
Tg(Myh11-cre,-EGFP)2Mik/0
(involves: C57BL/6 * C57BL/6N * DBA/2)
|
impaired smooth muscle contractility
|
J:204964
|
Mylktm1Avs/Mylktm1Avs
(B6.129-Mylktm1Avs)
|
abnormal muscle contractility
|
J:106058
|
| abnormal muscle relaxation
|
J:106058
|
Mylktm1Mzhu/Mylktm1Mzhu
Taglntm1(cre/ERT2)Feil/?
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6)
|
abnormal intestinal peristalsis
|
J:141907
|
| abnormal intestinal smooth muscle morphology
|
J:141907
|
Mylpftm1Jdp/Mylpftm1Jdp
(involves: 129S6/SvEvTac * C57BL/6)
|
absent skeletal muscle
|
J:131461
|
Mymktm1e(KOMP)Wtsi/Mymktm1e(KOMP)Wtsi
(involves: C57BL/6 * C57BL/6N)
|
abnormal muscle development
|
J:200444
|
| abnormal myoblast differentiation
|
J:200444
|
| abnormal myoblast fusion
|
J:200444
|
Mymxem1Shcs/Mymxem1Shcs
(involves: C57BL/6J)
|
abnormal intercostal muscle morphology
|
J:241564
|
| abnormal limb muscle morphology
|
J:241564
|
| abnormal muscle morphology
|
J:241564
|
| abnormal myoblast fusion
|
J:241564
|
| abnormal skeletal muscle morphology
|
J:241564
|
| muscle weakness
|
J:241564
|
Myo1eGt(ROSA)74Sor/Myo1eGt(ROSA)74Sor
Pdgfrbtm1Sor/Pdgfrb+
(involves: 129S4/SvJaeSor * 129S7/SvEvBrd)
|
abnormal smooth muscle morphology
|
J:117491
|
Myo5ad-15H/Myo5ad-15H
(Not Specified)
|
opisthotonus
|
J:13409
|
Myo5ad-50H/Myo5ad-50H
(involves: 101/H * C3H/HeH)
|
opisthotonus
|
J:178968
|
Myo5ad-51H/Myo5ad-51H
(involves: 101/H * C3H/HeH)
|
opisthotonus
|
J:178968
|
Myo5ad-53H/Myo5ad-53H
(involves: 101/H * C3H/HeH)
|
opisthotonus
|
J:178968
|
Myo5ad-80H/Myo5ad-80H
(involves: 101/H * C3H/HeH)
|
opisthotonus
|
J:178968
|
Myo5ad-82H/Myo5ad-82H
(involves: 101/H * C3H/HeH)
|
opisthotonus
|
J:178968
|
Myo5ad-83H/Myo5ad-83H
(involves: C3H/HeH)
|
opisthotonus
|
J:178968
|
Myo5ad-84H/Myo5ad-84H
(involves: 101/H)
|
opisthotonus
|
J:178968
|
Myo5ad-85H/Myo5ad-85H
(involves: 101/H * C3H/HeH)
|
opisthotonus
|
J:169366
|
Myo5ad-86H/Myo5ad-86H
(involves: 101/H * C3H/HeH)
|
opisthotonus
|
J:178968
|
Myo5ad-86H/Myo5ad-97H
(involves: 101/H * C3H/HeH)
|
opisthotonus
|
J:178968
|
Myo5ad-90H/Myo5ad-l
(involves: 101/H * C3H/HeH * C57BL/Gr)
|
opisthotonus
|
J:179353
|
Myo5ad-93H/Myo5ad-l
(involves: 101/H * C3H/HeH * C57BL/Gr)
|
opisthotonus
|
J:179353
|
Myo5ad-l20J/Myo5ad-l20J
(involves: C57BL/6J * DBA/2J)
|
opisthotonus
|
J:20299
|
Myo5ad-l32J/Myo5ad-l32J
(B6.Cg-Myo5ad-l32J/GrsrJ)
|
opisthotonus
|
J:169210
|
Myo5ad-l34J/Myo5ad-l34J
(BALB/cJ-Myo5ad-l34J/GrsrJ)
|
opisthotonus
|
J:216055
|
Myo5ad-l/d-100H
(involves: C3H/HeH * C57BL/Gr)
|
opisthotonus
|
J:181531
|
Myo5ad-l/Myo5ad-l
(involves: C57BL)
|
opisthotonus
|
J:12978
|
Myo5ad-n2Btlr/Myo5ad-n2Btlr
(C57BL/6J-Myo5ad-n2Btlr)
|
myoclonus
|
J:133120
|
| opisthotonus
|
J:133120
|
Myo5ad-n3Btlr/Myo5ad-n3Btlr
(C57BL/6J-Myo5ad-n3Btlr)
|
opisthotonus
|
J:201726
|
Myo5ad-nBtlr/Myo5ad-nBtlr
(C57BL/6J-Myo5ad-nBtlr)
|
myoclonus
|
J:133119
|
| opisthotonus
|
J:133119
|
Myo6chl/Myo6chl
(involves: C57BL/6JAnu)
|
cardiomyopathy
|
J:196601
|
Myo18atm1b(KOMP)Wtsi/Myo18atm1b(KOMP)Wtsi
(C57BL/6N-Myo18atm1b(KOMP)Wtsi)
|
abnormal A band morphology
|
J:277320
|
| abnormal muscle fiber morphology
|
J:277320
|
| abnormal sarcomere morphology
|
J:277320
|
Myo18btm1Jyo/Myo18btm1Jyo
(involves: C57BL/6J)
|
abnormal myocardium layer morphology
|
J:142442
|
Myocdem1Blk/Myocdtm1.1Msp
(involves: 129)
|
abnormal urinary bladder detrusor smooth muscle morphology
|
J:283803
|
Myocdtm1Eno/Myocdtm1Eno
(involves: 129S/SvEv * C57BL/6)
|
abnormal vascular smooth muscle morphology
|
J:84789
|
Myocdtm1Msp/Myocdtm1Msp
(involves: 129)
|
abnormal myocardial fiber morphology
|
J:154666
|
| increased cardiomyocyte apoptosis
|
J:154666
|
Myocdtm1Msp/Myocdtm1Msp
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: 129/Sv * C57BL/6J * FVB/N)
|
abnormal intercalated disk morphology
|
J:154666
|
| abnormal myocardial fiber morphology
|
J:154666
|
| abnormal sarcomere morphology
|
J:154666
|
| decreased cardiac muscle contractility
|
J:154666
|
| dilated cardiomyopathy
|
J:154666
|
| increased cardiomyocyte apoptosis
|
J:154666
|
| myocardial fiber degeneration
|
J:154666
|
| myocardial fiber disarray
|
J:154666
|
Myocdtm1Msp/Myocdtm1Msp
H2az2Tg(Wnt1-cre)11Rth/H2az2+
(involves: 129/Sv * C57BL/6 * CBA)
|
abnormal vascular smooth muscle morphology
|
J:131288
|
Myocdtm1Msp/Myocdtm1Msp
Tg(Myh6-cre)2182Mds/0
(involves: 129/Sv * FVB/N)
|
abnormal intercalated disk morphology
|
J:154666
|
| abnormal myocardial fiber morphology
|
J:154666
|
| abnormal sarcomere morphology
|
J:154666
|
| decreased cardiac muscle contractility
|
J:154666
|
| dilated cardiomyopathy
|
J:154666
|
| myocardial fiber degeneration
|
J:154666
|
Myod1tm1.1Glh/Myod1tm1.1Glh
(involves: 129 * C57BL/6J)
|
abnormal muscle development
|
J:87370
|
Myod1tm1Ahb/Myod1tm1Ahb
(Not Specified)
|
abnormal muscle morphology
|
J:116060
|
| abnormal muscle physiology
|
J:116060
|
| delayed skeletal muscle regeneration
|
J:116060
|
Myod1tm1Jae/Myod1tm1Jae
(involves: 129S4/SvJae)
|
abnormal myogenesis
|
J:168843
|
| increased satellite cell number
|
J:128921
|
Myoftm1Mcn/Myoftm1Mcn
(involves: 129X1/SvJ)
|
abnormal myogenesis
|
J:163585
|
| abnormal soleus morphology
|
J:163585
|
| decreased skeletal muscle fiber density
|
J:163585
|
| skeletal muscle fiber degeneration
|
J:163585
|
Myogtm1Sjb/Myogtm1Sjb
(involves: 129)
|
muscle phenotype
|
J:88178
|
Myogtm1Whk/Myogtm1Whk
(involves: 129S7/SvEvBrd * C57BL/6J)
|
decreased skeletal muscle fiber density
|
J:14208
|
| decreased skeletal muscle mass
|
J:14208
|
| muscle hypoplasia
|
J:14208
|
| thin diaphragm muscle
|
J:14208
|
Myogtm1Whk/Myogtm1Whk
(involves: 129S7/SvEvBrd)
|
abnormal laryngeal muscle morphology
|
J:110733
|
| abnormal muscle development
|
J:22984
|
| abnormal myoblast differentiation
|
J:22984
|
| abnormal myogenesis
|
J:22984
|
| muscle hypoplasia
|
J:110733,
J:22984
|
| thin diaphragm muscle
|
J:110733
|
Myogtm1Whk/Myogtm2Whk
(involves: 129S7/SvEvBrd * C57BL/6)
|
muscle hypoplasia
|
J:54065
|
Myogtm1Yin/Myogtm1Yin
(involves: 129P2/OlaHsd * BALB/c)
|
muscle hypoplasia
|
J:14059
|
Myogtm2Whk/Myogtm2Whk
(involves: 129S7/SvEvBrd * C57BL/6)
|
muscle hypoplasia
|
J:54065
|
Myogtm3Whk/Myogtm3Whk
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S7/SvEvBrd * C57BL/6 * CBA)
|
thin diaphragm muscle
|
J:105925
|
myol/myol
(C3.Cg-myol/GrsrJ)
|
impaired muscle relaxation
|
J:234691
|
Myoz1tm1Eno/Myoz1tm1Eno
(involves: 129 * C57BL/6J)
|
abnormal gastrocnemius morphology
|
J:144597
|
| abnormal muscle physiology
|
J:144597
|
| abnormal muscle tone
|
J:144597
|
| abnormal skeletal muscle fiber type ratio
|
J:144597
|
| abnormal skeletal muscle morphology
|
J:144597
|
| decreased gastrocnemius weight
|
J:144597
|
| decreased skeletal muscle fiber size
|
J:144597
|
| enhanced skeletal muscle regeneration
|
J:144597
|
| increased skeletal muscle fiber diameter
|
J:144597
|
| muscle degeneration
|
J:144597
|
Myoz2tm1Eno/Myoz2+
Tg(Myh6-MYOZ2*I246M)#Ajm/0
(involves: 129/Sv * FVB/N)
|
abnormal Z line morphology
|
J:210073
|
| heart left ventricle hypertrophy
|
J:210073
|
| increased myocardial fiber size
|
J:210073
|
Myoz2tm1Eno/Myoz2tm1Eno
(involves: 129 * C57BL/6J)
|
abnormal myocardial fiber morphology
|
J:94665
|
| abnormal skeletal muscle fiber type ratio
|
J:94665
|
| abnormal skeletal muscle morphology
|
J:94665
|
| cardiomyopathy
|
J:94665
|
| decreased cardiac muscle contractility
|
J:94665
|
| decreased myocardial fiber size
|
J:94665
|
| decreased skeletal muscle fiber size
|
J:94665
|
Myoz2tm1Eno/Myoz2tm1Eno
Tg(Myh6-Ppp3ca)37Eno/0
(involves: 129 * C57BL/6J)
|
increased myocardial fiber size
|
J:94665
|
Mypntm1.1Epu/Mypn+
(either: (involves: 129S6/SvEv) or (involves: 129S6/SvEv * C57BL/6NCrl))
|
abnormal cardiac muscle relaxation
|
J:243710
|
| abnormal intercalated disk morphology
|
J:243710
|
| abnormal myocardial fiber morphology
|
J:243710
|
Mypntm1.1Epu/Mypntm1.1Epu
(involves: 129S6/SvEvTac)
|
abnormal Z line morphology
|
J:248575
|
| myopathy
|
J:248575
|
Myt1tm1.1Ggu/Myt1tm1.1Ggu
(involves: 129 * C57BL/6 * CBA * CD-1 * SJL)
|
abnormal diaphragm morphology
|
J:127471
|
Myzaptm1Norf/Myzaptm1Norf
(involves: C57BL/6J)
|
abnormal cardiac muscle tissue morphology
|
J:231032
|
| decreased cardiac muscle contractility
|
J:231032
|
Nacatm1Dsr/Nacatm1Dsr
(129S6/SvEvTac-Nacatm1Dsr)
|
abnormal fetal cardiomyocyte proliferation
|
J:167169
|
| abnormal muscle physiology
|
J:167169
|
| abnormal myocardial trabeculae morphology
|
J:167169
|
| abnormal myocardium layer morphology
|
J:167169
|
| decreased skeletal muscle mass
|
J:167169
|
| impaired skeletal muscle regeneration
|
J:167169
|
| thin myocardium
|
J:167169
|
nad/nad
(C(D2)-nad)
|
skeletal muscle atrophy
|
J:156089
|
Nae1tm1c(EUCOMM)Wtsi/Nae1tm1c(EUCOMM)Wtsi
Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6J * C57BL/6N * FVB/N * SJL)
|
abnormal myocardial trabeculae morphology
|
J:261328
|
| abnormal myocardium layer morphology
|
J:261328
|
| decreased fetal cardiomyocyte proliferation
|
J:261328
|
| decreased ventricle muscle contractility
|
J:261328
|
| increased myocardial fiber size
|
J:261328
|
| myocardium hypoplasia
|
J:261328
|
| thin left ventricle myocardium compact layer
|
J:261328
|
| thin ventricle myocardium compact layer
|
J:261328
|
NbeaTg(GH1)240BNec/NbeaTg(GH1)240BNec
(involves: C57BL/6 * SJL)
|
impaired muscle contractility
|
J:128767
|
Nbnem3Jpt/Nbnem3Jpt
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas)
|
increased leiomyosarcoma incidence
|
J:251434
|
| increased rhabdomyosarcoma incidence
|
J:251434
|
Nbnem4Jpt/Nbnem4Jpt
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas)
|
increased leiomyosarcoma incidence
|
J:251434
|
| increased rhabdomyosarcoma incidence
|
J:251434
|
Ncam2tm1b(EUCOMM)Hmgu/Ncam2tm1b(EUCOMM)Hmgu
(C57BL/6N-Ncam2tm1b(EUCOMM)Hmgu/Orl)
|
decreased cardiac muscle contractility
|
J:211773
|
Ncf1tm1Shl/Ncf1tm1Shl
(involves: 129S2/SvPas * C57BL/6J)
|
decreased vasoconstriction
|
J:120187
|
Ncf1tm1Shl/Ncf1tm1Shl
(B6.129S2-Ncf1tm1Shl)
|
abnormal cardiac muscle contractility
|
J:133916
|
| abnormal vascular smooth muscle physiology
|
J:111142
|
Ncoa3tm1Jxu/Ncoa3tm1Jxu
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal skeletal muscle fiber morphology
|
J:144060
|
Ncoa6tm1.1Jkr/Ncoa6tm1.1Jkr
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
abnormal fetal cardiomyocyte proliferation
|
J:81217
|
| abnormal myocardium layer morphology
|
J:81217
|
| thin myocardium compact layer
|
J:81217
|
| trabecula carnea hypoplasia
|
J:81217
|
Ncoa6tm1Jkr/Ncoa6+
Tg(Myh6-cre)2182Mds/0
(involves: 129P2/OlaHsd * FVB/N)
|
decreased cardiac muscle contractility
|
J:269856
|
| dilated cardiomyopathy
|
J:269856
|
Ncoa6tm1Jkr/Ncoa6tm1Jkr
Tg(Myh6-cre)2182Mds/0
(involves: 129P2/OlaHsd * FVB/N)
|
abnormal sarcomere morphology
|
J:269856
|
| decreased cardiac muscle contractility
|
J:269856
|
| dilated cardiomyopathy
|
J:269856
|
Ncoa6tm1Jxu/Ncoa6tm1Jxu
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased fetal cardiomyocyte proliferation
|
J:80175
|
| disorganized myocardium
|
J:80175
|
| trabecula carnea hypoplasia
|
J:80175
|
Ncoa6tm1Pera/Ncoa6tm1Pera
(involves: 129X1/SvJ * C57BL/6)
|
disorganized myocardium
|
J:81818
|
| thin myocardium
|
J:81818
|
| trabecula carnea hypoplasia
|
J:81818
|
Ncor1tm1.1Ics/Ncor1tm1.1Ics
Tg(ACTA1-cre)79Jme/0
(involves: 129 * C57BL/6 * C57BL/6J * SJL)
|
abnormal gastrocnemius morphology
|
J:178827
|
| abnormal muscle physiology
|
J:178827
|
| abnormal quadriceps morphology
|
J:178827
|
| abnormal skeletal muscle fiber mitochondrial morphology
|
J:178827
|
| abnormal skeletal muscle morphology
|
J:178827
|
| abnormal soleus morphology
|
J:178827
|
| increased skeletal muscle fiber diameter
|
J:178827
|
nd/nd
(129/Sv-nd)
|
muscle hypertonia
|
J:24834
|
Ndntm1Stw/Ndn+
(involves: 129S1/Sv * C57BL/6)
|
hypotonia
|
J:57890
|
Ndntm2Stw/Ndn+
(involves: 129S1/Sv * C57BL/6)
|
hypotonia
|
J:57890
|
Ndnfem1Nou/Ndnfem1Nou
(C57BL/6J-Ndnfem1Nou)
|
skeletal muscle atrophy
|
J:322617
|
Ndrg1str/Ndrg1str
(involves: BALB/c * C57BL/6 * NOD/ShiLtWtsi)
|
skeletal muscle atrophy
|
J:172770
|
Ndrg1tm1Myta/Ndrg1tm1Myta
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
skeletal muscle atrophy
|
J:172770
|
Ndrg4tm1b(KOMP)Wtsi/Ndrg4tm1b(KOMP)Wtsi
(C57BL/6N-Ndrg4tm1b(KOMP)Wtsi/H)
|
decreased cardiac muscle contractility
|
J:211773
|
Ndst1b2b2230Clo/Ndst1b2b2230Clo
(C57BL/6J-Ndst1b2b2230Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
Ndst1tm1Je/Ndst1tm1Je
Robo4tm1Kzh/Robo4+
Tg(Tek-cre)1Ywa/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
abnormal diaphragm morphology
|
J:208012
|
| diaphragmatic hernia
|
J:208012
|
Ndst1tm1Je/Ndst1tm1Je
Robo4tm1Kzh/Robo4tm1Kzh
Tg(Tek-cre)1Ywa/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
abnormal diaphragm morphology
|
J:208012
|
| diaphragmatic hernia
|
J:208012
|
Ndst1tm1Je/Ndst1tm1Je
Slit3tm1.1Dor/Slit3+
Tg(Tek-cre)1Ywa/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
diaphragmatic hernia
|
J:208012
|
Ndst1tm1Je/Ndst1tm1Je
Slit3tm1.1Dor/Slit3tm1.1Dor
Tg(Tek-cre)1Ywa/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
diaphragmatic hernia
|
J:208012
|
Ndst1tm1Je/Ndst1tm1Je
Tg(Tek-cre)1Ywa/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
abnormal diaphragm central tendon morphology
|
J:208012
|
| abnormal diaphragm morphology
|
J:208012
|
| abnormal tendon cell morphology
|
J:208012
|
| abnormal tendon collagen fibril morphology
|
J:208012
|
| diaphragmatic hernia
|
J:208012
|
| thin diaphragm muscle
|
J:208012
|
Ndufs4tm1.1Rpa/Ndufs4tm1.1Rpa
(involves: 129S4/SvJaeSor)
|
abnormal muscle tone
|
J:161393
|
Ndufs4tm1.1Rpa/Ndufs4tm1.1Rpa
(B6.129S4-Ndufs4tm1.1Rpa)
|
hypotonia
|
J:190475
|
Ndufs4tm1Rpa/Ndufs4tm1Rpa
Tg(Nes-cre)1Kln/0
(involves: 129S4/SvJaeSor * C57BL/6 * SJL)
|
abnormal muscle tone
|
J:161393
|
Ndufs4tm1Rpa/Ndufs4tm1Rpa
Tg(Nes-cre)1Kln/0
(B6.Cg-Tg(Nes-cre)1Kln Ndufs4tm1Rpa)
|
hypotonia
|
J:190475
|
Ndufs6Gt(AR0138)Wtsi/Ndufs6Gt(AR0138)Wtsi
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal cardiac muscle relaxation
|
J:183619
|
| decreased ventricle muscle contractility
|
J:183619
|
Nebm1Anu/Nebm2Anu
(C57BL/6J-Nebm1Anu Nebm2Anu)
|
abnormal muscle fiber morphology
|
J:285564
|
| abnormal muscle physiology
|
J:285564
|
| abnormal skeletal muscle fiber type ratio
|
J:285564
|
| decreased skeletal muscle fiber diameter
|
J:285564
|
| decreased skeletal muscle fiber size
|
J:285564
|
| impaired skeletal muscle contractility
|
J:285564
|
| increased variability of skeletal muscle fiber size
|
J:285564
|
Nebtm1(cre)Chen/Nebtm1(cre)Chen
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss)
|
abnormal A band morphology
|
J:111470
|
| abnormal I band morphology
|
J:111470
|
| abnormal muscle fiber morphology
|
J:111470
|
| abnormal sarcomere morphology
|
J:111470
|
| abnormal Z line morphology
|
J:111470
|
| muscle phenotype
|
J:111470
|
Nebtm1.1Hgra/Nebtm1.1Hgra
(involves: C57BL/6 * C57BL/6J * SJL)
|
abnormal muscle physiology
|
J:206854
|
| abnormal sarcomere morphology
|
J:206854
|
| abnormal skeletal muscle fiber morphology
|
J:206854
|
| abnormal Z line morphology
|
J:206854
|
| decreased skeletal muscle fiber size
|
J:206854
|
| muscle weakness
|
J:206854
|
Nebtm1Slbt/Nebtm1Slbt
(involves: 129P2/OlaHsd)
|
abnormal H zone morphology
|
J:119578
|
| abnormal muscle contractility
|
J:119578
|
| abnormal sarcomere morphology
|
J:119578
|
| progressive muscle weakness
|
J:119578
|
Nebtm2.1Chen/Nebtm2.1Chen
(involves: 129 * Black Swiss)
|
abnormal muscle electrophysiology
|
J:211217
|
| muscle phenotype
|
J:211217
|
Nebtm2Hgra/Nebtm2Hgra
Tg(Ckmm-cre)5Khn/0
(involves: 129S6/SvEvTac * FVB)
|
abnormal A band morphology
|
J:225840
|
| abnormal H zone morphology
|
J:225840
|
| abnormal muscle fiber morphology
|
J:225840
|
| abnormal sarcomere morphology
|
J:225840
|
| abnormal skeletal muscle fiber size
|
J:225840
|
| abnormal skeletal muscle fiber type ratio
|
J:225840
|
| abnormal Z line morphology
|
J:225840
|
| decreased quadriceps weight
|
J:225840
|
| decreased skeletal muscle weight
|
J:225840
|
| impaired skeletal muscle contractility
|
J:225840
|
| increased skeletal muscle fiber number
|
J:225840
|
Nebltm1.1Epu/Nebltm1.1Epu
(involves: 129S/SvEv * C57BL/6)
|
abnormal myocardial fiber morphology
|
J:304786
|
| abnormal sarcomere morphology
|
J:304786
|
| decreased cardiac muscle relaxation
|
J:304786
|
| increased myocardial fiber size
|
J:304786
|
Nedd4Gt(XA209)Byg/Nedd4Gt(XA209)Byg
(involves: 129P2/OlaHsd)
|
centrally nucleated skeletal muscle fibers
|
J:207675
|
| delayed muscle development
|
J:207675
|
| increased variability of skeletal muscle fiber size
|
J:207675
|
Nedd4ltm1.2Blyg/Nedd4ltm1.2Blyg
(involves: 129X1/SvJ * C57BL/6J)
|
decreased cardiac muscle contractility
|
J:148641
|
Nek6tm1Dgen/Nek6tm1Dgen
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased cardiac muscle contractility
|
J:215160
|
| increased myocardial fiber size
|
J:215160
|
Nemfem8Cx/Nemfem8Cx
(C57BL/6J-Nemfem8Cx/Cx)
|
muscular atrophy
|
J:296528
|
Nemfpdft/Nemfpdft
(B6(C3)-Nemfpdft/Cx)
|
muscular atrophy
|
J:296528
|
Nemftvrm116/Nemftvrm116
(C57BL/6J-Nemftvrm116/PjnCx)
|
muscular atrophy
|
J:296528
|
Neu1tm1Adz/Neu1tm1Adz
(either: (involves: 129S1/Sv * C57BL/6) or (involves: 129S1/Sv * NMRI))
|
myoclonus
|
J:76937
|
Neu2em1Kyp/Neu2em1Kyp
(C57BL/6J-Neu2em1Kyp)
|
abnormal muscle morphology
|
J:321653
|
| decreased skeletal muscle fiber number
|
J:321653
|
| increased muscle free fatty acids level
|
J:321653
|
Neurl2tm1Adz/Neurl2tm1Adz
(involves: 129S1/Sv * C57BL/6)
|
abnormal skeletal muscle morphology
|
J:90054
|
Nexnem1Chen/Nexnem1Chen
(C57BL/6J-Nexnem1Chen)
|
abnormal myocardial fiber morphology
|
J:301807
|
| decreased cardiac muscle contractility
|
J:301807
|
| dilated cardiomyopathy
|
J:301807
|
Nexntm1.1Chen/Nexntm1.1Chen
(Not Specified)
|
decreased cardiac muscle contractility
|
J:290931
|
| dilated cardiomyopathy
|
J:290931
|
Nexntm1.1Zhh/Nexn+
(involves: C57BL/6NTac)
|
dilated cardiomyopathy
|
J:228046
|
Nexntm1.1Zhh/Nexntm1.1Zhh
(involves: C57BL/6NTac)
|
decreased cardiac muscle contractility
|
J:228046
|
| dilated cardiomyopathy
|
J:228046
|
Nexntm1Chen/Nexntm1Chen
Tg(myl7.L-cre)1118Tmhn/0
(involves: MF1)
|
abnormal myocardial fiber morphology
|
J:290931
|
| dilated cardiomyopathy
|
J:290931
|
Nexntm1Chen/Nexntm1Chen
Tg(Tnnt2-cre)5Blh/0
(involves: C57BL/6 * DBA/2)
|
dilated cardiomyopathy
|
J:290931
|
Nf1tm1Fcr/Nf1+
Trp53tm1Tyj/Trp53+
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6)
|
increased leiomyosarcoma incidence
|
J:58877
|
| increased rhabdomyosarcoma incidence
|
J:58877
|
Nf1tm1Fcr/Nf1tm1Fcr
(either: (involves: 129S/SvEv) or (involves: 129S/SvEv * C57BL/6J))
|
abnormal muscle morphology
|
J:18048
|
| delayed muscle development
|
J:18048
|
| disorganized myocardium
|
J:18048
|
| skeletal muscle hypoplasia
|
J:18048
|
Nf1tm1Par/Nf1tm1Par
Tg(Prrx1-cre)1Cjt/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * SJL/J)
|
abnormal muscle development
|
J:173779
|
| abnormal muscle fiber morphology
|
J:173779
|
| abnormal muscle morphology
|
J:173779
|
| abnormal muscle physiology
|
J:173779
|
| abnormal myoblast differentiation
|
J:173779
|
| abnormal myogenesis
|
J:173779
|
| decreased muscle weight
|
J:173779
|
| decreased skeletal muscle fiber number
|
J:173779
|
| decreased skeletal muscle mass
|
J:173779
|
| increased myoblast proliferation
|
J:173779
|
| skeletal muscle fibrosis
|
J:173779
|
Nf1tm1Par/Nf1tm1Par
Tg(Tek-cre)1Ywa/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
thin myocardium
|
J:80323
|
| thin myocardium compact layer
|
J:80323
|
Nf1tm1Tyj/Nf1tm1Tyj
(involves: 129S2/SvPas * C57BL/6)
|
abnormal myocardium layer morphology
|
J:18542
|
Nf1tm1Tyj/Nf1tm2Tyj
(chimera involves: 129S2/SvPas)
|
abnormal muscle morphology
|
J:58876
|
Nf2tm2Gth/Nf2+
Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * 129S7/SvEvBrd)
|
increased uterus leiomyoma incidence
|
J:132943
|
Nf2tm2Gth/Nf2tm2Gth
Trp53tm1Brd/Trp53+
Tg(Mpz-cre)2Brn/0
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * FVB/N)
|
increased leiomyosarcoma incidence
|
J:92413
|
Nf2tm2Gth/Nf2tm2Gth
Trp53tm1Brd/Trp53tm1Brd
Tg(Mpz-cre)2Brn/0
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * FVB/N)
|
increased rhabdomyosarcoma incidence
|
J:92413
|
Nf2tm2Gth/Nf2tm2Gth
Trp53tm1Brn/Trp53+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd)
|
increased uterus leiomyoma incidence
|
J:132943
|
Nf2tm2Gth/Nf2tm2Gth
Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * 129S7/SvEvBrd)
|
increased rhabdomyosarcoma incidence
|
J:132943
|
| increased uterus leiomyoma incidence
|
J:132943
|
Nfat5tm1Skc/Nfat5tm1Skc
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal fetal cardiomyocyte proliferation
|
J:175527
|
| abnormal myocardial trabeculae morphology
|
J:175527
|
| abnormal myocardium compact layer morphology
|
J:175527
|
Nfatc1tm1(cre)Bz/Nfatc1+
Smarca4tm1.2Pcn/Smarca4tm1.2Pcn
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ)
|
cardiomyopathy
|
J:226941
|
Nfatc1tm1.1(cre)Bz/Nfatc1+
Smarca4tm1.2Pcn/Smarca4tm1.2Pcn
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ)
|
thick myocardium
|
J:226941
|
Nfatc2tm1Glm/Nfatc2tm1Glm
Nfatc3tm1Glm/Nfatc3tm1Glm
Nfatc4tm1Grc/Nfatc4tm1Grc
(involves: 129S2/SvPas)
|
hypotonia
|
J:109139
|
Nfatc2tm1Glm/Nfatc2tm1Glm
Nfatc4tm1Grc/Nfatc4tm1Grc
(involves: 129S2/SvPas)
|
hypotonia
|
J:109139
|
Nfatc3tm1Glm/Nfatc3tm1Glm
(involves: 129S2/SvPas)
|
abnormal skeletal muscle morphology
|
J:68675
|
| decreased extensor digitorum longus weight
|
J:68675
|
| decreased skeletal muscle fiber number
|
J:68675
|
| decreased soleus weight
|
J:68675
|
| muscle weakness
|
J:68675
|
Nfatc3tm1Glm/Nfatc3tm1Glm
Nfatc4tm1Grc/Nfatc4tm1Grc
(involves: 129S2/SvPas)
|
trabecula carnea hypoplasia
|
J:84138
|
Nfatc3tm1Glm/Nfatc3tm1Glm
Nfatc4tm1Jmk/Nfatc4tm1Jmk
(involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6)
|
abnormal myocardial fiber mitochondrial morphology
|
J:84138
|
| abnormal myocardium compact layer morphology
|
J:84138
|
| abnormal myocardium layer morphology
|
J:84138
|
| abnormal trabecula carnea morphology
|
J:84138
|
Nfatc4tm1Jmk/Nfatc4tm1Jmk
Tg(Myh6-Ppp3ca)37Eno/?
(involves: 129S7/SvEvBrd * C57BL/6 * FVB)
|
abnormal myocardium layer morphology
|
J:79608
|
Nfkb1tm1Bal/Nfkb1tm1Bal
(B6;129P-Nfkb1tm1Bal/J)
|
muscle phenotype
|
J:135692
|
Ngftm1.1Blhe/Ngf+
(B6.Cg-Ngftm1.1Blhe)
|
abnormal myocardial fiber morphology
|
J:190893
|
| abnormal myocardium layer morphology
|
J:190893
|
| decreased cardiac muscle contractility
|
J:190893
|
| dilated cardiomyopathy
|
J:190893
|
| thin myocardium
|
J:190893
|
Ngftm1.1Blhe/Ngf+
Sort1tm1Tew/Sort1tm1Tew
(B6.Cg-Ngftm1.1Blhe Sort1tm1Tew)
|
dilated cardiomyopathy
|
J:190893
|
Ngfrtm1Jae/Ngfrtm1Jae
(involves: 129S4/SvJae * BALB/c)
|
abnormal muscle morphology
|
J:53825
|
| decreased muscle spindle number
|
J:53825
|
Ngfrtm1Jae/Ngfrtm1Jae
Ntf3tm1Jae/Ntf3+
(involves: 129S4/SvJae * BALB/c)
|
abnormal muscle morphology
|
J:53825
|
| absent muscle spindles
|
J:53825
|
| decreased muscle spindle number
|
J:53825
|
| dystonia
|
J:53825
|
| muscle spasm
|
J:53825
|
Nhlrc1tm1(KOMP)Vlcg/Nhlrc1tm1(KOMP)Vlcg
(involves: C57BL/6J * C57BL/6NTac)
|
increased cardiac muscle glycogen level
|
J:165994
|
| increased skeletal muscle glycogen level
|
J:165994,
J:218959
|
Nhlrc1tm1.2Geno/Nhlrc1tm1.2Geno
(involves: 129S2/SvPas * C57BL/6J)
|
myoclonus
|
J:181559
|
Nhlrc1tm1Bmin/Nhlrc1tm1Bmin
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NCr)
|
increased skeletal muscle glycogen level
|
J:181674
|
Nid1tm1Dong/Nid1tm1Dong
(involves: 129P2/OlaHsd)
|
abnormal muscle physiology
|
J:80843
|
NipblGt(RRS564)Byg/Nipbl+
(involves: 129P2/OlaHsd * CD-1)
|
abnormal myocardium compact layer morphology
|
J:154117
|
| abnormal ventricle myocardium morphology
|
J:154117
|
Nkx2-3tm1Rph/Nkx2-3tm1Rph
(involves: 129S1/Sv * C57BL/6)
|
abnormal intestinal peristalsis
|
J:64018
|
Nkx2-5em1Dsr/Nkx2-5em1Dsr
(involves: C57BL/6J)
|
abnormal trabecula carnea morphology
|
J:277399
|
| thin myocardium
|
J:277399
|
Nkx2-5tm1.1Burg/Nkx2-5tm1.1Burg
(involves: 129S1/Sv * 129S2/SvPasCrl * 129X1/SvJ)
|
abnormal trabecula carnea morphology
|
J:251389
|
| thin myocardium
|
J:251389
|
Nkx2-5tm1.1Gum/Nkx2-5tm1.1Gum
Tg(CAG-cre/Esr1*)5Amc/0
(involves: C57BL/6J)
|
abnormal pyloric sphincter morphology
|
J:228275
|
| abnormal stomach smooth muscle circular layer morphology
|
J:228275
|
| abnormal stomach smooth muscle outer longitudinal layer morphology
|
J:228275
|
Nkx2-5tm1.1Hkas/Nkx2-5+
(129S2.Cg-Nkx2-5tm1.1Hkas)
|
abnormal atrioventricular node morphology
|
J:273097
|
| abnormal left posterior bundle morphology
|
J:273097
|
| cardiomyopathy
|
J:273096
|
Nkx2-5tm1Krc/Nkx2-5tm1Krc
Isl1tm1(cre)Tmj/Isl1+
(involves: 129X1/SvJ * C57BL/6)
|
abnormal myocardial trabeculae morphology
|
J:214093
|
Nkx2-5tm1Siz/Nkx2-5+
(involves: 129S4/SvJaeSor)
|
abnormal Purkinje fiber morphology
|
J:89216
|
| decreased ventricle muscle contractility
|
J:174208
|
Nkx2-5tm1Siz/Nkx2-5tm1Siz
(involves: 129S4/SvJaeSor * C57BL/6J)
|
absent myocardial trabeculae
|
J:52597
|
Nkx2-5tm1Wehi/Nkx2-5tm1Wehi
(involves: 129P2/OlaHsd * C57BL/6J * C57BL/10)
|
abnormal myocardium layer morphology
|
J:27443
|
| abnormal myogenesis
|
J:27443
|
| absent trabeculae carneae
|
J:27443
|
| disorganized myocardium
|
J:27443
|
Nkx2-5tm2.1Mwc/Nkx2-5+
(B6J.Cg-Nkx2-5tm2.1Mwc/Mwc)
|
atrioventricular node hypoplasia
|
J:239808
|
| decreased ventricle muscle contractility
|
J:239808
|
Nkx2-5tm2Siz/Nkx2-5+
(involves: 129S4/SvJaeSor)
|
abnormal atrioventricular node morphology
|
J:89216
|
| abnormal impulse conducting system morphology
|
J:89216
|
| abnormal Purkinje fiber morphology
|
J:89216
|
Nkx2-5tm2Siz/Nkx2-5tm2Siz
(involves: 129S4/SvJaeSor)
|
absent atrioventricular node
|
J:89216
|
Nkx2-5tm3.1Mwc/Nkx2-5+
(B6J.Cg-Nkx2-5tm3.1Mwc/Mwc)
|
abnormal atrioventricular node morphology
|
J:239808
|
| decreased ventricle muscle contractility
|
J:239808
|
Nkx2-5tm4Rph/Nkx2-5+
(involves: 129S1/Sv)
|
decreased ventricle muscle contractility
|
J:98489
|
Nkx2-5tm4Rph/Nkx2-5+
Tbx20tm1.1Rph/Tbx20+
(involves: 129S1/Sv * C57BL/6)
|
decreased ventricle muscle contractility
|
J:98489
|
| dilated cardiomyopathy
|
J:98489
|
| myocardial fiber disarray
|
J:98489
|
Nkx2-5tm4Rph/Nkx2-5tm4Rph
(either: (involves: 129S1/Sv * 129T2/SvEms) or (involves: 129S1/Sv * C57BL/6J))
|
abnormal myocardium layer morphology
|
J:81343
|
Nkx2-5tm6Rph/Nkx2-5+
Tg(DMPK/tetO-EGFP/DMPK)5-313Masm/0
(involves: 129S1/Sv * FVB/N)
|
impaired muscle relaxation
|
J:131302
|
Nkx2-5tm6Rph/Nkx2-5+
Tg(DMPK/tetO-EGFP/DMPK)5-313Masm/Tg(DMPK/tetO-EGFP/DMPK)5-313Masm
(involves: 129S1/Sv * FVB/N)
|
impaired muscle relaxation
|
J:131302
|
Nkx3-2tm1(cre)Tsa/Nkx3-2+
Nr2f2tm2.1Tsa/Nr2f2tm2.1Tsa
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal stomach smooth muscle circular layer morphology
|
J:98520
|
nm3/nm3
(involves: RIIIS/J)
|
muscle phenotype
|
J:88298
|
nma/nma
(B6C3Fe a/a-nma/J)
|
muscle phenotype
|
J:60439
|
Nmf31/Nmf31
(BALB/cByJ-Nmf31/J)
|
myoclonus
|
J:87349
|
nmf67/nmf67
(C57BL/6J-nmf67/J)
|
muscle weakness
|
J:82238
|
nmf118/nmf118
(C57BL/6J-nmf118/J)
|
muscle degeneration
|
J:87349
|
nmf161/nmf161
(C57BL/6J-nmf161/J)
|
muscle spasm
|
J:82238
|
nmf242/nmf242
(C57BL/6J-nmf242/J)
|
muscle spasm
|
J:82238
|
nmf347/nmf347
(C57BL/6J-nmf347/J)
|
muscle spasm
|
J:87349
|
nmf356/nmf356
(C57BL/6J-nmf356/J)
|
muscle spasm
|
J:87349
|
| muscle weakness
|
J:87349
|
nmf391/nmf391
(C57BL/6J-nmf391/J)
|
dystrophic muscle
|
J:87349
|
| muscle weakness
|
J:87349
|
| myoclonus
|
J:87349
|
nmf418/nmf418
(B6;CByJ-nmf418/J)
|
muscle phenotype
|
J:87349
|
| muscle spasm
|
J:87349
|
| muscle weakness
|
J:87349
|
Nmnat2Gt(EUCE0262a08)Hmgu/Nmnat2Gt(EUCE0262a08)Hmgu
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal diaphragm development
|
J:200901
|
| decreased muscle weight
|
J:200901
|
| decreased skeletal muscle mass
|
J:192196
|
Nmnat2Gt(EUCE0262a08)Hmgu/Nmnat2Gt(EUCE0262a08)Hmgu
Wlds/+
(involves: 129P2/OlaHsd * C57BL/6J * C57BL/6Ola)
|
muscle phenotype
|
J:200901
|
Nmnat2Tn(sb-Tyr)2172.P9KK4BOve/Nmnat2Tn(sb-Tyr)2172.P9KK4BOve
(involves: FVB/N)
|
abnormal diaphragm development
|
J:192196
|
| decreased skeletal muscle mass
|
J:192196
|
NodalTgR(MPSVNeo)413.dRob/Nodaltm6Rob
(involves: 129S/SvEv * C57BL/6)
|
thin myocardium compact layer
|
J:94418
|
| trabecula carnea hypoplasia
|
J:94418
|
Nogtm1Amc/Nogtm1Amc
(involves: 129S1/Sv * CD-1)
|
abnormal muscle fiber morphology
|
J:108573
|
| abnormal muscle morphology
|
J:108573
|
Nol3tm1Rvh/Nol3tm1Rvh
(involves: C57BL/6)
|
decreased ventricle muscle contractility
|
J:121501
|
| increased cardiomyocyte apoptosis
|
J:121501
|
Nos1tm1Plh/Nos1tm1Plh
(involves: 129S4/SvJae * C57BL/6)
|
abnormal cardiac muscle relaxation
|
J:103346
|
| abnormal muscle physiology
|
J:104916
|
| decreased cardiac muscle contractility
|
J:75645
|
| heart left ventricle hypertrophy
|
J:75645
|
| increased ventricle muscle contractility
|
J:103346
|
| pyloric sphincter hypertrophy
|
J:16390
|
| stomach smooth muscle circular layer hypertrophy
|
J:16390
|
Nos1tm1Plh/Nos1tm1Plh
(involves: 129S4/SvJae)
|
abnormal gastroesophageal sphincter physiology
|
J:70182,
J:56948
|
| abnormal muscle physiology
|
J:89581
|
| abnormal muscle relaxation
|
J:56948,
J:89581
|
Nos1tm1Plh/Nos1tm1Plh
(involves: 129S4/SvJae * C57BL/6J)
|
pyloric sphincter hypertrophy
|
J:64225
|
Nos1tm1Plh/Nos1tm1Plh
(involves: 129S4/SvJae * C57BL/10ScSn)
|
muscle phenotype
|
J:48851
|
Nos1tm1Plh/Nos1tm1Plh
(B6.129S4-Nos1tm1Plh/J)
|
decreased skeletal muscle weight
|
J:144588
|
| impaired skeletal muscle contractility
|
J:144588
|
| increased muscle fatigability
|
J:144588
|
Nos1tm1Plh/Nos1tm1Plh
Nos2tm1Mrl/Nos2tm1Mrl
Nos3tm1Plh/Nos3tm1Plh
(involves: 129S4/SvJae * 129S7/SvEvBrd)
|
pyloric sphincter hypertrophy
|
J:100308
|
Nos1tm1Plh/Nos1tm1Plh
Nos3tm1Plh/Nos3tm1Plh
(B6.129S4-Nos3tm1Plh Nos1tm1Plh)
|
abnormal cardiac muscle relaxation
|
J:129064
|
| heart left ventricle hypertrophy
|
J:129064
|
| increased cardiac muscle contractility
|
J:129064
|
Nos1tm1Plh/Nos1tm1Plh
Nos3tm1Plh/Nos3tm1Plh
(involves: 129S4/SvJae * C57BL/6)
|
abnormal cardiac muscle relaxation
|
J:75645
|
| decreased cardiac muscle contractility
|
J:75645
|
| heart left ventricle hypertrophy
|
J:75645
|
| increased cardiac muscle contractility
|
J:75645
|
Nos1aptm1Tsso/Nos1aptm1Tsso
(involves: C57BL/6JJcl)
|
decreased cardiac muscle contractility
|
J:268528
|
Nos2tm1Lau/Nos2tm1Lau
(B6.129P2-Nos2tm1Lau)
|
abnormal myocardium layer morphology
|
J:71505
|
Nos2tm1Mrl/Nos2tm1Mrl
Tg(Myh6-Tnf)1.6Amf/?
(involves: 129S7/SvEvBrd * C57BL/6 * FVB)
|
abnormal cardiac muscle contractility
|
J:109732
|
| decreased cardiac muscle contractility
|
J:109732
|
Nos3tm1Gdk/Nos3tm1Gdk
(involves: 129P2/OlaHsd * C57BL/6)
|
increased vasoconstriction
|
J:46061
|
Nos3tm1Plh/Nos3tm1Plh
(involves: 129S4/SvJae)
|
abnormal vasodilation
|
J:112419
|
| decreased vasodilation
|
J:28778
|
| increased vasoconstriction
|
J:57624
|
| muscle phenotype
|
J:56948
|
Nos3tm1Plh/Nos3tm1Plh
(involves: 129S4/SvJae * C57BL/6)
|
decreased cardiac muscle contractility
|
J:75645
|
| heart left ventricle hypertrophy
|
J:75645
|
| increased cardiac muscle contractility
|
J:75645
|
Nos3tm1Unc/Nos3+
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased vasodilation
|
J:54772
|
Nos3tm1Unc/Nos3tm1Unc
(B6.129P2-Nos3tm1Unc/J)
|
decreased cardiac muscle contractility
|
J:103270
|
| increased ventricle muscle contractility
|
J:98094
|
Nos3tm1Unc/Nos3tm1Unc
(involves: 129P2/OlaHsd)
|
decreased cardiac muscle contractility
|
J:102136
|
| decreased vasodilation
|
J:103153
|
Nos3tm1Unc/Nos3tm1Unc
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal vasodilation
|
J:54772
|
| increased vasoconstriction
|
J:54772
|
Nos3tm1Weo/Nos3tm1Weo
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal cardiac muscle relaxation
|
J:51563
|
Nos3tm2.1Plh/Nos3tm2.1Plh
(involves: 129S4/SvJae * C57BL/6)
|
decreased vasodilation
|
J:198075
|
Notch1tm1Agt/Notch1tm1Agt
Tg(Tek-cre)1Ywa/0
(involves: 129 * C57BL/6 * SJL)
|
thin myocardium
|
J:100449
|
Notch1tm1Agt/Notch1tm1Agt
Tg(Tek-cre)12Flv/0
(involves: 129 * C3H * C57BL/6)
|
thin myocardium
|
J:100449
|
Notch1tm1Agt/Notch1tm1Agt
Tg(Wt1-cre)#Jbeb/0
(involves: 129)
|
myocardium hypoplasia
|
J:178290
|
| thin myocardium compact layer
|
J:178290
|
Notch1tm1Con/Notch1tm1Con
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal myocardium layer morphology
|
J:119151
|
| disorganized myocardium
|
J:119151
|
| trabecula carnea hypoplasia
|
J:119151
|
Notch1tm1Grid/Notch1+
Notch3tm1Grid/Notch3tm1Grid
(involves: 129S1/Sv * C57BL/6)
|
abnormal vascular smooth muscle morphology
|
J:227333
|
Notch2tm1Grid/Notch2tm1Grid
(involves: 129S1/Sv * C57BL/6J)
|
abnormal myocardial trabeculae morphology
|
J:67157
|
Notch2tm3Grid/Notch2tm3.1Grid
Pax3tm1(cre)Joe/Pax3+
(involves: 129 * C57BL/6)
|
abnormal vascular smooth muscle morphology
|
J:132939
|
Notch3hpbk/Notch3hpbk
(C57BL/6J-Notch3hpbk/GrsrJ)
|
myopathy
|
J:157222
|
| skeletal muscle atrophy
|
J:157222
|
Notch3tm1Grid/Notch3tm1Grid
(involves: 129S1/Sv)
|
abnormal vascular smooth muscle morphology
|
J:94047
|
Notch3tm1Grid/Notch3tm1Grid
(involves: 129S1/Sv * C57BL/6)
|
abnormal vascular smooth muscle morphology
|
J:227333
|
Notumem150Sinn/Notumem150Sinn
(Not Specified)
|
abnormal tracheal smooth muscle morphology
|
J:260471
|
Nox1tm1Cyn/Y
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal vasodilation
|
J:116837
|
Nox4tm1.1Jusa/Nox4tm1.1Jusa
Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6 * FVB)
|
decreased cardiac muscle contractility
|
J:163751
|
| decreased cardiomyocyte apoptosis
|
J:163751
|
| decreased ventricle muscle contractility
|
J:163751
|
| heart left ventricle hypertrophy
|
J:163751
|
Npas4tm1Ooe/Npas4tm1Ooe
(involves: 129/Sv * C57BL/6)
|
myoclonus
|
J:145569
|
Npattm1b(EUCOMM)Wtsi/Npattm1b(EUCOMM)Wtsi
(C57BL/6N-Npattm1b(EUCOMM)Wtsi/Wtsi)
|
abnormal digastric muscle morphology
|
J:239583
|
| abnormal infrahyoid muscle morphology
|
J:239583
|
Nplem1Avps/Nplem1Avps
(C57BL/6-Nplem1Avps)
|
decreased skeletal muscle fiber size
|
J:342764
|
| muscle phenotype
|
J:342764
|
| muscle weakness
|
J:342764
|
Nplem2Avps/Nplem2Avps
(C57BL/6-Nplem2Avps)
|
muscle phenotype
|
J:342764
|
| muscle weakness
|
J:342764
|
Nppatm1Unc/Nppa+
(involves: 129P2/OlaHsd * C57BL/6J)
|
heart right ventricle hypertrophy
|
J:64898
|
Nppatm1Unc/Nppatm1Unc
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal vascular smooth muscle morphology
|
J:54986
|
| heart left ventricle hypertrophy
|
J:54986
|
| heart right ventricle hypertrophy
|
J:54986,
J:64898
|
Nppbtm1Yog/Nppbtm1Yog
(either: 129X1/SvJ or (involves: 129 * C57BL/6J))
|
abnormal myocardial fiber morphology
|
J:61680
|
Npr1tm1Gar/Npr1tm1Gar
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal vasodilation
|
J:42893
|
Npr1tm1Kuhn/Npr1tm1Kuhn
Tg(Myh6-cre)2182Mds/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
abnormal cardiac muscle relaxation
|
J:83298
|
| abnormal myocardial fiber morphology
|
J:83298
|
Npr1tm1Kuhn/Npr1tm1Kuhn
Tg(Tagln-cre)1Her/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
abnormal vasodilation
|
J:76460
|
Npr1tm1Mae/Npr1tm1Mae
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal myocardium layer morphology
|
J:74420
|
| myocardium necrosis
|
J:74420
|
Npr2slw/Npr2slw
(involves: C57BL/6 * DDY)
|
abnormal pyloric sphincter morphology
|
J:163374
|
| impaired muscle relaxation
|
J:163374
|
Nprl3tm1.1Drhi/Nprl3tm1.1Drhi
(involves: 129P2/OlaHsd)
|
abnormal myocardial trabeculae morphology
|
J:183988
|
| abnormal ventricle myocardium morphology
|
J:183988
|
| thin ventricle myocardium compact layer
|
J:183988
|
Npy1rtm1Tped/Npy1rtm1Tped
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal vasoconstriction
|
J:47972
|
Nr1d1tm1Ven/Nr1d1tm1Ven
(Not Specified)
|
abnormal skeletal muscle fiber type ratio
|
J:95758
|
| increased skeletal muscle fiber size
|
J:95758
|
Nr1h2tm1.1Nph/Nr1h2tm1.1Nph
(B6.129-Nr1h2tm1.1Nph)
|
increased muscle cell glucose uptake
|
J:169945
|
Nr1h2tm1Djm/Nr1h2tm1Djm
(involves: 129S6/SvEvTac * C57BL/6)
|
impaired smooth muscle contractility
|
J:120923
|
Nr1h2tm1Djm/Nr1h2tm1Djm
Nr1h3tm1Djm/Nr1h3tm1Djm
(involves: 129S6/SvEvTac * C57BL/6)
|
impaired smooth muscle contractility
|
J:120923
|
Nr2f1tm1Mjts/Nr2f1+
(involves: 129S7/SvEvBrd)
|
hypotonia
|
J:286647
|
Nr2f2tm1Tsa/Nr2f2tm1Tsa
(either: 129S7/SvEvBrd or C57BL/6 or (involves: 129S7/SvEvBrd * C57BL/6 * ICR))
|
absent trabeculae carneae
|
J:54469
|
Nr3c1tm1.1Jaci/Nr3c1tm1.1Jaci
Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6 * FVB/N)
|
decreased cardiac muscle contractility
|
J:201995
|
| increased myocardial fiber size
|
J:201995
|
Nr3c2tm1.1Ics/Nr3c2tm1.1Ics
Tg(Acta2-cre/ERT2)#Pcn/0
(involves: 129S2/SvPas * FVB/N)
|
abnormal muscle tone
|
J:193438
|
| abnormal vasoconstriction
|
J:193438
|
| abnormal vasodilation
|
J:193438
|
| decreased vasoconstriction
|
J:193438
|
| increased vasoconstriction
|
J:193438
|
| increased vasodilation
|
J:193438
|
Nrastm1Tyj/Nras+
Meox2tm1(cre)Sor/Meox2+
(B6.Cg-Nrastm1Tyj Meox2tm1(cre)Sor)
|
abnormal myocardial trabeculae morphology
|
J:305401
|
| thin myocardium
|
J:305401
|
| thin ventricle myocardium compact layer
|
J:305401
|
Nrastm1Tyj/Nras+
Tg(Tek-cre)1Ywa/0
(B6.Cg-Nrastm1Tyj Tg(Tek-cre)1Ywa)
|
abnormal myocardial trabeculae morphology
|
J:305401
|
| thin ventricle myocardium compact layer
|
J:305401
|
Nrcamm1J/Nrcamm1J
Sh3tc2m1J/Sh3tc2m1J
(B6.Cg-Nrcamm1J Sh3tc2m1J/GrsrRwb)
|
muscular atrophy
|
J:240096
|
Nrg1tm1Cbm/Nrg1+
(involves: 129P2/OlaHsd)
|
decreased ventricle muscle contractility
|
J:100313
|
Nrg1tm1Cbm/Nrg1tm1Cbm
(involves: 129P2/OlaHsd * C57BL/6)
|
trabecula carnea hypoplasia
|
J:29971
|
Nrg1tm1Cbm/Nrg1tm1Cbm
(involves: 129P2/OlaHsd)
|
abnormal myocardium layer morphology
|
J:119151
|
Nrg1tm1Cbm/Nrg1tm3Cbm
Isl1tm1(cre)Tmj/Isl1+
(involves: 129P2/OlaHsd * 129X1/SvJ)
|
abnormal muscle spindle morphology
|
J:80793
|
Nrg1tm1Gne/Nrg1tm1Gne
(either: (involves: 129S2/SvPas * BALB/c) or (involves: 129S2/SvPas * C57BL/6J))
|
absent trabeculae carneae
|
J:45302
|
Nrg1tm1Leth/Nrg1tm1Leth
(involves: 129S1/Sv * C57BL/6)
|
decreased cardiac muscle contractility
|
J:33038
|
| trabecula carnea hypoplasia
|
J:33038
|
Nrg1tm1Lwr/Nrg1tm1Lwr
(129/Sv-Nrg1tm1Lwr)
|
abnormal intercostal muscle morphology
|
J:60159
|
| centrally nucleated skeletal muscle fibers
|
J:60159
|
| thin diaphragm muscle
|
J:60159
|
Nrg1tm1Lwr/Nrg1tm1Lwr
(involves: 129)
|
muscle phenotype
|
J:80793
|
Nrg1tm1Zhou/Nrg1tm1Zhou
(involves: 129S1/Sv * C57BL/6)
|
trabecula carnea hypoplasia
|
J:50592
|
Nrg1tm2Cbm/Nrg1tm2Cbm
(involves: 129P2/OlaHsd * C57BL/6)
|
trabecula carnea hypoplasia
|
J:29971
|
Nrg1tm3Cbm/Nrg1tm3Cbm
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal muscle spindle morphology
|
J:199150
|
| decreased muscle spindle number
|
J:199150
|
Nrg1tm4.1Cbm/Nrg1+
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)
|
decreased muscle spindle number
|
J:199150
|
Nrg1tm4Cbm/Nrg1tm4.1Cbm
H2az2Tg(Wnt1-cre)11Rth/H2az2+
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6J * CBA/J)
|
abnormal muscle spindle morphology
|
J:199150
|
| decreased muscle spindle number
|
J:199150
|
Nrp1tm1.1Izac/Nrp1tm1.1Izac
(involves: 129S2/SvPas * C57BL/6)
|
vascular smooth muscle hypoplasia
|
J:208348
|
Nrp2tm1.2Mom/Nrp2+
(involves: 129P2/OlaHsd * C57BL/6 * FVB/NJ)
|
myoclonus
|
J:166116
|
Nrp2tm1.2Mom/Nrp2tm1.2Mom
(involves: 129P2/OlaHsd * C57BL/6 * FVB/NJ)
|
myoclonus
|
J:166116
|
Nrtntm1Jmi/Nrtntm1Jmi
(involves: 129X1/SvJ * C57BL/6)
|
impaired smooth muscle contractility
|
J:53261
|
| intestinal hypoperistalsis
|
J:82456
|
Nsun2tm1a(EUCOMM)Wtsi/Nsun2tm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Nsun2tm1a(EUCOMM)Wtsi/Wtsi)
|
abnormal eye muscle morphology
|
J:239583
|
| abnormal infrahyoid muscle connection
|
J:239583
|
Ntf3tm1(Bdnf)Tes/Ntf3tm1(Bdnf)Tes
(involves: 129S1/Sv)
|
absent muscle spindles
|
J:72304
|
Ntf3tm1Jae/Ntf3+
(involves: 129S4/SvJae * BALB/c)
|
abnormal muscle morphology
|
J:53825,
J:23882
|
Ntf3tm1Jae/Ntf3tm1Jae
(involves: 129S4/SvJae * BALB/c)
|
abnormal muscle morphology
|
J:23882
|
| absent golgi tendon organ
|
J:23882
|
| absent muscle spindles
|
J:23882
|
Ntf3tm1Jae/Ntf3tm1Jae
(involves: 129S4/SvJae)
|
absent muscle spindles
|
J:43444
|
Ntf3tm1Jae/Ntf3tm1Jae
(involves: 129S4/SvJae * C57BL/6)
|
absent muscle spindles
|
J:83461
|
Ntf3tm1Jae/Ntf3tm1Jae
Tg(Myog-Ntf3)5160Wds/0
(involves: C57BL/6 * CBA * CF-1)
|
abnormal muscle spindle morphology
|
J:43444
|
Ntf3tm1Lfr/Ntf3tm1Lfr
(involves: 129S2/SvPas)
|
abnormal muscle spindle morphology
|
J:132854
|
| absent muscle spindles
|
J:18984
|
Ntf3tm1Par/Ntf3tm1Par
(involves: 129S1/Sv)
|
abnormal atrium myocardial trabeculae morphology
|
J:35639
|
| atrium myocardium hypoplasia
|
J:35639
|
| vascular smooth muscle hypotrophy
|
J:35639
|
Ntf3tm1Tojo/Ntf3tm1Tojo
(involves: C57BL/6 * DBA/2 * ICR)
|
muscular atrophy
|
J:22369
|
Ntrk1tm2(Ntrk3)Apat/Ntrk1tm2(Ntrk3)Apat
(involves: 129S1/Sv)
|
increased muscle spindle number
|
J:92099
|
Ntsr1tm2Dgen/Ntsr1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
intestinal hypoperistalsis
|
J:126020
|
Ntsr1tm2Dgen/Ntsr1tm2Dgen
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
intestinal hypoperistalsis
|
J:126020
|
Nuak1tm1Esu/Nuak1tm1Esu
Tg(Ckmm-cre)5Khn/0
(B6.Cg-Nuak1tm1Esu Tg(Ckmm-cre)5Khn)
|
abnormal muscle cell glucose uptake
|
J:185463
|
| increased skeletal muscle glycogen level
|
J:185463
|
| muscle phenotype
|
J:185463
|
Nuggcem1(IMPC)Ccpcz/Nuggcem1(IMPC)Ccpcz
(C57BL/6NCrl-Nuggcem1(IMPC)Ccpcz/Ccpcz)
|
abnormal skeletal muscle morphology
|
J:211773
|
Nup35m1Apb/Nup35m1Apb
(involves: C57BL/6N)
|
abnormal intestinal smooth muscle morphology
|
J:235141
|
| muscle phenotype
|
J:235141
|
nur15/nur15
(Not Specified)
|
opisthotonus
|
J:85113
|
nur16/nur16
(Not Specified)
|
opisthotonus
|
J:85113
|
nur33/nur33
(Not Specified)
|
muscle weakness
|
J:89098
|
| myoclonus
|
J:89098
|
Nxntm1a(EUCOMM)Wtsi/Nxn+
(C57BL/6N-Nxntm1a(EUCOMM)Wtsi/Bay)
|
decreased cardiac muscle contractility
|
J:211773
|
Nxnl2em1(IMPC)Ccpcz/Nxnl2em1(IMPC)Ccpcz
(C57BL/6NCrl-Nxnl2em1(IMPC)Ccpcz/Ccpcz)
|
abnormal skeletal muscle morphology
|
J:211773
|
Obscntm1.1Geno/Obscntm1.1Geno
(B6.129-Obscntm1.1Geno)
|
increased ventricle muscle contractility
|
J:243723
|
Obscntm1Chen/Obscntm1Chen
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal sarcoplasmic reticulum morphology
|
J:153150
|
| centrally nucleated skeletal muscle fibers
|
J:153150
|
| muscle phenotype
|
J:153150
|
| myopathy
|
J:153150
|
Obscntm1Chen/Obscntm1Chen
(involves: 129 * Black Swiss * C57BL/6 * SJL)
|
abnormal muscle physiology
|
J:283623
|
| abnormal sarcolemma morphology
|
J:283623
|
| abnormal sarcoplasmic reticulum morphology
|
J:283623
|
| increased skeletal muscle fiber diameter
|
J:283623
|
| muscle phenotype
|
J:283623
|
Obscntm1Chen/Obscntm1Chen
Obsl1tm1.1Slan/Obsl1tm1.1Slan
Tg(Myog-cre)1Eno/0
(involves: 129 * Black Swiss * C57BL/6 * SJL)
|
abnormal muscle physiology
|
J:283623
|
| abnormal sarcolemma morphology
|
J:283623
|
| abnormal sarcoplasmic reticulum morphology
|
J:283623
|
| decreased skeletal muscle fiber diameter
|
J:283623
|
| muscle phenotype
|
J:283623
|
Obsl1tm1.1Slan/Obsl1tm1.1Slan
Tg(Myog-cre)1Eno/0
(involves: 129 * Black Swiss * C57BL/6 * SJL)
|
increased extensor digitorum longus weight
|
J:283623
|
| increased skeletal muscle fiber diameter
|
J:283623
|
| muscle phenotype
|
J:283623
|
OclnGt(ROSA)39Tshi/OclnGt(ROSA)39Tshi
(involves: DBA/2)
|
abnormal stomach muscularis externa morphology
|
J:110222
|
Oclntm1Tshi/Oclntm1Tshi
(involves: C57BL/6 * DBA/2)
|
abnormal muscle morphology
|
J:110222
|
| abnormal stomach muscularis externa morphology
|
J:110222
|
Odad2b2b227.1Clo/Odad2b2b227.1Clo
(C57BL/6J-Odad2b2b227.1Clo)
|
cardiomyopathy
|
J:175213
|
Olig2tm1(cre)Tmj/Olig2+
Smn1tm1Jme/Smn1tm1Msd
Grm7Tg(SMN2)89Ahmb/Grm7Tg(SMN2)89Ahmb
(involves: 129 * 129P2/OlaHsd * FVB/N)
|
abnormal muscle morphology
|
J:164292
|
| decreased skeletal muscle fiber number
|
J:164292
|
| increased skeletal muscle fiber size
|
J:164292
|
| muscle weakness
|
J:164292
|
| muscular atrophy
|
J:164292
|
| skeletal muscle fiber degeneration
|
J:164292
|
Olig2tm1(cre/Esr1*)Htak/Olig2tm1(cre/Esr1*)Htak
(involves: BALB/c * C57BL/6 * C57BL/6NCrj * CBA)
|
hypotonia
|
J:77821
|
Olr1tm1Meht/Olr1tm1Meht
(B6.129X1-Olr1tm1Meht/Meht)
|
increased muscle relaxation
|
J:130794
|
Opa1M1Bewi/Opa1+
(involves: C3HeB/FeJ)
|
muscle phenotype
|
J:154865
|
Opa1tm1.1Geno/Opa1+
(involves: 129S2/SvPas)
|
abnormal cardiac muscle tissue morphology
|
J:237963
|
| abnormal muscle fiber morphology
|
J:237963
|
| abnormal sarcomere morphology
|
J:237963
|
| decreased muscle fiber mitochondrial DNA content
|
J:237963
|
Opa3m1Votr/Opa3m1Votr
(involves: C3H * C57BL/6JCrl)
|
abnormal ventricle myocardium morphology
|
J:181670
|
| dilated cardiomyopathy
|
J:181670
|
Or51e1tm1Jplu/Or51e1tm1Jplu
(involves: C57BL/6)
|
abnormal vascular smooth muscle physiology
|
J:346436
|
| decreased vasoconstriction
|
J:346436
|
| increased vasoconstriction
|
J:346436
|
| increased vasodilation
|
J:346436
|
Orm1tm1Smoc/Orm1tm1Smoc
(involves: C57BL/6J)
|
abnormal muscle electrophysiology
|
J:264446
|
Osr2tm5(cre)Jian/Osr2+
Tg(CAG-Nog)1Ych/0
(Not Specified)
|
abnormal palatopharyngeus muscle morphology
|
J:310908
|
| abnormal superior pharyngeal constrictor muscle morphology
|
J:310908
|
| small levator veli palatini muscle
|
J:310908
|
| small tensor veli palatini muscle
|
J:310908
|
Ostes/Ostes
(involves: 101/H * C3H/HeH)
|
dystrophic muscle
|
J:124220
|
| muscular atrophy
|
J:124220
|
Ostntm1.1Geno/Ostntm1.1Geno
(involves: C57BL/6)
|
abnormal skeletal muscle fiber type ratio
|
J:228285
|
Otx2tm1Sia/Otx2+
(involves: C57BL/6 * CBA)
|
abnormal extraocular muscle morphology
|
J:29682
|
Ovol2tm1Sito/Ovol2tm1Sito
(involves: 129P2/OlaHsd * C57BL/6J)
|
absent myocardial trabeculae
|
J:132526
|
Oxct1tm1a(KOMP)Wtsi/Oxct1tm1a(KOMP)Wtsi
(C57BL/6-Oxct1tm1a(KOMP)Wtsi)
|
abnormal muscle physiology
|
J:170537
|
Oxtrtm1.2Wsy/Oxtrtm1.2Wsy
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * SJL)
|
muscle phenotype
|
J:137445
|
P2rx4tm1Ando/P2rx4tm1Ando
(Not Specified)
|
abnormal vasodilation
|
J:104459
|
P2ry2tm1c(EUCOMM)Hmgu/P2ry2tm1c(EUCOMM)Hmgu
Tg(Tek-icre/ERT2)1Soff/0
(B6N.Cg-P2ry2tm1c(EUCOMM)Hmgu Tg(Tek-icre/ERT2)1Soff)
|
decreased vasodilation
|
J:224523
|
P2ry6tm1.1Brob/P2ry6tm1.1Brob
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
decreased vasoconstriction
|
J:169742
|
| decreased vasodilation
|
J:169742
|
P2ry14tm1Gbtm/P2ry14tm1Gbtm
(B6.129P2-P2ry14tm1Gbtm)
|
abnormal muscle physiology
|
J:149708
|
P3h1tm1b(EUCOMM)Wtsi/P3h1tm1b(EUCOMM)Wtsi
(C57BL/6N-P3h1tm1b(EUCOMM)Wtsi/Ucd)
|
abnormal skeletal muscle morphology
|
J:211773
|
P3h1tm1Dgen/P3h1tm1Dgen
(involves: C57BL/6)
|
abnormal tendon morphology
|
J:163884
|
P3h4tm1.2Rmr/P3h4tm1.2Rmr
(involves: 129S1/Sv * 129S4/SvJaeSor * C57BL/6J)
|
abnormal muscle morphology
|
J:232567
|
Pabpn1tm1.2Gpvl/Pabpn1+
(involves: C57BL/6 * FVB/N)
|
centrally nucleated skeletal muscle fibers
|
J:243638
|
| decreased skeletal muscle fiber diameter
|
J:243638
|
| increased skeletal muscle fiber diameter
|
J:243638
|
| skeletal muscle atrophy
|
J:243638
|
| skeletal muscle hypertrophy
|
J:243638
|
Pabpn1tm2.2Gpvl/Pabpn1+
(involves: C57BL/6 * FVB/N)
|
decreased skeletal muscle fiber diameter
|
J:243638
|
| increased skeletal muscle fiber diameter
|
J:243638
|
| muscle phenotype
|
J:243638
|
| skeletal muscle atrophy
|
J:243638
|
| skeletal muscle hypertrophy
|
J:243638
|
Pak1tm1.1Xwg/Pak1tm1.1Xwg
Myl2tm1(cre)Krc/Myl2+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6)
|
decreased cardiac muscle contractility
|
J:193804
|
| increased cardiomyocyte apoptosis
|
J:193804
|
| increased myocardial fiber size
|
J:193804
|
Pak1ip1mray/Pak1ip1mray
(involves: C57BL/6J * FVB/NJ)
|
abnormal masseter muscle morphology
|
J:204457
|
Pak4tm1Amin/Pak4tm1Amin
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129S2/SvPas * C57BL/6))
|
thin myocardium
|
J:85954
|
Pank1tm1.1Suja/Pank1tm1.1Suja
Pank2tm1.1Suja/Pank2tm1.1Suja
(involves: 129S/SvEv * C57BL/6J * FVB/N)
|
dystonia
|
J:189609
|
Pard3btm1b(EUCOMM)Wtsi/Pard3btm1b(EUCOMM)Wtsi
(C57BL/6N-Pard3btm1b(EUCOMM)Wtsi/Ieg)
|
increased cardiac muscle contractility
|
J:211773
|
Parltm1.1Bdes/Parltm1.1Bdes
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased skeletal muscle fiber diameter
|
J:116017
|
| decreased skeletal muscle mass
|
J:116017
|
| muscular atrophy
|
J:116017
|
Parltm1.1Bdes/Parltm1.1Bdes
(involves: 129P2/OlaHsd)
|
muscular atrophy
|
J:269785
|
Parltm1Bdes/Parltm1Bdes
Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
muscular atrophy
|
J:269785
|
Parms1BALB/cByJ/Parms1C57BL/6NCrl
Ptch1tm1Zim/Ptch1+
(involves: 129/Sv * BALB/cByJ * C57BL/6NCrl)
|
increased rhabdomyosarcoma incidence
|
J:93364
|
Parms1C57BL/6NCrl/Parms1C57BL/6NCrl
Ptch1tm1Zim/Ptch1+
(involves: 129/Sv * BALB/cByJ * C57BL/6NCrl)
|
increased rhabdomyosarcoma incidence
|
J:93364
|
Parvatm1Ref/Parvatm1Ref
(Not Specified)
|
abnormal vascular smooth muscle morphology
|
J:154437
|
Pasktm1Weng/Pasktm1Weng
(B6.129S6-Pasktm1Weng)
|
abnormal muscle physiology
|
J:125307
|
Pax1un-i/Pax1un-i
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J))
|
abnormal myotome development
|
J:100951
|
Pax3Sp-2H/Pax3Sp-2H
(involves: C57BL/6)
|
abnormal dermomyotome development
|
J:32016
|
| abnormal muscle precursor cell migration
|
J:32016
|
| abnormal myogenesis
|
J:18227,
J:32016
|
Pax3Sp-2H/Pax3Sp-2H
(involves: 101 * C3H/He * CBA/Ca)
|
decreased ventricle muscle contractility
|
J:46341
|
Pax3Sp-2H/Pax3Sp-2H
(involves: 101 * C3H/He)
|
decreased ventricle muscle contractility
|
J:46341
|
Pax3Sp/Pax3Sp
(involves: C57BL)
|
abnormal dermomyotome development
|
J:112275,
J:32016
|
| abnormal hypoglossal cord morphology
|
J:112275
|
| abnormal muscle precursor cell migration
|
J:32016
|
| abnormal myogenesis
|
J:18227,
J:112275,
J:32016
|
Pax3tm1(cre)Joe/Pax3+
Rbpjtm1Hon/Rbpjtm1Hon
(involves: 129P2/OlaHsd)
|
abnormal diaphragm morphology
|
J:120053
|
| abnormal epaxial muscle morphology
|
J:120053
|
| abnormal intercostal muscle morphology
|
J:120053
|
| abnormal myogenesis
|
J:120053
|
| decreased satellite cell number
|
J:120053
|
| hypaxial muscle hypoplasia
|
J:120053
|
Pax3tm1(cre)Joe/Pax3tm1(cre)Joe
(Not Specified)
|
abnormal diaphragm development
|
J:137730
|
| thin diaphragm muscle
|
J:137730
|
Pax3tm1(FOXO1A)Gcg/Pax3+
(either: (involves: 129X1/SvJ * C57BL/6) or (involves: 129X1/SvJ * NMRI))
|
abnormal diaphragm development
|
J:79365
|
| abnormal skeletal muscle morphology
|
J:79365
|
| abnormal tongue muscle morphology
|
J:79365
|
Pax3tm1.1Sjc/Pax3tm1.1Sjc
Pax7tm1.2Fan/Pax7tm1.2Fan
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129 * C57BL/6 * CBA * SJL)
|
muscle phenotype
|
J:150962
|
Pax3tm1Buck/Pax3Sp
(involves: 129P2/OlaHsd * C57BL)
|
abnormal dermomyotome development
|
J:86911
|
| abnormal myogenesis
|
J:86911
|
Pax3tm1Buck/Pax3tm1Buck
(involves: 129P2/OlaHsd)
|
abnormal dermomyotome development
|
J:176192
|
| abnormal muscle development
|
J:176192
|
| abnormal muscle precursor cell migration
|
J:176192
|
| abnormal myogenesis
|
J:86911
|
| abnormal myotome development
|
J:176192
|
Pax3tm1Buck/Pax3tm1Buck
Pax7tm2Pgr/Pax7tm2Pgr
(either: (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ) or (involves: 129P2/OlaHsd * 129S2/SvPas))
|
abnormal myotome development
|
J:99365
|
Pax3tm1Mrc/Pax3+
Pax7tm1(cre)Mrc/Pax7+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased satellite cell number
|
J:93443
|
| decreased skeletal muscle fiber diameter
|
J:93443
|
| decreased skeletal muscle mass
|
J:93443
|
| increased skeletal muscle fiber density
|
J:93443
|
| muscle hypoplasia
|
J:93443
|
Pax3tm1Mrc/Pax3+
Tg(CMV-cre)1Cgn/?
(involves: 129S1/Sv * 129X1/SvJ * BALB/cJ * C57BL/6)
|
hypaxial muscle hypoplasia
|
J:93443
|
| thin diaphragm muscle
|
J:93443
|
Pax3tm2.1(PAX3/FOXO1A)Buck/Pax3+
(involves: 129S2/SvPas * BALB/c * C57BL/6)
|
abnormal dermomyotome development
|
J:86911
|
| abnormal intercostal muscle morphology
|
J:86911
|
| abnormal muscle development
|
J:86911
|
| abnormal myogenesis
|
J:86911
|
| abnormal myotome morphology
|
J:86911
|
| abnormal skeletal muscle morphology
|
J:86911
|
Pax3tm2.1(PAX3/FOXO1A)Buck/Pax3Sp
(involves: 129S2/SvPas * BALB/c * C57BL * C57BL/6)
|
abnormal muscle development
|
J:86911
|
Pax3tm2Joe/Pax3tm2Joe
(involves: 129S1/Sv * 129X1/SvJ)
|
absent hypaxial muscle
|
J:159124
|
Pax3tm2Joe/Pax3tm2Joe
H2az2Tg(Wnt1-cre)11Rth/H2az2+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CBA/J)
|
hypaxial muscle hypoplasia
|
J:159124
|
Pax3tm3(Pax7)Buck/Pax3tm3(Pax7)Buck
(involves: 129S2/SvPas)
|
abnormal muscle development
|
J:90568
|
Pax3tm3.1(Pax7)Buck/Pax3Sp
(involves: 129S2/SvPas)
|
abnormal diaphragm development
|
J:90568
|
| abnormal myogenesis
|
J:90568
|
Pax3tm3.1(Pax7)Buck/Pax3tm3.1(Pax7)Buck
(involves: 129S2/SvPas)
|
abnormal diaphragm development
|
J:90568
|
| abnormal muscle development
|
J:176192
|
| abnormal muscle precursor cell migration
|
J:90568
|
| abnormal myogenesis
|
J:90568
|
Pax3tm5.1Buck/Pax3+
(involves: 129S2/SvPas * BALB/c * C57BL/6)
|
abnormal dermomyotome development
|
J:112275
|
| abnormal myogenesis
|
J:112275
|
Pax3tm6(Pax8)Buck/Pax3+
(involves: 129S2/SvPas)
|
abnormal muscle development
|
J:176192
|
| abnormal myotome development
|
J:176192
|
Pax3tm6(Pax8)Buck/Pax3tm6(Pax8)Buck
(involves: 129S2/SvPas)
|
absent skeletal muscle
|
J:176192
|
Pax3tm6.1(Pax8)Buck/Pax3+
(involves: 129S2/SvPas * BALB/c * C57BL/6)
|
abnormal muscle development
|
J:176192
|
| abnormal myotome development
|
J:176192
|
Pax3tm6.1(Pax8)Buck/Pax3tm6.1(Pax8)Buck
(involves: 129S2/SvPas * BALB/c * C57BL/6)
|
abnormal dermomyotome development
|
J:176192
|
| abnormal muscle development
|
J:176192
|
| abnormal muscle precursor cell migration
|
J:176192
|
| abnormal myotome development
|
J:176192
|
| absent skeletal muscle
|
J:176192
|
Pax3tm6.1(Pax8)Buck/Pax3tm6.2Buck
(involves: 129S2/SvPas * BALB/c * C57BL/6 * SJL)
|
abnormal muscle development
|
J:176192
|
Pax6tm2Pgr/Pax6+
Tg(Dct-cre)1Apdn/0
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal intraocular muscle morphology
|
J:152253
|
Pax7tm1(cre/ERT2)Gaka/0
Snhg15tm1.1Nju/Snhg15tm1.1Nju
(involves: C57BL/6J * SJL/J)
|
delayed skeletal muscle regeneration
|
J:291983
|
Pax7tm1(cre/ERT2)Gaka/Pax7+
Gt(ROSA)26Sortm1(DTA)Mrc/Gt(ROSA)26Sor+
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6)
|
decreased satellite cell number
|
J:174914
|
| impaired skeletal muscle regeneration
|
J:174914
|
| skeletal muscle fibrosis
|
J:174914
|
Pax7tm1.1(HBEGF,-EYFP)Mal/Pax7+
(involves: C57BL/6)
|
decreased skeletal muscle mass
|
J:180899
|
| impaired skeletal muscle regeneration
|
J:180899
|
| muscle phenotype
|
J:180899
|
| myositis
|
J:180899
|
Pax7tm1.1(HBEGF,-EYFP)Mal/Pax7+
Tg(Pax7-EGFP)15Tajb/0
(involves: C57BL/6 * SJL/J)
|
abnormal muscle regeneration
|
J:180899
|
| decreased satellite cell number
|
J:180899
|
Pax7tm1.1(rtTA)Sjl/Pax7tm1.1(rtTA)Sjl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased skeletal muscle weight
|
J:188599
|
Pax7tm1.1(rtTA)Sjl/Pax7tm1.1(rtTA)Sjl
Tg(Myl1-FST)F66Sjl/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
abnormal skeletal muscle fiber size
|
J:188599
|
| increased skeletal muscle weight
|
J:188599
|
Pax7tm1.1Thbr/Pax7tm1.1Thbr
(Not Specified)
|
abnormal skeletal muscle satellite cell proliferation
|
J:202693
|
Pax7tm1.1Thbr/Pax7tm1.1Thbr
Myf5tm1(cre)Mrc/Myf5+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)
|
decreased satellite cell number
|
J:202693
|
Pax7tm1.1Thbr/Pax7tm1.1Thbr
Myf5tm3(cre)Sor/Myf5+
(involves: 129S4/SvJaeSor)
|
decreased satellite cell number
|
J:202693
|
| decreased skeletal muscle fiber diameter
|
J:202693
|
| decreased skeletal muscle fiber number
|
J:202693
|
| impaired skeletal muscle regeneration
|
J:202693
|
Pax7tm1.1Thbr/Pax7tm1.1Thbr
Tg(CMV-cre)1Cgn/0
(involves: BALB/cJ)
|
abnormal muscle morphology
|
J:202693
|
| decreased satellite cell number
|
J:202693
|
Pax7tm1.1Thbr/Pax7tm2.1(cre/ERT2)Fan
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal muscle regeneration
|
J:202693
|
| abnormal skeletal muscle morphology
|
J:202693
|
| abnormal skeletal muscle satellite cell proliferation
|
J:202693
|
| decreased satellite cell number
|
J:202693
|
| decreased skeletal muscle size
|
J:202693
|
| muscle phenotype
|
J:202693
|
| skeletal muscle fibrosis
|
J:202693
|
| skeletal muscle necrosis
|
J:202693
|
Pax7tm1.2Fan/Pax7tm1.2Fan
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
impaired skeletal muscle regeneration
|
J:150962
|
| skeletal muscle fibrosis
|
J:150962
|
Pax7tm1Pgr/Pax7tm1Pgr
(involves: 129S2/SvPas)
|
abnormal muscle regeneration
|
J:64793
|
| decreased skeletal muscle fiber diameter
|
J:64793
|
| muscle phenotype
|
J:32018
|
| muscle weakness
|
J:64793
|
| thin diaphragm muscle
|
J:64793
|
Pax7tm2Pgr/Pax7tm2Pgr
(either: (involves: 129S1/Sv * 129X1/SvJ * C57BL/6) or (involves: 129S2/SvPas * C57BL/6))
|
abnormal muscle regeneration
|
J:92280
|
| decreased satellite cell number
|
J:92280
|
Pax9tm1Rbal/Pax9tm1Rbal
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal autopod muscle morphology
|
J:49857
|
| abnormal tendon morphology
|
J:49857
|
Pbx1tm1Mlc/Pbx1tm1Mlc
(involves: 129S6/SvEvTac * C57BL/6)
|
diaphragmatic hernia
|
J:182007
|
Pccatm1Tmiy/Pccatm1Tmiy
Tg(CAG-PCCA*A138T,-EGFP)#Maba/0
(involves: 129P2/OlaHsd * FVB/N)
|
decreased cardiac muscle contractility
|
J:282292
|
Pcdh15m2Btlr/Pcdh15m2Btlr
(involves: C57BL/6J)
|
dystonia
|
J:198553
|
Pcdhgtm1.1Tman/Pcdhgtm1.1Tman
(involves: 129S4/SvJae * C57BL/6)
|
muscle hypertonia
|
J:188341
|
Pcmt1tm1Shs/Pcmt1tm1Shs
(involves: 129P2/OlaHsd * C57BL/6)
|
myoclonus
|
J:46228
|
Pcolcetm1Dgr/Pcolcetm1Dgr
(involves: 129X1/SvJ * Black Swiss)
|
abnormal tendon morphology
|
J:104148
|
Pcsk1N222D/Pcsk1N222D
(C57BL/6-Pcsk1N222D)
|
decreased skeletal muscle mass
|
J:109531
|
| increased skeletal muscle mass
|
J:109531
|
Pdctm1Luhe/Pdctm1Luhe
(B6.129P2-Pdctm1Luhe)
|
decreased vasodilation
|
J:155373
|
| increased vasoconstriction
|
J:155373
|
| increased ventricle muscle contractility
|
J:155373
|
| vascular smooth muscle hypertrophy
|
J:155373
|
Pdcd1tm1Hon/Pdcd1tm1Hon
(C.129S2(B6)-Pdcd1tm1Hon)
|
abnormal cardiac muscle contractility
|
J:66979
|
Pdcd10tm1.1Wami/Pdcd10tm1.1Wami
(involves: 129 * C57BL/6)
|
myocardial trabeculae hypoplasia
|
J:171969
|
| thin myocardium
|
J:171969
|
Pdcd10tm1Kwhi/Pdcd10tm1Kwhi
Nfatc1tm1.1(cre)Bz/Nfatc1+
(involves: 129S1/Sv * 129X1/SvJ)
|
thin myocardium
|
J:238897
|
Pdcd10tm1Wami/Pdcd10tm1Wami
Tg(Tek-cre)12Flv/0
(involves: 129 * C3H * C57BL/6)
|
abnormal myocardium layer morphology
|
J:171969
|
| myocardial trabeculae hypoplasia
|
J:171969
|
| thin myocardium
|
J:171969
|
Pde1aem1Cjwa/Pde1aem1Cjwa
(C57BL/6J-Pde1aem1Cjwa)
|
increased cardiac muscle contractility
|
J:246596
|
Pde1aem2Cjwa/Pde1aem2Cjwa
(C57BL/6J-Pde1aem2Cjwa)
|
increased cardiac muscle contractility
|
J:246596
|
Pde4dtm1Mct/Pde4dtm1Mct
(involves: 129P2/OlaHsd)
|
increased cardiac muscle contractility
|
J:96125
|
Pdgfatm1Cbet/Pdgfatm1Cbet
(involves: 129P2/OlaHsd * C57BL)
|
heart right ventricle hypertrophy
|
J:33629
|
Pdgfatm1Cbet/Pdgfatm1Cbet
Pdgfctm1Nagy/Pdgfctm1Nagy
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal myotome development
|
J:93954
|
Pdgfbtm1Cbet/Pdgfbtm1Cbet
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal aorta smooth muscle morphology
|
J:20017
|
Pdgfbtm1Cbet/Pdgfbtm2Cbet
Tg(Tie1-cre)9Ref/0
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
thin myocardium
|
J:89186
|
Pdgfbtm3.1Cbet/Pdgfbtm3.1Cbet
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal vascular smooth muscle morphology
|
J:84701
|
Pdgfratm1Sor/Pdgfra+
Plekha1Gt(ROSA)82Sor/Plekha1Gt(ROSA)82Sor
(either: (involves: 129S4/SvJaeSor) or (involves: 129S4/SvJaeSor * C57BL/6))
|
abnormal vascular smooth muscle morphology
|
J:142042
|
Pdgfratm1Sor/Pdgfra+
Schip1Gt(ROSA)77Sor/Schip1Gt(ROSA)77Sor
(either: (involves: 129S4/SvJaeSor) or (involves: 129S4/SvJaeSor * C57BL/6))
|
abnormal vascular smooth muscle morphology
|
J:142042
|
Pdgfratm1Sor/Pdgfratm1Sor
(either: 129S4/SvJaeSor-Pdgfratm1Sor or (involves: 129S4/SvJaeSor * C57BL/6J))
|
abnormal myotome development
|
J:41814
|
| abnormal myotome morphology
|
J:41814
|
Pdgfratm2Sor/Pdgfratm2Sor
(either: 129S4/SvJaeSor-Pdgfratm2Sor or (involves: 129S4/SvJaeSor * C57BL/6J))
|
abnormal myotome development
|
J:41814
|
| abnormal myotome morphology
|
J:41814
|
Pdgfratm2Sor/Pdgfratm2Sor
(involves: 129S4/SvJaeSor * C57BL/6)
|
abnormal diaphragm development
|
J:160875
|
| diaphragmatic hernia
|
J:160875
|
Pdgfrbtm1Sor/Pdgfrb+
Schip1Gt(ROSA)77Sor/Schip1Gt(ROSA)77Sor
(involves: 129S4/SvJaeSor * 129S7/SvEvBrd)
|
abnormal smooth muscle morphology
|
J:117491
|
Pdgfrbtm1Sor/Pdgfrbtm5Sor
(either: (involves: 129S4/SvJaeSor * 129S7/SvEvBrd) or (involves: 129S4/SvJaeSor * 129S7/SvEvBrd * C57BL/6))
|
myocardial fiber disarray
|
J:67735
|
Pdgfrbtm14(Pdgfrb)Sor/Pdgfrb+
Tg(Tagln-cre)1Her/0
(involves: 129S4/SvJaeSor * C57BL/6 * SJL)
|
increased vascular smooth muscle cell proliferation
|
J:173602
|
| vascular smooth muscle hyperplasia
|
J:173602
|
Pdha1tm1Ptl/Y
Tg(Ckmm-cre)5Khn/0
(involves: 129P2/OlaHsd * FVB)
|
decreased cardiac muscle contractility
|
J:141289
|
| heart left ventricle hypertrophy
|
J:141289
|
| increased myocardial fiber size
|
J:141289
|
Pdha1tm1Ptl/Pdha1+
Tg(Ckmm-cre)5Khn/0
(involves: 129P2/OlaHsd * FVB)
|
decreased cardiac muscle contractility
|
J:141289
|
| increased myocardial fiber size
|
J:141289
|
Pdk2tm1Rhar/Pdk2tm1Rhar
(B6.129-Pdk2tm1Rhar)
|
impaired skeletal muscle contractility
|
J:172411
|
Pdlim3tm1Krc/Pdlim3tm1Krc
(either: (involves: 129S) or (involves: C57BL/6) or (involves: Black Swiss))
|
decreased ventricle muscle contractility
|
J:69097
|
| dilated cardiomyopathy
|
J:69097
|
| trabecula carnea hypoplasia
|
J:69097
|
Pdlim5tm1.1Chen/Pdlim5tm1.1Chen
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss)
|
abnormal cardiac muscle contractility
|
J:175042
|
| abnormal Z line morphology
|
J:175042
|
| dilated cardiomyopathy
|
J:175042
|
Pdlim5tm1Chen/Pdlim5tm1Chen
Tg(Tnnt2-cre)5Blh/?
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss * C57BL/6 * DBA/2)
|
decreased ventricle muscle contractility
|
J:175042
|
| dilated cardiomyopathy
|
J:175042
|
Pdpk1tm1.1Mlw/Pdpk1tm1.1Mlw
Tg(Ckmm-cre)5Khn/?
(involves: BALB/c)
|
abnormal myocardial fiber morphology
|
J:85498
|
| abnormal Z line morphology
|
J:85498
|
| decreased cardiac muscle contractility
|
J:85498
|
| dilated cardiomyopathy
|
J:85498
|
| heart right ventricle hypertrophy
|
J:85498
|
| myocardium hypoplasia
|
J:85498
|
Pdpntm1Acgg/Pdpntm1Acgg
(involves: 129S1/Sv * 129X1/SvJ * Swiss)
|
abnormal myocardial trabeculae morphology
|
J:132132
|
| abnormal myocardium compact layer morphology
|
J:132132
|
| abnormal myocardium layer morphology
|
J:132132
|
| thin myocardium
|
J:132132
|
Pds5aGt(RRM243)Byg/Pds5a+
Pds5btm1Jmi/Pds5btm1Jmi
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
thin ventricle myocardium compact layer
|
J:148890
|
Pds5aGt(RRM243)Byg/Pds5aGt(RRM243)Byg
Pds5btm1Jmi/Pds5b+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
thin ventricle myocardium compact layer
|
J:148890
|
Pdss2kd/Pdss2kd
(CBA/H-Pdss2kd)
|
myopathy
|
J:197578
|
Pdss2tm1.1Jdhu/Pdss2tm1.2Jdhu
Tg(Pax2-cre)1Akg/0
(involves: 129 * C57BL/6N * FVB/N)
|
abnormal skeletal muscle morphology
|
J:179845
|
Pdx1tm1Cvw/Pdx1tm1Cvw
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss)
|
abnormal pyloric sphincter morphology
|
J:32017
|
Pdx1tm2Cvw/Pdx1tm2Cvw
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss)
|
abnormal pyloric sphincter morphology
|
J:32017
|
Pdxptm1.2Ango/Pdxptm1.2Ango
(involves: C57BL/6J)
|
muscle weakness
|
J:270551
|
Pdzk1tm2b(EUCOMM)Wtsi/Pdzk1tm2b(EUCOMM)Wtsi
(C57BL/6N-Pdzk1tm2b(EUCOMM)Wtsi/Wtsi)
|
abnormal eye muscle morphology
|
J:239583
|
| abnormal infrahyoid muscle connection
|
J:239583
|
Pecam1Gt(OST16303)Lex/Pecam1Gt(OST16303)Lex
(B6.129S5-Pecam1Gt(OST16303)Lex)
|
decreased vasodilation
|
J:104082
|
Pecam1Gt(OST16303)Lex/Pecam1Gt(OST16303)Lex
(B6.129S-Pecam1Gt(OST16303)Lex/J)
|
abnormal vasodilation
|
J:114343
|
| decreased vasodilation
|
J:114343
|
Pepddal/Pepddal
(involves: C3H/HeJ * CBA/J)
|
abnormal cardiac muscle tissue morphology
|
J:215150
|
| abnormal myocardial fiber morphology
|
J:215150
|
| myocardium hypertrophy
|
J:215150
|
Perm1em1Jswn/Perm1em1Jswn
(C57BL/6-Perm1em1Jswn)
|
decreased cardiac muscle contractility
|
J:334191
|
Pex5tm1Baes/Pex5tm1Baes
(involves: 129S1/Sv * 129X1/SvJ)
|
muscle weakness
|
J:42719
|
Pex7tm1Rjaw/Pex7tm1Rjaw
(Swiss)
|
dystonia
|
J:92346
|
Pex13tm1.1Crne/Pex13tm1.1Crne
(involves: 129T2/SvEms * C57BL/6J)
|
hypotonia
|
J:84795
|
Pfkfb3tm1.1Pec/Pfkfb3tm1.1Pec
Tg(Pdgfb-icre/ERT2,-EGFP)1Frut/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NCrl * CBA)
|
decreased skeletal muscle fiber diameter
|
J:296552
|
| skeletal muscle necrosis
|
J:296552
|
Pfkmtm1Fbos/Pfkmtm1Fbos
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal muscle physiology
|
J:152153
|
| abnormal skeletal muscle fiber morphology
|
J:152153
|
| centrally nucleated skeletal muscle fibers
|
J:152153
|
| enhanced skeletal muscle regeneration
|
J:152153
|
| heart left ventricle hypertrophy
|
J:152153
|
| increased cardiac muscle glycogen level
|
J:152153
|
| increased skeletal muscle glycogen level
|
J:152153
|
| skeletal muscle fiber degeneration
|
J:152153
|
| skeletal muscle fiber necrosis
|
J:152153
|
Pgap2clpex/Pgap2tm1a(EUCOMM)Wtsi
(involves: A/J * C57BL/6N)
|
myocardium hypoplasia
|
J:277316
|
Pgrtm1Bwo/Pgrtm1Bwo
(involves: 129S7/SvEvBrd)
|
vascular smooth muscle hyperplasia
|
J:118403
|
Phc1tm1Os/Phc1tm1Os
(involves: 129S2/SvPas * C57BL/6)
|
heart right ventricle hypertrophy
|
J:43764
|
PhipGt(RRJ571)Byg/PhipGt(RRJ571)Byg
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased myocardial fiber size
|
J:164354
|
Phka1I/FnLn/Y
((I/FnLn x C57BL/FnLn)F1)
|
increased skeletal muscle glycogen level
|
J:5156
|
Phka1I/FnLn/Y
(I/FnLn)
|
increased skeletal muscle glycogen level
|
J:5156
|
Phka1I/FnLn/Phka1+
((C57BL/FnLn x I/FnLn)F1)
|
increased skeletal muscle glycogen level
|
J:5156
|
Phka1I/FnLn/Phka1+
((I/FnLn x C57BL/FnLn)F1)
|
increased skeletal muscle glycogen level
|
J:5156
|
Phka1I/FnLn/Phka1I/FnLn
(I/FnLn)
|
increased skeletal muscle glycogen level
|
J:5156
|
Pik3c3tm1c(EUCOMM)Wtsi/Pik3c3tm1c(EUCOMM)Wtsi
Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6N * FVB/N)
|
decreased cardiac muscle contractility
|
J:182628
|
Pik3catm1.1Rzl/Pik3catm1.1Rzl
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: 129S4/SvJaeSor * C57BL/6 * FVB/N)
|
decreased cardiac muscle contractility
|
J:166421
|
Pik3catm1.1Waph/Pik3ca+
Ptentm1Hwu/Ptentm1Hwu
(involves: 129S1/Sv * 129S4/SvJae * BALB/c * C57BL/6)
|
abnormal diaphragm morphology
|
J:184382
|
Pik3catm1Bvan/Pik3ca+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased skeletal muscle mass
|
J:109024
|
Pik3cgtm1Ehi/Pik3cgtm1Ehi
(Not Specified)
|
abnormal myocardial fiber morphology
|
J:91945
|
Pik3cgtm1Pngr/Pik3cgtm1Pngr
(involves: 129P2/OlaHsd)
|
abnormal cardiac muscle relaxation
|
J:79151
|
| increased cardiac muscle contractility
|
J:79151
|
Pik3cgtm1Pngr/Pik3cgtm1Pngr
Ptentm2Mak/Ptentm2Mak
Tg(Ckmm-cre)5Khn/0
(involves: 129P2/OlaHsd * FVB)
|
increased cardiac muscle contractility
|
J:79151
|
Pik3cgtm1Wym/Pik3cgtm1Wym
(involves: 129S1/Sv * 129X1/SvJ)
|
increased cardiac muscle contractility
|
J:79151
|
Pik3r1tm1Dfr/Pik3r1tm1Dfr
(involves: 129S6/SvEvTac * C57BL/6)
|
increased skeletal muscle fiber size
|
J:65523
|
Pik3r1tm1Lca/Pik3r1tm1Lca
Pik3r2tm1Lca/Pik3r2tm1Lca
Tg(Ckmm-cre)5Khn/0
(involves: 129S6/SvEvTac * C57BL/6 * FVB)
|
decreased myocardial fiber size
|
J:102176
|
Pik3r1tm1Tka/Pik3r1tm1Tka
(involves: C57BL/6 * CBA)
|
increased muscle cell glucose uptake
|
J:52576
|
Pik3r1tm2Dfr/Pik3r1tm2Dfr
(either: C.129S6-Pik3r1tm2Dfr or (involves: 129S6/SvEvTac * BALB/c * C57BL/6))
|
increased skeletal muscle fiber size
|
J:94077
|
Pik3r4tm1.1Mpnd/Pik3r4tm1.1Mpnd
Tg(ACTA1-cre)79Jme/0
(involves: 129S2/SvPas * C57BL/6J * C57BL/6N * SJL)
|
abnormal sarcolemma morphology
|
J:198770
|
| centrally nucleated skeletal muscle fibers
|
J:198770
|
| increased skeletal muscle glycogen level
|
J:198770
|
| muscle weakness
|
J:198770
|
| myopathy
|
J:198770
|
| myositis
|
J:198770
|
| skeletal muscle degeneration
|
J:198770
|
| skeletal muscle fiber necrosis
|
J:198770
|
PikfyveGt(AT0926)Wtsi/PikfyveGt(AT0926)Wtsi
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal atrium myocardium morphology
|
J:190368
|
| abnormal ventricle myocardium morphology
|
J:190368
|
Pikfyvetm1.1Ashi/Pikfyvetm1.1Ashi
Tg(Ckm-cre)28Arte/0
(involves: C57BL/6)
|
decreased muscle cell glucose uptake
|
J:199213
|
| muscle phenotype
|
J:199213
|
Pitx1tm1Rsd/Pitx1+
(involves: 129S1/Sv * 129X1/SvJ)
|
muscle hypoplasia
|
J:175799
|
Pitx2tm1.1Sac/Pitx2tm2Sac
H2az2Tg(Wnt1-cre)11Rth/H2az2+
Gt(ROSA)26Sortm1Sor/?
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6 * CBA)
|
abnormal eye muscle development
|
J:104125
|
Pitx2tm1Jfm/Pitx2tm1Jfm
(involves: 129S4/SvJaeSor)
|
absent extraocular muscles
|
J:57674
|
Pitx2tm1Kki/Pitx2tm1Kki
(involves: 129P2/OlaHsd * C57BL)
|
absent extraocular muscles
|
J:55455
|
Pitx2tm1Rsd/Pitx2tm1Rsd
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal extraocular muscle morphology
|
J:57673
|
| abnormal facial muscle morphology
|
J:57673
|
Pitx2tm1Sac/Pitx2tm1Sac
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal eye muscle morphology
|
J:51160
|
Pitx2tm2Sac/Pitx2tm2Sac
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal eye muscle development
|
J:51160
|
Pkd1b2b1585Clo/Pkd1b2b1585Clo
(C57BL/6J-Pkd1b2b1585Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
Pkd1tm1Rsa/Pkd1tm1Rsa
(involves: 129S4/SvJaeSor)
|
abnormal myocardial trabeculae morphology
|
J:72238
|
| thin myocardium
|
J:72238
|
Pkd1tm1Shh/Pkd1tm1.1Pcha
(involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6)
|
heart left ventricle hypertrophy
|
J:193544
|
| thick myocardium
|
J:193544
|
Pkn1tm1Ajmc/Pkn1tm1Ajmc
(B6.129P2-Pkn1tm1Ajmc)
|
decreased cardiac muscle contractility
|
J:258572
|
| decreased cardiac muscle relaxation
|
J:258572
|
Pkp2tm1Wbm/Pkp2tm1Wbm
(involves: C57BL/6)
|
abnormal myocardium layer morphology
|
J:93314
|
| trabecula carnea hypoplasia
|
J:93314
|
pl/pl
(involves: PERU-COPPOCK)
|
abnormal muscle tone
|
J:14122
|
Pla2g4atm1Jvb/Pla2g4atm1Jvb
(involves: 129S4/SvJae)
|
increased myocardial fiber size
|
J:99600
|
| increased skeletal muscle fiber diameter
|
J:99600
|
Pla2g5tm1.1Kiku/Pla2g5tm1.1Kiku
(involves: 129 * C57BL/6)
|
abnormal cardiac muscle contractility
|
J:186024
|
| abnormal cardiomyocyte apoptosis
|
J:186024
|
Pla2g6m1Sein/Pla2g6m1Sein
(C57BL/6JJcl-Pla2g6m1Sein)
|
muscular atrophy
|
J:153195
|
| skeletal muscle atrophy
|
J:155328
|
Pla2g10tm1Kiku/Pla2g10tm1Kiku
(B6.129P2-Pla2g10tm1Kiku)
|
abnormal cardiac muscle contractility
|
J:155082
|
Plaaem1Pmi/Plaaem1Pmi
(C57BL/6J-Plaaem1Pmi)
|
decreased skeletal muscle fiber diameter
|
J:240526
|
| skeletal muscle fiber atrophy
|
J:240526
|
| skeletal muscle necrosis
|
J:240526
|
Plattm1Mlg/Plattm1Mlg
(involves: 129S2/SvPas * C57BL/6)
|
decreased ventricle muscle contractility
|
J:95236
|
| heart left ventricle hypertrophy
|
J:95236
|
Plattm1Mlg/Plattm1Mlg
(B6.Cg-Plattm1Mlg)
|
muscle phenotype
|
J:68083
|
Platr4em#Dlsp/Platr4em#Dlsp
(B6.Cg-Platr4em#Dlsp)
|
abnormal myocardium layer morphology
|
J:331476
|
| decreased cardiac muscle contractility
|
J:331476
|
| heart left ventricle hypertrophy
|
J:331476
|
Plautm1Mlg/Plautm1Mlg
(involves: 129S2/SvPas * C57BL/6)
|
heart left ventricle hypertrophy
|
J:95236
|
| increased ventricle muscle contractility
|
J:95236
|
Plautm1Mlg/Plautm1Mlg
(B6.Cg-Plautm1Mlg)
|
impaired skeletal muscle regeneration
|
J:68083
|
| myopathy
|
J:73613
|
Plaurtm1Mlg/Plaurtm1Mlg
(B6.Cg-Plaurtm1Mlg)
|
myoclonus
|
J:81735
|
Plcb4tm1Hssh/Plcb4tm1Hssh
(Not Specified)
|
muscle phenotype
|
J:43077
|
Plce1tm1Avsm/Plce1tm1Avsm
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased cardiac muscle contractility
|
J:117556
|
Plce1tm1Tkat/Plce1tm1Tkat
(involves: 129/Sv * C57BL/6)
|
decreased cardiac muscle contractility
|
J:97661
|
Plectm1Gwi/Plectm1Gwi
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal intercalated disk morphology
|
J:59000
|
| abnormal myocardial fiber morphology
|
J:59000
|
| abnormal skeletal muscle fiber morphology
|
J:59000
|
| muscle degeneration
|
J:59000
|
| myopathy
|
J:59000
|
Plectm1Gwi/Plectm4Gwi
Tg(Ckmm-cre)5Khn/?
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB)
|
abnormal muscle fiber mitochondrial morphology
|
J:137067
|
| abnormal myocardial fiber morphology
|
J:137067
|
| abnormal sarcolemma morphology
|
J:137067
|
| abnormal skeletal muscle fiber morphology
|
J:137067
|
| abnormal soleus morphology
|
J:137067
|
| centrally nucleated skeletal muscle fibers
|
J:137067
|
| decreased skeletal muscle fiber number
|
J:137067
|
| decreased skeletal muscle mass
|
J:137067
|
| increased skeletal muscle fiber size
|
J:137067
|
| muscle phenotype
|
J:137067
|
| skeletal muscle fiber atrophy
|
J:137067
|
| skeletal muscle fiber necrosis
|
J:137067
|
Plectm2Gwi/Plectm2Gwi
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal intercalated disk morphology
|
J:59000
|
| abnormal myocardial fiber morphology
|
J:59000
|
| abnormal skeletal muscle fiber morphology
|
J:59000
|
| muscle degeneration
|
J:59000
|
| myopathy
|
J:59000
|
Plectm3Gwi/Plectm3Gwi
(involves: 129P2/OlaHsd)
|
muscle phenotype
|
J:137067
|
Plectm4Gwi/Plectm4Gwi
Tg(Ckmm-cre)5Khn/?
(involves: 129P2/OlaHsd * C57BL/6J * FVB)
|
abnormal muscle fiber mitochondrial morphology
|
J:137067
|
| abnormal myocardial fiber morphology
|
J:137067
|
| abnormal sarcolemma morphology
|
J:137067
|
| abnormal skeletal muscle fiber morphology
|
J:137067
|
| abnormal soleus morphology
|
J:137067
|
| centrally nucleated skeletal muscle fibers
|
J:137067
|
| decreased skeletal muscle fiber number
|
J:137067
|
| decreased skeletal muscle mass
|
J:137067
|
| increased skeletal muscle fiber size
|
J:137067
|
| muscle phenotype
|
J:137067
|
| skeletal muscle fiber atrophy
|
J:137067
|
| skeletal muscle fiber necrosis
|
J:137067
|
Plectm5Gwi/Plectm5Gwi
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal skeletal muscle fiber morphology
|
J:137067
|
| centrally nucleated skeletal muscle fibers
|
J:137067
|
| decreased skeletal muscle fiber diameter
|
J:137067
|
| increased skeletal muscle fiber size
|
J:137067
|
| skeletal muscle fiber necrosis
|
J:137067
|
Plectm6Gwi/Plectm6Gwi
(Not Specified)
|
muscle phenotype
|
J:137067
|
Plekha1Gt(ROSA)82Sor/Plekha1Gt(ROSA)82Sor
(either: (involves: 129S4/SvJaeSor) or (involves: 129S4/SvJaeSor * C57BL/6))
|
abnormal vascular smooth muscle morphology
|
J:142042
|
Plekha1tm1.1Arte/Plekha1tm1.1Arte
Plekha2tm1.1Arte/Plekha2tm1.1Arte
(C57BL/6J-Plekha1tm1.1Arte Plekha2tm1.1Arte)
|
increased cardiac muscle cell glucose uptake
|
J:169475
|
| increased muscle cell glucose uptake
|
J:169475
|
Plekhg5tm1Jbar/Plekhg5tm1Jbar
Tg(Tek-cre)1Ywa/0
(involves: C57BL/6 * SJL)
|
decreased ventricle muscle contractility
|
J:195233
|
Plin1tm1Chan/Plin1tm1Chan
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased gastrocnemius weight
|
J:66267
|
Plin4tm1Vlcg/Plin4tm1Vlcg
(B6.Cg-Plin4tm1Vlcg)
|
decreased cardiac muscle triglyceride level
|
J:195987
|
Plin5tm1e(KOMP)Wtsi/Plin5tm1e(KOMP)Wtsi
(involves: C57BL/6N)
|
decreased cardiac muscle triglyceride level
|
J:221539
|
| decreased skeletal muscle glycogen level
|
J:221539
|
| decreased skeletal muscle triglyceride level
|
J:221539
|
Plin5tm1Macl/Plin5tm1Macl
(involves: 129S6/SvEvTac * C57BL/6JBomTac)
|
decreased cardiac muscle contractility
|
J:286482
|
| decreased cardiac muscle triglyceride level
|
J:286482
|
| increased cardiac muscle cell glucose uptake
|
J:286482
|
Plin5tm1Tosu/Plin5tm1Tosu
(involves: C57BL/6JJcl)
|
decreased cardiac muscle contractility
|
J:188390
|
| decreased cardiac muscle triglyceride level
|
J:188390
|
Plk3tm1Dai/Plk3tm1Dai
(involves: 129S4/SvJae * C57BL/6)
|
increased leiomyosarcoma incidence
|
J:136425
|
Plntm1Egk/Plntm1Egk
(involves: 129S2/SvPas * CF-1)
|
increased cardiac muscle contractility
|
J:39745,
J:59967
|
Plntm1Egk/Plntm1Egk
(involves: 129S2/SvPas)
|
abnormal cardiac muscle relaxation
|
J:106044
|
| increased cardiac muscle contractility
|
J:106044
|
Plntm1Egk/Plntm1Egk
Tg(Myh6-Pln)11Egk/?
(involves: 129S2/SvPas)
|
abnormal cardiac muscle contractility
|
J:66084
|
Plntm1Egk/Plntm1Egk
Tnnt2tm2.1Feah/Tnnt2+
(involves: 129S2/SvPas * 129S6/SvEvTac * FVB/N)
|
decreased cardiac muscle contractility
|
J:243725
|
| dilated cardiomyopathy
|
J:243725
|
Plod1tm1Soin/Plod1tm1Soin
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal aorta smooth muscle morphology
|
J:120891
|
| hypotonia
|
J:120891
|
Plod3tm1Rmyl/Plod3tm1Rmyl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased vasodilation
|
J:106510
|
Plod3tm2Rmyl/Plod3tm2Rmyl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased vasodilation
|
J:106510
|
Plpp7em1Eno/Plpp7em1Eno
(involves: C3H * C57BL/6 * C57BL/6N)
|
abnormal cardiac muscle tissue morphology
|
J:302139
|
| abnormal muscle physiology
|
J:302139
|
| abnormal sarcomere morphology
|
J:302139
|
| abnormal skeletal muscle fiber morphology
|
J:302139
|
| decreased skeletal muscle fiber diameter
|
J:302139
|
| muscle phenotype
|
J:302139
|
| muscle weakness
|
J:302139
|
Plrg1tm2Jcbr/Plrg1tm2Jcbr
Tg(Ckmm-cre)5Khn/0
(involves: FVB)
|
decreased ventricle muscle contractility
|
J:149153
|
| dilated cardiomyopathy
|
J:149153
|
| increased cardiomyocyte apoptosis
|
J:149153
|
Pls3em1Bult/Y
(C57BL/6J-Pls3em1Bult/BultJ)
|
abnormal abdominal muscle morphology
|
J:341714
|
| abnormal diaphragm morphology
|
J:341714
|
| diaphragmatic hernia
|
J:341714
|
| thin diaphragm muscle
|
J:341714
|
Pls3em1Bult/Pls3em1Bult
(C57BL/6J-Pls3em1Bult/BultJ)
|
abnormal abdominal muscle morphology
|
J:341714
|
| abnormal diaphragm development
|
J:341714
|
| abnormal diaphragm morphology
|
J:341714
|
| diaphragmatic hernia
|
J:341714
|
| thin diaphragm muscle
|
J:341714
|
Plxnd1em1Zho/Plxnd1+
(C57BL/6-Plxnd1em1Zho)
|
abnormal ventricle myocardium morphology
|
J:326461
|
| thin myocardium
|
J:326461
|
Plxnd1em1Zho/Plxnd1em1Zho
(C57BL/6-Plxnd1em1Zho)
|
abnormal ventricle myocardium morphology
|
J:326461
|
| thin myocardium
|
J:326461
|
Plxnd1tm1.1Tmj/Plxnd1tm1.1Tmj
Tg(Tek-cre)1Ywa/0
(involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6 * SJL)
|
abnormal myocardium layer morphology
|
J:143763
|
Plxnd1tm1Joe/Plxnd1tm1Joe
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal vascular smooth muscle morphology
|
J:91658
|
pma/pma
(involves: CF-1)
|
abnormal muscle fiber morphology
|
J:4723,
J:4724,
J:8195
|
| muscle degeneration
|
J:4723
|
| muscular atrophy
|
J:86652,
J:4723,
J:4724,
J:6590,
J:8195
|
| myopathy
|
J:8195
|
Pmm2tm1.1Cknr/Pmm2tm2.1Cknr
(involves: C57BL/6J)
|
abnormal myocardium layer morphology
|
J:180794
|
Pmm2tm1.1Jins/Pmm2tm2.1Jins
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal myocardial fiber morphology
|
J:236704
|
| abnormal myocardium layer morphology
|
J:236704
|
| hypotonia
|
J:236704
|
Pmp22tm1Lnot/Pmp22tm1Lnot
(Not Specified)
|
muscle weakness
|
J:104989
|
Pmp22Tr-J/Pmp22+
(involves: C57BL/6)
|
muscle degeneration
|
J:39953
|
Pnpla2tm1Eek/Pnpla2tm1Eek
Tg(Ckmm-cre)5Khn/0
(involves: 129S * FVB/N)
|
increased cardiac muscle triglyceride level
|
J:176252
|
Pnpla2tm1Eek/Pnpla2tm1Eek
Tg(Myog-cre)1Eno/0
(involves: 129S * C57BL/6)
|
increased skeletal muscle triglyceride level
|
J:207007
|
Pnpla2tm1Rze/Pnpla2tm1Rze
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal cardiomyocyte apoptosis
|
J:108546
|
| abnormal myocardial fiber morphology
|
J:108546
|
| abnormal myocardium layer morphology
|
J:108546
|
| decreased ventricle muscle contractility
|
J:108546
|
| increased cardiac muscle triglyceride level
|
J:108546
|
Pnpla2tm1Rze/Pnpla2tm1Rze
(involves: 129P2/OlaHsd)
|
abnormal myocardial fiber mitochondrial morphology
|
J:176252
|
| abnormal myocardial fiber morphology
|
J:176252
|
| decreased ventricle muscle contractility
|
J:176252
|
| increased cardiac muscle glycogen level
|
J:176252
|
Pnpla7tm1.2Murm/Pnpla7tm1.2Murm
(B6.Cg-Pnpla7tm1.2Murm)
|
abnormal skeletal muscle fiber morphology
|
J:333442
|
Pogzem1Tnkw/Pogz+
(involves: C57BL/6NJcl)
|
muscle phenotype
|
J:286398
|
Polbtm1a(KOMP)Wtsi/Polbtm1a(KOMP)Wtsi
(C57BL/6N-Polbtm1a(KOMP)Wtsi/Wtsi)
|
abnormal eye muscle morphology
|
J:239583
|
Pold1tm1Loeb/Pold1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
cardiomyopathy
|
J:129046
|
Poldip2Gt(IST12080D9)Tigm/Poldip2+
(involves: C57BL/6N)
|
abnormal vasoconstriction
|
J:211022
|
| abnormal vasodilation
|
J:211022
|
Polgtm1.1Lrsn/Polgtm1.1Lrsn
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal myocardial fiber morphology
|
J:91077
|
Polgtm1Prol/Polgtm1Prol
(involves: 129S7/SvEvBrd * C57BL/6J * ICR)
|
decreased skeletal muscle mass
|
J:99764
|
Polrmttm1.1Arte/Polrmttm1.1Arte
Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6N * FVB)
|
dilated cardiomyopathy
|
J:258184
|
Pomgnt1Gt(OST179231)Lex/Pomgnt1Gt(OST179231)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
abnormal skeletal muscle fiber morphology
|
J:107697
|
| abnormal tongue muscle morphology
|
J:107697
|
| centrally nucleated skeletal muscle fibers
|
J:107697
|
| dystrophic muscle
|
J:107697
|
| increased variability of skeletal muscle fiber size
|
J:107697
|
Pomgnt1tm1Stk/Pomgnt1tm1Stk
(involves: 129S/SvEv)
|
abnormal muscle physiology
|
J:144928
|
| abnormal muscle regeneration
|
J:144928
|
| abnormal skeletal muscle satellite cell proliferation
|
J:144928
|
| decreased skeletal muscle fiber number
|
J:144928
|
| decreased skeletal muscle fiber size
|
J:144928
|
| dystrophic muscle
|
J:144928
|
Pomt1Gt(OST194127)Lex/Pomt1+
(involves: 129S5/SvEvBrd * C57BL/6J)
|
increased vasodilation
|
J:103485
|
Popdc2tm1Tbd/Popdc2tm1Tbd
(B6.129S2(FVB)-Popdc2tm1Tbd)
|
abnormal sinoatrial node morphology
|
J:184566
|
Portm1Cbk/Portm1Cbk
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal myocardium layer morphology
|
J:74666
|
| absent trabeculae carneae
|
J:74666
|
Postntm1Sjc/Postntm1Sjc
(involves: C57BL/6)
|
muscle phenotype
|
J:103753
|
Pparatm1Gonz/Pparatm1Gonz
(involves: 129S4/SvJae * C57BL/6N)
|
abnormal myocardial fiber morphology
|
J:50024
|
| cardiomyopathy
|
J:81834
|
Pparatm1Gonz/Pparatm1Gonz
(129S4/SvJae-Pparatm1Gonz)
|
abnormal myocardium layer morphology
|
J:56056
|
Pparatm1Gonz/Pparatm1Gonz
(involves: 129S4/SvJae)
|
abnormal myocardial fiber morphology
|
J:63801
|
| cardiomyopathy
|
J:63801
|
| myocardial fiber degeneration
|
J:63801
|
| myocardium necrosis
|
J:63801
|
Pparatm1Gonz/Pparatm1Gonz
(involves: 129S4/SvJae * C57BL/6J)
|
increased muscle cell glucose uptake
|
J:129848
|
| increased skeletal muscle triglyceride level
|
J:129848
|
Ppardtm1Dsvg/Ppardtm1Dsvg
(involves: 129S2/SvPas * C57BL/6)
|
decreased skeletal muscle mass
|
J:219677
|
| muscle weakness
|
J:219677
|
Ppargtm1.1Gonz/Ppargtm1.1Gonz
(involves: 129X1/SvJ * FVB)
|
increased myocardial fiber size
|
J:112034
|
Ppargtm1Lja/Pparg+
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased muscle cell glucose uptake
|
J:98786
|
Ppargtm1Rev/Ppargtm1Rev
(involves: 129S4/SvJae)
|
abnormal myocardial trabeculae morphology
|
J:58223
|
| thin myocardium
|
J:58223
|
| thin ventricle myocardium compact layer
|
J:58223
|
Ppargtm1Tka/Ppargtm1Tka
(involves: C57BL/6 * CBA)
|
thin myocardium
|
J:58222
|
Ppargtm2Rev/Ppargtm2Rev
Tg(Tagln-cre)1Her/?
(involves: 129S4/SvJae * C57BL/6 * SJL)
|
heart right ventricle hypertrophy
|
J:136168
|
Ppargtm2Rev/Ppargtm2Rev
Tg(Tek-cre)1Ywa/?
(involves: 129S4/SvJae * C57BL/6 * SJL)
|
heart right ventricle hypertrophy
|
J:155909
|
Ppargtm2Rev/Ppargtm2Rev
Tg(Tek-cre)12Flv/?
(B6.Cg-Ppargtm2Rev Tg(Tek-cre)12Flv)
|
abnormal vasodilation
|
J:154216
|
| impaired muscle relaxation
|
J:154216
|
Ppargc1atm1Brsp/Ppargc1atm1Brsp
(involves: 129/Sv * C57BL/6 * FVB/N)
|
dystonia
|
J:93896
|
| myoclonus
|
J:93896
|
Ppargc1atm1Dpk/Ppargc1atm1Dpk
(involves: 129X1/SvJ * C57BL/6)
|
abnormal skeletal muscle fiber morphology
|
J:96306
|
| decreased gastrocnemius weight
|
J:96306
|
| decreased skeletal muscle weight
|
J:96306
|
| decreased soleus weight
|
J:96306
|
| decreased ventricle muscle contractility
|
J:96306
|
| increased muscle fatigability
|
J:96306
|
Ppargc1atm1Dpk/Ppargc1atm1Dpk
Ppargc1btm1.1Dpk/Ppargc1btm1.1Dpk
(involves: 129X1/SvJ * FVB/N)
|
abnormal myocardium layer morphology
|
J:137598
|
Ppargc1atm1Dpk/Ppargc1atm1Dpk
Ppargc1btm1Dpk/Ppargc1btm1Dpk
Tg(Myh6-cre)2182Mds/0
(involves: 129X1/SvJ * FVB/N)
|
abnormal myocardium layer morphology
|
J:137598
|
Ppargc1btm1.1Avp/Ppargc1btm1.1Avp
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6)
|
abnormal myocardial fiber mitochondrial morphology
|
J:116167
|
| abnormal skeletal muscle fiber mitochondrial morphology
|
J:116167
|
Ppargc1btm1.1Dpk/Ppargc1btm1.1Dpk
(involves: 129X1/SvJ * FVB/N)
|
abnormal muscle physiology
|
J:137598
|
| muscle phenotype
|
J:137598
|
Ppp1r3atm1Adpr/Ppp1r3atm1Adpr
(either: (involves: 129/Sv) or (involves: 129/Sv * C57BL/6J))
|
decreased skeletal muscle glycogen level
|
J:68370
|
Ppp1r3atm1Ptwc/Ppp1r3atm1Ptwc
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased muscle cell glucose uptake
|
J:82422
|
| decreased skeletal muscle glycogen level
|
J:82422
|
Ppp1r3atm2Adpr/Ppp1r3a+
(involves: 129S6/SvEvTac * C57BL/6J)
|
decreased skeletal muscle glycogen level
|
J:134157
|
Ppp1r3atm2Adpr/Ppp1r3atm2Adpr
(involves: 129S6/SvEvTac * C57BL/6J)
|
decreased skeletal muscle glycogen level
|
J:134157
|
Ppp1r3ctm1Adpr/Ppp1r3ctm1Adpr
(B6.Cg-Ppp1r3ctm1Adpr)
|
increased muscle cell glucose uptake
|
J:242758
|
Ppp1r3ctm1Ars/Ppp1r3c+
(B6.129-Ppp1r3ctm1Ars)
|
decreased cardiac muscle glycogen level
|
J:83297
|
| decreased muscle cell glucose uptake
|
J:83297
|
| decreased skeletal muscle glycogen level
|
J:83297
|
| increased skeletal muscle triglyceride level
|
J:83297
|
Ppp1r12atm1Mzhu/Ppp1r12atm1Mzhu
Tg(Acta2-cre)#Xya/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA)
|
abnormal muscle contractility
|
J:207752
|
| abnormal muscle electrophysiology
|
J:207752
|
| abnormal smooth muscle morphology
|
J:207752
|
| intestinal hypoperistalsis
|
J:207752
|
Ppp1r12bem1(IMPC)J/Ppp1r12bem1(IMPC)J
(C57BL/6NJ-Ppp1r12bem1(IMPC)J/Mmjax)
|
increased cardiac muscle contractility
|
J:335272
|
Ppp1r12bem1Chana/Ppp1r12bem1Chana
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: C57BL/6J * FVB/N)
|
abnormal myocardial fiber morphology
|
J:346986
|
Ppp1r13ltm1.1Xlu/Ppp1r13ltm1.1Xlu
(involves: 129 * C57BL/6J)
|
abnormal intercalated disk morphology
|
J:220162
|
| abnormal myocardial fiber morphology
|
J:220162
|
| abnormal myocardium layer morphology
|
J:220162
|
| cardiac muscle degeneration
|
J:220162
|
| decreased ventricle muscle contractility
|
J:220162
|
| disorganized myocardium
|
J:220162
|
| ventricular cardiomyopathy
|
J:220162
|
Ppp1r13lwa3-J/Ppp1r13lwa3-J
(BALB/cJ-Ppp1r13lwa3-J/J)
|
cardiomyopathy
|
J:146206
|
| dilated cardiomyopathy
|
J:264272
|
Ppp1r13lwa3/Ppp1r13lwa3
(either: C57BL/6-Ppp1r13lwa3 or (involves: C57BL/6 * DBA/2J))
|
decreased cardiac muscle contractility
|
J:96392
|
| dilated cardiomyopathy
|
J:96392
|
| myocardium necrosis
|
J:96392
|
Ppp1r13lwoe2/Ppp1r13lwoe2
(involves: 129X1/SvJ * C57BL/6)
|
abnormal myocardium layer morphology
|
J:190557
|
Ppp1r14aem1Gpt/Ppp1r14a+
(involves: C57BL/6J)
|
decreased vasoconstriction
|
J:290992
|
Ppp1r14aem1Gpt/Ppp1r14aem1Gpt
(involves: C57BL/6J)
|
decreased vasoconstriction
|
J:290992
|
Ppp2r5cGt(XP0444)Wtsi/Ppp2r5cGt(XP0444)Wtsi
(B6.129P2-Ppp2r5cGt(XP0444)Wtsi)
|
abnormal Z line morphology
|
J:210365
|
| thin myocardium
|
J:210365
|
Ppp3catm1Jse/Ppp3catm1Jse
(involves: 129S4/SvJae)
|
abnormal skeletal muscle fiber type ratio
|
J:110822
|
| decreased skeletal muscle fiber number
|
J:110822
|
| increased skeletal muscle fiber diameter
|
J:110822
|
Ppp3cbtm1Jmk/Ppp3cbtm1Jmk
(involves: 129S6/SvEvTac)
|
abnormal skeletal muscle fiber type ratio
|
J:110822
|
| decreased skeletal muscle fiber diameter
|
J:110822
|
| increased skeletal muscle fiber number
|
J:110822
|
Ppp3cbtm1Jmk/Ppp3cbtm1Jmk
Tg(Myh6/tetO-Tnnc1*I61Q)1Jmol/0
Tg(Myh6-tTA)55Rbns/0
(involves: 129S6/SvEvTac * FVB)
|
decreased cardiac muscle contractility
|
J:234490
|
Ppp3r1tm1.1Jhon/Ppp3r1tm1.1Jhon
(involves: C57BL/6 * C57BL/6NTac)
|
abnormal myocardial fiber morphology
|
J:298603
|
| decreased cardiac muscle contractility
|
J:298603
|
| dilated cardiomyopathy
|
J:298603
|
| increased cardiomyocyte apoptosis
|
J:298603
|
Ppp3r1tm2Grc/Ppp3r1tm2.1Grc
Tg(Pax3-cre)1Joe/0
(involves: 129S6/SvEvTac)
|
impaired ureteric peristalsis
|
J:89217
|
Ppp3r1tm2Grc/Ppp3r1tm2Grc
Tg(Pax3-cre)1Joe/0
(involves: 129S6/SvEvTac)
|
impaired ureteric peristalsis
|
J:89217
|
Ppt1tm1Aj/Ppt1tm1Aj
(involves: 129S4/SvJae * C57BL/6)
|
myoclonus
|
J:95522
|
Ppt1tm1Hof/Ppt1tm1Hof
(involves: 129S6/SvEvTac * C57BL/6J)
|
myoclonus
|
J:72931
|
Ppt2tm1Hof/Ppt2tm1Hof
(involves: 129S6/SvEvTac * C57BL/6J)
|
muscle spasm
|
J:86202
|
Prdm1tm1.1Clme/Prdm1tm1.1Clme
(involves: 129S1/Sv * 129X1/SvJ * FVB/N * ICR)
|
abnormal dermomyotome development
|
J:101718
|
Prdm1tm1.1Clme/Prdm1tm2Rob
(involves: 129S/Sv * 129X1/Sv * C57BL/6 * FVB/N * ICR)
|
abnormal dermomyotome development
|
J:101718
|
Prdm1tm1Rob/Prdm1tm1Rob
(involves: 129S/SvEv * C57BL/6)
|
abnormal myotome development
|
J:101718
|
Prdm1tm2Rob/Prdm1tm2Rob
(involves: 129S/SvEv * C57BL/6)
|
abnormal myotome development
|
J:101718
|
Prdm4tm1b(EUCOMM)Hmgu/Prdm4tm1b(EUCOMM)Hmgu
(C57BL/6N-Prdm4tm1b(EUCOMM)Hmgu/H)
|
increased cardiac muscle contractility
|
J:211773
|
Prdm6tm1.2Jrld/Prdm6tm1.2Jrld
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * SJL)
|
thin myocardium
|
J:209773
|
Prdm16tm1.1Brsp/Prdm16tm1.1Brsp
Tg(myl7.L-cre)1118Tmhn/0
(involves: 129 * C57BL/6J * MF1)
|
cardiomyopathy
|
J:326525
|
| decreased cardiac muscle contractility
|
J:326525
|
| decreased fetal cardiomyocyte proliferation
|
J:326525
|
| thin left ventricle myocardium compact layer
|
J:326525
|
Prepltm1.2Sagh/Prepltm1.2Sagh
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J * Swiss Webster)
|
hypotonia
|
J:213429
|
Prickle1tm1.2Asw/Prickle1tm1.2Asw
(Not Specified)
|
abnormal myocardial fiber morphology
|
J:213772
|
Prkaa1tm1Sbj/Prkaa1tm1Sbj
(involves: 129S2/SvPas * C57BL/6J)
|
decreased muscle cell glucose uptake
|
J:87719
|
Prkaa2tm1.1Vio/Prkaa2tm1.1Vio
(involves: 129S2/SvPas * C57BL/6)
|
decreased skeletal muscle glycogen level
|
J:81120
|
Prkaa2tm1.1Vio/Prkaa2tm1.1Vio
(involves: 129S2/SvPas)
|
abnormal muscle cell glucose uptake
|
J:87719
|
| decreased skeletal muscle glycogen level
|
J:87719
|
Prkab1tm1Grst/Prkab1tm1Grst
Prkab2tm1Grst/Prkab2tm1Grst
Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6 * FVB)
|
abnormal skeletal muscle morphology
|
J:176578
|
| decreased muscle cell glucose uptake
|
J:176578
|
| increased muscle fatigability
|
J:176578
|
Prkab2Gt(AL0483)Wtsi/Prkab2Gt(AL0483)Wtsi
(B6.129P2-Prkab2Gt(AL0483)Wtsi)
|
decreased muscle cell glucose uptake
|
J:186658
|
| decreased skeletal muscle glycogen level
|
J:186658
|
Prkab2tm1.1Grst/Prkab2tm1.1Grst
(involves: C57BL/6)
|
decreased muscle cell glucose uptake
|
J:167339
|
| decreased skeletal muscle fiber size
|
J:167339
|
| decreased skeletal muscle glycogen level
|
J:167339
|
| increased muscle cell glucose uptake
|
J:167339
|
| muscle weakness
|
J:167339
|
Prkag2tm1.1Geno/Prkag2tm1.1Geno
(B6J.129S(Cg)-Prkag2tm1.1Geno)
|
abnormal sinoatrial node morphology
|
J:256296
|
| decreased cardiac muscle contractility
|
J:256296
|
| increased cardiac muscle glycogen level
|
J:256296
|
Prkag3tm1Sson/Prkag3tm1Sson
(involves: C57BL/6J)
|
decreased skeletal muscle glycogen level
|
J:92821
|
Prkar1atm2Gsm/Prkar1atm2Gsm
Tg(Plp1-cre)1Bzal/0
(involves: 129X1/SvJ * C57BL/6 * C57BL/6N * DBA/2)
|
muscular atrophy
|
J:148464
|
Prkar1atm2Gsm/Prkar1atm2Gsm
Tlx2tm1.1(cre)Rpk/Tlx2+
(involves: 129S4/SvJae * 129X1/SvJ * C57BL/6 * C57BL/6N * DBA/2)
|
intestinal hypoperistalsis
|
J:148464
|
Prkcatm1Far/Prkcatm1Far
(involves: 129/Sv * 129P2/OlaHsd)
|
increased muscle cell glucose uptake
|
J:85923
|
Prkcatm1Jmk/Prkcatm1Jmk
(involves: 129)
|
abnormal cardiac muscle contractility
|
J:132098
|
| abnormal myocardium layer morphology
|
J:132098
|
Prkcdtm1Qxu/Prkcdtm1Qxu
(involves: 129P2/OlaHsd)
|
vascular smooth muscle hyperplasia
|
J:78680
|
Prkcitm1Rfar/Prkci+
Tg(Ckmm-cre)5Khn/?
(involves: 129P2/OlaHsd * C57BL/6 * FVB)
|
decreased cardiac muscle cell glucose uptake
|
J:123964
|
| decreased muscle cell glucose uptake
|
J:123964
|
Prkcitm1Rfar/Prkcitm1Rfar
Tg(Ckmm-cre)5Khn/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB)
|
decreased cardiac muscle cell glucose uptake
|
J:123964
|
| decreased muscle cell glucose uptake
|
J:123964
|
Prkcqtm1Litt/Prkcqtm1Litt
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal muscle cell glucose uptake
|
J:92834
|
Prkd1tm1Eno/Prkd1tm1Eno
Tg(Myh6-cre)2182Mds/?
(involves: 129S/SvEv * C57BL/6 * FVB/N)
|
increased cardiac muscle contractility
|
J:132803
|
Prkdcscid/Prkdcscid
(involves: BALB/c * C57BL/10ScSn * C57BL/Ka)
|
muscle phenotype
|
J:125527
|
Prkg1tm1.1Arte/Prkg1tm1.1Arte
(C57BL/6-Prkg1tm1.1Arte)
|
decreased vasodilation
|
J:181180
|
Prkg1tm1Hfm/Prkg1tm1Hfm
(Not Specified)
|
abnormal cardiac muscle relaxation
|
J:48058
|
| abnormal intestinal peristalsis
|
J:48058
|
| abnormal vascular smooth muscle physiology
|
J:48058
|
| impaired muscle relaxation
|
J:60928,
J:48058
|
| impaired smooth muscle contractility
|
J:94387
|
| pyloric sphincter hypertrophy
|
J:48058
|
Prkg1tm1Meme/Prkg1tm1Meme
(involves: 129S/SvEv)
|
decreased vasodilation
|
J:134634
|
Prkg1tm1Naw/Prkg1tm1Naw
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
abnormal cardiac muscle contractility
|
J:84611
|
Prkg1tm2.1Naw/Prkg1tm2.1Naw
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal vascular smooth muscle physiology
|
J:134928
|
Prkntm1Roo/Prkntm1Roo
(either: 129S2/SvPas or (involves: 129S2/SvPas * C57BL/6))
|
muscle phenotype
|
J:85561
|
Prmt7tm1.1Rchd/Prmt7tm1.1Rchd
Pax7tm1(cre/ERT2)Gaka/Pax7+
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6NCrl)
|
abnormal muscle physiology
|
J:271361
|
| impaired skeletal muscle regeneration
|
J:271361
|
Prmt7tm1.2Rchd/Prmt7tm1.2Rchd
(involves: 129S4/SvJaeSor * FVB/N)
|
abnormal muscle physiology
|
J:271361
|
| abnormal myoblast differentiation
|
J:271361
|
| decreased satellite cell number
|
J:271361
|
| decreased skeletal muscle weight
|
J:271361
|
| impaired skeletal muscle regeneration
|
J:271361
|
Prnptm1Cwe/Prnptm1Cwe
Tg(Prnp*)#Rgab/0
(involves: 129S7/SvEvBrd * C57BL/6 * FVB/N)
|
muscular atrophy
|
J:183170
|
| myoclonus
|
J:183170
|
Prnptm1Cwe/Prnptm1Cwe
Tg(Prnp*S170N*N174T)1020Aag/0
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal muscle fiber morphology
|
J:143528
|
| muscle degeneration
|
J:143528
|
Prnptm2.1Cwe/Prnptm2.1Cwe
(involves: 129P2/OlaHsd)
|
abnormal muscle physiology
|
J:67593
|
Prorptm1.1Afi/Prorptm1.1Afi
Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6N * FVB)
|
cardiomyopathy
|
J:238964
|
| myocardium necrosis
|
J:238964
|
Pros1tm1.2Grl/Pros1tm1.2Grl
(involves: 129S1/SvImJ * FVB/N)
|
vascular smooth muscle hypoplasia
|
J:198769
|
Prox1tm2Gco/Prox1tm2Gco
Myf5tm3(cre)Sor/Myf5+
(involves: 129S1/Sv * 129S4/SvJae * C57BL/6J)
|
abnormal skeletal muscle morphology
|
J:212185
|
Prox1tm2Gco/Prox1tm2Gco
Nkx2-5tm1(cre)Rjs/Nkx2-5+
(involves: 129S1/Sv * 129S7/SvEvBrd)
|
abnormal myocardial fiber morphology
|
J:212185
|
| decreased cardiac muscle contractility
|
J:212185
|
| dilated cardiomyopathy
|
J:212185
|
| thin myocardium
|
J:212185
|
Prrc2btm1a(EUCOMM)Wtsi/Prrc2btm1a(EUCOMM)Wtsi
(C57BL/6N-Prrc2btm1a(EUCOMM)Wtsi/Wtsi)
|
abnormal eye muscle morphology
|
J:239583
|
| abnormal skeletal muscle morphology
|
J:239583
|
| absent skeletal muscle
|
J:239583
|
Prrt2tm1d(KOMP)Wtsi/Prrt2+
(B6(Cg)-Prrt2tm1d(KOMP)Wtsi)
|
dystonia
|
J:299667
|
Prrt2tm1d(KOMP)Wtsi/Prrt2tm1d(KOMP)Wtsi
(B6(Cg)-Prrt2tm1d(KOMP)Wtsi)
|
dystonia
|
J:299667
|
Prss48em1(IMPC)Ccpcz/Prss48em1(IMPC)Ccpcz
(C57BL/6NCrl-Prss48em1(IMPC)Ccpcz/Ccpcz)
|
increased cardiac muscle contractility
|
J:211773
|
Psaptm1Suz/Psaptm1Suz
(involves: 129P2/OlaHsd)
|
abnormal muscle fiber morphology
|
J:113052
|
| muscular atrophy
|
J:113052
|
| progressive muscle weakness
|
J:33477
|
Psaptm2Suz/Psaptm2Suz
(involves: 129S/SvEv * C57BL/6J)
|
abnormal intestinal peristalsis
|
J:78223
|
| muscle weakness
|
J:78223
|
| muscular atrophy
|
J:78223
|
Psen1tm1Hko/Psen1tm1Hko
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased vasodilation
|
J:84418
|
Psmb9tm1Stl/Psmb9tm1Stl
(involves: 129P2/OlaHsd * C57BL/6)
|
increased leiomyosarcoma incidence
|
J:73945
|
Psmf1tm1c(EUCOMM)Hmgu/Psmf1tm1c(EUCOMM)Hmgu
Mnx1tm4(cre)Tmj/Mnx1+
(involves: 129S1/Sv * C57BL/6J * C57BL/6N)
|
muscular atrophy
|
J:282431
|
Psmf1tm1c(EUCOMM)Hmgu/Psmf1tm1c(EUCOMM)Hmgu
Tg(CDX2-cre)101Erf/0
(involves: C57BL/6J * C57BL/6N * SJL/J)
|
abnormal muscle tone
|
J:282431
|
Psphtm1a(EUCOMM)Hmgu/Psphtm1a(EUCOMM)Hmgu
(C57BL/6N-Psphtm1a(EUCOMM)Hmgu/Wtsi)
|
abnormal eye muscle morphology
|
J:239583
|
| abnormal infrahyoid muscle connection
|
J:239583
|
| absent eye muscles
|
J:239583
|
Ptcd1tm1(KOMP)Vlcg/Ptcd1+
(C57BL/6N-Ptcd1tm1(KOMP)Vlcg)
|
increased cardiac muscle contractility
|
J:256004
|
Ptcd2Gt(RRF537)Byg/Ptcd2Gt(RRF537)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal myocardial fiber morphology
|
J:143946
|
| abnormal sarcolemma morphology
|
J:143946
|
| myocardial fiber degeneration
|
J:143946
|
Ptch1mes/Ptch1mes
(B6C3Fe a/a-Ptch1mes)
|
abnormal tendon morphology
|
J:23861
|
Ptch1tm1.1Hahn/Ptch1+
(involves: 129 * BALB/c * C57BL/6 * FVB/N)
|
increased rhabdomyosarcoma incidence
|
J:149148
|
Ptch1tm1Mps/Ptch1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased rhabdomyosarcoma incidence
|
J:205254
|
Ptch1tm1Mps/Ptch1+
(involves: 129S1/Sv * 129X1/SvJ)
|
increased rhabdomyosarcoma incidence
|
J:114992
|
Ptch1tm1Mps/Ptch1+
Ptch2tm1Pmc/Ptch2+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased rhabdomyosarcoma incidence
|
J:112118
|
| telangiectasia
|
J:112118
|
Ptch1tm1Mps/Ptch1+
Ptch2tm1Pmc/Ptch2tm1Pmc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased rhabdomyosarcoma incidence
|
J:112118
|
Ptch1tm1Mps/Ptch1+
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129 * 129S2/SvPas * C57BL/6)
|
increased rhabdomyosarcoma incidence
|
J:125534
|
Ptch1tm1Zim/Ptch1+
(either: (involves: 129 * C57BL/6) or (involves: 129 * CD-1))
|
increased rhabdomyosarcoma incidence
|
J:47421
|
Ptchd1tm2.2Gfng/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
hypotonia
|
J:232709
|
Ptentm1.1Yxy/Ptentm1.1Yxy
(involves: C57BL/6)
|
increased myocardial fiber mitochondrial DNA content
|
J:308567
|
Ptentm1Hwu/Ptentm1Hwu
(involves: 129S4/SvJae)
|
abnormal muscle fiber morphology
|
J:169364
|
Ptentm1Hwu/Ptentm1Hwu
Tg(Ckmm-cre)5Khn/?
(involves: 129S4/SvJae * FVB)
|
enhanced skeletal muscle regeneration
|
J:169364
|
Ptentm2Mak/Ptentm2Mak
Tg(Ckmm-cre)5Khn/0
(involves: 129P2/OlaHsd * FVB)
|
decreased cardiac muscle contractility
|
J:79151
|
| increased myocardial fiber size
|
J:79151
|
Ptentm2Mak/Ptentm2Mak
Tg(Ckmm-cre)5Khn/0
Tg(Myh6-Pik3ca)1Siz/0
(involves: 129P2/OlaHsd * FVB)
|
decreased cardiac muscle contractility
|
J:79151
|
Ptgdrtm1Dgen/Ptgdr+
(B6.129P2-Ptgdrtm1Dgen)
|
decreased vasodilation
|
J:109107
|
| increased vasodilation
|
J:109107
|
Ptgdrtm1Dgen/Ptgdrtm1Dgen
(B6.129P2-Ptgdrtm1Dgen)
|
decreased vasodilation
|
J:109107
|
Ptger2tm1Brey/Ptger2tm1Brey
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal vasodilation
|
J:53646
|
Ptger2tm1Brey/Ptger2tm1Brey
(involves: 129S6/SvEvTac)
|
abnormal vasodilation
|
J:78902
|
| increased vasoconstriction
|
J:78902
|
Ptger3tm1Cof/Ptger3tm1Cof
(involves: 129P2/OlaHsd)
|
increased vasodilation
|
J:77409
|
Ptger4tm1.1Matb/Ptger4tm1.1Matb
Tg(Myh6-cre)2182Mds/0
(involves: 129S6/SvEvTac * FVB/N)
|
abnormal cardiac muscle tissue morphology
|
J:158439
|
| abnormal myocardial fiber morphology
|
J:158439
|
| decreased cardiac muscle contractility
|
J:158439
|
| dilated cardiomyopathy
|
J:158439
|
Ptgs1tm1Unc/Ptgs1tm1Unc
(involves: 129P2/OlaHsd * C57BL/6)
|
hypotonia
|
J:146321
|
Ptgs1tm1Unc/Ptgs1tm1Unc
(B6;129P2-Ptgs1tm1Unc/Tac)
|
muscle phenotype
|
J:107751
|
Ptgs2tm1Gaf/Ptgs2tm1Gaf
A1cfTg(Myh6-cre/Esr1*)1Jmk/?
(involves: 129/Sv * C57BL/6 * FVB/N)
|
decreased ventricle muscle contractility
|
J:148331
|
| increased myocardial fiber size
|
J:148331
|
Ptgs2tm1Unc/Ptgs2tm1Unc
(involves: 129P2/OlaHsd * C57BL/6)
|
muscle phenotype
|
J:146321
|
Ptgs2tm1Unc/Ptgs2tm1Unc
(B6;129P2-Ptgs2tm1Unc/Tac)
|
impaired skeletal muscle regeneration
|
J:107751
|
Ptk2tm1.1Jtpa/Ptk2tm1.1Jtpa
(involves: 129P2/OlaHsd * C57BL/6)
|
muscle phenotype
|
J:142495
|
Ptk2tm1Imeg/Ptk2tm1Imeg
(involves: C57BL/6 * CBA)
|
thick myocardium
|
J:29978
|
Ptk2btm1Okig/Ptk2btm1Okig
(involves: C57BL/6)
|
decreased vasodilation
|
J:139849
|
Ptpn11tm1.1Ics/Ptpn11+
(involves: 129S2/SvPas * C57BL/6 * FVB/N)
|
decreased cardiac muscle contractility
|
J:216593
|
| decreased skeletal muscle triglyceride level
|
J:216593
|
| dilated cardiomyopathy
|
J:216593
|
| heart left ventricle hypertrophy
|
J:216593
|
Ptpn11tm1Bgn/Ptpn11+
(involves: 129S4/SvJae * C57BL/6J)
|
decreased cardiomyocyte apoptosis
|
J:91609
|
Ptpn11tm1Bgn/Ptpn11tm1Bgn
(involves: 129S4/SvJae * C57BL/6J)
|
decreased cardiomyocyte apoptosis
|
J:91609
|
| thin myocardium
|
J:91609
|
| thin myocardium compact layer
|
J:91609
|
Ptpn11tm1Gsf/Ptpn11tm1Gsf
Tg(Ckmm-cre)5Khn/0
(involves: 129S1/Sv * 129X1/SvJ * FVB)
|
decreased cardiac muscle cell glucose uptake
|
J:144767
|
| decreased muscle cell glucose uptake
|
J:144767
|
| decreased ventricle muscle contractility
|
J:144767
|
| dilated cardiomyopathy
|
J:144767
|
| increased cardiac muscle triglyceride level
|
J:144767
|
| increased myocardial fiber size
|
J:144767
|
| increased skeletal muscle triglyceride level
|
J:144767
|
Ptpn11tm1Yan/Ptpn11tm1Yan
Tg(Ckmm-cre)5Khn/0
(involves: 129/Sv * C57BL/6 * FVB)
|
decreased skeletal muscle fiber number
|
J:114499
|
| decreased skeletal muscle fiber size
|
J:114499
|
Ptpn11tm4.2Bgn/Ptpn11+
(involves: 129S6/SvEvTac * C57BL/6J * FVB/N)
|
decreased ventricle muscle contractility
|
J:172033
|
| dilated cardiomyopathy
|
J:172033
|
| heart left ventricle hypertrophy
|
J:172033
|
| increased myocardial fiber size
|
J:172033
|
Ptpn11tm6Bgn/Ptpn11+
Tg(Tek-cre)12Flv/0
(involves: 129S6/SvEvTac * C3H * C57BL/6)
|
thin myocardium
|
J:147154
|
Ptpn11tm7Bgn/Ptpn11tm7Bgn
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6)
|
thin myocardium
|
J:147154
|
Ptprbtm1Dgen/Ptprbtm1Dgen
(B6.Cg-Ptprbtm1Dgen)
|
abnormal myocardial trabeculae morphology
|
J:125783
|
Ptprdtm1Yiw/Ptprdtm1Yiw
Ptprstm1Mtr/Ptprstm1Mtr
(B6.Cg-Ptprdtm1Yiw Ptprstm1Mtr)
|
centrally nucleated skeletal muscle fibers
|
J:109122
|
| hypaxial muscle hypoplasia
|
J:109122
|
| thin diaphragm muscle
|
J:109122
|
Ptprjtm1Taka/Ptprjtm1Taka
(involves: 129S6/SvEvTac)
|
abnormal myocardial trabeculae morphology
|
J:82356
|
| abnormal vascular smooth muscle morphology
|
J:82356
|
| thin myocardium
|
J:82356
|
| vascular smooth muscle hypoplasia
|
J:82356
|
Ptprmtm1Mfbg/Ptprmtm1Mfbg
(FVB.129P2-Ptprmtm1Mfbg)
|
decreased vasodilation
|
J:97057
|
Ptprvtm1Kry/Ptprvtm1Kry
Tg(Col1a1-cre)1Kry/0
(involves: FVB)
|
abnormal muscle fiber mitochondrial morphology
|
J:126780
|
| increased muscle cell glucose uptake
|
J:126780
|
Ptrh2tm1.1Eruo/Ptrh2tm1.1Eruo
(C57BL/6-Ptrh2tm1.1Eruo)
|
abnormal epaxial muscle morphology
|
J:131853
|
| abnormal sarcolemma morphology
|
J:241883
|
| centrally nucleated skeletal muscle fibers
|
J:241883
|
| dystrophic muscle
|
J:241883
|
| increased variability of skeletal muscle fiber size
|
J:241883
|
| myopathy
|
J:241883
|
| progressive muscle weakness
|
J:241883,
J:131853
|
| skeletal muscle degeneration
|
J:241883
|
| skeletal muscle endomysial fibrosis
|
J:241883
|
Ptstm1Ich/Ptstm1Ich
Tg(DBH-PTS)6Csic/0
(involves: 129X1/SvJ * C57BL/6J)
|
dystonia
|
J:138968
|
Ptstm1Thny/Ptstm1Thny
(involves: 129/Sv * C57BL/6)
|
dystonia
|
J:84533
|
Pus1tm1.1Mdf/Pus1tm1.1Mdf
(B6.129S7(C)-Pus1tm1.1Mdf)
|
abnormal muscle physiology
|
J:237107
|
| decreased skeletal muscle fiber size
|
J:237107
|
| decreased skeletal muscle mass
|
J:237107
|
Pvalbtm1Swal/Pvalbtm1Swal
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal muscle contractility
|
J:53121
|
Pygmtm1.1Adru/Pygmtm1.1Adru
(involves: 129 * C57BL/6J)
|
increased skeletal muscle glycogen level
|
J:226312
|
| increased variability of skeletal muscle fiber size
|
J:226312
|
Qars1em1(IMPC)Mbp/Qars1+
(C57BL/6NCrl-Qars1em1(IMPC)Mbp/MbpMmucd)
|
abnormal skeletal muscle morphology
|
J:211773
|
Qkitm1Imeg/Qkitm1Imeg
(involves: 129P2/OlaHsd)
|
abnormal myocardium layer morphology
|
J:88215
|
Qrich1b2b2404Clo/Qrich1b2b2404Clo
(C57BL/6J-Qrich1b2b2404Clo)
|
abnormal myocardium compact layer morphology
|
J:175213
|
R3hdmltm1Mita/R3hdmltm1Mita
(B6.Cg-R3hdmltm1Mita)
|
abnormal muscle development
|
J:282737
|
| abnormal quadriceps morphology
|
J:282737
|
| abnormal sarcomere morphology
|
J:282737
|
| abnormal skeletal muscle fiber morphology
|
J:282737
|
| abnormal skeletal muscle satellite cell proliferation
|
J:282737
|
| decreased skeletal muscle fiber diameter
|
J:282737
|
| decreased skeletal muscle weight
|
J:282737
|
| diffuse Z line
|
J:282737
|
| impaired skeletal muscle regeneration
|
J:282737
|
Rac1tm1Djk/Rac1tm1.1Djk
Tg(Myh6-cre/Esr1*)1Liao/0
(involves: 129S4/SvJae * C57BL/6)
|
abnormal myocardial fiber morphology
|
J:109582
|
| abnormal myocardium layer morphology
|
J:109582
|
Rac1tm1Djk/Rac1tm1Djk
Tg(Mef2c-cre)2Blk/0
(involves: 129S4/SvJae * BALB/c * C57BL/6)
|
abnormal ventricle myocardium morphology
|
J:315097
|
| thin right ventricle myocardium compact layer
|
J:315097
|
| trabecula carnea hypoplasia
|
J:315097
|
Rac1tm1Djk/Rac1tm1Djk
Tg(Nkx2-5-cre)9Eno/0
(involves: 129S4/SvJae * BALB/c * C57BL/6)
|
abnormal myocardium compact layer morphology
|
J:321017
|
| abnormal trabecula carnea morphology
|
J:321017
|
| abnormal ventricle myocardium morphology
|
J:321017
|
| decreased fetal cardiomyocyte proliferation
|
J:321017
|
| thin myocardium compact layer
|
J:321017
|
| thin ventricle myocardium compact layer
|
J:321017
|
Rad18tm1a(EUCOMM)Wtsi/Rad18tm1a(EUCOMM)Wtsi
(B6Brd;B6Dnk;B6N-Tyrc-Brd Rad18tm1a(EUCOMM)Wtsi/Wtsi)
|
abnormal arrector pilli muscle morphology
|
J:232539
|
Raf1tm1.1Bgn/Raf1+
(involves: 129S6/SvEvTac * C57BL/6NCr)
|
decreased cardiac muscle contractility
|
J:172034
|
| dilated cardiomyopathy
|
J:172034
|
| increased cardiac muscle contractility
|
J:189143,
J:172034
|
| increased myocardial fiber size
|
J:172034
|
Raf1tm2.1Ara/Raf1tm2.1Ara
(involves: 129S6/SvEvTac * C57BL/6NCr)
|
increased cardiac muscle contractility
|
J:189143
|
| increased myocardial fiber size
|
J:189143
|
Raf1tm2Bacc/Raf1tm2Bacc
Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6J)
|
decreased cardiac muscle contractility
|
J:93418
|
| decreased ventricle muscle contractility
|
J:93418
|
| increased cardiomyocyte apoptosis
|
J:93418
|
| thin myocardium
|
J:93418
|
Ralatm1a(EUCOMM)Wtsi/Ralatm1a(EUCOMM)Wtsi
(C57BL/6N-Ralatm1a(EUCOMM)Wtsi/Wtsi)
|
abnormal eye muscle morphology
|
J:239583
|
Ralgapa1tm1.1Schen/Ralgapa1tm1.1Schen
(involves: C57BL/6J)
|
abnormal muscle physiology
|
J:287672
|
| decreased muscle cell glucose uptake
|
J:287672
|
Ralgapa1tm2c(KOMP)Wtsi/Ralgapa1tm2c(KOMP)Wtsi
Myl1tm1(cre)Sjb/Myl1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * C57BL/6N)
|
increased muscle cell glucose uptake
|
J:287672
|
Ramp1tm1.1Tsuj/Ramp1tm1.1Tsuj
(involves: 129S2/SvPas * C57BL/6)
|
decreased vasodilation
|
J:125974
|
Ramp2tm1Kmca/Ramp2tm1Kmca
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal aorta smooth muscle morphology
|
J:130930
|
Rangrftm1.1Tke/Rangrftm1.1Tke
(involves: C57BL/6)
|
abnormal cardiac muscle tissue morphology
|
J:325055
|
| abnormal I band morphology
|
J:325055
|
| abnormal myocardial fiber morphology
|
J:325055
|
| abnormal sarcomere morphology
|
J:325055
|
| decreased cardiac muscle contractility
|
J:325055
|
Rap1gds1tm1Ytk/Rap1gds1tm1Ytk
(involves: 129X1/SvJ * C57BL/6 * DBA)
|
abnormal myocardial trabeculae morphology
|
J:62244
|
| abnormal myocardium layer morphology
|
J:62244
|
| increased cardiomyocyte apoptosis
|
J:62244
|
Rapgef1Gt(pGT1.8geo)5Pgr/Rapgef1Gt(pGT1.8geo)5Pgr
(involves: 129/Sv * C57BL/6 * Swiss)
|
abnormal vascular smooth muscle morphology
|
J:80219
|
| vascular smooth muscle hypoplasia
|
J:80219
|
Rapgef3tm1.2Chen/Rapgef3tm1.2Chen
Rapgef4tm1.2Chen/Rapgef4tm1.2Chen
(involves: 129 * Black Swiss * C57BL/6 * SJL)
|
abnormal sarcoplasmic reticulum morphology
|
J:210426
|
Rapgef4tm1.2Chen/Rapgef4tm1.2Chen
(involves: 129 * Black Swiss * C57BL/6 * SJL)
|
abnormal sarcoplasmic reticulum morphology
|
J:210426
|
Rapsntm1Jrs/Rapsntm1Jrs
(involves: 129S1/Sv * 129X1/SvJ)
|
muscle weakness
|
J:28777
|
Raratm1Ipc/Raratm1Ipc
Rarbtm1Mma/Rarbtm1Mma
(involves: 129S2/SvPas * C57BL/6)
|
diaphragmatic hernia
|
J:43344
|
Raratm1Ipc/Raratm1Ipc
Rargtm1Ipc/Rargtm1Ipc
(involves: 129S2/SvPas)
|
ventricle myocardium hypoplasia
|
J:21034
|
Rarres2tm1Yktk/Rarres2tm1Yktk
(B6.Cg-Rarres2tm1Yktk)
|
increased muscle cell glucose uptake
|
J:206120
|
Rasa1tm1Wid/Rasa1tm1Wid
(involves: 129S/SvEv * 129S6/SvEvTac * C57BL/6N)
|
increased cardiomyocyte apoptosis
|
J:189241
|
Rb1tm1Tyj/Rb1+
Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas * C57BL/6)
|
increased leiomyosarcoma incidence
|
J:19542
|
Rb1tm1Tyj/Rb1tm1Tyj
Rbl1tm1Tyj/Rbl1tm1Tyj
(involves: 129S2/SvPas * C57BL/6)
|
muscle phenotype
|
J:34058
|
Rb1tm1Tyj/Rb1tm1Tyj
Tg(Rb1)1Blg/0
(involves: 129S2/SvPas * C57BL/6)
|
abnormal myogenesis
|
J:37145
|
| abnormal skeletal muscle fiber morphology
|
J:37145
|
| abnormal skeletal muscle morphology
|
J:37145
|
| decreased skeletal muscle fiber density
|
J:37145
|
| decreased skeletal muscle mass
|
J:37145
|
Rb1tm1Tyj/Rb1tm1Tyj
Tg(Rb1)1Blg/0
(involves: 129S2/SvPas)
|
abnormal myogenesis
|
J:65679
|
| abnormal skeletal muscle fiber morphology
|
J:65679
|
Rb1tm1Tyj/Rb1tm1Tyj
Tg(Rb1)1Blg/0
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas)
|
abnormal muscle physiology
|
J:65679
|
| abnormal skeletal muscle fiber morphology
|
J:65679
|
Rb1tm2.1Fad/Rb1tm2.1Fad
(involves: 129 * C57BL/6)
|
skeletal muscle atrophy
|
J:215358
|
Rb1tm2Brn/Rb1tm2Brn
Rbl2tm1Tyj/Rbl2tm1Tyj
Tg(Myh6-cre)2182Mds/Tg(Myh6-cre)2182Mds
(involves: 129 * 129S2/SvPas * FVB/N)
|
decreased ventricle muscle contractility
|
J:97589
|
| increased myocardial fiber size
|
J:97589
|
Rb1tm3Tyj/Rb1tm3.1Tyj
Tg(Nes-cre)1Atp/0
(involves: 129S4/SvJae * FVB/N)
|
abnormal myogenesis
|
J:81643
|
Rb1cc1tm1.2Guan/Rb1cc1tm1.2Guan
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal myocardial trabeculae morphology
|
J:114498
|
| abnormal myocardium compact layer morphology
|
J:114498
|
| abnormal myocardium layer morphology
|
J:114498
|
| abnormal trabecula carnea morphology
|
J:114498
|
| thin myocardium
|
J:114498
|
Rbfox2tm1.1Dblk/Rbfox2tm1.1Dblk
Pax3tm1(cre)Joe/0
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6J)
|
muscle phenotype
|
J:279139
|
Rbkstm1d(EUCOMM)Wtsi/Rbkstm1d(EUCOMM)Wtsi
(involves: C57BL/6N * C57BL/6NTac)
|
interstinal hyperperistalsis
|
J:236053
|
Rbl1tm1Mru/Rbl1tm1Mru
(involves: 129S4/SvJae * BALB/cJ)
|
abnormal muscle physiology
|
J:51060
|
Rbl2tm1Mru/Rbl2tm1Mru
(involves: 129S4/SvJae * BALB/cJ)
|
abnormal myotome development
|
J:50516
|
| muscle phenotype
|
J:50516
|
| thin myocardium
|
J:50516
|
Rbm20em1Hgra/Rbm20+
(C57BL/6-Rbm20em1Hgra)
|
abnormal sarcomere morphology
|
J:324088
|
| decreased ventricle muscle contractility
|
J:324088
|
| dilated cardiomyopathy
|
J:324088
|
| thin myocardium
|
J:324088
|
Rbm20em1Hgra/Rbm20em1Hgra
(C57BL/6-Rbm20em1Hgra)
|
decreased ventricle muscle contractility
|
J:324088
|
| dilated cardiomyopathy
|
J:324088
|
| thin myocardium
|
J:324088
|
Rbm20em1Hide/Rbm20+
(involves: C57BL/6J)
|
decreased cardiac muscle contractility
|
J:297234
|
Rbm20em1Hide/Rbm20em1Hide
(involves: C57BL/6J)
|
decreased cardiac muscle contractility
|
J:297234
|
| dilated cardiomyopathy
|
J:297234
|
Rbm20em2Hgra/Rbm20em2Hgra
(C57BL/6J-Rbm20em2Hgra)
|
dilated cardiomyopathy
|
J:324125
|
Rbm20em3Hide/Rbm20em3Hide
(involves: C57BL/6J)
|
decreased cardiac muscle contractility
|
J:297234
|
Rbm20tm1Hgra/Rbm20+
(involves: C57BL/6)
|
abnormal myocardial fiber morphology
|
J:208676
|
Rbm20tm1Hgra/Rbm20tm1Hgra
(involves: C57BL/6)
|
abnormal myocardial fiber morphology
|
J:208676
|
| abnormal sarcomere morphology
|
J:208676
|
| decreased cardiac muscle contractility
|
J:208676
|
Rbm20tm2.1Hgra/Rbm20+
Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6 * FVB/N)
|
abnormal myocardial fiber morphology
|
J:208676
|
Rbm24tm1.1Xch/Rbm24tm1.1Xch
(involves: FVB/N)
|
myocardial trabeculae hypoplasia
|
J:259290
|
Rbm24tm1.1Xixu/Rbm24tm1.1Xixu
Tg(Myh6-cre)1Xya/0
(involves: C57BL/6NTac)
|
abnormal M line morphology
|
J:302917
|
| abnormal sarcomere morphology
|
J:302917
|
| abnormal Z line morphology
|
J:302917
|
| decreased cardiac muscle contractility
|
J:302917
|
| dilated cardiomyopathy
|
J:302917
|
Rbp4tm1Gott/Rbp4tm1Gott
(involves: 129/Sv * C57BL/6 * CD-1)
|
abnormal fetal cardiomyocyte proliferation
|
J:82903
|
| abnormal myocardium compact layer morphology
|
J:82903
|
| trabecula carnea hypoplasia
|
J:82903
|
Rbpjtm1Hon/Rbpjtm1Hon
Tg(Lbx1-cre)3Cbm/0
(involves: 129P2/OlaHsd)
|
abnormal myogenesis
|
J:120053
|
| decreased satellite cell number
|
J:120053
|
| decreased skeletal muscle fiber density
|
J:120053
|
| hypaxial muscle hypoplasia
|
J:120053
|
Rbpjtm1Kyo/Rbpj+
(involves: 129S2/SvPas * CD-1)
|
decreased cardiac muscle contractility
|
J:187551
|
Rbpjtm1Kyo/Rbpjtm1Kyo
(involves: 129S2/SvPas)
|
abnormal fetal cardiomyocyte proliferation
|
J:119151
|
| abnormal myocardium layer morphology
|
J:119151
|
| disorganized myocardium
|
J:119151
|
| trabecula carnea hypoplasia
|
J:119151
|
Rbpmsem1Eno/Rbpmsem1Eno
(involves: C3H * C57BL/6)
|
abnormal myocardial trabeculae morphology
|
J:324468
|
| cardiomyopathy
|
J:324468
|
| decreased cardiac muscle contractility
|
J:324468
|
| thin ventricle myocardium compact layer
|
J:324468
|
Rcan1tm1Jmol/Rcan1tm1Jmol
(involves: 129 * C57BL/6)
|
abnormal myocardium layer morphology
|
J:109586
|
Rcan1tm1Jmol/Rcan1tm1Jmol
Rcan2tm1Jmol/Rcan2tm1Jmol
(involves: 129 * C57BL/6)
|
abnormal myocardium layer morphology
|
J:109586
|
Rce1tm2Kim/Rce1tm2.1Kim
Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6)
|
dilated cardiomyopathy
|
J:87958
|
| thin myocardium
|
J:87958
|
Relatm1Yuo/Relatm1Yuo
(involves: 129S/SvEv)
|
abnormal myogenesis
|
J:135692
|
Relatm1Yuo/Relatm1Yuo
Tnftm1Ljo/Tnftm1Ljo
(involves: 129S/SvEv * 129S1/Sv)
|
abnormal myogenesis
|
J:135692
|
| decreased skeletal muscle fiber diameter
|
J:135692
|
| increased skeletal muscle fiber number
|
J:135692
|
Relatm2.1Gho/Relatm2.1Gho
(involves: 129S6/SvEvTac * C57BL/6)
|
myositis
|
J:163663
|
Relbtm1Brv/Relbtm1Brv
(involves: 129S2/SvPas * C57BL/6)
|
myositis
|
J:22675
|
Relnrl-6J/Relnrl-6J
(C57BL/6J-Relnrl-6J/J)
|
muscle spasm
|
J:87349
|
Ren1tm1.2Sig/Ren1tm1.2Sig
(involves: C57BL/6J)
|
decreased vasoconstriction
|
J:169129
|
Ren1tm1Afu/Ren1tm1Afu
(involves: C57BL/6 * CBA)
|
vascular smooth muscle hyperplasia
|
J:59299
|
Rer1Gt(RRN159)Byg/Rer1+
(involves: 129P2/OlaHsd)
|
decreased skeletal muscle fiber diameter
|
J:169417
|
Rettm1Cos/Ret+
(involves: 129S/SvEv * C57BL/6)
|
intestinal hypoperistalsis
|
J:82456
|
Rettm1Cos/Rettm1Cos
(involves: 129S/SvEv * MF1)
|
intestinal hypoperistalsis
|
J:23852,
J:30389
|
Rettm1Heno/Rettm1Heno
(Not Specified)
|
abnormal gastrocnemius morphology
|
J:132854
|
| abnormal hypaxial muscle morphology
|
J:132854
|
| abnormal muscle spindle morphology
|
J:132854
|
Rettm2.1Heno/Rettm2.1Heno
(involves: C57BL/6 * FVB/N * SJL)
|
abnormal gastrocnemius morphology
|
J:132854
|
| abnormal hypaxial muscle morphology
|
J:132854
|
| abnormal muscle spindle morphology
|
J:132854
|
| muscular atrophy
|
J:132854
|
Rettm2Cos/Rettm2Cos
(involves: 129S1/Sv)
|
abnormal intestinal peristalsis
|
J:60659
|
Rettm3(RET)Vpa/Rettm3(RET)Vpa
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal intestinal peristalsis
|
J:102170
|
Rettm11(RET)Jmi/Rettm12(RET)Jmi
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal hypaxial muscle morphology
|
J:132854
|
| abnormal muscle spindle morphology
|
J:132854
|
| muscular atrophy
|
J:132854
|
Rettm12(RET)Jmi/Rettm12(RET)Jmi
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal hypaxial muscle morphology
|
J:132854
|
| abnormal muscle spindle morphology
|
J:132854
|
| muscular atrophy
|
J:132854
|
Retntm1Laz/Retntm1Laz
Tg(CD68-RETN)#Laz/?
(involves: 129S6/SvEvTac * C57BL/6)
|
increased skeletal muscle triglyceride level
|
J:171262
|
Rfx3b2b1213Clo/Rfx3b2b1213Clo
(C57BL/6J-Rfx3b2b1213Clo)
|
cardiomyopathy
|
J:175213
|
Rgs2tm1.1Kjb/Rgs2tm1.1Kjb
Tg(Tek-cre/ERT2)1Arnd/?
(involves: 129X1/SvJ * C57BL/6 * DBA/2)
|
decreased vasodilation
|
J:184284
|
Rgs2tm1Pngr/Rgs2tm1Pngr
(B6.129P2-Rgs2tm1Pngr)
|
decreased vasodilation
|
J:184284
|
| increased vasoconstriction
|
J:184284
|
Rhebtm1.1Otsu/Rhebtm1.1Otsu
Tg(Myh6-cre)2182Mds/0
(involves: 129 * C57BL/6J * FVB/N)
|
abnormal sarcomere morphology
|
J:197831
|
| cardiomyopathy
|
J:197831
|
| decreased cardiac muscle contractility
|
J:197831
|
| decreased myocardial fiber size
|
J:197831
|
Rictortm1Rueg/Rictortm1Rueg
Rptortm1Rueg/Rptortm1Rueg
Tg(ACTA1-cre)1Mll/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
abnormal muscle morphology
|
J:143748
|
| abnormal muscle physiology
|
J:143748
|
Rictortm1Rueg/Rictortm1Rueg
Tg(ACTA1-cre)1Mll/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
muscle phenotype
|
J:143748
|
Rint1tm1Whl/Rint1+
(Not Specified)
|
increased uterus leiomyoma incidence
|
J:122805
|
Ripply2tm1.1Ysa/Ripply2tm1.1Ysa
(involves: C57BL/6 * CBA * ICR)
|
abnormal myotome morphology
|
J:123846
|
Rnd3Gt(OST364657)Lex/Rnd3Gt(OST364657)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
abnormal hypaxial muscle morphology
|
J:172361
|
| abnormal tibialis anterior morphology
|
J:172361
|
Rnf5tm1Zron/Rnf5tm1Zron
(involves: 129S/SvEv * C57BL/6)
|
abnormal muscle regeneration
|
J:132185
|
Rnf170Gt(OST104375)Lex/Rnf170Gt(OST104375)Lex
(B6.129S-Rnf170Gt(OST104375)Lex)
|
abnormal muscle physiology
|
J:226836
|
Rnlstm1Gvd/Rnlstm1Gvd
(involves: 129S1/Sv * C57BL/6)
|
heart left ventricle hypertrophy
|
J:186878
|
Rnu2-8nmf291/Rnu2-8nmf291
(B6;129-Rnu2-8nmf291/J)
|
progressive muscle weakness
|
J:87349
|
Robo1b2b872Clo/Robo1b2b872Clo
(C57BL/6J-Robo1b2b872Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
Robo1tm1Matl/Robo1tm1Matl
Robo2tm1Mrt/Robo2tm1Mrt
(involves: 129P2/OlaHsd)
|
abnormal diaphragm morphology
|
J:193400
|
Robo1tm1Matl/Robo1tm1Matl
Robo2tm1Rilm/Robo2tm1Rilm
Twist2tm1(cre)Dor/Twist2+
(involves: 129 * 129X1/SvJ)
|
diaphragmatic hernia
|
J:193400
|
Robo4tm1Kzh/Robo4tm1Kzh
(involves: C57BL/6)
|
abnormal diaphragm morphology
|
J:208012
|
Robo4tm1Kzh/Robo4tm1Kzh
(Not Specified)
|
increased vasodilation
|
J:294754
|
Rock1tm1Liao/Rock1+
(C57BL/6-Rock1tm1Liao)
|
abnormal vascular smooth muscle morphology
|
J:135152
|
Rock2tm1.1Itl/Rock2+
Tg(Tagln-cre)1Her/0
(B6.Cg-Rock2tm1.1Itl Tg(Tagln-cre)1Her)
|
abnormal vascular smooth muscle physiology
|
J:222206
|
| decreased vascular smooth muscle cell proliferation
|
J:222206
|
Rorasg/Rorasg
(involves: C57BL/6)
|
abnormal vasoconstriction
|
J:109735
|
| abnormal vasodilation
|
J:109735
|
RpgrRd9/Y
(C57BL/6-RpgrRd9)
|
telangiectasia
|
J:237833
|
RpgrRd9/RpgrRd9
(C57BL/6-RpgrRd9)
|
telangiectasia
|
J:237833
|
Rpgrip1ltm1a(EUCOMM)Wtsi/Rpgrip1ltm1a(EUCOMM)Wtsi
(C57BL/6N-Rpgrip1ltm1a(EUCOMM)Wtsi/Wtsi)
|
abnormal eye muscle morphology
|
J:239583
|
Rpl3lem1Jmol/Rpl3lem1Jmol
(C57BL/6NTac-Rpl3lem1Jmol)
|
muscle phenotype
|
J:333030
|
Rpl3lem1Kei/Rpl3lem1Kei
(C57BL/6J-Rpl3em1Kei)
|
abnormal cardiac muscle contractility
|
J:335523
|
Rps6ka2tm1.1Mskf/Rps6ka2tm1.1Mskf
(B6.129(C)-Rps6ka2tm1.1Mskf)
|
abnormal myocardial fiber morphology
|
J:205403
|
Rps6ka3tm1.1Kry/Rps6ka3+
(involves: 129X1/SvJ)
|
muscle phenotype
|
J:89403
|
Rps6ka3tm1.1Kry/Rps6ka3tm1.1Kry
(involves: 129X1/SvJ)
|
muscle phenotype
|
J:89403
|
Rps6ka3tm1Ljg/Y
(involves: 129 * C57BL/6)
|
decreased skeletal muscle glycogen level
|
J:67575
|
Rps6kb1tm1Gtho/Rps6kb1tm1Gtho
(involves: 129P2/OlaHsd)
|
decreased skeletal muscle fiber diameter
|
J:129852
|
Rps6kb1tm1Gtho/Rps6kb1tm1Gtho
Rps6kb2tm1Gtho/Rps6kb2tm1Gtho
(involves: 129P2/OlaHsd)
|
abnormal muscle physiology
|
J:129852
|
| abnormal skeletal muscle morphology
|
J:129852
|
| decreased skeletal muscle fiber diameter
|
J:129852
|
| increased skeletal muscle glycogen level
|
J:129852
|
Rps6kb1tm1Nte/Rps6kb1tm1Nte
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal muscle regeneration
|
J:155912
|
| abnormal tibialis anterior morphology
|
J:155912
|
| decreased skeletal muscle weight
|
J:155912
|
Rptortm1Rueg/Rptortm1Rueg
Tg(ACTA1-cre)1Mll/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
abnormal muscle cell glucose uptake
|
J:143748
|
| abnormal muscle morphology
|
J:143748
|
| abnormal muscle physiology
|
J:143748
|
| decreased muscle weight
|
J:143748
|
| dystrophic muscle
|
J:143748
|
| increased skeletal muscle glycogen level
|
J:143748
|
| skeletal muscle interstitial fibrosis
|
J:143748
|
Rr28tm1Tilg/Rr28+
Igf2tm1Rob/Igf2+
(involves: 129S/SvEv * 129S1/Sv * C57BL/6J)
|
abnormal fetal cardiomyocyte proliferation
|
J:77413
|
| abnormal myocardium layer morphology
|
J:77413
|
Rr34tm1.1Lap/Rr34tm1.1Lap
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal myocardial fiber morphology
|
J:252154
|
| decreased cardiac muscle contractility
|
J:252154
|
Rr35tm1.1Lap/Rr35tm1.1Lap
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal myocardial fiber morphology
|
J:252154
|
| decreased cardiac muscle contractility
|
J:252154
|
Rr133tm1Eno/Rr133tm1Eno
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal tongue muscle morphology
|
J:81764
|
Rr143tm1.1Sson/Rr143+
(involves: BALB/c * C57BL/6)
|
increased skeletal muscle size
|
J:265506
|
Rr143tm1.1Sson/Rr143+
Zbed6tm1.2Sson/Zbed6tm1.2Sson
(involves: BALB/c * C57BL/6)
|
increased skeletal muscle size
|
J:265506
|
Rr277em1Flc/Rr277em1Flc
(C57BL/6J-Rr277em1Flc)
|
thick myocardium compact layer
|
J:324708
|
| thin ventricle myocardium compact layer
|
J:324708
|
Rr278em1Flc/Rr278em1Flc
(C57BL/6J-Rr278em1Flc)
|
thick myocardium compact layer
|
J:324708
|
Rr303em1Vave/Rr303em1Vave
(Not Specified)
|
abnormal sinoatrial node morphology
|
J:308878
|
Rradtm1Yec/Rradtm1Yec
(B6.129X1-Rradtm1Yec)
|
abnormal cardiac muscle contractility
|
J:143140
|
Rreb1em1Rtpl/Rreb1+
(C57BL/6J-Rreb1em1Rtpl)
|
cardiomyopathy
|
J:296982
|
| decreased cardiac muscle contractility
|
J:296982
|
| heart left ventricle hypertrophy
|
J:296982
|
| increased myocardial fiber size
|
J:296982
|
Rrm2bGt(OST85254)Lex/Rrm2bGt(OST85254)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
muscular atrophy
|
J:186071
|
Rrm2btm1Ynak/Rrm2btm1Ynak
(involves: 129 * C57BL/6J)
|
skeletal muscle atrophy
|
J:84841
|
Rsph9em1Jwji/Rsph9em1Jwji
(B6.Cg-Rsph9em1Jwji)
|
muscle weakness
|
J:294184
|
Rspo3tm1Arte/Rspo3tm1Arte
Isl1tm1(cre)Sev/Isl1+
(involves: 129 * C57BL/6)
|
thin myocardium
|
J:214093
|
Rtel1tm1Pml/Rtel1tm1Pml
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal dermomyotome development
|
J:91351
|
| abnormal myotome development
|
J:91351
|
Rtf1tm1c(KOMP)Wtsi/Rtf1tm1c(KOMP)Wtsi
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: C57BL/6N * FVB/N)
|
abnormal intercalated disk morphology
|
J:338311
|
| decreased ventricle muscle contractility
|
J:338311
|
| dilated cardiomyopathy
|
J:338311
|
| myocardial fiber disarray
|
J:338311
|
Rtn2tm1Lex/Rtn2+
(involves: 129S/SvEvBrd)
|
decreased muscle cell glucose uptake
|
J:158249
|
Rtn2tm1Lex/Rtn2tm1Lex
(involves: 129S/SvEvBrd)
|
decreased muscle cell glucose uptake
|
J:158249
|
| muscle phenotype
|
J:158249
|
Rundc1tm1b(EUCOMM)Wtsi/Rundc1tm1b(EUCOMM)Wtsi
(C57BL/6N-Rundc1tm1b(EUCOMM)Wtsi/Wtsi)
|
abnormal eye muscle morphology
|
J:239583
|
Runx2tm1Kish/Runx2tm1Kish
(involves: 129P2/OlaHsd * C57BL/6)
|
muscle phenotype
|
J:40783
|
Runx3tm1Yg/Runx3tm1Yg
(either: (involves: 129S1/Sv * 129X1/SvJ * ICR) or (involves: 129S1/Sv * 129X1/SvJ * MF1))
|
abnormal muscle tone
|
J:77764
|
| absent muscle spindles
|
J:77764
|
Runx3tm1Yg/Runx3tm1Yg
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal muscle tone
|
J:77764
|
Runx3tm1Yg/Runx3tm1Yg
(involves: 129S1/Sv * 129X1/SvJ * ICR)
|
decreased skeletal muscle fiber size
|
J:243559
|
Rxratm1.1Pcn/Rxratm1.1Pcn
(involves: 129S2/SvPas * C57BL/6 * SJL)
|
ventricular myocardium compact layer hypoplasia
|
J:146761
|
Rxratm1Ipc/Rxratm1Ipc
Rxrbtm1Mma/Rxrbtm1Mma
(involves: 129S2/SvPas * C57BL/6)
|
ventricular myocardium compact layer hypoplasia
|
J:146761
|
Rxratm1Rev/Rxra+
(involves: 129S4/SvJae * C57BL/6)
|
abnormal myocardial trabeculae morphology
|
J:35363
|
| abnormal myocardium compact layer morphology
|
J:35363
|
| abnormal myocardium layer morphology
|
J:35363
|
| abnormal ventricle papillary muscle morphology
|
J:35363
|
Rxratm1Rev/Rxratm1Rev
(involves: 129S4/SvJae * C57BL/6)
|
abnormal myocardial trabeculae morphology
|
J:35363
|
| abnormal myocardium compact layer morphology
|
J:18047
|
| abnormal myocardium layer morphology
|
J:35363,
J:18047
|
| abnormal ventricle papillary muscle morphology
|
J:35363
|
| decreased ventricle muscle contractility
|
J:65904
|
| trabecula carnea hypoplasia
|
J:18047
|
| ventricular myocardium compact layer hypoplasia
|
J:35363
|
Rxrgtm1Ysa/Rxrgtm1Ysa
(B6.129S2-Rxrgtm1Ysa)
|
increased muscle relaxation
|
J:77613
|
Ryr1em1Tmur/Ryr1+
(Not Specified)
|
abnormal muscle physiology
|
J:322211
|
Ryr1em1Zor/Ryr1+
(C57BL/6J-Ryr1em1Zor)
|
abnormal skeletal muscle fiber triad morphology
|
J:275501
|
| muscle phenotype
|
J:275501,
J:291685
|
| muscle weakness
|
J:275501
|
| skeletal muscle fiber degeneration
|
J:275501
|
Ryr1em1Zor/Ryr1em2Zor
(C57BL/6J-Ryr1em1Zor Ryr1em2Zor)
|
abnormal extraocular muscle morphology
|
J:291685
|
| abnormal muscle fiber morphology
|
J:291685
|
| abnormal skeletal muscle fiber mitochondrial morphology
|
J:292405
|
| abnormal skeletal muscle fiber morphology
|
J:292405
|
| abnormal skeletal muscle fiber triad morphology
|
J:292405
|
| decreased skeletal muscle weight
|
J:292405
|
| muscle weakness
|
J:292405
|
| skeletal muscle fiber degeneration
|
J:292405
|
Ryr1em2Zor/Ryr1+
(C57BL/6J-Ryr1em2Zor)
|
muscle phenotype
|
J:291685
|
Ryr1em2Zor/Ryr1em2Zor
(C57BL/6J-Ryr1em2Zor)
|
muscle phenotype
|
J:291685
|
Ryr1m1Bei/Ryr1m1Bei
(involves: A/J * FVB/N)
|
abnormal skeletal muscle morphology
|
J:75360
|
Ryr1m1Nisw/Ryr1+
(129S1.B6-Ryr1m1Nisw)
|
abnormal sarcomere morphology
|
J:219285
|
| abnormal sarcoplasmic reticulum morphology
|
J:219285
|
| abnormal skeletal muscle fiber morphology
|
J:219285
|
| abnormal Z line morphology
|
J:219285
|
| centrally nucleated skeletal muscle fibers
|
J:219285
|
| muscle weakness
|
J:219285
|
| myopathy
|
J:219285
|
Ryr1tm1.1Dhm/Ryr1+
(involves: 129S2/SvPasCrl * 129S6/SvEvTac)
|
abnormal muscle fiber morphology
|
J:155825
|
| abnormal sarcomere morphology
|
J:155825
|
| abnormal skeletal muscle fiber morphology
|
J:155825
|
| abnormal Z line morphology
|
J:155825
|
| decreased skeletal muscle fiber diameter
|
J:155825
|
| impaired muscle contractility
|
J:155825
|
| increased variability of skeletal muscle fiber size
|
J:155825
|
| muscle weakness
|
J:155825
|
| myopathy
|
J:155825
|
Ryr1tm1.1Dhm/Ryr1tm1.1Dhm
(involves: 129S6/SvEvTac * 129X1/SvJ)
|
abnormal diaphragm morphology
|
J:127629
|
| abnormal muscle development
|
J:127629
|
| abnormal muscle physiology
|
J:127629
|
| decreased skeletal muscle mass
|
J:127629
|
| impaired skeletal muscle contractility
|
J:127629
|
| skeletal muscle degeneration
|
J:127629
|
Ryr1tm1.1Inp/Ryr1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal muscle physiology
|
J:181523
|
Ryr1tm1.1Inp/Ryr1tm1.1Inp
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal muscle physiology
|
J:181523
|
| abnormal soleus morphology
|
J:181523
|
| impaired muscle relaxation
|
J:181523
|
Ryr1tm1.1Itl/?
(B6.Cg-Ryr1tm1.1Itl)
|
abnormal muscle contractility
|
J:176731
|
| abnormal muscle physiology
|
J:176731
|
| abnormal skeletal muscle morphology
|
J:176731
|
Ryr1tm1.1Msnr/Ryr1tm1.1Msnr
(129S.129P2-Ryr1tm1.1Msnr)
|
abnormal muscle contractility
|
J:195542
|
| abnormal muscle electrophysiology
|
J:195542
|
| muscle tetany
|
J:195542
|
| muscle twitch
|
J:195542
|
Ryr1tm1Slh/Ryr1+
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal muscle contractility
|
J:105738
|
| abnormal muscle physiology
|
J:105738
|
Ryr1tm1Slh/Ryr1tm1Slh
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal muscle physiology
|
J:105738
|
| abnormal skeletal muscle fiber morphology
|
J:105738
|
| abnormal skeletal muscle morphology
|
J:105738
|
| increased variability of skeletal muscle fiber size
|
J:105738
|
Ryr1tm1Tno/Ryr1tm1Tno
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal skeletal muscle fiber morphology
|
J:18895
|
| centrally nucleated skeletal muscle fibers
|
J:18895
|
| decreased skeletal muscle fiber number
|
J:18895
|
| decreased skeletal muscle fiber size
|
J:18895
|
| impaired skeletal muscle contractility
|
J:18895
|
| increased variability of skeletal muscle fiber size
|
J:18895
|
Ryr1tm2.1Itl/?
(B6.Cg-Ryr1tm2.1Itl)
|
abnormal muscle physiology
|
J:205099
|
| abnormal skeletal muscle fiber morphology
|
J:205099
|
| muscle phenotype
|
J:205099
|
Ryr1tm3.1Alle/Ryr1+
(involves: 129 * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal muscle physiology
|
J:303297
|
Ryr1tm3.1Alle/Ryr1tm3.1Alle
(involves: 129 * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal muscle physiology
|
J:303297
|
Ryr2tm1(CAG-KRAS*G12V,-lacZ)Nobs/Ryr2tm1(CAG-KRAS*G12V,-lacZ)Nobs
Trp53tm1Sia/Trp53+
(involves: 129X1/SvJ * C57BL/6 * CBA)
|
increased rhabdomyosarcoma incidence
|
J:117828
|
Ryr2tm1(CAG-KRAS*G12V,-lacZ)Nobs/Ryr2tm1(CAG-KRAS*G12V,-lacZ)Nobs
Trp53tm1Sia/Trp53tm1Sia
(involves: 129X1/SvJ * C57BL/6 * CBA)
|
increased rhabdomyosarcoma incidence
|
J:117828
|
| myositis
|
J:117828
|
Ryr2tm1.1Hta/Ryr2tm1.1Hta
(involves: 129S4/SvJae)
|
abnormal myocardial trabeculae morphology
|
J:48277
|
| disorganized myocardium
|
J:48277
|
Ryr2tm1.1Msnr/Ryr2tm1.1Msnr
(involves: 129S6/SvEvTac * FVB/N)
|
decreased ventricle muscle contractility
|
J:122033
|
| heart left ventricle hypertrophy
|
J:122033
|
Ryr2tm1Hhv/Ryr2tm1Hhv
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
abnormal myocardial fiber morphology
|
J:141342
|
Ryr2tm1Krbr/Ryr2tm1Krbr
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
cardiomyopathy
|
J:210083
|
Ryr2tm1Slh/Ryr2+
(involves: 129S7/SvEvBrd * C57BL/6)
|
cardiomyopathy
|
J:111780
|
| decreased cardiac muscle contractility
|
J:111780
|
Ryr2tm2.1Swch/Ryr2+
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss)
|
abnormal cardiac muscle contractility
|
J:214434
|
Ryr2tm2.1Wex/Ryr2tm2.1Wex
(B6.129S7-Ryr2tm2.1Wex)
|
abnormal myocardial fiber morphology
|
J:179475
|
| decreased cardiac muscle contractility
|
J:179475
|
Ryr2tm2.1Wex/Ryr2tm2.1Wex
(involves: 129S7/SvEvBrd)
|
abnormal sarcoplasmic reticulum morphology
|
J:210426
|
Ryr2tm2Amks/Ryr2+
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal myocardial fiber morphology
|
J:212640
|
| abnormal sarcoplasmic reticulum morphology
|
J:212640
|
Ryr2tm3.1Amks/Ryr2+
(involves: C57BL/6)
|
abnormal myocardial fiber morphology
|
J:212640
|
| abnormal sarcoplasmic reticulum morphology
|
J:212640
|
Ryr2tm4.1Amks/Ryr2+
(involves: 129 * C57BL/6)
|
abnormal myocardial fiber morphology
|
J:212640
|
| abnormal sarcoplasmic reticulum morphology
|
J:212640
|
Ryr3tm1Vso/Ryr3tm1Vso
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal muscle contractility
|
J:45244
|
| impaired muscle contractility
|
J:45244
|
Ryr3tm1Vso/Ryr3tm1Vso
(involves: 129P2/OlaHsd)
|
abnormal muscle contractility
|
J:106292
|
S1pr1tm1Rlp/S1pr1tm1Rlp
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal vascular smooth muscle morphology
|
J:71961
|
| vascular smooth muscle hypoplasia
|
J:71961
|
S1pr1tm1Rlp/S1pr1tm1Rlp
(involves: 129S6/SvEvTac)
|
abnormal aorta smooth muscle morphology
|
J:189010
|
S1pr1tm1Rlp/S1pr1tm2Rlp
Tg(Tek-cre)1Ywa/?
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
abnormal aorta smooth muscle morphology
|
J:106055
|
S100a1tm1Jhh/S100a1+
(involves: 129S1/Sv * C57BL/6)
|
decreased cardiac muscle contractility
|
J:75781
|
S100a1tm1Jhh/S100a1tm1Jhh
(involves: 129S1/Sv * C57BL/6)
|
decreased cardiac muscle contractility
|
J:75781
|
| decreased vasodilation
|
J:230300
|
S100a1tm1Mfs/S100a1tm1Mfs
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal muscle physiology
|
J:132177
|
Sacstm2Bebr/Sacstm2Bebr
(involves: C57BL/6)
|
abnormal gastrocnemius morphology
|
J:217753
|
| abnormal skeletal muscle fiber morphology
|
J:217753
|
| decreased gastrocnemius weight
|
J:217753
|
| decreased soleus weight
|
J:217753
|
| muscle weakness
|
J:217753
|
Sall3tm1.1(KOMP)Mbp/Sall3+
(C57BL/6NCrl-Sall3tm1.1(KOMP)Mbp/Ccpcz)
|
increased cardiac muscle contractility
|
J:211773
|
Sall4Gt(XE027)Byg/Sall4+
(involves: 129P2/OlaHsd * Black Swiss * C57BL/6)
|
disorganized myocardium
|
J:105332
|
| thin myocardium
|
J:105332
|
Samd1tm1Pfi/Samd1tm1Pfi
(involves: C57BL/6J * C57BL/6N)
|
skeletal muscle degeneration
|
J:333561
|
Samd4m1Btlr/Samd4m1Btlr
(C57BL/6J-Samd4m1Btlr)
|
abnormal muscle fiber morphology
|
J:208616
|
| abnormal skeletal muscle morphology
|
J:208616
|
| centrally nucleated skeletal muscle fibers
|
J:208616
|
| decreased skeletal muscle glycogen level
|
J:208616
|
| muscle hypoplasia
|
J:208616
|
| myopathy
|
J:208616
|
Sbno2tm1.1Aki/Sbno2tm1.1Aki
(involves: 129 * C57BL/6)
|
muscle phenotype
|
J:202853
|
Scamp5tm1Smoc/Scamp5tm1Smoc
(involves: C57BL/6J)
|
abnormal muscle electrophysiology
|
J:288324
|
Scn1aem1Anord/Scn1aem1Anord
(C57BL/6N-Scn1aem1Anord)
|
muscle phenotype
|
J:333350
|
Scn3btm1a(KOMP)Wtsi/Scn3btm1a(KOMP)Wtsi
(C57BL/6N-Scn3btm1a(KOMP)Wtsi/Wtsi)
|
abnormal hypodermis muscle layer morphology
|
J:232539
|
| myositis
|
J:232539
|
Scn4am1Aaa/Scn4a+
(involves: BALB/c * C57BL/6J)
|
abnormal muscle electrophysiology
|
J:217522
|
| abnormal muscle fiber morphology
|
J:217522
|
| abnormal muscle morphology
|
J:217522
|
| abnormal muscle physiology
|
J:217522
|
| centrally nucleated skeletal muscle fibers
|
J:217522
|
| impaired muscle relaxation
|
J:217522
|
| impaired skeletal muscle contractility
|
J:217522
|
| increased muscle fatigability
|
J:217522
|
| increased skeletal muscle fiber size
|
J:217522
|
| muscle twitch
|
J:217522
|
Scn4am1Aaa/Scn4am1Aaa
(involves: BALB/c * C57BL/6J)
|
muscle phenotype
|
J:217522
|
Scn4am1Aaa/Scn4atm1.1Ljh
(involves: 129S4/SvJae * BALB/c * C57BL/6J)
|
muscle phenotype
|
J:217522
|
Scn4atm1.1Cann/Scn4a+
(involves: 129)
|
muscle weakness
|
J:178228
|
Scn4atm1.1Cann/Scn4atm1.1Cann
(involves: 129)
|
abnormal muscle contractility
|
J:178228
|
| abnormal muscle fiber morphology
|
J:178228
|
| muscle weakness
|
J:178228
|
Scn4atm1.1Ljh/Scn4a+
(B6.129S4-Scn4atm1.1Ljh)
|
abnormal muscle physiology
|
J:135831
|
| abnormal skeletal muscle fiber morphology
|
J:135831
|
| impaired muscle relaxation
|
J:135831
|
| impaired skeletal muscle contractility
|
J:135831
|
| increased muscle fatigability
|
J:135831
|
| increased muscle relaxation
|
J:135831
|
| increased variability of skeletal muscle fiber size
|
J:135831
|
| muscle weakness
|
J:135831
|
| myopathy
|
J:135831
|
Scn4atm1.1Ljh/Scn4atm1.1Ljh
(B6.129S4-Scn4atm1.1Ljh)
|
abnormal skeletal muscle fiber morphology
|
J:135831
|
| increased variability of skeletal muscle fiber size
|
J:135831
|
| muscle weakness
|
J:135831
|
| myopathy
|
J:135831
|
| skeletal muscle atrophy
|
J:135831
|
Scn4atm1Ljh/Scn4a+
(B6.129S4-Scn4atm1Ljh)
|
abnormal muscle physiology
|
J:135831
|
| abnormal skeletal muscle fiber morphology
|
J:135831
|
| impaired muscle relaxation
|
J:135831
|
| impaired skeletal muscle contractility
|
J:135831
|
| increased muscle fatigability
|
J:135831
|
| increased muscle relaxation
|
J:135831
|
| increased variability of skeletal muscle fiber size
|
J:135831
|
| muscle weakness
|
J:135831
|
| myopathy
|
J:135831
|
Scn4atm1Ljh/Scn4atm1Ljh
(B6.129S4-Scn4atm1Ljh)
|
abnormal skeletal muscle fiber morphology
|
J:135831
|
| increased variability of skeletal muscle fiber size
|
J:135831
|
| muscle weakness
|
J:135831
|
| myopathy
|
J:135831
|
| skeletal muscle atrophy
|
J:135831
|
Scn5atm1(SCN5A)Rdn/Scn5atm3(SCN5A*)Rdn
(involves: 129S6/SvEvTac)
|
decreased cardiac muscle contractility
|
J:189389
|
| dilated cardiomyopathy
|
J:189389
|
Scn5atm1.1Iba/Scn5a+
(involves: 129 * C57BL/6)
|
increased myocardial fiber size
|
J:266290
|
Scn5atm1Agrc/Scn5atm1Agrc
(involves: 129 * C57BL/6J)
|
abnormal cardiac muscle contractility
|
J:76331
|
| abnormal trabecula carnea morphology
|
J:76331
|
| decreased myocardial fiber number
|
J:76331
|
Scn5atm3(SCN5A*)Rdn/Scn5atm3(SCN5A*)Rdn
(involves: 129S6/SvEvTac)
|
decreased cardiac muscle contractility
|
J:189389
|
| dilated cardiomyopathy
|
J:189389
|
Scn8a6J/Scn8a6J
(C57BL/6J-Scn8a6J/J)
|
muscular atrophy
|
J:90095
|
Scn8a7J/Scn8a7J
(involves: BALB/cByJ * C57BL/6J)
|
decreased skeletal muscle fiber size
|
J:87349
|
| myoclonus
|
J:87349
|
| myopathy
|
J:87349
|
Scn8a9J/Scn8a9J
(B6J.C-Scn8a9J/Mm)
|
dystonia
|
J:230867
|
| muscle weakness
|
J:230867
|
Scn8admu/Scn8admu
(involves: C3H * C57BL/6)
|
dystrophic muscle
|
J:71615
|
| muscle degeneration
|
J:71615
|
| myocardial fiber degeneration
|
J:71615
|
| skeletal muscle necrosis
|
J:71615
|
Scn8admu/Scn8amed
(involves: C3H * C3HeB/Fe * C57BL/6)
|
dystrophic muscle
|
J:71615
|
Scn8am11J/Scn8am11J
(B6.Cg-Scn8am11J/GrsrJ)
|
impaired muscle relaxation
|
J:231578
|
Scn8amed-J/Scn8amed-J
(involves: STOCK Krt71Ca)
|
dystonia
|
J:141236
|
Scn8amed-J/Scn8amed-J
Scnm1s/Scnm1s
(involves: C57BL/6J)
|
dystonia
|
J:79617
|
| muscular atrophy
|
J:79617
|
Scn8amed-J/Scn8amed-J
Scnm1s/Scnm1s
(involves: C57BL/6J * STOCK Krt71Ca)
|
muscle weakness
|
J:141236
|
Scn8amed-jo/Scn8amed-jo
(DBA/2WyDi-Scn8amed-jo)
|
muscle phenotype
|
J:24907
|
Scn8amed-TgA4Bs/Scn8amed-TgA4Bs
(involves: C3H * C57BL/6J)
|
muscular atrophy
|
J:24228
|
Scn8amed/Scn8amed
(PCT)
|
abnormal muscle physiology
|
J:5192
|
| abnormal muscle tone
|
J:28679
|
| muscular atrophy
|
J:5153
|
| progressive muscle weakness
|
J:28678,
J:5153
|
Sco2tm1.1Easc/Sco2tm2.1Easc
(129X1/SvJ-Sco2tm1.1Easc/Sco2tm2.1Easc)
|
muscle weakness
|
J:155116
|
Sco2tm2.1Easc/Sco2tm2.1Easc
(129X1/SvJ-Sco2tm2.1Easc)
|
muscle weakness
|
J:155116
|
scrny/scrny
(C57BL/6J-scrny/GrsrJ)
|
abnormal muscle fiber morphology
|
J:217859
|
Scxtm1.1Stzr/Scxtm1.1Stzr
(Not Specified)
|
abnormal tendon morphology
|
J:122742
|
| abnormal tendon stiffness
|
J:122742
|
Scxtm1.1Stzr/Scxtm1.1Stzr
Tg(Scx-GFP)1Stzr/0
(Not Specified)
|
abnormal tendon morphology
|
J:122742
|
Scyl1mdf/Scyl1mdf
(B6C3Fe a/a-Scyl1mdf/J)
|
abnormal muscle electrophysiology
|
J:30384
|
| abnormal muscle regeneration
|
J:30384
|
| muscular atrophy
|
J:30384
|
| skeletal muscle fiber necrosis
|
J:30384
|
Scyl1mdf/Scyl1mdf
(involves: CFW * C57BL/6J * C57BR)
|
decreased skeletal muscle mass
|
J:28676
|
| muscular atrophy
|
J:4479,
J:28676
|
Scyl1tm1.1Spel/Scyl1tm1.1Spel
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal skeletal muscle fiber type ratio
|
J:192445
|
| centrally nucleated skeletal muscle fibers
|
J:192445
|
| dystrophic muscle
|
J:192445
|
| increased variability of skeletal muscle fiber size
|
J:192445
|
| muscular atrophy
|
J:192445
|
Scyl1tm1.1Spel/Scyl1tm1.1Spel
(involves: 129S6/SvEvTac)
|
decreased skeletal muscle fiber diameter
|
J:262629
|
| skeletal muscle atrophy
|
J:262629
|
Scyl1tm1.1Spel/Scyl1tm1.1Spel
Scyl3tm1.1Spel/Scyl3tm1.1Spel
(involves: 129S6/SvEvTac * C57BL/6J)
|
decreased skeletal muscle fiber diameter
|
J:262629
|
Scyl1tm1Spel/Scyl1tm1Spel
Tg(Ckmm-cre)5Khn/0
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6J * FVB/N)
|
muscle phenotype
|
J:192445
|
Scyl1tm1Spel/Scyl1tm1Spel
Tg(Nes-cre)1Kln/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * SJL)
|
centrally nucleated skeletal muscle fibers
|
J:192445
|
| decreased myocardial fiber size
|
J:192445
|
| muscle phenotype
|
J:192445
|
Scyl3tm1.1Spel/Scyl3tm1.1Spel
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal skeletal muscle fiber morphology
|
J:262629
|
Sdc4tm1Goe/Sdc4tm1Goe
Tg(Myl1-FST)F66Sjl/0
(involves: 129S4/SvJae * C57BL/6 * SJL)
|
increased skeletal muscle fiber diameter
|
J:188599
|
| increased skeletal muscle fiber size
|
J:188599
|
| increased skeletal muscle mass
|
J:188599
|
| increased skeletal muscle weight
|
J:188599
|
Sdhaf4em1Bcgen/Sdhaf4em1Bcgen
Tg(Ckmm-cre)5Khn/0
(B6.Cg-Sdhaf4em1Bcgen Tg(Ckmm-cre)5Khn)
|
abnormal cardiac muscle contractility
|
J:345348
|
| abnormal myocardial fiber mitochondrial morphology
|
J:345348
|
| abnormal myocardial fiber morphology
|
J:345348
|
| decreased myocardial fiber mitochondrial DNA content
|
J:345348
|
| decreased ventricle muscle contractility
|
J:345348
|
| dilated cardiomyopathy
|
J:345348
|
| thick myocardium
|
J:345348
|
Sdhctm1c(EUCOMM)Wtsi/Sdhctm1c(EUCOMM)Wtsi
Gt(ROSA)26Sortm1.1(rtTA,tetO-cre)Bkmn/Gt(ROSA)26Sor+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6N)
|
abnormal muscle physiology
|
J:284745
|
Sec61a1m1Gek/Sec61a1m1Gek
(C57BL/6J-Sec61a1m1Gek)
|
decreased skeletal muscle mass
|
J:164159
|
Sectm1aem1Gcfa/Sectm1aem1Gcfa
(C57BL/6-Sectm1aem1Gcfa)
|
decreased cardiac muscle contractility
|
J:317204
|
Selenontm1.2Mred/Selenontm1.2Mred
(involves: 129S2/SvPas)
|
abnormal muscle physiology
|
J:168699
|
| abnormal muscle regeneration
|
J:168699
|
| decreased satellite cell number
|
J:168699
|
| skeletal muscle atrophy
|
J:168699
|
Selenontm1.2Mred/Selenontm1.2Mred
(involves: 129S2/SvPas * C57BL/6 * C57BL/6J * SJL)
|
abnormal muscle physiology
|
J:176499
|
| abnormal skeletal muscle fiber type ratio
|
J:176499
|
| abnormal skeletal muscle morphology
|
J:176499
|
| centrally nucleated skeletal muscle fibers
|
J:176499
|
| decreased extensor digitorum longus weight
|
J:176499
|
| decreased gastrocnemius weight
|
J:176499
|
| decreased quadriceps weight
|
J:176499
|
| decreased skeletal muscle fiber diameter
|
J:176499
|
| decreased skeletal muscle fiber size
|
J:176499
|
| decreased skeletal muscle mass
|
J:176499
|
| decreased soleus weight
|
J:176499
|
| decreased tibialis anterior weight
|
J:176499
|
| skeletal muscle atrophy
|
J:176499
|
Selenontm1Begg/Selenontm1Begg
(involves: C57BL/6 * C57BL/6NTac)
|
abnormal skeletal muscle morphology
|
J:197753
|
| skeletal muscle hypertrophy
|
J:197753
|
Selenostm1.1Sfa/Selenos+
(involves: C57BL/6)
|
muscle phenotype
|
J:264254
|
| muscle weakness
|
J:264254
|
Selenostm1.1Sfa/Selenostm1.1Sfa
(involves: C57BL/6)
|
muscle phenotype
|
J:264254
|
| muscle weakness
|
J:264254
|
Sema3atm1Mcf/Sema3atm1Mcf
(involves: 129S4/SvJae)
|
heart right ventricle hypertrophy
|
J:35824
|
Senp2Gt(AN0727)Wtsi/Senp2Gt(AN0727)Wtsi
(involves: 129P2/OlaHsd)
|
thin myocardium
|
J:162938
|
Serac1em1Bcgen/Serac1em1Bcgen
(C57BL/6N-Serac1em1Bcgen)
|
abnormal muscle fiber morphology
|
J:326672
|
| cardiomyopathy
|
J:326672
|
| decreased skeletal muscle fiber mitochondrial DNA content
|
J:326672
|
| muscle weakness
|
J:326672
|
Serp1tm1Hori/Serp1tm1Hori
(involves: 129X1/SvJ * C57BL/6)
|
abnormal skeletal muscle morphology
|
J:109619
|
Serpinc1tm1Sai/Serpinc1tm1Sai
(involves: 129S2/SvPas * C57BL/6J)
|
myocardial fiber degeneration
|
J:65092
|
Serpind1tm1Moto/Serpind1+
(B6.Cg-Serpind1tm1Moto)
|
vascular smooth muscle hyperplasia
|
J:122173
|
Serpine1tm1Mlg/Serpine1tm1Mlg
(involves: 129S2/SvPas * C57BL/6)
|
decreased skeletal muscle triglyceride level
|
J:87982
|
Setd3tm1.1(NCOM)Mfgc/Setd3tm1.1(NCOM)Mfgc
(C57BL/6N-Setd3tm1.1(NCOM)Mfgc/Tcp)
|
muscle phenotype
|
J:270048
|
Setd5tm1.1Mgn/Setd5tm1.1Mgn
(involves: 129S6/SvEvTac * CD-1)
|
abnormal myocardial trabeculae morphology
|
J:237500
|
| abnormal myocardium layer morphology
|
J:237500
|
Setd5tm1a(EUCOMM)Wtsi/Setd5+
(C57BL/6N-Setd5tm1a(EUCOMM)Wtsi/Wtsi)
|
abnormal eye muscle morphology
|
J:239583
|
| absent pectinate muscle
|
J:239583
|
Sfrp2tm1Sato/Sfrp2tm1Sato
(Not Specified)
|
increased cardiac muscle contractility
|
J:146963
|
Sgcatm1Eeng/Sgcatm1Eeng
(involves: 129S/SvEv * 129X1/SvJ)
|
impaired skeletal muscle contractility
|
J:83034
|
Sgcatm1Isrd/Sgcatm1Isrd
(involves: 129S2/SvPas * BALB/c * C57BL/6)
|
muscle phenotype
|
J:133929
|
Sgcatm1Kcam/Sgcatm1Kcam
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal muscle contractility
|
J:49992
|
| abnormal muscle fiber morphology
|
J:49992
|
| abnormal sarcolemma morphology
|
J:49992
|
| abnormal skeletal muscle fiber morphology
|
J:133929
|
| calcified muscle
|
J:49992
|
| cardiac muscle necrosis
|
J:177563
|
| cardiomyopathy
|
J:177563
|
| centrally nucleated skeletal muscle fibers
|
J:49992
|
| dystrophic muscle
|
J:49992
|
| increased extensor digitorum longus weight
|
J:49992
|
| increased soleus weight
|
J:49992
|
| muscle phenotype
|
J:177563
|
Sgcatm1Kcam/Sgcatm1Kcam
Sgcetm1Vinni/Sgcetm1Vinni
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
cardiac muscle necrosis
|
J:177563
|
| cardiomyopathy
|
J:177563
|
| decreased cardiac muscle contractility
|
J:177563
|
| muscle phenotype
|
J:177563
|
Sgcatm1Kcam/Sgcatm1Kcam
Tg(Ckm-SGCE)1Kcam/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * SJL)
|
cardiomyopathy
|
J:177563
|
Sgcatm2.1Kcam/Sgcatm2.1Kcam
(either: (involves: 129S4/SvJae * 129S6/SvEvTac) or (involves: 129S6/SvEvTac * C57BL/6J * FVB/N))
|
muscle phenotype
|
J:130252
|
Sgcatm2Kcam/Sgcatm2Kcam
(either: (129S6/SvEvTac-Sgcatm2Kcam) or (involves: 129S6/SvEvTac * C57BL/6J))
|
abnormal muscle contractility
|
J:130252
|
| abnormal muscle fiber morphology
|
J:130252
|
| abnormal sarcolemma morphology
|
J:130252
|
| calcified muscle
|
J:130252
|
| dystrophic muscle
|
J:130252
|
| increased muscle weight
|
J:130252
|
Sgcatm2Kcam/Sgcatm2Kcam
(B6.129S6-Sgcatm2Kcam/J)
|
abnormal muscle physiology
|
J:250485
|
| abnormal skeletal muscle morphology
|
J:250485
|
| dystrophic muscle
|
J:250485
|
| skeletal muscle fibrosis
|
J:250485
|
Sgcatm2Kcam/Sgcatm2Kcam
Tg(Ckmm-cre)5Khn/0
(either: (involves: 129S4/SvJae * 129S6/SvEvTac * FVB) or (involves: 129S6/SvEvTac * C57BL/6J * FVB))
|
muscle phenotype
|
J:130252
|
Sgcbtm1Kcam/Sgcbtm1Kcam
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal muscle morphology
|
J:60154
|
| abnormal sarcolemma morphology
|
J:60154
|
| abnormal vascular smooth muscle morphology
|
J:60154
|
| calcified muscle
|
J:60154
|
| cardiomyopathy
|
J:60154
|
| dystrophic muscle
|
J:60154
|
| muscular atrophy
|
J:60154
|
| myocardium necrosis
|
J:60154
|
Sgcbtm1Oza/Sgcbtm1Oza
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal skeletal muscle morphology
|
J:57590
|
| centrally nucleated skeletal muscle fibers
|
J:57590
|
| dystrophic muscle
|
J:57590
|
| increased gastrocnemius weight
|
J:57590
|
| increased tibialis anterior weight
|
J:57590
|
| myositis
|
J:57590
|
| skeletal muscle fiber degeneration
|
J:57590
|
| skeletal muscle fiber necrosis
|
J:57590
|
Sgcdtm1Kcam/Sgcdtm1Kcam
(involves: 129S1/Sv * 129X1/SvJ)
|
cardiomyopathy
|
J:57107
|
| dilated cardiomyopathy
|
J:57107
|
| dystrophic muscle
|
J:57107
|
| myocardium necrosis
|
J:57107
|
| skeletal muscle necrosis
|
J:57107
|
Sgcdtm1Mcn/Sgcdtm1Mcn
(involves: 129S1/Sv * 129T2/SvEmsJ * 129X1/SvJ)
|
abnormal muscle contractility
|
J:76730
|
| abnormal muscle physiology
|
J:76730
|
| cardiomyopathy
|
J:76730
|
| dystrophic muscle
|
J:76730
|
| muscle degeneration
|
J:76730
|
Sgcdtm1Mcn/Sgcdtm1Mcn
(B6.129-Sgcdtm1Mcn/J)
|
abnormal muscle physiology
|
J:250485
|
| abnormal skeletal muscle morphology
|
J:250485
|
| cardiac muscle degeneration
|
J:234761
|
| cardiac muscle necrosis
|
J:234761
|
| decreased cardiac muscle contractility
|
J:234761
|
| dilated cardiomyopathy
|
J:234761
|
| dystrophic muscle
|
J:250485
|
| skeletal muscle fibrosis
|
J:250485
|
Sgcdtm1Ojml/Sgcd+
(B6.129-Sgcdtm1Ojml)
|
dilated cardiomyopathy
|
J:234761
|
Sgcetm1Ygl/Sgce+
(involves: 129S2/SvPas)
|
myoclonus
|
J:180682
|
Sgcetm1Ygl/Sgcetm1Ygl
(involves: 129S2/SvPas * 129S4/SvJaeSor * BALB/c * C57BL/6)
|
myoclonus
|
J:101332
|
Sgcgtm1Mcn/Sgcgtm1Mcn
(involves: 129X1/SvJ * C57BL/6)
|
abnormal diaphragm morphology
|
J:49871
|
| dystrophic muscle
|
J:49871
|
| muscle phenotype
|
J:57664
|
| thick diaphragm muscle
|
J:49871
|
Sgcgtm1Oza/Sgcgtm1Oza
(involves: 129S4/SvJae * C57BL/6)
|
abnormal diaphragm morphology
|
J:102780
|
| abnormal muscle regeneration
|
J:102780
|
| abnormal tibialis anterior morphology
|
J:102780
|
| dystrophic muscle
|
J:102780
|
| increased skeletal muscle fiber size
|
J:102780
|
| increased skeletal muscle mass
|
J:102780
|
| muscle degeneration
|
J:102780
|
| myocardium necrosis
|
J:102780
|
| progressive muscle weakness
|
J:102780
|
| skeletal muscle hypertrophy
|
J:102780
|
| skeletal muscle interstitial fibrosis
|
J:102780
|
| skeletal muscle necrosis
|
J:102780
|
Sgpl1Gt(OST58278)Lex/Sgpl1Gt(OST58278)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
abnormal myocardial fiber morphology
|
J:145159
|
Sgpl1Gt(ROSA)78Sor/Sgpl1Gt(ROSA)78Sor
(involves: 129S4/SvJaeSor)
|
abnormal smooth muscle morphology
|
J:117491
|
Sgpl1Gt(ROSA)78Sor/Sgpl1Gt(ROSA)78Sor
(either: (involves: 129S4/SvJaeSor) or (involves: 129S4/SvJaeSor * C57BL/6))
|
abnormal vascular smooth muscle morphology
|
J:142042
|
Sgshmps3a/Sgshmps3a
(involves: 129X1/SvJ * CD-1 * C57BL/6 * SJL)
|
abnormal myocardium layer morphology
|
J:72142
|
Sh3bp2tm1Bjro/Sh3bp2tm1Bjro
(involves: 129S4/SvJae * BALB/cJ * C57BL/6J)
|
myositis
|
J:117880
|
Sh3pxd2atm1b(EUCOMM)Wtsi/Sh3pxd2atm1b(EUCOMM)Wtsi
(C57BL/6N-Sh3pxd2atm1b(EUCOMM)Wtsi/Wtsi)
|
abnormal digastric muscle connection
|
J:239583
|
| abnormal eye muscle morphology
|
J:239583
|
| abnormal eye muscle topology
|
J:239583
|
| abnormal infrahyoid muscle connection
|
J:239583
|
| abnormal muscle morphology
|
J:239583
|
| abnormal pectinate muscle morphology
|
J:239583
|
| diaphragmatic hernia
|
J:239583
|
Sh3pxd2bGt(GST_1527_E5)Lex/Sh3pxd2bGt(GST_1527_E5)Lex
(involves: 129X1/SvJ * C57BL/6)
|
abnormal myocardial trabeculae morphology
|
J:158635
|
Sh3tc1tm1b(EUCOMM)Hmgu/Sh3tc1tm1b(EUCOMM)Hmgu
(C57BL/6N-Sh3tc1tm1b(EUCOMM)Hmgu/Orl)
|
decreased cardiac muscle contractility
|
J:211773
|
Shc1tm1Paw/Shc1tm1Paw
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * CD-1))
|
abnormal vascular smooth muscle morphology
|
J:62182
|
| decreased cardiac muscle contractility
|
J:62182
|
| thin myocardium
|
J:62182
|
| trabecula carnea hypoplasia
|
J:62182
|
| vascular smooth muscle hypoplasia
|
J:62182
|
Shc1tm1Pgp/Shc1tm1Pgp
(involves: 129)
|
increased vasodilation
|
J:81977
|
Shc1tm3Paw/Shc1tm4Paw
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased muscle spindle number
|
J:122927
|
Shc1tm3Paw/Shc1tm7Paw
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased muscle spindle number
|
J:122927
|
Shc1tm4Paw/Shc1tm4Paw
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal muscle spindle morphology
|
J:122927
|
| abnormal myocardial trabeculae morphology
|
J:122927
|
Shc1tm7Paw/Shc1tm7Paw
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal muscle spindle morphology
|
J:122927
|
Shhtm1(EGFP/cre)Cjt/Shh+
Sox17tm1Ysk/Sox17+
(involves: 129S1/Sv * C57BL/6)
|
abnormal gallbladder smooth muscle morphology
|
J:241569
|
Shhtm1(EGFP/cre)Cjt/Shhtm1(EGFP/cre)Cjt
(Not Specified)
|
abnormal atrium myocardium morphology
|
J:204743
|
| abnormal gallbladder smooth muscle morphology
|
J:241569
|
| abnormal vascular smooth muscle morphology
|
J:204743
|
Shhtm1Amc/Shhtm1Amc
(involves: 129/Sv * C57BL/6J * CBA/J)
|
abnormal smooth muscle morphology
|
J:62158
|
| abnormal tracheal smooth muscle morphology
|
J:50051
|
Shox2tm1Ddu/Shox2tm3.1(cre)Ypc
(involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6)
|
sinoatrial node hypoplasia
|
J:199319
|
Shox2tm1Ypc/Shox2tm1Ypc
(involves: 129X1/SvJ)
|
sinoatrial node hypoplasia
|
J:199319
|
Shox2tm3.1(cre)Ypc/Shox2tm4.1Ypc
(involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6)
|
sinoatrial node hypoplasia
|
J:199319
|
Shroom3Gt(ROSA53)Sor/Shroom3Gt(ROSA53)Sor
(B6.129S4-Shroom3Gt(ROSA53)Sor/J)
|
increased fetal cardiomyocyte proliferation
|
J:293794
|
| thin left ventricle myocardium compact layer
|
J:293794
|
Sik2tm1Lex/Sik2tm1Lex
(involves: 129S/SvEvBrd)
|
decreased muscle cell glucose uptake
|
J:229999
|
Sirt1tm1Mcby/Sirt1tm1Mcby
(involves: 129)
|
heart right ventricle hypertrophy
|
J:81010
|
Sirt1tm1Mcby/Sirt1tm1Mcby
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
heart right ventricle hypertrophy
|
J:81010
|
Sirt7tm1Evbo/Sirt7tm1Evbo
(involves: 129/Sv * C57BL/6)
|
cardiomyopathy
|
J:147652
|
| increased cardiomyocyte apoptosis
|
J:147652
|
| increased myocardial fiber size
|
J:147652
|
Six1tm1Kwk/Six1tm1Kwk
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased skeletal muscle mass
|
J:104488
|
Six1tm1Mair/Six1tm1Mair
(either: (involves: 129/Sv) or (involves: 129/Sv * C57BL/6))
|
abnormal genioglossus muscle morphology
|
J:82459
|
| abnormal hypaxial muscle morphology
|
J:82459
|
| abnormal intercostal muscle morphology
|
J:82459
|
| abnormal muscle fiber morphology
|
J:82459
|
| abnormal myogenesis
|
J:82459
|
| decreased skeletal muscle mass
|
J:82459
|
| muscle hypoplasia
|
J:82459
|
| thin diaphragm muscle
|
J:82459
|
Six1tm1Mair/Six1tm1Mair
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal skeletal muscle morphology
|
J:172023
|
Six1tm1Mair/Six1tm1Mair
(involves: 129S2/SvPas)
|
abnormal epaxial muscle morphology
|
J:84417
|
| abnormal hypaxial muscle morphology
|
J:84417
|
| absent diaphragm
|
J:84417
|
Six1tm1Mair/Six1tm1Mair
Six4tm1Mair/Six4tm1Mair
(either: 129/Sv-Six1tm1Mair Six4tm1Mair or B6N.129-Six1tm1Mair Six4tm1Mair)
|
abnormal genioglossus muscle morphology
|
J:98519
|
| abnormal intrinsic tongue muscle morphology
|
J:98519
|
| abnormal muscle development
|
J:98519
|
| abnormal muscle precursor cell migration
|
J:98519
|
| abnormal skeletal muscle morphology
|
J:98519
|
| absent eye muscles
|
J:98519
|
| absent hypaxial muscle
|
J:98519
|
| absent tongue muscles
|
J:98519
|
| muscle hypoplasia
|
J:98519
|
Six1tm1Rsd/Six1tm1Rsd
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal hypaxial muscle morphology
|
J:86619
|
| abnormal muscle precursor cell migration
|
J:86619
|
Six1tm2.1Mair/Six1tm2.1Mair
Pax7tm1(cre/ERT2)Gaka/Pax7+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6Cr * C57BL/6NTac)
|
abnormal muscle physiology
|
J:190460
|
| abnormal muscle regeneration
|
J:190460
|
| muscle phenotype
|
J:190460
|
| skeletal muscle fibrosis
|
J:190460
|
Six1tm2.2Mair/Six1tm2.2Mair
(involves: C57BL/6NTac)
|
abnormal myogenesis
|
J:190460
|
Six5tm1Tap/Six5tm1Tap
(involves: 129/Sv * C57BL/6)
|
muscle phenotype
|
J:61882
|
Skitm1Cco/Skitm1Cco
(involves: 129P2/OlaHsd * C57BL/6)
|
muscle hypoplasia
|
J:42573
|
Skitm1Cco/Skitm1Cco
(involves: 129P2/OlaHsd * Black Swiss)
|
abnormal skeletal muscle fiber morphology
|
J:42573
|
| abnormal skeletal muscle morphology
|
J:42573
|
| decreased skeletal muscle fiber diameter
|
J:42573
|
| decreased skeletal muscle mass
|
J:42573
|
| muscle hypoplasia
|
J:42573
|
skimp/skimp
(involves: C3H/HeH)
|
opisthotonus
|
J:77535
|
Skmw1C57BL/6J/?
(involves: C57BL/6J * DBA/2J)
|
abnormal muscle morphology
|
J:86884
|
Skmw1C57BL/6J/Skmw1C57BL/6J
(involves: C57BL/6J * DBA/2J)
|
increased gastrocnemius weight
|
J:110033
|
Skmw1C57BL/6J/Skmw1DBA/2J
(involves: C57BL/6J * DBA/2J)
|
increased gastrocnemius weight
|
J:110033
|
Skmw2C57BL/6J/Skmw2DBA/2J
(involves: C57BL/6J * DBA/2J)
|
increased extensor digitorum longus weight
|
J:110033
|
Skmw2DBA/2J/?
(involves: C57BL/6J * DBA/2J)
|
abnormal muscle morphology
|
J:86884
|
Skmw2DBA/2J/Skmw2DBA/2J
(involves: C57BL/6J * DBA/2J)
|
increased extensor digitorum longus weight
|
J:110033
|
Skmw3DBA/2J/?
(involves: C57BL/6J * DBA/2J)
|
abnormal muscle morphology
|
J:86884
|
Skmw4C57BL/6J/?
(involves: C57BL/6J * DBA/2J)
|
abnormal muscle morphology
|
J:86884
|
Skmw5C57BL/6J/?
(involves: C57BL/6J * DBA/2J)
|
abnormal muscle morphology
|
J:86884
|
Skmw6C57BL/6J/Skmw6DBA/2J
(involves: C57BL/6J * DBA/2J)
|
increased soleus weight
|
J:99478,
J:110033
|
| increased tibialis anterior weight
|
J:99478,
J:110033
|
Skmw6DBA/2J/Skmw6DBA/2J
(involves: C57BL/6J * DBA/2J)
|
increased soleus weight
|
J:99478,
J:110033
|
| increased tibialis anterior weight
|
J:99478
|
Skmw7C57BL/6J/Skmw7C57BL/6J
(involves: C57BL/6J * DBA/2J)
|
increased extensor digitorum longus weight
|
J:99478
|
Skmw7C57BL/6J/Skmw7DBA/2J
(involves: C57BL/6J * DBA/2J)
|
increased extensor digitorum longus weight
|
J:99478
|
Skmw8C57BL/6J/Skmw8C57BL/6J
(involves: C57BL/6J * DBA/2J)
|
increased extensor digitorum longus weight
|
J:110033
|
| increased tibialis anterior weight
|
J:99478,
J:110033
|
Skmw8C57BL/6J/Skmw8DBA/2J
(involves: C57BL/6J * DBA/2J)
|
increased extensor digitorum longus weight
|
J:110033
|
Skmw9C57BL/6J/Skmw9C57BL/6J
(involves: C57BL/6J * DBA/2J)
|
increased gastrocnemius weight
|
J:99478,
J:110033
|
Skmw9C57BL/6J/Skmw9DBA/2J
(involves: C57BL/6J * DBA/2J)
|
increased gastrocnemius weight
|
J:99478,
J:110033
|
Skmw10C57BL/6J/Skmw10C57BL/6J
(involves: C57BL/6J * DBA/2J)
|
abnormal gastrocnemius morphology
|
J:99478,
J:110033
|
| increased muscle weight
|
J:110033
|
Skmw10C57BL/6J/Skmw10DBA/2J
(involves: C57BL/6J * DBA/2J)
|
increased gastrocnemius weight
|
J:99478
|
Skmw11C57BL/6J/Skmw11C57BL/6J
(involves: C57BL/6J * DBA/2J)
|
increased extensor digitorum longus weight
|
J:99478
|
| increased soleus weight
|
J:99478
|
| increased tibialis anterior weight
|
J:99478,
J:110033
|
Skmw11C57BL/6J/Skmw11DBA/2J
(involves: C57BL/6J * DBA/2J)
|
increased extensor digitorum longus weight
|
J:99478
|
| increased soleus weight
|
J:99478
|
| increased tibialis anterior weight
|
J:99478,
J:110033
|
Skmw12C57BL/6J/Skmw12C57BL/6J
(involves: C57BL/6J * DBA/2J)
|
increased gastrocnemius weight
|
J:110033
|
Skmw12C57BL/6J/Skmw12DBA/2J
(involves: C57BL/6J * DBA/2J)
|
increased gastrocnemius weight
|
J:110033
|
Skmw13C57BL/6J/Skmw13C57BL/6J
(involves: C57BL/6J * DBA/2J)
|
increased extensor digitorum longus weight
|
J:110033
|
Skmw13C57BL/6J/Skmw13DBA/2J
(involves: C57BL/6J * DBA/2J)
|
increased extensor digitorum longus weight
|
J:110033
|
Skmw14C57BL/6J/Skmw14C57BL/6J
(involves: C57BL/6J * DBA/2J)
|
increased soleus weight
|
J:110033
|
Skmw15C57BL/6J/Skmw15C57BL/6J
(involves: C57BL/6J * DBA/2J)
|
abnormal gastrocnemius morphology
|
J:110033
|
| increased muscle weight
|
J:110033
|
Skmw16C57BL/6J/Skmw16DBA/2J
(involves: C57BL/6J * DBA/2J)
|
increased soleus weight
|
J:110033
|
Skmw17C57BL/6J/Skmw17DBA/2J
(involves: C57BL/6J * DBA/2J)
|
increased extensor digitorum longus weight
|
J:110033
|
Skmw17DBA/2J/Skmw17DBA/2J
(involves: C57BL/6J * DBA/2J)
|
increased extensor digitorum longus weight
|
J:110033
|
Skmw18C57BL/6J/Skmw18C57BL/6J
(involves: C57BL/6J * DBA/2J)
|
increased soleus weight
|
J:110033
|
Skmw18C57BL/6J/Skmw18DBA/2J
(involves: C57BL/6J * DBA/2J)
|
increased soleus weight
|
J:110033
|
sky/sky
(DBA/2J-sky/J)
|
abnormal muscle morphology
|
J:136875
|
Slc2a4tm1Abel/Slc2a4+
Tg(Ckmm-cre)5Khn/0
(involves: 129S4/SvJae * FVB)
|
decreased muscle cell glucose uptake
|
J:110773
|
Slc2a4tm1Abel/Slc2a4tm1Abel
Tg(Ckmm-cre)5Khn/?
(involves: 129/Sv * C57BL/6)
|
abnormal muscle physiology
|
J:75418
|
| decreased muscle cell glucose uptake
|
J:75418
|
| muscle phenotype
|
J:75418
|
Slc2a4tm1Abel/Slc2a4tm1Abel
Tg(Ckmm-cre)5Khn/0
(involves: 129S4/SvJae * FVB)
|
decreased muscle cell glucose uptake
|
J:110773
|
Slc2a4tm1Abel/Slc2a4tm1Abel
Tg(Myhca-cre)1Abel/?
(involves: 129S4/SvJae * FVB)
|
abnormal myocardium layer morphology
|
J:59054
|
| decreased cardiac muscle cell glucose uptake
|
J:59054
|
Slc2a4tm1Abel/Slc2a4tm1Abel
Tg(Myhca-cre)1Abel/?
(involves: 129S4/SvJae * C57BL/6 * FVB)
|
decreased cardiac muscle cell glucose uptake
|
J:108830
|
| increased cardiac muscle cell glucose uptake
|
J:108830
|
| increased cardiac muscle glycogen level
|
J:108830
|
Slc2a4tm1Jdz/Slc2a4tm1Jdz
(involves: 129S1/Sv * C57BL/6)
|
decreased muscle cell glucose uptake
|
J:123335
|
Slc2a4tm1Jdz/Slc2a4tm1Jdz
Tg(ACTA1-cre)1Jdz/0
(involves: 129S1/Sv * C57BL/6 * CBA)
|
decreased muscle cell glucose uptake
|
J:123335
|
| increased cardiac muscle cell glucose uptake
|
J:123335
|
| increased muscle cell glucose uptake
|
J:123335
|
Slc2a4tm1Mch/Slc2a4+
(involves: 129/Sv * C57BL/6J * CD-1 * SJL)
|
decreased muscle cell glucose uptake
|
J:43935,
J:43650
|
| myocardium necrosis
|
J:43650
|
Slc2a4tm1Mch/Slc2a4tm1Mch
(involves: 129/Sv * C57BL/6 * C57BL/6J * CD-1 * SJL)
|
abnormal muscle physiology
|
J:49328
|
Slc2a4tm1Mch/Slc2a4tm1Mch
(involves: 129/Sv * C57BL/6 * C57BL/6J * SJL)
|
abnormal skeletal muscle fiber type ratio
|
J:75600
|
| decreased skeletal muscle glycogen level
|
J:75600
|
| decreased skeletal muscle mass
|
J:75600
|
| impaired skeletal muscle contractility
|
J:75600
|
| increased muscle fatigability
|
J:75600
|
Slc3a1tm1Jat/Slc3a1tm1Jat
(involves: 129 * C57BL/6)
|
abnormal urinary bladder detrusor smooth muscle morphology
|
J:254981
|
| impaired contractility of urinary bladder detrusor smooth muscle
|
J:254981
|
Slc4a1tm1Llp/Slc4a1tm1Llp
(B6;129S4-Slc4a1tm1Llp/J)
|
decreased ventricle muscle contractility
|
J:120610
|
Slc4a3tm1Ges/Slc4a3tm1Ges
Tg(Myh6-Tpm1*E180G)57Dfw/0
(involves: 129X1/SvJ * FVB/N)
|
abnormal cardiac muscle relaxation
|
J:171021
|
| decreased cardiac muscle contractility
|
J:171021
|
Slc4a4tm1.1Slin/Slc4a4tm1.1Slin
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased gastrocnemius weight
|
J:186877
|
Slc4a7Gt(40G1)Cmhd/Slc4a7Gt(40G1)Cmhd
(B6.129-Slc4a7Gt(40G1)Cmhd)
|
abnormal vascular smooth muscle physiology
|
J:189470
|
| abnormal vasoconstriction
|
J:189470
|
| decreased vasodilation
|
J:189470
|
Slc6a3tm1(cre)Lrsn/Slc6a3+
Tfamtm1Lrsn/Tfamtm1Lrsn
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
muscle spasm
|
J:119515
|
Slc6a4tm1Kpl/Slc6a4tm1Kpl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
heart right ventricle hypertrophy
|
J:62768
|
Slc6a4tm1Kpl/Slc6a4tm1Kpl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal intestinal peristalsis
|
J:237081
|
| decreased cardiac muscle contractility
|
J:121505
|
| dilated cardiomyopathy
|
J:121505
|
Slc6a4tm2.1Rbl/Slc6a4tm2.1Rbl
(involves: 129S4/SvJae * 129S6/SvEvTac)
|
intestinal hypoperistalsis
|
J:237081
|
Slc6a5m1J/Slc6a5m1J
(involves: 129S2/SvPas * NOD)
|
muscle hypertonia
|
J:184306
|
| muscle spasm
|
J:184306
|
Slc6a5tm1Betz/Slc6a5tm1Betz
(involves: 129P2/OlaHsd)
|
muscle hypertonia
|
J:86625
|
Slc6a6tm1Jaz/Slc6a6tm1Jaz
(involves: 129S2/SvPas * C57BL/6)
|
abnormal muscle fiber morphology
|
J:135159
|
| abnormal myocardial fiber morphology
|
J:135159
|
| decreased cardiac muscle contractility
|
J:135159
|
| decreased myocardial fiber size
|
J:135159
|
| decreased skeletal muscle fiber diameter
|
J:135159
|
| decreased skeletal muscle weight
|
J:135159
|
| dilated cardiomyopathy
|
J:135159
|
| muscular atrophy
|
J:135159
|
Slc6a8tm1e(KOMP)Wtsi/Y
(involves: C57BL/6J * C57BL/6N)
|
abnormal muscle morphology
|
J:264220
|
| abnormal muscle physiology
|
J:264220
|
| hypotonia
|
J:264220
|
| muscle weakness
|
J:264220
|
| skeletal muscle fiber atrophy
|
J:264220
|
Slc6a9tm1Betz/Slc6a9tm1Betz
(involves: 129P2/OlaHsd * C57BL/6)
|
hypotonia
|
J:86624
|
Slc6a9tm1Veul/Slc6a9tm1Veul
Tg(EIIa-cre)C5379Lmgd/?
(involves: 129P2/OlaHsd * FVB/N)
|
hypotonia
|
J:161993
|
Slc6a9tm1Veul/Slc6a9tm1Veul
Tg(Gfap-cre)2Brn/?
(involves: 129P2/OlaHsd * FVB/N)
|
hypotonia
|
J:161993
|
Slc6a9tm1Veul/Slc6a9tm1Veul
Tg(Syn1-cre)671Jxm/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
muscle phenotype
|
J:161993
|
Slc7a7Gt(OST41878)Lex/Slc7a7Gt(OST41878)Lex
(B6.129S-Slc7a7Gt(OST41878)Lex)
|
hypotonia
|
J:125847
|
Slc7a10tm1Dgen/Slc7a10tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
myoclonus
|
J:100127
|
Slc8a1tm1Hssh/Slc8a1tm1Hssh
(involves: 129S4/SvJae * C57BL/6J)
|
trabecula carnea hypoplasia
|
J:74096
|
Slc8a1tm1Hssh/Slc8a1tm1Hssh
(involves: 129S4/SvJae * C3H * C57BL/6)
|
abnormal myocardium layer morphology
|
J:106177
|
Slc8a1tm1Yin/Slc8a1+
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal cardiac muscle relaxation
|
J:75050
|
| heart left ventricle hypertrophy
|
J:75050
|
| impaired smooth muscle contractility
|
J:65985
|
| increased ventricle muscle contractility
|
J:75050
|
Slc8a1tm1Yin/Slc8a1tm1Yin
(involves: 129X1/SvJ * C57BL/6J)
|
absent Z line
|
J:102564
|
| increased cardiomyocyte apoptosis
|
J:65985
|
Slc8a3tm1Sso/Slc8a3tm1Sso
(Not Specified)
|
skeletal muscle fiber necrosis
|
J:87615
|
Slc8b1tm1c(EUCOMM)Wtsi/Slc8b1tm1c(EUCOMM)Wtsi
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: 129S4/SvJaeSor * C57BL/6N * FVB/N)
|
abnormal sarcomere morphology
|
J:325413
|
| decreased ventricle muscle contractility
|
J:325413
|
| increased myocardial fiber size
|
J:325413
|
Slc12a6tm1Tjj/Slc12a6tm1Tjj
(involves: 129/Sv * C57BL/6)
|
muscle hypertonia
|
J:86183
|
Slc13a5tm1.2Helf/Slc13a5tm1.2Helf
(B6.Cg-Slc13a5tm1.2Helf)
|
abnormal muscle physiology
|
J:176732
|
| increased muscle cell glucose uptake
|
J:176732
|
Slc16a3tm1Tac/Slc16a3tm1Tac
(B6NTac.Cg-Slc16a3tm1Tac/Tac)
|
muscle phenotype
|
J:288233
|
Slc16a13em1Tac/Slc16a13em1Tac
(C57BL/6N-Slc16a13em1Tac)
|
muscle phenotype
|
J:309785
|
Slc18a2tm2Kmo/Slc18a2tm2Kmo
(involves: 129P2/OlaHsd * C57BL/6)
|
muscle phenotype
|
J:150414
|
Slc25a3tm1.1Jmol/Slc25a3tm1.1Jmol
A1cfTg(Myh6-cre/Esr1*)1Jmk/?
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N)
|
abnormal cardiac muscle tissue morphology
|
J:229795
|
| abnormal sarcomere morphology
|
J:229795
|
| cardiomyopathy
|
J:229795
|
| decreased cardiac muscle contractility
|
J:229795
|
Slc25a4tm2Dwa/Slc25a4tm2Dwa
(involves: 129S4/SvJae * C57BL/6J)
|
myopathy
|
J:41256
|
Slc25a25tm1.1Kz/Slc25a25tm1.1Kz
(involves: C57BL/6J * FVB/N)
|
muscle phenotype
|
J:170924
|
Slc26a4em1Jgao/Slc26a4em1Jgao
(involves: CBA/CaJ)
|
torticollis
|
J:291230
|
Slc27a1tm1Jkk/Slc27a1tm1Jkk
(involves: 129S/SvEv * C57BL/6J)
|
abnormal muscle cell glucose uptake
|
J:88657
|
| abnormal skeletal muscle triglyceride level
|
J:88657
|
Slc32a1tm1Bros/Slc32a1tm1Bros
(involves: 129P2/OlaHsd)
|
muscle hypertonia
|
J:122318
|
Slc34a1tm1Hten/Slc34a1tm1Hten
(involves: 129S2/SvPas * C57BL/6J)
|
muscle weakness
|
J:47637
|
Slc39a4tm2Gka/Slc39a4tm2Gka
Tg(Vil1-cre/ERT2)23Syr/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
decreased muscle weight
|
J:187178
|
Slc39a8tm1.2Mrl/Slc39a8tm1.2Mrl
(B6(Cg)-Slc39a8tm1.2Mrl)
|
abnormal myocardial trabeculae morphology
|
J:258360
|
| increased fetal cardiomyocyte proliferation
|
J:258360
|
| thin myocardium compact layer
|
J:258360
|
Slc39a14tm1Thir/Slc39a14tm1Thir
(involves: 129 * C57BL/6)
|
torticollis
|
J:171670
|
Slit3b2b2362.1Clo/Slit3b2b2362.1Clo
(C57BL/6J-Slit3b2b2362.1Clo)
|
abnormal myocardial trabeculae morphology
|
J:175213
|
Slit3Gt(OST106158)Lex/Slit3Gt(OST106158)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
diaphragmatic hernia
|
J:86149
|
| heart right ventricle hypertrophy
|
J:86149
|
Slit3tm1.1Dor/Slit3tm1.1Dor
(involves: 129S1/Sv * C57BL/6J)
|
abnormal diaphragm morphology
|
J:83292
|
| diaphragmatic hernia
|
J:83292
|
| thin diaphragm muscle
|
J:83292
|
Slit3tm1.1Dor/Slit3tm1.1Dor
(involves: 129S1/Sv * C57BL/6)
|
abnormal diaphragm central tendon morphology
|
J:208012
|
| abnormal diaphragm morphology
|
J:208012
|
| diaphragmatic hernia
|
J:208012
|
Slit3tm1Dor/Slit3tm1Dor
(involves: 129S1/Sv * C57BL/6J)
|
abnormal diaphragm central tendon morphology
|
J:83292
|
| abnormal diaphragm development
|
J:83292
|
| diaphragmatic hernia
|
J:83292
|
| thin diaphragm muscle
|
J:83292
|
SlkGt(BC0415)Wtsi/SlkGt(BC0415)Wtsi
(involves: 129P2/OlaHsd * FVB/N)
|
abnormal myogenesis
|
J:211339
|
Slntm1Peri/Slntm1Peri
(involves: Black Swiss * C57BL/6)
|
increased cardiac muscle contractility
|
J:127150
|
Smad4tm2.1Cxd/Smad4tm2.1Cxd
Kdrtm1(cre)Sato/Kdr+
(involves: 129S1/Sv * 129S6/SvEvTac)
|
abnormal trabecula carnea morphology
|
J:112269
|
Smad4tm2.1Cxd/Smad4tm2.1Cxd
Tg(ACTA1-cre)AMcle/0
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal trabecula carnea morphology
|
J:164492
|
| thin ventricle myocardium compact layer
|
J:164492
|
Smad5tm1Cxd/Smad5tm1Cxd
(either: (involves: 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * NIH Black Swiss))
|
vascular smooth muscle hypotrophy
|
J:53289
|
Smad5tm1Huy/Smad5tm1.1Huy
Tg(Tagln-cre)1Her/0
(involves: 129P2/OlaHsd * C57BL/6 * CD-1 * SJL)
|
decreased cardiac muscle contractility
|
J:121072
|
Smad6tm1Glvn/Smad6tm1Glvn
(involves: 129S6/SvEvTac * BALB/cByJ)
|
decreased vasodilation
|
J:60214
|
Smad7Gt(YHC053)Byg/Smad7+
Tbx1tm1Bld/Tbx1+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J)
|
increased vascular smooth muscle cell proliferation
|
J:212881
|
| vascular smooth muscle hypoplasia
|
J:212881
|
Smad7tm1.1Shou/Smad7tm1.1Shou
(involves: C57BL/6 * FVB)
|
abnormal trabecula carnea morphology
|
J:145777
|
| decreased cardiac muscle contractility
|
J:145777
|
Smad7tm1Shou/Smad7tm1Shou
Tg(Tek-cre)12Flv/0
(involves: C3H * C57BL/6)
|
abnormal trabecula carnea morphology
|
J:145777
|
| decreased cardiac muscle contractility
|
J:145777
|
Smarca2tm1Mya/Smarca2tm1Mya
(involves: 129S2/SvPas)
|
abnormal muscle physiology
|
J:172661
|
Smarca2tm1Mya/Smarca2tm1Mya
Smarca4tm1.1Pcn/Smarca4+
(involves: 129S2/SvPas * C57BL/6 * DBA/2)
|
abnormal muscle physiology
|
J:172661
|
Smarca2tm1Mya/Smarca2tm1Mya
Smarca4tm1.2Pcn/Smarca4tm1.1Pcn
Tg(Myh11-cre,-EGFP)2Mik/0
(involves: 129S2/SvPas * C57BL/6 * DBA/2)
|
abnormal intestinal smooth muscle morphology
|
J:172661
|
| abnormal muscle physiology
|
J:172661
|
| impaired smooth muscle contractility
|
J:172661
|
Smarca4tm1.2Pcn/Smarca4tm1.1Pcn
Tg(Myh11-cre,-EGFP)2Mik/0
(involves: 129S2/SvPas * C57BL/6 * DBA/2)
|
abnormal intestinal smooth muscle morphology
|
J:172661
|
| abnormal muscle physiology
|
J:172661
|
| impaired smooth muscle contractility
|
J:172661
|
Smarcb1tm1Sho/Smarcb1tm3Sho
Tg(Mx1-cre)1Cgn/?
(involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6 * CBA)
|
increased rhabdomyoma incidence
|
J:80224
|
Smarcb1tm2Sho/Smarcb1tm2Sho
Trp53tm1Brn/Trp53tm1Brn
Tg(GFAP-cre)#Gtm/0
(involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6 * CBA)
|
dystonia
|
J:226786
|
Smarcd3tm1.1Bbr/Smarcd3tm1.1Bbr
Nkx2-5tm1(cre)Rjs/Nkx2-5+
(either: (involves: 129 * C57BL/6 * SJL) or (involves: 129 * C57BL/6 * ICR * SJL))
|
abnormal myocardial trabeculae morphology
|
J:257963
|
| thin myocardium
|
J:257963
|
Smarcd3tm1.1Bbr/Smarcd3tm1.1Bbr
Tg(Myh6-cre)2182Mds/0
(either: (involves: 129 * C57BL/6 * FVB/N * SJL) or (involves: 129 * C57BL/6 * FVB/N * ICR * SJL))
|
abnormal intercalated disk morphology
|
J:257963
|
| abnormal sarcomere morphology
|
J:257963
|
| decreased cardiac muscle contractility
|
J:257963
|
| increased cardiomyocyte apoptosis
|
J:257963
|
Smarcd3tm1.2Bbr/Smarcd3tm1.2Bbr
(either: (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * ICR * SJL))
|
abnormal cardiac muscle relaxation
|
J:257963
|
| abnormal I band morphology
|
J:257963
|
| abnormal M line morphology
|
J:257963
|
| abnormal sarcomere morphology
|
J:257963
|
| abnormal Z line morphology
|
J:257963
|
| decreased cardiac muscle contractility
|
J:257963
|
| decreased fetal cardiomyocyte proliferation
|
J:257963
|
Smarcd3tm1.2Bbr/Smarcd3tm1.2Bbr
(B6.129(Cg)-Smarcd3tm1.2Bbr)
|
abnormal myocardial trabeculae morphology
|
J:257963
|
| thin myocardium compact layer
|
J:257963
|
Smg9em1(IMPC)J/Smg9em1(IMPC)J
(involves: C57BL/6NJ)
|
thin myocardium
|
J:231968
|
Smg9tm1b(EUCOMM)Wtsi/Smg9tm1b(EUCOMM)Wtsi
(C57BL/6N-Smg9tm1b(EUCOMM)Wtsi/Wtsi)
|
abnormal eye muscle morphology
|
J:239583
|
Smn1tm1.1Dscd/Smn1tm1.1Dscd
(involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6)
|
increased skeletal muscle fiber size
|
J:164889
|
Smn1tm1Hung/Smn1tm1Hung
Tg(SMN2)2Hung/0
(B6N.Cg-Smn1tm1Hung Tg(SMN2)2Hung)
|
decreased skeletal muscle fiber size
|
J:193844
|
Smn1tm1Hung/Smn1tm1Hung
Tg(SMN2)2Hung/0
(FVB.Cg-Smn1tm1Hung Tg(SMN2)2Hung/J)
|
decreased skeletal muscle fiber size
|
J:193844
|
Smn1tm1Hung/Smn1tm1Hung
Tg(SMN2)2Hung/0
(involves: 129P2/OlaHsd * C57BL/6N * FVB/N)
|
increased skeletal muscle fiber size
|
J:193844
|
Smn1tm1Hung/Smn1tm1Hung
Tg(SMN2)2Hung/Tg(SMN2)2Hung
(involves: 129P2/OlaHsd * FVB/N)
|
abnormal skeletal muscle fiber morphology
|
J:59313
|
| decreased skeletal muscle fiber diameter
|
J:59313
|
| decreased skeletal muscle fiber number
|
J:59313
|
| increased skeletal muscle fiber size
|
J:59313
|
| muscular atrophy
|
J:59313
|
Smn1tm1Jme/Smn1tm1.1Jme
Tg(ACTA1-cre)79Jme/0
(involves: 129 * C57BL/6J * SJL)
|
abnormal muscle physiology
|
J:67884
|
| abnormal skeletal muscle fiber morphology
|
J:67884
|
| centrally nucleated skeletal muscle fibers
|
J:67884
|
| increased variability of skeletal muscle fiber size
|
J:67884
|
| skeletal muscle necrosis
|
J:67884
|
Smn1tm1Jme/Smn1tm1.1Jme
Tg(Eno2-cre)39Jme/0
(involves: 129 * C57BL/6J * SJL)
|
abnormal skeletal muscle fiber morphology
|
J:61396
|
| hypotonia
|
J:61396
|
Smn1tm1Msd/Smn1tm1Msd
Grm7Tg(SMN2)89Ahmb/?
(involves: 129P2/OlaHsd * C57BL/6J * FVB)
|
muscle phenotype
|
J:60592
|
Smn1tm1Msd/Smn1tm1Msd
Grm7Tg(SMN2)89Ahmb/Grm7Tg(SMN2)89Ahmb
(FVB.Cg-Grm7Tg(SMN2)89Ahmb Smn1tm1Msd/J)
|
decreased skeletal muscle fiber diameter
|
J:132467
|
Smn1tm1Msd/Smn1tm1Msd
Grm7Tg(SMN2)89Ahmb/Grm7Tg(SMN2)89Ahmb
Tg(SMN2*A111G)588Ahmb/0
(involves: 129P2/OlaHsd * FVB/N)
|
abnormal gastrocnemius morphology
|
J:148541
|
| abnormal skeletal muscle morphology
|
J:148541
|
Smn1tm1Msd/Smn1tm1Msd
Grm7Tg(SMN2)89Ahmb/Grm7Tg(SMN2)89Ahmb
Tg(SMN2*delta7)4299Ahmb/0
(FVB.Cg-Grm7Tg(SMN2)89Ahmb Smn1tm1Msd Tg(SMN2*delta7)4299Ahmb/J)
|
decreased skeletal muscle fiber size
|
J:194969
|
Smn1tm1Msd/Smn1tm1Msd
Grm7Tg(SMN2)89Ahmb/Grm7Tg(SMN2)89Ahmb
Tg(SMN2*delta7)4299Ahmb/Tg(SMN2*delta7)4299Ahmb
(FVB.Cg-Grm7Tg(SMN2)89Ahmb Smn1tm1Msd Tg(SMN2*delta7)4299Ahmb/J)
|
decreased skeletal muscle fiber diameter
|
J:132467
|
| dilated cardiomyopathy
|
J:164446
|
Smn1tm1Msd/Smn1tm1Msd
Grm7Tg(SMN2)89Ahmb/Grm7Tg(SMN2)89Ahmb
Tg(SMN2*delta7)4299Ahmb/Tg(SMN2*delta7)4299Ahmb
(FVB.Cg-Grm7Tg(SMN2)89Ahmb Smn1tm1Msd Tg(SMN2*delta7)4299Ahmb)
|
skeletal muscle fiber atrophy
|
J:97103
|
Smn1tm1Msd/Smn1tm1Msd
Tg(ACTA1-SMN)63Ahmb/Tg(ACTA1-SMN)63Ahmb
Grm7Tg(SMN2)89Ahmb/Grm7Tg(SMN2)89Ahmb
(involves: 129P2/OlaHsd * FVB/N)
|
decreased skeletal muscle fiber size
|
J:131663
|
Smn1tm1Msd/Smn1tm1Msd
Tg(Prnp-SMN)92Ahmb/Tg(Prnp-SMN)92Ahmb
Grm7Tg(SMN2)89Ahmb/Grm7Tg(SMN2)89Ahmb
(involves: 129P2/OlaHsd * FVB/N)
|
decreased skeletal muscle fiber size
|
J:131663
|
Smn1tm1Msd/Smn1tm1Msd
Tg(SMN1*A2G)2023Ahmb/0
Grm7Tg(SMN2)89Ahmb/Grm7+
(involves: 129P2/OlaHsd * FVB/N)
|
abnormal muscle electrophysiology
|
J:81238
|
| muscular atrophy
|
J:81238
|
Smn1tm1Msd/Smn1tm1Msd
Tg(SMN1-SMN2*)16Cll/0
Grm7Tg(SMN2)89Ahmb/Grm7Tg(SMN2)89Ahmb
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
decreased skeletal muscle fiber size
|
J:194969
|
Smn1tm1Msd/Smn1tm1Msd
Tg(SMN2)11Tro/0
Tg(SMN2)46Tro/0
(B6.Cg-Tg(SMN2)11Tro Tg(SMN2)46Tro Smn1tm1Msd/J)
|
abnormal muscle electrophysiology
|
J:159930
|
| abnormal skeletal muscle fiber morphology
|
J:159930
|
| muscular atrophy
|
J:159930
|
| progressive muscle weakness
|
J:159930
|
Smn1tm1Msd/Smn1tm1Msd
Tg(SMN2)566Ahmb/?
(involves: 129P2/OlaHsd * C57BL/6J * FVB)
|
muscle phenotype
|
J:60592
|
Smn1tm5(Smn1/SMN2)Mrph/Smn1tm5(Smn1/SMN2)Mrph
(involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NTac)
|
decreased skeletal muscle fiber size
|
J:186987
|
Smotm2Amc/Smotm2Amc
Nkx3-2tm1(cre)Wez/Nkx3-2+
(involves: 129S1/Sv * 129S7/SvEvBrd * 129X1/SvJ)
|
abnormal intestinal smooth muscle morphology
|
J:199664
|
Smstm1a(EUCOMM)Wtsi/Y
(involves: C57BL/6N)
|
muscle weakness
|
J:200082
|
Smtntm1Gve/Smtntm1Gve
(involves: 129/Sv * C57BL/6)
|
decreased vasoconstriction
|
J:158046
|
| impaired contractility of jejunal smooth muscle
|
J:104648
|
| intestinal hypoperistalsis
|
J:104648
|
Smtntm2Gve/Smtntm2Gve
(B6.129-Smtntm2Gve)
|
decreased vasoconstriction
|
J:158046
|
Smtnl1tm1Tajh/Smtnl1tm1Tajh
(129S6.129P2-Smtnl1tm1Tajh)
|
abnormal skeletal muscle fiber type ratio
|
J:136573
|
| decreased vasoconstriction
|
J:136573
|
| increased vasodilation
|
J:136573
|
Smyd1tm1Dsr/Smyd1tm1Dsr
(involves: 129S6/SvEvTac)
|
trabecula carnea hypoplasia
|
J:76212
|
Smyd3em1Yzzh/Smyd3em1Yzzh
(C57BL/6-Smyd3em1Yzzh)
|
abnormal vasodilation
|
J:296379
|
Snap25tm1Mcw/Snap25tm1Mcw
(involves: C57BL/6)
|
abnormal intercostal muscle morphology
|
J:73755
|
| thin diaphragm muscle
|
J:73755
|
Snap25tm2Mcw/Snap25tm2Mcw
(involves: C57BL/6J)
|
myoclonus
|
J:94005
|
Snhg15tm1Nju/Snhg15tm1Nju
(involves: C57BL/6J)
|
delayed skeletal muscle regeneration
|
J:291983
|
| muscle phenotype
|
J:291983
|
Snrktm2Rra/Snrktm2Rra
Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6J * FVB/N)
|
decreased ventricle muscle contractility
|
J:218247
|
Snta1tm1Scf/Snta1tm1Scf
(involves: 129P2/OlaHsd * C57BL/6)
|
muscle phenotype
|
J:76455
|
Snta1tm1Stk/Snta1tm1Stk
(involves: 129P2/OlaHsd * C57BL/6)
|
muscle phenotype
|
J:52275
|
Socs1tm2Wehi/Socs1tm2Wehi
(C57BL/6-Socs1tm2Wehi)
|
myositis
|
J:72528
|
Socs2tm1Wehi/Socs2tm1Wehi
(involves: C57BL/6 * C57BL/6J)
|
increased skeletal muscle triglyceride level
|
J:186227
|
Sod1m1H/Sod1m1H
(involves: C3H/HeH * C57BL/6J)
|
abnormal muscle fiber morphology
|
J:219360
|
| progressive muscle weakness
|
J:219360
|
Sod1tm1Dkd/Sod1tm1Dkd
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased cardiac muscle contractility
|
J:60470
|
| myocardium necrosis
|
J:89952,
J:60470
|
Sod1tm1Svb/Sod1tm1Svb
Tg(ACTA1-cre)79Jme/0
(involves: C57BL/6J * SJL)
|
abnormal muscle physiology
|
J:201098
|
| abnormal muscle regeneration
|
J:201098
|
| centrally nucleated skeletal muscle fibers
|
J:201098
|
| increased extensor digitorum longus weight
|
J:201098
|
| increased gastrocnemius weight
|
J:201098
|
| increased quadriceps weight
|
J:201098
|
| increased skeletal muscle mass
|
J:201098
|
| increased soleus weight
|
J:201098
|
| increased tibialis anterior weight
|
J:201098
|
| muscle phenotype
|
J:201098
|
| muscle weakness
|
J:201098
|
Sod2tm1(tetO-Sod2)Evbo/Sod2+
(involves: 129S4/SvJae * C57BL/6)
|
decreased ventricle muscle contractility
|
J:162190
|
| increased cardiomyocyte apoptosis
|
J:162190
|
| increased myocardial fiber size
|
J:162190
|
| myocardium necrosis
|
J:162190
|
Sod2tm1(tetO-Sod2)Evbo/Sod2tm1(tetO-Sod2)Evbo
(involves: 129S4/SvJae * C57BL/6)
|
increased cardiomyocyte apoptosis
|
J:162190
|
Sod2tm1.1Kskk/Sod2+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal myocardial fiber morphology
|
J:98289
|
| increased cardiomyocyte apoptosis
|
J:98289
|
Sod2tm1.1Kskk/Sod2tm1.1Kskk
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal myocardial fiber morphology
|
J:98289
|
Sod2tm1Cje/Sod2tm1Cje
(involves: C57BL/6J * CD-1)
|
abnormal skeletal muscle morphology
|
J:29899
|
| dilated cardiomyopathy
|
J:29899
|
| hypotonia
|
J:29899
|
Sod2tm1Cje/Sod2tm1Cje
(involves: C57BL/6J)
|
dilated cardiomyopathy
|
J:45913
|
Sod2tm1Cje/Sod2tm1Cje
(B6.Cg-Sod2tm1Cje/Mmmh)
|
dilated cardiomyopathy
|
J:73998
|
Sod2tm1Cje/Sod2tm1Cje
(involves: C57BL/6J * DBA/2J)
|
abnormal skeletal muscle fiber morphology
|
J:98007
|
| decreased skeletal muscle fiber size
|
J:98007
|
Sod2tm1Leb/Sod2tm1Leb
(B6.129S7-Sod2tm1Leb/J)
|
decreased skeletal muscle mass
|
J:36148
|
| dilated cardiomyopathy
|
J:36148
|
Sod2tm1Shs/Sod2tm1Shs
Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6CrSlc * FVB)
|
abnormal cardiac muscle tissue morphology
|
J:117386
|
| abnormal myocardium layer morphology
|
J:117386
|
| abnormal skeletal muscle morphology
|
J:117386
|
| cardiac muscle necrosis
|
J:117386
|
| decreased cardiac muscle contractility
|
J:117386
|
| dilated cardiomyopathy
|
J:117386
|
| increased cardiac muscle glycogen level
|
J:117386
|
| myocardial fiber degeneration
|
J:117386
|
Sod2tm1Shs/Sod2tm1Shs
Tg(Ckmm-cre)5Khn/0
(involves: FVB)
|
dilated cardiomyopathy
|
J:171017
|
| myocardial fiber degeneration
|
J:171017
|
| myocardial fiber disarray
|
J:171017
|
Sod2tm1Shs/Sod2tm1Shs
Tg(TNNI2-icre)1Vrmn/0
(involves: C57BL/6)
|
abnormal muscle contractility
|
J:155917
|
| abnormal muscle physiology
|
J:155917
|
| abnormal skeletal muscle fiber mitochondrial morphology
|
J:155917
|
| abnormal skeletal muscle morphology
|
J:155917
|
| abnormal tibialis anterior morphology
|
J:155917
|
| increased muscle cell glucose uptake
|
J:155917
|
| increased muscle fatigability
|
J:155917
|
| muscle phenotype
|
J:155917
|
Sod3tm1Svp/Sod3tm1Svp
(involves: 129S6/SvEvTac * C57BL/6NTac)
|
heart right ventricle hypertrophy
|
J:285340
|
Sorl1tm1Bujo/Sorl1tm1Bujo
(involves: 129/Sv * C57BL/6)
|
abnormal vascular smooth muscle physiology
|
J:140878
|
Sos1tm1.2Rak/Sos1+
(involves: 129S/Sv * C57BL/6 * FVB/N * SJL)
|
abnormal fetal cardiomyocyte proliferation
|
J:171873
|
| abnormal myocardial fiber morphology
|
J:171873
|
| heart left ventricle hypertrophy
|
J:171873
|
| increased cardiomyocyte apoptosis
|
J:171873
|
| increased myocardial fiber size
|
J:171873
|
Sos1tm1.2Rak/Sos1tm1.2Rak
(involves: 129S/Sv * C57BL/6 * FVB/N * SJL)
|
abnormal fetal cardiomyocyte proliferation
|
J:171873
|
| heart right ventricle hypertrophy
|
J:171873
|
| myocardial fiber degeneration
|
J:171873
|
Sos1tm1Dlb/Sos1tm1Dlb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal myocardial trabeculae morphology
|
J:38321
|
Sos1tm1Dlb/Sos1tm1Dlb
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal myocardial trabeculae morphology
|
J:38321
|
Sox2tm2Skn/Sox2tm3Skn
(involves: 129S/SvEv * 129S1/Sv * C57BL/6J)
|
dystonia
|
J:92063
|
Sox7tm1.1Dsco/Sox7+
(involves: 129S/SvEv * C57BL/6)
|
abnormal diaphragm morphology
|
J:187416
|
| diaphragmatic hernia
|
J:187416
|
Sox7tm1.1Dsco/Sox7+
(B6.129-Sox7tm1.1Dsco)
|
muscle phenotype
|
J:187416
|
Sox9tm1Gsr/Sox9tm1Gsr
Tg(Pax3-cre)1Joe/0
(involves: 129P2/OlaHsd * C57BL/6 * NMRI * SJL)
|
impaired ureteric peristalsis
|
J:166547
|
Sox11tm2.2Weg/Sox11tm2.2Weg
Sox4tm1.1Vlf/Sox4+
(involves: 129 * C57BL/6 * FVB/N)
|
myocardium hypoplasia
|
J:175338
|
Sox15tm1Imad/Sox15tm1Imad
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
abnormal myoblast differentiation
|
J:93031
|
| impaired skeletal muscle regeneration
|
J:93031
|
| increased satellite cell number
|
J:93031
|
Sox17tm1Ysk/Sox17+
(B6.129S1-Sox17tm1Ysk)
|
abnormal gallbladder smooth muscle morphology
|
J:241569
|
Sox17tm2Sjm/Sox17tm2Sjm
Tg(Cdh5-cre/ERT2)1Rha/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal vascular smooth muscle morphology
|
J:234137
|
Sp4tm1Krc/Sp4tm1Krc
(involves: 129S4/SvJae * Black Swiss)
|
abnormal Purkinje fiber morphology
|
J:77375
|
Sp4tm2Krc/Sp4tm2Krc
Tg(Pax3-cre)1Joe/0
(involves: C57BL/6 * SJL)
|
abnormal impulse conducting system morphology
|
J:107057
|
Spaarem1Ppp/Spaarem1Ppp
(C57BL/6J-Spaarem1Ppp)
|
abnormal muscle physiology
|
J:238474
|
| enhanced muscle regeneration
|
J:238474
|
Spegtm1Mkap/Spegtm1Mkap
(either: B6.129S2-Spegtm1Mkap or (involves: 129S2/SvPas * C57BL/6))
|
decreased cardiac muscle contractility
|
J:163968
|
Sphk1tm1Rlp/Sphk1tm1Rlp
Sphk2tm1Rlp/Sphk2tm1Rlp
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal vascular smooth muscle morphology
|
J:103755
|
Spp1tm1Blh/Spp1tm1Blh
(involves: 129S6/SvEvTac * Black Swiss)
|
abnormal vasodilation
|
J:103050
|
Spp1tm1Rit/Spp1tm1Rit
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased cardiac muscle contractility
|
J:95591
|
Sprtntm1Yjm/Sprtntm1Yjm
(involves: 129S/SvEv * C57BL/6)
|
muscle phenotype
|
J:225198
|
Spta1sph/Spta1sph
((WB.C3-Spta1sph x B6.C3-Spta1sph)F1)
|
myocardium necrosis
|
J:44313
|
Sptan1Gt(RRQ171)Byg/Sptan1Gt(RRQ171)Byg
(B6.129P2-Sptan1Gt(RRQ171)Byg)
|
thin myocardium compact layer
|
J:186305
|
Sptbja/Sptbja
((WB.129-Sptbja/J x B6.129-Sptbja/J)F1)
|
abnormal myocardium layer morphology
|
J:44313
|
Sptbn1tm1a(EUCOMM)Wtsi/Sptbn1tm1a(EUCOMM)Wtsi
(involves: C57BL/6N)
|
decreased fetal cardiomyocyte proliferation
|
J:219548
|
| myocardial trabeculae hypoplasia
|
J:219548
|
| thin left ventricle myocardium compact layer
|
J:219548
|
Sptbn1tm1c(EUCOMM)Wtsi/Sptbn1tm1c(EUCOMM)Wtsi
(involves: C57BL/6J * C57BL/6N)
|
decreased fetal cardiomyocyte proliferation
|
J:219548
|
Sptbn1tm1Mish/Sptbn1tm1Mish
(either: (involves: 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * NIH Black Swiss))
|
abnormal myocardial fiber morphology
|
J:81747
|
Sptbn4Gt(ROSABetageo)62Sor/Sptbn4Gt(ROSABetageo)62Sor
(involves: 129S4/SvJaeSor * C57BL/6J)
|
abnormal muscle contractility
|
J:120916,
J:77228
|
Sptbn4Gt(ROSABetageo)62Sor/Sptbn4Gt(ROSABetageo)62Sor
(129S4/SvJaeSor-Spnb4Gt(ROSABetageo)62Sor)
|
abnormal muscle contractility
|
J:77228
|
Sptbn4Gt(ROSABetageo)62Sor/Sptbn4Gt(ROSABetageo)62Sor
(B6.129S4-Sptbn4Gt(ROSABetageo)62Sor/Mmucd)
|
abnormal muscle contractility
|
J:77228
|
Sptbn4qv-7J/Sptbn4qv-7J
(A.B6 Tyr+-Sptbn4qv-7J/J)
|
muscle phenotype
|
J:82238
|
Sptbn4qv-J/Sptbn4qv-J
(C3FeB6 A/Aw-J-Sptbn4qv-J/J)
|
muscle phenotype
|
J:37678
|
Srftm1Rjs/Srftm2.1Nor
Tg(Myh6-cre)2182Mds/0
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * FVB/N)
|
abnormal myocardium layer morphology
|
J:101311
|
| increased cardiomyocyte apoptosis
|
J:101311
|
Srftm1Rmn/Srftm1Rmn
Tg(Tagln-cre)1Jomm/0
(involves: CD-1)
|
abnormal myocardial fiber morphology
|
J:94725
|
| vascular smooth muscle hypotrophy
|
J:94725
|
Srftm1Zli/Srftm1Zli
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: 129 * C57BL/6J * FVB/N)
|
abnormal cardiac muscle relaxation
|
J:135043
|
| abnormal intercalated disk morphology
|
J:135043
|
| abnormal myocardial fiber morphology
|
J:135043
|
| abnormal myocardium layer morphology
|
J:135043
|
| abnormal Z line morphology
|
J:135043
|
| decreased ventricle muscle contractility
|
J:135043
|
| dilated cardiomyopathy
|
J:135043
|
Srftm1Zli/Srftm1Zli
Tg(Myh7-cre)1Zli/0
(involves: 129/Sv * C57BL/6)
|
abnormal myocardial fiber morphology
|
J:91025
|
| disorganized myocardium
|
J:91025
|
| thin myocardium
|
J:91025
|
| trabecula carnea hypoplasia
|
J:91025
|
Srftm2.1Nor/Srftm2.1Nor
Tg(Ckmm-cre)5Khn/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal skeletal muscle fiber morphology
|
J:96122
|
Srftm2.1Nor/Srftm2.1Nor
Tg(Myog-cre)1Eno/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal diaphragm morphology
|
J:96122
|
| abnormal skeletal muscle fiber morphology
|
J:96122
|
| decreased skeletal muscle mass
|
J:96122
|
Srltm1Hta/Srltm1Hta
(B6.129S4-Srltm1Hta)
|
abnormal muscle physiology
|
J:101569
|
Srltm1Hta/Srltm1Hta
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal cardiac muscle relaxation
|
J:96983
|
| abnormal muscle contractility
|
J:96983
|
| abnormal sarcoplasmic reticulum morphology
|
J:96983
|
| decreased cardiac muscle contractility
|
J:96983
|
| impaired skeletal muscle contractility
|
J:96983
|
Srpk3tm1Eno/Y
(either: (involves: 129S6/SvEvTac) or (involves: 129S6/SvEvTac * C57BL/6J))
|
abnormal skeletal muscle morphology
|
J:100494
|
| centrally nucleated skeletal muscle fibers
|
J:100494
|
| decreased skeletal muscle mass
|
J:100494
|
Srpk3tm1Eno/Srpk3tm1Eno
(either: (involves: 129S6/SvEvTac) or (involves: 129S6/SvEvTac * C57BL/6J))
|
abnormal skeletal muscle morphology
|
J:100494
|
| centrally nucleated skeletal muscle fibers
|
J:100494
|
| decreased skeletal muscle mass
|
J:100494
|
Srsf4tm1c(EUCOMM)Wtsi/Srsf4tm1c(EUCOMM)Wtsi
Nkx2-5tm2(cre)Rph/Nkx2-5+
(involves: 129S1/Sv * C57BL/6 * C57BL/6N)
|
heart left ventricle hypertrophy
|
J:344969
|
| increased myocardial fiber size
|
J:344969
|
Srsf5em1Nju/Srsf5em1Nju
(C57BL/6JGpt-Srsf5em1Nju)
|
abnormal trabecula carnea morphology
|
J:311867
|
| abnormal ventricle myocardium morphology
|
J:311867
|
| decreased cardiac muscle contractility
|
J:311867
|
| decreased fetal cardiomyocyte proliferation
|
J:311867
|
| thin ventricle myocardium compact layer
|
J:311867
|
Srsf10tm1Jalm/Srsf10tm1Jalm
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal myocardium layer morphology
|
J:149480
|
| disorganized myocardium
|
J:149480
|
| thin myocardium
|
J:149480
|
Sspntm1Kcam/Sspntm1Kcam
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
muscle phenotype
|
J:60294
|
Sspntm1Kcam/Sspntm1Kcam
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal muscle physiology
|
J:187752
|
| abnormal skeletal muscle fiber type ratio
|
J:187752
|
| increased quadriceps weight
|
J:187752
|
Ssr2tm1b(EUCOMM)Wtsi/Ssr2tm1b(EUCOMM)Wtsi
(C57BL/6N-Ssr2tm1b(EUCOMM)Wtsi/Wtsi)
|
abnormal diaphragm morphology
|
J:239583
|
| abnormal digastric muscle morphology
|
J:239583
|
| abnormal eye muscle morphology
|
J:239583
|
| abnormal infrahyoid muscle connection
|
J:239583
|
| thin myocardium compact layer
|
J:239583
|
Stab1tm1.1Cger/Stab1tm1.1Cger
Stab2tm1.1Cger/Stab2tm1.1Cger
(C.129S2-Stab2tm1.1Cger Stab1tm1.1Cger)
|
dilated cardiomyopathy
|
J:171818
|
Stac3tm1a(KOMP)Wtsi/Stac3tm1a(KOMP)Wtsi
(B6(Cg)-Stac3tm1a(KOMP)Wtsi)
|
abnormal extensor digitorum longus morphology
|
J:200631
|
| abnormal skeletal muscle fiber morphology
|
J:200631
|
| abnormal Z line morphology
|
J:200631
|
| centrally nucleated skeletal muscle fibers
|
J:200631
|
| decreased skeletal muscle fiber number
|
J:200631
|
| increased skeletal muscle fiber diameter
|
J:200631
|
| thin diaphragm muscle
|
J:200631
|
Stac3tm1a(KOMP)Wtsi/Stac3tm1a(KOMP)Wtsi
(involves: C57BL/6N)
|
abnormal diaphragm morphology
|
J:222015
|
| abnormal muscle electrophysiology
|
J:222015
|
| abnormal sarcomere morphology
|
J:222015
|
| abnormal skeletal muscle fiber morphology
|
J:222015
|
| abnormal skeletal muscle morphology
|
J:222015
|
| abnormal tongue muscle morphology
|
J:222015
|
| centrally nucleated skeletal muscle fibers
|
J:222015
|
| decreased skeletal muscle mass
|
J:222015
|
| impaired skeletal muscle contractility
|
J:222015
|
| thin diaphragm muscle
|
J:222015
|
Stag1Gt(P099A04)Wrst/Stag1Gt(P099A04)Wrst
(involves: 129S2/SvPas)
|
abnormal muscle morphology
|
J:184719
|
Stat1tm1Rds/Stat1tm1Rds
(129S6/SvEv-Stat1tm1Rds/Tac)
|
increased cardiomyocyte apoptosis
|
J:120449
|
Stat3tm1Vpo/Stat3+
Tg(Myh6-cre)2182Mds/0
(involves: 129P2/OlaHsd * FVB/N)
|
cardiomyopathy
|
J:141591
|
Stat3tm1Vpo/Stat3tm1Vpo
Tg(Myh6-cre)2182Mds/0
(involves: 129P2/OlaHsd * FVB/N)
|
abnormal myocardial fiber morphology
|
J:141591
|
| cardiomyopathy
|
J:141591
|
| decreased cardiac muscle contractility
|
J:141591
|
| increased cardiomyocyte apoptosis
|
J:141591
|
Stat3tm1Xyfu/Stat3tm1.1Xyfu
Tg(Myh6-cre)2182Mds/0
(involves: 129S1/Sv * FVB/N)
|
decreased cardiac muscle contractility
|
J:86400
|
| increased cardiomyocyte apoptosis
|
J:86400
|
Steap4tm1Dgen/Steap4tm1Dgen
(involves: 129P2/OlaHsd)
|
decreased muscle cell glucose uptake
|
J:187736
|
Stim1tm1.1Pg/Stim1+
(involves: C57BL/6)
|
abnormal muscle physiology
|
J:285187
|
| abnormal skeletal muscle fiber morphology
|
J:285187
|
| abnormal skeletal muscle morphology
|
J:285187
|
| centrally nucleated skeletal muscle fibers
|
J:285187
|
| decreased gastrocnemius weight
|
J:285187
|
| decreased quadriceps weight
|
J:285187
|
| decreased skeletal muscle fiber diameter
|
J:285187
|
| decreased skeletal muscle weight
|
J:285187
|
| increased soleus weight
|
J:285187
|
| increased variability of skeletal muscle fiber size
|
J:285187
|
| myopathy
|
J:285187
|
| skeletal muscle endomysial fibrosis
|
J:285187
|
| skeletal muscle necrosis
|
J:285187
|
Stim1tm3Ics/Stim1+
(involves: C57BL/6N)
|
abnormal muscle physiology
|
J:277842,
J:327797
|
| abnormal muscle weight
|
J:277842
|
| abnormal skeletal muscle fiber mitochondrial morphology
|
J:277842
|
| abnormal skeletal muscle fiber morphology
|
J:277842,
J:327797
|
| abnormal skeletal muscle morphology
|
J:277842
|
| centrally nucleated skeletal muscle fibers
|
J:277842
|
| decreased gastrocnemius weight
|
J:277842
|
| decreased muscle fatigability
|
J:277842
|
| enhanced skeletal muscle regeneration
|
J:327797
|
| impaired muscle relaxation
|
J:277842
|
| increased skeletal muscle cell apoptosis
|
J:327797
|
| increased soleus weight
|
J:277842
|
| muscle weakness
|
J:277842
|
| myositis
|
J:277842
|
| skeletal muscle fibrosis
|
J:277842
|
Stk11tm1.1Arte/Stk11tm1.1Arte
(involves: C57BL/6J)
|
abnormal muscle physiology
|
J:208379
|
Stk11tm1Keis/Stk11tm1Keis
Tg(Ckmm-cre)5Khn/0
(involves: FVB)
|
decreased muscle cell glucose uptake
|
J:98513
|
Stk11tm1Tpm/Stk11tm1Tpm
(Not Specified)
|
abnormal vascular smooth muscle morphology
|
J:70892
|
Stk11tm2.1Tpm/Stk11tm2.1Tpm
(involves: BALB/c * C57BL/6)
|
abnormal vascular smooth muscle morphology
|
J:70892
|
Stk39tm2.1Arte/Stk39tm2.1Arte
(involves: C57BL/6J)
|
decreased vasoconstriction
|
J:224087
|
Stmn1tm1Wed/Stmn1tm1Wed
(involves: 129P2/OlaHsd * C57BL/6)
|
myopathy
|
J:74496
|
Stradaem1Pbcr/Stradaem1Pbcr
(C57BL/6N-Stradaem1Pbcr)
|
hypotonia
|
J:308972
|
Strip2tm1.2Tac/Strip2tm1.2Tac
(Not Specified)
|
decreased cardiac muscle contractility
|
J:306481
|
Strit1em1Eno/Strit1em1Eno
(involves: C57BL/6)
|
impaired muscle relaxation
|
J:229305
|
Stub1tm1Cpat/Stub1tm1Cpat
(involves: 129S/SvEv * C57BL/6)
|
abnormal muscle fiber morphology
|
J:245069
|
| abnormal sarcoplasmic reticulum morphology
|
J:245069
|
| abnormal skeletal muscle fiber type ratio
|
J:245069
|
Sucla2Gt(IST10208H1)Tigm/Sucla2+
(involves: 129S/SvEv * C57BL/6N)
|
decreased myocardial fiber mitochondrial DNA content
|
J:241325
|
SufuGt(XB699)Byg/Sufu+
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
increased rhabdomyosarcoma incidence
|
J:125534
|
Sufutm1Aeb/Sufutm1Aeb
(either: 129S1/Sv-Sufutm1Aeb or (involves: 129S1/Sv * C57BL/6))
|
abnormal myocardium layer morphology
|
J:101731
|
Sulf1tm1.1Cpe/Sulf1tm1.1Cpe
Sulf2tm1.1Cpe/Sulf2tm1.1Cpe
(involves: 129S/SvEv * C57BL/6)
|
impaired smooth muscle contractility
|
J:124898
|
Sult1a1em1(IMPC)Ccpcz/Sult1a1em1(IMPC)Ccpcz
(C57BL/6NCrl-Sult1a1em1(IMPC)Ccpcz/Ccpcz)
|
abnormal skeletal muscle morphology
|
J:211773
|
Sun1tm1Mhan/Sun1+
Sun2tm1Mhan/Sun2tm1Mhan
(involves: 129S6/SvEvTac)
|
abnormal muscle morphology
|
J:150047
|
Sun1tm1Mhan/Sun1tm1Mhan
(involves: 129S6/SvEvTac)
|
abnormal muscle morphology
|
J:150047
|
Sun1tm1Mhan/Sun1tm1Mhan
Sun2tm1Mhan/Sun2+
(involves: 129S6/SvEvTac)
|
abnormal muscle morphology
|
J:150047
|
Sun1tm1Mhan/Sun1tm1Mhan
Sun2tm1Mhan/Sun2tm1Mhan
(involves: 129S6/SvEvTac)
|
abnormal muscle morphology
|
J:150047
|
Supv3l1tm2.1Jkl/Supv3l1tm2.2Jkl
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6 * FVB/N)
|
decreased skeletal muscle mass
|
J:144991
|
| dystrophic muscle
|
J:144991
|
Supv3l1tm2Jkl/Supv3l1tm2Jkl
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased skeletal muscle mass
|
J:144991
|
| dystrophic muscle
|
J:144991
|
Supv3l1tm2Jkl/Supv3l1tm2Jkl
Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
muscular atrophy
|
J:144991
|
Syislem1Bzuo/Syislem1Bzuo
(involves: C57BL/6)
|
abnormal myoblast differentiation
|
J:266240
|
| abnormal myoblast fusion
|
J:266240
|
| abnormal skeletal muscle fiber morphology
|
J:266240
|
| decreased myoblast proliferation
|
J:266240
|
| enhanced muscle regeneration
|
J:266240
|
| increased gastrocnemius weight
|
J:266240
|
| increased quadriceps weight
|
J:266240
|
| increased skeletal muscle fiber number
|
J:266240
|
| increased tibialis anterior weight
|
J:266240
|
Synctm1.1Ked/Synctm1.1Ked
(involves: 129/Sv * C57BL/6)
|
impaired skeletal muscle contractility
|
J:138552
|
| muscle phenotype
|
J:138552
|
Synctm1Chen/Synctm1Chen
(involves: 129X1/SvJ * Black Swiss)
|
abnormal muscle physiology
|
J:136645
|
| muscle phenotype
|
J:136645
|
Syne1tm1.1Chen/Syne1tm1.1Chen
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * Black Swiss)
|
abnormal muscle physiology
|
J:155342
|
| abnormal skeletal muscle fiber morphology
|
J:155342
|
| centrally nucleated skeletal muscle fibers
|
J:155342
|
Syne1tm1.1Mcn/Syne1tm1.1Mcn
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL)
|
dystrophic muscle
|
J:144757
|
Syne1tm1Chen/Syne1tm1Chen
Syne2tm1.1Chen/Syne2tm1.1Chen
Tg(Nkx2-5-cre)9Eno/?
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * Black Swiss)
|
decreased cardiac muscle contractility
|
J:211007
|
| increased cardiomyocyte apoptosis
|
J:211007
|
Syne1tm1Rexu/Syne1tm1Rexu
(involves: 129 * C57BL/6)
|
abnormal muscle fiber morphology
|
J:118671
|
Syne2tm1Rexu/Syne2tm1Rexu
(involves: 129 * C57BL/6)
|
muscle phenotype
|
J:118671
|
Syngr1em1(IMPC)Ccpcz/Syngr1em1(IMPC)Ccpcz
(C57BL/6NCrl-Syngr1em1(IMPC)Ccpcz/Ccpcz)
|
abnormal skeletal muscle morphology
|
J:211773
|
Synmtm1.1(KOMP)Vlcg/Synmtm1.1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
abnormal muscle fiber morphology
|
J:224030
|
| abnormal muscle morphology
|
J:224030
|
| abnormal muscle physiology
|
J:224030
|
| abnormal sarcolemma morphology
|
J:224030
|
| abnormal skeletal muscle morphology
|
J:224030
|
| cardiomyopathy
|
J:257039
|
| decreased skeletal muscle mass
|
J:224030
|
| decreased skeletal muscle size
|
J:224030
|
| decreased ventricle muscle contractility
|
J:257039
|
| heart left ventricle hypertrophy
|
J:257039
|
| increased muscle fatigability
|
J:224030
|
| increased myocardial fiber size
|
J:257039
|
| muscle twitch
|
J:224030
|
| myocardium hypertrophy
|
J:257039
|
| skeletal muscle necrosis
|
J:224030
|
Synmtm1.1Ics/Synmtm1.1Ics
(involves: 129S2/SvPas * C57BL/6 * FVB/N * SJL)
|
abnormal muscle electrophysiology
|
J:268425
|
| abnormal sarcolemma morphology
|
J:268425
|
| abnormal sarcomere morphology
|
J:268425
|
| abnormal skeletal muscle fiber morphology
|
J:268425
|
| abnormal skeletal muscle fiber type ratio
|
J:268425
|
| abnormal skeletal muscle regeneration
|
J:268425
|
| centrally nucleated skeletal muscle fibers
|
J:268425
|
| increased satellite cell number
|
J:268425
|
| increased skeletal muscle fiber diameter
|
J:268425
|
| increased skeletal muscle mass
|
J:268425
|
| myopathy
|
J:268425
|
| skeletal muscle fiber degeneration
|
J:268425
|
Sypl2tm1Hta/Sypl2tm1Hta
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal sarcoplasmic reticulum morphology
|
J:59188
|
| abnormal skeletal muscle fiber morphology
|
J:59188
|
| abnormal skeletal muscle fiber triad morphology
|
J:59188
|
| decreased skeletal muscle fiber size
|
J:59188
|
| impaired skeletal muscle contractility
|
J:59188
|
Syt1tm1a(EUCOMM)Wtsi/Syt1tm1a(EUCOMM)Wtsi
(C57BL/6N-Syt1tm1a(EUCOMM)Wtsi/Wtsi)
|
abnormal infrahyoid muscle connection
|
J:239583
|
Syt7tm1Nan/Syt7tm1Nan
(involves: 129S1/Sv * C57BL/6)
|
abnormal skeletal muscle morphology
|
J:85201
|
| myositis
|
J:85201
|
| skeletal muscle interstitial fibrosis
|
J:85201
|
Taar8bem1(IMPC)Mbp/Taar8bem1(IMPC)Mbp
(C57BL/6N-Taar8bem1(IMPC)Mbp/MbpMmucd)
|
abnormal skeletal muscle morphology
|
J:211773
|
Tab1tm1Geny/Tab1tm1Geny
(involves: C57BL/6 * CBA)
|
abnormal myocardial fiber morphology
|
J:80766
|
| abnormal myocardial trabeculae morphology
|
J:80766
|
| thin myocardium
|
J:80766
|
Taf7ltm1.1Jw/Y
(B6J.Cg-Taf7ltm1.1Jw)
|
abnormal muscle development
|
J:228546
|
| abnormal muscle physiology
|
J:228546
|
Tafazzinem1Xfa/Y
Tg(myl7.L-cre)1118Tmhn/0
(involves: C57BL/6NCrl * MF1)
|
decreased cardiac muscle contractility
|
J:339058
|
| dilated cardiomyopathy
|
J:339058
|
Tafazzinem1Xfa/Tafazzinem1Xfa
Tg(myl7.L-cre)1118Tmhn/0
(involves: C57BL/6NCrl * MF1)
|
decreased cardiac muscle contractility
|
J:339058
|
| dilated cardiomyopathy
|
J:339058
|
Taglntm1Liw/Tagln+
Tbx18tm1.1Mwmy/Tbx18tm1.1Mwmy
(involves: 129 * C57BL/6J)
|
abnormal vascular smooth muscle morphology
|
J:203805
|
Tal1Hpt/Tal1+
(HPT/Le)
|
heart left ventricle hypertrophy
|
J:1780
|
Taok1em1Bcgen/Taok1+
(C57BL/6N-Taok1em1Bcgen)
|
hypotonia
|
J:341142
|
Tarbp2tm1.1Dzw/Tarbp2tm1.1Dzw
Tg(Tnnt2-cre)5Blh/0
(involves: 129 * C57BL/6 * DBA/2J)
|
decreased ventricle muscle contractility
|
J:222613
|
| dilated cardiomyopathy
|
J:222613
|
Tardbpm1H/Tardbp+
(involves: C3H/HeH * C57BL/6J)
|
abnormal muscle tone
|
J:211620
|
| impaired muscle relaxation
|
J:211620
|
Tardbpm1H/Tardbp+
Tg(SOD1*G93A)1Gur/0
(involves: C3H/HeH * C57BL/6 * C57BL/6J * SJL)
|
abnormal muscle tone
|
J:211620
|
| decreased extensor digitorum longus weight
|
J:211620
|
| impaired muscle relaxation
|
J:211620
|
Tardbptm1.1Sobue/Tardbptm1.1Sobue
Tg(SLC18A3-cre)Misa/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * C57BL/6NTac)
|
muscular atrophy
|
J:324570
|
Tardbptm3.1Ckjs/Tardbp+
(involves: C57BL/6J)
|
skeletal muscle atrophy
|
J:285792
|
Tbc1d1Gt(E140H06)Wrst/Tbc1d1Gt(E140H06)Wrst
(B6.129P2-Tbc1d1Gt(E140H06)Wrst)
|
abnormal muscle cell glucose uptake
|
J:203285
|
Tbc1d4tm1.1Arte/Tbc1d4tm1.1Arte
(involves: C57BL/6)
|
decreased muscle cell glucose uptake
|
J:169477
|
| increased muscle cell glucose uptake
|
J:169477
|
Tbc1d4tm1.1Arte/Tbc1d4tm1.1Arte
(Not Specified)
|
muscle phenotype
|
J:186867
|
Tbc1d4tm1.2Arte/Tbc1d4tm1.2Arte
(involves: C57BL/6 * CBA)
|
decreased muscle cell glucose uptake
|
J:194026
|
Tbc1d4tm1Lex/Tbc1d4tm1Lex
(involves: 129S/SvEvBrd * C57BL/6J * C57BL/6N)
|
decreased muscle cell glucose uptake
|
J:191749
|
Tbc1d7em1Hms/Tbc1d7em1Hms
(C57BL/6J-Tbc1d7em1Hms)
|
increased skeletal muscle fiber size
|
J:325096
|
Tbc1d20em1Djsi/Tbc1d20em1Djsi
(involves: C57BL/6 * DBA/2)
|
abnormal eye muscle morphology
|
J:315009
|
Tbc1d25Gt(IST10205D5)Tigm/Y
(involves: C57BL/6N)
|
decreased cardiac muscle contractility
|
J:295960
|
| decreased ventricle muscle contractility
|
J:295960
|
| increased myocardial fiber size
|
J:295960
|
Tbcepmn/Tbcepmn
(NMRI/Pan)
|
muscular atrophy
|
J:30914
|
| progressive muscle weakness
|
J:1717
|
Tbl1xr1tm1.1Arte/Tbl1xr1tm1.1Arte
Tg(Fabp4-cre)1Rev/0
(involves: C57BL/6)
|
increased skeletal muscle triglyceride level
|
J:198124
|
Tbx1tm1Bem/Tbx1tm1Bem
(FVB.Cg-Tbx1tm1Bem)
|
absent masseter muscle
|
J:91664
|
| absent pterygoid muscle
|
J:91664
|
Tbx1tm1Bld/Tbx1+
(involves: 129S7/SvEvBrd * C57BL/6J)
|
increased vascular smooth muscle cell proliferation
|
J:212881
|
| vascular smooth muscle hypoplasia
|
J:212881
|
Tbx1tm1Pa/Tbx1tm1Pa
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal hypoglossal cord morphology
|
J:94411
|
| abnormal laryngeal muscle morphology
|
J:94411
|
| abnormal myogenesis
|
J:94411
|
| abnormal pharyngeal muscle morphology
|
J:150130
|
Tbx1tm2.1Bem/Tbx1tm2.2Bem
Foxg1tm1(cre)Skm/Foxg1+
(involves: 129 * C57BL/6J * SJL * Swiss Webster)
|
absent masseter muscle
|
J:105980
|
| absent pterygoid muscle
|
J:105980
|
Tbx1tm2.2Bem/Tbx1tm2.2Bem
(involves: 129/Sv * C57BL/6J * SJL * Swiss Webster)
|
absent facial muscle
|
J:105980
|
Tbx3tm1.1(cre)Vmc/Tbx3tm1.1(cre)Vmc
(involves: 129P2/OlaHsd * FVB)
|
abnormal sinoatrial node morphology
|
J:121230
|
| decreased sinoatrial node size
|
J:121230
|
Tbx3tm1.1Moon/Tbx3tm2Moon
(involves: 129 * C57BL/6 * SJL)
|
sinoatrial node hypoplasia
|
J:179977
|
Tbx3tm2.1Moon/Tbx3tm2.1Moon
(involves: 129 * BALB/cJ * C57BL/6 * SJL)
|
increased cardiac muscle contractility
|
J:179977
|
| sinoatrial node hypoplasia
|
J:179977
|
Tbx5tm1.1Jse/Tbx5+
(either: (involves: 129/Sv) or (involves: Black Swiss))
|
abnormal atrioventricular bundle morphology
|
J:92050
|
| abnormal impulse conducting system morphology
|
J:92050
|
| abnormal left posterior bundle morphology
|
J:92050
|
| abnormal right bundle morphology
|
J:92050
|
Tbx5tm1Jse/Tbx5tm1Jse
Tg(Prrx1-cre/ERT2)1Mlgn/0
Tg(Scx-GFP)1Stzr/0
(Not Specified)
|
abnormal tendon morphology
|
J:157917
|
Tbx15tm1Akis/Tbx15tm1Akis
(involves: 129P2/OlaHsd * NMRI)
|
decreased skeletal muscle mass
|
J:96466
|
Tbx18tm1.1Mwmy/Tbx18tm1.1Mwmy
(involves: 129 * C57BL/6J)
|
abnormal myocardium compact layer morphology
|
J:203805
|
Tbx20tm1.1Rph/Tbx20+
(involves: C57BL/6)
|
decreased ventricle muscle contractility
|
J:98489
|
| dilated cardiomyopathy
|
J:98489
|
Tbx20tm1.1Rph/Tbx20tm1.1Rph
(involves: C57BL/6)
|
abnormal fetal cardiomyocyte proliferation
|
J:98489
|
Tbx20tm1.1Sev/Tbx20tm1.1Sev
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal fetal cardiomyocyte proliferation
|
J:98516
|
Tbx20tm1Akis/Tbx20tm1Akis
(involves: 129S1/SvImJ * NMRI)
|
abnormal fetal cardiomyocyte proliferation
|
J:98806
|
Tcaf2em1(IMPC)Ccpcz/Tcaf2em1(IMPC)Ccpcz
(C57BL/6NCrl-Tcaf2em1(IMPC)Ccpcz/Ccpcz)
|
abnormal skeletal muscle morphology
|
J:211773
|
Tcaptm1Mkc/Tcaptm1Mkc
(involves: 129 * C57BL/6)
|
abnormal muscle physiology
|
J:159687
|
| centrally nucleated skeletal muscle fibers
|
J:159687
|
| decreased skeletal muscle fiber diameter
|
J:159687
|
| muscle phenotype
|
J:159687
|
| myopathy
|
J:159687
|
| skeletal muscle fiber atrophy
|
J:159687
|
Tcaptm1Rnk/Tcaptm1Rnk
(Not Specified)
|
abnormal sarcomere morphology
|
J:188832
|
| increased cardiomyocyte apoptosis
|
J:188832
|
Tcf7l2tm1a(EUCOMM)Wtsi/Tcf7l2tm1a(EUCOMM)Wtsi
(C57BL/6N-Tcf7l2tm1a(EUCOMM)Wtsi/Wtsi)
|
abnormal eye muscle morphology
|
J:239583
|
Tcf7l2tm3.1(cre/ERT2)Mrc/Tcf7l2+
Gt(ROSA)26Sortm1(DTA)Mrc/Gt(ROSA)26Sor+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal muscle morphology
|
J:174914
|
| abnormal muscle regeneration
|
J:174914
|
| decreased satellite cell number
|
J:174914
|
Tcf15tm1Eno/Tcf15tm1Eno
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal intercostal muscle morphology
|
J:37117
|
| abnormal skeletal muscle morphology
|
J:37117
|
| absent myotome
|
J:37117
|
| skeletal muscle hypertrophy
|
J:37117
|
Tcf21tm2Eno/Tcf21tm2Eno
(involves: 129 * C57BL/6)
|
thin myocardium
|
J:185552
|
Tcratm1Mom/Tcratm1Mom
Trex1tm1Tld/Trex1tm1Tld
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
myositis
|
J:181257
|
Tdgtm1.1Abc/Tdgtm1.1Abc
(B6.129-Tdgtm1.1Abc)
|
myocardium hypoplasia
|
J:174772
|
| thin myocardium
|
J:174772
|
Tead1Gt(ROSA5)Sor/Tead1Gt(ROSA5)Sor
(Not Specified)
|
trabecula carnea hypoplasia
|
J:20882
|
Tead1tm1Hssk/Tead1tm1Hssk
(either: (involves: C57BL/6 * CBA) or (involves: C57BL/6 * CBA * CD-1))
|
abnormal myocardial trabeculae morphology
|
J:131426
|
Tefmtm1.1Lrsn/Tefmtm1.1Lrsn
Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6N * FVB)
|
abnormal myocardial fiber morphology
|
J:276874
|
Tektm1Ber/Tektm1Ber
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
absent myocardial trabeculae
|
J:99096
|
Tektm1Dmt/Tektm1Dmt
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
absent myocardial trabeculae
|
J:99096
|
Tektm1Dmt/Tektm1Dmt
Tie1tm1Jpa/Tie1tm1Jpa
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
abnormal myocardial trabeculae morphology
|
J:54983
|
Tektm1Sato/Tektm1Sato
(involves: 129S1/Sv * C57BL/6J)
|
absent trabeculae carneae
|
J:79305
|
Terctm1Rdp/Terctm1Rdp
(involves: 129/Sv * C57BL/6J * SJL)
|
abnormal cardiac muscle contractility
|
J:110900
|
| abnormal cardiac muscle relaxation
|
J:110900
|
| abnormal fetal cardiomyocyte proliferation
|
J:110900
|
| abnormal myocardial fiber morphology
|
J:110900
|
| decreased myocardial fiber number
|
J:110900
|
| dilated cardiomyopathy
|
J:110900
|
| heart left ventricle hypertrophy
|
J:110900
|
| increased cardiomyocyte apoptosis
|
J:110900
|
Tfamtm1Lrsn/Tfamtm1Lrsn
Tg(Ckmm-cre)1Lrsn/0
(involves: 129S1/Sv * 129X1/SvJ)
|
dilated cardiomyopathy
|
J:51964
|
| increased cardiomyocyte apoptosis
|
J:125471
|
Tfap2bem1Fenli/Tfap2bem1Fenli
(involves: C57BL/6)
|
abnormal vascular smooth muscle physiology
|
J:278067
|
Tfap2btm1Rbu/Tfap2btm1Rbu
(129P2.129-Tfap2btm1Rbu)
|
muscle spasm
|
J:83000
|
Tfb1mtm1.1Lrsn/Tfb1mtm1.1Lrsn
Tg(Ckmm-cre)5Khn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB * SJL)
|
abnormal myocardial fiber morphology
|
J:148166
|
Tg(ACTA1*D286G)#Kjno/Tg(ACTA1*D286G)#Kjno
(involves: C57BL/6 * CBA)
|
abnormal sarcomere morphology
|
J:209273
|
| abnormal skeletal muscle morphology
|
J:209273
|
| abnormal Z line morphology
|
J:209273
|
| impaired skeletal muscle contractility
|
J:209273
|
| muscle weakness
|
J:209273
|
Tg(ACTA1*D286G/EGFP)#Kjno/0
(involves: C57BL/6J * CBA/Ca)
|
abnormal skeletal muscle morphology
|
J:182255
|
| abnormal Z line morphology
|
J:182255
|
| impaired skeletal muscle contractility
|
J:182255
|
| muscle weakness
|
J:182255
|
Tg(ACTA1-Ar)78Kyjo/0
(Not Specified)
|
abnormal skeletal muscle fiber morphology
|
J:127205
|
Tg(ACTA1-Ar)141Kyjo/0
(Not Specified)
|
abnormal skeletal muscle fiber morphology
|
J:127205
|
| decreased skeletal muscle fiber number
|
J:127205
|
| increased skeletal muscle fiber size
|
J:127205
|
| muscle weakness
|
J:127205
|
| muscular atrophy
|
J:127205
|
Tg(ACTA1-Capn3)7.2Spc/0
(involves: BALB/c * C57BL/6J)
|
centrally nucleated skeletal muscle fibers
|
J:77348
|
| muscle phenotype
|
J:77348
|
Tg(ACTA1-Capn3*)10.3Spc/0
(involves: BALB/c * C57BL/6J)
|
centrally nucleated skeletal muscle fibers
|
J:77348
|
Tg(ACTA1-Capn3*)27.10Spc/0
(involves: BALB/c * C57BL/6J)
|
centrally nucleated skeletal muscle fibers
|
J:77348
|
| decreased skeletal muscle mass
|
J:77348
|
Tg(ACTA1-Capn3*)37.3Spc/0
(involves: BALB/c * C57BL/6J)
|
centrally nucleated skeletal muscle fibers
|
J:77348
|
| decreased skeletal muscle mass
|
J:77348
|
Tg(ACTA1-Capn3*)37.9Spc/0
(involves: BALB/c * C57BL/6J)
|
centrally nucleated skeletal muscle fibers
|
J:77348
|
| decreased skeletal muscle mass
|
J:77348
|
Tg(ACTA1-Capn3*)39.1Spc/0
(involves: BALB/c * C57BL/6J)
|
centrally nucleated skeletal muscle fibers
|
J:77348
|
| decreased skeletal muscle mass
|
J:77348
|
Tg(ACTA1-Capn3*)41.1Spc/0
(involves: BALB/c * C57BL/6J)
|
centrally nucleated skeletal muscle fibers
|
J:77348
|
| decreased skeletal muscle mass
|
J:77348
|
Tg(ACTA1-Capn3*)42Spc/0
(involves: BALB/c * C57BL/6J)
|
centrally nucleated skeletal muscle fibers
|
J:77348
|
| decreased skeletal muscle mass
|
J:77348
|
Tg(ACTA1-cre/ERT2)97.16Mtz/0
Tg(CAG-DMPK*)1323Coop/0
(involves: FVB)
|
abnormal skeletal muscle fiber morphology
|
J:132154
|
| decreased skeletal muscle size
|
J:132154
|
| impaired muscle relaxation
|
J:132154
|
| skeletal muscle degeneration
|
J:132154
|
| skeletal muscle fibrosis
|
J:132154
|
Tg(ACTA1-Ctss)1Jmol/?
(FVB/N-Tg(ACTA1-Ctss)1Jmol)
|
centrally nucleated skeletal muscle fibers
|
J:230788
|
| dystrophic muscle
|
J:230788
|
| skeletal muscle fibrosis
|
J:230788
|
Tg(ACTA1-FRG1)highRotu/0
(C57BL/6-Tg(ACTA1-FRG1)highRotu)
|
abnormal skeletal muscle fiber morphology
|
J:106896
|
| centrally nucleated skeletal muscle fibers
|
J:106896
|
| decreased skeletal muscle mass
|
J:106896
|
| dystrophic muscle
|
J:106896
|
Tg(ACTA1-FRG1)lowRotu/0
(C57BL/6-Tg(ACTA1-FRG1)lowRotu)
|
muscle phenotype
|
J:106896
|
Tg(ACTA1-FRG1)medRotu/0
(C57BL/6-Tg(ACTA1-FRG1)medRotu)
|
abnormal skeletal muscle fiber morphology
|
J:106896
|
| centrally nucleated skeletal muscle fibers
|
J:106896
|
| decreased skeletal muscle mass
|
J:106896
|
| dystrophic muscle
|
J:106896
|
Tg(ACTA1-IGF1)1Rjs/0
(involves: FVB)
|
abnormal cardiac muscle contractility
|
J:58354
|
| abnormal myocardial fiber morphology
|
J:58354
|
| increased skeletal muscle fiber size
|
J:25522
|
Tg(ACTA1-Il15*)11650Lsq/0
(involves: C3H * C57BL/6)
|
decreased extensor digitorum longus weight
|
J:145611
|
Tg(ACTA1-MYOT)12Mah/?
(involves: C57BL/6 * SJL)
|
abnormal sarcolemma morphology
|
J:110377
|
| abnormal skeletal muscle morphology
|
J:110377
|
Tg(ACTA1-MYOT*T57I)71Mah/?
(involves: C57BL/6 * SJL)
|
abnormal skeletal muscle fiber morphology
|
J:110377
|
| abnormal skeletal muscle morphology
|
J:110377
|
| diffuse Z line
|
J:110377
|
| dystrophic muscle
|
J:110377
|
| impaired skeletal muscle contractility
|
J:110377
|
| muscle weakness
|
J:110377
|
| skeletal muscle interstitial fibrosis
|
J:110377
|
Tg(ACTA1-PABPN1*A17)1Drub/0
(involves: FVB/N)
|
abnormal skeletal muscle fiber morphology
|
J:115642
|
| centrally nucleated skeletal muscle fibers
|
J:115642
|
| muscle weakness
|
J:115642
|
| progressive muscle weakness
|
J:115642
|
Tg(Acta1-Slmap)#Eno/0
(Not Specified)
|
decreased skeletal muscle fiber size
|
J:247651
|
X/Tg(ACTA1-STIM1)2Jmol
(involves: FVB/N)
|
centrally nucleated skeletal muscle fibers
|
J:101977
|
| skeletal muscle interstitial fibrosis
|
J:101977
|
Tg(ACTA1-STIM1)4Jmol/?
(involves: FVB/N)
|
centrally nucleated skeletal muscle fibers
|
J:101977
|
| skeletal muscle interstitial fibrosis
|
J:101977
|
Tg(ACTA1-TPM3*M9R)4Hrd/0
(FVB/NJ-Tg(ACTA1-TPM3*M9R)4Hrd)
|
abnormal muscle physiology
|
J:67596
|
| abnormal skeletal muscle fiber morphology
|
J:67596
|
| abnormal skeletal muscle morphology
|
J:67596
|
| increased skeletal muscle fiber size
|
J:67596
|
| muscle weakness
|
J:67596
|
| myopathy
|
J:67596
|
Tg(ACTB-EGFP,-Kcnj8*)1Wco/0
Tg(Myh6-cre)2182Mds/0
(involves: FVB/N)
|
abnormal myocardial fiber morphology
|
J:134852
|
Tg(ACTB-EGFP,-Kcnj8*G343D)9Nich/0
Tg(Myh11-icre/ERT2)1Soff/0
(involves: C57BL/6 * CBA * FVB/N)
|
abnormal vascular smooth muscle physiology
|
J:202037
|
| decreased vasoconstriction
|
J:202037
|
Tg(ACTB-SOD2)66Ysh/0
(involves: C3H * C57BL/6)
|
increased cardiac muscle contractility
|
J:127776
|
| myocardium necrosis
|
J:89952
|
Tg(ACTB-Twnk*)DSuom/0
(involves: FVB/N)
|
abnormal muscle fiber morphology
|
J:104378
|
| muscle phenotype
|
J:104378
|
Tg(ACTB-Twnk*A360T)HSuom/0
(involves: FVB/N)
|
abnormal muscle fiber morphology
|
J:104378
|
| muscle phenotype
|
J:104378
|
Tg(AGT)2-5Afu/0
(involves: C57BL/6)
|
decreased cardiac muscle contractility
|
J:194606
|
| myocardium hypertrophy
|
J:130455
|
Tg(ANX6)2Agh/0
(FVB/N-Tg(ANX6)2Agh)
|
cardiomyopathy
|
J:92579
|
| decreased cardiac muscle contractility
|
J:92579
|
| heart right ventricle hypertrophy
|
J:92579
|
| myocardium necrosis
|
J:92579
|
Tg(aP2-SREBF1c)9884Reh/0
(involves: C57BL/6J * SJL)
|
abnormal muscle morphology
|
J:249664
|
| abnormal skeletal muscle morphology
|
J:249664
|
Tg(APCS-Ifng)5Imeg/0
(involves: C57BL/6 * DBA/2)
|
abnormal myocardial fiber morphology
|
J:135124
|
| cardiac muscle atrophy
|
J:135124
|
| cardiac muscle degeneration
|
J:135124
|
| decreased cardiac muscle contractility
|
J:135124
|
| dilated cardiomyopathy
|
J:135124
|
Tg(AR*100Q)C25Als/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal muscle morphology
|
J:89772
|
| muscle weakness
|
J:89772
|
| skeletal muscle atrophy
|
J:89772
|
Tg(AR*100Q)C32Als/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
skeletal muscle atrophy
|
J:89772
|
Tg(C9orf72)500Lpwr/0
(FVB/NJ-Tg(C9orf72)500Lpwr)
|
abnormal muscle morphology
|
J:239579
|
| skeletal muscle atrophy
|
J:239579
|
Tg(CAG-APPL1)#Ymli/0
(involves: C57BL/6 * CBA)
|
abnormal vasodilation
|
J:189487
|
| decreased vasoconstriction
|
J:189487
|
| increased muscle cell glucose uptake
|
J:230004
|
| increased vasodilation
|
J:189487
|
Tg(CAG-AR*97Q)7-8Sobue/?
(involves: C57BL/6 * C57BL/6J * DBA/2)
|
dystrophic muscle
|
J:128619
|
| muscular atrophy
|
J:121559
|
Tg(CAG-AR*97Q)7-8Sobue/?
Tg(CAG-STUB1)1Sobue/Tg(CAG-STUB1)1Sobue
(involves: C57BL/6 * C57BL/6J * DBA/2)
|
muscular atrophy
|
J:121559
|
Tg(CAG-Btc)2Ewo/0
(FVB/N-Tg(CAG-Btc)2Ewo)
|
heart left ventricle hypertrophy
|
J:103364
|
| heart right ventricle hypertrophy
|
J:103364
|
Tg(CAG-Btc)4Ewo/0
(FVB/N-Tg(CAG-Btc)4Ewo)
|
heart left ventricle hypertrophy
|
J:103364
|
| heart right ventricle hypertrophy
|
J:103364
|
Tg(CAG-Calr)#Mlk/0
Tg(Myh6-cre/Esr1*)1Liao/0
(involves: C57BL/6)
|
decreased cardiac muscle contractility
|
J:199413
|
| dilated cardiomyopathy
|
J:199413
|
Tg(CAG-cat,-Ptpn11*Q97R)1Rbns/0
Tg(Tek-cre)12Flv/0
(involves: C3H * C57BL/6 * FVB/N)
|
ventricular cardiomyopathy
|
J:142212
|
Tg(CAG-cat,-TBX3)1Vmc/0
Tg(Myh6-cre)2182Mds/0
(involves: FVB/N)
|
myocardium hypoplasia
|
J:181526
|
| ventricle myocardium hypoplasia
|
J:181526
|
Tg(CAG-COL4A3BP)#Jsau/0
(B6.Cg-Tg(CAG-COL4A3BP)#Jsau)
|
abnormal muscle development
|
J:177789
|
Tg(CAG-cre/Esr1*)5Amc/0
Tg(CAG-LacZ,-ACVR1*,-EGFP)35-1Mis/0
(involves: C57BL/6 * CBA * DBA/2)
|
muscle phenotype
|
J:142253
|
Tg(CAG-dsRed2/RNAi:Tardbp)6Zxu/0
(involves: C57BL/6 * C57BL/6J * FVB/NJ * SJL)
|
abnormal muscle morphology
|
J:207750
|
| muscle degeneration
|
J:207750
|
| progressive muscle weakness
|
J:207750
|
| skeletal muscle fiber necrosis
|
J:207750
|
Tg(CAG-EPM2A*C266S)1Bmin/0
(involves: 129 * C57BL/6 * SJL)
|
increased skeletal muscle glycogen level
|
J:120356
|
Tg(CAG-GLVP)#Cath/0
Tg(GAL4-PABPN1*A16)#Cath/0
(involves: C57BL/6 * FVB)
|
abnormal muscle fiber morphology
|
J:178541
|
| dilated cardiomyopathy
|
J:178541
|
| increased variability of skeletal muscle fiber size
|
J:178541
|
| myopathy
|
J:178541
|
| skeletal muscle fiber atrophy
|
J:178541
|
Tg(CAG-LacZ,-ACVR1*,-EGFP)35-1Mis/0
(involves: C57BL/6 * DBA/2)
|
myositis
|
J:142253
|
Tg(CAG-LacZ,-ACVR1*,-EGFP)35-1Mis/0
Tg(KRT14-cre)1Amc/0
(involves: C57BL/6 * CBA * DBA/2)
|
abnormal soft palate muscle morphology
|
J:233662
|
| abnormal tensor veli palatini muscle morphology
|
J:233662
|
Tg(CAG-lacZ,-SV40)#Bcv/0
(involves: FVB/N)
|
abnormal diaphragm morphology
|
J:158388
|
Tg(CAG-LARGE)126Fmu/0
(involves: C57BL/10 * CBA/Ca)
|
abnormal muscle physiology
|
J:168339
|
Tg(CAG-Large)#Kcam/0
(B6J.B6NTac-Tg(CAG-Large)#Kcam)
|
decreased skeletal muscle fiber diameter
|
J:206057
|
Tg(CAG-Map3k7*K63W)1232Mds/0
Tg(Myh6-cre)2182Mds/0
(involves: FVB/N)
|
abnormal myocardial fiber morphology
|
J:117108
|
| abnormal ventricle papillary muscle morphology
|
J:117108
|
| cardiomyopathy
|
J:117108
|
| increased cardiac muscle glycogen level
|
J:117108
|
Tg(CAG-Ncoa6)71Hwl/0
(involves: FVB)
|
dilated cardiomyopathy
|
J:269856
|
Tg(CAG-Ncoa6)84Hwl/0
(involves: FVB)
|
dilated cardiomyopathy
|
J:269856
|
Tg(CAG-Ncoa6)87Hwl/0
(involves: FVB)
|
decreased cardiac muscle contractility
|
J:269856
|
| dilated cardiomyopathy
|
J:269856
|
Tg(CAG-Ncoa6)104Hwl/0
(involves: FVB)
|
dilated cardiomyopathy
|
J:269856
|
Tg(CAG-NRIP1)51Row/0
(involves: FVB/N)
|
abnormal myocardial fiber mitochondrial morphology
|
J:175885
|
| abnormal myocardial fiber morphology
|
J:175885
|
| cardiomyopathy
|
J:175885
|
| decreased cardiac muscle contractility
|
J:175885
|
| myocardial fiber disarray
|
J:175885
|
Tg(CAG-OTC/CAT)#Wcl/0
(involves: C3H * C57BL/6)
|
abnormal muscle physiology
|
J:176731
|
Tg(CAG-rtTA)72Wiek/0
Tg(tetO-Rnf5)1Zron/0
(involves: C3H * C57BL/6 * DBA/2)
|
abnormal skeletal muscle fiber morphology
|
J:132185
|
| centrally nucleated skeletal muscle fibers
|
J:132185
|
| decreased skeletal muscle weight
|
J:132185
|
| increased variability of skeletal muscle fiber size
|
J:132185
|
| muscle degeneration
|
J:132185
|
Tg(CAG-STUB1)1Sobue/?
(involves: C57BL/6 * DBA/2)
|
muscle phenotype
|
J:121559
|
Tg(CAG-STUB1)1Sobue/Tg(CAG-STUB1)1Sobue
(involves: C57BL/6 * DBA/2)
|
muscle phenotype
|
J:121559
|
Tg(CAG-VCP*A232E)93Jpat/0
(involves: C57BL/6 * SJL)
|
abnormal sarcomere morphology
|
J:158713
|
| abnormal skeletal muscle fiber morphology
|
J:158713
|
| myopathy
|
J:158713
|
| progressive muscle weakness
|
J:158713
|
| skeletal muscle degeneration
|
J:158713
|
Tg(CAG-VCP*R155H)55Jpat/0
(involves: C57BL/6 * SJL)
|
abnormal sarcomere morphology
|
J:158713
|
| abnormal skeletal muscle fiber morphology
|
J:158713
|
| myopathy
|
J:158713
|
| progressive muscle weakness
|
J:158713
|
| skeletal muscle degeneration
|
J:158713
|
Tg(CAMalpha1b)7Wjk/?
(Not Specified)
|
abnormal myocardium layer morphology
|
J:82721
|
| decreased ventricle muscle contractility
|
J:134704
|
| dilated cardiomyopathy
|
J:134704
|
| heart right ventricle hypertrophy
|
J:82721
|
| myocardial fiber disarray
|
J:134704
|
Tg(Camk2a-tTA)1Mmay/0
Fgf14Tg(tetO-MAPT*P301L)4510Kha/Fgf14+
(involves: FVB/N)
|
dystonia
|
J:102973
|
Tg(Camk2a-tTA)1Mmay/0
Tg(tetO-HTT*94Q,-lacZ)1Rhn/0
(involves: C57BL/6 * CBA)
|
dystonia
|
J:61490
|
Tg(CD2-Ifngr2)2Pbro/?
(NOD.Cg-Tg(CD2-Ifngr2)2Pbro)
|
myositis
|
J:81981
|
Tg(Ckm*-Mstn)1Nfg/?
(involves: BALB/c * C57BL/6)
|
decreased skeletal muscle mass
|
J:123052
|
Tg(Ckm-APPSw)A2Lfa/0
(involves: C57BL/6 * SJL)
|
centrally nucleated skeletal muscle fibers
|
J:76338
|
| myositis
|
J:76338
|
Tg(Ckm-APPSw)A6Lfa/0
(involves: C57BL/6 * SJL)
|
centrally nucleated skeletal muscle fibers
|
J:76338
|
| myositis
|
J:76338
|
Tg(Ckm-Cd36)1Naa/0
(involves: FVB)
|
abnormal muscle physiology
|
J:57650
|
Tg(Ckm-Chrnd*S262T)40Cgz/0
(involves: C57BL/6 * DBA/2)
|
muscle phenotype
|
J:31221
|
Tg(Ckm-Chrne*L269F)5Cgz/?
(involves: FVB/NJ)
|
abnormal skeletal muscle fiber morphology
|
J:193524
|
| muscle weakness
|
J:193524
|
| skeletal muscle fiber degeneration
|
J:193524
|
Tg(Ckm-CUGBP1)1039Coop/0
(FVB-Tg(Ckm-CUGBP1)1039Coop)
|
abnormal skeletal muscle fiber morphology
|
J:99370
|
| skeletal muscle fiber degeneration
|
J:99370
|
Tg(Ckm-DGAT2)10Far/0
(involves: C57BL/6NHsd)
|
increased skeletal muscle triglyceride level
|
J:129495
|
Tg(Ckm-DNAJB6_ib*F93L)#Ccwe/0
(B6.Cg-Tg(Ckm-DNAJB6_ib*F93L)#Ccwe)
|
abnormal muscle fiber morphology
|
J:226488
|
| abnormal Z line morphology
|
J:226488
|
| myopathy
|
J:226488
|
| progressive muscle weakness
|
J:226488
|
Tg(Ckm-Fstl1)#Mvdh/0
(involves: C57BL/6)
|
decreased cardiac muscle contractility
|
J:177416
|
| increased myocardial fiber size
|
J:177416
|
Tg(Ckm-GSN*D187N)AJewe/0
(C57BL/6J-Tg(Ckm-GSN*D187N)AJewe)
|
centrally nucleated skeletal muscle fibers
|
J:150825
|
| increased variability of skeletal muscle fiber size
|
J:150825
|
| muscle degeneration
|
J:150825
|
| progressive muscle weakness
|
J:150825
|
| skeletal muscle fiber atrophy
|
J:150825
|
Tg(Ckm-GSN*D187N)AJewe/Tg(Ckm-GSN*D187N)AJewe
(C57BL/6J-Tg(Ckm-GSN*D187N)AJewe)
|
abnormal skeletal muscle fiber morphology
|
J:150825
|
| muscular atrophy
|
J:150825
|
| skeletal muscle fiber atrophy
|
J:150825
|
Tg(Ckm-IGF1R*K1003R)1Dlr/0
(FVB/N-Tg(Ckm-IGF1R*K1003R)1Dlr)
|
decreased muscle cell glucose uptake
|
J:71205
|
Tg(Ckm-LPL)HRze/0
(involves: C57BL/6J * CBA/J)
|
abnormal muscle fiber morphology
|
J:101818
|
| abnormal myocardial fiber morphology
|
J:101818
|
| abnormal skeletal muscle morphology
|
J:101818
|
| decreased skeletal muscle mass
|
J:101818
|
| increased muscle free fatty acids level
|
J:101818
|
| increased skeletal muscle glycogen level
|
J:101818
|
| myopathy
|
J:101818
|
Tg(Ckm-LPL)LRze/0
(involves: C57BL/6J * CBA/J)
|
abnormal skeletal muscle morphology
|
J:101818
|
Tg(Ckm-LPL)MRze/0
(involves: C57BL/6J * CBA/J)
|
abnormal muscle fiber morphology
|
J:101818
|
| abnormal myocardial fiber morphology
|
J:101818
|
| abnormal skeletal muscle morphology
|
J:101818
|
| increased muscle free fatty acids level
|
J:101818
|
| increased skeletal muscle glycogen level
|
J:101818
|
| myopathy
|
J:101818
|
Tg(Ckm-Mir499)#Eno/0
(Not Specified)
|
abnormal skeletal muscle fiber type ratio
|
J:155756
|
Tg(Ckm-Mkl1)1Eno/0
(Not Specified)
|
decreased skeletal muscle mass
|
J:96122
|
| myopathy
|
J:96122
|
Tg(Ckm-Mstn)1Nfg/?
(involves: BALB/c * C57BL/6)
|
abnormal myocardium layer morphology
|
J:123052
|
| abnormal skeletal muscle fiber morphology
|
J:123052
|
| decreased skeletal muscle fiber size
|
J:123052
|
| decreased skeletal muscle mass
|
J:123052
|
Tg(Ckm-Pnpla2)164Eek/0
(involves: FVB/N)
|
decreased skeletal muscle triglyceride level
|
J:207007
|
Tg(Ckm-Ppara)HEDpk/0
(involves: C57BL/6 * CBA)
|
decreased muscle cell glucose uptake
|
J:129848
|
| increased skeletal muscle triglyceride level
|
J:129848
|
Tg(Ckm-Ppard)MEDpk/0
(involves: C57BL/6 * CBA)
|
abnormal muscle cell glucose uptake
|
J:129848
|
Tg(Ckm-Ppargc1a)31Brsp/0
(C57BL/6-Tg(Ckm-Ppargc1a)31Brsp)
|
abnormal muscle physiology
|
J:78333
|
| abnormal skeletal muscle morphology
|
J:78333
|
Tg(Ckm-Ppargc1b)T37Brsp/0
(FVB-Tg(Ckm-Ppargc1b)T37Brsp)
|
abnormal muscle physiology
|
J:118258
|
| abnormal skeletal muscle fiber type ratio
|
J:118258
|
| abnormal skeletal muscle morphology
|
J:118258
|
| decreased skeletal muscle fiber size
|
J:118258
|
| skeletal muscle hypoplasia
|
J:118258
|
Tg(Ckm-Prkaa2*K45R)1Mbb/0
(involves: C57BL/6J * SJL/J)
|
abnormal muscle physiology
|
J:110092
|
| abnormal myocardial fiber morphology
|
J:91969
|
| decreased ventricle muscle contractility
|
J:91969
|
Tg(Ckm-PTPN1)45Bbk/0
(involves: FVB)
|
decreased muscle cell glucose uptake
|
J:122895
|
Tg(Ckm-PTPN1)45Bbk/?
Tg(Ckm-PTPRF)13Bbk/?
(involves: FVB)
|
decreased muscle cell glucose uptake
|
J:122895
|
Tg(Ckm-PTPRF)13Bbk/0
(involves: FVB)
|
decreased muscle cell glucose uptake
|
J:122895
|
Tg(Ckm-Sgcg)4Mcn/0
(involves: C57BL/6 * DBA/2)
|
abnormal skeletal muscle morphology
|
J:128649
|
| centrally nucleated skeletal muscle fibers
|
J:128649
|
| decreased skeletal muscle mass
|
J:128649
|
| dystrophic muscle
|
J:128649
|
| increased variability of skeletal muscle fiber size
|
J:128649
|
Tg(Ckm-Sox6)#Eno/0
(Not Specified)
|
abnormal skeletal muscle fiber type ratio
|
J:155756
|
Tg(Ckmm-Cav3)1Ysu/0
(involves: C57BL/Slc * DBA/Slc)
|
abnormal muscle physiology
|
J:67174
|
| abnormal myocardial fiber morphology
|
J:87692
|
| centrally nucleated skeletal muscle fibers
|
J:67174
|
| increased myocardial fiber size
|
J:87692
|
| increased variability of skeletal muscle fiber size
|
J:67174
|
| increased ventricle muscle contractility
|
J:87692
|
| myopathy
|
J:67174
|
| skeletal muscle atrophy
|
J:67174
|
| skeletal muscle fiber degeneration
|
J:67174
|
Tg(CKMM-tTA)A3Rhvh/0
Tg(tetO-H2-K1)#Papl/0
(B6.Cg-Tg(CKMM-tTA)A3Rhvh Tg(tetO-H2-K1)#Papl)
|
abnormal skeletal muscle morphology
|
J:205907
|
| muscle weakness
|
J:205907
|
| myositis
|
J:205907
|
| skeletal muscle fiber atrophy
|
J:205907
|
| skeletal muscle fiber degeneration
|
J:205907
|
Tg(CKMM-tTA)A3Rhvh/0
Tg(tetO-Hgf,-EGFP)24Tcre/0
(involves: FVB)
|
abnormal skeletal muscle fiber morphology
|
J:237183
|
| decreased skeletal muscle fiber size
|
J:237183
|
| increased satellite cell number
|
J:237183
|
Tg(Ckmm-Ucp1)1Boud/0
(involves: C57BL/6J * DBA/2J)
|
abnormal skeletal muscle fiber type ratio
|
J:80053
|
| abnormal skeletal muscle morphology
|
J:80053
|
| decreased gastrocnemius weight
|
J:80053
|
| decreased skeletal muscle fiber diameter
|
J:80053
|
| decreased skeletal muscle mass
|
J:80053
|
| decreased skeletal muscle weight
|
J:80053
|
Tg(Ckmm-Ucp1)1Boud/Tg(Ckmm-Ucp1)1Boud
(involves: C57BL/6J * DBA/2J)
|
abnormal skeletal muscle fiber type ratio
|
J:80053
|
| abnormal skeletal muscle morphology
|
J:80053
|
| decreased gastrocnemius weight
|
J:80053
|
| decreased skeletal muscle fiber diameter
|
J:80053
|
| decreased skeletal muscle mass
|
J:80053
|
| decreased skeletal muscle weight
|
J:80053
|
Tg(CMV-Abcc9)1Ajo/?
(either: (involves: BALB/c * CBA) or (involves: BALB/c * C57BL/6J * CBA))
|
abnormal sarcolemma morphology
|
J:111456
|
Tg(CMV-APPL2)1Smoc/0
(Not Specified)
|
decreased muscle cell glucose uptake
|
J:230004
|
Tg(CMV-ATXN3*135Q)CPama/0
(C57BL/6-Tg(CMV-ATXN3*135Q)CPama)
|
abnormal muscle tone
|
J:222991
|
Tg(CMV-cat,-ROCK2*)3-1Koba/0
Tg(Tagln-cre)1Her/0
(involves: C57BL/6 * C57BL/6JJcl * DBA/2 * SJL)
|
abnormal fetal cardiomyocyte proliferation
|
J:242116
|
| abnormal intercalated disk morphology
|
J:242116
|
| decreased cardiac muscle contractility
|
J:242116
|
| disorganized myocardium
|
J:242116
|
| myocardium steatosis
|
J:242116
|
| ventricular cardiomyopathy
|
J:242116
|
Tg(CMV-Gja1)BClo/Tg(CMV-Gja1)BClo
(involves: SJL/J * SWR/J)
|
abnormal myocardial trabeculae morphology
|
J:40388
|
| abnormal myocardium layer morphology
|
J:40388
|
| thin right ventricle myocardium compact layer
|
J:40388
|
Tg(CMV-IghvaD11)CCat/0
Tg(CMV-IgkvaD11)BCat/0
(involves: C57BL/6 * SJL)
|
abnormal skeletal muscle fiber morphology
|
J:79946
|
| decreased skeletal muscle fiber diameter
|
J:79946
|
| decreased skeletal muscle mass
|
J:79946
|
Tg(CMV-IghvaD11)DCat/0
Tg(CMV-IgkvaD11)ACat/0
(involves: C57BL/6 * SJL)
|
abnormal skeletal muscle fiber morphology
|
J:79946
|
| decreased skeletal muscle fiber diameter
|
J:79946
|
| decreased skeletal muscle mass
|
J:79946
|
Tg(Cnp-EGFR)10Nrat/0
(involves: C57BL/6 * SJL)
|
increased rhabdomyosarcoma incidence
|
J:95933
|
Tg(Crh)227.1Pbl/0
(involves: C57BL/6 * SJL)
|
muscular atrophy
|
J:92996
|
Tg(DM15)26Bew/0
(involves: FVB)
|
abnormal muscle relaxation
|
J:93614
|
| abnormal myocardial fiber morphology
|
J:33711,
J:93614
|
| abnormal skeletal muscle fiber morphology
|
J:93614
|
| cardiomyopathy
|
J:33711,
J:93614
|
| centrally nucleated skeletal muscle fibers
|
J:93614
|
| dystrophic muscle
|
J:93614
|
| heart left ventricle hypertrophy
|
J:93614
|
| increased variability of skeletal muscle fiber size
|
J:93614
|
| myopathy
|
J:93614
|
Tg(DMPK/tetO-EGFP/DMPK)5-313Masm/0
(involves: FVB/N)
|
centrally nucleated skeletal muscle fibers
|
J:207560
|
| dystrophic muscle
|
J:207560
|
| impaired muscle relaxation
|
J:131302,
J:207560
|
| increased variability of skeletal muscle fiber size
|
J:207560
|
| skeletal muscle fiber atrophy
|
J:207560
|
Tg(DMWD,DMPK*,SIX5)328Ggo/0
(involves: C57BL/6 * DBA/2)
|
abnormal skeletal muscle fiber morphology
|
J:73187
|
| centrally nucleated skeletal muscle fibers
|
J:73187
|
| impaired muscle relaxation
|
J:73187
|
| increased variability of skeletal muscle fiber size
|
J:73187
|
| skeletal muscle fibrosis
|
J:73187
|
Tg(DMWD,DMPK*,SIX5)328Ggo/Tg(DMWD,DMPK*,SIX5)328Ggo
(involves: C57BL/6 * DBA/2)
|
abnormal diaphragm morphology
|
J:196337
|
| abnormal skeletal muscle fiber type ratio
|
J:196337
|
| impaired muscle relaxation
|
J:73187
|
| increased variability of skeletal muscle fiber size
|
J:73187
|
Tg(DMWD,DMPK*,SIX5)1177Ggo/0
(involves: C57BL/6 * DBA/2)
|
abnormal skeletal muscle fiber morphology
|
J:73187
|
| centrally nucleated skeletal muscle fibers
|
J:73187
|
| increased variability of skeletal muscle fiber size
|
J:73187
|
| muscular atrophy
|
J:73187
|
| skeletal muscle degeneration
|
J:73187
|
| skeletal muscle fibrosis
|
J:73187
|
Tg(DMWD,DMPK*,SIX5)1177Ggo/Tg(DMWD,DMPK*,SIX5)1177Ggo
(involves: C57BL/6 * DBA/2)
|
impaired muscle relaxation
|
J:73187
|
| increased variability of skeletal muscle fiber size
|
J:73187
|
Tg(DUX4*)1Maar/?
(involves: C57BL/6J * CBA/J)
|
delayed skeletal muscle regeneration
|
J:195481
|
Tg(Edn1-NOS3)22Yky/0
(involves: C57BL/6 * DBA/2)
|
decreased vasodilation
|
J:81132
|
Tg(EIF1AX-Aldh2*E487K)101Oht/Tg(EIF1AX-Aldh2*E487K)101Oht
(C57BL/6-Tg(EIF1AX-Aldh2*E487K)101Oht)
|
muscle weakness
|
J:137374
|
Tg(Eno2-Bmp4)3Jake/0
(involves: BALB/c * C57BL/6)
|
abnormal muscle fiber morphology
|
J:93682
|
| abnormal muscle morphology
|
J:93682
|
Tg(Eno2-TOR1A*)13Shas/0
(involves: C3H * C57BL/6J)
|
dystonia
|
J:95447
|
Tg(Fabp2-Arg1)1Wla/Tg(Fabp2-Arg1)1Wla
(involves: FVB)
|
decreased skeletal muscle fiber diameter
|
J:80556
|
Tg(Fabp4-LMNA*R482Q)11ACdl/0
(FVB-Tg(Fabp4-LMNA*R482Q)11ACdl)
|
decreased muscle cell glucose uptake
|
J:149858
|
| muscle phenotype
|
J:149858
|
Tg(Fabp4-LMNA*R482Q)17CCdl/0
(FVB/N-Tg(Fabp4-LMNA*R482Q)17CCdl)
|
abnormal muscle cell glucose uptake
|
J:149858
|
Tg(FOXJ1-ACE2)1Rba/0
(involves: C3H * C57BL/6)
|
abnormal myocardial fiber morphology
|
J:288386
|
Tg(Gata1-Zfpm1)1Sho/0
Zfpm1tm1Sho/Zfpm1tm1Sho
(involves: 129S1/Sv * C57BL/6N * CD-1)
|
thin myocardium
|
J:99745
|
Tg(Gfap-TGFB1)64Lms/0
Zbtb20Tg(PDGFB-APPSwInd)20Lms/0
(involves: BALB/c * C57BL/6 * DBA/2 * SJL)
|
decreased vasodilation
|
J:167619
|
Tg(Gpx1)41Dkd/0
(involves: C3H * C57BL/6)
|
increased cardiac muscle contractility
|
J:127782
|
| myocardium necrosis
|
J:89952,
J:127782
|
Tg(GSK3B*S9A)1Vln/0
Tg(Thy1-MAPT)1Vln/Tg(Thy1-MAPT)1Vln
(involves: FVB)
|
muscle phenotype
|
J:100971
|
Tg(GSK3B*S9A)1Vln/0
Tg(Thy1-MAPT)2Vln/Tg(Thy1-MAPT)2Vln
(involves: FVB)
|
muscle phenotype
|
J:100971
|
Tg(H2-K-Fosl1)1Wag/0
(involves: C57BL/6 * CBA)
|
decreased cardiac muscle contractility
|
J:95691
|
Tg(H2-K-Fosl2,-EGFP)13Wag/0
(B6.Cg-Tg(H2-K-Fosl2,-EGFP)13Wag)
|
vascular smooth muscle hyperplasia
|
J:238723
|
Tg(H2-K-Hmga1)#Lmsr/0
(involves: C57BL/6 * SJL)
|
increased uterus leiomyoma incidence
|
J:121308
|
Tg(HBB-Myc)#Cos/0
(involves: C57BL/6J * CBA/J)
|
muscular atrophy
|
J:276641
|
Tg(HBx-HCV)C5Tto/0
(involves: C57BL/6 * DBA/2)
|
abnormal cardiac muscle tissue morphology
|
J:105313
|
| abnormal myocardial fiber morphology
|
J:105313
|
| abnormal Z line morphology
|
J:105313
|
| cardiomyopathy
|
J:105313
|
| decreased cardiac muscle contractility
|
J:105313
|
| increased myocardial fiber size
|
J:105313
|
Tg(HCRT-tTA)1Ahky/0
Tg(tetO-DTA)1Gfi/0
(B6.Cg-Tg(HCRT-tTA)1Ahky Tg(tetO-DTA)1Gfi)
|
abnormal muscle physiology
|
J:211045
|
Tg(HDexon1)61Gpb/?
(involves: C57BL/6 * CBA)
|
decreased myocardial fiber size
|
J:203027
|
Tg(HDexon1)62Gpb/0
(B6CBA-Tg(HDexon1)62Gpb/1J)
|
abnormal myocardial fiber morphology
|
J:116660
|
| decreased ventricle muscle contractility
|
J:116660
|
Tg(HIV)26Aln/0
(involves: FVB/N)
|
myocardium degeneration
|
J:90297
|
| myositis
|
J:90297
|
| skeletal muscle degeneration
|
J:90297
|
Tg(HRAS)2Jic/?
(involves: BALB/c * C57BL/6)
|
abnormal limb muscle morphology
|
J:135606
|
| abnormal pectoral muscle morphology
|
J:135606
|
| abnormal skeletal muscle fiber morphology
|
J:99371
|
| abnormal skeletal muscle morphology
|
J:99371
|
| centrally nucleated skeletal muscle fibers
|
J:99371
|
| increased variability of skeletal muscle fiber size
|
J:99371
|
| skeletal muscle fiber degeneration
|
J:99371,
J:135606
|
| skeletal muscle fiber necrosis
|
J:99371
|
| skeletal muscle interstitial fibrosis
|
J:135606
|
Tg(HSA*LR)20aCath/?
(involves: FVB/N)
|
abnormal muscle fiber morphology
|
J:64493
|
| impaired muscle relaxation
|
J:64493
|
Tg(HSA*LR)20bCath/?
(involves: FVB/N)
|
abnormal muscle electrophysiology
|
J:125885
|
| abnormal muscle fiber morphology
|
J:64493
|
| impaired muscle relaxation
|
J:64493
|
Tg(HSA*LR)21Cath/?
(involves: FVB/N)
|
abnormal muscle fiber morphology
|
J:64493
|
| impaired muscle relaxation
|
J:64493
|
Tg(HSA*LR)32aCath/?
(involves: FVB/N)
|
abnormal muscle fiber morphology
|
J:64493
|
| impaired muscle relaxation
|
J:64493
|
Tg(HSA*LR)32bCath/?
(involves: FVB/N)
|
abnormal muscle fiber morphology
|
J:64493
|
| impaired muscle relaxation
|
J:64493
|
Tg(HSA*LR)41Cath/?
(involves: FVB/N)
|
abnormal muscle fiber morphology
|
J:64493
|
| impaired muscle relaxation
|
J:64493
|
Tg(HSA*SR)29Cath/?
(involves: FVB/N)
|
muscle phenotype
|
J:64493
|
Tg(HTT*)AXwy/0
(involves: FVB/NJ)
|
dystonia
|
J:219890
|
Tg(HTT*)LXwy/0
(involves: FVB/NJ)
|
dystonia
|
J:219890
|
Tg(HTT*)NXwy/0
(involves: FVB/NJ)
|
dystonia
|
J:219890
|
| skeletal muscle fiber atrophy
|
J:219890
|
Tg(IGFBP1)2Miel/0
(involves: C57BL * CBA)
|
decreased vasoconstriction
|
J:84652
|
Tg(Krt14-Angptl2)1Yo/0
(C.Cg-Tg(Krt14-Angptl2)1Yo)
|
muscle phenotype
|
J:181261
|
Tg(Lck-Tnfsf4)1Nish/0
(B6.Cg-Tg(Lck-Tnfsf4)1Nish)
|
heart right ventricle hypertrophy
|
J:194882
|
| increased vasoconstriction
|
J:194882
|
Tg(Lck-Tnfsf14)24Yxf/?
(C57BL/6-Tg(Lck-Tnfsf14)24Yxf)
|
myositis
|
J:129951
|
Tg(LMNA*G608G)HClns/?
(C57BL/6-Tg(LMNA*G608G)HClns/J)
|
abnormal vascular smooth muscle morphology
|
J:107176
|
Tg(Lmnb1)1Yfu/0
(involves: C57BL/6J)
|
muscle spasm
|
J:197168
|
Tg(LONP1-mt-ND4*,-mCherry*)#Jguy
(B6(D2)-Tg(LONP1-mt-ND4*,-mCherry*)#Jguy)
|
muscle phenotype
|
J:224897
|
Tg(Mdm2)1Snj/0
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased rhabdomyosarcoma incidence
|
J:51661
|
Tg(MMTV-NCOA3)#Mybr/0
(FVB/N-Tg(MMTV-NCOA3)#Mybr)
|
increased leiomyosarcoma incidence
|
J:93548
|
Tg(Mnx1-Mfn2*T105M,-EGFP)1Dcc/Tg(Mnx1-Mfn2*T105M,-EGFP)1Dcc
(Not Specified)
|
decreased skeletal muscle size
|
J:132035
|
| muscle weakness
|
J:132035
|
Tg(Mnx1-Zfp106,-EGFP)1Blk/0
Zfp106tm1b(KOMP)Wtsi/Zfp106tm1b(KOMP)Wtsi
(involves: C57BL/6N)
|
abnormal muscle fiber morphology
|
J:241305
|
Tg(Mnx1-Zfp106,-EGFP)2Blk/0
Zfp106tm1b(KOMP)Wtsi/Zfp106tm1b(KOMP)Wtsi
(involves: C57BL/6N)
|
abnormal muscle fiber morphology
|
J:241305
|
Tg(Mpz)80.2Wra/0
(involves: FVB/N)
|
muscular atrophy
|
J:78758
|
Tg(Mpz)88.1Mfel/0
(FVB/N-Tg(Mpz)88.1Mfel)
|
muscle weakness
|
J:77658
|
| muscular atrophy
|
J:77658
|
Tg(Mpz)88.2Mfel/0
(FVB/N-Tg(Mpz)88.2Mfel)
|
muscle weakness
|
J:77658
|
| muscular atrophy
|
J:77658
|
Tg(Mpz)88.4Mfel/0
(FVB/N-Tg(Mpz)88.4Mfel)
|
muscle weakness
|
J:77658
|
Tg(Mpz*S63C)32Mes/0
(involves: FVB/N)
|
muscular atrophy
|
J:105751
|
Tg(Mpz*S63C)33Mes/0
(involves: FVB/N)
|
muscular atrophy
|
J:105751
|
Tg(Mpz*S63X)30Mes/0
(involves: FVB/N)
|
muscular atrophy
|
J:105751
|
Tg(Mpz*S63X)31Mes/0
(involves: FVB/N)
|
muscular atrophy
|
J:105751
|
Tg(Mt1-Hgf)19Lmb/0
(involves: FVB/N)
|
ectopic skeletal muscle
|
J:34022
|
Tg(Mt1-Hgf)19Lmb/0
(involves: C57BL/6 * FVB/N)
|
ectopic skeletal muscle
|
J:34022
|
Tg(MT2A-TGFBR2)#Rser/0
(involves: C57BL/6 * DBA)
|
decreased cardiac muscle contractility
|
J:158480
|
| dilated cardiomyopathy
|
J:158480
|
Tg(Myh6*)1Lnwd/0
(involves: C57BL/6 * FVB/N)
|
decreased cardiac muscle relaxation
|
J:55938
|
| disorganized myocardium
|
J:55938
|
| heart left ventricle hypertrophy
|
J:55938
|
Tg(Myh6*)1Lnwd/Tg(Myh6*)1Lnwd
(involves: C57BL/6 * FVB/N)
|
heart left ventricle hypertrophy
|
J:55938
|
Tg(Myh6*)131Lnwd/0
(involves: C57BL/6 * CBA)
|
heart left ventricle hypertrophy
|
J:31537
|
Tg(Myh6*)140Lnwd/0
(involves: C57BL/6 * CBA)
|
abnormal vascular smooth muscle morphology
|
J:31537,
J:36522
|
| decreased cardiac muscle contractility
|
J:134706
|
| heart left ventricle hypertrophy
|
J:31537,
J:36522,
J:134706
|
| myocardial fiber degeneration
|
J:36522
|
Tg(Myh6*)140Lnwd/0
Tg(WTbeta2)4Wjk/0
(involves: C57BL/6 * CBA)
|
abnormal cardiac muscle contractility
|
J:134706
|
Tg(Myh6*/tetO-BAG3)69Atsa/0
Tg(Myh6-tTA)55Rbns/0
(involves: C57BL/6CrSlc * FVB/NJ)
|
decreased cardiac muscle contractility
|
J:273465
|
Tg(Myh6*/tetO-Capn1)L2Gwd/0
(involves: FVB/N)
|
decreased ventricle muscle contractility
|
J:133797
|
Tg(Myh6*/tetO-Capn1)L3Gwd/0
(involves: FVB/N)
|
decreased ventricle muscle contractility
|
J:133797
|
| myocardium necrosis
|
J:133797
|
Tg(Myh6*/tetO-FXYD1*S68E)39Jych/0
Tg(Myh6-tTA)55Rbns/0
(involves: FVB/N)
|
abnormal cardiac muscle contractility
|
J:182365
|
| increased ventricle muscle contractility
|
J:182365
|
Tg(Myh6*/tetO-Hspb8*K141N)#Atsa/0
Tg(Myh6-tTA)55Rbns/0
(involves: C57BL/6CrSlc * FVB/NJ)
|
cardiomyopathy
|
J:197853
|
| decreased cardiac muscle contractility
|
J:197853
|
Tg(Myh6*/tetO-Slc8a1)BJych/0
Tg(Myh6-tTA)55Rbns/0
(involves: FVB/N)
|
abnormal cardiac muscle contractility
|
J:151091
|
| abnormal myocardial fiber morphology
|
J:151091
|
Tg(Myh6-1810058I24Rik)#Eno/0
(involves: C57BL/6)
|
cardiomyopathy
|
J:325962
|
| decreased cardiac muscle contractility
|
J:325962
|
Tg(Myh6-ACE2)1Rbre/0
(involves: FVB/N)
|
abnormal myocardial fiber morphology
|
J:128793
|
Tg(Myh6-ACE2)2Rbre/0
(involves: FVB/N)
|
abnormal myocardial fiber morphology
|
J:128793
|
Tg(Myh6-Acsl1)J3Jesc/0
(FVB/N-Tg(Myh6-Acsl1)J3Jesc)
|
decreased ventricle muscle contractility
|
J:68639
|
| heart left ventricle hypertrophy
|
J:68639
|
Tg(Myh6-Acsl1)M13Jesc/0
(FVB/N-Tg(Myh6-Acsl1)M13Jesc)
|
decreased ventricle muscle contractility
|
J:68639
|
| heart left ventricle hypertrophy
|
J:68639
|
Tg(Myh6-Acsl1)O7Jesc/0
(FVB/N-Tg(Myh6-Acsl1)O7Jesc)
|
abnormal myocardial fiber morphology
|
J:68639
|
| cardiomyopathy
|
J:68639
|
| decreased ventricle muscle contractility
|
J:68639
|
| heart left ventricle hypertrophy
|
J:68639
|
| increased cardiac muscle triglyceride level
|
J:68639
|
| increased cardiomyocyte apoptosis
|
J:68639
|
Tg(Myh6-ACTC1*E99K)#Sbm/0
(involves: C57BL/10 * CBA/Ca)
|
abnormal cardiac muscle relaxation
|
J:175388
|
| decreased cardiac muscle contractility
|
J:175388
|
| dilated cardiomyopathy
|
J:175388
|
| heart left ventricle hypertrophy
|
J:175388
|
| myocardial fiber disarray
|
J:175388
|
Tg(Myh6-ACTC1*E361G)361.20Sbm/0
(Not Specified)
|
decreased cardiac muscle relaxation
|
J:242344
|
| decreased ventricle muscle contractility
|
J:242344
|
| dilated cardiomyopathy
|
J:242344
|
Tg(Myh6-Actc1*R312H)307Iko/?
(involves: C57BL/6)
|
decreased cardiac muscle contractility
|
J:178587
|
| dilated cardiomyopathy
|
J:178587
|
| increased cardiomyocyte apoptosis
|
J:178587
|
| myocardial fiber degeneration
|
J:178587
|
Tg(Myh6-Adra1a)A1A1Rmgr/0
(FVB/N-Tg(Myh6-Adra1a)A1A1Rmgr)
|
abnormal cardiac muscle relaxation
|
J:108879
|
| increased cardiac muscle contractility
|
J:108879
|
| increased ventricle muscle contractility
|
J:108867
|
Tg(Myh6-Adra1a)A1A4Rmgr/0
(FVB/N-Tg(Myh6-Adra1a)A1A4Rmgr)
|
increased cardiac muscle contractility
|
J:108879
|
| increased cardiomyocyte apoptosis
|
J:108867
|
| increased ventricle muscle contractility
|
J:108867
|
| myocardial fiber degeneration
|
J:108867
|
Tg(Myh6-ADRB1)4Mjlo/0
(FVB/N-Tg(Myh6-ADRB1)4Mjlo)
|
decreased cardiac muscle contractility
|
J:55719
|
| decreased ventricle muscle contractility
|
J:55719
|
| increased cardiac muscle contractility
|
J:55719
|
| increased myocardial fiber size
|
J:55719
|
Tg(Myh6-ADRBK1)27Wjk/0
(involves: C57BL/6 * SJL)
|
increased cardiac muscle contractility
|
J:134706
|
Tg(Myh6-AIP/PLN*)46Jded/0
(FVB/N-Tg(Myh6-AIP/PLN*)46Jded)
|
abnormal cardiac muscle relaxation
|
J:84333
|
Tg(Myh6-Akt1)20Anr/Y
(involves: C57BL/6)
|
heart left ventricle hypertrophy
|
J:77257
|
Tg(Myh6-Akt1)20Anr/0
(involves: C57BL/6)
|
abnormal myocardial fiber morphology
|
J:77257
|
| heart left ventricle hypertrophy
|
J:77257
|
Tg(Myh6-Akt1)564Anr/0
(involves: C57BL/6)
|
abnormal myocardial fiber morphology
|
J:77257
|
Tg(Myh6-Akt1*T308D*S473D)1Siz/0
(Not Specified)
|
abnormal myocardial fiber morphology
|
J:75780
|
| decreased cardiac muscle contractility
|
J:75780
|
Tg(Myh6-ANKRD1)#Camm/0
(involves: FVB)
|
abnormal cardiac muscle contractility
|
J:302922
|
| abnormal myocardial fiber mitochondrial morphology
|
J:302922
|
| abnormal myocardial fiber morphology
|
J:302922
|
| decreased cardiac muscle contractility
|
J:302922
|
Tg(Myh6-Atp1a2)1Jmol/0
(involves: FVB)
|
abnormal myocardial fiber morphology
|
J:223625
|
Tg(Myh6-BAG3*P209L)#Mswi/0
(involves: C57BL/6 * DBA/2)
|
decreased cardiac muscle contractility
|
J:234278
|
| decreased cardiac muscle relaxation
|
J:234278
|
| increased myocardial fiber size
|
J:234278
|
Tg(Myh6-Bclaf1)#Cya/0
(Not Specified)
|
decreased cardiac muscle contractility
|
J:301260
|
| increased cardiomyocyte apoptosis
|
J:301260
|
Tg(Myh6-BRUNOL4*)10Coop/0
(involves: FVB)
|
decreased cardiac muscle contractility
|
J:99369
|
| dilated cardiomyopathy
|
J:99369
|
| myocardial fiber degeneration
|
J:99369
|
Tg(Myh6-CACNA1C)M1Aschw/0
(involves: FVB/N)
|
abnormal myocardial fiber morphology
|
J:134761,
J:129494
|
| dilated cardiomyopathy
|
J:134761
|
| increased cardiac muscle contractility
|
J:129494
|
| increased cardiac muscle relaxation
|
J:129494
|
| increased cardiomyocyte apoptosis
|
J:134761
|
Tg(Myh6-Camk2d)1Jhb/0
(involves: C57BL/6)
|
decreased cardiac muscle contractility
|
J:73694
|
| decreased cardiac muscle relaxation
|
J:73694
|
Tg(Myh6-Camk2d)1Xdfu/0
(Not Specified)
|
abnormal cardiac muscle contractility
|
J:96039
|
| dilated cardiomyopathy
|
J:96039
|
Tg(Myh6-Camk2d_ic)LJhb/0
(either: (involves: Black Swiss) or (involves: C57BL/6))
|
decreased cardiac muscle contractility
|
J:130644
|
| dilated cardiomyopathy
|
J:130644
|
| increased myocardial fiber size
|
J:130644
|
Tg(Myh6-Camk2d_ic)MJhb/0
(either: (involves: Black Swiss) or (involves: C57BL/6))
|
decreased cardiac muscle contractility
|
J:130644
|
| dilated cardiomyopathy
|
J:130644
|
| increased myocardial fiber size
|
J:130644
|
Tg(Myh6-Camta2)1Eno/0
(Not Specified)
|
dilated cardiomyopathy
|
J:115868
|
Tg(Myh6-CASQ2)1Mord/0
(Not Specified)
|
abnormal myocardial fiber morphology
|
J:46786
|
| abnormal sarcoplasmic reticulum morphology
|
J:46786
|
| decreased cardiac muscle contractility
|
J:79838
|
| decreased cardiac muscle relaxation
|
J:79838
|
| decreased ventricle muscle contractility
|
J:79838
|
| dilated cardiomyopathy
|
J:79838
|
Tg(Myh6-CASQ2)1Mord/0
Tg(Myh6-TNNI3K)#Dmar/0
Tnni3kB/Tnni3kB
(involves: C57BL/6J * DBA/2J * SJL/J)
|
decreased cardiac muscle contractility
|
J:154116
|
| dilated cardiomyopathy
|
J:154116
|
Tg(Myh6-CASQ2)1Mord/0
Tnni3kB/Tnni3kA
(involves: AKR/J * DBA/2J)
|
decreased cardiac muscle contractility
|
J:154116
|
Tg(Myh6-Cast)1Gwd/0
(involves: FVB/N)
|
abnormal myocardial fiber morphology
|
J:133797
|
| decreased ventricle muscle contractility
|
J:133797
|
| dilated cardiomyopathy
|
J:133797
|
Tg(Myh6-Ccna2)58Djw/0
(involves: C57BL/6 * CBA)
|
abnormal myocardial fiber morphology
|
J:92551
|
| decreased cardiac muscle contractility
|
J:92551
|
| decreased myocardial fiber size
|
J:92551
|
Tg(Myh6-Ccnd1)#Ljf/0
(involves: C3HeB/FeJ * DBA/2J)
|
abnormal myocardial fiber morphology
|
J:40920
|
Tg(Myh6-cre)TG9Pjay/0
(involves: FVB/N)
|
decreased cardiac muscle contractility
|
J:198043
|
| dilated cardiomyopathy
|
J:198043,
J:119070
|
| increased cardiomyocyte apoptosis
|
J:198043
|
Tg(Myh6-CREB1*S133A)1Jml/0
(involves: CD-1)
|
abnormal cardiac muscle contractility
|
J:133881
|
| abnormal myocardial fiber morphology
|
J:133881
|
| cardiac muscle atrophy
|
J:133881
|
| decreased ventricle muscle contractility
|
J:133881
|
| dilated cardiomyopathy
|
J:133881
|
Tg(Myh6-Cryab*R120G)708Rbns/0
(FVB/N-Tg(Myh6-Cryab*R120G)708Rbns)
|
abnormal myocardial fiber morphology
|
J:133093
|
| abnormal Z line morphology
|
J:133093
|
| decreased cardiac muscle contractility
|
J:133093
|
| decreased cardiac muscle relaxation
|
J:133093
|
| increased myocardial fiber size
|
J:133093
|
Tg(Myh6-CRYAB*R120G)7302Ijb/0
(involves: C57BL/6)
|
abnormal myocardium layer morphology
|
J:126781
|
| cardiomyopathy
|
J:126781
|
Tg(Myh6-Des*)641Rbns/0
(involves: FVB/N)
|
abnormal cardiac muscle relaxation
|
J:108730
|
| abnormal myocardial fiber morphology
|
J:108730
|
| abnormal Z line morphology
|
J:108730
|
| decreased ventricle muscle contractility
|
J:108730
|
| increased myocardial fiber size
|
J:108730
|
Tg(Myh6-EGFR*)9-12Iko/0
(involves: C57BL/6 * DBA/2)
|
decreased cardiac muscle contractility
|
J:182337
|
| dilated cardiomyopathy
|
J:182337
|
Tg(Myh6-EP300)21Csk/0
(C57BL/6-Tg(Myh6-EP300)21Csk)
|
abnormal myocardial fiber morphology
|
J:110549
|
| decreased cardiac muscle contractility
|
J:110549
|
Tg(Myh6-EP300)39Csk/0
(C57BL/6-Tg(Myh6-EP300)39Csk)
|
abnormal myocardial fiber morphology
|
J:110549
|
| decreased cardiac muscle contractility
|
J:110549
|
Tg(Myh6-Erbb2)6Kaga/0
(involves: C57BL/6J * SJL/J)
|
abnormal myocardium layer morphology
|
J:189979
|
| cardiomyopathy
|
J:189979
|
| decreased cardiac muscle contractility
|
J:189979
|
| increased myocardial fiber size
|
J:189979
|
| myocardium hypertrophy
|
J:189979
|
Tg(Myh6-GFP,MAP2K3)58Ywa/?
Myl2tm1(cre)Krc/Myl2+
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal myocardial fiber morphology
|
J:72242
|
Tg(Myh6-GFP,MAP2K6)8Ywa/?
Myl2tm1(cre)Krc/Myl2+
(involves: 129S1/Sv * 129X1/SvJ)
|
increased myocardial fiber size
|
J:72242
|
Tg(Myh6-Gnaq)25Gwd/0
(involves: FVB/N)
|
decreased cardiac muscle contractility
|
J:144736,
J:41949
|
| decreased ventricle muscle contractility
|
J:41949
|
| heart left ventricle hypertrophy
|
J:41949
|
| increased myocardial fiber size
|
J:41949
|
Tg(Myh6-Gnaq)25Gwd/0
Tg(Myh6-Gnaq)40Gwd/0
(involves: FVB/N)
|
dilated cardiomyopathy
|
J:41949
|
Tg(Myh6-Gnaq)#Gwd/0
(involves: FVB/N)
|
decreased cardiac muscle contractility
|
J:145086
|
| increased cardiomyocyte apoptosis
|
J:145086
|
Tg(Myh6-Gnaq)#Gwd/0
Tg(Myh6-tTA)55Rbns/0
Tg(tetO-Bnip3l)1Gwd/0
(involves: FVB/N)
|
decreased cardiac muscle contractility
|
J:145086
|
| increased cardiomyocyte apoptosis
|
J:145086
|
Tg(Myh6-Gnaq*Q209L)44Ejne/0
(involves: FVB)
|
dilated cardiomyopathy
|
J:127756
|
Tg(Myh6-Gnaq*Q209L)44Ejne/Tg(Myh6-Gnaq*Q209L)44Ejne
(involves: FVB)
|
abnormal myocardial fiber morphology
|
J:127756
|
| decreased cardiac muscle contractility
|
J:127756
|
| dilated cardiomyopathy
|
J:127756
|
| increased myocardial fiber size
|
J:127756
|
Tg(Myh6-Gnaq*Q209L)52Ejne/?
(involves: FVB)
|
abnormal atrium myocardial trabeculae morphology
|
J:204274
|
| decreased cardiac muscle contractility
|
J:127756
|
| dilated cardiomyopathy
|
J:204274,
J:127756
|
| increased myocardial fiber size
|
J:204274
|
| myocardial fiber degeneration
|
J:204274
|
| myocardium hypertrophy
|
J:204274
|
Tg(Myh6-Gnaq*Q209L/Esr1*)7Rzl/0
(involves: C57BL/6)
|
abnormal cardiac muscle relaxation
|
J:104100
|
| decreased cardiac muscle contractility
|
J:104100
|
| dilated cardiomyopathy
|
J:104100
|
Tg(Myh6-Grem2)1Akh/0
(involves: C57BL/6)
|
increased cardiac muscle contractility
|
J:250034
|
Tg(Myh6-HBEGF)#Iko/0
(involves: C57BL/6 * DBA/2)
|
decreased cardiac muscle contractility
|
J:93335
|
| dilated cardiomyopathy
|
J:93335
|
| increased myocardial fiber size
|
J:93335
|
| myocardial fiber degeneration
|
J:93335
|
Tg(Myh6-Hod)3Joe/?
(Not Specified)
|
increased myocardial fiber size
|
J:121995
|
Tg(Myh6-Htr2b)1Lum/0
(involves: CD-1)
|
abnormal myocardial fiber morphology
|
J:128784
|
| increased myocardial fiber number
|
J:128784
|
| increased myocardial fiber size
|
J:128784
|
Tg(Myh6-IGF1R)7Jmcm/0
(involves: FVB/N)
|
increased myocardial fiber size
|
J:87944
|
| increased ventricle muscle contractility
|
J:87944
|
Tg(Myh6-Jund1)9Wag/0
(Not Specified)
|
decreased cardiac muscle contractility
|
J:95691
|
Tg(Myh6-Jup*)1Ajm/0
(involves: FVB/N)
|
decreased ventricle muscle contractility
|
J:192719
|
Tg(Myh6-JUP*)1Dpju/0
(FVB/N-Tg(Myh6-JUP*)1Dpju)
|
increased cardiomyocyte apoptosis
|
J:235770
|
Tg(Myh6-KDM4A)BZpl/0
(involves: FVB)
|
decreased cardiac muscle contractility
|
J:173908
|
| increased myocardial fiber size
|
J:173908
|
Tg(Myh6-LDB3*S196L)93Mva/0
(involves: C57BL/6J)
|
abnormal sarcomere morphology
|
J:243711
|
| abnormal Z line morphology
|
J:243711
|
| decreased cardiac muscle contractility
|
J:243711
|
Tg(Myh6-Lef1)2Tfo/0
(involves: C57BL/6J * FVB/N)
|
decreased ventricle muscle contractility
|
J:109612
|
| dilated cardiomyopathy
|
J:109612
|
Tg(Myh6-LMNA*E82K)35Lizh/0
(involves: C57BL/6J)
|
abnormal cardiac muscle tissue morphology
|
J:167734
|
| abnormal myocardial fiber morphology
|
J:167734
|
| abnormal sarcomere morphology
|
J:167734
|
| decreased cardiac muscle contractility
|
J:167734
|
| decreased ventricle muscle contractility
|
J:167734
|
| dilated cardiomyopathy
|
J:167734
|
| increased cardiomyocyte apoptosis
|
J:167734
|
Tg(Myh6-Map2k1*)1Jmol/?
(involves: FVB)
|
decreased cardiomyocyte apoptosis
|
J:66102
|
| heart left ventricle hypertrophy
|
J:66102
|
| increased myocardial fiber size
|
J:66102
|
Tg(Myh6-Map2k1*)1Jmol/?
(involves: FVB/N)
|
decreased cardiomyocyte apoptosis
|
J:127872
|
Tg(Myh6-Map2k1*)1Jmol/0
Tg(Myh6/tetO-Tnnc1*I61Q)1Jmol/0
Tg(Myh6-tTA)55Rbns/0
(involves: FVB)
|
increased cardiac muscle contractility
|
J:234490
|
Tg(Myh6-Map2k3*)1Jmol/0
(FVB-Tg(Myh6-Map2k3*)1Jmol)
|
cardiomyopathy
|
J:83547
|
| decreased cardiac muscle contractility
|
J:83547
|
| decreased ventricle muscle contractility
|
J:83547
|
| heart left ventricle hypertrophy
|
J:83547
|
| increased myocardial fiber size
|
J:83547
|
Tg(Myh6-Map2k6*)1Jmol/0
(FVB-Tg(Myh6-Map2k6*)1Jmol)
|
decreased cardiac muscle contractility
|
J:83547
|
| decreased ventricle muscle contractility
|
J:83547
|
| heart left ventricle hypertrophy
|
J:83547
|
| increased myocardial fiber size
|
J:83547
|
Tg(Myh6-Map2k7)1Jmol/0
(involves: FVB/N)
|
abnormal cardiac muscle contractility
|
J:102152
|
| decreased cardiomyocyte apoptosis
|
J:102152
|
Tg(Myh6-Mapk8*,Myh6-Mapk9*)22.4Jmol/0
(involves: FVB/N)
|
abnormal myocardium layer morphology
|
J:102152
|
| decreased cardiomyocyte apoptosis
|
J:102152
|
Tg(Myh6-Mapk14*)1Jmol/0
(FVB-Tg(Myh6-Mapk14*)1Jmol)
|
cardiomyopathy
|
J:83547
|
| decreased cardiac muscle contractility
|
J:83547
|
| decreased ventricle muscle contractility
|
J:83547
|
| heart left ventricle hypertrophy
|
J:83547
|
| increased myocardial fiber size
|
J:83547
|
Tg(Myh6-MEF2A)1Jmol/0
(involves: FVB)
|
decreased ventricle muscle contractility
|
J:111573
|
| increased myocardial fiber size
|
J:111573
|
Tg(Myh6-Mef2c)2Jmol/0
(involves: FVB)
|
decreased cardiac muscle contractility
|
J:111573
|
| dilated cardiomyopathy
|
J:111573
|
Tg(Myh6-Mef2c)2Jmol/0
Tg(Myh6-Ppp3ca)37Eno/0
(involves: FVB)
|
decreased cardiac muscle contractility
|
J:111573
|
Tg(Myh6-Mef2c/VP16)1Eno/0
(Not Specified)
|
abnormal skeletal muscle fiber type ratio
|
J:127416
|
Tg(Myh6-Mef2d)2Eno/0
(Not Specified)
|
cardiomyopathy
|
J:130825
|
Tg(Myh6-Mir30c-1)AEec/0
(involves: C57BL/6JOlaHsd * FVB/N)
|
dilated cardiomyopathy
|
J:216095
|
Tg(Myh6-Mir30c-1)BEec/0
(involves: C57BL/6JOlaHsd * FVB/N)
|
decreased cardiac muscle contractility
|
J:216095
|
| dilated cardiomyopathy
|
J:216095
|
Tg(Myh6-Mmp2*V107G)712Ajb/0
(involves: 129/Sv * CD-1)
|
abnormal myocardial trabeculae morphology
|
J:105703
|
| abnormal myocardium layer morphology
|
J:105703
|
| decreased cardiac muscle contractility
|
J:105703
|
Tg(Myh6-Mtg1)3Ywxu/0
(involves: C57BL/6J)
|
increased cardiac muscle contractility
|
J:271147
|
| increased myocardial fiber number
|
J:271147
|
Tg(Myh6-Mtpn)4Ssen/0
(involves: FVB)
|
decreased cardiac muscle contractility
|
J:89823
|
| increased myocardial fiber size
|
J:89823
|
| myocardial fiber disarray
|
J:89823
|
Tg(Myh6-Murc)#Tue/0
(Not Specified)
|
increased myocardial fiber size
|
J:136004
|
Tg(Myh6-Mybpc3*)24Rbns/0
(Not Specified)
|
abnormal myocardial fiber mitochondrial morphology
|
J:59702
|
| abnormal sarcomere morphology
|
J:59702
|
| abnormal Z line morphology
|
J:59702
|
Tg(Myh6-Mybpc3*)32Rbns/0
(Not Specified)
|
abnormal myocardial fiber morphology
|
J:50237
|
| abnormal sarcomere morphology
|
J:50237
|
| myocardial fiber degeneration
|
J:50237
|
Tg(Myh6-Myh7)102Rbns/Tg(Myh6-Myh7)102Rbns
(involves: FVB/N)
|
decreased cardiac muscle contractility
|
J:166125
|
Tg(Myh6-Myh7)137Rbns/0
(involves: FVB/N)
|
decreased cardiac muscle contractility
|
J:166125
|
Tg(Myh6-MYH7B)#Lnwd/0
(C57BL/6-Tg(Myh6-MYH7B)#Lnwd)
|
decreased cardiac muscle contractility
|
J:285433
|
Tg(Myh6-Myl2*)21Rbns/0
(Not Specified)
|
abnormal cardiac muscle contractility
|
J:114298
|
| abnormal cardiac muscle relaxation
|
J:114298
|
| abnormal intercalated disk morphology
|
J:114298
|
| abnormal myocardial fiber morphology
|
J:114298
|
| abnormal sarcomere morphology
|
J:114298
|
| decreased cardiac muscle contractility
|
J:110993
|
| myocardial fiber degeneration
|
J:114298
|
Tg(Myh6-MYL2*A13T)L1Dsc/0
(involves: C57BL/6 * SJL)
|
cardiomyopathy
|
J:181028
|
Tg(Myh6-MYL2*D94A)1Dsc/0
(Not Specified)
|
abnormal myocardium layer morphology
|
J:258888
|
| abnormal sarcomere morphology
|
J:258888
|
| decreased cardiac muscle contractility
|
J:258888
|
| dilated cardiomyopathy
|
J:258888
|
Tg(Myh6-MYL2*E22K)4Dsc/0
(involves: C57BL/6 * SJL)
|
papillary muscle hypertrophy
|
J:101467
|
Tg(Myh6-MYL2*K104E)2Dsc/0
(involves: C57BL/6 * SJL)
|
cardiomyopathy
|
J:263776
|
| decreased cardiac muscle relaxation
|
J:263776
|
| increased cardiac muscle contractility
|
J:263776
|
Tg(Myh6-MYL2*N47K)#Dsc/0
(involves: C57BL/6 * SJL)
|
abnormal myocardial fiber morphology
|
J:144685
|
Tg(Myh6-MYL2*R58Q)#Dsc/0
(involves: C57BL/6 * SJL)
|
abnormal cardiac muscle contractility
|
J:162200
|
| abnormal myocardial fiber morphology
|
J:144685
|
| decreased cardiac muscle relaxation
|
J:162200
|
Tg(Myh6-MYL3*)#Dsc/0
(involves: C57BL/6 * SJL)
|
abnormal cardiac muscle tissue morphology
|
J:178377
|
| abnormal myocardium layer morphology
|
J:195614
|
Tg(Myh6-MYL3*A57G)#Dsc/0
(involves: C57BL/6 * SJL)
|
abnormal cardiac muscle tissue morphology
|
J:178377
|
| increased cardiac muscle contractility
|
J:202154
|
| increased myocardial fiber size
|
J:202154
|
Tg(Myh6-MYL3*E143K)2Dsc/0
(Not Specified)
|
abnormal cardiac muscle relaxation
|
J:258831
|
| abnormal sarcomere morphology
|
J:258831
|
| abnormal Z line morphology
|
J:258831
|
| absent M line
|
J:258831
|
| cardiomyopathy
|
J:258831
|
Tg(Myh6-MYOZ2*I246M)#Ajm/0
(involves: FVB)
|
heart left ventricle hypertrophy
|
J:210073
|
| increased myocardial fiber size
|
J:210073
|
Tg(Myh6-MYOZ2*S48P)114Ajm/0
(involves: FVB)
|
heart left ventricle hypertrophy
|
J:210073
|
| increased myocardial fiber size
|
J:210073
|
Tg(Myh6-MYPN*Y20C)#Jato/0
(involves: C57BL/6J)
|
abnormal intercalated disk morphology
|
J:181871
|
| abnormal myocardial fiber morphology
|
J:181871
|
| decreased cardiac muscle contractility
|
J:181871
|
| increased myocardial fiber size
|
J:181871
|
Tg(Myh6-Ncor2*)1Kjep/0
(Not Specified)
|
thin myocardium compact layer
|
J:132982
|
Tg(Myh6-NEBL*A592E)#Jato/0
(Not Specified)
|
abnormal cardiac muscle tissue morphology
|
J:242962
|
| abnormal Z line morphology
|
J:242962
|
| decreased cardiac muscle contractility
|
J:242962
|
| dilated cardiomyopathy
|
J:242962
|
Tg(Myh6-NEBL*G202R)#Jato/0
(Not Specified)
|
abnormal cardiac muscle tissue morphology
|
J:242962
|
| abnormal intercalated disk morphology
|
J:242962
|
| abnormal myocardial fiber morphology
|
J:242962
|
| decreased cardiac muscle contractility
|
J:242962
|
| dilated cardiomyopathy
|
J:242962
|
Tg(Myh6-NFATC4)#Eno/0
(involves: FVB)
|
myocardial fiber disarray
|
J:93176
|
Tg(Myh6-Nox4)#Jusa/0
(FVB-Tg(Myh6-Nox4)#Jusa)
|
abnormal ventricle myocardium morphology
|
J:163751,
J:164275
|
| decreased ventricle muscle contractility
|
J:163751,
J:164275
|
| increased cardiomyocyte apoptosis
|
J:163751,
J:164275
|
Tg(Myh6-Pfkfb3)7Pne/0
(FVB-Tg(Myh6-Pfkfb3)7Pne)
|
decreased cardiac muscle cell glucose uptake
|
J:94475
|
| decreased cardiac muscle contractility
|
J:94475
|
| increased cardiac muscle glycogen level
|
J:94475
|
Tg(Myh6-Pik3ca)1Siz/0
(involves: FVB/N)
|
decreased myocardial fiber size
|
J:62707
|
Tg(Myh6-Pik3r1/PIK3CA)BSiz/0
(involves: FVB/N)
|
increased myocardial fiber size
|
J:62707
|
Tg(Myh6-Pkp2*/mRuby)4Rbrug/0
(involves: C57BL/6 * DBA/2)
|
cardiomyopathy
|
J:237859
|
Tg(Myh6-Pkp2*/mRuby)4Rbrug/0
Tg(Myh6-Pkp2*/mRuby)5Rbrug/0
(involves: C57BL/6 * DBA/2)
|
abnormal intercalated disk morphology
|
J:237859
|
| cardiomyopathy
|
J:237859
|
| decreased cardiac muscle contractility
|
J:237859
|
Tg(Myh6-Pkp2*/mRuby)5Rbrug/0
(involves: C57BL/6 * DBA/2)
|
cardiomyopathy
|
J:237859
|
Tg(Myh6-Pln)416Egk/?
(FVB/N-Tg(Myh6-Pln)416Egk)
|
abnormal cardiac muscle contractility
|
J:135899
|
Tg(Myh6-Pln*)#Egk/0
(Not Specified)
|
abnormal cardiac muscle tissue morphology
|
J:105976
|
| dilated cardiomyopathy
|
J:105976
|
Tg(Myh6-Pln*R9C)#Ces/0
(involves: FVB/N)
|
decreased ventricle muscle contractility
|
J:82353
|
| dilated cardiomyopathy
|
J:82353
|
| increased myocardial fiber size
|
J:82353
|
Tg(Myh6-POLG*Y955C)DWcc/0
(Not Specified)
|
abnormal myocardial fiber mitochondrial morphology
|
J:122507
|
| abnormal myocardial fiber morphology
|
J:122507
|
| cardiomyopathy
|
J:122507
|
| decreased myocardial fiber mitochondrial DNA content
|
J:122507
|
| increased myocardial fiber size
|
J:122507
|
Tg(Myh6-Ppara)402-2Dpk/0
(involves: C57BL/6 * CBA/J)
|
abnormal myocardial fiber morphology
|
J:110580
|
| cardiomyopathy
|
J:110580
|
| decreased ventricle muscle contractility
|
J:110580
|
Tg(Myh6-Ppara)404-3Dpk/0
(involves: C57BL/6 * CBA/J)
|
abnormal myocardial fiber morphology
|
J:110580
|
| cardiomyopathy
|
J:81834,
J:110580
|
| decreased cardiac muscle cell glucose uptake
|
J:110580
|
| decreased ventricle muscle contractility
|
J:110580
|
Tg(Myh6-Ppara)404-4Dpk/0
(involves: C57BL/6 * CBA/J)
|
abnormal myocardial fiber morphology
|
J:110580
|
Tg(Myh6-Ppard)HEDpk/0
(involves: C57BL/6 * CBA)
|
decreased cardiac muscle contractility
|
J:130750
|
| increased cardiac muscle cell glucose uptake
|
J:130750
|
| increased cardiac muscle glycogen level
|
J:130750
|
Tg(Myh6-Ppif)26.2Jmol/0
(FVB/N-Tg(Myh6-Ppif)26.2Jmol)
|
abnormal myocardial fiber mitochondrial morphology
|
J:97660
|
Tg(Myh6-Ppp3ca)37Eno/0
(involves: FVB)
|
increased myocardial fiber size
|
J:94665
|
| myocardial fiber disarray
|
J:93176
|
Tg(Myh6-Prkaa2*D157A)1Rti/0
Tg(Myh6-PRKAG2*T400N)1Feah/0
(involves: FVB)
|
decreased ventricle muscle contractility
|
J:123005
|
| increased cardiac muscle glycogen level
|
J:123005
|
Tg(Myh6-Prkaca)2Eno/0
(Not Specified)
|
decreased cardiac muscle contractility
|
J:263774
|
| dilated cardiomyopathy
|
J:263774
|
| increased myocardial fiber size
|
J:263774
|
Tg(Myh6-Prkaca)33Eno/0
(Not Specified)
|
dilated cardiomyopathy
|
J:263774
|
| increased myocardial fiber size
|
J:263774
|
Tg(Myh6-PRKAG2)2Dca/0
(involves: C57BL/10 * CBA/Ca)
|
increased cardiac muscle glycogen level
|
J:108517
|
Tg(Myh6-PRKAG2)#Rro/0
(involves: FVB)
|
abnormal myocardial fiber morphology
|
J:108102
|
| decreased ventricle muscle contractility
|
J:108102
|
Tg(Myh6-PRKAG2*N488I)4623Jse/0
(involves: FVB)
|
decreased cardiac muscle contractility
|
J:128648
|
| increased cardiac muscle glycogen level
|
J:128648
|
| increased myocardial fiber size
|
J:128648
|
Tg(Myh6-PRKAG2*R302Q)#Rro/0
(involves: FVB)
|
abnormal myocardial fiber morphology
|
J:108102
|
| decreased ventricle muscle contractility
|
J:108102
|
| increased cardiac muscle glycogen level
|
J:108102
|
Tg(Myh6-PRKAG2*R531G)22Dca/0
(involves: C57BL/10 * CBA/Ca)
|
decreased cardiac muscle contractility
|
J:108517
|
| increased cardiac muscle glycogen level
|
J:108517
|
Tg(Myh6-PRKAG2*T400N)1Feah/0
(involves: FVB/N)
|
abnormal myocardial fiber morphology
|
J:123005
|
| decreased ventricle muscle contractility
|
J:123005
|
| increased cardiac muscle glycogen level
|
J:123005
|
Tg(Myh6-Prkca)1Jmk/0
(involves: FVB)
|
decreased cardiac muscle contractility
|
J:88510
|
Tg(Myh6-PRKCE*A159E)344Robo/?
(involves: FVB)
|
calcified myocardium
|
J:133478
|
| decreased cardiac muscle contractility
|
J:133478
|
| dilated cardiomyopathy
|
J:133478
|
Tg(Myh6-PROKR1)13Cagn/0
(involves: C57BL/6 * CD-1 * DBA/2)
|
abnormal cardiac muscle contractility
|
J:149020
|
Tg(Myh6-Rab1a)highGwd/0
(involves: FVB/N)
|
decreased ventricle muscle contractility
|
J:134581
|
| dilated cardiomyopathy
|
J:134581
|
Tg(Myh6-Rab1a)lowGwd/0
(involves: FVB/N)
|
decreased ventricle muscle contractility
|
J:134581
|
| dilated cardiomyopathy
|
J:134581
|
Tg(Myh6-Rab1a)medGwd/0
(involves: FVB/N)
|
abnormal myocardial fiber morphology
|
J:134581
|
| decreased ventricle muscle contractility
|
J:134581
|
| dilated cardiomyopathy
|
J:134581
|
| increased myocardial fiber size
|
J:134581
|
Tg(Myh6-Rest*)474Ysai/0
(involves: C57BL/6J)
|
abnormal myocardial fiber morphology
|
J:86837
|
| abnormal Z line morphology
|
J:86837
|
| decreased cardiac muscle contractility
|
J:86837
|
| decreased ventricle muscle contractility
|
J:86837
|
| dilated cardiomyopathy
|
J:86837
|
Tg(Myh6-rtTA)8585Jam/0
Tg(Myh6*/tetO-SCN5A*F1759A)#Marx/0
(involves: C57BL/6 * CBA * FVB/NTac)
|
abnormal myocardial fiber morphology
|
J:229825
|
| cardiomyopathy
|
J:229825
|
| decreased ventricle muscle contractility
|
J:229825
|
| increased cardiac muscle glycogen level
|
J:229825
|
Tg(Myh6-rtTA)8585Jam/0
Tg(tetO-CUGBP1)3413Coop/0
(involves: FVB * FVB/N * FVB/NTac)
|
cardiac muscle degeneration
|
J:157646
|
| decreased cardiac muscle contractility
|
J:157646
|
| dilated cardiomyopathy
|
J:157646
|
| myocardium necrosis
|
J:157646
|
Tg(Myh6-rtTA)8585Jam/0
Tg(tetO-Fgfr3*R248C/Fgfr1)#Dor/0
(involves: 129 * C57BL/6 * FVB/N * FVB/NTac)
|
abnormal cardiac muscle relaxation
|
J:211151
|
| cardiomyopathy
|
J:211151
|
| increased cardiac muscle contractility
|
J:211151
|
| increased myocardial fiber size
|
J:211151
|
| myocardial fiber disarray
|
J:211151
|
Tg(Myh6-rtTA)8585Jam/0
Tg(tetO-Ppargc1a)1Dpk/0
(involves: FVB/N * FVB/NTac)
|
abnormal myocardial fiber morphology
|
J:96614
|
| cardiomyopathy
|
J:96614
|
| decreased cardiac muscle contractility
|
J:96614
|
Tg(Myh6-Rxra)41Pcn/0
(Not Specified)
|
abnormal M line morphology
|
J:60351
|
| abnormal myocardial fiber morphology
|
J:60351
|
| abnormal sarcomere morphology
|
J:60351
|
| abnormal Z line morphology
|
J:60351
|
| dilated cardiomyopathy
|
J:60351
|
| myocardial fiber degeneration
|
J:60351
|
Tg(Myh6-Sgcd*S151A)5Mcn/0
(involves: 129T2/SvEms * C57BL/6J)
|
abnormal myocardial fiber morphology
|
J:117855
|
| dilated cardiomyopathy
|
J:117855
|
Tg(Myh6-SLC2A1)54Rti/0
(FVB-Tg(Myh6-SLC2A1)54Rti)
|
increased cardiac muscle cell glucose uptake
|
J:106467
|
| increased cardiac muscle glycogen level
|
J:106467
|
Tg(Myh6-Sln)26Peri/0
(involves: C57BL/6)
|
abnormal cardiac muscle relaxation
|
J:108309
|
| decreased cardiac muscle contractility
|
J:108309
|
Tg(Myh6-Snai1)B10Jcc/0
(Not Specified)
|
decreased cardiac muscle contractility
|
J:126850
|
| dilated cardiomyopathy
|
J:126850
|
Tg(Myh6-Snai1)B10Jcc/Tg(Myh6-Snai1)B10Jcc
(Not Specified)
|
decreased cardiac muscle contractility
|
J:126850
|
| dilated cardiomyopathy
|
J:126850
|
Tg(Myh6-STK4)28Jusa/0
(involves: C57BL/6)
|
abnormal myocardial fiber morphology
|
J:139414
|
| decreased myocardial fiber number
|
J:139414
|
| decreased myocardial fiber size
|
J:139414
|
| decreased ventricle muscle contractility
|
J:139414
|
| dilated cardiomyopathy
|
J:139414
|
| increased cardiomyocyte apoptosis
|
J:139414
|
Tg(Myh6-STK4*K59R)10Jusa/0
(involves: C57BL/6)
|
decreased cardiomyocyte apoptosis
|
J:139414
|
Tg(Myh6-Sumo2*)9606Jwang/0
(either: B6.FVB-Tg(Myh6-Sumo2*)9606Jwang or (involves: C57BL/6 * FVB/N))
|
cardiomyopathy
|
J:230540
|
| increased cardiomyocyte apoptosis
|
J:230540
|
| increased myocardial fiber size
|
J:230540
|
Tg(Myh6-Sumo2*)9608Jwang/0
(either: B6.FVB-Tg(Myh6-Sumo2*)9608Jwang or (involves: C57BL/6 * FVB/N))
|
cardiomyopathy
|
J:230540
|
Tg(Myh6-Sumo2*)9610Jwang/0
(either: B6.FVB-Tg(Myh6-Sumo2*)9610Jwang or (involves: C57BL/6 * FVB/N))
|
decreased cardiac muscle contractility
|
J:230540
|
| increased myocardial fiber size
|
J:230540
|
Tg(Myh6-Tcap)#Rnk/0
(Not Specified)
|
decreased cardiomyocyte apoptosis
|
J:188832
|
Tg(Myh6-Tmem11)#Kwan/0
(C57BL/6JGpt-Tg(Myh6-Tmem11)#Kwan)
|
increased myocardial fiber size
|
J:345326
|
Tg(Myh6-Tmod1)65Msus/Tg(Myh6-Tmod1)65Msus
(involves: FVB/N)
|
abnormal cardiac muscle relaxation
|
J:107823
|
| abnormal myocardial fiber morphology
|
J:107823
|
| decreased cardiac muscle contractility
|
J:107823
|
| decreased ventricle muscle contractility
|
J:107823
|
| dilated cardiomyopathy
|
J:107823
|
| myocardial fiber degeneration
|
J:107823
|
| thin myocardium
|
J:107823
|
Tg(Myh6-Tmod1)65Msus/Tg(Myh6-Tmod1)65Msus
(FVB/N-Tg(Myh6-Tmod1)65Msus)
|
abnormal myocardial fiber morphology
|
J:58879
|
| dilated cardiomyopathy
|
J:58879
|
Tg(Myh6-Tnf)1.6Amf/0
(involves: FVB)
|
decreased cardiac muscle contractility
|
J:104759
|
| dilated cardiomyopathy
|
J:104759
|
Tg(Myh6-Tnf)1Brgi/?
(involves: C57BL/6J * SJL)
|
decreased ventricle muscle contractility
|
J:100006
|
Tg(Myh6-Tnf)2Brgi/?
(involves: C57BL/6J * SJL)
|
decreased ventricle muscle contractility
|
J:100006
|
Tg(Myh6-Tnni3*)1Ammu/0
(involves: A/J * C57BL/6)
|
abnormal cardiac muscle relaxation
|
J:59433
|
| abnormal myocardium layer morphology
|
J:59433
|
| decreased cardiac muscle contractility
|
J:104770,
J:59433
|
| dilated cardiomyopathy
|
J:104770
|
Tg(Myh6-TNNI3*G203S)1Chs/0
(Not Specified)
|
abnormal myocardial fiber morphology
|
J:114537
|
| cardiomyopathy
|
J:114537
|
| heart left ventricle hypertrophy
|
J:114537
|
Tg(Myh6-TNNI3*G203S)4Chs/0
(Not Specified)
|
abnormal myocardial fiber morphology
|
J:114537
|
| cardiomyopathy
|
J:114537
|
| heart left ventricle hypertrophy
|
J:114537
|
Tg(Myh6-Tnni3*R146G)121Rbns/0
(Not Specified)
|
abnormal myocardial fiber morphology
|
J:243628
|
| decreased cardiac muscle relaxation
|
J:243628
|
| increased cardiac muscle contractility
|
J:243628
|
Tg(Myh6-Tnni3*R146G)133Rbns/0
(Not Specified)
|
abnormal I band morphology
|
J:243628
|
| abnormal myocardial fiber mitochondrial morphology
|
J:243628
|
| abnormal myocardial fiber morphology
|
J:243628
|
| abnormal sarcomere morphology
|
J:243628
|
| abnormal sarcoplasmic reticulum morphology
|
J:243628
|
| abnormal Z line morphology
|
J:243628
|
Tg(Myh6-Tnni3*R193H)42Xhu/0
(involves: C57BL/6)
|
cardiomyopathy
|
J:119991
|
| decreased cardiac muscle contractility
|
J:119991
|
| decreased cardiac muscle relaxation
|
J:119991
|
Tg(Myh6-Tnni3*R193H)594Jmme/0
(involves: C57BL/6 * SJL)
|
cardiomyopathy
|
J:186721
|
| decreased cardiac muscle relaxation
|
J:186721
|
| increased cardiac muscle contractility
|
J:186721
|
Tg(Myh6-Tnnt2)117Lnwd/0
(involves: C57BL/6)
|
abnormal cardiac muscle relaxation
|
J:48301
|
| abnormal myocardial fiber morphology
|
J:56911,
J:48301
|
| abnormal Z line morphology
|
J:56911
|
| decreased cardiac muscle contractility
|
J:48301
|
| decreased myocardial fiber number
|
J:48301
|
| decreased myocardial fiber size
|
J:48301
|
| disorganized myocardium
|
J:48301
|
| myocardial fiber degeneration
|
J:56911,
J:48301
|
Tg(Myh6-Tnnt2)191Lnwd/0
(involves: C57BL/6)
|
abnormal cardiac muscle relaxation
|
J:48301
|
| abnormal myocardial fiber morphology
|
J:48301
|
| decreased cardiac muscle contractility
|
J:48301
|
| decreased myocardial fiber number
|
J:48301
|
| decreased myocardial fiber size
|
J:48301
|
| disorganized myocardium
|
J:48301
|
| myocardial fiber degeneration
|
J:48301
|
Tg(Myh6-Tnnt2*)1Feah/0
(129S.FVB-Tg(Myh6-Tnnt2*)1Feah)
|
dilated cardiomyopathy
|
J:137964
|
Tg(Myh6-Tnnt2*)1Feah/0
Tnnt2tm1Feah/Tnnt2+
(involves: 129S/SvEv * 129S6/SvEvTac * FVB/N)
|
decreased cardiac muscle contractility
|
J:137964
|
| dilated cardiomyopathy
|
J:137964
|
Tg(Myh6-Tnnt2*R92L)1Jcf/0
(B6.Cg-Tg(Myh6-Tnnt2*R92L)1Jcf)
|
abnormal myocardial fiber morphology
|
J:104369
|
| cardiomyopathy
|
J:104369
|
| decreased cardiac muscle contractility
|
J:104369
|
| decreased cardiac muscle relaxation
|
J:104369
|
| myocardial fiber degeneration
|
J:104369
|
Tg(Myh6-Tnnt2*R92Q)1Lnwd/0
(involves: C57BL/6)
|
abnormal sarcomere morphology
|
J:56911
|
Tg(Myh6-Tnnt2*R92Q)2Lnwd/0
(involves: C57BL/6)
|
abnormal cardiac muscle contractility
|
J:56911
|
| abnormal cardiac muscle relaxation
|
J:56911
|
| abnormal myocardial fiber morphology
|
J:56911
|
| abnormal sarcomere morphology
|
J:56911
|
| decreased myocardial fiber size
|
J:56911
|
| increased cardiac muscle contractility
|
J:56911
|
| myocardial fiber degeneration
|
J:56911
|
Tg(Myh6-Tnnt2*R92Q)3Lnwd/0
(involves: C57BL/6)
|
abnormal myocardial fiber morphology
|
J:56911
|
| abnormal sarcomere morphology
|
J:56911
|
| myocardial fiber degeneration
|
J:56911
|
| myocardial fiber disarray
|
J:56911
|
Tg(Myh6-TNNT2*R92Q)#Ajm/0
(involves: C3H * C57BL/6 * ICR)
|
abnormal myocardial fiber morphology
|
J:161899,
J:162685
|
Tg(Myh6-Tnnt2*R92W)1Jcf/0
(B6.Cg-Tg(Myh6-Tnnt2*R92W)1Jcf)
|
abnormal myocardial fiber morphology
|
J:104369
|
| cardiomyopathy
|
J:104369
|
| decreased cardiac muscle contractility
|
J:104369
|
| decreased cardiac muscle relaxation
|
J:104369
|
| decreased myocardial fiber size
|
J:104369
|
| dilated sarcoplasmic reticulum
|
J:104369
|
| myocardial fiber degeneration
|
J:104369
|
Tg(Myh6-TNNT2*R141W)#Lian/0
(involves: C57BL/6J)
|
abnormal myocardial fiber morphology
|
J:211769
|
| decreased cardiac muscle contractility
|
J:211769
|
| dilated cardiomyopathy
|
J:211769
|
Tg(Myh6-Tpm1*D175N)#Dfw/0
(Not Specified)
|
decreased cardiac muscle contractility
|
J:57365
|
| decreased cardiac muscle relaxation
|
J:57365
|
| disorganized myocardium
|
J:57365
|
| increased myocardial fiber size
|
J:57365
|
| myocardium hypertrophy
|
J:57365
|
Tg(Myh6-Tpm1*D230N)HJcf/0
(B6.FVB-Tg(Myh6-Tpm1*D230N)HJcf)
|
abnormal intercalated disk morphology
|
J:243724
|
| decreased cardiac muscle contractility
|
J:243724
|
| decreased ventricle muscle contractility
|
J:243724
|
| dilated cardiomyopathy
|
J:243724
|
Tg(Myh6-Tpm1*E54K)30Dfw/0
(involves: FVB/N)
|
abnormal myocardial fiber morphology
|
J:137813
|
| decreased cardiac muscle contractility
|
J:137813
|
| decreased cardiac muscle relaxation
|
J:137813
|
| decreased ventricle muscle contractility
|
J:137813
|
| dilated cardiomyopathy
|
J:137813
|
| increased myocardial fiber size
|
J:137813
|
Tg(Myh6-Tpm1*E54K)67Dfw/0
(involves: FVB/N)
|
abnormal myocardial fiber morphology
|
J:137813
|
| decreased cardiac muscle contractility
|
J:137813
|
| decreased cardiac muscle relaxation
|
J:137813
|
| decreased ventricle muscle contractility
|
J:137813
|
| dilated cardiomyopathy
|
J:137813
|
| increased myocardial fiber size
|
J:137813
|
Tg(Myh6-Tpm1*E180G)57Dfw/0
(involves: FVB/N)
|
abnormal cardiac muscle contractility
|
J:127507,
J:172340
|
| abnormal cardiac muscle relaxation
|
J:127507,
J:172340
|
| abnormal myocardial fiber morphology
|
J:127507
|
| decreased cardiac muscle contractility
|
J:171021
|
| heart left ventricle hypertrophy
|
J:127507
|
| increased cardiac muscle contractility
|
J:172340
|
Tg(Myh6-Trim72)1Rpx/0
(C57BL/6-Tg(Myh6-Trim72)1Rpx)
|
cardiomyopathy
|
J:234132
|
| decreased cardiac muscle contractility
|
J:234132
|
| myocardium hypertrophy
|
J:234132
|
Tg(Myh6-tTA)6Smbf/0
Tg(tetO-DTA)1Gfi/0
(involves: C57BL/6 * CBA)
|
decreased myocardial fiber number
|
J:128617
|
| increased cardiomyocyte apoptosis
|
J:128617
|
Tg(Myh6-tTA)6Smbf/0
Tg(tetO-EDN1,-lacZ)9Mhus/0
(involves: C57BL/6 * CBA)
|
abnormal myocardial fiber morphology
|
J:131245
|
| cardiac muscle necrosis
|
J:131245
|
| increased myocardial fiber size
|
J:131245
|
Tg(Myh6-tTA)6Smbf/0
Tg(tetO-HDAC5*)1Eno/0
(involves: C3H * C57BL/6 * CBA)
|
myocardium necrosis
|
J:81967
|
Tg(Myh6-tTA)6Smbf/0
Tg(tetO-Mir208a)#Dzw/0
(involves: C3H * C57BL/6 * CBA)
|
abnormal myocardial fiber morphology
|
J:152696
|
| decreased cardiac muscle contractility
|
J:152696
|
Tg(Myh6-tTA)6Smbf/0
Tg(tetO-NOS2,-lacZ)240iMhus/0
(involves: C57BL/6 * CBA)
|
abnormal atrioventricular node morphology
|
J:132082
|
| cardiac muscle necrosis
|
J:132082
|
Tg(Myh6-tTA)6Smbf/0
Tg(tetO-Spp1)5Gad/0
(involves: C57BL/6 * CBA)
|
decreased cardiac muscle contractility
|
J:194810
|
| dilated cardiomyopathy
|
J:194810
|
Tg(Myh6-tTA)6Smbf/0
Tg(tetO-TPR/MET,-EGFP)12Tcre/0
(FVB.Cg-Tg(Myh6-tTA)6Smbf Tg(tetO-TPR/MET,-EGFP)12Tcre)
|
decreased skeletal muscle weight
|
J:241276
|
Tg(Myh6-tTA)6Smbf/0
Tg(tetORo1-lacZ)3Conk/0
(FVB.Cg-Tg(Myh6-tTA)6Smbf Tg(tetORo1-lacZ)3Conk)
|
abnormal cardiac muscle relaxation
|
J:107363
|
| abnormal myocardium layer morphology
|
J:107363
|
| decreased cardiac muscle contractility
|
J:107363
|
| decreased ventricle muscle contractility
|
J:107363
|
| dilated cardiomyopathy
|
J:107363
|
| myocardial fiber disarray
|
J:107363
|
Tg(Myh6-tTA)55Rbns/?
Tg(Myh6/tetO-BNIP3)1Gwd/?
(Not Specified)
|
increased cardiomyocyte apoptosis
|
J:127533
|
Tg(Myh6-tTA)55Rbns/0
Tg(Myh6/tetO-PRKAG2*N488I)1Chib/0
(Not Specified)
|
abnormal myocardial fiber morphology
|
J:145090
|
| decreased cardiac muscle contractility
|
J:145090
|
| heart left ventricle hypertrophy
|
J:145090
|
| increased cardiac muscle glycogen level
|
J:145090
|
Tg(Myh6-tTA)55Rbns/0
Tg(Myh6/tetO-PRKCA*)1Jmk/0
(involves: FVB/N)
|
abnormal cardiac muscle contractility
|
J:132098
|
| abnormal myocardium layer morphology
|
J:132098
|
| decreased cardiac muscle contractility
|
J:132098
|
| decreased ventricle muscle contractility
|
J:132098
|
Tg(Myh6-tTA)55Rbns/0
Tg(tetO-Bnip3l)1Gwd/0
(involves: FVB/N)
|
decreased cardiac muscle contractility
|
J:145086
|
| increased cardiomyocyte apoptosis
|
J:145086
|
Tg(Myh6-tTA)55Rbns/0
Tg(tetO-Dusp6)1Jmol/0
(involves: FVB/N)
|
decreased cardiac muscle contractility
|
J:124903
|
| increased cardiomyocyte apoptosis
|
J:124903
|
| increased myocardial fiber size
|
J:124903
|
Tg(Myh6-Yap1*S112A)#Eno/0
(involves: C3H * C57BL/6)
|
decreased cardiomyocyte apoptosis
|
J:200670
|
| enhanced cardiac muscle regeneration
|
J:200670
|
| thick myocardium
|
J:200670
|
Tg(Myh6/tetO-Mybpc3*)#Rbns/0
Tg(Myh6-tTA)55Rbns/0
(involves: FVB/N)
|
abnormal muscle fiber morphology
|
J:213370
|
| abnormal sarcomere morphology
|
J:213370
|
| decreased cardiac muscle contractility
|
J:213370
|
Tg(Myh6/tetO-PRKAG2*N488I)1Chib/0
(Not Specified)
|
abnormal myocardial fiber morphology
|
J:145090
|
Tg(Myh6/tetO-Tnnc1*I61Q)1Jmol/0
Tg(Myh6-tTA)55Rbns/0
(involves: FVB)
|
abnormal sarcomere morphology
|
J:234490
|
| decreased cardiac muscle contractility
|
J:234490
|
| increased cardiac muscle relaxation
|
J:234490
|
Tg(Myh6/tetO-Tnnc1*L48Q)2Jmol/0
Tg(Myh6-tTA)55Rbns/0
(involves: FVB)
|
abnormal cardiac muscle contractility
|
J:234490
|
| decreased cardiac muscle relaxation
|
J:234490
|
| increased cardiac muscle contractility
|
J:234490
|
Tg(Myh7-BVp35-EGFP)#Ksa/?
(involves: C3H * C57BL/6)
|
abnormal cardiomyocyte apoptosis
|
J:102279
|
Tg(Myh7-Phc1)#Yota/0
(involves: C57BL/6)
|
abnormal M line morphology
|
J:75968
|
| abnormal myocardial fiber morphology
|
J:75968
|
| abnormal sarcomere morphology
|
J:75968
|
| abnormal Z line morphology
|
J:75968
|
| decreased ventricle muscle contractility
|
J:75968
|
| dilated cardiomyopathy
|
J:75968
|
| increased cardiomyocyte apoptosis
|
J:75968
|
| thin myocardium
|
J:75968
|
Tg(Myh7-Pln)2Egk/0
(FVB/N-Tg(Myh7-Pln)2Egk)
|
abnormal muscle physiology
|
J:224766
|
| abnormal skeletal muscle fiber morphology
|
J:224766
|
| abnormal skeletal muscle fiber type ratio
|
J:224766
|
| centrally nucleated skeletal muscle fibers
|
J:224766
|
| decreased soleus weight
|
J:224766
|
| impaired skeletal muscle contractility
|
J:94077
|
| muscle weakness
|
J:224766
|
| myopathy
|
J:224766
|
| skeletal muscle atrophy
|
J:94077,
J:224766
|
| skeletal muscle endomysial fibrosis
|
J:224766
|
| skeletal muscle fibrosis
|
J:224766
|
Tg(Myh7-Pln)2Egk/?
(involves: FVB/N)
|
abnormal skeletal muscle fiber type ratio
|
J:127873
|
| abnormal soleus morphology
|
J:127873
|
| impaired muscle relaxation
|
J:127873
|
| impaired skeletal muscle contractility
|
J:127873
|
Tg(Myh7-Ptpn11*Q79R)11Rbns/0
(FVB.Cg-Tg(Myh7-Ptpn11*Q79R)11Rbns)
|
decreased cardiac muscle contractility
|
J:123963
|
| ventricular cardiomyopathy
|
J:123963
|
Tg(Myh7-Ptpn11*Q510E)#Krnz/0
(FVB/N-Tg(Myh7-Ptpn11*Q510E)#Krnz)
|
abnormal myocardial fiber morphology
|
J:222124
|
| cardiomyopathy
|
J:181656
|
| decreased cardiac muscle contractility
|
J:181656
|
| increased cardiac muscle contractility
|
J:222124
|
| increased myocardial fiber size
|
J:181656,
J:222124
|
| myocardial fiber disarray
|
J:181656
|
Tg(Myh7-RARA/lacZ)30Mcco/0
(Not Specified)
|
abnormal cardiac muscle relaxation
|
J:146424
|
| decreased cardiac muscle contractility
|
J:146424
|
| dilated cardiomyopathy
|
J:146424
|
| increased myocardial fiber size
|
J:146424
|
| papillary muscle hypoplasia
|
J:146424
|
| thin myocardium
|
J:146424
|
Tg(Myh7-RARA/lacZ)32Mcco/0
(Not Specified)
|
abnormal cardiac muscle relaxation
|
J:146424
|
| decreased cardiac muscle contractility
|
J:146424
|
| increased myocardial fiber size
|
J:146424
|
Tg(MYH7-Yap1*S112A)#Eno/?
(involves: C3H * C57BL/6)
|
abnormal myocardial trabeculae morphology
|
J:189577
|
| abnormal myocardium layer morphology
|
J:189577
|
| thick myocardium
|
J:189577
|
Tg(Myhca-Casq2)418Egk/0
(involves: FVB/N)
|
abnormal cardiac muscle relaxation
|
J:50498
|
| decreased cardiac muscle contractility
|
J:50498
|
| increased myocardial fiber size
|
J:50498
|
Tg(Myl1-cre)13Nros/0
(involves: FVB)
|
muscle phenotype
|
J:140318
|
Tg(Myl1-FST)F66Sjl/0
(involves: C57BL/6 * SJL)
|
increased skeletal muscle fiber diameter
|
J:188599
|
| increased skeletal muscle fiber size
|
J:188599
|
| increased skeletal muscle mass
|
J:188599
|
| increased skeletal muscle weight
|
J:188599
|
Tg(Myl1-Igf1)1Nros/0
Tg(SOD1*G93A)1Gur/0
(involves: C57BL/6 * FVB/N * SJL)
|
abnormal skeletal muscle fiber type ratio
|
J:95812
|
| centrally nucleated skeletal muscle fibers
|
J:95812
|
| decreased skeletal muscle fiber diameter
|
J:95812
|
Tg(Myl1-Prkag3*R225Q)1Sson/0
(involves: C57BL/6J * CBA)
|
increased skeletal muscle glycogen level
|
J:92821
|
Tg(Myl1-SOD1*G93A)#Amu/0
(FVB/NJ-Tg(Myl1-SOD1*G93A)#Amu)
|
abnormal muscle physiology
|
J:143747
|
| abnormal sarcomere morphology
|
J:143747
|
| abnormal sarcoplasmic reticulum morphology
|
J:143747
|
| abnormal skeletal muscle fiber morphology
|
J:143747
|
| abnormal Z line morphology
|
J:143747
|
| skeletal muscle atrophy
|
J:143747
|
Tg(Myl1-Trp53inp2)1Azo/0
(involves: C57BL/6J)
|
abnormal skeletal muscle morphology
|
J:212763
|
| decreased skeletal muscle fiber diameter
|
J:212763
|
| decreased skeletal muscle mass
|
J:212763
|
| decreased skeletal muscle weight
|
J:212763
|
Tg(Myl1-Trp53inp2)2Azo/0
(involves: C57BL/6J)
|
decreased skeletal muscle weight
|
J:212763
|
Tg(Myl2-FGF19)1Dfre/?
(involves: FVB)
|
decreased skeletal muscle triglyceride level
|
J:76323
|
Tg(Myl2SLC2A1)2Mue/0
(involves: C57BL/6 * SJL)
|
increased muscle cell glucose uptake
|
J:93868
|
Tg(Myog-Myhas)#Bcgen/0
(C57BL/6J-Tg(Myog-Myhas)#Bcgen)
|
abnormal muscle physiology
|
J:240240
|
| increased extensor digitorum longus weight
|
J:240240
|
| increased gastrocnemius weight
|
J:240240
|
| increased skeletal muscle fiber diameter
|
J:240240
|
| increased tibialis anterior weight
|
J:240240
|
| skeletal muscle hypertrophy
|
J:240240
|
Tg(Myog-Ntf3)5160Wds/0
(involves: C57BL/6 * CBA * CF-1)
|
abnormal muscle spindle morphology
|
J:43444
|
Tg(Myog-tTA)1Eno/0
Tg(tetO-HDAC5*)1Eno/0
(involves: C3H * C57BL/6)
|
abnormal muscle physiology
|
J:127416
|
Tg(NEFH)200Jpj/0
(Not Specified)
|
progressive muscle weakness
|
J:69180
|
Tg(NEFH)200Jpj/Tg(NEFH)200Jpj
(Not Specified)
|
progressive muscle weakness
|
J:69180
|
Tg(NEFH-tTA)8Vle/0
Tg(tetO-TARDBP*)4Vle/0
(involves: C3H/HeJ * C57BL/6J)
|
decreased skeletal muscle mass
|
J:225639
|
Tg(NEFL*E397K)#Milg/0
(Not Specified)
|
muscular atrophy
|
J:173771
|
Tg(NFH)120Jpj/0
(Not Specified)
|
progressive muscle weakness
|
J:69180
|
Tg(NFH)120Jpj/Tg(NFH)120Jpj
(Not Specified)
|
progressive muscle weakness
|
J:69180
|
Tg(Notch3*R169C)88Bbb/0
(involves: FVB/N)
|
abnormal vascular smooth muscle physiology
|
J:220006
|
| decreased vasoconstriction
|
J:156682,
J:220006
|
Tg(NPPA-Bmp10)1Krc/0
(Not Specified)
|
abnormal myocardial trabeculae morphology
|
J:89404
|
Tg(Pgk1-FGF2)15Cofn/0
(involves: FVB/N)
|
vascular smooth muscle hypertrophy
|
J:33064
|
Tg(Pgk1-FGF2)16Cofn/0
(involves: FVB/N)
|
vascular smooth muscle hypertrophy
|
J:33064
|
Tg(Pgk1-FGF2)48Cofn/0
(involves: FVB/N)
|
vascular smooth muscle hypertrophy
|
J:33064
|
Tg(Pkd1)6Mtru/0
(involves: C57BL/6J * CBA/J)
|
heart left ventricle hypertrophy
|
J:157952
|
| increased cardiac muscle contractility
|
J:157952
|
Tg(Pkd1)26Mtru/0
(involves: C57BL/6J * CBA/J)
|
abnormal myocardium layer morphology
|
J:157952
|
| heart left ventricle hypertrophy
|
J:157952
|
Tg(Prnp*)#Rgab/0
(involves: C57BL/6 * FVB/N)
|
muscular atrophy
|
J:183170
|
| myoclonus
|
J:183170
|
Tg(Prnp*P101L)2866Sbp/0
(involves: FVB/N)
|
abnormal muscle fiber morphology
|
J:136434
|
| abnormal skeletal muscle fiber type ratio
|
J:136434
|
| abnormal skeletal muscle morphology
|
J:136434
|
| myopathy
|
J:136434
|
| skeletal muscle fiber degeneration
|
J:136434
|
Tg(Prnp-APPSweArc)#Rmni/0
(involves: C57BL/6 * DBA/2)
|
abnormal vasodilation
|
J:239408
|
Tg(Prnp-CCS)17Jlel/?
Tg(SOD1*G93A)dl1Gur/?
(involves: C57BL/6 * SJL)
|
muscle hypertonia
|
J:120361
|
Tg(Prnp-FUS)WT3Cshw/0
(involves: C57BL/6 * Crl:CD-1(ICR))
|
muscle phenotype
|
J:189360
|
Tg(Prnp-FUS)WT3Cshw/Tg(Prnp-FUS)WT3Cshw
(involves: C57BL/6 * Crl:CD-1(ICR))
|
abnormal muscle physiology
|
J:189360
|
| abnormal skeletal muscle fiber type ratio
|
J:189360
|
| impaired muscle relaxation
|
J:189360
|
| impaired skeletal muscle contractility
|
J:189360
|
| muscular atrophy
|
J:189360
|
Tg(Prnp-FUS*R521C)3313Ejh/0
(involves: C57BL/6 * SJL)
|
muscle degeneration
|
J:209419
|
Tg(Prnp-Immt/SOD1*G93A)7Gmnf/Tg(Prnp-Immt/SOD1*G93A)7Gmnf
(involves: C57BL/6 * CBA * SJL)
|
decreased skeletal muscle size
|
J:177846
|
| decreased skeletal muscle weight
|
J:177846
|
| decreased ventricle muscle contractility
|
J:177846
|
| muscular atrophy
|
J:177846
|
| skeletal muscle atrophy
|
J:177846
|
Tg(Prnp-MAPT*)2652Gds/0
(B6.Cg-Tg(Prnp-MAPT*)2652Gds)
|
skeletal muscle fiber atrophy
|
J:244052
|
Tg(Prnp-MAPT*P301L)#Ruvi/Tg(Prnp-MAPT*P301L)#Ruvi
(involves: C3HeB/FeJ * C57BL/6)
|
dystonia
|
J:197198
|
Tg(Prnp-MAPT*P301L)JNPL3Hlmc/?
(involves: C57BL/6 * DBA/2)
|
abnormal sarcomere morphology
|
J:63887
|
| abnormal skeletal muscle fiber morphology
|
J:63887
|
Tg(Prnp-MAPT*P301S)PS19Vle/0
(involves: C3H * C57BL/6)
|
dystrophic muscle
|
J:119741
|
| progressive muscle weakness
|
J:119741
|
Tg(Prnp-MAPT*R406W)21807Dwst/?
(FVB/N-Tg(Prnp-MAPT*R406W)21807Dwst)
|
muscle phenotype
|
J:95971
|
Tg(Prnp-PFN1*C71G)22Zxu/0
(involves: FVB/N)
|
progressive muscle weakness
|
J:235427
|
Tg(Prnp-PFN1*C71G)22Zxu/0
Tg(Thy1-PFN1*C71G)67Zxu/0
(involves: FVB/N)
|
progressive muscle weakness
|
J:235427
|
Tg(Prnp-PFN1*C71G)22Zxu/0
Tg(Thy1-PFN1*C71G)67Zxu/Tg(Thy1-PFN1*C71G)67Zxu
(involves: FVB/N)
|
increased variability of skeletal muscle fiber size
|
J:235427
|
| progressive muscle weakness
|
J:235427
|
| skeletal muscle fiber atrophy
|
J:235427
|
Tg(Prnp-SNCA*A53T)25Mkle/0
(involves: C3H/HeJ * C57BL/6J)
|
dystonia
|
J:77344
|
Tg(Prnp-SNCA*A53T)83Vle/Tg(Prnp-SNCA*A53T)83Vle
(involves: C3H * C57BL/6)
|
abnormal gastrocnemius morphology
|
J:76657
|
Tg(Prnp-TARDBP)4Jlel/0
(involves: C57BL/6 * CD-1 * SJL)
|
hypotonia
|
J:165985
|
| increased variability of skeletal muscle fiber size
|
J:165985
|
| muscle weakness
|
J:165985
|
| myopathy
|
J:165985
|
Tg(Prnp-TARDBP)96Dwc/0
Tg(Prnp-TARDBP*Q331K)31Dwc/0
(involves: C3H * C57BL/6)
|
skeletal muscle fiber degeneration
|
J:239141
|
Tg(Prnp-TARDBP*A315T)23Jlel/0
(involves: C57BL/6 * CD-1 * SJL)
|
abnormal quadriceps morphology
|
J:165985
|
| muscle weakness
|
J:165985
|
| skeletal muscle atrophy
|
J:165985
|
Tg(Prnp-TARDBP*A315T)95Balo/0
(involves: C57BL/6 * CBA)
|
abnormal muscle electrophysiology
|
J:153197
|
| abnormal skeletal muscle fiber morphology
|
J:153197
|
| abnormal skeletal muscle morphology
|
J:153197
|
| muscle weakness
|
J:153197
|
Tg(Prnp-TARDBP*Q331K)31Dwc/?
(involves: C3H * C57BL/6)
|
abnormal skeletal muscle fiber morphology
|
J:239141
|
Tg(Prnp-TARDBP*Q331K)103Dwc/?
(involves: C57BL/6 * C3H)
|
abnormal muscle electrophysiology
|
J:191785
|
| abnormal muscle physiology
|
J:191785
|
| abnormal muscle regeneration
|
J:191785
|
| skeletal muscle degeneration
|
J:191785
|
Tg(RSV-BDKRB2)8905Chao/0
(involves: C57BL/6 * DBA/2)
|
impaired smooth muscle contractility
|
J:128651
|
Tg(Scgb1a1-IL6)9Flv/0
(involves: C57BL/6 * CBA)
|
heart right ventricle hypertrophy
|
J:156430
|
Tg(SFTPC-Il18)AThos/0
(B6N.Cg-Tg(SFTPC-Il18)AThos)
|
decreased skeletal muscle weight
|
J:219136
|
| heart right ventricle hypertrophy
|
J:147547
|
Tg(SFTPC-rtTA)2Jaw/0
Tg(tetO-CTGF)#Swu/0
(involves: 129 * C57BL/6 * C57BL/6J)
|
heart right ventricle hypertrophy
|
J:171151
|
Tg(SOD1)2Gur/0
Tg(Thy1-SOD1*G93A)T3Hgrd/0
(involves: C57BL/6 * CBA * FVB * SJL)
|
muscle weakness
|
J:134095
|
Tg(SOD1)3Cje/0
(involves: BALB/c * C57BL/6J * DBA/2)
|
myocardium necrosis
|
J:89952
|
Tg(SOD1*)DF7Yaw/0
(C57BL/6-Tg(SOD1*)DF7Yaw)
|
abnormal muscle physiology
|
J:97932
|
| muscular atrophy
|
J:97932
|
Tg(SOD1*)DF7Yaw/Tg(SOD1*)DF7Yaw
(C57BL/6-Tg(SOD1*)DF7Yaw)
|
abnormal muscle physiology
|
J:97932
|
| muscular atrophy
|
J:97932
|
Tg(SOD1*G37R)9Dpr/0
(involves: C3H/HeJ * C57BL/6J)
|
abnormal muscle electrophysiology
|
J:69178
|
| muscular atrophy
|
J:69178
|
Tg(SOD1*G37R)29Dpr/0
(involves: C3H/HeJ * C57BL/6J)
|
abnormal muscle electrophysiology
|
J:69178
|
| muscular atrophy
|
J:69178
|
Tg(SOD1*G37R)42Dpr/0
(involves: C3H/HeJ * C57BL/6J)
|
abnormal muscle electrophysiology
|
J:69178
|
| muscular atrophy
|
J:69178
|
Tg(SOD1*G37R)106Dpr/0
(involves: C3H/HeJ * C57BL/6J)
|
abnormal muscle electrophysiology
|
J:69178
|
| muscular atrophy
|
J:69178
|
Tg(SOD1*G85R)74Dwc/?
(Not Specified)
|
muscular atrophy
|
J:77600
|
| progressive muscle weakness
|
J:77600
|
Tg(SOD1*G85R)148Dwc/?
(Not Specified)
|
muscular atrophy
|
J:77600
|
| progressive muscle weakness
|
J:77600
|
Tg(Sod1*G86R)M1Jwg/0
(involves: FVB/N)
|
abnormal muscle physiology
|
J:91800
|
| muscle degeneration
|
J:22628
|
Tg(SOD1*G93A)1Gur/0
(involves: C57BL/6 * SJL)
|
abnormal muscle physiology
|
J:111498
|
| muscle weakness
|
J:109423,
J:84843
|
| skeletal muscle atrophy
|
J:76718
|
Tg(SOD1*G93A)1Gur/0
(B6.Cg-Tg(SOD1*G93A)1Gur/J)
|
abnormal skeletal muscle fiber type ratio
|
J:95812
|
| decreased skeletal muscle fiber diameter
|
J:95812
|
Tg(SOD1*G93A)1Gur/0
(B6SJL-Tg(SOD1*G93A)1Gur/J)
|
abnormal muscle physiology
|
J:158298
|
| abnormal skeletal muscle fiber morphology
|
J:158298
|
| muscle weakness
|
J:130811
|
| progressive muscle weakness
|
J:103582,
J:146652
|
Tg(SOD1*G93A)1Gur/0
(B6.Cg-Tg(SOD1*G93A)1Gur)
|
decreased skeletal muscle size
|
J:155140
|
Tg(SOD1*G93A)1Gur/0
Vegfatm2Pec/Vegfatm2Pec
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
muscle weakness
|
J:84843
|
Tg(SOD1*G93A)2Gur/0
(involves: C57BL/6 * SJL)
|
progressive muscle weakness
|
J:32665
|
Tg(SOD1*G93A)dl1Gur/0
(involves: C57BL/6 * CBA * SJL)
|
muscle weakness
|
J:134095
|
| progressive muscle weakness
|
J:134095
|
Tg(SOD1*G93A)dl1Gur/0
(involves: C57BL/6 * SJL)
|
muscle weakness
|
J:106420
|
Tg(SOD1*G93A)dl1Gur/0
Tg(Thy1-SOD1*G93A)T3Hgrd/0
(involves: C57BL/6 * CBA * FVB * SJL)
|
muscle weakness
|
J:134095
|
| progressive muscle weakness
|
J:134095
|
Tg(SOD1*H46R)#Maw/0
(involves: C57BL/6 * DBA/2)
|
muscle degeneration
|
J:99701
|
| progressive muscle weakness
|
J:99701
|
Tg(SOD1*H46R)LAra/0
(involves: C57BL/6 * DBA/2)
|
abnormal tibialis anterior morphology
|
J:221350
|
| decreased tibialis anterior weight
|
J:221350
|
| muscular atrophy
|
J:221350
|
Tg(Tagln-Ager)#Yon/?
(C57BL/6-Tg(Tagln-Ager)#Yon)
|
abnormal vascular smooth muscle physiology
|
J:82620
|
| decreased vascular smooth muscle cell proliferation
|
J:82620
|
Tg(Tagln-rtTA)E1Jwst/0
Tg(tetO-Bmpr2*R899X)#Jwst/0
(involves: FVB/N)
|
heart right ventricle hypertrophy
|
J:164503
|
Tg(Tagln-rtTA)E1Jwst/0
Tg(tetO-BMPR2*T504)1Jwst/0
(involves: FVB/N)
|
abnormal vascular smooth muscle morphology
|
J:98898
|
Tg(Tagln-SLC6A4)#Edd/?
(Not Specified)
|
abnormal vascular smooth muscle morphology
|
J:144126
|
| heart right ventricle hypertrophy
|
J:144126
|
Tg(Tagln-tTA)1Mrab/0
Tg(tetO-Mcpt1)1Mrab/0
(involves: C57BL/6 * SJL)
|
abnormal vasoconstriction
|
J:70031
|
| increased vasoconstriction
|
J:70031
|
Tg(tetO-NEFL)173.2Jpj/0
Tg(THY1-tTA)177Jpj/0
(involves: C3H * C57BL/6)
|
increased skeletal muscle fiber size
|
J:160704
|
Tg(tetO-TARDBP*A315T)13Lmit/0
Tg(Thy1-tTA)6Lmit/0
(involves: C57BL/6)
|
skeletal muscle atrophy
|
J:245760
|
Tg(Thy1-APP)3Somm/0
(involves: C57BL/6J * DBA/2)
|
vascular smooth muscle hypoplasia
|
J:67583
|
Tg(Thy1-App*R609D*K612E)4Vln/0
(involves: FVB)
|
facial muscle spasm
|
J:32213
|
| myoclonus
|
J:32213
|
Tg(Thy1-App*R609D*K612E)4Vln/Tg(Thy1-App*R609D*K612E)4Vln
(involves: FVB)
|
facial muscle spasm
|
J:32213
|
| myoclonus
|
J:32213
|
Tg(Thy1-App*R609D*K612E)6Vln/0
(involves: FVB)
|
facial muscle spasm
|
J:32213
|
| myoclonus
|
J:32213
|
Tg(Thy1-App*R609D*K612E)6Vln/Tg(Thy1-App*R609D*K612E)6Vln
(involves: FVB)
|
facial muscle spasm
|
J:32213
|
| myoclonus
|
J:32213
|
Tg(Thy1-APPDutch)#Jckr/0
(involves: C57BL/6J)
|
vascular smooth muscle hypoplasia
|
J:92796
|
Tg(Thy1-BSCL2*N88S)1Dit/0
(involves: C57BL/6 * DBA/2)
|
muscular atrophy
|
J:175537
|
Tg(Thy1-DCTN1*G59S)M2Pcw/?
(involves: C57BL/6 * SJL)
|
abnormal skeletal muscle fiber morphology
|
J:132857
|
| muscular atrophy
|
J:132857
|
| progressive muscle weakness
|
J:132857
|
Tg(Thy1-FUS*)19Vlb/0
(B6.Cg-Tg(Thy1-FUS*)19Vlb)
|
muscular atrophy
|
J:203550
|
Tg(Thy1-GLRA1*R271Q)300Wha/0
(involves: C57BL/6 * DBA/2)
|
abnormal muscle physiology
|
J:173399
|
| abnormal muscle tone
|
J:173399
|
Tg(Thy1-HSPB1*P182L)#Lvdb/0
(involves: FVB/N)
|
abnormal gastrocnemius morphology
|
J:174508
|
| skeletal muscle fiber atrophy
|
J:174508
|
Tg(Thy1-HSPB1*S135F)#Lvdb/0
(involves: FVB/N)
|
abnormal gastrocnemius morphology
|
J:174508
|
| skeletal muscle fiber atrophy
|
J:174508
|
Tg(Thy1-MAPT)1Vln/0
(FVB/N-Tg(Thy1-MAPT)1Vln)
|
muscular atrophy
|
J:96869
|
Tg(Thy1-MAPT)1Vln/Tg(Thy1-MAPT)1Vln
(involves: FVB)
|
decreased skeletal muscle mass
|
J:100972
|
| muscle weakness
|
J:100972
|
| muscular atrophy
|
J:100971,
J:100972
|
| skeletal muscle fiber atrophy
|
J:100972
|
Tg(Thy1-MAPT)2Vln/Tg(Thy1-MAPT)2Vln
(involves: FVB)
|
muscular atrophy
|
J:100971
|
Tg(Thy1-MAPT*)1Avil/Tg(Thy1-MAPT*)1Avil
(involves: C57BL/6 * CBA)
|
myoclonus
|
J:201700
|
Tg(Thy1-MAPT*K369I)K3Gotz/0
(B6.Cg-Tg(Thy1-MAPT*K369I)K3Gotz)
|
muscular atrophy
|
J:143439
|
Tg(Thy1-MAPT*P301S)2541Godt/Tg(Thy1-MAPT*P301S)2541Godt
(involves: C57BL/6J * CBA/Ca)
|
muscle weakness
|
J:108870
|
| skeletal muscle fiber atrophy
|
J:108870
|
Tg(Thy1-Nrg1*I)1Kan/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal muscle spindle morphology
|
J:199150
|
| increased muscle spindle number
|
J:199150
|
Tg(Thy1-PFN1*C71G)67Zxu/0
(Not Specified)
|
progressive muscle weakness
|
J:235427
|
Tg(Thy1-PFN1*C71G)67Zxu/Tg(Thy1-PFN1*C71G)67Zxu
(Not Specified)
|
progressive muscle weakness
|
J:235427
|
Tg(Thy1-Snca)1S13Putt/?
(involves: C57BL/6)
|
abnormal muscle fiber morphology
|
J:177661
|
Tg(Thy1-SNCA*)#Ztzh/0
(involves: C57BL/6J)
|
muscle weakness
|
J:313970
|
Tg(Thy1-SNCA*A30P)18Pjk/Tg(Thy1-SNCA*A30P)18Pjk
(involves: C57BL/6)
|
progressive muscle weakness
|
J:80181
|
Tg(Thy1-SNCA*A53T)9813Putt/0
(involves: C57BL/6)
|
muscular atrophy
|
J:63836
|
Tg(Thy1-SOD1*G93A)T1Hgrd/0
Tg(Thy1-SOD1*G93A)T3Hgrd/0
(involves: C57BL/6 * CBA * FVB)
|
progressive muscle weakness
|
J:134095
|
Tg(Thy1-SOD1*G93A)T3Hgrd/Tg(Thy1-SOD1*G93A)T3Hgrd
(involves: C57BL/6 * CBA * FVB)
|
progressive muscle weakness
|
J:134095
|
Tg(Thy1-TARDBP)4Singh/Tg(Thy1-TARDBP)4Singh
(involves: C57BL/6J * SJL/J)
|
facial muscle fasciculation
|
J:157550
|
| facial muscle spasm
|
J:157550
|
Tg(Thy1-UBQLN2*P497S)3Mont/?
(involves: C3H * C57BL/6 * C57BL/6J)
|
abnormal skeletal muscle fiber morphology
|
J:239510
|
| decreased skeletal muscle fiber diameter
|
J:239510
|
| muscle degeneration
|
J:239510
|
Tg(Thy1-UBQLN2*P506T)6Mont/?
(involves: C3H * C57BL/6 * C57BL/6J)
|
abnormal skeletal muscle fiber morphology
|
J:239510
|
| decreased skeletal muscle fiber diameter
|
J:239510
|
| muscle degeneration
|
J:239510
|
Tg(Tnnt2-TNNT2*R92Q)#Ajm/0
(involves: C3H * C57BL/6 * ICR)
|
abnormal myocardial fiber morphology
|
J:117554
|
Tg(Tnnt2-TNNT2*R92Q)M-2Ajm/0
(involves: C3H * C57BL/6 * ICR)
|
abnormal myocardial fiber morphology
|
J:117554
|
Tg(Trp53A135V)L3Ber/0
(involves: C57BL/6 * CD-1)
|
decreased skeletal muscle mass
|
J:73757
|
Tg(Tuba1-MAPT)14Vle/0
(involves: C57BL/6 * SJL)
|
dystonia
|
J:78400
|
Tg(UAS-Shh)1Rth/0
Tg(Wnt1-GAL4)1Rth/0
(involves: C57BL/6J * CBA/J)
|
abnormal epaxial muscle morphology
|
J:57948
|
Tg(WTbeta2)4Wjk/?
(Not Specified)
|
abnormal cardiac muscle relaxation
|
J:17862
|
| abnormal myocardial fiber morphology
|
J:128583
|
| cardiomyopathy
|
J:128583
|
| decreased cardiac muscle contractility
|
J:128583
|
| heart left ventricle hypertrophy
|
J:128583
|
| increased cardiac muscle contractility
|
J:17862
|
| increased myocardial fiber size
|
J:128583
|
| increased ventricle muscle contractility
|
J:17862
|
| myocardial fiber degeneration
|
J:128583
|
Tg(WTbeta2)4Wjk/0
(involves: C57BL/6)
|
abnormal cardiac muscle contractility
|
J:134706
|
Tgfatm1Unc/Tgfatm1Unc
(involves: 129P2/OlaHsd * C57BL/6J)
|
orbicularis oculi muscle hypoplasia
|
J:4605
|
Tgfb1tm1Doe/Tgfb1tm1Doe
(involves: 129S2/SvPas * CF-1)
|
abnormal diaphragm morphology
|
J:2892
|
| diaphragmitis
|
J:2892
|
| myocardium necrosis
|
J:2892
|
| myositis
|
J:2892
|
Tgfb1i1tm1.1Knos/Tgfb1i1tm1.1Knos
(involves: C57BL/6)
|
abnormal vascular smooth muscle physiology
|
J:223628
|
Tgfb2tm1Doe/Tgfb2tm1Doe
(involves: 129P2/OlaHsd * Black Swiss)
|
abnormal myocardium layer morphology
|
J:41682,
J:103391
|
| trabecula carnea hypoplasia
|
J:41682
|
Tgfbr1tm1.1Karl/Tgfbr1tm1.1Karl
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: 129S/Sv * C57BL/6 * FVB/N)
|
decreased cardiac muscle contractility
|
J:164749
|
| dilated cardiomyopathy
|
J:164749
|
Tgfbr1tm1Spo/Tgfbr1tm1Spo
(either: (involves: 129S4/SvJae) or (involves: 129 * C57BL/6))
|
abnormal vascular smooth muscle morphology
|
J:104918
|
Tgfbr2tm1.2Hlm/Tgfbr2tm1.2Hlm
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N)
|
decreased cardiac muscle contractility
|
J:164749
|
| dilated cardiomyopathy
|
J:164749
|
Tgfbr2tm1.2Hlm/Tgfbr2tm1.2Hlm
H2az2Tg(Wnt1-cre)11Rth/H2az2+
(involves: 129S6/SvEvTac * C57BL/6 * CBA)
|
abnormal soft palate muscle morphology
|
J:208431
|
Tgfbr2tm1.2Hlm/Tgfbr2tm1.2Hlm
Tg(KRT14-cre)52Smr/0
(involves: 129S6/SvEvTac * C57BL/6J * SJL/J)
|
abnormal skeletal muscle fiber morphology
|
J:208431
|
| abnormal soft palate muscle morphology
|
J:208431
|
| centrally nucleated skeletal muscle fibers
|
J:208431
|
| small levator veli palatini muscle
|
J:208431
|
| small tensor veli palatini muscle
|
J:208431
|
Tgfbr2tm1Karl/Tgfbr2tm1Karl
H2az2Tg(Wnt1-cre)11Rth/H2az2+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
abnormal vasodilation
|
J:96359
|
Tgfbr3tm1.1Jba/Tgfbr3tm1.1Jba
(involves: 129S6/SvEvTac * C57BL/6)
|
thin myocardium
|
J:141344
|
Tgfbr3tm1Stv/Tgfbr3tm1Stv
(involves: 129/Sv * C57BL/6)
|
abnormal fetal cardiomyocyte proliferation
|
J:83727
|
| decreased myocardial fiber number
|
J:83727
|
| trabecula carnea hypoplasia
|
J:83727
|
| ventricle myocardium hypoplasia
|
J:83727
|
Tgm2tm1Gml/Tgm2tm1Gml
(involves: C57BL/6)
|
disorganized myocardium
|
J:131975
|
Thap11em1Poche/Thap11em1Poche
(C57BL/6J-Thap11em1Poche)
|
abnormal trabecula carnea morphology
|
J:317822
|
| abnormal ventricle myocardium morphology
|
J:317822
|
Thbs1tm1Hyn/Thbs1tm1Hyn
(either: (involves: 129S2/SvPas * 129/Sv) or (involves: 129S2/SvPas * C57BL/6))
|
vascular smooth muscle hyperplasia
|
J:48446
|
Thbs1tm1Hyn/Thbs1tm1Hyn
(involves: 129S2/SvPas * C57BL/6)
|
abnormal muscle fiber morphology
|
J:139652
|
| muscle phenotype
|
J:139652
|
Thbs2tm1Bst/Thbs2tm1Bst
(either: (involves: 129S4/SvJae * 129X1/SvJ) or (involves: 129X1/SvJ))
|
abnormal tendon collagen fibril morphology
|
J:45509
|
| abnormal tendon morphology
|
J:45509
|
Thbs4tm1Dgen/Thbs4tm1Dgen
(B6.129P2-Thbs4tm1Dgen)
|
decreased ventricle muscle contractility
|
J:187437
|
Thratm1Jas/Thratm1Jas
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased ventricle muscle contractility
|
J:68577
|
Thratm1Syc/Thra+
(involves: 129S6/SvEvTac)
|
decreased cardiac muscle cell glucose uptake
|
J:95397
|
Thratm2Jas/Thratm2Jas
(involves: 129)
|
decreased ventricle muscle contractility
|
J:68577
|
Thrbtm1.1Syc/Thrbtm1.1Syc
(involves: 129S6/SvEvTac)
|
increased cardiac muscle cell glucose uptake
|
J:95397
|
Thsd4tm1.2Lysa/Thsd4+
(involves: C57BL/6)
|
abnormal aorta smooth muscle morphology
|
J:346290
|
Tigartm1.2Smat/Tigartm1.2Smat
Tg(CAG-EGFP/Map1lc3b)53Nmz/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6JJcl * C57BL/6NCrj)
|
decreased cardiomyocyte apoptosis
|
J:183674
|
| increased cardiac muscle contractility
|
J:183674
|
Timp3tm1Osya/Timp3tm1Osya
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased vasodilation
|
J:211441
|
Timp3tm1Rkho/Timp3tm1Rkho
(involves: 129 * C57BL/6)
|
decreased cardiac muscle contractility
|
J:112033
|
| dilated cardiomyopathy
|
J:112033
|
Timp3tm1Rkho/Timp3tm1Rkho
(B6.129-Timp3tm1Rkho)
|
abnormal cardiac muscle relaxation
|
J:102205
|
| decreased ventricle muscle contractility
|
J:102205
|
| dilated cardiomyopathy
|
J:102205
|
Timp3tm1Rkho/Timp3tm1Rkho
Tnftm1Gkl/Tnftm1Gkl
(involves: 129 * 129S/SvEv * C57BL/6)
|
decreased ventricle muscle contractility
|
J:112033
|
Tincrem1(IMPC)Ccpcz/Tincrem1(IMPC)Ccpcz
(C57BL/6NCrl-Tincrem1(IMPC)Ccpcz/Ccpcz)
|
increased cardiac muscle contractility
|
J:211773
|
TiparpGt(ROSA)79Sor/TiparpGt(ROSA)79Sor
(involves: 129S4/SvJaeSor)
|
abnormal smooth muscle morphology
|
J:117491
|
Tk2tm1Anka/Tk2tm1Anka
(involves: 129X1/SvJ * C57BL/6)
|
abnormal myocardial fiber morphology
|
J:137664
|
Tk2tm1Mihi/Tk2tm1Mihi
(involves: 129S6/SvEv * C57BL/6J)
|
decreased muscle fiber mitochondrial DNA content
|
J:166725
|
| decreased myocardial fiber mitochondrial DNA content
|
J:166725
|
| muscle phenotype
|
J:139195
|
Tll1b2b2476Clo/Tll1b2b2476Clo
(C57BL/6J-Tll1b2b2476Clo)
|
abnormal myocardium compact layer morphology
|
J:175213
|
Tll2tm1.1Sjl/Tll2tm1.1Sjl
(B6N.129(FVB)-Tll2tm1.1Sjl/Sjl)
|
increased muscle weight
|
J:132807
|
Tln1tm4.1Crit/Tln1tm4.1Crit
Tln2tm1.1Crit/Tln2tm1.1Crit
Tg(ACTA1-cre)1Mll/0
(involves: 129P2/OlaHsd * BALB/cJ)
|
abnormal muscle morphology
|
J:153959
|
| abnormal myoblast fusion
|
J:153959
|
| abnormal myotome morphology
|
J:153959
|
| abnormal sarcomere morphology
|
J:153959
|
| abnormal Z line morphology
|
J:153959
|
| increased variability of skeletal muscle fiber size
|
J:153959
|
Tln2tm1.1Crit/Tln2tm1.1Crit
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal skeletal muscle morphology
|
J:152372
|
Tln2tm1.1Crit/Tln2tm1.1Crit
(involves: 129P2/OlaHsd * BALB/cJ)
|
centrally nucleated skeletal muscle fibers
|
J:153959
|
| muscle phenotype
|
J:153959
|
Tln2tm2Crit/Tln2tm2Crit
(involves: 129P2/OlaHsd * C57BL/6)
|
centrally nucleated skeletal muscle fibers
|
J:190037
|
| dystrophic muscle
|
J:190037
|
Tlr2tm1Aki/Tlr2tm1Aki
(involves: 129P2/OlaHsd)
|
muscle phenotype
|
J:116310
|
Tlr3tm1Aki/Tlr3tm1Aki
(involves: 129P2/OlaHsd)
|
abnormal vascular smooth muscle physiology
|
J:116310
|
Tlr4Lps-d/Tlr4Lps-d
(involves: C3H/HeJ)
|
muscle phenotype
|
J:116310
|
Tlr4Lps-d/Tlr4Lps-d
(C3H/HeJ-Tlr4Lps-d)
|
abnormal muscle cell glucose uptake
|
J:126488
|
Tlr7em2Anu/Y
(C57BL/6NCrl-Tlr7em2Anu)
|
abnormal muscle morphology
|
J:324448
|
Tlr7em2Anu/Tlr7em2Anu
(C57BL/6NCrl-Tlr7em2Anu)
|
abnormal muscle morphology
|
J:324448
|
tlss/tlss
(Not Specified)
|
intestinal hypoperistalsis
|
J:169366
|
Tmem11em4Gpt/Tmem11em4Gpt
(C57BL/6JGpt-Tmem11em4Gpt)
|
decreased myocardial fiber size
|
J:345326
|
| increased myocardial fiber number
|
J:345326
|
Tmem38atm1Hta/Tmem38a+
Tmem38btm1Hta/Tmem38b+
(involves: 129S4/SvJae)
|
abnormal muscle physiology
|
J:122817
|
| decreased myocardial fiber number
|
J:122817
|
Tmem70tm1a(KOMP)Wtsi/Tmem70+
(involves: C57BL/6N)
|
decreased ventricle muscle contractility
|
J:238642
|
Tmem94em1Mcvm/Tmem94em1Mcvm
(C57BL/6-Tmem94em1Mcvm)
|
abnormal cardiac muscle tissue morphology
|
J:269160
|
Tmem100tm1.1Ysai/Tmem100tm1.1Ysai
(C57BL/6-Tmem100tm1.1Ysai)
|
abnormal trabecula carnea morphology
|
J:186473
|
| thin myocardium
|
J:186473
|
Tmem100tm1.1Ysai/Tmem100tm2.1Ysai
Tg(Tek-cre)1Ywa/0
(involves: C57BL/6 * SJL)
|
abnormal trabecula carnea morphology
|
J:186473
|
Tmem106bem1Damme/Tmem106bem1Damme
(C57BL/6-Tmem106bem1Damme)
|
abnormal orbicularis oculi muscle morphology
|
J:288278
|
Tmem184bGt(IST10294F4)Tigm/Tmem184bGt(IST10294F4)Tigm
(involves: C57BL/6N)
|
abnormal skeletal muscle fiber morphology
|
J:231818
|
Tmem204tm1.1Ali/Tmem204tm1.1Ali
(involves: BALB/c * C57BL/6)
|
abnormal lymphatic vessel smooth muscle morphology
|
J:159519
|
Tmem263em1Gww/Tmem263em1Gww
(C57BL/6J-Tmem263em1Gww)
|
decreased skeletal muscle weight
|
J:345905
|
Tmlheem1Plaa/Tmlheem1Plaa
(C57BL/6N-Tmlheem1Plaa)
|
abnormal myocardial fiber morphology
|
J:341247
|
Tmod1tm1Sung/Tmod1tm1Sung
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal myocardial fiber morphology
|
J:89956
|
| abnormal myocardial trabeculae morphology
|
J:89956
|
Tmod1tm1Vmf/Tmod1tm1Vmf
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal cardiac muscle contractility
|
J:87158
|
| abnormal myocardial fiber morphology
|
J:87158
|
| abnormal sarcomere morphology
|
J:87158
|
| absent myocardial trabeculae
|
J:87158
|
| thin myocardium
|
J:87158
|
Tmprss2tm2b(EUCOMM)Hmgu/Tmprss2tm2b(EUCOMM)Hmgu
(C57BL/6N-Tmprss2tm2b(EUCOMM)Hmgu/Orl)
|
decreased cardiac muscle contractility
|
J:211773
|
Tmsb4xtm1Prri/Tmsb4xtm1Prri
(B6.129-Tmsb4xtm1Prri)
|
abnormal vascular smooth muscle development
|
J:195902
|
| thin myocardium
|
J:195902
|
Tnftm1Gkl/Tnftm1Gkl
Zfp36tm1Pjb/Zfp36tm1Pjb
(involves: 129S/SvEv * C57BL/6)
|
abnormal vasodilation
|
J:214114
|
Tnftm2Gkl/Tnf+
(involves: 129S/SvEv * C57BL/6J)
|
decreased ventricle muscle contractility
|
J:264147
|
Tnfrsf1atm1Imx/Tnfrsf1atm1Imx
Tnfrsf1btm1Imx/Tnfrsf1btm1Imx
(involves: 129S7/SvEvBrd * C57BL/6)
|
impaired skeletal muscle regeneration
|
J:104990
|
Tnfsf11gum/Tnfsf11gum
(STOCK Tnfsf11gum/GrsrJ)
|
dystrophic muscle
|
J:223062
|
TnksGt(RRC239)Byg/TnksGt(RRC239)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
increased muscle cell glucose uptake
|
J:154388
|
Tnmdtm1Ref/Tnmdtm1Ref
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal tendon morphology
|
J:96005
|
Tnnc1tm1.1Jrpi/Tnnc1+
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal myocardial fiber morphology
|
J:274007
|
| cardiomyopathy
|
J:274007
|
| heart right ventricle hypertrophy
|
J:274007
|
| papillary muscle hypertrophy
|
J:274007
|
Tnnc1tm1.1Jrpi/Tnnc1tm1.1Jrpi
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal cardiac muscle contractility
|
J:249978
|
| abnormal cardiac muscle relaxation
|
J:249978
|
| cardiomyopathy
|
J:274007
|
| decreased cardiac muscle relaxation
|
J:274007
|
| heart left ventricle hypertrophy
|
J:274007
|
| heart right ventricle hypertrophy
|
J:274007
|
| increased cardiac muscle contractility
|
J:274007
|
| myocardial fiber disarray
|
J:274007
|
| papillary muscle hypertrophy
|
J:274007
|
Tnni3tm1Jww/Tnni3tm1Jww
(Not Specified)
|
abnormal myocardial fiber morphology
|
J:53628
|
| abnormal myocardium layer morphology
|
J:53628
|
| abnormal sarcomere morphology
|
J:53628
|
Tnni3kB/Tnni3kB
(involves: C57BL/6J * DBA/2J)
|
decreased cardiac muscle contractility
|
J:339644
|
Tnni3ktm1.1Tfo/Tnni3ktm1.1Tfo
(involves: C57BL/6)
|
increased myocardial fiber number
|
J:249318
|
| muscle phenotype
|
J:249318
|
Tnni3ktm1Tfo/Tnni3ktm1Tfo
A1cfTg(Myh6-cre/Esr1*)1Jmk/?
(involves: C57BL/6 * FVB/N)
|
increased myocardial fiber number
|
J:249318
|
Tnnt1tm1.2Jin/Tnnt1tm1.2Jin
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal muscle contractility
|
J:219907
|
| abnormal muscle fiber morphology
|
J:219907
|
| abnormal muscle physiology
|
J:219907
|
| abnormal muscle relaxation
|
J:219907
|
| abnormal skeletal muscle fiber type ratio
|
J:219907
|
| abnormal skeletal muscle size
|
J:219907
|
| centrally nucleated skeletal muscle fibers
|
J:219907
|
| decreased skeletal muscle fiber diameter
|
J:219907
|
| decreased skeletal muscle fiber size
|
J:219907
|
| increased skeletal muscle fiber diameter
|
J:219907
|
| skeletal muscle fiber atrophy
|
J:219907
|
Tnnt1tm1Jin/Tnnt1tm1Jin
(B6.129P2-Tnnt1tm1Jin)
|
abnormal muscle contractility
|
J:219907
|
| abnormal muscle fiber morphology
|
J:219907
|
| abnormal muscle physiology
|
J:219907
|
| abnormal muscle relaxation
|
J:219907
|
| abnormal skeletal muscle fiber type ratio
|
J:219907
|
| centrally nucleated skeletal muscle fibers
|
J:219907
|
| decreased skeletal muscle fiber diameter
|
J:219907
|
| decreased skeletal muscle fiber size
|
J:219907
|
| increased skeletal muscle fiber diameter
|
J:219907
|
| skeletal muscle fiber atrophy
|
J:219907
|
Tnnt2tm1Feah/Tnnt2tm1Feah
(involves: 129S6/SvEvTac * FVB/N)
|
abnormal myocardial fiber morphology
|
J:137964
|
| decreased cardiac muscle contractility
|
J:137964
|
Tnnt2tm1Mmto/Tnnt2tm1Mmto
(involves: 129S/SvEv)
|
abnormal sarcomere morphology
|
J:141967
|
Tnnt2tm2.1Feah/Tnnt2+
(involves: 129S6/SvEvTac * FVB/N)
|
decreased cardiac muscle contractility
|
J:243725
|
| dilated cardiomyopathy
|
J:243725
|
Tnnt2tm2Mmto/Tnnt2+
(involves: 129S/SvEv * C57BL/6)
|
decreased ventricle muscle contractility
|
J:137784
|
Tnnt2tm2Mmto/Tnnt2tm2Mmto
(involves: 129S/SvEv * C57BL/6)
|
abnormal cardiac muscle contractility
|
J:137784
|
| decreased ventricle muscle contractility
|
J:137784
|
Tnnt3tm2a(KOMP)Wtsi/Tnnt3tm2a(KOMP)Wtsi
(involves: C57BL/6N)
|
thin diaphragm muscle
|
J:204474
|
Tor1atm1Calak/Tor1atm1Calak
(involves: 129 * C57BL/6)
|
dystonia
|
J:247570
|
Tor1atm1Wtd/Tor1atm3.1Wtd
Tg(Nes-cre)1Kln/0
(involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6J * SJL)
|
dystonia
|
J:288753,
J:213785
|
Tor1atm2Wtd/Tor1atm3.1Wtd
Tg(Nes-cre)1Kln/0
(involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6J * SJL)
|
dystonia
|
J:213785
|
Tph1tm1Mlt/Tph1tm1Mlt
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
decreased cardiac muscle contractility
|
J:99733
|
Tpm3tm3Pgun/Tpm3tm3Pgun
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal muscle contractility
|
J:200893
|
| abnormal muscle morphology
|
J:200893
|
Tpm3tm4.1Pgun/Tpm3tm4.1Pgun
(B6JArc.Cg-Tpm3tm4.1Pgun)
|
abnormal muscle contractility
|
J:200893
|
Tpp1m1J/Tpp1m1J
(STOCK Tpp1m1J/GrsrJ)
|
myopathy
|
J:201119
|
Traf2tm1Mak/Traf2tm1Mak
(either: (involves: 129P2/OlaHsd * C57BL/6J) or (involves: 129P2/OlaHsd * BALB/c * C57BL/6J))
|
decreased skeletal muscle mass
|
J:44360
|
Traf6tm2a(EUCOMM)Wtsi/Traf6tm2a(EUCOMM)Wtsi
(C57BL/6N-Traf6tm2a(EUCOMM)Wtsi/Wtsi)
|
abnormal eye muscle morphology
|
J:239583
|
| abnormal myocardium compact layer morphology
|
J:239583
|
Trak1hyrt/Trak1hyrt
(involves: AKR * C3HeB/FeJ * C57BL/6J)
|
abnormal muscle physiology
|
J:105231
|
Trappc9tm1a(EUCOMM)Wtsi/Trappc9tm1a(EUCOMM)Wtsi
(C57BL/6N-Trappc9tm1a(EUCOMM)Wtsi/Wtsi)
|
abnormal infrahyoid muscle connection
|
J:239583
|
Trappc10b2b2416Clo/Trappc10b2b2416Clo
(Trappc10b2b2416Clo)
|
heart left ventricle hypertrophy
|
J:175213
|
| heart right ventricle hypertrophy
|
J:175213
|
Trdntm1.1Cfp/Trdntm1.1Cfp
(involves: 129X1/SvJ * FVB/N)
|
abnormal skeletal muscle fiber triad morphology
|
J:128951
|
Trdntm1.2Isma/Trdntm1.2Isma
(involves: 129S2/SvPas * C57BL/6 * SJL)
|
abnormal muscle electrophysiology
|
J:157794
|
| abnormal muscle physiology
|
J:157794
|
| abnormal sarcoplasmic reticulum morphology
|
J:157794
|
| abnormal skeletal muscle fiber triad morphology
|
J:157794
|
| skeletal muscle hypertrophy
|
J:157794
|
Trex1tm1Tld/Trex1tm1Tld
(involves: 129P2/OlaHsd)
|
abnormal myocardial fiber morphology
|
J:92264
|
| cardiomyopathy
|
J:92264
|
| myocardial fiber degeneration
|
J:92264
|
Trex1tm1Tld/Trex1tm1Tld
(involves: 129P2/OlaHsd * C57BL/6)
|
myositis
|
J:181257
|
Trex1tm1Tld/Trex1tm1Tld
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6N)
|
myositis
|
J:234263
|
Trim32Gt(BGA355)Byg/Trim32Gt(BGA355)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal skeletal muscle fiber morphology
|
J:146155
|
| abnormal skeletal muscle fiber type ratio
|
J:146155
|
| centrally nucleated skeletal muscle fibers
|
J:146155
|
| decreased muscle weight
|
J:146155
|
| decreased skeletal muscle fiber diameter
|
J:146155
|
| increased variability of skeletal muscle fiber size
|
J:146155
|
| muscle phenotype
|
J:146155
|
| myopathy
|
J:146155
|
Trim32tm1Hdin/Trim32tm1Hdin
(involves: 129S1/Sv)
|
abnormal muscle physiology
|
J:184218
|
| abnormal skeletal muscle morphology
|
J:184218
|
| centrally nucleated skeletal muscle fibers
|
J:184218
|
| delayed skeletal muscle regeneration
|
J:184218
|
| increased satellite cell number
|
J:184218
|
| myopathy
|
J:184218
|
Trim32tm1Spc/Trim32tm1Spc
(involves: 129S/SvEvBrd * BALB/cJ * C57BL/6J)
|
abnormal skeletal muscle fiber morphology
|
J:175798
|
| centrally nucleated skeletal muscle fibers
|
J:175798
|
| dystrophic muscle
|
J:175798
|
Trim37Gt(RRO307)Byg/Trim37Gt(RRO307)Byg
(B6J.129P2-Trim37Gt(RRO307)Byg)
|
abnormal trabecula carnea morphology
|
J:232482
|
| cardiomyopathy
|
J:232482
|
Trim54tm1Eno/Trim54tm1Eno
(B6.Cg-Trim54tm1Eno)
|
abnormal cardiac muscle contractility
|
J:120068
|
| abnormal sarcomere morphology
|
J:120068
|
| dilated cardiomyopathy
|
J:120068
|
| increased cardiomyocyte apoptosis
|
J:120068
|
| myocardial fiber degeneration
|
J:120068
|
Trim55tm1Cpat/Trim55tm1Cpat
Trim63tm1Glas/Trim63tm1Glas
(involves: 129S1/Sv * C57BL/6)
|
abnormal M line morphology
|
J:267246
|
| abnormal myocardial fiber morphology
|
J:267246
|
| abnormal sarcomere morphology
|
J:267246
|
| abnormal Z line morphology
|
J:267246
|
| decreased cardiac muscle contractility
|
J:267246
|
Trim55tm1Slbt/Trim55tm1Slbt
(involves: 129 * C57BL/6)
|
increased quadriceps weight
|
J:130921
|
| increased skeletal muscle fiber size
|
J:130921
|
| skeletal muscle hypertrophy
|
J:130921
|
Trim55tm1Slbt/Trim55tm1Slbt
Trim63tm1Slbt/Trim63tm1Slbt
(involves: 129 * C57BL/6)
|
abnormal myocardial fiber morphology
|
J:130921
|
| abnormal myocardium layer morphology
|
J:130921
|
| abnormal Z line morphology
|
J:130921
|
| decreased cardiac muscle contractility
|
J:130921
|
| increased quadriceps weight
|
J:130921
|
Trim63tm1.1Vlcg/Trim63tm1.1Vlcg
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
muscle phenotype
|
J:150424
|
Trim63tm1Glas/Trim63tm1Glas
(involves: 129S1/Sv)
|
decreased susceptibility to induced muscular atrophy
|
J:150424,
J:77660
|
Trim63tm1Glas/Trim63tm1Glas
(involves: 129S1/Sv * C57BL/6)
|
heart left ventricle hypertrophy
|
J:133708
|
Trim63tm1Slbt/Trim63tm1Slbt
(involves: 129 * C57BL/6)
|
increased quadriceps weight
|
J:130921
|
| increased skeletal muscle fiber size
|
J:130921
|
Trim63tm2.1Vlcg/Trim63tm2.1Vlcg
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased susceptibility to induced muscular atrophy
|
J:150424
|
Trim72tm1Hta/Trim72tm1Hta
(Not Specified)
|
abnormal muscle physiology
|
J:146965
|
| abnormal muscle regeneration
|
J:146965
|
| abnormal skeletal muscle morphology
|
J:146965
|
| centrally nucleated skeletal muscle fibers
|
J:146965
|
| decreased skeletal muscle fiber diameter
|
J:146965
|
| impaired skeletal muscle contractility
|
J:146965
|
Trim72tm1Rpx/Trim72tm1Rpx
(involves: 129/SvJ * C57BL/6)
|
muscle phenotype
|
J:342778
|
Trim72tm1Ygko/Trim72tm1Ygko
(Not Specified)
|
abnormal myogenesis
|
J:186368
|
| centrally nucleated skeletal muscle fibers
|
J:186368
|
Triotm1Mst/Triotm1Mst
(involves: 129S4/SvJae * BALB/c)
|
abnormal myogenesis
|
J:65380
|
| abnormal skeletal muscle fiber morphology
|
J:65380
|
| abnormal skeletal muscle morphology
|
J:65380
|
Trp53tm1.1Thst/Trp53tm1.1Thst
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)
|
increased leiomyosarcoma incidence
|
J:198482
|
Trp53tm1Brd/Trp53tm1Brd
(involves: 129S7/SvEvBrd)
|
increased rhabdomyosarcoma incidence
|
J:51661
|
Trp53tm1Ldo/Trp53+
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased skeletal muscle mass
|
J:73757
|
| muscular atrophy
|
J:73757
|
Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas * C57BL/6)
|
increased leiomyosarcoma incidence
|
J:17728
|
| increased rhabdomyosarcoma incidence
|
J:17728
|
Trp53tm1Tyj/Trp53+
Trp63tm1Fmc/Trp63+
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6)
|
increased rhabdomyosarcoma incidence
|
J:98958
|
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * C57BL/6)
|
increased rhabdomyosarcoma incidence
|
J:17728
|
Trp53tm1Tyj/Trp53tm1Tyj
Tg(CAG-EGFP/Map1lc3b)53Nmz/0
(involves: 129S2/SvPas * C57BL/6 * C57BL/6NCrj)
|
decreased cardiomyocyte apoptosis
|
J:183674
|
| increased cardiac muscle contractility
|
J:183674
|
Trp53bp2tm1Xlu/Trp53bp2+
(involves: 129S6/SvEvTac * C57BL/6J)
|
increased rhabdomyosarcoma incidence
|
J:108701
|
Trp53inp2tm1Azo/Trp53inp2tm1Azo
Myl1tm1(cre)Sjb/Myl1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal skeletal muscle morphology
|
J:212763
|
| increased skeletal muscle fiber diameter
|
J:212763
|
| increased skeletal muscle weight
|
J:212763
|
| skeletal muscle hypertrophy
|
J:212763
|
Trp63tm2Brd/Trp63tm2Brd
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal urinary bladder detrusor smooth muscle morphology
|
J:119657
|
Trp63tm2Brd/Trp63tm2Brd
(involves: 129S7/SvEvBrd)
|
muscle phenotype
|
J:98439
|
Trpc4tm1Bni/Trpc4tm1Bni
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J))
|
decreased vasodilation
|
J:68178
|
Trpc6tm1Lbi/Trpc6tm1Lbi
(involves: 129S/SvEv * C57BL/6J)
|
abnormal vascular smooth muscle physiology
|
J:106082
|
| abnormal vasoconstriction
|
J:106082
|
| increased vasoconstriction
|
J:106082
|
Trpm2tm1.1Jych/Trpm2tm1.1Jych
(involves: FVB/N)
|
abnormal myocardial fiber morphology
|
J:196475
|
| decreased cardiac muscle contractility
|
J:196475
|
Trpv4tm1Rck/Trpv4tm1Rck
(Not Specified)
|
abnormal vasodilation
|
J:129365
|
Tsc1tm1Hin/Tsc1+
(involves: 129S4/SvJae * C57BL/6J)
|
increased leiomyosarcoma incidence
|
J:70463
|
| increased uterus leiomyoma incidence
|
J:70463
|
Tsc2tm1.1Mjg/Tsc2tm1.1Mjg
Pgrtm2(cre)Lyd/Pgr+
(involves: 129S1/Sv * 129X1/SvJ)
|
increased uterus leiomyoma incidence
|
J:221228
|
Tsc2tm1Tno/Tsc2tm1Tno
(involves: 129S4/SvJae * C57BL/6J)
|
thick myocardium
|
J:52464
|
Tshz3tm1Lafa/Tshz3tm1Lafa
(involves: 129P2/OlaHsd * CD-1)
|
impaired ureteric peristalsis
|
J:138769
|
X/Tspy-pstm1(Mlc3-Gdf8)Mgs
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
increased muscle weight
|
J:98460
|
| increased skeletal muscle fiber size
|
J:98460
|
X/Tspy-pstm2(Mlc3-Gdf8)Mgs
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
increased muscle weight
|
J:98460
|
| increased skeletal muscle fiber size
|
J:98460
|
Ttnem1Kage/Ttnem1Kage
(B6J.B6N-Ttnem1Kage)
|
abnormal myocardium layer morphology
|
J:302920
|
| decreased ventricle muscle contractility
|
J:302920
|
| muscle phenotype
|
J:302920
|
Ttnmdm/Ttnmdm
(Not Specified)
|
muscle degeneration
|
J:14016
|
| myositis
|
J:14016
|
Ttnmdm/Ttnmdm
(involves: C57BL/6J)
|
muscle phenotype
|
J:87870
|
Ttnshru/Ttnshru
(B6.BTBR-Ttnshru)
|
decreased cardiac muscle contractility
|
J:92178
|
| trabecula carnea hypoplasia
|
J:92178
|
Ttntm1.1Her/Ttntm1.1Her
(involves: 129S4/SvJae * 129T2/SvEms)
|
abnormal myocardial fiber morphology
|
J:111284
|
| abnormal myocardial trabeculae morphology
|
J:111284
|
| abnormal myocardium layer morphology
|
J:111284
|
| thin myocardium
|
J:111284
|
Ttntm1.1Hgra/Ttntm1.1Hgra
(B6.Cg-Ttntm1.1Hgra)
|
abnormal myocardial fiber morphology
|
J:206712
|
Ttntm1.1Hgra/Ttntm1.1Hgra
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal diaphragm morphology
|
J:206713
|
| abnormal muscle contractility
|
J:206713
|
| decreased soleus weight
|
J:206713
|
| skeletal muscle fiber atrophy
|
J:206713
|
Ttntm1.1Isrd/Ttn+
(involves: 129S2/SvPas * C57BL/6)
|
abnormal limb muscle morphology
|
J:165576
|
| abnormal quadriceps morphology
|
J:165576
|
| abnormal tibialis anterior morphology
|
J:165576
|
| dystrophic muscle
|
J:165576
|
Ttntm1.1Isrd/Ttntm1.1Isrd
(involves: 129S2/SvPas * C57BL/6)
|
abnormal gastrocnemius morphology
|
J:165576
|
| abnormal limb muscle morphology
|
J:165576
|
| abnormal M line morphology
|
J:165576
|
| abnormal skeletal muscle morphology
|
J:165576
|
| abnormal soleus morphology
|
J:165576
|
| abnormal tibialis anterior morphology
|
J:165576
|
| centrally nucleated skeletal muscle fibers
|
J:165576
|
| decreased ventricle muscle contractility
|
J:165576
|
| dilated cardiomyopathy
|
J:165576
|
| dystrophic muscle
|
J:165576
|
| impaired skeletal muscle contractility
|
J:165576
|
| increased variability of skeletal muscle fiber size
|
J:165576
|
| myositis
|
J:165576
|
| skeletal muscle fiber necrosis
|
J:165576
|
Ttntm1Brge/Ttn+
(B6.Cg-Ttntm1Brge)
|
decreased cardiac muscle contractility
|
J:152736
|
| dilated cardiomyopathy
|
J:152736
|
Ttntm1Brge/Ttntm1Brge
(B6.Cg-Ttntm1Brge)
|
abnormal myocardium layer morphology
|
J:152736
|
Ttntm1Her/Ttntm1Her
Tg(Ckmm-cre)5Khn/0
(Not Specified)
|
abnormal M line morphology
|
J:81993
|
| abnormal sarcomere morphology
|
J:81993
|
| progressive muscle weakness
|
J:81993
|
Ttntm1Mgot/Ttntm1Mgot
(involves: 129 * C57BL/6)
|
abnormal sarcomere morphology
|
J:125922
|
Ttntm2.1Hgra/Ttntm2.1Hgra
(B6J.Cg-Ttntm2.1Hgra)
|
abnormal myocardial fiber morphology
|
J:216466
|
| abnormal sarcomere morphology
|
J:216466
|
| heart left ventricle hypertrophy
|
J:216466
|
| increased myocardial fiber size
|
J:216466
|
Ttntm2.1Mgot/Ttn+
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
abnormal muscle physiology
|
J:169969
|
Ttntm2.1Mgot/Ttntm2.1Mgot
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
abnormal cardiac muscle contractility
|
J:169969
|
| abnormal muscle physiology
|
J:169969
|
| abnormal sarcomere morphology
|
J:169969
|
| heart left ventricle hypertrophy
|
J:169969
|
| increased myocardial fiber size
|
J:169969
|
Ttpatm1Hsz/Ttpatm1Hsz
(involves: 129S7/SvEvBrd * C57BL/6J)
|
dystonia
|
J:90006
|
| increased variability of skeletal muscle fiber size
|
J:90006
|
| skeletal muscle fiber atrophy
|
J:90006
|
Tubb4aem1Avan/Tubb4aem1Avan
(involves: C57BL/6)
|
dystonia
|
J:291062
|
Tulp4tm1a(KOMP)Wtsi/Tulp4+
(involves: C57BL/6N * C57BL/6NRj)
|
abnormal infrahyoid muscle morphology
|
J:344151
|
| telangiectasia
|
J:344151
|
Twist1tm1Bhr/Twist1+
Twist2tm1(cre)Dor/Twist2+
(involves: 129/Sv * 129X1/SvJ)
|
abnormal skeletal muscle morphology
|
J:81485
|
Twist1tm1Bhr/Twist1tm1Bhr
(involves: 129S7/SvEvBrd)
|
abnormal muscle development
|
J:124278
|
Twist2tm1(cre)Dor/Twist2tm1(cre)Dor
(involves: 129/Sv * 129X1/SvJ)
|
abnormal skeletal muscle morphology
|
J:81485
|
| decreased skeletal muscle glycogen level
|
J:81485
|
| dystonia
|
J:81485
|
Txniptm1.1Rlee/Txniptm1.1Rlee
(involves: 129S4/SvJae)
|
decreased ventricle muscle contractility
|
J:141487
|
| increased cardiac muscle cell glucose uptake
|
J:141487
|
Txniptm1.1Road/Txniptm1.1Road
(B6.Cg-Txniptm1.1Road)
|
increased muscle cell glucose uptake
|
J:132756
|
Txniptm1Rlee/Txniptm1Rlee
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: 129S4/SvJae * FVB/N)
|
increased cardiac muscle cell glucose uptake
|
J:141487
|
Txnrd2tm1.1Marc/Txnrd2tm1.1Marc
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased fetal cardiomyocyte proliferation
|
J:94136
|
| trabecula carnea hypoplasia
|
J:94136
|
Ube4btm1Kei/Ube4btm1Kei
(involves: C57BL/6)
|
abnormal myocardial fiber morphology
|
J:103761
|
| abnormal myocardial trabeculae morphology
|
J:103761
|
| abnormal myocardium layer morphology
|
J:103761
|
| increased cardiomyocyte apoptosis
|
J:103761
|
Ubp1tm1Jmc/Ubp1tm1Jmc
(involves: 129S7/SvEvBrd * C57BL/6)
|
thin myocardium
|
J:92266
|
| trabecula carnea hypoplasia
|
J:92266
|
Ubr1tm1Avar/Ubr1tm1Avar
(either: (involves: 129S/SvEv * 129S1/Sv) or (involves: 129S1/Sv * C57BL/6J))
|
decreased skeletal muscle mass
|
J:72859
|
Ubr1tm1Avar/Ubr1tm1Avar
Ubr2tm1Ytkw/Ubr2tm1Ytkw
(involves: 129S1/Sv * C57BL/6)
|
abnormal myocardial trabeculae morphology
|
J:109036
|
| disorganized myocardium
|
J:109036
|
Uchl3tm1Tilg/Uchl3tm1Tilg
(involves: 129S1/Sv * C57BL/6)
|
abnormal skeletal muscle fiber morphology
|
J:83810
|
Ucp3tm1Brnd/Ucp3tm1Brnd
(Not Specified)
|
decreased skeletal muscle triglyceride level
|
J:106901
|
Ugt1tm1.1Afmu/Ugt1tm1.1Afmu
(involves: 129 * C57BL/6 * SJL)
|
dystonia
|
J:182805
|
Ugt1tm1.1Afmu/Ugt1tm1.1Afmu
(FVB.Cg-Ugt1tm1.1Afmu)
|
dystonia
|
J:216224
|
uns/uns
(involves: C57BL/6J * CD-1)
|
abnormal muscle contractility
|
J:14139
|
| abnormal muscle electrophysiology
|
J:14139
|
| skeletal muscle atrophy
|
J:14139
|
Usp14ax-J/Usp14ax-J
(involves: STOCK Mafbkr)
|
muscular atrophy
|
J:12283
|
Usp14nmf375/Usp14nmf375
(B6;CByJ-Usp14nmf375/J)
|
muscle degeneration
|
J:87349
|
| muscle spasm
|
J:87349
|
Usp14nmf375/Usp14nmf375
(C.B6-Usp14nmf375)
|
muscle phenotype
|
J:203043
|
| muscle weakness
|
J:203043
|
Usp19Gt(XG128)Byg/Usp19Gt(XG128)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased skeletal muscle fiber diameter
|
J:225526
|
| decreased susceptibility to induced muscular atrophy
|
J:225526
|
Utf1tm1Okud/Utf1tm1Okud
(B6.129P2-Utf1tm1Okud)
|
thin myocardium
|
J:204409
|
Utrntm1Ked/Utrntm1Ked
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)
|
muscle phenotype
|
J:70949
|
Uts2rtm1Djbe/Uts2rtm1Djbe
(B6.129P2-Uts2rtm1Djbe)
|
abnormal vasoconstriction
|
J:103118
|
UvragTn(pb-Act-RFP)1.100107015-HRAZhu/UvragTn(pb-Act-RFP)1.100107015-HRAZhu
(involves: FVB/NJ)
|
cardiomyopathy
|
J:219546
|
| decreased cardiac muscle contractility
|
J:219546
|
| increased cardiomyocyte apoptosis
|
J:219546
|
| increased myocardial fiber size
|
J:219546
|
Vamp4em1(IMPC)Ccpcz/Vamp4em1(IMPC)Ccpcz
(C57BL/6NCrl-Vamp4em1(IMPC)Ccpcz/Ccpcz)
|
abnormal skeletal muscle morphology
|
J:211773
|
Vapbtm1.1Tsud/Vapbtm1.1Tsud
(involves: 129S7/SvEvBrd)
|
centrally nucleated skeletal muscle fibers
|
J:226459
|
| skeletal muscle fiber atrophy
|
J:226459
|
Vapbtm1.2Ics/Vapbtm1.2Ics
(B6N.129S2-Vapbtm1.2Ics)
|
hypotonia
|
J:198145
|
Vav2tm1Tnr/Vav2tm1Tnr
(involves: 129P2/OlaHsd)
|
heart left ventricle hypertrophy
|
J:124056
|
| increased myocardial fiber size
|
J:124056
|
| vascular smooth muscle hyperplasia
|
J:124056
|
Vav3tm1Xrb/Vav3tm1Xrb
(Not Specified)
|
abnormal myocardial fiber morphology
|
J:111973
|
| decreased ventricle muscle contractility
|
J:111973
|
| heart left ventricle hypertrophy
|
J:111973
|
vc/vc
(DBA/1-vc)
|
muscle weakness
|
J:297
|
Vcam1tm1Roml/Vcam1tm1Roml
(involves: 129S1/Sv * C57BL/6J)
|
abnormal myocardium layer morphology
|
J:23137
|
| disorganized myocardium
|
J:23137,
J:28110
|
| thin ventricle myocardium compact layer
|
J:23137,
J:28110
|
Vcltm1Eda/Vcl+
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss)
|
abnormal intercalated disk morphology
|
J:92398
|
| abnormal myocardial fiber morphology
|
J:92398
|
| decreased ventricle muscle contractility
|
J:92398
|
Vcltm1Eda/Vcltm1Eda
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss)
|
decreased cardiac muscle contractility
|
J:45781
|
| decreased myocardial fiber number
|
J:45781
|
| thin myocardium
|
J:45781
|
Vcptm1Itl/Vcp+
(B6.129S-Vcptm1Itl)
|
abnormal skeletal muscle fiber morphology
|
J:166230
|
| centrally nucleated skeletal muscle fibers
|
J:166230
|
| increased variability of skeletal muscle fiber size
|
J:166230
|
| myopathy
|
J:166230
|
| progressive muscle weakness
|
J:166230
|
Vcptm1Itl/Vcptm1Itl
(involves: 129S6/SvEvTac)
|
abnormal sarcomere morphology
|
J:191963
|
| abnormal skeletal muscle fiber morphology
|
J:191963
|
| abnormal skeletal muscle morphology
|
J:191963
|
| centrally nucleated skeletal muscle fibers
|
J:191963
|
| decreased skeletal muscle mass
|
J:191963
|
| increased variability of skeletal muscle fiber size
|
J:191963
|
| muscle weakness
|
J:191963
|
| myopathy
|
J:191963
|
| skeletal muscle endomysial fibrosis
|
J:191963
|
| skeletal muscle fiber necrosis
|
J:191963
|
Vdac3tm1Wjc/Vdac3tm1Wjc
(Not Specified)
|
abnormal muscle physiology
|
J:72188
|
| abnormal skeletal muscle fiber mitochondrial morphology
|
J:72188
|
Vdrtm1.1Sgcg/Vdrtm1.2Sgcg
Myl2tm1(cre)Krc/Myl2+
(involves: 129 * C57BL/6 * CBA * SJL)
|
increased myocardial fiber size
|
J:189471
|
Vegfatm1.1Nagy/Vegfatm1.1Nagy
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal myocardial trabeculae morphology
|
J:64090
|
| thin ventricle myocardium compact layer
|
J:64090
|
Vegfatm1Pec/Vegfatm1Pec
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal cardiac muscle relaxation
|
J:56003
|
| abnormal myocardial fiber morphology
|
J:56003
|
| abnormal sarcomere morphology
|
J:56003
|
| decreased cardiac muscle contractility
|
J:56003
|
| increased myocardial fiber size
|
J:56003
|
| myocardial fiber degeneration
|
J:56003
|
Vegfatm2Gne/Vegfatm2Gne
Tg(Tnnt2-cre)5Blh/0
(involves: 129/Sv * C57BL/6 * DBA)
|
myocardium necrosis
|
J:193198
|
Vegfatm2Pec/Vegfatm2Pec
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal muscle physiology
|
J:69797
|
| progressive muscle weakness
|
J:69797
|
| skeletal muscle fiber atrophy
|
J:69797
|
Vegfbtm1Gfk/Vegfbtm1Gfk
(involves: 129T2/SvEms)
|
heart right ventricle hypertrophy
|
J:102808
|
Vgll2tm1Tm/Vgll2tm1Tm
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal skeletal muscle fiber type ratio
|
J:258195
|
Vgll4tm1b(EUCOMM)Hmgu/Vgll4tm1b(EUCOMM)Hmgu
(involves: C57BL/6N * CBA)
|
increased cardiac muscle contractility
|
J:273437
|
Vgll4tm1b(EUCOMM)Hmgu/Vgll4tm1c(EUCOMM)Hmgu
Tg(Tek-cre)1Ywa/0
(involves: C57BL/6N * CBA * SJL)
|
decreased cardiac muscle contractility
|
J:273437
|
| increased myocardial fiber size
|
J:273437
|
Vhltm1Jae/Vhltm1Jae
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S4/SvJae * BALB/c * C57BL/6 * DBA)
|
abnormal vasodilation
|
J:97652
|
Vhltm1Jae/Vhltm1Jae
Tg(Myh6-cre)2182Mds/0
(involves: 129S4/SvJae * FVB/N)
|
cardiomyopathy
|
J:179490
|
| decreased ventricle muscle contractility
|
J:179490
|
Vimtm1Cba/Vimtm1Cba
(involves: 129S2/SvPas)
|
abnormal vasoconstriction
|
J:43049
|
| abnormal vasodilation
|
J:43049
|
Viptm1Clw/Viptm1Clw
(involves: 129S/Sv * C57BL/6)
|
heart right ventricle hypertrophy
|
J:132313
|
Vipas39tm1c(KOMP)Mbp/Vipas39tm1c(KOMP)Mbp
Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sor+
(involves: C57BL/6 * C57BL/6J * C57BL/6N)
|
abnormal tendon collagen fibril morphology
|
J:236095
|
Vkorc1tm1.1Jobg/Vkorc1tm1.1Jobg
(involves: 129S4/SvJae * BALB/cJ * C57BL/6)
|
muscle hemorrhage
|
J:207884
|
Vms1A/J/Vms1A/J
(involves: A/J * C57BL/10SnSg)
|
abnormal sarcolemma morphology
|
J:121574
|
Vms2C57BL/10SnSg/?
(involves: A/J * C57BL/10SnSg)
|
abnormal sarcolemma morphology
|
J:121574
|
Vms3C57BL/10SnSg/?
(involves: A/J * C57BL/10SnSg)
|
abnormal sarcolemma morphology
|
J:121574
|
Vnn3em1(IMPC)Ccpcz/Vnn3em1(IMPC)Ccpcz
(C57BL/6NCrl-Vnn3em1(IMPC)Ccpcz/Ccpcz)
|
abnormal skeletal muscle morphology
|
J:211773
|
Vps16em1Weli/Vps16em1Weli
(C57BL/6J-Vps16em1Weli)
|
dystonia
|
J:243974
|
Vps33btm1.1Arte/Vps33btm1.1Arte
Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sor+
(involves: C57BL/6 * C57BL/6J)
|
abnormal tendon collagen fibril morphology
|
J:236095
|
Vps54Gt(RRI497)Byg/Vps54Gt(RRI497)Byg
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal myocardial fiber morphology
|
J:104824
|
Vps54wr/Vps54wr
(multiple strains)
|
abnormal muscle physiology
|
J:5102
|
| abnormal skeletal muscle fiber morphology
|
J:5102
|
| facial muscle atrophy
|
J:5102
|
| muscle weakness
|
J:5102
|
| muscular atrophy
|
J:6388,
J:5102
|
Vps54wr/Vps54wr
(involves: C57BL/6J * C57BL/Fa)
|
progressive muscle weakness
|
J:181019
|
Vwa1tm1Jfba/Vwa1tm1Jfba
(C57BL/6-Vwa1tm1Jfba)
|
muscle phenotype
|
J:149746
|
Wars1tm1b(EUCOMM)Hmgu/Wars1+
(C57BL/6N-Warstm1b(EUCOMM)Hmgu/Ieg)
|
decreased cardiac muscle contractility
|
J:211773
|
Wars2mpc151H/Wars2mpc151H
(involves: BALB/c * C3H/HeH * C57BL/6J)
|
cardiomyopathy
|
J:234901
|
Wasf1Gt(VICTR37)1Kwak/Wasf1Gt(VICTR37)1Kwak
(involves: 129S5/SvEvBrd * C57BL/6)
|
skeletal muscle fiber atrophy
|
J:83377
|
Wasf2tm1Tta/Wasf2tm1Tta
(involves: 129P2/OlaHsd * C57BL/6J)
|
trabecula carnea hypoplasia
|
J:84651
|
Wdfy3Tn(pb-Act-RFP)1.1Zhu/Wdfy3Tn(pb-Act-RFP)1.1Zhu
(involves: C57BL/6 * FVB/NJ)
|
abnormal trabecula carnea morphology
|
J:285853
|
Wdr1tm1.1Zzy/Wdr1tm1.1Zzy
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal myocardial fiber morphology
|
J:211364
|
| increased myocardial fiber size
|
J:211364
|
Wdr1tm1.1Zzy/Wdr1tm1.1Zzy
Tg(Myh6-cre)1Xya/0
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal myocardial fiber morphology
|
J:211364
|
| abnormal myocardium layer morphology
|
J:211364
|
| decreased ventricle muscle contractility
|
J:211364
|
| increased myocardial fiber size
|
J:211364
|
Wdr19twto/Wdr19twto
(involves: FVB/NJ)
|
abnormal dermomyotome development
|
J:181888
|
| abnormal myotome development
|
J:181888
|
Wdr35yeti/Wdr35yeti
(Not Specified)
|
diaphragmatic hernia
|
J:171617
|
Wfikkn1tm1.1Sjl/Wfikkn1tm1.1Sjl
(involves: 129 * C57BL/6)
|
abnormal limb muscle morphology
|
J:201148
|
| abnormal skeletal muscle fiber type ratio
|
J:201148
|
| decreased quadriceps weight
|
J:201148
|
| decreased skeletal muscle weight
|
J:201148
|
| impaired skeletal muscle regeneration
|
J:201148
|
Wfikkn1tm1.1Sjl/Wfikkn1tm1.1Sjl
Wfikkn2tm1.1Sjl/Wfikkn2tm1.1Sjl
(involves: 129 * C57BL/6)
|
impaired skeletal muscle regeneration
|
J:201148
|
Wfikkn2tm1.1Sjl/Wfikkn2tm1.1Sjl
(involves: 129 * C57BL/6)
|
abnormal limb muscle morphology
|
J:201148
|
| abnormal skeletal muscle fiber type ratio
|
J:201148
|
| decreased quadriceps weight
|
J:201148
|
| decreased skeletal muscle weight
|
J:201148
|
| impaired skeletal muscle regeneration
|
J:201148
|
Wlstm1Xzg/Wlstm1Xzg
Tg(Msx2-cre)5Rem/0
(Not Specified)
|
abnormal muscle development
|
J:184918
|
| abnormal tendon morphology
|
J:184918
|
Wnk1Gt(OST38262)Lex/Wnk1Gt(OST38262)Lex
(involves: 129S5/SvEvBrd)
|
abnormal myocardial trabeculae morphology
|
J:152906
|
| thin myocardium
|
J:152906
|
| trabecula carnea hypoplasia
|
J:152906
|
Wnk1tm1Clhu/Wnk1tm1Clhu
Tg(Tek-cre)12Flv/0
(involves: C3H * C57BL/6)
|
abnormal myocardial trabeculae morphology
|
J:152906
|
| thin myocardium
|
J:152906
|
Wnt1sw/Wnt1sw
(Not Specified)
|
muscle hypertonia
|
J:30722
|
Wnt1tm1Brd/Wnt1tm1Brd
Wnt3atm1Amc/Wnt3atm1Amc
(involves: 129S1/Sv * 129S7/SvEvBrd)
|
abnormal dermomyotome development
|
J:50279
|
| abnormal myotome development
|
J:50279
|
Wnt10btm1Ptr/Wnt10btm1Ptr
(involves: FVB)
|
abnormal muscle development
|
J:99298
|
| abnormal muscle regeneration
|
J:99298
|
Wsb2tm1b(EUCOMM)Hmgu/Wsb2tm1b(EUCOMM)Hmgu
(C57BL/6N-Wsb2tm1b(EUCOMM)Hmgu/Cnrm)
|
decreased cardiac muscle contractility
|
J:211773
|
Wt1tm1(EGFP/cre)Wtp/Wt1+
Zfpm2tm1Sho/Zfpm2tm2Sho
(involves: 129S1/Sv * 129S4/SvJae * 129S7/SvEvBrd)
|
thin myocardium compact layer
|
J:150452
|
Wt1tm1.1Ndha/Wt1tm1.1Ndha
Tg(Gata4*G2-cre)#Roja/0
(involves: 129P2/OlaHsd)
|
abnormal diaphragm development
|
J:238024
|
| diaphragmatic hernia
|
J:238024
|
| thin ventricle myocardium compact layer
|
J:229936
|
Wt1tm1Jae/Wt1tm1Jae
(involves: 129S4/SvJae * C57BL/6)
|
diaphragmatic hernia
|
J:14317
|
Wt1tm1Jae/Wt1tm1Jae
(involves: 129S4/SvJae * C57BL/6 * MF1)
|
abnormal diaphragm development
|
J:114565
|
| diaphragmatic hernia
|
J:114565
|
Wt1tm1Jae/Wt1tm1Jae
(involves: 129S4/SvJae)
|
abnormal diaphragm development
|
J:238024
|
Wt1tm1Mlh/Wt1tm1Mlh
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal diaphragm development
|
J:135449
|
| myocardium hypoplasia
|
J:135449
|
Wwtr1tm1.1Eno/Wwtr1+
Yap1tm1.1Eno/Yap1tm1.1Eno
Tg(Myh6-cre)2182Mds/0
(involves: 129S/SvEv * FVB/N)
|
increased cardiomyocyte apoptosis
|
J:200670
|
| myocardium hypoplasia
|
J:200670
|
| thin myocardium
|
J:200670
|
Wwtr1tm1.1Eno/Wwtr1tm1.1Eno
Yap1tm1.1Eno/Yap1+
Tg(Myh6-cre)2182Mds/0
(involves: 129S/SvEv * FVB/N)
|
dilated cardiomyopathy
|
J:200670
|
Xbp1tm1Nogu/Xbp1tm1Nogu
(involves: 129S/SvEv * A/J)
|
absent trabeculae carneae
|
J:56678
|
| myocardium necrosis
|
J:56678
|
Xdhtm1Mrc/Xdh+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal skeletal muscle morphology
|
J:80993
|
Xiaptm1Vdr/Xiaptm1Vdr
(involves: 129S1/Sv)
|
decreased cardiac muscle contractility
|
J:182515
|
Xirp1tm1Dofr/Xirp1tm1Dofr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal cardiac muscle contractility
|
J:159352
|
| abnormal myocardium layer morphology
|
J:159352
|
| abnormal sarcomere morphology
|
J:159352
|
| decreased cardiac muscle contractility
|
J:159352
|
Xirp1tm1Jl/Xirp1+
(involves: 129)
|
abnormal trabecula carnea morphology
|
J:132079
|
| abnormal ventricle myocardium morphology
|
J:132079
|
| cardiomyopathy
|
J:132079
|
| increased myocardial fiber size
|
J:132079
|
Xirp1tm1Jl/Xirp1tm1Jl
(involves: 129)
|
abnormal A band morphology
|
J:132079
|
| abnormal I band morphology
|
J:132079
|
| abnormal intercalated disk morphology
|
J:132079,
J:112201
|
| abnormal myocardial fiber morphology
|
J:132079,
J:112201
|
| abnormal sarcomere morphology
|
J:132079
|
| abnormal trabecula carnea morphology
|
J:132079
|
| abnormal ventricle myocardium morphology
|
J:132079
|
| cardiomyopathy
|
J:132079
|
| diffuse Z line
|
J:132079
|
| increased myocardial fiber size
|
J:132079
|
Xirp2tm1Itl/Xirp2tm1Itl
(Not Specified)
|
increased myocardial fiber size
|
J:170869
|
Xirp2tm1Jl/Xirp2tm1Jl
(B6.129-Xirp2tm1Jl)
|
abnormal atrioventricular bundle morphology
|
J:255706
|
| abnormal intercalated disk morphology
|
J:158491
|
| abnormal myocardial fiber morphology
|
J:158491
|
| abnormal Purkinje fiber morphology
|
J:255706
|
| abnormal trabecula carnea morphology
|
J:158491
|
| decreased myocardial fiber size
|
J:158491
|
| disorganized myocardium
|
J:158491
|
| increased cardiomyocyte apoptosis
|
J:158491
|
| ventricular myocardium compact layer hypoplasia
|
J:158491
|
Xktm1Ariv/Xktm1Ariv
(B6.Cg-Xktm1Ariv)
|
abnormal skeletal muscle fiber morphology
|
J:206464
|
| centrally nucleated skeletal muscle fibers
|
J:206464
|
| increased variability of skeletal muscle fiber size
|
J:206464
|
| muscle phenotype
|
J:206464
|
Xlch/?
(C57BL/6J-Xlch)
|
abnormal myocardial fiber morphology
|
J:136798
|
| abnormal ventricle papillary muscle morphology
|
J:136798
|
| dilated sarcoplasmic reticulum
|
J:136798
|
| disorganized myocardium
|
J:136798
|
| heart left ventricle hypertrophy
|
J:136798
|
| increased cardiac muscle contractility
|
J:136798
|
Xpnpep1tm1a(KOMP)Wtsi/Xpnpep1tm1a(KOMP)Wtsi
(C57BL/6N-Xpnpep1tm1a(KOMP)Wtsi/Wtsi)
|
abnormal eye muscle morphology
|
J:239583
|
| abnormal infrahyoid muscle connection
|
J:239583
|
| abnormal infrahyoid muscle morphology
|
J:239583
|
Yap1tm1.1Eno/Yap1tm1.1Eno
Nkx2-5tm1(cre)Rjs/Nkx2-5+
(involves: 129S/SvEv)
|
abnormal myocardium layer morphology
|
J:189577
|
| thin myocardium
|
J:189577
|
Yap1tm1.1Eno/Yap1tm1.1Eno
Tg(Myh6-cre)2182Mds/0
(involves: 129S/SvEv * FVB/N)
|
decreased cardiac muscle contractility
|
J:200670
|
| dilated cardiomyopathy
|
J:200670
|
Yme1l1tm1Tlan/Yme1l1tm1Tlan
Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6 * C57BL/6NCrl * FVB/N)
|
abnormal muscle physiology
|
J:229455
|
| abnormal myocardial fiber mitochondrial morphology
|
J:229455
|
| cardiac muscle necrosis
|
J:229455
|
| decreased ventricle muscle contractility
|
J:229455
|
| dilated cardiomyopathy
|
J:229455
|
| increased cardiac muscle cell glucose uptake
|
J:229455
|
Ywhaetm1Awb/Ywhae+
(involves: 129S6/SvEvTac)
|
thin ventricle myocardium compact layer
|
J:192860
|
Ywhaetm1Awb/Ywhaetm1Awb
(involves: 129S6/SvEvTac)
|
abnormal myocardial trabeculae morphology
|
J:192860
|
| decreased fetal cardiomyocyte proliferation
|
J:192860
|
| thin myocardium compact layer
|
J:192860
|
| thin ventricle myocardium compact layer
|
J:192860
|
YwhaqGt(RRR746)Byg/Ywhaq+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased cardiomyocyte apoptosis
|
J:118280
|
Zbed6tm1.2Sson/Zbed6tm1.2Sson
(involves: BALB/c * C57BL/6)
|
increased skeletal muscle size
|
J:265506
|
Zdhhc9tm1Lex/Y
(B6.129S5-Zdhhc9tm1Lex)
|
hypotonia
|
J:268248
|
Zdhhc13skc4/Zdhhc13skc4
(involves: 129S6/SvEvTac * C3H * C57BL/6)
|
muscular atrophy
|
J:161519
|
Zdhhc16tm1Goff/Zdhhc16tm1Goff
(involves: 129S1/Sv)
|
abnormal sarcomere morphology
|
J:228307
|
| cardiomyopathy
|
J:228307
|
Zeb1tm2Yhi/Zeb1tm2Yhi
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal vascular smooth muscle physiology
|
J:110800
|
Zfand5Gt(ROSA)72Sor/Zfand5Gt(ROSA)72Sor
(involves: 129S4/SvJaeSor)
|
vascular smooth muscle hypoplasia
|
J:117491
|
Zfp36tm1Pjb/Zfp36tm1Pjb
(B6.Cg-Zfp36tm1Pjb)
|
abnormal vasodilation
|
J:214114
|
Zfp36tm4.1Pjb/Zfp36tm4.1Pjb
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N)
|
abnormal myocardium layer morphology
|
J:188677
|
Zfp36l1tm1Seb/Zfp36l1tm1Seb
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
trabecula carnea hypoplasia
|
J:113396
|
Zfp106em1Blk/Zfp106em1Blk
(Not Specified)
|
abnormal skeletal muscle morphology
|
J:241305
|
| skeletal muscle fiber atrophy
|
J:241305
|
| skeletal muscle fiber degeneration
|
J:241305
|
Zfp106tm1a(KOMP)Wtsi/Zfp106tm1a(KOMP)Wtsi
(involves: C57BL/6Brd * C57BL/6Dnk * C57BL/6N)
|
abnormal gastrocnemius morphology
|
J:229162
|
| abnormal muscle electrophysiology
|
J:229162
|
| abnormal muscle physiology
|
J:229162
|
| abnormal skeletal muscle fiber type ratio
|
J:229162
|
| abnormal soleus morphology
|
J:229162
|
| centrally nucleated skeletal muscle fibers
|
J:229162
|
| decreased gastrocnemius weight
|
J:229162
|
| decreased skeletal muscle fiber number
|
J:229162
|
| decreased soleus weight
|
J:229162
|
| decreased tibialis anterior weight
|
J:229162
|
| increased variability of skeletal muscle fiber size
|
J:229162
|
| skeletal muscle atrophy
|
J:229162
|
| skeletal muscle fiber atrophy
|
J:229162
|
| skeletal muscle fibrosis
|
J:229162
|
Zfp106tm1b(KOMP)Wtsi/Zfp106tm1b(KOMP)Wtsi
(involves: C57BL/6N)
|
abnormal skeletal muscle morphology
|
J:241305
|
| skeletal muscle fiber atrophy
|
J:241305
|
| skeletal muscle fiber degeneration
|
J:241305
|
Zfp235tm1b(KOMP)Wtsi/Zfp235tm1b(KOMP)Wtsi
(C57BL/6N-Zfp235tm1b(KOMP)Wtsi/Bay)
|
increased cardiac muscle contractility
|
J:211773
|
Zfp280dem1(IMPC)Hmgu/Zfp280dem1(IMPC)Hmgu
(C57BL/6N-Zfp280dem1(IMPC)Hmgu/Ieg)
|
decreased cardiac muscle contractility
|
J:211773
|
Zfp418em#Juli/Zfp418em#Juli
(Not Specified)
|
heart left ventricle hypertrophy
|
J:251673
|
Zfp422em1Mode/Zfp422em1Mode
Myf5tm3(cre)Sor/Myf5+
(involves: 129S4/SvJaeSor * C57BL/6J)
|
abnormal myoblast differentiation
|
J:297035
|
| abnormal skeletal muscle fiber morphology
|
J:297035
|
| decreased skeletal muscle fiber size
|
J:297035
|
Zfp422em1Mode/Zfp422em1Mode
Pax7tm1(cre/ERT2)Gaka/Pax7+
(involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NCrl)
|
abnormal myoblast differentiation
|
J:297035
|
| impaired skeletal muscle regeneration
|
J:297035
|
Zfp950Gt(ROSA)76Sor/Zfp950Gt(ROSA)76Sor
(involves: 129S4/SvJaeSor)
|
abnormal smooth muscle morphology
|
J:117491
|
Zfpm1tm4Sho/Zfpm1tm4Sho
Tg(Gata1-Zfpm1)1Sho/0
Tg(Tek-cre)1Ywa/0
(involves: 129S6/SvEvTac * C57BL/6 * CD-1 * SJL)
|
thin myocardium
|
J:99745
|
Zfpm2lil/Zfpm2lil
(involves: A/J)
|
abnormal diaphragm morphology
|
J:100119
|
| thin diaphragm muscle
|
J:100119
|
| thin myocardium
|
J:100119
|
| thin myocardium compact layer
|
J:100119
|
Zfpm2tm1.1Esv/Zfpm2tm1.1Esv
(involves: 129S1/SvImJ * 129S2/SvPas * 129S4/SvJae * 129S6/SvEvTac * C57BL/6)
|
decreased ventricle muscle contractility
|
J:216295
|
| thin myocardium compact layer
|
J:216295
|
Zfpm2tm1Jml/Zfpm2tm1Jml
(involves: 129X1/SvJ)
|
thin left ventricle myocardium compact layer
|
J:63121
|
Zfpm2tm1Sho/Zfpm2tm1Sho
(involves: 129S1/Sv)
|
thin ventricle myocardium compact layer
|
J:62879
|
| ventricular myocardium compact layer hypoplasia
|
J:62879
|
Zfpm2tm1Sho/Zfpm2tm2Sho
Nkx2-5tm1(cre)Rjs/Nkx2-5+
(involves: 129S1/Sv * 129S7/SvEvBrd)
|
thin myocardium compact layer
|
J:150452
|
Zfpm2tm1Sho/Zfpm2tm2Sho
Tg(Myh6-cre)2182Mds/0
(involves: 129S1/Sv * 129S7/SvEvBrd)
|
decreased cardiac muscle contractility
|
J:150452
|
| decreased ventricle muscle contractility
|
J:150452
|
| increased cardiomyocyte apoptosis
|
J:150452
|
Zfpm2tm1Sho/Zfpm2tm2Sho
Tg(Tnnt2-rtTA,tetO-cre)1Wtp/0
(involves: 129S1/Sv * 129S7/SvEvBrd)
|
decreased cardiac muscle contractility
|
J:150452
|
| increased cardiomyocyte apoptosis
|
J:150452
|
Zic1tm1Jaru/Zic1+
(B6.129S4-Zic1tm1Jaru)
|
hypotonia
|
J:72342
|
Zmpste24tm1Otin/Zmpste24tm1Otin
(involves: 129P2/Ola * C57BL/6)
|
dilated cardiomyopathy
|
J:76209
|
| dystrophic muscle
|
J:76209
|
Zmpste24tm1Sgy/Zmpste24tm1Sgy
(involves: 129S4/SvJae * C57BL/6)
|
progressive muscle weakness
|
J:95274,
J:79501
|
Zmynd11em1(IMPC)Wtsi/Zmynd11em1(IMPC)Wtsi
(C57BL/6N-Zmynd11em1(IMPC)Wtsi/WtsiIeg)
|
abnormal diaphragm morphology
|
J:239583
|
| abnormal eye muscle morphology
|
J:239583
|
| abnormal infrahyoid muscle connection
|
J:239583
|
| thin myocardium
|
J:239583
|
Analysis Tools